PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kaufman, J				Kaufman, J			The origins of the adaptive immune system: whatever next?	NATURE IMMUNOLOGY			English	Editorial Material							VARIABLE DOMAINS; EVOLUTION; MOLECULES; RECEPTORS	The discovery of a V-like Ig multigene family in the protochordate amphioxus provides new insights into the evolution of the adaptive immune response.	Inst Anim Hlth, Compton RG20 7NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Kaufman, J (corresponding author), Inst Anim Hlth, Compton RG20 7NN, Berks, England.			Kaufman, Jim/0000-0002-7216-8422				Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLMGREN A, 1989, NATURE, V342, P248, DOI 10.1038/342248a0; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0	12	19	21	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1124	1125		10.1038/ni1202-1124	http://dx.doi.org/10.1038/ni1202-1124			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447367				2022-12-18	WOS:000179467800007
J	Billingham, LK; Stoolman, JS; Vasan, K; Rodriguez, AE; Poor, TA; Szibor, M; Jacobs, HT; Reczek, CR; Rashidi, A; Zhang, P; Miska, J; Chandel, NS				Billingham, Leah K.; Stoolman, Joshua S.; Vasan, Karthik; Rodriguez, Arianne E.; Poor, Taylor A.; Szibor, Marten; Jacobs, Howard T.; Reczek, Colleen R.; Rashidi, Aida; Zhang, Peng; Miska, Jason; Chandel, Navdeep S.			Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation	NATURE IMMUNOLOGY			English	Article							SUCCINATE-DEHYDROGENASE; CREATINE-PHOSPHATE; MOUSE MODEL; K+ EFFLUX; SUPEROXIDE; ATP; LIPOPOLYSACCHARIDE; OXIDOREDUCTASE; METABOLISM; INHIBITION	The NLRP3 inflammasome is linked to sterile and pathogen-dependent inflammation, and its dysregulation underlies many chronic diseases. Mitochondria have been implicated as regulators of the NLRP3 inflammasome through several mechanisms including generation of mitochondrial reactive oxygen species (ROS). Here, we report that mitochondrial electron transport chain (ETC) complex I, II, III and V inhibitors all prevent NLRP3 inflammasome activation. Ectopic expression of Saccharomyces cerevisiae NADH dehydrogenase (NDI1) or Ciona intestinalis alternative oxidase, which can complement the functional loss of mitochondrial complex I or III, respectively, without generation of ROS, rescued NLRP3 inflammasome activation in the absence of endogenous mitochondrial complex I or complex III function. Metabolomics revealed phosphocreatine (PCr), which can sustain ATP levels, as a common metabolite that is diminished by mitochondrial ETC inhibitors. PCr depletion decreased ATP levels and NLRP3 inflammasome activation. Thus, the mitochondrial ETC sustains NLRP3 inflammasome activation through PCr-dependent generation of ATP, but via a ROS-independent mechanism. How the mitochondrial electron transport chain (ETC) interacts with the NLRP3 inflammasome is somewhat unclear. Here the authors use individual complex inhibitors and new genetic models to show that ETC is critical in providing ATP via the phosphocreatine shuttle to activate the NLRP3 inflammasome.	[Billingham, Leah K.; Stoolman, Joshua S.; Vasan, Karthik; Rodriguez, Arianne E.; Poor, Taylor A.; Reczek, Colleen R.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Szibor, Marten; Jacobs, Howard T.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Szibor, Marten] Jena Univ Hosp, Ctr Sepsis Control & Care CSCC, Dept Cardiothorac Surg, Jena, Germany; [Szibor, Marten; Jacobs, Howard T.] La Trobe Univ, Dept Environm & Genet, Melbourne, Vic, Australia; [Rashidi, Aida; Zhang, Peng; Miska, Jason] Northwestern Univ, Feinberg Sch Med, Lou & Jean Malnati Brain Tumor Inst, Dept Neurol Surg, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Tampere University; Friedrich Schiller University of Jena; La Trobe University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.; Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.	nav@northwestern.edu		Szibor, Marten/0000-0003-4029-160X; Jacobs, Howard/0000-0003-1895-6003	National Institutes for Health (NIH) [5R35CA197532, 5P01HL071643-15, 5PO1AG049665]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [T32HL076139-15]; NIH [F30CA250236, 1R01NS115955-01]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) [T32AI083216]; Ford Foundation; National Cancer Institute Cancer Center Support Grant (NCI CCSG) [P30 CA060553]; NIH/NHLBI [T32HL076139-17]	National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ford Foundation; National Cancer Institute Cancer Center Support Grant (NCI CCSG); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes for Health (NIH) (5R35CA197532, 5P01HL071643-15 and 5PO1AG049665) to N.S.C.; L.K.B. was supported by the NIH/National Heart, Lung, and Blood Institute (NHLBI) (T32HL076139-15). J.M. was supported by the NIH (1R01NS115955-01). J.S.S. was supported by the NIH/National Institute of Allergy and Infectious Diseases (NIAID) T32 (T32AI083216). Additional support from the NIH (F30CA250236) to K.V., NIH/NHLBI T32HL076139-17 to T.A.P. and the Ford Foundation to A.E.R. We thank the Robert H. Lurie Cancer Center Flow Cytometry facility and Metabolomics Core supported by National Cancer Institute Cancer Center Support Grant (NCI CCSG) P30 CA060553 for their invaluable assistance. We thank P. Gao at Northwestern University for his expertise in metabolomics. We thank H. Abdala-Valencia at Northwestern University for RNA sequencing. We thank O. Grob at University of Freiburg for his helpful comments and discussion of the paper. Some figure elements were generated with biorender.com.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ANNESLEY TM, 1977, BIOCHEM BIOPH RES CO, V74, P185, DOI 10.1016/0006-291X(77)91392-4; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dhandapani PK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49231-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Goncalve RLS, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101341; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Holley CL, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1109; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kazak L, 2020, NAT REV ENDOCRINOL, V16, P421, DOI 10.1038/s41574-020-0365-5; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kong H, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb7272; Kurmi K, 2018, CELL METAB, V28, P833, DOI 10.1016/j.cmet.2018.08.008; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lauterbach MA, 2019, IMMUNITY, V51, P997, DOI 10.1016/j.immuni.2019.11.009; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Martinez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6; McElroy GS, 2020, CELL METAB, V32, P301, DOI 10.1016/j.cmet.2020.06.003; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neuwirt E, 2021, CURR OPIN BIOTECH, V68, P300, DOI 10.1016/j.copbio.2021.03.009; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Prochnicki T, 2017, CELL METAB, V26, P71, DOI 10.1016/j.cmet.2017.06.018; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Reczek CR, 2017, NAT CHEM BIOL, V13, P1274, DOI [10.1038/NCHEMBIO.2499, 10.1038/nchembio.2499]; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Sandall CF, 2020, MOLECULES, V25, DOI 10.3390/molecules25194572; Scialo F, 2021, FREE RADICAL BIO MED, V164, P187, DOI 10.1016/j.freeradbiomed.2021.01.018; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Seim GL, 2019, NAT METAB, V1, P731, DOI 10.1038/s42255-019-0083-2; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Soberanes S, 2019, CELL METAB, V29, P335, DOI [10.1016/j.cmet.2018.09.019, 10.1016/j.cmet.2018.12.001]; Sommers N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0694; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Szibor M, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148137; Szibor M, 2017, DIS MODEL MECH, V10, P163, DOI 10.1242/dmm.027839; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	64	18	18	7	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					692	+		10.1038/s41590-022-01185-3	http://dx.doi.org/10.1038/s41590-022-01185-3		APR 2022	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35484407	Green Published, hybrid			2022-12-18	WOS:000788458200001
J	Minervina, AA; Pogorelyy, MV; Kirk, AM; Crawford, JC; Allen, EK; Chou, CH; Mettelman, RC; Allison, KJ; Lin, CY; Brice, DC; Zhu, X; Vegesana, K; Wu, G; Trivedi, S; Kottapalli, P; Darnell, D; McNeely, S; Olsen, SR; Schultz-Cherry, S; Estepp, JH; McGargill, MA; Wolf, J; Thomas, PG				Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Kirk, Allison M.; Crawford, Jeremy Chase; Allen, E. Kaitlynn; Chou, Ching-Heng; Mettelman, Robert C.; Allison, Kim J.; Lin, Chun-Yang; Brice, David C.; Zhu, Xun; Vegesana, Kasi; Wu, Gang; Trivedi, Sanchit; Kottapalli, Pratibha; Darnell, Daniel; McNeely, Suzanne; Olsen, Scott R.; Schultz-Cherry, Stacey; Estepp, Jeremie H.; McGargill, Maureen A.; Wolf, Joshua; Thomas, Paul G.		SJTRC Study Team	SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article								Thomas and colleagues describe how multiple SARS-CoV-2 antigen exposures, including mRNA vaccine boosters, primary infection and breakthrough infection, shape T cell immunity. Although mRNA vaccine efficacy against severe coronavirus disease 2019 remains high, variant emergence has prompted booster immunizations. However, the effects of repeated exposures to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens on memory T cells are poorly understood. Here, we utilize major histocompatibility complex multimers with single-cell RNA sequencing to profile SARS-CoV-2-responsive T cells ex vivo from humans with one, two or three antigen exposures, including vaccination, primary infection and breakthrough infection. Exposure order determined the distribution between spike-specific and non-spike-specific responses, with vaccination after infection leading to expansion of spike-specific T cells and differentiation to CCR7(-)CD45RA(+) effectors. In contrast, individuals after breakthrough infection mount vigorous non-spike-specific responses. Analysis of over 4,000 epitope-specific T cell antigen receptor (TCR) sequences demonstrates that all exposures elicit diverse repertoires characterized by shared TCR motifs, confirmed by monoclonal TCR characterization, with no evidence for repertoire narrowing from repeated exposure. Our findings suggest that breakthrough infections diversify the T cell memory repertoire and current vaccination protocols continue to expand and differentiate spike-specific memory.	[Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Kirk, Allison M.; Crawford, Jeremy Chase; Allen, E. Kaitlynn; Chou, Ching-Heng; Mettelman, Robert C.; Lin, Chun-Yang; Brice, David C.; McGargill, Maureen A.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Allison, Kim J.; Schultz-Cherry, Stacey; Wolf, Joshua] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhu, Xun; Wu, Gang] St Jude Childrens Res Hosp, Ctr Appl Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vegesana, Kasi] St Jude Childrens Res Hosp, Informat Serv, 332 N Lauderdale St, Memphis, TN 38105 USA; [Trivedi, Sanchit; Kottapalli, Pratibha; Darnell, Daniel; McNeely, Suzanne; Olsen, Scott R.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Estepp, Jeremie H.] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Wolf, J (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	joshua.wolf@stjude.org; paul.thomas@stjude.org	Minervina, Anastasia A/P-7067-2016; Hodges, Jason/AAC-6412-2021; Pogorelyy, Mikhail V/H-9610-2014; Crawford, Jeremy Chase/G-5711-2013; Vegesana, Kasi/AAE-1820-2022; Wolf, Joshua/ADO-0221-2022; Mettelman, Robert/AAA-4274-2020	Minervina, Anastasia A/0000-0001-9884-6351; Hodges, Jason/0000-0002-7418-6632; Pogorelyy, Mikhail V/0000-0003-0773-1204; Crawford, Jeremy Chase/0000-0003-4096-6048; Vegesana, Kasi/0000-0001-8847-3774; Mettelman, Robert/0000-0002-3527-5616; Kirk, Allison/0000-0002-4286-3678	American Lebanese Syrian Associated Charities (ALSAC) at St. Jude; Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) [75N93019C00052]; St. Jude Center of Excellence for Influenza Research and Surveillance [HHSN272201400006C, 3U01AI144616-02S1, R01AI136514]	American Lebanese Syrian Associated Charities (ALSAC) at St. Jude(American Lebanese Syrian Associated Charities (ALSAC)); Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP); St. Jude Center of Excellence for Influenza Research and Surveillance	We thank all the donors who volunteered for the SJTRC study, P. Bradley and S. Schattgen for their consultations on TCRdist and CoNGA algorithms, G. Lennon from St. Jude Immunology flow core for his help with FACS. This work was funded by American Lebanese Syrian Associated Charities (ALSAC) at St. Jude, the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP; contract no. 75N93019C00052 to S.S.-C. and P.G.T.), the St. Jude Center of Excellence for Influenza Research and Surveillance (HHSN272201400006C to S.S.-C., M.A.M. and P.G.T.; 3U01AI144616-02S1 to P.G.T., M.A.M. and S.S.-C., and R01AI136514 to P.G.T.).	Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bange EM, 2021, NAT MED, V27, P1280, DOI 10.1038/s41591-021-01386-7; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dolton G., 2021, EMERGENCE IMMUNE ESC, DOI [10.1101/2021.06.21.21259010, DOI 10.1101/2021.06.21.21259010]; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Flemming A, 2022, NAT REV IMMUNOL, V22, P75, DOI 10.1038/s41577-022-00676-6; Francis JM, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abk3070; Gangaev A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22811-y; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Kared H, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145476; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Kundu Rhia, 2022, Nat Commun, V13, P80, DOI 10.1038/s41467-021-27674-x; Kusnadi A, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe4782; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Lozano-Ojalvo D, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109570; Mallajosyula V, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5669; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mazzoni A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149150; Minervina AA, 2021, ELIFE, V10, DOI 10.7554/eLife.63502; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Nielsen SSF, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103410; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Peng YC, 2022, NAT IMMUNOL, V23, P50, DOI 10.1038/s41590-021-01084-z; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Rha MS, 2021, IMMUNITY, V54, P44, DOI 10.1016/j.immuni.2020.12.002; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Saini SK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7550; Schattgen SA, 2022, NAT BIOTECHNOL, V40, P54, DOI 10.1038/s41587-021-00989-2; Schreibing F., 2021, DISSECTING CD8 T CEL, DOI [10.1101/2021.03.03.432690, DOI 10.1101/2021.03.03.432690]; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Snyder Thomas M, 2020, medRxiv, DOI 10.1101/2020.07.31.20165647; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3	58	18	18	5	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					781	+		10.1038/s41590-022-01184-4	http://dx.doi.org/10.1038/s41590-022-01184-4		APR 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35383307	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000779043800001
J	Irvine, EB; O'Neil, A; Darrah, PA; Shin, S; Choudhary, A; Li, WJ; Honnen, W; Mehra, S; Kaushal, D; Gideon, HP; Flynn, JL; Roederer, M; Seder, RA; Pinter, A; Fortune, S; Alter, G				Irvine, Edward B.; O'Neil, Anthony; Darrah, Patricia A.; Shin, Sally; Choudhary, Alok; Li, Wenjun; Honnen, William; Mehra, Smriti; Kaushal, Deepak; Gideon, Hannah Priyadarshini; Flynn, JoAnne L.; Roederer, Mario; Seder, Robert A.; Pinter, Abraham; Fortune, Sarah; Alter, Galit			Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques	NATURE IMMUNOLOGY			English	Article							FC-RECEPTORS; B-CELLS; INNATE; BCG; PROTECTION; ANTIBODIES; PROTEIN; GLYCOPROTEIN; ADHESIN; GAMMA	Alter and colleagues show that IgM titers in the plasma and bronchoalveolar lavage fluid represent markers of reduced Mtb burden in rhesus macaques vaccinated intravenously with Bacille Calmette-Guerin. Development of an effective tuberculosis (TB) vaccine has suffered from an incomplete understanding of the correlates of protection against Mycobacterium tuberculosis (Mtb). Intravenous (i.v.) vaccination with Bacille Calmette-Guerin (BCG) provides nearly complete protection against TB in rhesus macaques, but the antibody response it elicits remains incompletely defined. Here we show that i.v. BCG drives superior antibody responses in the plasma and the lungs of rhesus macaques compared to traditional intradermal BCG administration. While i.v. BCG broadly expands antibody titers and functions, IgM titers in the plasma and lungs of immunized macaques are among the strongest markers of reduced bacterial burden. IgM was also enriched in macaques that received protective vaccination with an attenuated strain of Mtb. Finally, an Mtb-specific IgM monoclonal antibody reduced Mtb survival in vitro. Collectively, these data highlight the potential importance of IgM responses as a marker and mediator of protection against TB.	[Irvine, Edward B.; O'Neil, Anthony; Shin, Sally; Fortune, Sarah; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Irvine, Edward B.; Fortune, Sarah] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Darrah, Patricia A.; Roederer, Mario; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Choudhary, Alok; Honnen, William; Pinter, Abraham] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ USA; [Li, Wenjun] Univ Massachusetts, Dept Med, Med Sch, Worcester, MA 01605 USA; [Mehra, Smriti] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Kaushal, Deepak] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Gideon, Hannah Priyadarshini; Flynn, JoAnne L.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [Gideon, Hannah Priyadarshini; Flynn, JoAnne L.] Univ Pittsburgh, Ctr Vaccine Res, Sch Med, Pittsburgh, PA USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Tulane University; Texas Biomedical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fortune, S; Alter, G (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.; Fortune, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu; galter@mgh.harvard.edu	; Li, Wenjun/F-5634-2015	Shin, Sally/0000-0002-9306-2264; Li, Wenjun/0000-0001-5335-7386; Kaushal, Deepak/0000-0003-3521-1257; Irvine, Edward/0000-0002-8185-6454; Gideon, Hannah/0000-0002-4443-2134; Choudhary, Alok/0000-0002-2933-9812; Fortune, Sarah/0000-0001-7565-9975; Darrah, Patricia/0000-0002-0035-2802				Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Brown EP, 2017, J IMMUNOL METHODS, V443, P33, DOI 10.1016/j.jim.2017.01.010; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Caruso AM, 1999, J IMMUNOL, V162, P5407; Choudhary A, 2018, J IMMUNOL, V200, P3053, DOI 10.4049/jimmunol.1701673; Cirovic B, 2020, CELL HOST MICROBE, V28, P322, DOI 10.1016/j.chom.2020.05.014; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Dijkman K, 2019, NAT MED, V25, P255, DOI 10.1038/s41591-018-0319-9; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Esmail H, 2018, ANNU REV IMMUNOL, V36, P603, DOI 10.1146/annurev-immunol-042617-053420; Esparza M, 2015, SCAND J IMMUNOL, V81, P46, DOI 10.1111/sji.12249; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; Hoffmann E, 2012, P NATL ACAD SCI USA, V109, P14556, DOI 10.1073/pnas.1203912109; Karsten CB, 2019, J IMMUNOL METHODS, V471, P46, DOI 10.1016/j.jim.2019.05.006; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Lu LL, 2019, NAT MED, V25, P977, DOI 10.1038/s41591-019-0441-3; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Meryk A, 2019, CELL REP, V26, P2681, DOI 10.1016/j.celrep.2019.02.024; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/nejmoa1714021, 10.1056/NEJMoa1714021]; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Schlottmann SA, 2006, J IMMUNOL METHODS, V309, P75, DOI 10.1016/j.jim.2005.11.019; Tait DR, 2019, NEW ENGL J MED, V381, P2429, DOI 10.1056/NEJMoa1909953; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; van Woudenbergh E., 2020, MSPHERE, V5, pE00104, DOI DOI 10.1128/mSphere.00104-20; Watson A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20930-0; WHO, 2021, TUBERCULOSIS; Yang HL, 2012, FEMS IMMUNOL MED MIC, V66, P273, DOI 10.1111/j.1574-695X.2012.01002.x; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	50	18	18	5	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1515	+		10.1038/s41590-021-01066-1	http://dx.doi.org/10.1038/s41590-021-01066-1		NOV 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811542	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000722315400002
J	Zhao, Y; Oreskovic, E; Zhang, QW; Lu, Q; Gilman, A; Lin, YFS; He, JY; Zheng, ZZ; Lu, JYY; Lee, JN; Ke, ZH; Ablaeva, J; Sweet, MJ; Horvath, S; Zhang, ZD; Nevo, E; Seluanov, A; Gorbunova, V				Zhao, Yang; Oreskovic, Ena; Zhang, Quanwei; Lu, Quan; Gilman, Abbey; Lin, Yifei S.; He, Junyue; Zheng, Zhizhong; Lu, J. Yuyang; Lee, Jina; Ke, Zhonghe; Ablaeva, Julia; Sweet, Matthew J.; Horvath, Steve; Zhang, Zhengdong; Nevo, Eviatar; Seluanov, Andrei; Gorbunova, Vera			Transposon-triggered innate immune response confers cancer resistance to the blind mole rat	NATURE IMMUNOLOGY			English	Article							SOMATIC RETROTRANSPOSITION; SENESCENT CELLS; SEQUENCE; ELEMENTS; GENE; IFN; METHYLATION; PATHWAY; GENOME; DNMT1	Blind mole rats (BMRs) are small rodents, characterized by an exceptionally long lifespan (>21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). Cells and tissues of BMRs express very low levels of DNA methyltransferase 1. Following cell hyperplasia, the BMR genome DNA loses methylation, resulting in the activation of RTEs. Upregulated RTEs form cytoplasmic RNA-DNA hybrids, which activate the cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and humans. We propose that RTEs were co-opted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of the innate immune response. Activation of RTEs is a double-edged sword, serving as a tumor suppressor but contributing to aging in late life via the induction of sterile inflammation. Blind mole rats are small rodents characterized by an exceptionally long lifespan and resistance to both spontaneous and induced tumorigenesis. Gorbunova and colleagues show that a transposon-triggered innate immune response confers cancer resistance to the blind mole rat.	[Zhao, Yang; Oreskovic, Ena; Lu, Quan; Gilman, Abbey; Lin, Yifei S.; He, Junyue; Zheng, Zhizhong; Lu, J. Yuyang; Lee, Jina; Ke, Zhonghe; Ablaeva, Julia; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhang, Quanwei; Zhang, Zhengdong] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Horvath, Steve] Univ Calif Los Angeles, Los Angeles, CA USA; [Nevo, Eviatar] Univ Haifa, Haifa, Israel; [Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; Yeshiva University; Albert Einstein College of Medicine; University of Queensland; University of California System; University of California Los Angeles; University of Haifa; University of Rochester	Seluanov, A; Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.; Seluanov, A; Gorbunova, V (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu	zhang, zheng/HCH-9684-2022; Zhao, Yang/AFQ-4168-2022; Sweet, Matthew/F-2229-2011	Zhao, Yang/0000-0002-8703-3678; Zheng, Zhizhong/0000-0003-0352-4806; Lin, Yifei Sylvia/0000-0003-4404-4593; Lu, Quan/0000-0002-3491-6768; Sweet, Matthew/0000-0002-0406-8139				Anandakrishnan R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006881; Armando RG, 2020, INT J ONCOL, V56, P651, DOI 10.3892/ijo.2020.4966; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barillari G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00806; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourque G, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1577-z; Burns KH, 2020, ANNU REV PATHOL-MECH, V15, P51, DOI 10.1146/annurev-pathmechdis-012419-032633; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Fang X, 2014, NAT COMMUN, V5; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fukuda S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022751118; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Gorbunova V, 2012, P NATL ACAD SCI USA, V109, P19392, DOI 10.1073/pnas.1217211109; Gu ZM, 2021, NAT GENET, V53, P672, DOI 10.1038/s41588-021-00829-8; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Hou YZ, 2018, IMMUNITY, V49, P490, DOI 10.1016/j.immuni.2018.07.008; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jangam D, 2017, TRENDS GENET, V33, P817, DOI 10.1016/j.tig.2017.07.011; Jin J, 2014, IMMUNITY, V40, P342, DOI 10.1016/j.immuni.2014.02.006; Jin Y, 2015, BIOINFORMATICS, V31, P3593, DOI 10.1093/bioinformatics/btv422; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu HY, 2019, NAT MED, V25, P95, DOI 10.1038/s41591-018-0302-5; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Manov I, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-91; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Mehdipour P, 2020, NATURE, V588, P169, DOI 10.1038/s41586-020-2844-1; MIKI Y, 1992, CANCER RES, V52, P643; Nevo, 1999, MOSAIC EVOLUTION SUB; Numajiri A, 2006, J INTERF CYTOK RES, V26, P214, DOI 10.1089/jir.2006.26.214; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; QUENTIN Y, 1994, NUCLEIC ACIDS RES, V22, P2222, DOI 10.1093/nar/22.12.2222; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Schaffer BS, 2010, MOL CANCER THER, V9, P2354, DOI 10.1158/1535-7163.MCT-10-0207; Schneider K, 2013, NUCLEIC ACIDS RES, V41, P4860, DOI 10.1093/nar/gkt191; Seluanov A, 2018, NAT REV CANCER, V18, P433, DOI 10.1038/s41568-018-0004-9; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Simon M, 2019, CELL METAB, V29, P871, DOI 10.1016/j.cmet.2019.02.014; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Song L, 2018, BRIT J PHARMACOL, V175, P1241, DOI 10.1111/bph.14036; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, pCh4, DOI DOI 10.1002/0471250953.BI0410S25; Tian X, 2018, PHILOS T R SOC B, V373, DOI [10.1098/rstb.2018.0319, 10.1098/rstb.2016.0443]; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wylie A, 2016, GENE DEV, V30, P64, DOI 10.1101/gad.266098.115; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Zhang W, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0081-z; Zhao Y, 2018, P NATL ACAD SCI USA, V115, P1801, DOI 10.1073/pnas.1721160115	72	18	18	4	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1219	+		10.1038/s41590-021-01027-8	http://dx.doi.org/10.1038/s41590-021-01027-8		SEP 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556881	Green Accepted			2022-12-18	WOS:000751833700008
J	Brusilovsky, M; Rochman, M; Rochman, Y; Caldwell, JM; Mack, LE; Felton, JM; Habel, JE; Porollo, A; Pasare, C; Rothenberg, ME				Brusilovsky, Michael; Rochman, Mark; Rochman, Yrina; Caldwell, Julie M.; Mack, Lydia E.; Felton, Jennifer M.; Habel, Jeff E.; Porollo, Aleksey; Pasare, Chandrashekhar; Rothenberg, Marc E.			Environmental allergens trigger type 2 inflammation through ripoptosome activation	NATURE IMMUNOLOGY			English	Article							IL-1 FAMILY; INTERLEUKIN 33; CUTTING EDGE; ASTHMA; CYTOKINE; CELLS; ST2; MECHANISMS; EXPRESSION; IL-1-BETA	IL-33 plays a central role in type II immune responses and is generally thought to be released following cellular damage and processed extracellularly. Rothenberg and colleagues describe a new ripoptosome pathway that is assembled following exposure to various unrelated environmental allergens and that processes IL-33 into an active form intracellularly. Environmental allergens, including fungi, insects and mites, trigger type 2 immunity; however, the innate sensing mechanisms and initial signaling events remain unclear. Herein, we demonstrate that allergens trigger RIPK1-caspase 8 ripoptosome activation in epithelial cells. The active caspase 8 subsequently engages caspases 3 and 7, which directly mediate intracellular maturation and release of IL-33, a pro-atopy, innate immunity, alarmin cytokine. Mature IL-33 maintained functional interaction with the cognate ST2 receptor and elicited potent pro-atopy inflammatory activity in vitro and in vivo. Inhibiting caspase 8 pharmacologically and deleting murine Il33 and Casp8 each attenuated allergic inflammation in vivo. Clinical data substantiated ripoptosome activation and IL-33 maturation as likely contributors to human allergic inflammation. Our findings reveal an epithelial barrier, allergen-sensing mechanism that converges on the ripoptosome as an intracellular molecular signaling platform, triggering type 2 innate immune responses. These findings have significant implications for understanding and treating human allergic diseases.	[Brusilovsky, Michael; Rochman, Mark; Rochman, Yrina; Caldwell, Julie M.; Mack, Lydia E.; Felton, Jennifer M.; Habel, Jeff E.; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Porollo, Aleksey] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Porollo, Aleksey] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Porollo, Aleksey; Pasare, Chandrashekhar; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Pasare, Chandrashekhar] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Div Immunobiol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA.; Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA.	marc.rothenberg@cchmc.org		Rothenberg, Marc/0000-0001-9790-6332; Pasare, Chandrashekhar/0000-0002-8142-2488; Porollo, Alexey/0000-0002-3202-5099; Rochman, Mark/0000-0002-0818-927X; Rochman, Yrina/0000-0002-1129-5946	NIH [R37 AI045898]; Campaign Urging Research for Eosinophilic Disease (CURED); Sunshine Charitable Foundation [R01 AI123176, R01 AI113125, R01 CA231303]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease (CURED); Sunshine Charitable Foundation	This work was supported in part by NIH grant no. R37 AI045898; the Campaign Urging Research for Eosinophilic Disease (CURED); the Sunshine Charitable Foundation and its supporters, Denise and David Bunning (M.E.R.); and by grant nos. R01 AI123176, R01 AI113125 and R01 CA231303 (C.P.). We thank S. Hottinger for medical writing assistance.	Bae S, 2012, J BIOL CHEM, V287, P8205, DOI 10.1074/jbc.M111.295055; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Bressenot A, 2009, J HISTOCHEM CYTOCHEM, V57, P289, DOI 10.1369/jhc.2008.952044; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Chinthrajah S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131347; Codina R, 2009, J ALLERGY CLIN IMMUN, V123, pS97, DOI 10.1016/j.jaci.2008.12.350; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dinarello CA, 2005, IMMUNITY, V23, P461, DOI 10.1016/j.immuni.2005.10.004; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gour N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aam9841; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Gunther S, 2017, IMMUNITY, V47, P510, DOI 10.1016/j.immuni.2017.08.004; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Hill AA, 2018, IMMUNITY, V49, P389, DOI 10.1016/j.immuni.2018.08.027; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Iwata A, 2003, J IMMUNOL, V170, P3386, DOI 10.4049/jimmunol.170.6.3386; Jain A, 2020, NAT IMMUNOL, V21, P65, DOI 10.1038/s41590-019-0559-y; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Travers J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05485-x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079	50	18	18	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1316	+		10.1038/s41590-021-01011-2	http://dx.doi.org/10.1038/s41590-021-01011-2		SEP 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34531562	Green Accepted			2022-12-18	WOS:000696445900001
J	Li, YY; Lu, Y; Lin, SH; Li, N; Han, YC; Huang, QR; Zhao, Y; Xie, F; Guo, YX; Deng, BL; Tsun, A; Du, J; Li, D; Sun, J; Shi, GC; Zheng, F; Su, X; Duan, SZ; Zheng, SG; Wang, G; Tong, XM; Li, B				Li, Yangyang; Lu, Ying; Lin, Shu-Hai; Li, Ning; Han, Yichao; Huang, Qianru; Zhao, Yi; Xie, Feng; Guo, Yixian; Deng, Biaolong; Tsun, Andy; Du, Juan; Li, Dan; Sun, Joanne; Shi, Guochao; Zheng, Fang; Su, Xiao; Duan, Shengzhong; Zheng, Song Guo; Wang, Gang; Tong, Xuemei; Li, Bin			Insulin signaling establishes a developmental trajectory of adipose regulatory T cells	NATURE IMMUNOLOGY			English	Article							BEIGE FAT; TISSUE; IL-33; GLUCOSE; BROWN; GAMMA; CD39; ACCUMULATION; ADIPOCYTES; ACTIVATION	Adipose tissue-resident regulatory T (T-reg) cells are important for maintaining normal metabolic function and adiposity. Li and colleagues demonstrate that insulin signaling directly controls adipose T-reg cell development and functionality Systematic characterizations of adipose regulatory T (T-reg) cell subsets and their phenotypes remain uncommon. Using single-cell ATAC-sequencing and paired single-cell RNA and T cell receptor (TCR) sequencing to map mouse adipose T-reg cells, we identified CD73(hi)ST2(lo) and CD73(lo)ST2(hi) subsets with distinct clonal expansion patterns. Analysis of TCR-sharing data implied a state transition between CD73(hi)ST2(lo) and CD73(lo)ST2(hi) subsets. Mechanistically, we revealed that insulin signaling occurs through a HIF-1 alpha-Med23-PPAR-gamma axis to drive the transition of CD73(hi)ST2(lo) into a CD73(lo)ST2(hi) adipose T-reg cell subset. T-reg cells deficient in insulin receptor, HIF-1 alpha or Med23 have decreased PPAR-gamma expression that in turn promotes accumulation of CD73(hi)ST2(lo) adipose T-reg cells and physiological adenosine production to activate beige fat biogenesis. We therefore unveiled a developmental trajectory of adipose T-reg cells and its dependence on insulin signaling. Our findings have implications for understanding the dynamics of adipose T-reg cell subsets in aged and obese contexts.	[Li, Yangyang; Li, Ning; Han, Yichao; Huang, Qianru; Zhao, Yi; Xie, Feng; Guo, Yixian; Deng, Biaolong; Tsun, Andy; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China; [Lu, Ying; Lin, Shu-Hai; Tong, Xuemei] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol,Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai, Peoples R China; [Tsun, Andy; Sun, Joanne] Biotheus Inc, Zhuhai, Peoples R China; [Du, Juan; Shi, Guochao; Li, Bin] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Pulm & Crit Care Med, Sch Med, Shanghai, Peoples R China; [Zheng, Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China; [Su, Xiao] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Resp Infect & Immun, Shanghai, Peoples R China; [Duan, Shengzhong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Lab Oral Microbiota & Syst Dis, Sch Med, Shanghai, Peoples R China; [Zheng, Song Guo] Sun Yat Sen Univ, Dept Clin Immunol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Wang, Gang] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China; [Wang, Gang] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Li, Bin] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Henan Key Lab Digest Organ Transplantat, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Li, Bin] Shanghai Univ Tradit Chinese Med, Guanghua Integrat Med Hosp, Inst Arthrit Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; Sun Yat Sen University; Fudan University; Fudan University; Zhengzhou University; Shanghai University of Traditional Chinese Medicine	Li, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China.; Tong, XM (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol,Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai, Peoples R China.; Li, B (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Pulm & Crit Care Med, Sch Med, Shanghai, Peoples R China.; Wang, G (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.; Li, B (corresponding author), Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Henan Key Lab Digest Organ Transplantat, Affiliated Hosp 1, Zhengzhou, Peoples R China.; Li, B (corresponding author), Shanghai Univ Tradit Chinese Med, Guanghua Integrat Med Hosp, Inst Arthrit Res, Shanghai, Peoples R China.	gwang_fd@fudan.edu.cn; xuemeitong@shsmu.edu.cn; binli@shsmu.edu.cn	lI, Bin/AAR-4966-2021; Su, Xiao/CAG-9884-2022	lI, Bin/0000-0002-7640-8884; Su, Xiao/0000-0002-8692-8365; Li, Yangyang/0000-0002-5791-9443; HAN, YICHAO/0000-0002-9691-3028; WANG, Gang/0000-0002-4582-501X; Lu, Ying/0000-0002-3545-1026				Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Chu YJ, 2014, CELL RES, V24, P1250, DOI 10.1038/cr.2014.120; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer HJ, 2017, J IMMUNOL, V198, P1910, DOI 10.4049/jimmunol.1601011; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gnad T, 2020, CELL METAB, V32, P56, DOI 10.1016/j.cmet.2020.06.006; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Han JM, 2015, J IMMUNOL, V194, P4777, DOI 10.4049/jimmunol.1500020; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Ikebuchi R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01098; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tsai S, 2018, CELL METAB, V28, P922, DOI 10.1016/j.cmet.2018.08.003; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2020, J EXP MED, V217, DOI 10.1084/jem.20191542; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zeng FF, 2021, J INVEST DERMATOL, V141, P596, DOI 10.1016/j.jid.2020.07.027; Zhao XY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6191	41	18	18	4	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1175	+		10.1038/s41590-021-01010-3	http://dx.doi.org/10.1038/s41590-021-01010-3		AUG 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34429546				2022-12-18	WOS:000687942300008
J	Huang, D; Chen, XM; Zeng, X; Lao, LY; Li, JQ; Xing, Y; Lu, YW; Ouyang, QA; Chen, JI; Yang, LB; Su, FX; Yao, HR; Liu, Q; Su, SC; Song, EW				Huang, Di; Chen, Xueman; Zeng, Xin; Lao, Liyan; Li, Jiaqian; Xing, Yue; Lu, Yiwen; Ouyang, Qian; Chen, Jianing; Yang, Linbin; Su, Fengxi; Yao, Herui; Liu, Qiang; Su, Shicheng; Song, Erwei			Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTORS; RGS PROTEINS; EXPRESSION; LOCALIZATION; RECRUITMENT; MIGRATION; NAIVE; IMMUNOSUPPRESSION; INFILTRATION; INFLAMMATION	Effective control of tumors requires the presence of inflammatory helper and cytotoxic T cells. Song and colleagues demonstrate that the protein RGS1 cell-intrinsically regulates effector T cell homing to tumors and thereby impairs tumor control. Reduced infiltration of anti-tumor lymphocytes remains a major cause of tumor immune evasion and is correlated with poor cancer survival. Here, we found that upregulation of regulator of G protein signaling (RGS)1 in helper T(H)1 cells and cytotoxic T lymphocytes (CTLs) reduced their trafficking to and survival in tumors and was associated with shorter survival of patients with breast and lung cancer. RGS1 was upregulated by type II interferon (IFN)-signal transducer and activator of transcription (STAT)1 signaling and impaired trafficking of circulating T cells to tumors by inhibiting calcium influx and suppressing activation of the kinases ERK and AKT. RGS1 knockdown in adoptively transferred tumor-specific CTLs significantly increased their infiltration and survival in breast and lung tumor grafts and effectively inhibited tumor growth in vivo, which was further improved when combined with programmed death ligand (PD-L)1 checkpoint inhibition. Our findings reveal RGS1 is important for tumor immune evasion and suggest that targeting RGS1 may provide a new strategy for tumor immunotherapy.	[Huang, Di; Chen, Xueman; Lao, Liyan; Li, Jiaqian; Xing, Yue; Lu, Yiwen; Ouyang, Qian; Chen, Jianing; Yang, Linbin; Su, Fengxi; Yao, Herui; Liu, Qiang; Su, Shicheng; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Guangzhou, Peoples R China; [Huang, Di; Chen, Xueman; Lao, Liyan; Li, Jiaqian; Xing, Yue; Lu, Yiwen; Ouyang, Qian; Chen, Jianing; Yang, Linbin; Su, Fengxi; Yao, Herui; Liu, Qiang; Su, Shicheng; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China; [Huang, Di; Chen, Xueman; Zeng, Xin; Lao, Liyan; Li, Jiaqian; Xing, Yue; Lu, Yiwen; Ouyang, Qian; Chen, Jianing; Yang, Linbin; Su, Fengxi; Yao, Herui; Liu, Qiang; Su, Shicheng; Song, Erwei] Bioland Lab, Guangzhou, Peoples R China; [Zeng, Xin; Song, Erwei] Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Peoples R China; [Song, Erwei] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Fountain Valley Inst Life Sci, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Su, SC; Song, EW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Guangzhou, Peoples R China.; Su, SC; Song, EW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China.; Su, SC; Song, EW (corresponding author), Bioland Lab, Guangzhou, Peoples R China.; Song, EW (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou, Peoples R China.; Song, EW (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Fountain Valley Inst Life Sci, Guangzhou, Peoples R China.	sushch@mail.sysu.edu.cn; songew@mail.sysu.edu.cn		, Qian/0000-0002-1862-946X; Liu, Qiang/0000-0002-5451-4862	National Key Research and Development Program of China [2017YFA0106300, 2016YFC1302300]; Natural Science Foundation of China [81621004, 81720108029, 81930081, 91940305, 81802643, 82002786, 91942309, 92057210]; Guangdong Basic and Applied Basic Research Foundation [2018A030310085, 2020A1515011458, 2021A1515010238]; Clinical Innovation Research Program of Bioland Laboratory [2018GZR0201004]; Guangdong Science and Technology Department [2020B1212060018, 2020B1212030004]; Guangzhou Science Technology and Innovation Commission [201803040015]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2019BT02Y198]; Science and Technology Program of Guangzhou [202103000070]; China Postdoctoral Science Foundation [2020M683106]; Fountain-Valley Life Sciences Fund of the University of Chinese Academy of Sciences Education Foundation	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation; Clinical Innovation Research Program of Bioland Laboratory; Guangdong Science and Technology Department; Guangzhou Science Technology and Innovation Commission; Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Science and Technology Program of Guangzhou; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fountain-Valley Life Sciences Fund of the University of Chinese Academy of Sciences Education Foundation	This work was supported by grants from the National Key Research and Development Program of China (2017YFA0106300 (S.S.), 2016YFC1302300 (E.S.)), the Natural Science Foundation of China (81621004 (E.S.), 81720108029 (E.S.), 81930081 (E.S.), 91940305 (E.S.), 81802643 (D.H.), 82002786 (L.Y.), 91942309 (S.S.) and 92057210 (S.S.)), the Guangdong Basic and Applied Basic Research Foundation (2018A030310085 (D.H.), 2020A1515011458 (D.H.) and 2021A1515010238 (X.C.)), the Clinical Innovation Research Program of Bioland Laboratory (2018GZR0201004 (E.S.)), the Guangdong Science and Technology Department (2020B1212060018 (E.S.) and 2020B1212030004 (E.S.)), the Guangzhou Science Technology and Innovation Commission (201803040015 (E.S.)), the Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2019BT02Y198 (E.S.)), the Science and Technology Program of Guangzhou (202103000070 (S.S.)) and the China Postdoctoral Science Foundation (2020M683106 (X.C.)). The research was partly supported by the Fountain-Valley Life Sciences Fund of the University of Chinese Academy of Sciences Education Foundation.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Bernhard H, 2008, CANCER IMMUNOL IMMUN, V57, P271, DOI 10.1007/s00262-007-0355-7; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dangaj D, 2019, CANCER CELL, V35, P885, DOI 10.1016/j.ccell.2019.05.004; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Denecke B, 1999, J BIOL CHEM, V274, P26860, DOI 10.1074/jbc.274.38.26860; Emens LA, 2019, JAMA ONCOL, V5, P74, DOI 10.1001/jamaoncol.2018.4224; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Gibbons DL, 2011, J IMMUNOL, V187, P2067, DOI 10.4049/jimmunol.1100833; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; He S, 2008, J LEUKOCYTE BIOL, V84, P1549, DOI 10.1189/jlb.0708420; HONG JX, 1993, J IMMUNOL, V150, P3895; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Hu JM, 2018, CLIN CANCER RES, V24, P2920, DOI 10.1158/1078-0432.CCR-17-1365; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lin YP, 2010, MOL IMMUNOL, V47, P2022, DOI 10.1016/j.molimm.2010.04.011; Liu J, 2021, NAT CANCER, V2, P457, DOI 10.1038/s43018-021-00196-7; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Nolz JC, 2011, IMMUNOTHERAPY-UK, V3, P1223, DOI [10.2217/IMT.11.100, 10.2217/imt.11.100]; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Stanford MM, 2003, J LEUKOCYTE BIOL, V74, P791, DOI 10.1189/jlb.1102547; Su SC, 2018, CELL, V175, P442, DOI 10.1016/j.cell.2018.09.007; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8	49	18	19	6	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					865	+		10.1038/s41590-021-00939-9	http://dx.doi.org/10.1038/s41590-021-00939-9		JUN 2021	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34140678				2022-12-18	WOS:000662827000001
J	Zhou, JJ; Kryczek, I; Li, SS; Li, X; Aguilar, A; Wei, S; Grove, S; Vatan, L; Yu, JL; Yan, YJ; Liao, P; Lin, H; Li, J; Li, GP; Du, W; Wang, WC; Lang, XT; Wang, WM; Wang, SM; Zou, WP				Zhou, Jiajia; Kryczek, Ilona; Li, Shasha; Li, Xiong; Aguilar, Angelo; Wei, Shuang; Grove, Sara; Vatan, Linda; Yu, Jiali; Yan, Yijian; Liao, Peng; Lin, Heng; Li, Jing; Li, Gaopeng; Du, Wan; Wang, Weichao; Lang, Xueting; Wang, Weimin; Wang, Shaomeng; Zou, Weiping			The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity	NATURE IMMUNOLOGY			English	Article								Targeting the p53-MDM2 pathway to reactivate tumor p53 is a chemotherapeutic approach. However, the involvement of this pathway in CD8(+) T cell-mediated antitumor immunity is unknown. Here, we report that mice with MDM2 deficiency in T cells exhibit accelerated tumor progression and a decrease in tumor-infiltrating CD8(+) T cell survival and function. Mechanistically, MDM2 competes with c-Cbl for STAT5 binding, reduces c-Cbl-mediated STAT5 degradation and enhances STAT5 stability in tumor-infiltrating CD8(+) T cells. Targeting the p53-MDM2 interaction with a pharmacological agent, APG-115, augmented MDM2 in T cells, thereby stabilizing STAT5, boosting T cell immunity and synergizing with cancer immunotherapy. Unexpectedly, these effects of APG-115 were dependent on p53 and MDM2 in T cells. Clinically, MDM2 abundance correlated with T cell function and interferon-gamma signature in patients with cancer. Thus, the p53-MDM2 pathway controls T cell immunity, and targeting this pathway may treat patients with cancer regardless of tumor p53 status. The E3 ubiquitin ligase MDM2 inhibits the tumor suppressor p53 and is an important therapeutic target. Zou and colleagues demonstrate that MDM2 also has a T cell-intrinsic role that supports antitumor responses.	[Zhou, Jiajia; Kryczek, Ilona; Li, Shasha; Li, Xiong; Wei, Shuang; Grove, Sara; Vatan, Linda; Yu, Jiali; Yan, Yijian; Liao, Peng; Lin, Heng; Li, Jing; Li, Gaopeng; Du, Wan; Wang, Weichao; Lang, Xueting; Wang, Weimin; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Zhou, Jiajia; Kryczek, Ilona; Li, Shasha; Li, Xiong; Wei, Shuang; Grove, Sara; Vatan, Linda; Yu, Jiali; Yan, Yijian; Liao, Peng; Lin, Heng; Li, Jing; Li, Gaopeng; Du, Wan; Wang, Weichao; Lang, Xueting; Wang, Weimin; Zou, Weiping] Univ Michigan, Sch Med, Rogel Canc Ctr, Ctr Excellence Canc Immunol & Immunotherapy, Ann Arbor, MI 48109 USA; [Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Sch Med, Dept Med Chem, Ann Arbor, MI USA; [Zou, Weiping] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Sch Med, Grad Program Canc Biol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Sch Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Rogel Canc Ctr, Ctr Excellence Canc Immunol & Immunotherapy, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Grad Program Canc Biol, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	wzou@med.umich.edu	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Zhou, Jiajia/0000-0002-3113-8278; Liao, Peng/0000-0002-8409-5574	NIH/NCI [CA248430, CA217648, CA123088, CA099985, CA193136, CA152470]; NIH through University of Michigan Rogel Cancer Center support grant [P30CA46592]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH through University of Michigan Rogel Cancer Center support grant	We thank Y. Sun for providing the His-Ub and His-Ub K48R plasmids, W. Wei for providing the HA-MDM2 plasmid, F. Hua for providing the HA-c-Cbl plasmid and G. Lozano for providing the Mdm2<SUP>flox/flox</SUP> mice. We are grateful to Y. Sun and W. Wei for scientific input. This work was supported in part by research grants from the NIH/NCI (CA248430, CA217648, CA123088, CA099985, CA193136 and CA152470 to W.Z.) and from the NIH through University of Michigan Rogel Cancer Center support grant P30CA46592.; .	Aguilar A, 2017, J MED CHEM, V60, P2819, DOI 10.1021/acs.jmedchem.6b01665; Banerjee A, 2016, CANCER RES, V76, P5229, DOI 10.1158/0008-5472.CAN-15-1798; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Dieudonne FX, 2013, STEM CELLS, V31, P1340, DOI 10.1002/stem.1380; Fang DD, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0750-6; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Goh ELK, 2002, ENDOCRINOLOGY, V143, P3590, DOI 10.1210/en.2002-220374; Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Huang M, 2018, NAT METHODS, V15, P539, DOI 10.1038/s41592-018-0033-z; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Karni-Schmidt O, 2016, ANNU REV PATHOL-MECH, V11, P617, DOI 10.1146/annurev-pathol-012414-040349; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Li YB, 2019, J MED CHEM, V62, P448, DOI 10.1021/acs.jmedchem.8b00909; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pan Y, 1999, CANCER RES, V59, P2064; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Waldmann TA, 2017, ANNU REV IMMUNOL, V35, P533, DOI 10.1146/annurev-immunol-110416-120628; Wang DD, 2016, BIOMATERIALS, V100, P27, DOI 10.1016/j.biomaterials.2016.05.027; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	34	18	19	4	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					460	+		10.1038/s41590-021-00888-3	http://dx.doi.org/10.1038/s41590-021-00888-3		MAR 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33767425	Green Accepted			2022-12-18	WOS:000632800300001
J	Grassmann, S; Mihatsch, L; Mir, J; Kazeroonian, A; Rahimi, R; Flommersfeld, S; Schober, K; Hensel, I; Leube, J; Pachmayr, LO; Kretschmer, L; Zhang, Q; Jolly, A; Chaudhry, MZ; Schiemann, M; Cicin-Sain, L; Hofer, T; Busch, DH; Flossdorf, M; Buchholz, VR				Grassmann, Simon; Mihatsch, Lorenz; Mir, Jonas; Kazeroonian, Atefeh; Rahimi, Roza; Flommersfeld, Sophie; Schober, Kilian; Hensel, Inge; Leube, Justin; Pachmayr, Ludwig O.; Kretschmer, Lorenz; Zhang, Qin; Jolly, Adrien; Chaudhry, M. Zeeshan; Schiemann, Matthias; Cicin-Sain, Luka; Hofer, Thomas; Busch, Dirk H.; Flossdorf, Michael; Buchholz, Veit R.			Early emergence of T central memory precursors programs clonal dominance during chronic viral infection	NATURE IMMUNOLOGY			English	Article							HIGHLY PATHOGENIC SIV; CELL RESPONSES; EFFECTOR; CD4(+); REPERTOIRE; EXPANSION; DIFFERENTIATION; SELECTION; VIRUS; FATE	Chronic cytomegalovirus (CMV) infection leads to long-term maintenance of extraordinarily large CMV-specific T cell populations. The magnitude of this so-called 'memory inflation' is thought to mainly depend on antigenic stimulation during the chronic phase of infection. However, by mapping the long-term development of CD8(+) T cell families derived from single naive precursors, we find that fate decisions made during the acute phase of murine CMV infection can alter the level of memory inflation by more than 1,000-fold. Counterintuitively, a T cell family's capacity for memory inflation is not determined by its initial expansion. Instead, those rare T cell families that dominate the chronic phase of infection show an early transcriptomic signature akin to that of established T central memory cells. Accordingly, a T cell family's long-term dominance is best predicted by its early content of T central memory precursors, which later serve as a stem-cell-like source for memory inflation. T cell memory formation is often described as occurring during the chronic phases of infection. Buchholz and colleagues use the phenomenon of 'memory inflation' following cytomegalovirus infection to show that a tiny subset of self-renewing T cells branch off early from the bulk population to generate memory.	[Grassmann, Simon; Mihatsch, Lorenz; Mir, Jonas; Kazeroonian, Atefeh; Rahimi, Roza; Flommersfeld, Sophie; Schober, Kilian; Hensel, Inge; Leube, Justin; Pachmayr, Ludwig O.; Kretschmer, Lorenz; Schiemann, Matthias; Busch, Dirk H.; Flossdorf, Michael; Buchholz, Veit R.] Tech Univ Munich TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Grassmann, Simon] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Zhang, Qin; Jolly, Adrien; Hofer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, Heidelberg, Germany; [Zhang, Qin; Jolly, Adrien; Hofer, Thomas] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany; [Chaudhry, M. Zeeshan; Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Chaudhry, M. Zeeshan; Cicin-Sain, Luka] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Braunschweig, Germany; [Busch, Dirk H.; Buchholz, Veit R.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	Technical University of Munich; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; German Center for Infection Research	Buchholz, VR (corresponding author), Tech Univ Munich TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Buchholz, VR (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	veit.buchholz@tum.de	Buchholz, Veit R./AAF-6966-2021; Höfer, Thomas/G-5665-2013; Chaudhry, M. Zeeshan/AAJ-8203-2021	Buchholz, Veit R./0000-0003-0441-3913; Höfer, Thomas/0000-0003-3560-8780; Chaudhry, M. Zeeshan/0000-0002-1372-4257; Mihatsch, Lorenz Leopold/0000-0003-3835-7964; Mir, Jonas/0000-0003-2067-6289; Grassmann, Simon/0000-0002-8336-3418	Else Kroner-Fresenius-Stiftung [EKFS 2019_A91]; DFG - SFB 1054 [210592381]; TUM Seed Funds (SCIMAP); BMBF project Quan-T-cell (e:Med initiative on Systems Medicine) [FKZ 01ZX1505]; BMBF project TIDY (Computational Life Sciences) [FKZ 031L0170A]; Helmholtz association [PIE-008]; DFG - TRR 179 [031L0170A]	Else Kroner-Fresenius-Stiftung; DFG - SFB 1054(German Research Foundation (DFG)); TUM Seed Funds (SCIMAP); BMBF project Quan-T-cell (e:Med initiative on Systems Medicine)(Federal Ministry of Education & Research (BMBF)); BMBF project TIDY (Computational Life Sciences)(Federal Ministry of Education & Research (BMBF)); Helmholtz association(Helmholtz Association); DFG - TRR 179(German Research Foundation (DFG))	We thank thank J. Sun and N. Adams as well as all members of the Buchholz laboratory for discussion and support. This work was supported by the Else Kroner-Fresenius-Stiftung -EKFS 2019_A91 ("Dissecting the induction of inflationary CD8+ T cell memory on the single-cell level') to V.R.B., the DFG - SFB 1054 (project no. 210592381) to V.R.B. and D.H.B., the TUM Seed Funds (SCIMAP) to V.R.B., the BMBF project Quan-T-cell (e:Med initiative on Systems Medicine, FKZ 01ZX1505) to M.F., the BMBF project TIDY (Computational Life Sciences, FKZ 031L0170A) to T.H., the Helmholtz association project PIE-008 to L.C.S. and the DFG - TRR 179 (project number 031L0170A) to M.S.	Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Byrne SM, 2012, J IMMUNOL, V189, P1133, DOI 10.4049/jimmunol.1003406; Cho YL, 2017, CELL REP, V20, P806, DOI 10.1016/j.celrep.2017.07.005; Davenport MP, 2002, J IMMUNOL, V168, P3309, DOI 10.4049/jimmunol.168.7.3309; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Dekhtiarenko I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006072; Dekhtiarenko I, 2013, J IMMUNOL, V190, P3399, DOI 10.4049/jimmunol.1203173; DeTomaso D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1176-5; Flossdorf M, 2015, NAT IMMUNOL, V16, P891, DOI 10.1038/ni.3235; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Gulati GS, 2020, SCIENCE, V367, P405, DOI 10.1126/science.aax0249; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jeng MY, 2018, J EXP MED, V215, P51, DOI 10.1084/jem.20161066; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963; Kim C, 2013, IMMUNITY, V39, P508, DOI 10.1016/j.immuni.2013.08.033; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Kretschmer L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13788-w; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Miao TZ, 2017, J EXP MED, V214, P1787, DOI 10.1084/jem.20160553; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schober K, 2020, NAT IMMUNOL, V21, P434, DOI 10.1038/s41590-020-0628-2; Shrestha S, 2014, P NATL ACAD SCI USA, V111, P14858, DOI 10.1073/pnas.1404264111; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Welten SPM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16219-3; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	57	18	18	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1563	+		10.1038/s41590-020-00807-y	http://dx.doi.org/10.1038/s41590-020-00807-y		OCT 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33106669				2022-12-18	WOS:000583963700001
J	Rohan, H; McKay, G				Rohan, Hana; McKay, Gillian			The Ebola outbreak in the Democratic Republic of the Congo: why there is no 'silver bullet'	NATURE IMMUNOLOGY			English	Article								Despite new vaccines, therapeutics, and the extensive lessons learned from the West African Ebola outbreak, the DRC's 2018-2020 outbreak has taken nearly 20 months to bring under control. This Comment explores some of the factors that have made this outbreak so complex.	[Rohan, Hana] London Sch Hyg & Trop Med, UK Publ Hlth Rapid Support Team, London, England; [McKay, Gillian] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Rohan, H (corresponding author), London Sch Hyg & Trop Med, UK Publ Hlth Rapid Support Team, London, England.	Hana.Rohan@lshtm.ac.uk		Rohan, Hana/0000-0002-5327-6348; McKay, Gillian/0000-0003-1510-9212	UK Department of Health and Social Care; Public Health England (PHE); London School of Hygiene & Tropical Medicine (LSHTM); Pierre Elliott Trudeau Foundation; Elhra's Research for Health in Humanitarian Crises (R2HC) programme - UK Department for International Development (DFID); Wellcome; UK National Institute for Health Research (NIHR)	UK Department of Health and Social Care; Public Health England (PHE); London School of Hygiene & Tropical Medicine (LSHTM); Pierre Elliott Trudeau Foundation; Elhra's Research for Health in Humanitarian Crises (R2HC) programme - UK Department for International Development (DFID); Wellcome; UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The UK Public Health Rapid Support Team is funded by aid from the UK Department of Health and Social Care and is jointly run by Public Health England (PHE) and the London School of Hygiene & Tropical Medicine (LSHTM). The University of Oxford and King's College London are academic partners. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health and Social Care. Gillian McKay is supported by the Pierre Elliott Trudeau Foundation; she conducted research on the DRC outbreak as part of a project funded by Elhra's Research for Health in Humanitarian Crises (R2HC) programme, which is funded by the UK Department for International Development (DFID), Wellcome, and the UK National Institute for Health Research (NIHR).	[Anonymous], 2019, POL OPT TEMP FEE EL; [Anonymous], 2019, ATR AL 182 DEM REP C; [Anonymous], 2019, BBC; ARIE S, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/bmj.l4522; Bardosh K., 2019, SOCIAL SCI BEHAV DAT; Bedford J., 2018, KEY CONSIDERATIONS C; Brunner B., 2018, ROLE PRIVATE SECTOR; Gavi, 2020, PLAN ACT BOOST IMM C; McKay G, 2019, NOT ALL BLEEDS IS EB; Mehtar S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0144-1; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Ntembwa HK, 2015, DEMOCRATIC REPUBLIC; Potter C., 2019, EBOLA DRC BATTLES ME; Sweet R., 2018, HATSAPP LOCAL MEDIA; Tariq A, 2019, EPIDEMICS-NETH, V26, P128, DOI 10.1016/j.epidem.2019.01.003; The Central Intelligence Agency, 2020, CIA WORLD FACTB DEM; Trapido J, 2019, LANCET INFECT DIS, V19, P457, DOI 10.1016/S1473-3099(19)30044-1; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Vogel C., 2019, FOREIGN POLICY; Wannier SR, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.100353; WHO, GLOB HLTH EXP DAT; World Health Organization, 2019, PREL RES EFF RVSV ZE; World Health Organization, 2016, EB VIR DIS SIT REP 1; World Health Organization, 2019, 69 WHO 69 WHO; World Health Organization, 2020, 85 WHO	25	18	18	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					591	594		10.1038/s41590-020-0675-8	http://dx.doi.org/10.1038/s41590-020-0675-8		APR 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32317804	hybrid			2022-12-18	WOS:000528106700001
J	Brzostek, J; Gautam, N; Zhao, X; Chen, EW; Mehta, M; Tung, DWH; Chua, YL; Yap, JW; Cho, SH; Sankaran, S; Rybakin, V; Fu, G; Gascoigne, NRJ				Brzostek, Joanna; Gautam, Namrata; Zhao, Xiang; Chen, Elijah W.; Mehta, Monika; Tung, Desmond W. H.; Chua, Yen Leong; Yap, Jiawei; Cho, Su H.; Sankaran, Shvetha; Rybakin, Vasily; Fu, Guo; Gascoigne, Nicholas R. J.			T cell receptor and cytokine signal integration in CD8(+) T cells is mediated by the protein Themis	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; SELF-PEPTIDE; TCR; EXPRESSION; AFFINITY; PROLIFERATION; SPECIFICITY; HOMEOSTASIS; THRESHOLD; STRENGTH	T cell homeostasis and functional responsiveness require signals from self-peptide-major histocompatibility complex (self-pMHC) and cytokines, but the mechanisms controlling this signal integration are unknown. Using a conditional deletion of the T cell lineage-specific protein Themis, we show that Themis is required for the maintenance of peripheral CD8(+) T cells and for proliferative CD8(+) T cell responses to low-affinity pMHC aided by cytokines. Themis-deficient peripheral T cells show a phenotype indicative of reduced tonic signaling from self-pMHC, strongly suggesting that Themis is a positive regulator of T cell receptor signal strength in response to low-affinity self-pMHC in peripheral T cells. Signals from low-affinity pMHC and cytokines synergistically induce phosphorylation of the kinase Akt, metabolic changes and c-Myc transcription factor induction in CD8(+) T cells only in the presence of Themis. This function of Themis is mediated through Shp1 phosphatase, as peripheral Themis and Shp1 double deletion rescues the peripheral CD8(+) T cell maintenance. T cell homeostasis requires integration of signals from antigen and cytokine receptors. Gascoigne and colleagues demonstrate that the protein Themis supports signals from low-affinity TCR ligands to maintain normal CD8(+) cell function.	[Brzostek, Joanna; Gautam, Namrata; Zhao, Xiang; Chen, Elijah W.; Mehta, Monika; Tung, Desmond W. H.; Chua, Yen Leong; Yap, Jiawei; Cho, Su H.; Sankaran, Shvetha; Rybakin, Vasily; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Rybakin, Vasily] Katholieke Univ Leuven, Rega Inst Med Res, Lab Immunobiol, Leuven, Belgium; [Fu, Guo] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Gascoigne, Nicholas R. J.] Natl Univ Singapore, Life Sci Inst, Immunol Programme, Singapore, Singapore	National University of Singapore; KU Leuven; Xiamen University; National University of Singapore	Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.; Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Life Sci Inst, Immunol Programme, Singapore, Singapore.	micnrjg@nus.edu.sg		Gautam, Namrata/0000-0001-5757-5348; Tung, Desmond/0000-0001-9126-4519; Brzostek, Joanna/0000-0002-5621-2649	Singapore Ministry of Education [2014-T2-1-136]; Singapore Ministry of Health's National Medical Research Council [CBRG/0097/2015]	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This research was supported by Singapore Ministry of Education grant 2014-T2-1-136 and the Singapore Ministry of Health's National Medical Research Council under grant CBRG/0097/2015 (to N.R.J.G.). The authors thank S. Kupriyanov from the Scripps Research Institute Mouse Genetics Core for the initial derivation of the Themis cKO mice, P. Hutchinson and G.H. Teo from the NUS Immunology Programme Flow Cytometry Core Facility for cell sorting, and the NIH tetramer core facility for the H-2Kb monomers.	Au-Yeung BB, 2017, J IMMUNOL, V198, P2445, DOI 10.4049/jimmunol.1601453; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bezbradica JS, 2014, NAT IMMUNOL, V15, P333, DOI 10.1038/ni.2845; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carow B, 2016, J IMMUNOL, V197, P2261, DOI 10.4049/jimmunol.1600827; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Choi S, 2017, TRENDS IMMUNOL, V38, P622, DOI 10.1016/j.it.2017.06.006; Choi S, 2017, NAT IMMUNOL, V18, P433, DOI 10.1038/ni.3692; Chua YL, 2016, J IMMUNOL, V197, P3771, DOI 10.4049/jimmunol.1502676; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Gascoigne NRJ, 2016, ANNU REV CELL DEV BI, V32, P327, DOI 10.1146/annurev-cellbio-111315-125324; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Goplen NP, 2016, J IMMUNOL, V197, P2434, DOI 10.4049/jimmunol.1600037; Grossman Z, 2015, ANNU REV IMMUNOL, V33, P677, DOI 10.1146/annurev-immunol-032712-100027; Hoerter JAH, 2013, J EXP MED, V210, P1807, DOI 10.1084/jem.20122528; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Mehta M, 2018, P NATL ACAD SCI USA, V115, pE11331, DOI 10.1073/pnas.1720209115; Mercadante ER, 2017, J IMMUNOL, V199, P129, DOI 10.4049/jimmunol.1602171; Miah SMS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01326; Myers DR, 2017, TRENDS IMMUNOL, V38, P844, DOI 10.1016/j.it.2017.06.010; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Santori FR, 2004, J IMMUNOL, V173, P5517, DOI 10.4049/jimmunol.173.9.5517; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Starbeck-Miller GR, 2014, J EXP MED, V211, P105, DOI 10.1084/jem.20130901; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Walsh MC, 2014, J IMMUNOL, V193, P3992, DOI 10.4049/jimmunol.1400396; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Zhao X, 2019, JOVE-J VIS EXP, DOI 10.3791/59126; Zhao X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05288-0; Zvezdova E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1576	55	18	18	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					186	+		10.1038/s41590-019-0570-3	http://dx.doi.org/10.1038/s41590-019-0570-3		JAN 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31932808				2022-12-18	WOS:000508182300006
J	Allen, CE; Beverley, PCL; Collin, M; Diamond, EL; Egeler, RM; Ginhoux, F; Glass, C; Minkov, M; Rollins, BJ; van Halteren, A				Allen, Carl E.; Beverley, Peter C. L.; Collin, Matthew; Diamond, Eli L.; Egeler, R. Maarten; Ginhoux, Florent; Glass, Christopher; Minkov, Milen; Rollins, Barrett J.; van Halteren, Astrid			The coming of age of Langerhans cell histiocytosis	NATURE IMMUNOLOGY			English	Article							ERDHEIM-CHESTER DISEASE; DENDRITIC CELLS; T-CELLS; EXPRESSION; MUTATIONS; ASSOCIATION; DISTINCT; PATHOGENESIS; NEOPLASMS; LESIONS		[Allen, Carl E.; Beverley, Peter C. L.; Collin, Matthew; Diamond, Eli L.; Egeler, R. Maarten; Ginhoux, Florent; Glass, Christopher; Minkov, Milen; Rollins, Barrett J.; van Halteren, Astrid] Nikolas Symposia, Sci Member Steering Comm, Piraeus, Greece; [Allen, Carl E.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Beverley, Peter C. L.] Imperial Coll London, Natl Heart & Lung Inst, TB Res Ctr, London, England; [Collin, Matthew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Diamond, Eli L.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Egeler, R. Maarten] Leiden Univ, Leiden, Netherlands; [Egeler, R. Maarten] Univ Toronto, Toronto, ON, Canada; [Ginhoux, Florent] Univ Calif San Diego, La Jolla, CA 92093 USA; [Glass, Christopher] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Minkov, Milen] Sigmund Freud Univ, Dept Pediat & Adolescent Med, Clin Floridsdorf City Vienna, Vienna, Austria; [Rollins, Barrett J.] Brigham & Womens Hosp, Dept Med, Dana Farber Canc Inst, Dept Med Oncol, 75 Francis St, Boston, MA 02115 USA; [Rollins, Barrett J.] Harvard Med Sch, Boston, MA 02115 USA; [van Halteren, Astrid] Leiden Univ, Med Ctr, Utrecht, Netherlands; [van Halteren, Astrid] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Baylor College of Medicine; Texas Children's Cancer Center; Imperial College London; Newcastle University - UK; Memorial Sloan Kettering Cancer Center; Leiden University; Leiden University - Excl LUMC; University of Toronto; University of California System; University of California San Diego; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Beverley, PCL (corresponding author), Nikolas Symposia, Sci Member Steering Comm, Piraeus, Greece.; Beverley, PCL (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, TB Res Ctr, London, England.	pbeverley347@gmail.com		Glass, Christopher/0000-0003-4344-3592; Minkov, Milen/0000-0001-6471-8423; Ginhoux, Florent/0000-0002-2857-7755; Diamond, Eli/0000-0001-5456-5961	Kontoyannis family; Artemis Association on Histiocytosis; Diana Shipping; National Institutes of Health/National Cancer Institute Core Grant [P30 CA008748]; Frame Fund; Joy Family West Foundation; Histiocytosis Association; Barr Program for Innovative Basic Cancer Research; Histiocytosis Nederland; 1000 Kaarsjes voor Juultje Foundation	Kontoyannis family; Artemis Association on Histiocytosis; Diana Shipping; National Institutes of Health/National Cancer Institute Core Grant; Frame Fund; Joy Family West Foundation; Histiocytosis Association; Barr Program for Innovative Basic Cancer Research; Histiocytosis Nederland; 1000 Kaarsjes voor Juultje Foundation	Many individuals have contributed to the success of the Nikolas Symposia and their importance in the story of Langerhans cell histiocytosis. First and foremost are Nikolas and his family. Nikolas has been an inspiration to all attendees at the symposia, facing his handicaps and suffering with courage and patience. Without the funding provided by the Kontoyannis family and cosponsors the Artemis Association on Histiocytosis and S. Palios (Diana Shipping), no symposium would have taken place. The late John Pritchard organized the first meeting and insisted on the attendance of non-clinical scientists at subsequent symposia. A more formal Steering Committee organized later meetings. Steering Committee members have included A. Abbas (University of California, San Francisco, USA), R. Arceci (deceased), J. Austyn, (University of Oxford, UK), P. Bienenstock (The Nikolas Symposia), A. Chu (Charing Cross Hospital, UK), G. D'Angio (deceased), I. Davis (The Nikolas Symposia), B. Favara (Hamilton, Montana, USA), L. Filipovitch (Cincinnati, Ohio, USA), H. Gadner (Children's Cancer Research Institute, Vienna, Austria), J.-I. Henter (Karolinska University, Sweden), R. Jaffe (Children's Hospital, Pittsburgh, USA), A. Kontoyannis (The Nikolas Symposia), P. Leenen (Erasmus Medical Center, Rotterdam, The Netherlands), M. Malone (deceased), K. McClain (Baylor College of Medicine, Texas, USA), M. Merad (Mount Sinai Medical School, New York, USA), D. Moustaka (The Nikolas Symposia), K. Nichols (St Jude's Children's Research Hospital, Tennessee, USA), H. Perry (University of Southampton, UK), J. Pritchard (deceased), C. Rodriguez-Galindo (Dana-Farber Cancer Institute, Boston, USA), R. Steinman (deceased), J. Toughill (Histocytosis Association of America), C. Willman (University of New Mexico, USA) and J. Whitlock (University of Toronto, Canada).r E.L.D. is supported by the National Institutes of Health/National Cancer Institute Core Grant (P30 CA008748), the Frame Fund and the Joy Family West Foundation. B.J.R has been supported by the Histiocytosis Association and the Barr Program for Innovative Basic Cancer Research. A.V.H. is supported by Histiocytosis Nederland and 1000 Kaarsjes voor Juultje Foundation.	Aguilera-Montilla N., 2013, BLOOD, V121, P2012; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Annels NE, 2003, J EXP MED, V197, P1385, DOI 10.1084/jem.20030137; [Anonymous], 1987, Lancet, V1, P208; Aubart FC, 2017, BLOOD, V130, P1377, DOI 10.1182/blood-2017-03-771873; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Baumgartner C, 2018, CELL STEM CELL, V22, P879, DOI 10.1016/j.stem.2018.05.003; Berres ML, 2015, BRIT J HAEMATOL, V169, P3, DOI 10.1111/bjh.13247; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Cai JY, 2019, INT J CANCER, V144, P117, DOI 10.1002/ijc.31636; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Durham BH, 2019, SEMIN CELL DEV BIOL, V86, P62, DOI 10.1016/j.semcdb.2018.03.002; Durham BH, 2017, BLOOD, V130, P176, DOI 10.1182/blood-2016-12-757377; Eckstein OS, 2019, BLOOD, V133, P1691, DOI 10.1182/blood-2018-10-878363; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; Egeler RM, 2000, EUR J CANCER, V36, P2105, DOI 10.1016/S0959-8049(00)00296-3; EGELER RM, 1994, MED PEDIATR ONCOL, V23, P81, DOI 10.1002/mpo.2950230204; Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]; Gadner H, 2001, J PEDIATR-US, V138, P728, DOI 10.1067/mpd.2001.111331; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Gatalica Z, 2015, ONCOTARGET, V6, P19819, DOI 10.18632/oncotarget.4378; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Grois N, 2010, J PEDIATR-US, V156, P873, DOI 10.1016/j.jpeds.2010.03.001; Halbritter F, 2019, CANCER DISCOV, V9, P1406, DOI 10.1158/2159-8290.CD-19-0138; Hamdorf M, 2011, STEM CELLS, V29, P297, DOI 10.1002/stem.564; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Heritier S, 2016, J CLIN ONCOL, V34, P3023, DOI 10.1200/JCO.2015.65.9508; Hervier B, 2014, BLOOD, V124, P1119, DOI 10.1182/blood-2013-12-543793; Hutter C, 2012, BLOOD, V120, P5199, DOI 10.1182/blood-2012-02-410241; Kamata T, 2017, BLOOD, V130, P514, DOI 10.1182/blood-2017-02-770149; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Milne P, 2017, BLOOD, V130, P167, DOI 10.1182/blood-2016-12-757823; Minkov M, 2011, PEDIATR DRUGS, V13, P75, DOI 10.2165/11538540-000000000-00000; Mourah S, 2016, EUR RESPIR J, V47, P1785, DOI 10.1183/13993003.01677-2015; Murakami I, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0261-y; Naik S. H., 2007, NAT IMMUNOL, V1217-1226; Peckham-Gregory EC, 2017, BLOOD, V130, P2229, DOI 10.1182/blood-2017-08-800565; Petersen BL, 2003, HISTOPATHOLOGY, V42, P186, DOI 10.1046/j.1365-2559.2003.01565.x; Quispel W. T., 2015, ONCOIMMUNOLOGY, V5, P331; Quispel WT, 2015, J INTERF CYTOK RES, V35, P831, DOI 10.1089/jir.2014.0190; Schouten B, 2002, J PEDIAT HEMATOL ONC, V24, P727, DOI 10.1097/00043426-200212000-00009; Schwentner R, 2019, PEDIATR RES, V85, P856, DOI 10.1038/s41390-018-0238-y; Senechal B, 2007, PLOS MED, V4, P1374, DOI 10.1371/journal.pmed.0040253; Weintraub M, 1998, J PEDIAT HEMATOL ONC, V20, P12, DOI 10.1097/00043426-199801000-00002; Willman C. L., 1994, NEW ENGL J MED, V154-160, P343; Yang JF, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/196098; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2	53	18	20	4	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					1	7		10.1038/s41590-019-0558-z	http://dx.doi.org/10.1038/s41590-019-0558-z			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31831887				2022-12-18	WOS:000515136500001
J	Melum, E; Jiang, XJ; Baker, KD; Macedo, MF; Fritsch, J; Dowds, CM; Wang, J; Pharo, A; Kaser, A; Tan, C; Pereira, CS; Kelly, SL; Duan, JJ; Karlsen, TH; Exley, MA; Schutze, S; Zajonc, DM; Merrill, AH; Schuchman, EH; Zeissig, S; Blumberg, RS				Melum, Espen; Jiang, Xiaojun; Baker, Kristi D.; Macedo, M. Fatima; Fritsch, Juergen; Dowds, C. Marie; Wang, Jing; Pharo, Anne; Kaser, Arthur; Tan, Corey; Pereira, Catia S.; Kelly, Samuel L.; Duan, Jingjing; Karlsen, Tom H.; Exley, Mark A.; Schuetze, Stefan; Zajonc, Dirk M.; Merrill, Alfred H.; Schuchman, Edward H.; Zeissig, Sebastian; Blumberg, Richard S.			Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; HUMAN ACID SPHINGOMYELINASE; LYSOSOMAL STORAGE; CD1D; MICE; SPHINGOLIPIDS; ACTIVATION; EXPRESSION; FEATURES; DISTINCT	Invariant natural killer T (iNKT) cells recognize activating self and microbial lipids presented by CD1d. CD1d can also bind non-activating lipids, such as sphingomyelin. We hypothesized that these serve as endogenous regulators and investigated humans and mice deficient in acid sphingomyelinase (ASM), an enzyme that degrades sphingomyelin. We show that ASM absence in mice leads to diminished CD1d-restricted antigen presentation and iNKT cell selection in the thymus, resulting in decreased iNKT cell levels and resistance to iNKT cell-mediated inflammatory conditions. Defective antigen presentation and decreased iNKT cells are also observed in ASM-deficient humans with Niemann-Pick disease, and ASM activity in healthy humans correlates with iNKT cell phenotype. Pharmacological ASM administration facilitates antigen presentation and restores the levels of iNKT cells in ASM-deficient mice. Together, these results demonstrate that control of non-agonistic CD1d-associated lipids is critical for iNKT cell development and function in vivo and represents a tight link between cellular sphingolipid metabolism and immunity.	[Melum, Espen; Tan, Corey; Exley, Mark A.; Blumberg, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Gastroenterol Div, Dept Med, Boston, MA 02115 USA; [Melum, Espen; Jiang, Xiaojun; Tan, Corey; Karlsen, Tom H.] Oslo Univ Hosp, Div Surg Inflammatory Dis & Transplantat, Dept Transplantat Med, Norwegian PSC Res Ctr,Rikshosp, Oslo, Norway; [Melum, Espen; Jiang, Xiaojun; Pharo, Anne; Tan, Corey; Karlsen, Tom H.] Univ Oslo, Oslo, Norway; [Baker, Kristi D.] Univ Alberta, Dept Oncol Med Microbiol & Immunol, Edmonton, AB, Canada; [Macedo, M. Fatima] Univ Porto, i3S, Porto, Portugal; [Macedo, M. Fatima; Pereira, Catia S.] Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; [Macedo, M. Fatima] Univ Aveiro, Dept Med Sci, Aveiro, Portugal; [Fritsch, Juergen; Schuetze, Stefan] Univ Kiel, Inst Immunol, Kiel, Germany; [Fritsch, Juergen] Univ Regensburg, Dept Infect Prevent & Infect Dis, Regensburg, Germany; [Dowds, C. Marie] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Wang, Jing] Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA USA; [Kaser, Arthur] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge, England; [Kelly, Samuel L.; Merrill, Alfred H.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Kelly, Samuel L.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Zajonc, Dirk M.] Univ Ghent, Dept Internal Med, Fac Med & Hlth Sci, Ghent, Belgium; [Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zeissig, Sebastian] Tech Univ Dresden, Univ Med Ctr Dresden, Dept Med 1, Dresden, Germany; [Zeissig, Sebastian] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Duan, Jingjing; Zeissig, Sebastian; Blumberg, Richard S.] Nanchang Univ, Human Aging Res Inst, Sch Life Sci, Nanchang, Jiangxi, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; National Hospital Norway; University of Oslo; University of Alberta; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade de Aveiro; University of Kiel; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Cambridge; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Ghent University; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden; Technische Universitat Dresden; Nanchang University	Melum, E (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Gastroenterol Div, Dept Med, Boston, MA 02115 USA.; Melum, E (corresponding author), Oslo Univ Hosp, Div Surg Inflammatory Dis & Transplantat, Dept Transplantat Med, Norwegian PSC Res Ctr,Rikshosp, Oslo, Norway.	espen.melum@medisin.uio.no; rblumberg@bwh.harvard.edu	Zeissig, Sebastian/B-6297-2012; Center, Norwegian Transgenic/T-2512-2018; Macedo, Fatima/L-4623-2013; Fritsch, Jürgen/Z-1146-2018	Zeissig, Sebastian/0000-0001-5124-0897; Macedo, Fatima/0000-0002-2252-6105; Fritsch, Jürgen/0000-0001-6909-6096; Exley, Mark/0000-0002-5088-1032; Cardoso, Maria Teresa/0000-0001-9908-3739; Melum, Espen/0000-0001-6903-6878; Dowds, C Marie/0000-0002-7170-0667	US National Institutes of Health [HD28607, DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK034854]; Southeastern Norwegian Health Trust; Unger-Vetlesen Foundation; Caroline Musaeus Aarvolds fund; Norwegian PSC Research Center; European Research Council (ERC Starting Grant agreement) [336528]; Deutsche Forschungsgemeinschaft (DFG) [ZE 814/4-1, ZE 814/7-1]; DFG Excellence Cluster Center for Regenerative Therapies Dresden; DFG [SCHU733/14-1]; DFG Excellence Cluster Inflammation at Interfaces Schleswig-Holstein [EXC 306]; FEDER funds under the Portugal 2020 partnership agreement through the Norte Portugal Regional Operational Program (Norte 2020) [Norte-010145-FEDER-000012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028607] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Southeastern Norwegian Health Trust; Unger-Vetlesen Foundation; Caroline Musaeus Aarvolds fund; Norwegian PSC Research Center; European Research Council (ERC Starting Grant agreement); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Cluster Center for Regenerative Therapies Dresden(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG Excellence Cluster Inflammation at Interfaces Schleswig-Holstein(German Research Foundation (DFG)); FEDER funds under the Portugal 2020 partnership agreement through the Norte Portugal Regional Operational Program (Norte 2020); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by US National Institutes of Health grants HD28607 (MERIT Award) (to E.H.S.), DK044319, DK051362, DK053056, DK088199 and the Harvard Digestive Diseases Center DK034854 (to R.S.B.), the Southeastern Norwegian Health Trust, the Unger-Vetlesen Foundation, the Caroline Musaeus Aarvolds fund and the Norwegian PSC Research Center (to E.M.), the European Research Council (ERC Starting Grant agreement no. 336528), the Deutsche Forschungsgemeinschaft (DFG) (ZE 814/4-1, ZE 814/7-1) and the DFG Excellence Cluster Center for Regenerative Therapies Dresden (to S.Z.), the DFG (SCHU733/14-1) (to S.S. and J.F.) and the DFG Excellence Cluster Inflammation at Interfaces Schleswig-Holstein (EXC 306) (to S.S.). This work was partially funded by FEDER funds under the Portugal 2020 partnership agreement through the Norte Portugal Regional Operational Program (Norte 2020) (Norte-010145-FEDER-000012). J. Bame, J. Danielson, A. Dias, M.L. Maia, S. Torquato, J. Ogaard and J. Anmarkrud are thanked for invaluable technical help. We thank the following physicians for patient and control subject recruitment in Portugal: T. Cardoso and N. Alegrete (CHS Joao, Porto), E. Martins and E. Silva (CH Porto, Porto), and L. Ribeiro and A. Pereira (CHU Coimbra, Coimbra). We acknowledge the blood bank of CHS Joao, Porto, and the National Institutes of Health tetramer core facility for provision of PBS57loaded CD1d tetramer and CD1d monomer.	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Balreira A, 2005, BRIT J HAEMATOL, V129, P667, DOI 10.1111/j.1365-2141.2005.05503.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Behar SM, 1999, J IMMUNOL, V162, P161; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fritsch J, 2019, TRAFFIC, V20, P246, DOI 10.1111/tra.12631; Gapin L, 2013, CURR OPIN IMMUNOL, V25, P168, DOI 10.1016/j.coi.2013.01.002; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; He XX, 1999, BBA-PROTEIN STRUCT M, V1432, P251, DOI 10.1016/S0167-4838(99)00069-2; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGovern MM, 2013, GENET MED, V15, P618, DOI 10.1038/gim.2013.4; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Miranda SRP, 2000, FASEB J, V14, P1988, DOI 10.1096/fj.00-0014com; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira CS, 2013, MOL GENET METAB, V108, P241, DOI 10.1016/j.ymgme.2013.01.018; Perrotta C, 2010, PHYSIOLOGY, V25, P64, DOI 10.1152/physiol.00048.2009; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; SALINAS FA, 1972, J CELL PHYSIOL, V80, P339, DOI 10.1002/jcp.1040800304; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Speak AO, 2012, EUR J IMMUNOL, V42, P1886, DOI 10.1002/eji.201141821; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Thedrez A, 2007, BLOOD, V110, P251, DOI 10.1182/blood-2007-01-066217; Truman JP, 2011, CELL MOL LIFE SCI, V68, P3293, DOI 10.1007/s00018-011-0686-6; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zeissig Sebastian, 2013, Methods Mol Biol, V960, P557, DOI 10.1007/978-1-62703-218-6_41; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	59	18	18	3	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1644	+		10.1038/s41590-019-0504-0	http://dx.doi.org/10.1038/s41590-019-0504-0			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31636468	Green Submitted, Green Accepted			2022-12-18	WOS:000497949800019
J	Damo, M; Joshi, NS				Damo, Martina; Joshi, Nikhil S.			T-reg cell IL-10 and IL-35 exhaust CD8(+) T cells in tumors	NATURE IMMUNOLOGY			English	Editorial Material								Expression of the immunosuppressive cytokines IL-10 and IL-35 by tumor-infiltrating regulatory T cells drives exhaustion of intratumoral CD8(+) T cells through a common pathway dependent on the transcription factor BLIMP-1.	[Damo, Martina; Joshi, Nikhil S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA	Yale University	Joshi, NS (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.	nikhil.joshi@yale.edu		Joshi, Nikhil/0000-0002-7045-7837				Groux H, 1998, J IMMUNOL, V160, P3188; Karydis I, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1143997; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sawant DV, 2019, NAT IMMUNOL, V20, P724, DOI 10.1038/s41590-019-0346-9; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806; 2013, J EXP MED, V210, P1695, DOI DOI 10.1084/JEM.20130579; 2015, TRENDS IMMUNOL, V36, P265, DOI DOI 10.1016/J.IT.2015.02.008	13	18	21	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					674	675		10.1038/s41590-019-0389-y	http://dx.doi.org/10.1038/s41590-019-0389-y			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31011189				2022-12-18	WOS:000468505100010
J	Sekine, H; Yamamoto, M; Motohashi, H				Sekine, Hiroki; Yamamoto, Masayuki; Motohashi, Hozumi			Tumors sweeten macrophages with acids	NATURE IMMUNOLOGY			English	Editorial Material							LACTATE		[Sekine, Hiroki; Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Motohashi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi, Japan.	hozumim@med.tohoku.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Sekine, Hiroki/0000-0002-0929-6456				Bohn, 2018, NAT IMMUNOL, DOI [10.1038/s41590-018-0226-8, DOI 10.1038/S41590-018-0226-8]; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Kitamura H, 2017, ONCOGENE, V36, P6315, DOI 10.1038/onc.2017.236; Seliger B, 1998, EUR J IMMUNOL, V28, P122, DOI 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F; Walenta S, 2000, CANCER RES, V60, P916	10	18	19	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1281	1283		10.1038/s41590-018-0258-0	http://dx.doi.org/10.1038/s41590-018-0258-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30397351				2022-12-18	WOS:000452873000008
J	Etzensperger, R; Kadakia, T; Tai, XG; Alag, A; Guinter, TI; Egawa, T; Erman, B; Singer, A				Etzensperger, Ruth; Kadakia, Tejas; Tai, Xuguang; Alag, Amala; Guinter, Terry I.; Egawa, Takeshi; Erman, Batu; Singer, Alfred			Identification of lineage-specifying cytokines that signal all CD8(+)-cytotoxic-lineage-fate 'decisions' in the thymus	NATURE IMMUNOLOGY			English	Article							T-CELL LINEAGE; TGF-BETA; STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTORS; RUNX PROTEINS; DIFFERENTIATION; THYMOCYTES; EXPRESSION; PROMOTES; CD4	T cell antigen receptor (TCR) signaling in the thymus initiates positive selection, but the CD8(+)-lineage fate is thought to be induced by cytokines after TCR signaling has ceased, although this remains controversial and unproven. We have identified four cytokines (IL-6, IFN-gamma, TSLP and TGF-beta) that did not signal via the common gamma-chain (gamma(c)) receptor but that, like IL-7 and IL-15, induced expression of the lineage-specifying transcription factor Runx3d and signaled the generation of CD8(+) T cells. Elimination of in vivo signaling by all six of these 'lineage-specifying cytokines' during positive selection eliminated Runx3d expression and completely abolished the generation of CD8(+) single-positive thymocytes. Thus, this study proves that signaling during positive selection by lineage-specifying cytokines is responsible for all CD8(+)-lineage-fate 'decisions' in the thymus.	[Etzensperger, Ruth; Kadakia, Tejas; Tai, Xuguang; Alag, Amala; Guinter, Terry I.; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Erman, Batu] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Sabanci University	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	singera@nih.gov	erman, batu/AAE-1963-2020	Egawa, Takeshi/0000-0001-7489-1051	Intramural Research Program of the US National Institutes of Health; National Cancer Institute; Center for Cancer Research; US National Institutes of Health [R01AI097244-01A1]; NATIONAL CANCER INSTITUTE [ZIABC011111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. McCaughtry for initial contributions to the project; J.-H. Park, V. Lazarevic, D. Singer, X. Zhou and M. Kimura for critical reading of the manuscript; M. Kubo (Tokyo University of Science) for SOCS<SUP>Tg</SUP> mice; W. Leonard (National Heart, Lung and Blood Institute) for TSLPR<SUP>KO</SUP> mice; W. Chen (National Institute of Dental and Craniofacial Research) for Tgfbr1<SUP>fl</SUP> mice; D. Littman (New York University) for Runx3d<SUP>YFP</SUP> mice; R. Bosselut (National Cancer Institute) for ThPOK<SUP>KO</SUP> mice; and S. Sharrow, A. Adams and L. Granger for flow cytometry. Supported by the Intramural Research Program of the US National Institutes of Health, the National Cancer Institute, the Center for Cancer Research and the US National Institutes of Health (R01AI097244-01A1 to T.E.).	Adoro S, 2012, EMBO J, V31, P366, DOI 10.1038/emboj.2011.388; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Catlett IM, 2005, NAT IMMUNOL, V6, P715, DOI 10.1038/ni1211; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Dewas C, 2015, J IMMUNOL, V194, P1372, DOI 10.4049/jimmunol.1400519; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Kappes DJ, 2006, IMMUNOL REV, V209, P237, DOI 10.1111/j.0105-2896.2006.00344.x; Kimura MY, 2016, NAT IMMUNOL, V17, P1415, DOI 10.1038/ni.3560; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; KULKARNI AB, 1993, AM J PATHOL, V143, P3; Kurd N, 2016, IMMUNOL REV, V271, P114, DOI 10.1111/imr.12398; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Littman DR, 2016, J IMMUNOL, V196, P1983, DOI 10.4049/jimmunol.1600032; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Ouyang WM, 2013, IMMUNITY, V39, P335, DOI 10.1016/j.immuni.2013.07.016; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pobezinsky LA, 2015, NAT IMMUNOL, V16, P517, DOI 10.1038/ni.3146; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shi MJ, 1998, J IMMUNOL, V161, P6751; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vaillant F, 1999, ONCOGENE, V18, P7124, DOI 10.1038/sj.onc.1203202; Voon DCC, 2015, IMMUNOLOGY, V146, P523, DOI 10.1111/imm.12535; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Xiong YM, 2011, EUR J IMMUNOL, V41, P568, DOI 10.1002/eji.201041098; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	53	18	18	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1218	+		10.1038/ni.3847	http://dx.doi.org/10.1038/ni.3847			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28945245	Green Accepted			2022-12-18	WOS:000413457300008
J	Berthault, C; Ramond, C; Burlen-Defranoux, O; Soubigou, G; Chea, S; Golub, R; Pereira, P; Vieira, P; Cumano, A				Berthault, Claire; Ramond, Cyrille; Burlen-Defranoux, Odile; Soubigou, Guillaume; Chea, Sylvestre; Golub, Rachel; Pereira, Pablo; Vieira, Paulo; Cumano, Ana			Asynchronous lineage priming determines commitment to T cell and B cell lineages in fetal liver	NATURE IMMUNOLOGY			English	Article							COMMON LYMPHOID PROGENITORS; BONE-MARROW; INTERLEUKIN-7 RECEPTOR; GENE-EXPRESSION; DENDRITIC CELLS; FLT3 LIGAND; STEM-CELLS; ADULT; DIFFERENTIATION; IDENTIFICATION	The molecular events that initiate lymphoid-lineage specification remain unidentified because the stages of differentiation during which lineage commitment occurs are difficult to characterize. We isolated fetal liver progenitor cells undergoing restriction of their differentiation potential toward the T cell-innate lymphoid cell lineage or the B cell lineage. Transcripts that defined the molecular signatures of these two subsets were sequentially upregulated in lympho-myeloid precursor cells and in common lymphoid progenitor cells, respectively, and this preceded lineage restriction; this indicates that T cell-versus-B cell commitment is not a binary fate 'decision'. The T cell-bias and B cell-bias transcriptional programs were frequently co-expressed in common lymphoid progenitor cells and were segregated in subsets biased toward T cell differentiation or B cell differentiation, after interleukin 7 (IL-7) signaling that controlled the number of progenitor cells engaging in T cell differentiation versus B cell differentiation.	[Berthault, Claire; Ramond, Cyrille; Burlen-Defranoux, Odile; Chea, Sylvestre; Golub, Rachel; Pereira, Pablo; Vieira, Paulo; Cumano, Ana] Pasteur Inst, Immunol Dept, Unit Lymphopoiesis, Paris, France; [Berthault, Claire; Ramond, Cyrille; Burlen-Defranoux, Odile; Chea, Sylvestre; Golub, Rachel; Pereira, Pablo; Vieira, Paulo; Cumano, Ana] INSERM, U1223, Paris, France; [Berthault, Claire; Burlen-Defranoux, Odile; Chea, Sylvestre; Golub, Rachel; Pereira, Pablo; Vieira, Paulo; Cumano, Ana] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Ramond, Cyrille] Univ Paris 06, Paris, France; [Soubigou, Guillaume] Inst Pasteur, Dept Genomes & Genet, Plate Forme Transcriptome & Epigenome, Paris, France; [Berthault, Claire; Ramond, Cyrille] Inst Cochin, INSERM, Res Ctr Growth & Signaling, U1016, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cumano, A (corresponding author), Pasteur Inst, Immunol Dept, Unit Lymphopoiesis, Paris, France.; Cumano, A (corresponding author), INSERM, U1223, Paris, France.; Cumano, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France.	ana.cumano@pasteur.fr	GOLUB, rachel/X-8717-2019; Rachel, GOLUB/M-7188-2014	GOLUB, rachel/0000-0002-2306-5363; Rachel, GOLUB/0000-0002-2306-5363; Cumano, Ana/0000-0002-4578-959X; Berthault, Claire/0000-0001-6848-0993; Vieira, Paulo/0000-0003-1307-5119; Pereira, Pablo/0000-0003-1784-2776	Pasteur Institute; Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de la Recherche; Association pour la Recherche sur le Cancer; La Ligue Contre Le Cancer; Universite Paris Diderot; Universite Pierre et Marie Curie; Agence Nationale de la Recherche; program REVIVE (Investment for the Future); project Twothyme; Pasteur-Weizmann Foundation	Pasteur Institute; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Ligue Contre Le Cancer(Ligue nationale contre le cancer); Universite Paris Diderot; Universite Pierre et Marie Curie; Agence Nationale de la Recherche(French National Research Agency (ANR)); program REVIVE (Investment for the Future); project Twothyme; Pasteur-Weizmann Foundation	We thank A. Bandeira and D. Guy-Grand for critical reading; S. Novault and S. Schmutz for support; H.-R. Rodewald (German Cancer Center DKFZ) for the IL-7R alpha-Cre mouse line; and P. Chambon (IGBMC Strasbourg) for the TSLP-KO mice. This work benefited from data assembled by the ImmGen Consortium. Supported by the Pasteur Institute, Institut National de la Sante et de la Recherche Medicale (INSERM), the Ministere de la Recherche (C.B., C.R. and S.C.), Association pour la Recherche sur le Cancer (S.C. and R.G.), La Ligue Contre Le Cancer (C.B. and C.R.), Universite Paris Diderot (C.B., R.G. and S.C.), Universite Pierre et Marie Curie (C.R.), the Agence Nationale de la Recherche (project Myeloten (R.G.); program REVIVE (Investment for the Future) (A.C.); and project Twothyme (A.C.) and the Pasteur-Weizmann Foundation (A.C.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Borge OJ, 1999, BLOOD, V94, P3781, DOI 10.1182/blood.V94.11.3781.423k04_3781_3790; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Cvejic A, 2016, IMMUNOL CELL BIOL, V94, P230, DOI 10.1038/icb.2015.96; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Sousa AP, 2012, J IMMUNOL, V189, P3822, DOI 10.4049/jimmunol.1103723; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Lee DM, 1996, IMMUNOGENETICS, V44, P108; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	49	18	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1139	+		10.1038/ni.3820	http://dx.doi.org/10.1038/ni.3820			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28825702				2022-12-18	WOS:000411134000018
J	Benoist, C				Benoist, Christophe		ImmGen Consortium	Open-source ImmGen: mononuclear phagocytes	NATURE IMMUNOLOGY			English	Letter									[Benoist, Christophe; ImmGen Consortium] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Harvard Medical School	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.	cbdm@hms.harvard.edu			NIAID NIH HHS [R24 AI072073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032	4	18	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					741	741		10.1038/ni.3478	http://dx.doi.org/10.1038/ni.3478			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27327993	Bronze			2022-12-18	WOS:000378283200001
J	Bandukwala, HS; Rao, A				Bandukwala, Hozefa S.; Rao, Anjana			'Nurr'ishing T-reg cells: Nr4a transcription factors control Foxp3 expression	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; MUTANT	The Nr4a family of transcription factors transactivate expression of the transcription factor Foxp3 and are essential for the generation of regulatory T cells. Mice deficient in all three members of the Nr4a family develop massive multiorgan inflammation.	[Bandukwala, Hozefa S.; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signalling & Gene Express, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Bandukwala, HS (corresponding author), La Jolla Inst Allergy & Immunol, Div Signalling & Gene Express, La Jolla, CA 92037 USA.	arao@liai.org			NCI NIH HHS [R01 CA042471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	10	18	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					201	203		10.1038/ni.2546	http://dx.doi.org/10.1038/ni.2546			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416671	Green Accepted			2022-12-18	WOS:000315065400008
J	Ikemizu, S; Chirifu, M; Davis, SJ				Ikemizu, Shinji; Chirifu, Mami; Davis, Simon J.			IL-2 and IL-15 signaling complexes: different but the same	NATURE IMMUNOLOGY			English	News Item							CRYSTAL-STRUCTURE; RECEPTOR; INTERLEUKIN-2; BIOLOGY; TRANS	Interleukin 2 (IL-2) and IL-15 use receptors with the same signaling subunits. New structural data show that the signaling complexes they form are topologically nearly identical, which suggests that other factors are responsible for the distinct signaling properties of these complexes.	[Ikemizu, Shinji; Chirifu, Mami] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Davis, Simon J.] Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford, England; [Davis, Simon J.] Radcliffe Dept Med, Human Immunol Unit, MRC, Oxford, England	Kumamoto University; University of Oxford	Ikemizu, S (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	ikemizu@gpo.kumamoto-u.ac.jp; simon.davis@imm.ox.ac.uk			MRC [MC_UU_12010/4] Funding Source: UKRI; Medical Research Council [MC_UU_12010/4] Funding Source: researchfish; Wellcome Trust [098274] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Liparoto SF, 2002, BIOCHEMISTRY-US, V41, P2543, DOI 10.1021/bi011692m; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Olsen SK, 2007, J BIOL CHEM, V282, P37191, DOI 10.1074/jbc.M706150200; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893	12	18	21	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1141	1142		10.1038/ni.2472	http://dx.doi.org/10.1038/ni.2472			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160210				2022-12-18	WOS:000311217900006
J	Zelante, T; Ricciardi-Castagnoli, P				Zelante, Teresa; Ricciardi-Castagnoli, Paola			The yin-yang nature of CSF1R-binding cytokines	NATURE IMMUNOLOGY			English	Editorial Material							LANGERHANS CELLS; DENDRITIC CELLS; MYELOID CELLS; IN-VIVO; MACROPHAGES; RECEPTOR; CSF-1; IL-34	Most myeloid cells express the growth-factor receptor CSF1R. Recognition of interleukin 34 by CSF1R is required for the development of tissue-resident Langerhans cells and microglia, which explains the independence of their growth from CSF1.	[Zelante, Teresa; Ricciardi-Castagnoli, Paola] Biopolis, Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Zelante, T (corresponding author), Biopolis, Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.	paola_castagnoli@immunol.a-star.edu.sg	zelante, teresa/F-7933-2017	zelante, teresa/0000-0002-7071-0302				Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	13	18	18	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					717	719		10.1038/ni.2375	http://dx.doi.org/10.1038/ni.2375			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814343				2022-12-18	WOS:000306569600005
J	Ippagunta, SK; Malireddi, RKS; Shaw, PJ; Neale, GA; Vande Walle, L; Fukui, Y; Green, DR; Lamkanfi, M; Kanneganti, TD				Ippagunta, Sirish K.; Malireddi, R.K. Subbarao; Shaw, Patrick J.; Neale, Geoffrey A.; Vande Walle, Lieselotte; Fukui, Yoshinori; Green, Douglas R.; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Defective Dock2 expression in a subset of ASC-deficient mouse lines	NATURE IMMUNOLOGY			English	Editorial Material							INNATE IMMUNE-RESPONSES; RAC ACTIVATION; ADAPTER ASC; INFLAMMASOME; CASPASE-1; PROTEIN; CELLS; RNA		[Ippagunta, Sirish K.; Malireddi, R.K. Subbarao; Shaw, Patrick J.; Green, Douglas R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN USA; [Neale, Geoffrey A.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN USA; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, Ghent, Belgium; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] VIB, Dept Med Prot Res, Ghent, Belgium; [Fukui, Yoshinori] Kyushu Univ, Dept Immunobiol, Kyushu, Japan; [Fukui, Yoshinori] Kyushu Univ, Neurosci Med Inst Bioregulat, Kyushu, Japan	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Ghent University; Flanders Institute for Biotechnology (VIB); Kyushu University; Kyushu University	Lamkanfi, M (corresponding author), Univ Ghent, Dept Biochem, Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be; thirumala-devi.kanneganti@stjude.org	Green, Douglas R/N-8083-2018; Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013; Kanneganti, Thirumala-Devi/Y-2503-2019	Green, Douglas R/0000-0002-7332-1417; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Ippagunta, Sirish Kumar/0000-0002-7449-0511; Fukui, Yoshinori/0000-0003-2335-8745				Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	21	18	18	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					701	703		10.1038/ni.2389	http://dx.doi.org/10.1038/ni.2389			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22905357	Bronze			2022-12-18	WOS:000305483800016
J	Ellyard, JI; Vinuesa, CG				Ellyard, Julia I.; Vinuesa, Carola G.			A BATF-ling connection between B cells and follicular helper T cells	NATURE IMMUNOLOGY			English	Editorial Material							C-MAF; DIFFERENTIATION; EXPRESSION; IL-21; INTERLEUKIN-21; GENERATION; BCL6	The transcription factor BATF directly regulates key components of the formation and function of follicular helper T cells and antibody class switching in B cells.	[Ellyard, Julia I.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Ellyard, JI (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298				Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	12	18	20	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					519	520		10.1038/ni.2042	http://dx.doi.org/10.1038/ni.2042			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21587310				2022-12-18	WOS:000290707100010
J	Ohkura, N; Sakaguchi, S				Ohkura, Naganari; Sakaguchi, Shimon			Maturation of effector regulatory T cells	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTIONAL REPRESSOR BLIMP-1; HOMEOSTASIS; TOLERANCE	Regulatory T cells adopt specialized differentiation programs controlled by transcription factors. The transcription factors Blimp-1 and IRF4 are now shown to be pivotal in the maturation of effector regulatory T cells.	[Ohkura, Naganari; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan; [Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan	Kyoto University; Osaka University	Ohkura, N (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	12	18	21	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					283	284		10.1038/ni0411-283	http://dx.doi.org/10.1038/ni0411-283			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21423222				2022-12-18	WOS:000288593400004
J	Rothenberg, ME				Rothenberg, Marc E.			Innate sensing of nickel	NATURE IMMUNOLOGY			English	Editorial Material							ALLERGY	Although nickel allergy is very common, the specific receptor for nickel has not been identified. TLR4 is now shown to bind nickel and cause inflammation, an interaction that is specific to humans.	Univ Cincinnati, Coll Med, Dept Pediat,Med Ctr, Div Allergy & Immunol,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat,Med Ctr, Div Allergy & Immunol,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA.	Rothenberg@cchmc.org						Carlsen BC, 2010, CONTACT DERMATITIS, V63, P89, DOI 10.1111/j.1600-0536.2010.01748.x; Fonacier LS, 2010, J ALLERGY CLIN IMMUN, V125, pS138, DOI 10.1016/j.jaci.2009.05.039; Gilmour PS, 2004, INHAL TOXICOL, V16, P5, DOI 10.1080/08958370490442827; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Moennich JN, 2009, CUTIS, V84, P199; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198	8	18	18	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					781	782		10.1038/ni0910-781	http://dx.doi.org/10.1038/ni0910-781			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20720584				2022-12-18	WOS:000281115500005
J	Paterson, AM; Sharpe, AH				Paterson, Alison M.; Sharpe, Arlene H.			Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE-DISEASE; TOLERANCE	CTLA-4 is a potent coinhibitory molecule that is critical for peripheral T cell tolerance. New data suggest that CTLA-4 exerts its critical immunoregulatory functions by controlling antigen-specific conventional T cells as well as regulatory T cells.	[Paterson, Alison M.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Paterson, AM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu			NIAID NIH HHS [R37 AI038310, R01 AI040614, P01 AI056299] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040614, R37AI038310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bachmann MF, 1999, J IMMUNOL, V163, P1128; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	14	18	20	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					109	111		10.1038/ni0210-109	http://dx.doi.org/10.1038/ni0210-109			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084066	Green Accepted			2022-12-18	WOS:000273730200005
J	Mathis, D; Benoist, C				Mathis, Diane; Benoist, Christophe			Levees of immunological tolerance	NATURE IMMUNOLOGY			English	Review							CELL-DIRECTED THERAPIES; T-CELLS; AUTOIMMUNE-DISEASE; NOD MICE; MECHANISMS; REPERTOIRE; DEFICIENCY; ESCAPE; GENE; AIRE	Immunological tolerance guards against spurious immune responses to body constituents. Tolerance encompasses a network of mechanisms: central and peripheral, cell-autonomous and cell-interactive. Our understanding of these mechanisms has improved greatly over recent years, often reflecting new insights into the processes underlying particular autoimmune diseases. Yet it is possible that important tolerance mechanisms remain to be discovered, perhaps an explanation for the so-far disappointing clinical translation to the prevention and cure of autoimmune diseases.	[Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu			US National Institutes of Health [DK059658, DK060027, AI051530, AI56299]; Juvenile Diabetes Research Foundation [4-2007-1057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530, R01AI051530, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059658, R01DK060027, R37DK060027] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors' laboratory is funded by grants from the US National Institutes of Health (DK059658, DK060027, AI051530, AI56299) and the Juvenile Diabetes Research Foundation (4-2007-1057).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Binstadt BA, 2009, P NATL ACAD SCI USA, V106, P16758, DOI 10.1073/pnas.0909132106; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; GAMMON G, 1989, NATURE, V342, P183, DOI 10.1038/342183a0; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Leandro MJ, 2009, CLIN EXP IMMUNOL, V157, P191, DOI 10.1111/j.1365-2249.2009.03978.x; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; MUELLER DL, 2010, PROBLEM PERIPHERAL S, V11, P21; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; PALMER MT, 2010, AUTOIMMUNITY INCREAS, V11, P36; Rasooly L, 1996, CLIN IMMUNOL IMMUNOP, V81, P287, DOI 10.1006/clin.1996.0191; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; VAYSBURD M, 1995, J EXP MED, V182, P897, DOI 10.1084/jem.182.3.897; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008	28	18	19	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					3	6		10.1038/ni.1833	http://dx.doi.org/10.1038/ni.1833			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016503				2022-12-18	WOS:000272855300002
J	Cao, XT				Cao, Xuetao			New DNA-sensing pathway feeds RIG-I with RNA	NATURE IMMUNOLOGY			English	Editorial Material							INNATE IMMUNITY; CYTOSOLIC DNA; CELLS; INTERFERONS; INDUCE; BETA	Cytosolic DNA sensors have remained poorly defined so far. Two recent studies identify a previously undefined cytosolic DNA-sensing pathway that depends on the RNA polymerase III-mediated conversion of microbial DNA into 5'-triphosphate double-stranded RNA that activates the RNA helicase RIG-I.	[Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@public3.sta.net.cn						Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	11	18	26	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1049	1051		10.1038/ni1009-1049	http://dx.doi.org/10.1038/ni1009-1049			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19767723				2022-12-18	WOS:000270006900005
J	Iizasa, H; Nishikura, K				Iizasa, Hisashi; Nishikura, Kazuko			A new function for the RNA-editing enzyme ADAR1	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSION; GENE		[Iizasa, Hisashi; Nishikura, Kazuko] Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA	The Wistar Institute	Iizasa, H (corresponding author), Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA.	kazuko@wistar.org	Iizasa, Hisashi/A-9821-2012		NHLBI NIH HHS [R01 HL070045-04, R01 HL070045] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536-18, R01 GM040536] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	12	18	21	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					16	18		10.1038/ni0109-16	http://dx.doi.org/10.1038/ni0109-16			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088736	Green Accepted			2022-12-18	WOS:000261788800007
J	Billadeau, DD				Billadeau, Daniel D.			PTEN gives neutrophils direction	NATURE IMMUNOLOGY			English	Editorial Material							CHEMOTAXIS; MIGRATION; FMLP		[Billadeau, Daniel D.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Billadeau, Daniel D.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Billadeau, DD (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu						Campbell JJ, 1997, EUR J IMMUNOL, V27, P2571, DOI 10.1002/eji.1830271016; Chodniewicz D, 2003, BLOOD, V101, P1181, DOI 10.1182/blood-2002-05-1435; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107	13	18	20	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					716	718		10.1038/ni0708-716	http://dx.doi.org/10.1038/ni0708-716			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18563079				2022-12-18	WOS:000256904900006
J	Kasturi, SP; Pulendran, B				Kasturi, Sudhir Pai; Pulendran, Bali			Cross-presentation: avoiding trafficking chaos?	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; COMPARTMENT; PHAGOSOMES; ANTIGENS; ER	Cross-presentation of antigens is essential for the responses of cytotoxic T cells to tumors and viruses. Two new papers offer insights into the subcellular compartment and types of dendritic cells that mediate cross-presentation.	[Kasturi, Sudhir Pai; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA	Emory University	Kasturi, SP (corresponding author), Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021					Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LIN ML, 2008, IMMUNOL CELL BIOL; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018	14	18	19	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					461	463		10.1038/ni0508-461	http://dx.doi.org/10.1038/ni0508-461			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425099				2022-12-18	WOS:000255153500005
J	Cao, XT				Cao, Xuetao			Immunology in China: the past, present and future	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; T-CELLS; RESPONSES; GAMMA	Over the past decade immunological research in China has developed rapidly. This commentary describes the history, summarizes the present research funding system, institutions and representative work, and discusses the future of immunological research in China.	Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn						Abbas A.K., 2016, CELL MOL IMMUNOL, V9th; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Cao XT, 1998, J IMMUNOL, V161, P6238; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; LANGER WL, 1976, SCI AM, V234, P112, DOI 10.1038/scientificamerican0176-112; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; Meng SD, 2001, LANCET, V357, P528, DOI 10.1016/S0140-6736(00)04050-2; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wu YZ, 2002, J VIROL, V76, P10264, DOI 10.1128/JVI.76.20.10264-10269.2002; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao X, 2007, VACCINE, V25, P1771, DOI 10.1016/j.vaccine.2006.11.019; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; 巴德年, 2004, [中国免疫学杂志, Chinese Journal of Immunology], V20, P7	19	18	28	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					339	342		10.1038/ni0408-339	http://dx.doi.org/10.1038/ni0408-339			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349809	Bronze			2022-12-18	WOS:000254123200005
J	Strominger, JL				Strominger, Jack L.			Bacterial cell walls, innate immunity and immunoadjuvants	NATURE IMMUNOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA COLI; D-ALANINE; PENICILLIN; MECHANISM; RECOGNITION	Jack Strominger recounts his seminal work and contributions to understanding bacterial cell wall components, and thus how penicillin functions, and the implications of these discoveries for immunology.	Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Harvard University	Strominger, JL (corresponding author), Harvard Univ, Dept Mol & Cell Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	jlstrom@fas.harvard.edu						ADAM A, 1981, MOL CELL BIOCHEM, V41, P27; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Fitzgerald KA, 2007, SCIENCE, V316, P1574, DOI 10.1126/science.1144483; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; IZAKI K, 1966, P NATL ACAD SCI USA, V55, P656, DOI 10.1073/pnas.55.3.656; JUERGENS WG, 1963, J EXP MED, V117, P925, DOI 10.1084/jem.117.6.925; MANDELSTAM M, 1961, BIOCHEM BIOPH RES CO, V5, P466, DOI 10.1016/0006-291X(61)90097-3; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MATSUHASHI M, 1964, J BIOL CHEM, V239, P2454; NATHENSON S, 1961, J PHARMACOL EXP THER, V131, P1; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; PARK JT, 1952, J BIOL CHEM, V194, P897; PARK JT, 1957, SCIENCE, V125, P99, DOI 10.1126/science.125.3238.99; Strominger J L, 1968, Harvey Lect, V64, P179; STROMINGER JACK L., 1959, COMPT REND TRAV LAB CARLSBERG SER CHIM, V31, P181; Strominger JL, 2006, ANNU REV IMMUNOL, V24, P1, DOI 10.1146/annurev.immunol.24.021605.090703; STROMINGER JL, 1959, BIOCHIM BIOPHYS ACTA, V36, P83, DOI 10.1016/0006-3002(59)90072-1; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; WILMANSKI JM, 2007, J LEUKOC BIOL	21	18	18	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1269	1271		10.1038/ni1207-1269	http://dx.doi.org/10.1038/ni1207-1269			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026075				2022-12-18	WOS:000251267000002
J	Oldstone, MBA				Oldstone, Michael B. A.			A suspenseful game of 'hide and seek' between virus and host	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PERSISTENT VIRAL-INFECTION; CENTRAL-NERVOUS-SYSTEM; T-CELLS; IMMUNOLOGICAL TOLERANCE; LYMPHOID CELLS; IN-VIVO; MICE; SELECTION; RECEPTOR	As part of the most important contributions to the understanding of viral immunity, Michael Oldstone recounts his pioneering work on lymphocytic choriomeningitis virus.	Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Infectol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Oldstone, MBA (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	mbaobo@scripps.edu			NIAID NIH HHS [AI045927, AI055540, AI009484] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009484, R21AI055540, R37AI009484, R01AI055540, R01AI045927] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; BURNET FM, 1949, PRODUCTION ANTIBODIE, P1; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; COLE GA, 1972, NATURE, V238, P335, DOI 10.1038/238335a0; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dockter J, 1996, J VIROL, V70, P1799, DOI 10.1128/JVI.70.3.1799-1803.1996; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; LUNDSTED.C, 1969, ACTA PATHOL MIC SC, V75, P139; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Oldstone M B, 1994, Curr Top Microbiol Immunol, V189, P1; OLDSTONE MB, 1967, SCIENCE, V158, P1193, DOI 10.1126/science.158.3805.1193; OLDSTONE MB, 1972, P NATL ACAD SCI USA, V69, P134, DOI 10.1073/pnas.69.1.134; OLDSTONE MB, 1969, FED PROC, V28, P429; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Traub E, 1939, J EXP MED, V69, P801, DOI 10.1084/jem.69.6.801; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; VOLKERT M, 1965, ACTA PATHOL MIC SC, V63, P172, DOI 10.1111/apm.1965.63.2.172; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zinkernagel RM, 2002, CURR TOP MICROBIOL, V263, P1	33	18	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					325	327		10.1038/ni0407-325	http://dx.doi.org/10.1038/ni0407-325			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375090				2022-12-18	WOS:000245075900003
J	Dostert, C; Tschopp, J				Dostert, Catherine; Tschopp, Juerg			DEteCTINg fungal pathogens	NATURE IMMUNOLOGY			English	Editorial Material							BETA-GLUCAN RECEPTOR; DECTIN-1; RECOGNITION	Fungal infection is 'sensed' by host cell - expressed receptors. Two papers demonstrate that the C-type lectin receptor dectin-1 is required in vivo for cytokine production and killing of different fungal pathogens.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Dostert, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Dostert, Catherine/AAJ-5473-2020					Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725	12	18	19	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					17	18		10.1038/ni0107-17	http://dx.doi.org/10.1038/ni0107-17			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179965				2022-12-18	WOS:000242934400007
J	McEver, RP				McEver, RP			A sulfated address for lymphocyte homing	NATURE IMMUNOLOGY			English	Editorial Material							L-SELECTIN LIGANDS; GLYCAM-1		Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.ouhsc.edu						Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; IMAI Y, 1993, NATURE, V361, P555; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	14	18	19	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1067	1069		10.1038/ni1105-1067	http://dx.doi.org/10.1038/ni1105-1067			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239918				2022-12-18	WOS:000232833300003
J	Lira, SA				Lira, SA			A passport into the lymph node	NATURE IMMUNOLOGY			English	Editorial Material							CHEMOKINE; EXPRESSION; MIGRATION; ORGANS	Lymphocytes continuously recirculate throughout the body. Evidence now suggests chemokine receptor CCR7 actively controls lymphocyte entry into afferent lymphatic vessels.	CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Lira, SA (corresponding author), CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA.	sergio.lira@mssm.edu						Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Martin AP, 2004, J IMMUNOL, V173, P4791, DOI 10.4049/jimmunol.173.8.4791; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702	10	18	18	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					866	868		10.1038/ni0905-866	http://dx.doi.org/10.1038/ni0905-866			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116464				2022-12-18	WOS:000231369800007
J	Casali, P; Zan, H				Casali, P; Zan, H			Class switching and Myc translocation: how does DNA break?	NATURE IMMUNOLOGY			English	Editorial Material							SOMATIC HYPERMUTATION; AID; RECOMBINATION		Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Casali, P (corresponding author), Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA.	pcasali@uci.edu; hzan@uci.edu	Casali, Paolo/F-6579-2010		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R01AI045011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040908] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045011, R56 AI045011] Funding Source: Medline; NIAMS NIH HHS [R01 AR040908] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chua KF, 2002, J EXP MED, V195, pF37, DOI 10.1084/jem.20020380; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1	12	18	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1101	1103		10.1038/ni1104-1101	http://dx.doi.org/10.1038/ni1104-1101			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496946	Green Accepted			2022-12-18	WOS:000224692700004
J	Grady, C				Grady, C			Ethics of vaccine research	NATURE IMMUNOLOGY			English	Editorial Material							DEVELOPING-COUNTRIES; TRIALS; ISSUES; BENEFITS	Vaccination has attracted controversy at every stage of its development and use. Ethical debates should consider its basic goal, which is to benefit the community at large rather than the individual.	NIH, Dept Clin Bioeth, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Grady, C (corresponding author), NIH, Dept Clin Bioeth, Warren Grant Magnuson Clin Ctr, Bldg 10-1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov						Berkley S, 2003, LANCET, V362, P992, DOI 10.1016/S0140-6736(03)14371-1; Edwards KM, 1996, NEW ENGL J MED, V334, P391, DOI 10.1056/NEJM199602083340609; El Setouhy M, 2002, SCIENCE, V298, P2133; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Hall AJ, 1999, INT J TUBERC LUNG D, V3, P745; HOFFMAN S, 2003, VACCINE BOOK, P291; INNIS B, 1994, JAMA-J AM MED ASSOC, V271, P1363; Leach A, 1999, SOC SCI MED, V48, P139, DOI 10.1016/S0277-9536(98)00317-7; Levine M M, 1998, Dev Biol Stand, V95, P169; MACKLIN R, 2003, VACCINE BOOK, P119; MACKLIN R, 2003, VACCINE BOOK, P123; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; Snider DE, 2000, CLIN INFECT DIS, V30, pS271, DOI 10.1086/313872; Spier RE, 1998, VACCINE, V16, P1788, DOI 10.1016/S0264-410X(98)00169-8; Ulmer JB, 2002, NAT REV IMMUNOL, V2, P291, DOI 10.1038/nri780; UNAIDS and WHO, 2000, ETH CONS HIV PREV VA; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	17	18	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					465	468		10.1038/ni0504-465	http://dx.doi.org/10.1038/ni0504-465			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116109	Bronze			2022-12-18	WOS:000221101100005
J	Cantor, H				Cantor, H			Reviving suppression?	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; TOLL-LIKE RECEPTORS; MICE; VACCINATION; MOUSE; ENCEPHALOMYELITIS; IDENTIFICATION; THYMECTOMY; TOLERANCE; ANTIGEN		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu						Avichezer D, 2003, J EXP MED, V198, P1665, DOI 10.1084/jem.20030413; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; BLOOM BR, 1992, IMMUNOL TODAY, V13, P131, DOI 10.1016/0167-5699(92)90110-S; BURNET FM, 1969, SELF NOT SELF; CANTOR H, 1978, J EXP MED, V148, P871, DOI 10.1084/jem.148.4.871; CANTOR H, 2004, ADV IMMUNOL, V83, P1; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; COHEN IR, 1988, IMMUNOL TODAY, V9, P332, DOI 10.1016/0167-5699(88)91330-8; CONNOLLY DJ, 1993, J IMMUNOL, V151, P6089; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HU D, IN PRESS NAT IMMUNOL; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; LALANNE JL, 1985, CELL, V41, P469, DOI 10.1016/S0092-8674(85)80020-9; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; PANOUTSAKOPOULO.V, IN PRESS J CLIN INVE; SAKAGUCHI S, 1982, J EXP MED, V156, P1577, DOI 10.1084/jem.156.6.1577; Sakaguchi S, 2003, J EXP MED, V197, P397, DOI 10.1084/jem.20030012; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Silverstein AM, 2002, NAT IMMUNOL, V3, P793, DOI 10.1038/ni0902-793; STANTON TH, 1976, IMMUNOGENETICS, V3, P525, DOI 10.1007/BF01576982	28	18	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					347	349		10.1038/ni0404-347	http://dx.doi.org/10.1038/ni0404-347			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052259				2022-12-18	WOS:000220515900002
J	Lien, E; Golenbock, DT				Lien, E; Golenbock, DT			Adjuvants and their signaling pathways: beyond TLRs	NATURE IMMUNOLOGY			English	Editorial Material							DOUBLE-STRANDED-RNA; NF-KAPPA-B; DENDRITIC CELLS; VIRAL-INFECTION; TRIF; TRAM		Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, 364 Plantat St,Lazare Res Bldg 308, Worcester, MA 01605 USA.	egil.lien@umassmed.edu; douglas.golenbock@umassmed.edu						Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	10	18	34	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1162	1164		10.1038/ni1203-1162	http://dx.doi.org/10.1038/ni1203-1162			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639464	Bronze			2022-12-18	WOS:000186769500007
J	Solomon, S; Buck, J; Chaguturu, SK; Ganesh, AK; Kumarasamy, N				Solomon, S; Buck, J; Chaguturu, SK; Ganesh, AK; Kumarasamy, N			Stopping HIV before it begins: issues faced by women in India	NATURE IMMUNOLOGY			English	Editorial Material									Voluntary Hlth Serv, YRG Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India; Brown Univ, Sch Med, Providence, RI 02912 USA	Brown University	Solomon, S (corresponding author), Voluntary Hlth Serv, YRG Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India.		Kumarasasmy, Nagalingeswaran/AAB-7348-2021					Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; GUPTA GR, 2002, EXPERT CONSULTATION; *JOINT UN PROGR HI, 2001, AIDS EP UPD 2001; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; National AIDS Control Organization, 2001, SURV HIV INF AIDS CA; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Solomon S., 2000, AIDS BEHAV, V4, P71, DOI 10.1023/A:1009540908691; *UN DEV FUND WOM, 2000, PROGR S AS WOM 2000; Weiss E, 2000, SEX RELATIONSHIP THE, V153, P233, DOI DOI 10.1080/14681990050109836	10	18	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					719	721		10.1038/ni0803-719	http://dx.doi.org/10.1038/ni0803-719			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888788				2022-12-18	WOS:000184441500004
J	Rifkin, IR; Marshak-Rothstein, A				Rifkin, IR; Marshak-Rothstein, A			T-bet: The Toll-bridge to class-switch recombination?	NATURE IMMUNOLOGY			English	Editorial Material							CPG MOTIFS; BACTERIAL-DNA; CELLS; INFLAMMATION; MICE	CpG signaling through TLR9 elicits type 1 cytokine production, which can suppress IgE-associated hypersensitivity reactions. CpG also acts directly on B cells by inducing STAT1-independent T-bet expression.	Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Rifkin, IR (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.			Rifkin, Ian/0000-0002-2674-3991				Ballas ZK, 1996, J IMMUNOL, V157, P1840; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee YL, 1999, SCAND J IMMUNOL, V49, P229; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; SLACK JH, 1984, J IMMUNOL, V132, P1271; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wild JS, 2001, ALLERGY, V56, P365, DOI 10.1034/j.1398-9995.2001.056005365.x	11	18	30	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					650	652		10.1038/ni0703-650	http://dx.doi.org/10.1038/ni0703-650			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830144				2022-12-18	WOS:000183952500011
J	Ganz, T				Ganz, T			Angiogenin: an antimicrobial ribonuclease	NATURE IMMUNOLOGY			English	Editorial Material							HOST-DEFENSE; ACTIVATION; BACTERIA	Angiogenin was discovered as an inducer of blood vessel formation. However, a new study implicates it in antimicrobial host defense.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.		Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Ganz, Tomas/0000-0002-2830-5469				Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cole AM, 2001, BLOOD, V97, P297, DOI 10.1182/blood.V97.1.297; GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9; GANZ T, IN PRESS BLOOD; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	10	18	20	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					213	214		10.1038/ni0303-213	http://dx.doi.org/10.1038/ni0303-213			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605229				2022-12-18	WOS:000181201000008
J	Kavanagh, DG; Bhardwaj, N				Kavanagh, DG; Bhardwaj, N			A division of labor: DC subsets and HIV receptor diversity	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INFECTION; SIGN	DCs from different anatomical sites express distinct arrays of alternative HIV receptors. Some of these subsets could represent good gatekeepers, whereas others may be "Trojan horses" that carry HIV into the lymph node.	Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Rockefeller Univ, New York, NY 10021 USA; NYU, Sch Med, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Rockefeller University; New York University	Kavanagh, DG (corresponding author), Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA.							CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399	12	18	20	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					891	893		10.1038/ni1002-891	http://dx.doi.org/10.1038/ni1002-891			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352961				2022-12-18	WOS:000178242100004
J	Honjo, T				Honjo, T			Does AID need another aid?	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; MECHANISM		Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016					Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	13	18	21	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					800	801		10.1038/ni0902-800	http://dx.doi.org/10.1038/ni0902-800			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205466				2022-12-18	WOS:000177694900005
J	Lanzavecchia, A				Lanzavecchia, A			Lack of fair play in the T cell response	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN-PRESENTING CELLS; PEPTIDE-MHC COMPLEXES; DENDRITIC CELLS; IN-VIVO; SURFACE MOLECULES; MATURATION; EPITOPES		Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Biomed Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch						Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; EMDEMA JP, 2001, J EXP MED, V194, P657; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; LANZAVECCHIA A, 1988, NATURE, V334, P530, DOI 10.1038/334530a0; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Ludewig B, 2001, EUR J IMMUNOL, V31, P1772, DOI 10.1002/1521-4141(200106)31:6<1772::AID-IMMU1772>3.3.CO;2-#; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; NAGY Z, 1976, J EXP MED, V143, P648, DOI 10.1084/jem.143.3.648; Ronchese F, 2001, J EXP MED, V194, pF23, DOI 10.1084/jem.194.5.F23; Wolpert EZ, 1998, J IMMUNOL, V161, P4499	20	18	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					9	10		10.1038/ni0102-9	http://dx.doi.org/10.1038/ni0102-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753400				2022-12-18	WOS:000173148700005
J	Henneke, P; Golenbock, DT				Henneke, P; Golenbock, DT			TRAP: how Toll receptors fraternize	NATURE IMMUNOLOGY			English	News Item							NF-KAPPA-B; ACTIVATION; PATHWAY	Although some cellular responses induced by TLRs are abolished in MyD88-deficient mice,TLR4, unlike TLR9, can still induce activation of NF-kappaB and MAPKs. The discovery of a cytoplasmic adapter protein for TLR4, called TRAP, helps explain this phenomenon.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Henneke, P (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01655 USA.							Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; FITZGERALD K, 2001, IN PRESS NATURE; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	15	18	22	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					828	830		10.1038/ni0901-828	http://dx.doi.org/10.1038/ni0901-828			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526396				2022-12-18	WOS:000170781200021
J	Murre, C				Murre, C			Intertwining proteins in thymocyte development and cancer	NATURE IMMUNOLOGY			English	News Item							LOOP-HELIX PROTEIN; T-CELL DEVELOPMENT; ALPHA-BETA; E2A; GENES; E47	Perturbation of T cell differentiation by overexpression of SCL and LMO can lead to leukemia. This dysregulation may be initiated by inactivation of E2A.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.							Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Blom B, 1999, EMBO J, V18, P2793, DOI 10.1093/emboj/18.10.2793; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Kim D, 1999, MOL CELL BIOL, V19, P8240; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	12	18	18	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					97	98		10.1038/77881	http://dx.doi.org/10.1038/77881			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248796				2022-12-18	WOS:000089814900005
J	Jacquelot, N; Seillet, C; Vivier, E; Belz, GT				Jacquelot, Nicolas; Seillet, Cyril; Vivier, Eric; Belz, Gabrielle T.			Innate lymphoid cells and cancer	NATURE IMMUNOLOGY			English	Review							ROR-GAMMA-T; DIFFERENTIATION; PLASTICITY; SUBSETS; INTERLEUKIN-22; TRAFFICKING; LYMPHOCYTES; SUFFICIENT; IMMUNITY; PROMOTES	The innate lymphoid cell (ILC) family is composed of natural killer (NK) cells, ILC1, ILC2 and ILC3, which participate in immune responses to virus, bacteria, parasites and transformed cells. ILC1, ILC2 and ILC3 subsets are mostly tissue-resident, and are profoundly imprinted by their organ of residence. They exhibit pleiotropic effects, driving seemingly paradoxical responses such as tissue repair and, alternatively, immunopathology toward allergens and promotion of tumorigenesis. Despite this, a trickle of studies now suggests that non-NK ILCs may not be overwhelmingly tumorigenic and could potentially be harnessed to drive anti-tumor responses. Here, we examine the pleiotropic behavior of ILCs in cancer and begin to unravel the gap in our knowledge that exposes a new horizon for thinking about modifying ILCs and targeting them for immunotherapy. Gabrielle Belz and colleagues review the influence that innate lymphoid cells have on cancer immune responses.	[Jacquelot, Nicolas] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Seillet, Cyril] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Seillet, Cyril] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Vivier, Eric] Innate Pharma, Marseille, France; [Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Vivier, Eric] Hosp Timone, AP HP, Marseille, France; [Belz, Gabrielle T.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Walter & Eliza Hall Institute; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Queensland	Belz, GT (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	g.belz@uq.edu.au	Jacquelot, Nicolas/AAY-6937-2020; Vivier, Eric/F-8939-2010; Belz, Gabrielle/C-9350-2013	Vivier, Eric/0000-0001-7022-8287; Jacquelot, Nicolas/0000-0003-0282-1892; Belz, Gabrielle/0000-0002-9660-9587	National Health and Medical Research Council (NHMRC) of Australia [APP1165443, 1122277, 1054925, 1135898, 1123000]; University of Queensland Chair of Immunology (Diamantina Institute); Cure Cancer Australia; Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme [APP1163990]; Cancer Council NSW [RG21-05]; European Research Council (ERC) under the European Union [694502, 875102]; Agence Nationale de la Recherche [ANR-17-RHUS-0007]; MSDAvenir; Innate Pharma	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Chair of Immunology (Diamantina Institute); Cure Cancer Australia; Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme; Cancer Council NSW(Cancer Council New South Wales); European Research Council (ERC) under the European Union(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); MSDAvenir; Innate Pharma	This work was supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia (APP1165443 to C. S., G. T. B. and E. V., and 1122277, 1054925, 1135898, 1123000 to G. T. B.), support from The University of Queensland Chair of Immunology (Diamantina Institute, G. T. B.), Cure Cancer Australia and Cancer Australia through the Cancer Australia Priority-driven Cancer Research Scheme (APP1163990 to N. J.) and Cancer Council NSW (RG21-05 G. T. B. and N. J.). The E.V. laboratory at CIML and Assistance-Publique des Hopitaux de Marseille is supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC, grant agreement no. 694502 and MInfla-TILC, grant agreement no. 875102, MInfla-Tilc), the Agence Nationale de la Recherche including the PIONEER Project (ANR-17-RHUS-0007), MSDAvenir, Innate Pharma and institutional grants awarded to the CIML (INSERM, CNRS, and Aix-Marseille University) and Marseille Immunopole.	Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Bai L, 2021, SCIENCE, V371, P1332, DOI 10.1126/science.aba4177; Bailur JK, 2017, BLOOD ADV, V1, P2343, DOI 10.1182/bloodadvances.2017012732; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bie QL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/923135; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Cai T, 2019, J ALLERGY CLIN IMMUN, V143, P229, DOI 10.1016/j.jaci.2018.03.007; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chan IH, 2014, MUCOSAL IMMUNOL, V7, P842, DOI 10.1038/mi.2013.101; Chevalier MF, 2017, J CLIN INVEST, V127, P2916, DOI 10.1172/JCI89717; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cuff AO, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02180; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Daher M, 2021, CANCER DISCOV, V11, P45, DOI 10.1158/2159-8290.CD-20-0556; de Weerdt I, 2016, HAEMATOLOGICA, V101, pE461, DOI 10.3324/haematol.2016.144725; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Demaria O, 2021, EUR J IMMUNOL, V51, P1934, DOI 10.1002/eji.202048953; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Ducimetiere L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026271118; Dutton EE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8082; Ercolano G, 2020, CANCER IMMUNOL RES, V8, P556, DOI 10.1158/2326-6066.CIR-19-0504; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gauthier L, 2019, CELL, V177, P1701, DOI 10.1016/j.cell.2019.04.041; Goc J, 2021, CELL, V184, P5015, DOI 10.1016/j.cell.2021.07.029; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Han X, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0302-0; Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059; Hernandez DC, 2021, IMMUNITY, V54, P2417, DOI 10.1016/j.immuni.2021.07.019; Huang QT, 2021, CANCERS, V13, DOI 10.3390/cancers13030559; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hughes T, 2014, CELL REP, V8, P150, DOI 10.1016/j.celrep.2014.05.042; Irshad S, 2017, CANCER RES, V77, P1083, DOI 10.1158/0008-5472.CAN-16-0598; Jacquelot N, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1900508; Jacquelot N, 2021, NAT IMMUNOL, V22, P851, DOI 10.1038/s41590-021-00943-z; Karta MR, 2018, J ALLERGY CLIN IMMUN, V141, P329, DOI 10.1016/j.jaci.2017.03.010; Kerbauy LN, 2021, CLIN CANCER RES, V27, P3744, DOI 10.1158/1078-0432.CCR-21-0164; Kim J, 2016, J IMMUNOL, V196, P2410, DOI 10.4049/jimmunol.1501730; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Koh J, 2019, CLIN CANCER RES, V25, P4026, DOI 10.1158/1078-0432.CCR-18-3458; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Liu YH, 2019, EBIOMEDICINE, V41, P333, DOI 10.1016/j.ebiom.2019.02.050; Long A, 2018, J IMMUNOL, V201, P3456, DOI 10.4049/jimmunol.1800173; Loyon R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02121; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Moreno-Nieves UY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101169118; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Myers JA, 2021, NAT REV CLIN ONCOL, V18, P85, DOI 10.1038/s41571-020-0426-7; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum K, 2017, J EXP MED, V214, P2331, DOI 10.1084/jem.20162031; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; Parker ME, 2020, J EXP MED, V217, DOI 10.1084/jem.20191030; Peng L, 2021, AGING-US, V13, P6740, DOI 10.18632/aging.202531; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Qi JJ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100353; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Raykova A, 2017, BLOOD ADV, V1, P2679, DOI 10.1182/bloodadvances.2017008839; Rethacker L, 2021, CANCERS, V13, DOI 10.3390/cancers13061446; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Salimi M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4262-4; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Saranchova I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20608-6; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Soriani A, 2018, CYTOKINE GROWTH F R, V42, P47, DOI 10.1016/j.cytogfr.2018.02.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Sun C, 2015, CELL MOL IMMUNOL, V12, P292, DOI 10.1038/cmi.2014.91; Tizian C, 2020, ELIFE, V9, DOI 10.7554/eLife.52549; Trabanelli S, 2018, CYTOM PART B-CLIN CY, V94, P392, DOI 10.1002/cyto.b.21614; Trabanelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00678-2; Trabanelli S, 2015, HAEMATOLOGICA, V100, pE257, DOI 10.3324/haematol.2014.119602; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wagner M, 2020, CELL REP, V30, P2743, DOI 10.1016/j.celrep.2020.01.103; Wang S, 2020, CELL RES, V30, P610, DOI 10.1038/s41422-020-0312-y; Xuan X, 2020, CLIN TRANSL ONCOL, V22, P563, DOI 10.1007/s12094-019-02160-5; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zhang KN, 2017, J IMMUNOL, V198, P1798, DOI 10.4049/jimmunol.1601421; Zhang SL, 2021, INT IMMUNOPHARMACOL, V91, DOI 10.1016/j.intimp.2020.107318	100	17	17	6	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					371	379		10.1038/s41590-022-01127-z	http://dx.doi.org/10.1038/s41590-022-01127-z		FEB 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35228695				2022-12-18	WOS:000762163700001
J	Bruchard, M; Geindreau, M; Perrichet, A; Truntzer, C; Ballot, E; Boidot, R; Racoeur, C; Barsac, E; Chalmin, F; Hibos, C; Baranek, T; Paget, C; Ryffel, B; Rebe, C; Paul, C; Vegran, F; Ghiringhelli, F				Bruchard, Melanie; Geindreau, Mannon; Perrichet, Anais; Truntzer, Caroline; Ballot, Elise; Boidot, Romain; Racoeur, Cindy; Barsac, Emilie; Chalmin, Fanny; Hibos, Christophe; Baranek, Thomas; Paget, Christophe; Ryffel, Bernhard; Rebe, Cedric; Paul, Catherine; Vegran, Frederique; Ghiringhelli, Francois			Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses	NATURE IMMUNOLOGY			English	Article							T-CELL; LUNG; INFLAMMATION; IL-1-BETA; PREDICT; CANCER; CCR6; IL-1	The function of type 3 innate lymphoid cells (ILC3s) in cancer is still poorly understood. Bruchard et al. demonstrate that ILC3s are critical for the recruitment of T cells to the tumor microenvironment and thereby play important roles in antitumor responses. Tumors poorly infiltrated by T cells are more resistant to immunogenic chemotherapies and checkpoint inhibition than highly infiltrated tumors. Using murine models, we found that CCR6(+) type 3 innate lymphoid cells (ILC3s) can trigger an increase in the number of T cells infiltrating a tumor. Shortly after administration of cisplatin chemotherapy, production of the chemokine CCL20 and proinflammatory cytokine IL-1 beta at the tumor site led to the recruitment and activation of ILC3s. Within the tumor, ILC3 production of the chemokine CXCL10 was responsible for the recruitment of CD4(+) and CD8(+) T lymphocytes to the tumor. ILC3-dependent infiltration of T cells was essential for antitumor immune responses and increased the efficacy of checkpoint inhibition. Thus, we reveal an essential role of CCL20 and IL-1 beta, which promote ILC3-dependent antitumor immunity and enhance tumor sensitivity to immunotherapy.	[Bruchard, Melanie; Geindreau, Mannon; Perrichet, Anais; Truntzer, Caroline; Ballot, Elise; Chalmin, Fanny; Hibos, Christophe; Rebe, Cedric; Vegran, Frederique; Ghiringhelli, Francois] INSERM, Equipe Labellisee Ligue Canc, U1231, Dijon, France; [Bruchard, Melanie; Perrichet, Anais; Truntzer, Caroline; Ballot, Elise; Chalmin, Fanny; Rebe, Cedric; Vegran, Frederique; Ghiringhelli, Francois] Georges Francois Leclerc Canc Ctr UNICANCER, Canc Biol Transfer Platform, Dijon, France; [Bruchard, Melanie; Geindreau, Mannon; Perrichet, Anais; Hibos, Christophe; Vegran, Frederique; Ghiringhelli, Francois] Univ Burgundy & Franche Comte, Dijon, France; [Truntzer, Caroline; Ballot, Elise; Ghiringhelli, Francois] Genet & Immunol Med Inst, Dijon, France; [Boidot, Romain] Georges Francois Leclerc Canc Ctr UNICANCER, Dept Biol & Pathol Tumors, Dijon, France; [Racoeur, Cindy; Paul, Catherine] Univ Burgundy & Franche Comte, LIIC, EA7269, Dijon, France; [Racoeur, Cindy; Paul, Catherine] PSL Res Univ, Immunol & Immunotherapy Canc Lab, EPHE, Paris, France; [Barsac, Emilie; Baranek, Thomas; Paget, Christophe] Univ Tours, Fac Med, Ctr Etud Pathol Resp, INSERM,UMR1100, Tours, France; [Ryffel, Bernhard] Univ Orleans & Artimmune, Lab Expt & Mol Immunol & Neurogenet INEM, CNRS, UMR 7355, Orleans, France; [Ghiringhelli, Francois] Georges Francois Leclerc Canc Ctr, Dept Med Oncol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite de Bourgogne; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Georges-Francois Leclerc	Bruchard, M (corresponding author), INSERM, Equipe Labellisee Ligue Canc, U1231, Dijon, France.; Bruchard, M (corresponding author), Georges Francois Leclerc Canc Ctr UNICANCER, Canc Biol Transfer Platform, Dijon, France.; Bruchard, M (corresponding author), Univ Burgundy & Franche Comte, Dijon, France.	melanie.bruchard@u-bourgogne.fr	Paul, Catherine/F-8376-2019; REBE, Cédric/AAD-4316-2019; Paget, Christophe/P-5165-2014	REBE, Cédric/0000-0001-8831-145X; Paul, Catherine/0000-0002-7657-5535; Paget, Christophe/0000-0002-5374-5407; HIBOS, Christophe/0000-0003-0191-363X; GEINDREAU, Mannon/0000-0003-0926-1998	Association pour la Recherche sur le Cancer; ISITE-BFC senior fellowship; LabEx LipSTIC (Lipoproteines et Sante) grant [ANR-11-LABX0021]; Ligue Contre Le Cancer CCIR EST; Fondation de France; Equipe labelisee Ligue Nationale Contre le Cancer	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); ISITE-BFC senior fellowship; LabEx LipSTIC (Lipoproteines et Sante) grant; Ligue Contre Le Cancer CCIR EST; Fondation de France(Fondation de France); Equipe labelisee Ligue Nationale Contre le Cancer	We thank T.C. Wu (Johns Hopkins School of Medicine, Baltimore, MD) for providing TC-1 cells. This work was supported by the Association pour la Recherche sur le Cancer (M.B. and F.G.), an ISITE-BFC senior fellowship (F.G.), LabEx LipSTIC (Lipoproteines et Sante) grant ANR-11-LABX0021 (F.G.), Ligue Contre Le Cancer CCIR EST (F.V.,M.B. and F.G.) and the Fondation de France (M.B.). F.G.'s team is supported by Equipe labelisee Ligue Nationale Contre le Cancer.	Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Irshad S, 2017, CANCER RES, V77, P1083, DOI 10.1158/0008-5472.CAN-16-0598; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kim JW, 2013, CANCER RES TREAT, V45, P325, DOI 10.4143/crt.2013.45.4.325; Kirchberger Stefanie, 2013, J Exp Med, V210, P917; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Koh J, 2019, CLIN CANCER RES, V25, P4026, DOI 10.1158/1078-0432.CCR-18-3458; Kuo PT, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00271; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Li Z., 2016, NAT COMMUN, V7; Martinez-Reza I, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/6384278; Matsutani S, 2018, CANCER SCI, V109, P966, DOI 10.1111/cas.13542; Maurice NJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12980-2; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nussbaum K, 2017, J EXP MED, V214, P2331, DOI 10.1084/jem.20162031; Paget C, 2015, IMMUNOL CELL BIOL, V93, P198, DOI 10.1038/icb.2014.94; Ranasinghe R, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54050088; Rebe C, 2020, CANCERS, V12, DOI 10.3390/cancers12071791; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Sato Y, 2016, ANN SURG ONCOL, V23, P936, DOI 10.1245/s10434-015-4909-1; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trabanelli S, 2015, HAEMATOLOGICA, V100, pE257, DOI 10.3324/haematol.2014.119602; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Voronov E, 2015, CANCER MICROENVIRON, V8, P187, DOI 10.1007/s12307-015-0177-7; Wang D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0701-2; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x	43	17	17	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					262	+		10.1038/s41590-021-01120-y	http://dx.doi.org/10.1038/s41590-021-01120-y		JAN 2022	37	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35102345				2022-12-18	WOS:000750323300004
J	Chen, SC				Chen, Shih-Chung			Taiwan's experience in fighting COVID-19	NATURE IMMUNOLOGY			English	Editorial Material								Taiwan has leveraged its experience in containing the 2003 SARS outbreak by responding to the COVID-19 crisis with rapid measures, early deployment, prudent actions and transparency. Collectively, these actions have created the 'Taiwan model' for combating COVID-19.	[Chen, Shih-Chung] Minist Hlth & Welf, Taipei, Taiwan		Chen, SC (corresponding author), Minist Hlth & Welf, Taipei, Taiwan.	clockchen@mohw.gov.tw							0	17	17	3	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					393	394		10.1038/s41590-021-00908-2	http://dx.doi.org/10.1038/s41590-021-00908-2		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33772224	Bronze			2022-12-18	WOS:000633314600001
J	Zhou, H; Wang, H; Yu, MJ; Schugar, RC; Qian, W; Tang, FQ; Liu, WW; Yang, H; McDowell, RE; Zhao, JJ; Gao, J; Dongre, A; Carman, JA; Yin, M; Drazba, JA; Dent, R; Hine, C; Chen, YR; Smith, JD; Fox, PL; Brown, JM; Li, XX				Zhou, Hao; Wang, Han; Yu, Minjia; Schugar, Rebecca C.; Qian, Wen; Tang, Fangqiang; Liu, Weiwei; Yang, Hui; McDowell, Ruth E.; Zhao, Junjie; Gao, Ji; Dongre, Ashok; Carman, Julie A.; Yin, Mei; Drazba, Judith A.; Dent, Robert; Hine, Christopher; Chen, Yeong-Renn; Smith, Jonathan D.; Fox, Paul L.; Brown, J. Mark; Li, Xiaoxia			IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes	NATURE IMMUNOLOGY			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; NF-KAPPA-B; ADIPOSE-TISSUE; PHB COMPLEX; OBESITY; PROTEIN; SUPERCOMPLEX; ORGANIZATION; INFLAMMATION; EXPRESSION	Chronic inflammation is a common feature of obesity, with elevated cytokines such as interleukin-1 (IL-1) in the circulation and tissues. Here, we report an unconventional IL-1R-MyD88-IRAK2-PHB/OPA1 signaling axis that reprograms mitochondrial metabolism in adipocytes to exacerbate obesity. IL-1 induced recruitment of IRAK2 Myddosome to mitochondria outer membranes via recognition by TOM20, followed by TIMM50-guided translocation of IRAK2 into mitochondria inner membranes, to suppress oxidative phosphorylation and fatty acid oxidation, thereby attenuating energy expenditure. Adipocyte-specific MyD88 or IRAK2 deficiency reduced high-fat-diet-induced weight gain, increased energy expenditure and ameliorated insulin resistance, associated with a smaller adipocyte size and increased cristae formation. IRAK2 kinase inactivation also reduced high-fat diet-induced metabolic diseases. Mechanistically, IRAK2 suppressed respiratory super-complex formation via interaction with PHB1 and OPA1 upon stimulation of IL-1. Taken together, our results suggest that the IRAK2 Myddosome functions as a critical link between inflammation and metabolism, representing a novel therapeutic target for patients with obesity. Obesity is often accompanied by chronic inflammation. Li and colleagues show that, in mice fed high-fat diets, IL-1 signaling in adipocytes induces an unconventional IRAK2 translocation to mitochondria and suppresses respiratory super-complex formation to alter mitochondrial function, and exacerbates obesity.	[Zhou, Hao; Wang, Han; Yu, Minjia; Qian, Wen; Tang, Fangqiang; Liu, Weiwei; Yang, Hui; McDowell, Ruth E.; Zhao, Junjie; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Wang, Han] Lanzhou Univ, Sch Life Sci, Lanzhou, Peoples R China; [Yu, Minjia] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA USA; [Schugar, Rebecca C.; Hine, Christopher; Smith, Jonathan D.; Fox, Paul L.; Brown, J. Mark] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Gao, Ji; Dongre, Ashok; Carman, Julie A.] Bristol Myers Squibb, Discovery Biol, Princeton, NJ USA; [Yin, Mei; Drazba, Judith A.] Cleveland Clin, Lerner Res Inst, Imaging Core, Cleveland, OH 44106 USA; [Dent, Robert] Univ Ottawa, Ottawa, ON, Canada; [Dent, Robert] Ottawa Hosp, Ottawa, ON, Canada; [Chen, Yeong-Renn] Northeast Ohio Med Univ, Dept Integrat Med Sci, Coll Med, Rootstown, OH USA; [Carman, Julie A.] Janssen Res & Dev, Immunol Discovery, Spring House, PA USA	Cleveland Clinic Foundation; Lanzhou University; Harvard University; Mount Auburn Hospital; Cleveland Clinic Foundation; Bristol-Myers Squibb; Cleveland Clinic Foundation; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Northeast Ohio Medical University (NEOMED); Johnson & Johnson; Janssen Pharmaceuticals	Li, XX (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021	Zhou, Hao/0000-0001-9109-2489; Wang, Han/0000-0002-1442-4539	NIH [2P01HL029582, R01 AA023722, P01CA062220, R01 HL122283, P50AA024333]; National Multiple Sclerosis Society [RG5130A2/1]; American Diabetes Association [1-16-PDF-138]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Diabetes Association(American Diabetes Association)	This work was supported by grants from the NIH (2P01HL029582, R01 AA023722, P01CA062220, R01 HL122283 and P50AA024333) and National Multiple Sclerosis Society (RG5130A2/1). H.Z. was supported by a Postdoctoral Research Fellowship Award (1-16-PDF-138) from the American Diabetes Association.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Bozkurt B, 2016, CIRCULATION, V134, pE535, DOI 10.1161/CIR.0000000000000450; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DASCOMBE MJ, 1989, INT J OBESITY, V13, P367; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; delRey A, 1996, EXP CLIN ENDOCR DIAB, V104, P317, DOI 10.1055/s-0029-1211461; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; FELGNER PL, 1979, J BIOL CHEM, V254, P4946; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Galmozzi A, 2014, CELL REP, V9, P1584, DOI 10.1016/j.celrep.2014.10.066; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; Han ZS, 2007, AM J PHYSIOL-CELL PH, V292, pC1103, DOI 10.1152/ajpcell.00389.2006; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jian CS, 2017, J CELL SCI, V130, P2620, DOI 10.1242/jcs.198523; Juge-Aubry CE, 2004, J CLIN ENDOCR METAB, V89, P2652, DOI 10.1210/jc.2003-031219; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Krautbauer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086866; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rosselin M, 2017, EMBO REP, V18, P451, DOI 10.15252/embr.201642931; Said S, 2016, CURR VASC PHARMACOL, V14, P415, DOI 10.2174/1570161114666160722121615; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Salerno F, 2016, J IMMUNOL, V196, P3695, DOI 10.4049/jimmunol.1501997; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun XJ, 2017, J BIOL CHEM, V292, P12339, DOI 10.1074/jbc.M117.779108; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yeh ST, 2009, J MOL CELL CARDIOL, V47, P789, DOI 10.1016/j.yjmcc.2009.09.003; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314; Zhou H, 2017, ELIFE, V6, DOI 10.7554/eLife.29630	58	17	18	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1219	+		10.1038/s41590-020-0750-1	http://dx.doi.org/10.1038/s41590-020-0750-1		AUG 2020	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32778760	Green Accepted			2022-12-18	WOS:000558125100001
J	Ramsdell, F; Rudensky, AY				Ramsdell, Fred; Rudensky, Alexander Y.			Foxp3: a genetic foundation for regulatory T cell differentiation and function	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE OOPHORITIS; THYMECTOMY; THYMUS; MICE; ENTEROPATHY; REQUIREMENT; PREVENTION; SCURFIN; EVENTS	Fred Ramsdell and Alexander Rudensky revisit the discovery of theFoxp3gene and its foundational role in the differentiation and function of regulatory T cells.	[Ramsdell, Fred] Sonoma Biotherapeut, San Francisco, CA 94080 USA; [Ramsdell, Fred] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ramsdell, F (corresponding author), Sonoma Biotherapeut, San Francisco, CA 94080 USA.; Ramsdell, F (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.	framsdell@sonomabio.com; rudenska@mskcc.org						Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KOJIMA A, 1976, LAB INVEST, V34, P601; MILLER JF, 1961, LANCET, V2, P748; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Raffin C, 2020, NAT REV IMMUNOL, V20, P158, DOI 10.1038/s41577-019-0232-6; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1982, J EXP MED, V156, P1577, DOI 10.1084/jem.156.6.1577; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437	20	17	18	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					708	709		10.1038/s41590-020-0694-5	http://dx.doi.org/10.1038/s41590-020-0694-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577010				2022-12-18	WOS:000542863800006
J	Dybas, JM; O'Leary, CE; Ding, H; Spruce, LA; Seeholzer, SH; Oliver, PM				Dybas, Joseph M.; O'Leary, Claire E.; Ding, Hua; Spruce, Lynn A.; Seeholzer, Steven H.; Oliver, Paula M.			Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							CBL-B; UBIQUITINATION SITES; MEDIATED DEGRADATION; NEGATIVE REGULATION; LINEAR UBIQUITIN; GENE-EXPRESSION; PROTEIN; PROTEASOME; QUANTIFICATION; PROMOTES	Despite gathering evidence that ubiquitylation can direct non-degradative outcomes, most investigations of ubiquitylation in T cells have focused on degradation. Here, we integrated proteomic and transcriptomic datasets from primary mouse CD4(+) T cells to establish a framework for predicting degradative or non-degradative outcomes of ubiquitylation. Di-glycine remnant profiling was used to reveal ubiquitylated proteins, which in combination with whole-cell proteomic and transcriptomic data allowed prediction of protein degradation. Analysis of ubiquitylated proteins identified by di-glycine remnant profiling indicated that activation of CD4(+) T cells led to an increase in non-degradative ubiquitylation. This correlated with an increase in non-proteasome-targeted K29, K33 and K63 polyubiquitin chains. This study revealed over 1,200 proteins that were ubiquitylated in primary mouse CD4(+) T cells and highlighted the relevance of non-proteasomally targeted ubiquitin chains in T cell signaling.	[Dybas, Joseph M.; Oliver, Paula M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Protect Immun, Philadelphia, PA 19104 USA; [Dybas, Joseph M.; O'Leary, Claire E.; Ding, Hua; Spruce, Lynn A.; Seeholzer, Steven H.; Oliver, Paula M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Cell Pathol Div, Philadelphia, PA 19104 USA; [Dybas, Joseph M.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Oliver, Paula M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Oliver, PM (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Protect Immun, Philadelphia, PA 19104 USA.; Oliver, PM (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Cell Pathol Div, Philadelphia, PA 19104 USA.; Oliver, PM (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	paulao@pennmedicine.upenn.edu		Spruce, Lynn/0000-0001-9640-9158; O'Leary, Claire/0000-0001-9052-4593; Oliver, Paula/0000-0002-0455-3767	NIH [R01 AI093566, R01 AI114515]; NRSA [F31 CA180300]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114515, R01AI093566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge the helpful discussion and methods development insight from H. Fazelinia and D. Taylor at the Children's Hospital of Philadelphia. This work was supported by NIH grants to P.M.O. (grant nos. R01 AI093566 and R01 AI114515), and an NRSA to C.E.O. (grant no. F31 CA180300).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Cowan JL, 2004, EUR J BIOCHEM, V271, P3596, DOI 10.1111/j.0014-2956.2004.04306.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hsu TS, 2014, J IMMUNOL, V193, P1672, DOI 10.4049/jimmunol.1301416; Hu HB, 2016, J EXP MED, V213, P399, DOI 10.1084/jem.20151426; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Ivanova E, 2016, MOL IMMUNOL, V73, P19, DOI 10.1016/j.molimm.2016.03.006; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jin HS, 2013, P NATL ACAD SCI USA, V110, P624, DOI 10.1073/pnas.1213819110; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; O'Leary CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11226; Okamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36135; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Sap KA, 2017, J PROTEOME RES, V16, P2848, DOI 10.1021/acs.jproteome.7b00156; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shibata Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006162; Singh RK, 2012, MOL CELL PROTEOMICS, V11, P1595, DOI 10.1074/mcp.M112.022467; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; van der Wal L, 2018, J PROTEOMICS, V172, P49, DOI 10.1016/j.jprot.2017.10.014; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Xie JJ, 2013, J IMMUNOL, V190, P4027, DOI 10.4049/jimmunol.1202742; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236	55	17	17	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					747	+		10.1038/s41590-019-0381-6	http://dx.doi.org/10.1038/s41590-019-0381-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31061531	Green Accepted			2022-12-18	WOS:000468505100017
J	Bujisic, B; Martinon, F				Bujisic, Bojan; Martinon, Fabio			IRE1 gives weight to obesity-associated inflammation	NATURE IMMUNOLOGY			English	Editorial Material							ENDOPLASMIC-RETICULUM STRESS; MACROPHAGES; ACTIVATION	IRE1 alpha is a stress sensor that is activated by a high-fat diet. In adipose-tissue macrophages, it serves as a major switch toward pro-inflammatory M1 polarization and thereby contributes to obesity and associated diseases.	[Bujisic, Bojan; Martinon, Fabio] Univ Lausanne, Dept Biochem, Epalinges, Switzerland	University of Lausanne	Martinon, F (corresponding author), Univ Lausanne, Dept Biochem, Epalinges, Switzerland.	fabio.martinon@unil.ch	Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X				Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035	11	17	17	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					479	480		10.1038/ni.3725	http://dx.doi.org/10.1038/ni.3725			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418390				2022-12-18	WOS:000399378700002
J	Mujal, AM; Gilden, JK; Gerard, A; Kinoshita, M; Krummel, MF				Mujal, Adriana M.; Gilden, Julia K.; Gerard, Audrey; Kinoshita, Makoto; Krummel, Matthew F.			A septin requirement differentiates autonomous and contact-facilitated T cell proliferation	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; HOMEOSTATIC PROLIFERATION; BYSTANDER ACTIVATION; NAIVE; DIVISION; COMPARTMENTALIZATION; LYMPHODEPLETION; CYTOSKELETON; COMPLETION; CONVERSION	T cell proliferation is initiated by T cell antigen receptor (TCR) triggering, soluble growth factors or both. In characterizing T cells lacking the septin cytoskeleton, we found that successful cell division has discrete septin-dependent and septin-independent pathways. Septin-deficient T cells failed to complete cytokinesis when prompted by pharmacological activation or cytokines. In contrast, cell division was not dependent on septins when cell-cell contacts, such as those with antigen-presenting cells, provided a niche. This septin-independent pathway was mediated by phosphatidylinositol-3-OH kinase activation through a combination of integrins and costimulatory signals. We were able to differentiate between cytokine- and antigen-driven expansion in vivo and thus show that targeting septins has strong potential to moderate detrimental bystander or homeostatic cytokinedriven proliferation without influencing expansion driven by conventional antigen-presentation.	[Mujal, Adriana M.; Gilden, Julia K.; Gerard, Audrey; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Kinoshita, Makoto] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Gilden, Julia K.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of California System; University of California San Francisco; Nagoya University; University of Wisconsin System; University of Wisconsin Madison	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	matthew.krummel@ucsf.edu		KINOSHITA, MAKOTO/0000-0002-7592-2400	US National Institutes of Health [R01AI52116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116, R01AI114787, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Biological Imaging Development Center personnel (UCSF) for technical assistance with imaging, J. Roose and O. Ksionda (UCSF) for reagents and helpful discussion, E. Palmer (University Hospital Basel and University of Basel) and D. Zehn (Swiss Vaccine Research Institute and Lausanne University Hospital) for reagents, and M. Kuhns (University of Arizona College of Medicine) for critical reading of the manuscript. Supported by the US National Institutes of Health (R01AI52116 to (M.F.K).	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cho JH, 2013, J IMMUNOL, V191, P5559, DOI 10.4049/jimmunol.1302293; Choo DK, 2010, J IMMUNOL, V185, P3436, DOI 10.4049/jimmunol.1001421; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; El Amine N, 2013, J CELL BIOL, V203, P487, DOI 10.1083/jcb.201305053; Estey MP, 2013, J BIOL CHEM, V288, P30075, DOI 10.1074/jbc.M113.474932; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kitchin JES, 1997, J AM ACAD DERMATOL, V37, P445, DOI 10.1016/S0190-9622(18)30747-3; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Maleth J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6843; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Menon MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004558; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Monti P, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/217934; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Murali-Krishna K, 1998, ADV EXP MED BIOL, V452, P123; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tchao NK, 2012, AM J TRANSPLANT, V12, P1079, DOI 10.1111/j.1600-6143.2012.04008.x; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	50	17	18	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					315	322		10.1038/ni.3330	http://dx.doi.org/10.1038/ni.3330			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26692174	Green Submitted, Green Accepted			2022-12-18	WOS:000370469300016
J	Van Hauwermeiren, F; Lamkanfi, M				Van Hauwermeiren, Filip; Lamkanfi, Mohamed			The NEK-sus of the NLRP3 inflammasome	NATURE IMMUNOLOGY			English	Editorial Material							CRYOPYRIN/NALP3; ACTIVATION	The NLRP3 inflammasome has broad biomedical relevance, but its activation mechanisms are incompletely understood. NEK7, a kinase that regulates microtubules during mitosis, is identified as a critical and selective upstream regulator of NLRP3 inflammasome activation.	[Van Hauwermeiren, Filip; Lamkanfi, Mohamed] VIB, Inflammat Res Ctr, Ghent, Belgium; [Van Hauwermeiren, Filip; Lamkanfi, Mohamed] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Lamkanfi, M (corresponding author), VIB, Inflammat Res Ctr, Ghent, Belgium.; Lamkanfi, M (corresponding author), Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium.	mohamed.lamkanfi@irc.vib-ugent.be						Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004	12	17	17	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					223	224		10.1038/ni.3391	http://dx.doi.org/10.1038/ni.3391			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882252				2022-12-18	WOS:000370469300004
J	Leon, B; Lund, FE				Leon, Beatriz; Lund, Frances E.			IL-17-producing B cells combat parasites	NATURE IMMUNOLOGY			English	Editorial Material							CRUZI TRANS-SIALIDASE; TRYPANOSOMA-CRUZI	Interleukin 17 (IL-17) confers protection against Trypanosoma cruzi. Surprisingly, B cells are the relevant source, producing IL-17 via a unique pathway independent of the transcription factor ROR gamma t, induced by T. cruzi trans-sialidase.	[Leon, Beatriz; Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Leon, B (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	flund@uab.edu						Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Chan AC, 2011, MOL IMMUNOL, V48, P1344, DOI 10.1016/j.molimm.2010.11.021; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Giorgi ME, 2011, CARBOHYD RES, V346, P1389, DOI 10.1016/j.carres.2011.04.006; Muia RP, 2010, GLYCOBIOLOGY, V20, P833, DOI 10.1093/glycob/cwq037; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Yuki N, 2006, CURR OPIN NEUROL, V19, P451, DOI 10.1097/01.wco.0000245367.36576.e9; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	12	17	18	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					419	421		10.1038/ni.2593	http://dx.doi.org/10.1038/ni.2593			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598388				2022-12-18	WOS:000317732100003
J	Le Friec, G; Kohl, J; Kemper, C				Le Friec, Gaelle; Koehl, Joerg; Kemper, Claudia			A complement a day keeps the Fox(p3) away	NATURE IMMUNOLOGY			English	Editorial Material							DECAY-ACCELERATING FACTOR; IFN-GAMMA; C5A; IMMUNITY; CELLS	Signaling via the complement factors C3a and C5a regulates effector T cell responses. Evidence now links the absence of local complement activation with a default pathway that leads to the polarization of Foxp3(+) regulatory T cells.	[Le Friec, Gaelle; Kemper, Claudia] Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England; [Koehl, Joerg] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Cellular & Mol Immunol, Cincinnati, OH USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Le Friec, G (corresponding author), Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England.	claudia.kemper@kcl.ac.uk	Koehl, Joerg/C-8531-2011; Kemper, Claudia/B-1502-2015	Koehl, Joerg/0000-0003-1121-3178; Le Friec, Gaelle/0000-0002-2051-3829; Kemper, Claudia/0000-0003-4196-1417	MRC [G1002165] Funding Source: UKRI; Medical Research Council [MR/J006742/1, G1002165] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Fischer MB, 1998, J IMMUNOL, V160, P2619; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Pavlov V, 2008, J IMMUNOL, V181, P4580, DOI 10.4049/jimmunol.181.7.4580; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333	12	17	17	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					110	112		10.1038/ni.2515	http://dx.doi.org/10.1038/ni.2515			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334823				2022-12-18	WOS:000313918400002
J	Krieg, AM				Krieg, Arthur M.			AIMing 2 defend against intracellular pathogens	NATURE IMMUNOLOGY			English	Editorial Material							CYTOPLASMIC DNA; INFLAMMASOME; ACTIVATION		Pfizer, Cambridge, MA USA	Pfizer	Krieg, AM (corresponding author), Pfizer, Cambridge, MA USA.	arthur.krieg@pfizer.com	Krieg, Art/R-6166-2019; Krieg, Arthur M/K-8109-2019					Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Heit A, 2003, J IMMUNOL, V170, P2802, DOI 10.4049/jimmunol.170.6.2802; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841	10	17	18	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					367	369		10.1038/ni0510-367	http://dx.doi.org/10.1038/ni0510-367			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20404848				2022-12-18	WOS:000276852200004
J	Menendez, A; Ferreira, RBR; Finlay, BB				Menendez, Alfredo; Ferreira, Rosana B. R.; Finlay, B. Brett			Defensins keep the peace too	NATURE IMMUNOLOGY			English	Editorial Material							SEGMENTED FILAMENTOUS BACTERIA; IMMUNE-SYSTEM; PANETH CELLS; KEY ROLE; INNATE	The mammalian intestine contains a large number of commensal bacterial strains. New work suggests that antimicrobial peptides used for defense against pathogenic bacteria are also used to adjust the balance among bacterial populations and to control intestinal homeostasis.	[Menendez, Alfredo; Ferreira, Rosana B. R.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Menendez, A (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca	Ferreira, Rosana BR/A-3682-2019; Ferreira, Rosana/E-5169-2013	Ferreira, Rosana BR/0000-0002-7162-0026; 				Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Talham GL, 1999, INFECT IMMUN, V67, P1992; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	13	17	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					49	50		10.1038/ni0110-49	http://dx.doi.org/10.1038/ni0110-49			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016512				2022-12-18	WOS:000272855300010
J	Gapin, L				Gapin, Laurent			The making of NKT cells	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; CD1D TETRAMERS; LINEAGE; PATHWAY	Natural killer T cells acquire their unique phenotype and characteristics during development in the thymus. Evidence suggests that the transcription factor PLZF has a unique function in the development of these cells and their acquisition of 'innate-like' characteristics.	[Gapin, Laurent] Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; [Gapin, Laurent] Natl Jewish Hlth, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Gapin, L (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 4200 E 9th Ave, Denver, CO 80206 USA.	gapinl@njc.org		Gapin, Laurent/0000-0001-9730-5174	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057485] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057485, R01 AI057485-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	14	17	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1009	1011		10.1038/ni0908-1009	http://dx.doi.org/10.1038/ni0908-1009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711440	Green Accepted			2022-12-18	WOS:000258559600010
J	Haynes, L; Adams, SL; Boss, JM				Haynes, Laura; Adams, Sherrill L.; Boss, Jeremy M.			Mentoring and networking: how to make it work	NATURE IMMUNOLOGY			English	Editorial Material								Mentoring and networking are critical components for success in science. Here the importance and steps required for good mentoring and networking are described.	[Haynes, Laura] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Adams, Sherrill L.] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Boss, Jeremy M.] Emory Univ Hosp, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Trudeau Institute; University of Pennsylvania; Emory University	Haynes, L (corresponding author), Trudeau Inst Inc, Saranac Lake, NY 12983 USA.	lhaynes@trudeauinstitute.org							0	17	17	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					3	5		10.1038/ni0108-3	http://dx.doi.org/10.1038/ni0108-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087246				2022-12-18	WOS:000251820800002
J	Krieg, AM				Krieg, Arthur M.			TLR9 and DNA 'feel' RAGE	NATURE IMMUNOLOGY			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHROMATIN PROTEIN HMGB1; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; CELLS; COMPLEXES	The immune system has several signaling pathways that detect invading pathogens. When activated in certain conditions, these pathways can also serve to exacerbate or even cause autoimmune disease.	Coley Pharmaceut Grp, Wellesley, MA 02481 USA	Coley Pharmaceutical Group	Krieg, AM (corresponding author), Coley Pharmaceut Grp, Wellesley, MA 02481 USA.	akrieg@coleypharma.com	Krieg, Arthur M/K-8109-2019; Krieg, Art/R-6166-2019					Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dumitriu IE, 2005, EUR J IMMUNOL, V35, P2184, DOI 10.1002/eji.200526066; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696	13	17	18	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					475	477		10.1038/ni0507-475	http://dx.doi.org/10.1038/ni0507-475			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440455				2022-12-18	WOS:000245831600009
J	Youssef, S; Steinman, L				Youssef, Sawsan; Steinman, Lawrence			At once harmful and beneficial: the dual properties of NF-kappa B	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; NF-KAPPA-B2	Transcription factor NF-kappa B is key in both the injury and repair of damaged tissues. Astrocytes use the non-canonical NF-kappa B activation pathway to modulate brain inflammation in experimental autoimmune encephalomyelitis.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Interdept Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Youssef, S (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250				Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hilliard B, 1999, J IMMUNOL, V163, P2937; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; JOAZEIRO C, 2006, CANCER RES, V66, P1; Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372	13	17	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					901	902		10.1038/ni0906-901	http://dx.doi.org/10.1038/ni0906-901			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924250				2022-12-18	WOS:000239942300005
J	Pulendran, B				Pulendran, Bali			Division of labor and cooperation between dendritic cells	NATURE IMMUNOLOGY			English	Editorial Material								Cooperation between dendritic cell subtypes and a newly identified function for interleukin 15 demonstrate the complexity surrounding the initial events required for effective antipathogen immunity.	Emory Vaccine Ctr, Atlanta, GA 30329 USA	Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021					Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Combe CL, 2006, P NATL ACAD SCI USA, V103, P6635, DOI 10.1073/pnas.0506180103; Ishii KJ, 2005, EUR J IMMUNOL, V35, P2397, DOI 10.1002/eji.200425795; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	12	17	18	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					699	700		10.1038/ni0706-699	http://dx.doi.org/10.1038/ni0706-699			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785884				2022-12-18	WOS:000238377700005
J	O'Shea, JJ; Watford, W				O'Shea, JJ; Watford, W			A peek at PIAS	NATURE IMMUNOLOGY			English	Editorial Material							PROTEINS; SUMO	Members of the PIAS family can negatively regulate the cytokine-activated Jak-STAT pathway in vitro. One member of this family, PIAS1, is a nonredundant and physiologic regulator of certain STAT1-dependent interferon-induced genes.	NIAMSD, Mol Immunol & Inflammat Branch, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Rockville, MD 20852 USA.	osheajo@mail.nih.gov			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200	13	17	18	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					875	876		10.1038/ni0904-875	http://dx.doi.org/10.1038/ni0904-875			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334080				2022-12-18	WOS:000223612500006
J	Bendelac, A				Bendelac, A			Nondeletional pathways for the development of autoreactive thymocytes	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; CLASS-I; INTRAEPITHELIAL LYMPHOCYTES; SELECTION	Conventional wisdom holds that autoreactive thymocytes always undergo negative selection. This paradigm should be reassessed in light of evidence showing that alternative T cell lineages can develop in certain autoreactive conditions.	Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu						Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	13	17	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					557	558		10.1038/ni0604-557	http://dx.doi.org/10.1038/ni0604-557			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164010				2022-12-18	WOS:000221664000002
J	Folkman, J; Kaipainen, A				Folkman, J; Kaipainen, A			Genes tell lymphatics to sprout or not	NATURE IMMUNOLOGY			English	Editorial Material							MICE LACKING; VIABILITY	Lymphatic and vascular vessel formation develop in response to specific cues. With the identification of key factors responsible for these interactions, new therapies for the treatment of lymphatic disorders might be on the horizon.	Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Folkman, J (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	judah.folkman@tch.harvard.edu						Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; CHANG LK, 2002, J ANN NY ACAD SCI, V979, P1; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Folkman J, 2003, CANC MED, P161; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Jussila L, 2002, PHYSIOL REV, V82, P673, DOI 10.1152/physrev.00005.2002; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yuan L, 2002, DEVELOPMENT, V129, P4797	12	17	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					11	12		10.1038/ni0104-11	http://dx.doi.org/10.1038/ni0104-11			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699399				2022-12-18	WOS:000187635800005
J	Villunger, A; Marsden, VS; Strasser, A				Villunger, A; Marsden, VS; Strasser, A			Efficient T cell receptor-mediated apoptosis in nonobese diabetic mouse thymocytes	NATURE IMMUNOLOGY			English	Letter									Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Innsbruck, Inst Pathophysiol, A-6020 Innsbruck, Austria	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Innsbruck	Villunger, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	andreas.villunger@uibk.ac.at; strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891					0	17	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					717	717		10.1038/ni0803-717	http://dx.doi.org/10.1038/ni0803-717			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888786	Bronze			2022-12-18	WOS:000184441500002
J	Badovinac, VP; Harty, JT				Badovinac, VP; Harty, JT			Memory lanes	NATURE IMMUNOLOGY			English	Editorial Material							CUTTING EDGE; T-CELLS	The lineage relationships of T-EM and T-CM and their ability to confer protective immunity are not well understood. New data suggest T-EM are poorer mediators of protective immunity and convert to TCM over time.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, 3-512 Bowen Sci Bldg,51 Newton Rd, Iowa City, IA 52242 USA.		badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Harty, John/0000-0001-7266-2802				Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864	11	17	17	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					212	213		10.1038/ni0303-212	http://dx.doi.org/10.1038/ni0303-212			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605228				2022-12-18	WOS:000181201000007
J	Gamadia, LE; ten Berge, IJM; Picker, LJ; van Lier, RAW				Gamadia, LE; ten Berge, IJM; Picker, LJ; van Lier, RAW			Skewed maturation of virus-specific CTLs?	NATURE IMMUNOLOGY			English	Letter							CD8(+) T-CELLS; MEMORY; SUBSETS		Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Renal Transplant Unit, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Oregon Health & Science University	Gamadia, LE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Renal Transplant Unit, NL-1105 AZ Amsterdam, Netherlands.	r.vanlier@amc.uva.rl		van Lier, Rene/0000-0002-3201-7144				Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Gamadia LE, 2001, BLOOD, V98, P754, DOI 10.1182/blood.V98.3.754; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Roos MTL, 2000, J INFECT DIS, V182, P451, DOI 10.1086/315737; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19	9	17	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					203	203		10.1038/ni0302-203	http://dx.doi.org/10.1038/ni0302-203			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875453	Bronze			2022-12-18	WOS:000174074000002
J	Sercarz, EE				Sercarz, EE			Processing creates the self	NATURE IMMUNOLOGY			English	Editorial Material							DETERMINANT; MOLECULES; PEPTIDE; CAPTURE	Autoreactive T cells may escape tolerance induction owing to enzymatic cleavage of dominant determinants in the thymus. Processing events both in the thymus and the periphery influence the spectrum of determinants available to T cells.	La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Sercarz, EE (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.							Anderton SM, 2002, NAT IMMUNOL, V3, P175, DOI 10.1038/ni756; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; BENICHOU G, 1994, INT IMMUNOL, V6, P131, DOI 10.1093/intimm/6.1.131; Castellino F, 1998, J IMMUNOL, V161, P4048; Givogri MI, 2001, J NEUROSCI RES, V66, P679, DOI 10.1002/jnr.10031; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; McAdam SN, 2001, J EXP MED, V193, P1239, DOI 10.1084/jem.193.11.1239; PARHAM P, 1998, IMMUNOL REV, V164; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SOARES LRB, 1994, INT IMMUNOL, V6, P785, DOI 10.1093/intimm/6.5.785; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821	13	17	17	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					110	112		10.1038/ni0202-110	http://dx.doi.org/10.1038/ni0202-110			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812983				2022-12-18	WOS:000173562400007
J	Storb, U				Storb, U			DNA polymerases in immunity: profiting from errors	NATURE IMMUNOLOGY			English	News Item							CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES	Multiple error-prone DNA polymerase appear to contribute to immunoglobulin somatic hypermutation. Genetic and biochemical data now indicate that DNA polymerase eta may be responsible for the generation of some of the strand-biased hotspot A mutations in the immunoglobulin loci.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Storb, U (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.							BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Esposito G, 2000, P NATL ACAD SCI USA, V97, P1166, DOI 10.1073/pnas.97.3.1166; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Shapiro GS, 1999, J IMMUNOL, V163, P259; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Storb U, 1998, CURR TOP MICROBIOL, V229, P11; Storb U, 1999, COLD SPRING HARB SYM, V64, P227, DOI 10.1101/sqb.1999.64.227; Tissier A, 2000, GENE DEV, V14, P1642; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	18	17	17	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					484	485		10.1038/88673	http://dx.doi.org/10.1038/88673			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376332				2022-12-18	WOS:000169078000009
J	Surace, L; Doisne, JM; Croft, CA; Thaller, A; Escoll, P; Marie, S; Petrosemoli, N; Guillemot, V; Dardalhon, V; Topazio, D; Cama, A; Buchrieser, C; Taylor, N; Amit, I; Musumeci, O; Di Santo, JP				Surace, Laura; Doisne, Jean-Marc; Croft, Carys A.; Thaller, Anna; Escoll, Pedro; Marie, Solenne; Petrosemoli, Natalia; Guillemot, Vincent; Dardalhon, Valerie; Topazio, Davide; Cama, Antonia; Buchrieser, Carmen; Taylor, Naomi; Amit, Ido; Musumeci, Olimpia; Di Santo, James P.			Dichotomous metabolic networks govern human ILC2 proliferation and function	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; MITOCHONDRIAL DYNAMICS; ACTIVATION; MEMORY; FATE; MAINTENANCE; PRECURSORS; GLYCOLYSIS; RECEPTOR; SUPPORT	ILC2 metabolism has been largely unexplored. Di Santo and colleagues examine metabolic profiles from naive and cytokine-activated ILC2s and find that IL-33-triggered ILC2s rely on distinct metabolic pathways to sustain proliferation and function. Group 2 innate lymphoid cells (ILC2s) represent innate homologs of type 2 helper T cells (T(H)2) that participate in immune defense and tissue homeostasis through production of type 2 cytokines. While T lymphocytes metabolically adapt to microenvironmental changes, knowledge of human ILC2 metabolism is limited, and its key regulators are unknown. Here, we show that circulating 'naive' ILC2s have an unexpected metabolic profile with a higher level of oxidative phosphorylation (OXPHOS) than natural killer (NK) cells. Accordingly, ILC2s are severely reduced in individuals with mitochondrial disease (MD) and impaired OXPHOS. Metabolomic and nutrient receptor analysis revealed ILC2 uptake of amino acids to sustain OXPHOS at steady state. Following activation with interleukin-33 (IL-33), ILC2s became highly proliferative, relying on glycolysis and mammalian target of rapamycin (mTOR) to produce IL-13 while continuing to fuel OXPHOS with amino acids to maintain cellular fitness and proliferation. Our results suggest that proliferation and function are metabolically uncoupled in human ILC2s, offering new strategies to target ILC2s in disease settings.	[Surace, Laura; Doisne, Jean-Marc; Croft, Carys A.; Thaller, Anna; Marie, Solenne; Di Santo, James P.] Inserm U1223, Innate Immun Unit, Inst Pasteur, Paris, France; [Croft, Carys A.; Thaller, Anna] Univ Paris, Sorbonne Paris Cite, Paris, France; [Escoll, Pedro; Buchrieser, Carmen] CNRS, Biol Intracellular Bacteria Unit, Inst Pasteur, UMR 3525, Paris, France; [Petrosemoli, Natalia; Guillemot, Vincent] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Bioinformat & Biostat Hub, Paris, France; [Dardalhon, Valerie; Taylor, Naomi] Univ Montpellier, Inst Genet Mol Montpellier, CNRS, Montpellier, France; [Topazio, Davide] Hosp Mazzini, Dept Otolaryngol, Teramo, Italy; [Cama, Antonia] Hosp F Renzetti, Dept Maxillofacial & Otolaryngol, Lanciano, Italy; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Disorders, Messina, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Weizmann Institute of Science; University of Messina	Di Santo, JP (corresponding author), Inserm U1223, Innate Immun Unit, Inst Pasteur, Paris, France.	james.di-santo@pasteur.fr	Taylor, Naomi/H-4016-2014; Di Santo, James P/M-4298-2014; Doisne, Jean-Marc/C-4543-2015; Escoll, Pedro/B-2034-2017	Di Santo, James P/0000-0002-7146-1862; Buchrieser, Carmen/0000-0003-3477-9190; surace, laura/0000-0001-8152-0611; Doisne, Jean-Marc/0000-0001-6714-1308; Croft, Carys Anne/0000-0002-4392-5498; Escoll, Pedro/0000-0002-5933-094X	ANR [ANR-10-INSB-04-01]; Institut National de la Sante et de la Recherche Medicale (INSERM); Institut Pasteur; Agence National pour le Recherche (ANR); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [695467]; European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie grant [765104]; Fondation pour la Recherche Medicale (FRM) [EQU201903007847]; SNSF-Early PostDoc.Mobility fellowship; Marie Curie grant (H2020- MSCA-IF-2017);  [ANR-10-LABX-62-IBEID]	ANR(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Agence National pour le Recherche (ANR)(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie grant; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); SNSF-Early PostDoc.Mobility fellowship; Marie Curie grant (H2020- MSCA-IF-2017); 	We thank all the members of the Innate Immunity Unit for helpful discussions, the Centre de Recherche Translationnelle and the logistic department of Institut Pasteur. We thank the CB-UTechS platform for cytometry support and the Imagopole-CiTech (part of France-BioImaging supported by ANR grant no. ANR-10-INSB-04-01, Conseil de la Region Ile-de-France, FRM) for technical support. The Innate Immunity Unit is supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Pasteur, the Agence National pour le Recherche (ANR) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (695467, ILC_REACTIVITY). A.T. is supported by European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie grant agreement no. 765104. C.B.'s group was supported by the Fondation pour la Recherche Medicale (FRM) grant no. EQU201903007847 and the grant no. ANR-10-LABX-62-IBEID. L.S. was supported by an SNSF-Early PostDoc.Mobility fellowship and a Marie Curie grant (H2020- MSCA-IF-2017).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Di Luccia B, 2019, J EXP MED, V216, P2231, DOI 10.1084/jem.20180549; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Escoll P, 2017, CELL HOST MICROBE, V22, P302, DOI 10.1016/j.chom.2017.07.020; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Karagiannis F, 2020, IMMUNITY, V52, P620, DOI 10.1016/j.immuni.2020.03.003; Kelly B, 2020, CELL METAB, V32, P154, DOI 10.1016/j.cmet.2020.06.010; Klose CSN, 2020, CELL RES, V30, P475, DOI 10.1038/s41422-020-0323-8; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Mazzurana L, 2021, CELL RES, V31, P554, DOI 10.1038/s41422-020-00445-x; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Miller MM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay3994; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nicoli F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02736; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Puleston DJ, 2017, CELL METAB, V26, P131, DOI 10.1016/j.cmet.2017.06.019; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shao D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05362-7; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Surace L, 2021, BLOOD ADV, V5, P26, DOI 10.1182/bloodadvances.2020003458; Tanimine N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217761; van der Ploeg EK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd3489; van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001	60	16	16	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1367	+		10.1038/s41590-021-01043-8	http://dx.doi.org/10.1038/s41590-021-01043-8		OCT 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686862	Green Published, hybrid			2022-12-18	WOS:000710077900001
J	Quandt, J; Arnovitz, S; Haghi, L; Woehlk, J; Mohsin, A; Okoreeh, M; Mathur, PS; Emmanuel, AO; Osman, A; Krishnan, M; Morin, SB; Pearson, AT; Sweis, RF; Pekow, J; Weber, CR; Khazaie, K; Gounari, F				Quandt, Jasmin; Arnovitz, Stephen; Haghi, Leila; Woehlk, Janine; Mohsin, Azam; Okoreeh, Michael; Mathur, Priya S.; Emmanuel, Akinola Olumide; Osman, Abu; Krishnan, Manisha; Morin, Samuel B.; Pearson, Alexander T.; Sweis, Randy F.; Pekow, Joel; Weber, Christopher R.; Khazaie, Khashayarsha; Gounari, Fotini			Wnt-beta-catenin activation epigenetically reprograms T-reg cells in inflammatory bowel disease and dysplastic progression	NATURE IMMUNOLOGY			English	Article								Gounari and colleagues examine how the Wnt-beta-catenin signaling axis in regulatory T cells promotes inflammatory bowel disease and colonic dysplasia. Activated beta-catenin induces epigenetic changes that alter expression of genes co-regulated by Foxp3 and TCF-1. The diversity of regulatory T (T-reg) cells in health and in disease remains unclear. Individuals with colorectal cancer harbor a subpopulation of ROR gamma t(+) T-reg cells with elevated expression of beta-catenin and pro-inflammatory properties. Here we show progressive expansion of ROR gamma t(+) T-reg cells in individuals with inflammatory bowel disease during inflammation and early dysplasia. Activating Wnt-beta-catenin signaling in human and murine T-reg cells was sufficient to recapitulate the disease-associated increase in the frequency of ROR gamma t(+) T-reg cells coexpressing multiple pro-inflammatory cytokines. Binding of the beta-catenin interacting partner, TCF-1, to DNA overlapped with Foxp3 binding at enhancer sites of pro-inflammatory pathway genes. Sustained Wnt-beta-catenin activation induced newly accessible chromatin sites in these genes and upregulated their expression. These findings indicate that TCF-1 and Foxp3 together limit the expression of pro-inflammatory genes in T-reg cells. Activation of beta-catenin signaling interferes with this function and promotes the disease-associated ROR gamma t(+) T-reg phenotype.	[Quandt, Jasmin; Arnovitz, Stephen; Haghi, Leila; Woehlk, Janine; Mohsin, Azam; Okoreeh, Michael; Mathur, Priya S.; Krishnan, Manisha; Gounari, Fotini] Univ Chicago, Knapp Res Ctr, Sect Rheumatol, Dept Med, Chicago, IL 60637 USA; [Osman, Abu; Khazaie, Khashayarsha] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Osman, Abu; Khazaie, Khashayarsha] Mayo Clin, Coll Med, Dept Surg, Rochester, MN 55905 USA; [Morin, Samuel B.; Pearson, Alexander T.; Sweis, Randy F.] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Pekow, Joel] Univ Chicago, Dept Med, Sect Gastroenterol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Weber, Christopher R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; Mayo Clinic; Mayo Clinic; University of Chicago; University of Chicago; University of Chicago	Gounari, F (corresponding author), Univ Chicago, Knapp Res Ctr, Sect Rheumatol, Dept Med, Chicago, IL 60637 USA.; Khazaie, K (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.; Khazaie, K (corresponding author), Mayo Clin, Coll Med, Dept Surg, Rochester, MN 55905 USA.	khazaie@mayo.edu; fgounari@uchicago.edu	MATHUR, PRIYA/ABI-7670-2020; Mathur, Priya/AGZ-9232-2022	MATHUR, PRIYA/0000-0003-0378-7171; Mathur, Priya/0000-0003-0378-7171; Okoreeh, Michael/0000-0001-7680-9488	National Institutes of Health (NIH) [R21AI076720, R01AI147652]; Digestive Diseases Research Core Center pilot award [NIDDK P30DK42086]; ASH bridge grant; Praespero autoimmunity fund; Chicago Biomedical Consortium; NIH; NRSA [T32 HL07605]; AAI Careers in Immunology Fellowship;  [R01AI108682];  [R01CA160436];  [T32HD007009]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center pilot award; ASH bridge grant; Praespero autoimmunity fund; Chicago Biomedical Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAI Careers in Immunology Fellowship; ; ; 	We thank clinical research coordinators B. Putz and A. Duong for facilitating the patient sample supply, S. Keerthivasan for introducing relevant mouse strains to the laboratory, and M. -L. Alegre for helpful advice on the manuscript. We also want to thank the Flow Cytometry Core (UCFlow), Human Tissue Resource Center and the Animal Resources Center at the University of Chicago. This work was supported by National Institutes of Health (NIH) grants R21AI076720 and R01AI147652, a Digestive Diseases Research Core Center pilot award (NIDDK P30DK42086) and an ASH bridge grant (to F.G.), and grants R01AI108682 (to F.G. and K.K.) and R01CA160436 (to K.K). Further support came from the Praespero autoimmunity fund (to F.G. and K.K.) and the Chicago Biomedical Consortium (to F.G.). A.O.E. was supported by an NIH minority supplement. P.S.M. was supported by T32 HL07605 Institutional NRSA and is currently an LLS fellow. J.Q. was supported by an AAI Careers in Immunology Fellowship. M.O. is a T32HD007009 award recipient.	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Franckaert D, 2015, IMMUNOL CELL BIOL, V93, P417, DOI 10.1038/icb.2014.108; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kassambara A., 2017, PACKAGE SURVMINER; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Kovalovsky D, 2009, J IMMUNOL, V183, P3873, DOI 10.4049/jimmunol.0901369; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moparthi L, 2019, DIFFERENTIATION, V108, P24, DOI 10.1016/j.diff.2019.01.002; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pratama A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190428; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumida T, 2018, NAT IMMUNOL, V19, P1391, DOI 10.1038/s41590-018-0236-6; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Therneau TM, 2015, PACKAGE SURVIVAL ANA; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wing JB, 2019, IMMUNITY, V50, P302, DOI 10.1016/j.immuni.2019.01.020; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zitvogel L, 2016, CELL, V165, P276, DOI 10.1016/j.cell.2016.03.001	70	16	16	4	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					471	+		10.1038/s41590-021-00889-2	http://dx.doi.org/10.1038/s41590-021-00889-2		MAR 2021	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33664518	Green Accepted			2022-12-18	WOS:000625937500002
J	Rivas, MA; Meydan, C; Chin, CR; Challman, MF; Kim, D; Bhinder, B; Kloetgen, A; Viny, AD; Teater, MR; McNally, DR; Doane, AS; Beguelin, W; Fernandez, MTC; Shen, H; Wang, X; Levine, RL; Chen, ZM; Tsirigos, A; Elemento, O; Mason, CE; Melnick, AM				Rivas, Martin A.; Meydan, Cem; Chin, Christopher R.; Challman, Matt F.; Kim, Daleum; Bhinder, Bhavneet; Kloetgen, Andreas; Viny, Aaron D.; Teater, Matt R.; McNally, Dylan R.; Doane, Ashley S.; Beguelin, Wendy; Fernandez, Maria Teresa Calvo; Shen, Hao; Wang, Xiang; Levine, Ross L.; Chen, Zhengming; Tsirigos, Aristotelis; Elemento, Olivier; Mason, Christopher E.; Melnick, Ari M.			Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; COHESIN COMPLEX; 3-DIMENSIONAL ORGANIZATION; GENOMIC INTERACTIONS; READ ALIGNMENT; DIFFERENTIATION; LYMPHOMA; REVEALS; ROLES; IDENTIFICATION	During the germinal center (GC) reaction, B cells undergo extensive redistribution of cohesin complex and three-dimensional reorganization of their genomes. Yet, the significance of cohesin and architectural programming in the humoral immune response is unknown. Herein we report that homozygous deletion of Smc3, encoding the cohesin ATPase subunit, abrogated GC formation, while, in marked contrast, Smc3 haploinsufficiency resulted in GC hyperplasia, skewing of GC polarity and impaired plasma cell (PC) differentiation. Genome-wide chromosomal conformation and transcriptional profiling revealed defects in GC B cell terminal differentiation programs controlled by the lymphoma epigenetic tumor suppressors Tet2 and Kmt2d and failure of Smc3-haploinsufficient GC B cells to switch from B cell- to PC-defining transcription factors. Smc3 haploinsufficiency preferentially impaired the connectivity of enhancer elements controlling various lymphoma tumor suppressor genes, and, accordingly, Smc3 haploinsufficiency accelerated lymphomagenesis in mice with constitutive Bcl6 expression. Collectively, our data indicate a dose-dependent function for cohesin in humoral immunity to facilitate the B cell to PC phenotypic switch while restricting malignant transformation.	[Rivas, Martin A.; Chin, Christopher R.; Challman, Matt F.; Kim, Daleum; Teater, Matt R.; McNally, Dylan R.; Doane, Ashley S.; Beguelin, Wendy; Fernandez, Maria Teresa Calvo; Shen, Hao; Wang, Xiang; Melnick, Ari M.] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Meydan, Cem; Chin, Christopher R.; Elemento, Olivier; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Meydan, Cem; Chin, Christopher R.; Elemento, Olivier; Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al Sa, New York, NY USA; [Bhinder, Bhavneet; McNally, Dylan R.; Doane, Ashley S.; Elemento, Olivier] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Kloetgen, Andreas; Tsirigos, Aristotelis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Viny, Aaron D.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Viny, Aaron D.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Chen, Zhengming] Weill Cornell Med, Dept Populat Hlth Sci, Div Biostat & Epidemiol, New York, NY USA; [Tsirigos, Aristotelis] NYU, Sch Med, Inst Computat Med, New York, NY USA; [Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med, WorldQuant Initiat Quantitat Predict, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA	Cornell University; Cornell University; Cornell University; Cornell University; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; New York University; New York University; Cornell University; Cornell University	Melnick, AM (corresponding author), Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA.	amm2014@med.cornell.edu	Mason, Christopher/HCH-3977-2022; Viny, Aaron/AAH-5964-2020	Viny, Aaron/0000-0001-7039-0110; Chin, Christopher/0000-0002-2140-3197; Kloetgen, Andreas/0000-0003-0991-4442; Rivas, Martin/0000-0002-9603-6897; Challman, Matthew/0000-0002-2508-0030; Tsirigos, Aristotelis/0000-0002-7512-8477; Wang, Xiang/0000-0003-4603-7186	NCI/NIH [R35 CA220499, P01 CA229086-01A1]; Samuel Waxman Cancer Research Foundation; Follicular Lymphoma Consortium; Chemotherapy Foundation; Lymphoma Research Foundation; NHLBI [5 T32 HL135465-3]; NIH [UL1TR002384, R01 CA194547, R01 CA249054, R01 AI151059, P01 CA214274, R01 AI125416-03, R21 AI129851-02]; NCI [P30 CA008748, R35 CA197594-01A1, R01 CA216421, PS-OC U54 CA143869-05, K08 CA215317]; Damon Runyon Cancer Research Foundation [DRG 117-15]; Edward P. Evans Foundation; Starr Cancer Consortium [I7-A765, I9-A9-071, I13-0052]; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance; Leukemia and Lymphoma Society [LLS 9238-16, LLS MCL-982]; American Cancer Society [RSG-15-189-01-RMC]; St. Baldrick's Scholar Award; NCI/NIH Cancer Center Support Grant [P30 CA016087.]; LLS-SCOR [180078-02, 7021-20, 7012-16]; LLS-TRP [6572-19]	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation; Follicular Lymphoma Consortium; Chemotherapy Foundation; Lymphoma Research Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Edward P. Evans Foundation; Starr Cancer Consortium; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); St. Baldrick's Scholar Award; NCI/NIH Cancer Center Support Grant; LLS-SCOR; LLS-TRP	We thank J. Yan and B. Ren (University of California, San Diego) for their help in setting up the in situ Hi-C protocol. Sequencing was performed in the Epigenomics Core and the Genomics Core at Weill Cornell Medicine. The authors thank J. McCormick and T. Baumgartner from the Flow Cytometry Core Facility at Weill Cornell Medicine and G. Nanjangud from the Molecular Genetics Core at Memorial Sloan Kettering Cancer Center for expert assistance with protocols. A.M.M. is supported by NCI/NIH R35 CA220499, NCI/NIH P01 CA229086-01A1 (together with A.T.), LLS-SCOR 7012-16, LLS-TRP 6572-19, the Samuel Waxman Cancer Research Foundation, the Follicular Lymphoma Consortium and the Chemotherapy Foundation. M.A.R. was a recipient of a postdoctoral fellowship grant from the Lymphoma Research Foundation and is funded by an NHLBI 5 T32 HL135465-3 training grant. O.E. is supported by NIH grants UL1TR002384 and R01 CA194547 and LLS-SCOR grants 180078-02 and 7021-20. R.L.L. was supported by NCI P30 CA008748, NCI R35 CA197594-01A1, NCI R01 CA216421 and NCI PS-OC U54 CA143869-05. A.D.V. is supported by NCI K08 CA215317, the William Raveis Charitable Fund Fellowship of the Damon Runyon Cancer Research Foundation (DRG 117-15) and an Evans MDS Young Investigator grant from the Edward P. Evans Foundation. C.E.M. thanks the Scientific Computing Unit, XSEDE Supercomputing Resources as well as the Starr Cancer Consortium (I7-A765, I9-A9-071 and I13-0052) and acknowledges funding from the WorldQuant Foundation, The Pershing Square Sohn Cancer Research Alliance, the NIH (grants R01 CA249054, R01 AI151059, P01 CA214274, R01 AI125416-03 and R21 AI129851-02) and Leukemia and Lymphoma Society grants LLS 9238-16 and LLS MCL-982. A.T. is funded by American Cancer Society RSG-15-189-01-RMC, a St. Baldrick's Scholar Award and NCI/NIH Cancer Center Support Grant P30 CA016087.	Agirre X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08679-z; Beguelin W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01029-x; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cuartero S, 2018, NAT IMMUNOL, V19, P932, DOI 10.1038/s41590-018-0184-1; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; De Koninck M, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026476; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez PM, 2018, CANCER DISCOV, V8, P1632, DOI 10.1158/2159-8290.CD-18-0657; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fudenberg G, 2017, COLD SH Q B, V82, P45, DOI 10.1101/sqb.2017.82.034710; Girardot C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1284-2; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Ise W, 2019, IMMUNOL REV, V288, P64, DOI 10.1111/imr.12751; Jais JP, 2008, LEUKEMIA, V22, P1917, DOI 10.1038/leu.2008.188; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Johanson TM, 2018, NAT IMMUNOL, V19, P1257, DOI 10.1038/s41590-018-0234-8; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Ladurner R, 2014, CURR BIOL, V24, P2228, DOI 10.1016/j.cub.2014.08.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazaris C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3387-6; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mlynarczyk C, 2019, IMMUNOL REV, V288, P214, DOI 10.1111/imr.12755; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sasca D, 2019, BLOOD, V134, P2195, DOI 10.1182/blood.2019001553; Scharer CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04125-8; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Silverman J., 2014, THE IACUC HDB, VThird, DOI DOI 10.1201/B17109; Soro PG, 1999, J IMMUNOL, V163, P611; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas-Claudepierre AS, 2013, J EXP MED, V210, P2495, DOI 10.1084/jem.20130166; van Galen P, 2016, MOL CELL, V61, P170, DOI 10.1016/j.molcel.2015.11.003; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wolff J, 2018, NUCLEIC ACIDS RES, V46, pW11, DOI 10.1093/nar/gky504; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zheng XB, 2018, BIOINFORMATICS, V34, P1568, DOI 10.1093/bioinformatics/btx802	80	16	16	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					240	U278		10.1038/s41590-020-00827-8	http://dx.doi.org/10.1038/s41590-020-00827-8		JAN 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33432228	Green Accepted			2022-12-18	WOS:000607030200002
J	Zhao, B; Yoganathan, K; Li, LQ; Lee, JY; Zuniga-Pflucker, JC; Love, PE				Zhao, Bin; Yoganathan, Kogulan; Li, LiQi; Lee, Jan Y.; Zuniga-Pflucker, Juan Carlos; Love, Paul E.			Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; ALPHA-BETA; MICE LACKING; GAMMA; DEGRADATION; P27(KIP1); SKP2; DIFFERENTIATION; UBIQUITIN; CHAIN	Proliferation is tightly regulated during T cell development, and is limited to immature CD4(-)CD8(-) thymocytes. The major proliferative event is initiated at the 'beta-selection' stage following successful rearrangement of Tcr beta, and is triggered by and dependent on concurrent signaling by Notch and the pre-T cell receptor (TCR); however, it is unclear how these signals cooperate to promote cell proliferation. Here, we found that beta-selection-associated proliferation required the combined activity of two Skp-cullin-F-box (SCF) ubiquitin ligase complexes that included as substrate recognition subunits the F-box proteins Fbxl1 or Fbxl12. Both SCF complexes targeted the cyclin-dependent kinase inhibitor Cdkn1b for polyubiquitination and proteasomal degradation. We found that Notch signals induced the transcription of Fbxl1, whereas pre-TCR signals induced the transcription of Fbxl12. Thus, concurrent Notch and pre-TCR signaling induced the expression of two genes, Fbxl1 and Fbxl12, whose products functioned identically but additively to promote degradation of Cdkn1b, cell cycle progression, and proliferation of beta-selected thymocytes.	[Zhao, Bin; Li, LiQi; Lee, Jan Y.; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD 20892 USA; [Yoganathan, Kogulan; Zuniga-Pflucker, Juan Carlos] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Love, PE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD 20892 USA.	lovep@mail.nih.gov	Zhao, Bin/ABB-6186-2021; Zuniga-Pflucker, Juan C/H-1295-2012	Zhao, Bin/0000-0001-7065-2416; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [1ZIAHD001803-25]; Swedish Society for Medical Research; Canadian Institutes of Health Research [FND-154332]; National Institutes of Health [1P01AI102853-01]; Canada Research Chair in Developmental Immunology; Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102853] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Society for Medical Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Developmental Immunology(Canada Research Chairs); Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (project number 1ZIAHD001803-25 to P.E.L.), a grant from the Swedish Society for Medical Research (to B.Z.), the Canadian Institutes of Health Research (FND-154332 to J.C.Z.-P.) and the National Institutes of Health (1P01AI102853-01 to J.C.Z.-P.). J.C.Z.-P. is supported by a Canada Research Chair in Developmental Immunology, and K.Y. is supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. The authors thank R. Bosselut for critical reading of the manuscript, and R. Bosselut, A. Bhandoola, B. J. Fowlkes, N. Taylor and H. Petrie for helpful discussions on the project.	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Del Debbio CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152025; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2006, IMMUNOL REV, V209, P170, DOI 10.1111/j.0105-2896.2006.00356.x; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hristova NR, 2013, INT J ONCOL, V43, P1967, DOI 10.3892/ijo.2013.2140; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Matsumoto A, 2014, BLOOD, V123, P3429, DOI 10.1182/blood-2013-10-532390; Mohtashami M, 2013, INT IMMUNOL, V25, P601, DOI 10.1093/intimm/dxt027; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nishiyama M, 2015, STEM CELLS, V33, P3327, DOI 10.1002/stem.2088; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PENIT C, 1995, J IMMUNOL, V154, P5103; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Shortman K, 1990, Semin Immunol, V2, P3; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Tussiwand R, 2011, EUR J IMMUNOL, V41, P3371, DOI 10.1002/eji.201141824; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015	53	16	17	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1381	+		10.1038/s41590-019-0469-z	http://dx.doi.org/10.1038/s41590-019-0469-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31451788	Green Accepted			2022-12-18	WOS:000486615900021
J	Munitz, A; Hogan, SP				Munitz, Ariel; Hogan, Simon Patrick			Alarming eosinophils to combat tumors	NATURE IMMUNOLOGY			English	Editorial Material							IN-VIVO; INFILTRATION		[Munitz, Ariel] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Hogan, Simon Patrick] Univ Michigan, Dept Pathol, Michigan Med, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Michigan Med, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu		Hogan, Simon/0000-0001-5793-4304				Broxmeyer HE, 2016, STEM CELLS DEV, V25, P575, DOI 10.1089/scd.2016.0026; Carretero R, 2015, NAT IMMUNOL, V16, P609, DOI 10.1038/ni.3159; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Cormier SA, 2006, J LEUKOCYTE BIOL, V79, P1131, DOI 10.1189/jlb.0106027; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Hollande C, 2019, NAT IMMUNOL, V20, P257, DOI 10.1038/s41590-019-0321-5; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Reichman H, 2016, TRENDS CANCER, V2, P664, DOI 10.1016/j.trecan.2016.10.002; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Thomson L, 2002, CLIN EXP ALLERGY, V32, P1187, DOI 10.1046/j.1365-2745.2002.01444.x; Varricchi G, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1393134; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	14	16	17	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					250	252		10.1038/s41590-019-0318-0	http://dx.doi.org/10.1038/s41590-019-0318-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30778244				2022-12-18	WOS:000458893600008
J	Stojanovic, A; Cerwenka, A				Stojanovic, Ana; Cerwenka, Adelheid			Checkpoint inhibition: NK cells enter the scene	NATURE IMMUNOLOGY			English	Editorial Material							CANCER-IMMUNOTHERAPY; TIGIT	Tumor-associated natural killer cells have elevated expression of the checkpoint inhibitory receptor TIGIT. Monoclonal antibody-mediated blockade targeting TIGIT unleashes the anti-tumor activity of both natural killer cells and T cells in preclinical mouse models and efficiently delays tumor growth.	[Stojanovic, Ana; Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol, Mannheim, Germany; [Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Cerwenka, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol, Mannheim, Germany.; Cerwenka, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, Mannheim, Germany.	adelheid.cerwenka@medma.uni-heidelberg.de		Cerwenka, Adelheid/0000-0001-6977-3536; Stojanovic, Ana/0000-0001-9503-2256				Blake SJ, 2016, CLIN CANCER RES, V22, P5183, DOI 10.1158/1078-0432.CCR-16-0933; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chiossone L, 2017, SEMIN IMMUNOL, V31, P55, DOI 10.1016/j.smim.2017.08.003; Della Chiesa M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00351; Garrido F, 2016, CURR OPIN IMMUNOL, V39, P44, DOI 10.1016/j.coi.2015.12.007; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Stojanovic A, 2013, CANCER MICROENVIRON, V6, P135, DOI 10.1007/s12307-012-0125-8; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0	12	16	16	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					650	652		10.1038/s41590-018-0142-y	http://dx.doi.org/10.1038/s41590-018-0142-y			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29915295				2022-12-18	WOS:000436341300008
J	Ernst, PB; Carvunis, AR				Ernst, Peter B.; Carvunis, Anne-Ruxandra			Of mice, men and immunity: a case for evolutionary systems biology	NATURE IMMUNOLOGY			English	Article							MOUSE; GENES	Animal models have been tremendously useful to translational research, but there is a need to maximize their predictive value to human disease. This Comment proposes novel strategies that consider evolutionary history and the presence, absence or modification of molecular networks in one species that are being studied in the other.	[Ernst, Peter B.] Univ Calif San Diego, Ctr Vet Sci & Comparat Med, Dept Pathol, La Jolla, CA 92093 USA; [Ernst, Peter B.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Carvunis, Anne-Ruxandra] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Evolutionary Biol & Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	University of California System; University of California San Diego; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carvunis, AR (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Ctr Evolutionary Biol & Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	pernst@ucsd.edu; anc201@pitt.edu		Ernst, Peter/0000-0001-7777-1813; Carvunis, Anne-Ruxandra/0000-0002-6474-6413	US National Institutes of Health [GM 108865, AI AI079145]; Wayne and Gladys Valley Foundation; Takeda California; Chiba University-UC San Diego Program in Mucosal Immunology, Allergy and Vaccines; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079145, R01AI079145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM108865, K99GM108865] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne and Gladys Valley Foundation; Takeda California; Chiba University-UC San Diego Program in Mucosal Immunology, Allergy and Vaccines; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Pessah, M. Nicotra, T. Benos and E. Gomez for suggestions, and the reviewers for the comments (whose wording was, in some cases, included). Supported by the US National Institutes of Health (GM 108865 for A.R.C.; and AI AI079145 for P.B.E.), The Wayne and Gladys Valley Foundation, Takeda California and the Chiba University-UC San Diego Program in Mucosal Immunology, Allergy and Vaccines. P.B.E. holds a joint appointment in the Department of Immunology, Chiba University, Chiba, Japan.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bolker JA, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700089; Breschi A, 2017, NAT REV GENET, V18, P425, DOI 10.1038/nrg.2017.19; Canas CA, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/784315; Carvunis AR, 2015, ELIFE, V4, DOI 10.7554/eLife.11615; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Ramos PS, 2015, J HUM GENET, V60, P657, DOI 10.1038/jhg.2015.94; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Singh RS, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P1; Stroud Cheryl, 2016, Clin Transl Med, V5, P26, DOI 10.1186/s40169-016-0107-4; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Thomas DW, 2016, CLIN DEV SUCCESS RAT; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	24	16	16	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					421	425		10.1038/s41590-018-0084-4	http://dx.doi.org/10.1038/s41590-018-0084-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670240	Green Accepted			2022-12-18	WOS:000430562400001
J	Bergthaler, A; Menche, J				Bergthaler, Andreas; Menche, Joerg			The immune system as a social network	NATURE IMMUNOLOGY			English	Editorial Material								The immune system employs a multitude of molecules, cells and organs that act together throughout the entire body to guard human health. Much like in a social network, immune cells can exert full functionality only through effective collaboration and communication.	[Bergthaler, Andreas; Menche, Joerg] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Menche, J (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.	jmenche@cemm.oeaw.ac.at	Bergthaler, Andreas/ABG-5047-2020; Menche, Jörg/AAB-7008-2021; Menche, Jörg/G-3994-2015	Bergthaler, Andreas/0000-0003-0597-1976; Menche, Jörg/0000-0002-1583-6404; Menche, Jörg/0000-0002-1583-6404				Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; De Domenico M, 2016, NAT PHYS, V12, P901, DOI 10.1038/nphys3865; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Karsenty G, 2016, CELL, V164, P1248, DOI 10.1016/j.cell.2016.02.043; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Liu SH, 2014, TRENDS ENDOCRIN MET, V25, P356, DOI 10.1016/j.tem.2014.05.002; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005	14	16	18	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					481	482		10.1038/ni.3727	http://dx.doi.org/10.1038/ni.3727			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418389				2022-12-18	WOS:000399378700003
J	Thompson, LJ; Lai, JF; Valladao, AC; Thelen, TD; Urry, ZL; Ziegler, SF				Thompson, Lucas J.; Lai, Jen-Feng; Valladao, Andrea C.; Thelen, Tennille D.; Urry, Zoe L.; Ziegler, Steven F.			Conditioning of naive CD4(+) T cells for enhanced peripheral Foxp3 induction by nonspecific bystander inflammation	NATURE IMMUNOLOGY			English	Article							PERSISTENT LCMV INFECTION; CHRONIC VIRAL-INFECTION; I INTERFERONS; TH1 IMMUNITY; CANCER; RESPONSES; ANTIGEN; ACTIVATION; EXPRESSION; TOLERANCE	Inflammation induced during infection can both promote and suppress immunity. This contradiction suggests that inflammatory cytokines affect the immune system in a context-dependent manner. Here we show that nonspecific bystander inflammation conditions naive CD4(+) T cells for enhanced peripheral Foxp3 induction and reduced effector differentiation. This results in inhibition of immune responses in vivo via a Foxp3-dependent effect on antigen-specific naive CD4(+) T cell precursors. Such conditioning may have evolved to allow immunity to infection while limiting subsequent autoimmunity caused by release of self-antigens in the wake of infection. Furthermore, this phenothenon suggests a mechanistic explanation for the idea that early tuning of the immune system by infection affects the long-term quality of immune regulation.	[Thompson, Lucas J.; Lai, Jen-Feng; Valladao, Andrea C.; Thelen, Tennille D.; Ziegler, Steven F.] Immunol Res Program, Benaroya Res Inst, Seattle, WA USA; [Valladao, Andrea C.; Thelen, Tennille D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Urry, Zoe L.] Kings Coll London, London WC2R 2LS, England	Benaroya Research Institute; University of Washington; University of Washington Seattle; University of London; King's College London	Ziegler, SF (corresponding author), Immunol Res Program, Benaroya Res Inst, Seattle, WA USA.	sziegler@benaroyaresearch.org			American Cancer Society [121930-PF-12-071-01-LIB]; National Institute of Allergy and Infectious Diseases (NIAID) [T32 AI007411]; Juvenile Diabetes Research Foundation Cooperative Center for Cellular Therapy; US National Institutes of Health [CA182783]; NATIONAL CANCER INSTITUTE [R01CA182783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007411, R01AI108463, R01AI112323] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation Cooperative Center for Cellular Therapy; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Campbell, J. Hamerman and E. Bettelli for helpful discussion, and S. Ma and Aru K. for technical assistance. We thank A. Abbas, M. Orr and A. Marshak-Rothstein for mice and materials. Supported by American Cancer Society postdoctoral fellowship 121930-PF-12-071-01-LIB and National Institute of Allergy and Infectious Diseases (NIAID) grant T32 AI007411 (L.J.T.) and the Juvenile Diabetes Research Foundation Cooperative Center for Cellular Therapy and US National Institutes of Health grant CA182783 (S.F.Z.).	Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Christen U, 2011, CELL MOL IMMUNOL, V8, P193, DOI 10.1038/cmi.2010.71; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; DUMONT FJ, 1986, EUR J IMMUNOL, V16, P735, DOI 10.1002/eji.1830160704; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Durrant DM, 2010, IMMUNOL INVEST, V39, P526, DOI 10.3109/08820131003615498; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Saff RR, 2004, J IMMUNOL, V172, P6598, DOI 10.4049/jimmunol.172.11.6598; Schmitz ML, 2011, BBA-MOL CELL RES, V1813, P2165, DOI 10.1016/j.bbamcr.2011.06.019; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Stelekati E, 2014, IMMUNITY, V40, P801, DOI 10.1016/j.immuni.2014.04.010; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thompson LJ, 2011, J IMMUNOL, V186, P4551, DOI 10.4049/jimmunol.1003573; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	47	16	19	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					297	303		10.1038/ni.3329	http://dx.doi.org/10.1038/ni.3329			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26752376	Green Accepted			2022-12-18	WOS:000370469300014
J	Koyasu, S				Koyasu, Shigeo			Inflammatory ILC2 cells: disguising themselves as progenitors?	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; RESPONSES; ELICITS; IL-25		RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	RIKEN	Koyasu, S (corresponding author), RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.	shigeo.koyasu@riken.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038	Grants-in-Aid for Scientific Research [22229004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Banh C, 2009, BLOOD, V114, P5299, DOI 10.1182/blood-2009-06-228353; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743	11	16	16	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					133	134		10.1038/ni.3080	http://dx.doi.org/10.1038/ni.3080			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594455				2022-12-18	WOS:000348143100002
J	Neumann, K; Ruland, J				Neumann, Konstantin; Ruland, Juergen			Kinases conquer the inflammasomes	NATURE IMMUNOLOGY			English	Editorial Material							TYROSINE KINASE; ACTIVATION; INHIBITOR	Inflammasomes are signaling platforms of the innate immune system that activate proinflammatory cytokines after microbial pathogens are sensed or sterile danger is detected. The kinases Syk and Jnk control inflammasome activation by mediating phosphorylation of the inflammasome adaptor ASC.	[Neumann, Konstantin; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany	Technical University of Munich	Neumann, K (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany.	jruland@lrz.tum.de	Neumann, Konstantin/AAD-5056-2019; Ruland, Jürgen/Q-6680-2018	Neumann, Konstantin/0000-0002-5527-2834; Ruland, Jürgen/0000-0002-8381-3597				Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krenitsky VP, 2012, BIOORG MED CHEM LETT, V22, P1433, DOI 10.1016/j.bmcl.2011.12.027; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500	12	16	17	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1207	1208		10.1038/ni.2763	http://dx.doi.org/10.1038/ni.2763			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24240152				2022-12-18	WOS:000327149400004
J	Dupaul-Chicoine, J; Saleh, M				Dupaul-Chicoine, Jeremy; Saleh, Maya			A new path to IL-1 beta production controlled by caspase-8	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME; ACTIVATION	Maturation of the proinflammatory cytokine IL-1 beta is achieved mainly by the canonical caspase-1 inflammasome. An alternative caspase-8-dependent inflammasome that is engaged after stimulation with dectin-1 during fungal and mycobacterial infection has now been described.	[Dupaul-Chicoine, Jeremy; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ, Canada; [Saleh, Maya] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Dupaul-Chicoine, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	maya.saleh@mcgill.ca		Saleh, Maya/0000-0003-1538-9146				Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Hailfinger S, 2009, IMMUNOL REV, V232, P334, DOI 10.1111/j.1600-065X.2009.00830.x; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Joly S, 2010, VIRULENCE, V1, P276, DOI 10.4161/viru.1.4.11482; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040	13	16	18	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					211	212		10.1038/ni.2241	http://dx.doi.org/10.1038/ni.2241			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344277				2022-12-18	WOS:000300510600006
J	Germain, RN; Schwartzberg, PL				Germain, Ronald N.; Schwartzberg, Pamela L.			The human condition: an immunological perspective	NATURE IMMUNOLOGY			English	Article							YELLOW-FEVER VACCINE; SYSTEMS BIOLOGY; INFLAMMATION; GENETICS; FUTURE; IMMUNITY; AUTOIMMUNITY; MANAGEMENT; GENOMICS; LESSONS	Despite enormous progress in basic research, there are many gaps in understanding human immunity. Here we describe how new investigational tools and computational methods promise to improve the diagnosis, prognosis and therapy of the many diseases with components from the immune system.	[Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, Program Syst Immunol & Infect Dis Modeling,NIH, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NHGRI, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, NIH, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, Program Syst Immunol & Infect Dis Modeling,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI000974-05] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berger JR, 2010, DRUG SAFETY, V33, P969, DOI 10.2165/11537510-000000000-00000; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; COLLINS T, 1999, ROBBINS PATHOLOGICAL, P52; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Cornwell WD, 2010, SEMIN RESP CRIT CARE, V31, P257, DOI 10.1055/s-0030-1254066; Cowin PA, 2010, ANNU REV GENOM HUM G, V11, P133, DOI 10.1146/annurev-genom-082509-141536; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kircik LH, 2009, J DRUGS DERMATOL, V8, P546; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Macilwain C, 2011, CELL, V144, P167, DOI 10.1016/j.cell.2011.01.002; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; Meier-Schellersheim M, 2009, WIRES SYST BIOL MED, V1, P4, DOI 10.1002/wsbm.33; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Petsko GA, 2009, EMBO REP, V10, P1282, DOI 10.1038/embor.2009.240; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ryan JG, 2008, J ALLERGY CLIN IMMUN, V121, P260, DOI 10.1016/j.jaci.2007.09.021; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Schmidt A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-242; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Steward-Tharp SM, 2010, ANN NY ACAD SCI, V1183, P123, DOI 10.1111/j.1749-6632.2009.05124.x; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Weinstock GM, 2007, GENOME RES, V17, P667, DOI 10.1101/gr.6534207; Zabow G, 2008, NATURE, V453, P1058, DOI 10.1038/nature07048	59	16	16	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					369	372		10.1038/ni0511-369	http://dx.doi.org/10.1038/ni0511-369			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502986	Green Accepted			2022-12-18	WOS:000289666600003
J	Tone, M; Greene, MI				Tone, Masahide; Greene, Mark I.			Cooperative regulatory events and Foxp3 expression	NATURE IMMUNOLOGY			English	Editorial Material							SMAD3; GENE; ENHANCER; NFAT	The molecular mechanisms that control T(reg) and T(H)17 development and the precise role of transforming growth factor-beta in this process are complex and imperfectly understood. New findings indicate that the helix-loop-helix proteins E2A and Id3 are also critically involved in some of these processes.	[Tone, Masahide] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Cedars Sinai Medical Center; University of Pennsylvania	Tone, M (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.	masahide.tone@csmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073489] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI073489-03, P01 AI073489] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	12	16	17	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					14	16		10.1038/ni0111-14	http://dx.doi.org/10.1038/ni0111-14			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21170000	Green Accepted			2022-12-18	WOS:000285465100007
J	Bowdridge, S; Gause, WC				Bowdridge, Scott; Gause, William C.			Regulation of alternative macrophage activation by chromatin remodeling	NATURE IMMUNOLOGY			English	Editorial Material							CELLS; PROTEINS	The regulation of gene expression through changes in chromatin structure is increasingly recognized as a chief component of activation of cells of the immune response. It now seems that histone demethylation of the promoter of the gene encoding the transcription factor IRF4 contributes to alternative macrophage activation.	[Bowdridge, Scott; Gause, William C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Bowdridge, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, 185 S Orange Ave, Newark, NJ 07103 USA.	gausewc@umdnj.edu						Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; DE SANTA F, 2009, EMBO J, V28, P3341; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400	12	16	17	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					879	881		10.1038/ni1010-879	http://dx.doi.org/10.1038/ni1010-879			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20856215				2022-12-18	WOS:000281926900003
J	Klein, L				Klein, Ludger			Dead man walking: how thymocytes scan the medulla	NATURE IMMUNOLOGY			English	Editorial Material							CENTRAL TOLERANCE; DENDRITIC CELLS; THYMUS	The thymic medulla provides a unique milieu for the induction of T cell tolerance. New work now provides a first glimpse of how thymocytes scan this microenvironment and thus maximize their chances of encountering self antigen.	Univ Munich, Inst Immunol, D-8000 Munich, Germany	University of Munich	Klein, L (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-8000 Munich, Germany.	ludger.klein@med.lmu.de	Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X				Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	14	16	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					809	811		10.1038/ni0809-809	http://dx.doi.org/10.1038/ni0809-809			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621041				2022-12-18	WOS:000268141400007
J	von Boehmer, H; Nolting, J				von Boehmer, Harald; Nolting, Jens			What turns on Foxp3?	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSION	Inducible regulatory T cells respond to TGF-beta upregulating Foxp3 expression. Tone and colleagues identify an enchancer site in Foxp3 that binds transcription factors Smad3 and NFAT, suggesting a means by which TGF-beta regulates Foxp3 expression.	[von Boehmer, Harald; Nolting, Jens] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu						Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	10	16	16	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					121	122		10.1038/ni0208-121	http://dx.doi.org/10.1038/ni0208-121			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204423				2022-12-18	WOS:000252503000006
J	Palucka, AK; Banchereau, J				Palucka, AK; Banchereau, J			Langerhans cells: daughters of monocytes	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; CONTACT HYPERSENSITIVITY; BLOOD MONOCYTES; DIFFERENTIATION; IMMUNITY; DISTINCT		Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Palucka, AK (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	karolinp@baylorhealth.edu; jacquesb@baylorhealth.edu						Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ito T, 1999, J IMMUNOL, V163, P1409; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Rolland A, 2005, J IMMUNOL, V174, P3067, DOI 10.4049/jimmunol.174.5.3067; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309	15	16	17	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					223	224		10.1038/ni0306-223	http://dx.doi.org/10.1038/ni0306-223			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482165				2022-12-18	WOS:000235360400002
J	O'Neill, LAJ				O'Neill, LAJ			How NOD-ing off leads to Crohn disease	NATURE IMMUNOLOGY			English	Editorial Material							PEPTIDOGLYCAN	Many patients with Crohn disease, an inflammatory bowel disorder, carry mutations in NOD2. The finding that NOD2 normally dampens Toll-like receptor 2-mediated inflammation may explain this association.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092	9	16	20	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					776	778		10.1038/ni0804-776	http://dx.doi.org/10.1038/ni0804-776			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282558				2022-12-18	WOS:000222955600006
J	Beg, AA				Beg, AA			ComPPARtmentalizing NF-kappa B in the gut	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATED RECEPTOR-GAMMA; INHIBIT; EXPRESSION; RESPONSES; COLITIS	How do commensal gut bacteria coexist with the host without causing uncontrolled inflammation? The answer may lie in the induction of the association of PPAR-gamma with NF-kappaB.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Beg, AA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	aab41@columbia.edu						Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Setoguchi K, 2001, J CLIN INVEST, V108, P1667; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tomczak MF, 2003, J IMMUNOL, V171, P1484, DOI 10.4049/jimmunol.171.3.1484	12	16	18	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					14	16		10.1038/ni0104-14	http://dx.doi.org/10.1038/ni0104-14			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699401				2022-12-18	WOS:000187635800007
J	Falk, K; Rotzschke, O				Falk, K; Rotzschke, O			The final cut: how ERAPI trims MHC ligands to size	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; INTERFERON-GAMMA; PEPTIDES; COMPLEX	Proteolytic cleavage generates the peptide repertoire displayed by MHC class I. Now, an interferon-gamma-inducible aminopeptidase in the endoplasmic reticulum has been identified as the final player in this complex process.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Falk, K (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.		Roetzschke, Olaf/GXH-0012-2022					Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	13	16	17	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1121	1122		10.1038/ni1202-1121	http://dx.doi.org/10.1038/ni1202-1121			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447365				2022-12-18	WOS:000179467800005
J	Macpherson, AJ; Lamarre, A				Macpherson, AJ; Lamarre, A			BLySsful interactions between DCs and B cells	NATURE IMMUNOLOGY			English	Editorial Material							RESPONSES; BACTERIA; MICE		Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Macpherson, AJ (corresponding author), Univ Spital Zurich, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Lamarre, Alain/C-3006-2009					DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Haas C, 1998, J IMMUNOL, V160, P3713; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Maloy KJ, 1998, P NATL ACAD SCI USA, V95, P1160, DOI 10.1073/pnas.95.3.1160; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; SNAPPER CM, 1999, FUNDAMENTAL IMMUNOLO, P831	13	16	22	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					798	800		10.1038/ni0902-798	http://dx.doi.org/10.1038/ni0902-798			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205465				2022-12-18	WOS:000177694900004
J	Dorshkind, K				Dorshkind, K			Multilineage development from adult bone marrow cells	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; NUCLEAR TRANSFER; PLASTICITY; MICE		Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Dorshkind, K (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.uda.edu						Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gollner G, 1999, CYTOKINE, V11, P656, DOI 10.1006/cyto.1998.0475; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Verfaillie CM, 2002, NAT IMMUNOL, V3, P314, DOI 10.1038/ni0402-314; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wei G, 2000, STEM CELLS, V18, P409, DOI 10.1634/stemcells.18-6-409; WEISS P, 1939, PRINCIPLES DEV	21	16	19	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					311	313		10.1038/ni0402-311	http://dx.doi.org/10.1038/ni0402-311			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919565				2022-12-18	WOS:000174623600002
J	Feinberg, MB; Silvestri, G				Feinberg, MB; Silvestri, G			T-S cells and immune tolerance induction: a regulatory renaissance?	NATURE IMMUNOLOGY			English	Editorial Material							REJECTION	CD8(+) T-S cells induce antigen-specific tolerance. The T-S cells may do this by increasing the expression of inhibitory receptor ILT3 and ILT4 on DCs, rendering these cells toleregenic to CD4 cells.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA	Emory University	Feinberg, MB (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	mbf@sph.emory.edu						Adams AB, 2001, PHILOS T R SOC B, V356, P703, DOI 10.1098/rstb.2001.0854; Allan DSJ, 2000, IMMUNOBIOLOGY, V202, P34, DOI 10.1016/S0171-2985(00)80050-9; Bumgardner GL, 2000, TRANSPLANTATION, V70, P1771, DOI 10.1097/00007890-200012270-00017; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Cortesini R, 2001, IMMUNOL REV, V182, P201, DOI 10.1034/j.1600-065X.2001.1820116.x; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Knechtle SJ, 2000, CURR OPIN IMMUNOL, V12, P552, DOI 10.1016/S0952-7915(00)00137-0; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Williams MA, 2000, J IMMUNOL, V165, P6849, DOI 10.4049/jimmunol.165.12.6849	12	16	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					215	217		10.1038/ni0302-215	http://dx.doi.org/10.1038/ni0302-215			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875459				2022-12-18	WOS:000174074000008
J	Bogdan, C				Bogdan, C			Species differences in macrophage NO production are important - Response	NATURE IMMUNOLOGY			English	Letter							NITRIC-OXIDE SYNTHASE; LEISHMANIA-MAJOR; EXPRESSION		Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Bogdan, C (corresponding author), Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, Wasserturmstr 3, D-91054 Erlangen, Germany.							Bogdan C., 2000, V143, P443; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Sharara AI, 1997, J EXP MED, V186, P1495, DOI 10.1084/jem.186.9.1495; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Weinberg JB, 1998, MOL MED, V4, P557, DOI 10.1007/BF03401758; Zhang XO, 1996, J LEUKOCYTE BIOL, V59, P575, DOI 10.1002/jlb.59.4.575	12	16	16	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					102	102		10.1038/ni0202-102b	http://dx.doi.org/10.1038/ni0202-102b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ		Bronze			2022-12-18	WOS:000173562400003
J	Hua, XX; Thompson, CB				Hua, XX; Thompson, CB			Quiescent T cells: actively maintaining inactivity	NATURE IMMUNOLOGY			English	Editorial Material							GROWTH-FACTOR; BETA; DISEASE		Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hua, XX (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.							BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Massague J, 2000, GENE DEV, V14, P627; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7	11	16	16	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1097	1098		10.1038/ni1201-1097	http://dx.doi.org/10.1038/ni1201-1097			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725297				2022-12-18	WOS:000172473200009
J	Di Santo, JP				Di Santo, JP			Lung Krupple-like factor: a quintessential player in T cell quiescence	NATURE IMMUNOLOGY			English	News Item							IN-VIVO; SURVIVAL; NAIVE; PROLIFERATION	The molecular events behind T cell quiescence are poorly understood. Evidence is now emerging that the transcription factor LKLF can potentially programme cells to a resting state in a c-Myc-dependent manner.	Inst Pasteur, Unite Cytokines & Dev Lymphoide, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Di Santo, JP (corresponding author), Inst Pasteur, Unite Cytokines & Dev Lymphoide, 25-28 Rue Docteur Roux, F-75724 Paris 15, France.		Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862				Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; CHAN X, 2000, J BIOL CHEM, V275, P18391; CHEN X, 2001, IN PRESS J BIOL CHEM, V276; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schober SL, 1999, J IMMUNOL, V163, P3662; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1	14	16	16	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					667	668		10.1038/90598	http://dx.doi.org/10.1038/90598			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477398				2022-12-18	WOS:000170230100005
J	Aderem, A; Hood, L				Aderem, A; Hood, L			Immunology in the post-genomic era	NATURE IMMUNOLOGY			English	Editorial Material									Inst Syst Biol, Seattle, WA 98105 USA	Institute for Systems Biology (ISB)	Aderem, A (corresponding author), Inst Syst Biol, 4225 Roosevelt Way, Seattle, WA 98105 USA.							COOKDEGAN R, 1996, GENE WARS SCI POLITI; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; *HUM GEN PROJ, 2001, SCIENCE, V291, P1145; *HUM GEN PROJ, 2001, NATURE, V409, P745; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9	5	16	17	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					373	375		10.1038/87665	http://dx.doi.org/10.1038/87665			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323684				2022-12-18	WOS:000168549800004
J	Gewirtz, AT; Madara, JL				Gewirtz, AT; Madara, JL			Periscope, up! Monitoring microbes in the intestine	NATURE IMMUNOLOGY			English	News Item									Emory Univ, Dept Pathol, WMB 2315, Atlanta, GA 30322 USA	Emory University	Gewirtz, AT (corresponding author), Emory Univ, Dept Pathol, WMB 2315, 1639 Pierce Dr, Atlanta, GA 30322 USA.							Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Madara JL, 1997, ALIMENT PHARM THERAP, V11, P57; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Neutra MR, 1999, CURR TOP MICROBIOL, V236, P17; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373	10	16	17	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					288	290		10.1038/86292	http://dx.doi.org/10.1038/86292			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276197				2022-12-18	WOS:000167982900008
J	Henson, P				Henson, P			Complementing asthma	NATURE IMMUNOLOGY			English	News Item							INTERLEUKIN-12	The complement inflammatory cascade is crucial to our innate ability to ward off infection. Two papers now provide evidence linking C5 and C3a to murine airway hyperresponsiveness, a partial model of human asthma. Surprisingly, these complement proteins appear to have opposite effects.	Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA	National Jewish Health	Henson, P (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, 1400 Jackson St,Rm D508, Denver, CO 80206 USA.	hensonp@njc.org						BRUGMAN SM, 1993, AM REV RESPIR DIS, V147, P314, DOI 10.1164/ajrccm/147.2.314; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; HUMBLES AA, 2000, IN PRESS NATURE, P406; IRVIN CG, 1986, AM REV RESPIR DIS, V134, P777; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; Regal JF, 2000, IMMUNOPHARMACOLOGY, V46, P15, DOI 10.1016/S0162-3109(99)00152-6; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Teran LM, 1997, CLIN EXP ALLERGY, V27, P396	9	16	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					190	192		10.1038/79723	http://dx.doi.org/10.1038/79723			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973272				2022-12-18	WOS:000089815100007
J	Blacher, E; Tsai, C; Litichevskiy, L; Shipony, Z; Iweka, CA; Schneider, KM; Chuluun, B; Heller, HC; Menon, V; Thaiss, CA; Andreasson, KI				Blacher, Eran; Tsai, Connie; Litichevskiy, Lev; Shipony, Zohar; Iweka, Chinyere Agbaegbu; Schneider, Kai Markus; Chuluun, Bayarsaikhan; Heller, H. Craig; Menon, Vilas; Thaiss, Christoph A.; Andreasson, Katrin I.			Aging disrupts circadian gene regulation and function in macrophages	NATURE IMMUNOLOGY			English	Article							CLOCK; EXPRESSION; NETWORK; LIPOPOLYSACCHARIDE; ACCESSIBILITY; FIBROBLASTS; RECRUITMENT; CYTOKINES; VARIANTS; PATHWAYS	Aging is characterized by an increased vulnerability to infection and the development of inflammatory diseases, such as atherosclerosis, frailty, cancer and neurodegeneration. Here, we find that aging is associated with the loss of diurnally rhythmic innate immune responses, including monocyte trafficking from bone marrow to blood, response to lipopolysaccharide and phagocytosis. This decline in homeostatic immune responses was associated with a striking disappearance of circadian gene transcription in aged compared to young tissue macrophages. Chromatin accessibility was significantly greater in young macrophages than in aged macrophages; however, this difference did not explain the loss of rhythmic gene transcription in aged macrophages. Rather, diurnal expression of Kruppel-like factor 4 (Klf4), a transcription factor (TF) well established in regulating cell differentiation and reprogramming, was selectively diminished in aged macrophages. Ablation of Klf4 expression abolished diurnal rhythms in phagocytic activity, recapitulating the effect of aging on macrophage phagocytosis. Examination of individuals harboring genetic variants of KLF4 revealed an association with age-dependent susceptibility to death caused by bacterial infection. Our results indicate that loss of rhythmic Klf4 expression in aged macrophages is associated with disruption of circadian innate immune homeostasis, a mechanism that may underlie age-associated loss of protective immune responses. Blacher et al. examine the effect of aging on the myeloid circadian clock. They find that aging disrupts circadian transcriptional responses and identify KLF4 as a critical oscillating transcription factor that regulates macrophage gene expression and phagocytosis.	[Blacher, Eran; Andreasson, Katrin I.] Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Tsai, Connie] Stanford Univ, Neurosci Grad Program, Stanford, CA 94305 USA; [Litichevskiy, Lev; Thaiss, Christoph A.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Litichevskiy, Lev; Schneider, Kai Markus; Thaiss, Christoph A.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Litichevskiy, Lev; Schneider, Kai Markus; Thaiss, Christoph A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shipony, Zohar] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Chuluun, Bayarsaikhan; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Menon, Vilas] Columbia Univ, Dept Neurol, Ctr Translat & Computat Neuro immunol, Med Ctr, New York, NY USA; [Andreasson, Katrin I.] Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; Columbia University; Stanford University; Stanford University	Andreasson, KI (corresponding author), Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Thaiss, CA (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.; Thaiss, CA (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Thaiss, CA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.; Andreasson, KI (corresponding author), Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.	thaiss@pennmedicine.upenn.edu; kandreas@stanford.edu	Blacher, Eran/X-3010-2019	Blacher, Eran/0000-0003-3207-0153; Litichevskiy, Lev/0000-0002-0510-4509; Heller, H Craig/0000-0003-4479-5880; Schneider, Kai Markus/0000-0002-0047-3794; Agbaegbu Iweka, Chinyere/0000-0001-9228-2436	American Heart Association [19PABH134580007, RO1NS100180, 1P30 AG066515]; Zhang-Jiang Research Fund; T32 Neuroscience Institute; NSF GRFP [DP2AG067492]; Edward Mallinckrodt, Jr. Foundation; UPenn Institute for Immunology; UPenn Diabetes Research Center [P30-DK-019525]; Pew Biomedical Scholarship; Fritz Thyssen Foundation; UPenn Institute on Aging; Marie Sklodowska-Curie Grant [888494]; Stanford School of Medicine Dean's Postdoctoral Fellowship; Medical Scientist Training Program [T32 GM07170]; Training Grant in Computational Biology [5-T32-HG-000046-21]; NIH [S10OD018220];  [RO1AG048232];  [RF1AG058047]	American Heart Association(American Heart Association); Zhang-Jiang Research Fund; T32 Neuroscience Institute; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Edward Mallinckrodt, Jr. Foundation; UPenn Institute for Immunology; UPenn Diabetes Research Center; Pew Biomedical Scholarship; Fritz Thyssen Foundation; UPenn Institute on Aging; Marie Sklodowska-Curie Grant; Stanford School of Medicine Dean's Postdoctoral Fellowship; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant in Computational Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by RO1AG048232 (K.I.A.), RF1AG058047 (K.I.A.), the American Heart Association 19PABH134580007 (K.I.A.), RO1NS100180 (K.I.A.), 1P30 AG066515 (K.I.A.), The Zhang-Jiang Research Fund, T32 Neuroscience Institute (C.T.), NSF GRFP (C.T.), DP2AG067492 (C.A.T.), the Edward Mallinckrodt, Jr. Foundation (C.A.T.), UPenn Institute for Immunology (C.A.T.), UPenn Diabetes Research Center P30-DK-019525 (C.A.T.), Pew Biomedical Scholarship (C.A.T.), Fritz Thyssen Foundation (C.A.T.) and the UPenn Institute on Aging (C.A.T.), Marie Sklodowska-Curie Grant 888494 (E.B.), Stanford School of Medicine Dean's Postdoctoral Fellowship (E.B.), Medical Scientist Training Program T32 GM07170 (L.L.) and Training Grant in Computational Biology 5-T32-HG-000046-21 (L.L.). We thank L. de Lecea for support in housing mice, the Stanford Shared FACS facility for flow cytometry analysis on LSR instruments (S10RR027431-01) and SCGPM for sequencing on a HiSeq 2000. The ATAC-seq sequencing data were generated on an Illumina HiSeq 4000 that was purchased with funds from NIH S10OD018220 for the Stanford Functional Genomics Facility. Schematic illustrations were created with BioRender.com.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bhadra U, 2017, SLEEP MED, V35, P49, DOI 10.1016/j.sleep.2017.04.008; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Deng WJ, 2018, CELL REP, V24, P366, DOI 10.1016/j.celrep.2018.06.026; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dykstra B, 2008, CELL TISSUE RES, V331, P91, DOI 10.1007/s00441-007-0529-9; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Geiger SS, 2019, IMMUNOLOGY, V157, P122, DOI 10.1111/imm.13053; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Herzog ED, 2001, SEMIN CELL DEV BIOL, V12, P295, DOI 10.1006/scdb.2001.0257; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Huo MY, 2017, FASEB J, V31, P1097, DOI 10.1096/fj.201601030R; Hutchison AL, 2018, J BIOL RHYTHM, V33, P339, DOI 10.1177/0748730418789536; Ipseiz N, 2020, MOL THER-METH CLIN D, V16, P21, DOI 10.1016/j.omtm.2019.10.004; Leone MJ, 2012, CHRONOBIOL INT, V29, P715, DOI 10.3109/07420528.2012.682681; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kitchen GB, 2020, P NATL ACAD SCI USA, V117, P1543, DOI 10.1073/pnas.1915932117; KNYSZYNSKI A, 1981, J IMMUNOL, V127, P2508; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liu H, 2016, HUM MOL GENET, V25, P766, DOI 10.1093/hmg/ddv614; Liu QK, 2019, NAT IMMUNOL, V20, P1023, DOI 10.1038/s41590-019-0421-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Misharin AV, 2012, J LEUKOCYTE BIOL, V92, P325, DOI 10.1189/jlb.1111560; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Oliva-Ramirez J, 2014, IMMUNOLOGY, V143, P490, DOI 10.1111/imm.12329; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Rahman SA, 2015, BRAIN BEHAV IMMUN, V47, P4, DOI 10.1016/j.bbi.2014.11.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratopoulos A, 2019, PHARMACOGENOMICS, V20, P791, DOI 10.2217/pgs-2019-0063; Stremitzer S, 2017, PHARMACOGENOMICS J, V17, P29, DOI 10.1038/tpj.2015.86; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thaben PF, 2014, J BIOL RHYTHM, V29, P391, DOI 10.1177/0748730414553029; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	57	15	15	8	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					229	+		10.1038/s41590-021-01083-0	http://dx.doi.org/10.1038/s41590-021-01083-0		DEC 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	34949832	Green Accepted			2022-12-18	WOS:000733694100001
J	Ravichandran, S; Tang, JJ; Grubbs, G; Lee, YR; Pourhashemi, S; Hussaini, L; Lapp, SA; Jerris, RC; Singh, V; Chahroudi, A; Anderson, EJ; Rostad, CA; Khurana, S				Ravichandran, Supriya; Tang, Juanjie; Grubbs, Gabrielle; Lee, Youri; Pourhashemi, Sara; Hussaini, Laila; Lapp, Stacey A.; Jerris, Robert C.; Singh, Vidisha; Chahroudi, Ann; Anderson, Evan J.; Rostad, Christina A.; Khurana, Surender			SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19	NATURE IMMUNOLOGY			English	Article							HUMAN-ANTIBODY REPERTOIRE; DIVERSITY; AFFINITY	There is limited understanding of the viral antibody fingerprint following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. Herein, SARS-CoV-2 proteome-wide immunoprofiling of children with mild/moderate or severe coronavirus disease 2019 (COVID-19) versus multisystem inflammatory syndrome in children versus hospitalized control patients revealed differential cytokine responses, IgM/IgG/IgA epitope diversity, antibody binding and avidity. Apart from spike and nucleocapsid, IgG/IgA recognized epitopes in nonstructural protein (NSP) 2, NSP3, NSP12-NSP14 and open reading frame (ORF) 3a-ORF9. Peptides representing epitopes in NSP12, ORF3a and ORF8 demonstrated SARS-CoV-2 serodiagnosis. Antibody-binding kinetics with 24 SARS-CoV-2 proteins revealed antibody parameters that distinguish children with mild/moderate versus severe COVID-19 or multisystem inflammatory syndrome in children. Antibody avidity to prefusion spike correlated with decreased illness severity and served as a clinical disease indicator. The fusion peptide and heptad repeat 2 region induced SARS-CoV-2-neutralizing antibodies in rabbits. Thus, we identified SARS-CoV-2 antibody signatures in children associated with disease severity and delineate promising serodiagnostic and virus neutralization targets. These findings might guide the design of serodiagnostic assays, prognostic algorithms, therapeutics and vaccines in this important but understudied population. Pediatric COVID-19 can be associated with subsequent multisystem inflammatory syndrome in children (MIS-C), but how these pathologies are related or differ is unclear. Here the authors compare and contrast pediatric COVID-19 and MIS-C immunophenotypes using SARS-CoV-2 antibody fingerprinting proteomics.	[Ravichandran, Supriya; Tang, Juanjie; Grubbs, Gabrielle; Lee, Youri; Pourhashemi, Sara; Khurana, Surender] FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Silver Spring, MD 20993 USA; [Hussaini, Laila; Lapp, Stacey A.; Singh, Vidisha; Chahroudi, Ann; Anderson, Evan J.; Rostad, Christina A.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Hussaini, Laila; Lapp, Stacey A.; Chahroudi, Ann; Anderson, Evan J.; Rostad, Christina A.] Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA USA; [Hussaini, Laila; Lapp, Stacey A.; Chahroudi, Ann; Anderson, Evan J.; Rostad, Christina A.] Emory Univ, Atlanta, GA 30322 USA; [Jerris, Robert C.] Childrens Healthcare Atlanta, Dept Pathol, Atlanta, GA USA; [Jerris, Robert C.] Childrens Healthcare Atlanta, Lab Med, Atlanta, GA USA; [Jerris, Robert C.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, Evan J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	US Food & Drug Administration (FDA); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Healthcare of Atlanta (CHOA); Children's Healthcare of Atlanta (CHOA); Emory University; Emory University	Khurana, S (corresponding author), FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Silver Spring, MD 20993 USA.	surender.khurana@fda.hhs.gov	Tang, Juanjie/AGW-9966-2022	Rostad, Christina/0000-0001-8439-0592	CHOA; FDA's Medical Countermeasures Initiative (MCMi) grant [OCET 2021-1565]; FDA's Perinatal Health Center of Excellence (PHCE) project [GCBER005]; Emergent Ventures at the Mercatus Center of George Mason University; Center for Childhood Infections and Vaccines of CHOA; Emory University	CHOA; FDA's Medical Countermeasures Initiative (MCMi) grant; FDA's Perinatal Health Center of Excellence (PHCE) project; Emergent Ventures at the Mercatus Center of George Mason University; Center for Childhood Infections and Vaccines of CHOA; Emory University	We thank the Emory clinical research team, including L. Macoy, A. Lu, F. Glover, A. Samuel, V. Patel, K. Dibernardo, M. Richardson, B. Desai and K. Stephens for their assistance with enrolling patients and collecting clinical samples. We thank the CHOA clinical and research laboratories for facilitating collection of residual samples and laboratory data. We thank the Emory Children's Center-Vaccine Research Clinic and Hope Clinic laboratories and the research laboratory of A.C. at Emory University for processing and storing clinical samples. We thank the treating clinicians at Emory University and CHOA for their support and for the meticulous care they provided to children affected by COVID-19. Lastly, we thank the patients and their families for participating in this study to further our understanding of COVID-19 and MIS-C in children. The antibody characterization work described in this paper was supported by FDA's Medical Countermeasures Initiative (MCMi) grant no. OCET 2021-1565 and FDA's Perinatal Health Center of Excellence (PHCE) project grant no. GCBER005 to S.K. The clinical study was supported by a Fast Grant from Emergent Ventures at the Mercatus Center of George Mason University (to A.C.) and pilot funds from the Center for Childhood Infections and Vaccines of CHOA and Emory University (to C.A.R.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	[Anonymous], 2020, CELL, DOI DOI 10.1016/S0140-6736(20)31189-2; Bartsch YC, 2021, NAT MED, V27, P454, DOI 10.1038/s41591-021-01263-3; Birhane M, 2021, MMWR-MORBID MORTAL W, V70, P792, DOI 10.15585/mmwr.mm7021e3; Bordi L, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104416; Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y; Fuentes S, 2020, J INFECT DIS, V221, P636, DOI 10.1093/infdis/jiz608; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; Goldenberger D, 2020, J VIROL METHODS, V284, DOI 10.1016/j.jviromet.2020.113925; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Hachim A, 2020, NAT IMMUNOL, V21, P1293, DOI 10.1038/s41590-020-0773-7; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMoa2105000, 10.1056/NEJMc2107808]; Hogan CA, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104410; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jiang HW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17488-8; Khurana S, 2020, CELL HOST MICROBE, V27, P262, DOI 10.1016/j.chom.2020.01.001; Khurana S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11296-5; Khurana S, 2016, NAT MED, V22, P1439, DOI 10.1038/nm.4201; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ravichandran S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf2467; Ravichandran S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3539; Rayichandran S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09914-3; Rostad CA, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-018242; Tang JJ, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103006; Tang JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21463-2; Thao TTN, 2020, NATURE, V582, P561, DOI 10.1038/s41586-020-2294-9; Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yonker LM, 2020, J PEDIATR-US, V227, P45, DOI 10.1016/j.jpeds.2020.08.037	37	15	16	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1452	+		10.1038/s41590-021-01051-8	http://dx.doi.org/10.1038/s41590-021-01051-8		OCT 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34611361	Bronze			2022-12-18	WOS:000703821300001
J	Osman, A; Yan, BY; Li, Y; Pavelko, KD; Quandt, J; Saadalla, A; Singh, MP; Kazemian, M; Gounari, F; Khazaie, K				Osman, Abu; Yan, Bingyu; Li, Ying; Pavelko, Kevin D.; Quandt, Jasmine; Saadalla, Abdulrahman; Singh, Mahendra Pal; Kazemian, Majid; Gounari, Fotini; Khazaie, Khashayarsha			TCF-1 controls T-reg cell functions that regulate inflammation, CD8(+) T cell cytotoxicity and severity of colon cancer	NATURE IMMUNOLOGY			English	Article							GENERATION; INDUCTION; T(H)17; FAMILY	Khazaie and colleagues show that TCF-1 cooperates with FOXP3 to differentially regulate independent suppressive activities of T-reg cells. T-reg cell-specific deficiency of TCF-1 increases tumor load in mice predisposed to polyposis. Functionally, TCF-1-deficient T-reg cells suppress viral antigen-specific CD8(+) T cell cytotoxicity, but TCF-1-deficient T-reg cells fail to suppress T(H)1 or T(H)17 polarization of conventional CD4(+) T cells. This scenario leads to increased cytokine-mediated tissue inflammation but still restrains the adaptive antitumor cytotoxicity. The transcription factor TCF-1 is essential for the development and function of regulatory T (T-reg) cells; however, its function is poorly understood. Here, we show that TCF-1 primarily suppresses transcription of genes that are co-bound by Foxp3. Single-cell RNA-sequencing analysis identified effector memory T cells and central memory T-reg cells with differential expression of Klf2 and memory and activation markers. TCF-1 deficiency did not change the core T-reg cell transcriptional signature, but promoted alternative signaling pathways whereby T-reg cells became activated and gained gut-homing properties and characteristics of the T(H)17 subset of helper T cells. TCF-1-deficient T-reg cells strongly suppressed T cell proliferation and cytotoxicity, but were compromised in controlling CD4(+) T cell polarization and inflammation. In mice with polyposis, T-reg cell-specific TCF-1 deficiency promoted tumor growth. Consistently, tumor-infiltrating T-reg cells of patients with colorectal cancer showed lower TCF-1 expression and increased T(H)17 expression signatures compared to adjacent normal tissue and circulating T cells. Thus, T-reg cell-specific TCF-1 expression differentially regulates T(H)17-mediated inflammation and T cell cytotoxicity, and can determine colorectal cancer outcome.	[Osman, Abu; Pavelko, Kevin D.; Saadalla, Abdulrahman; Singh, Mahendra Pal; Khazaie, Khashayarsha] Mayo Clin, Dept Immunol, Rochester, MN 55902 USA; [Osman, Abu; Quandt, Jasmine; Gounari, Fotini] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Yan, Bingyu; Kazemian, Majid] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Li, Ying] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Kazemian, Majid] Purdue Univ, Dept Comp Sci, Purdue, IN 47907 USA	Mayo Clinic; University of Chicago; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Mayo Clinic; Purdue University System; Purdue University	Khazaie, K (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55902 USA.; Gounari, F (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA.; Kazemian, M (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Kazemian, M (corresponding author), Purdue Univ, Dept Comp Sci, Purdue, IN 47907 USA.	kazemian@purdue.edu; fgounari@uchicago.edu; Khazaie@mayo.edu	Singh, Mahendra Pal/J-8391-2019; Kazemian, Majid/C-7917-2018	Yan, Bingyu/0000-0003-4429-8200; Kazemian, Majid/0000-0001-7080-8820; Pavelko, Kevin/0000-0001-7555-1315; Gounari, Fotini/0000-0003-2936-066X; Osman, Abu/0000-0003-3232-2007	NIH [R01 AI 108682, RO1 AI 147652, R35GM138283]; Praespero Innovation Award Alberta, Canada	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Praespero Innovation Award Alberta, Canada	This work was supported by NIH grants R01 AI 108682 (to F.G. and K.K.), RO1 AI 147652 (to F.G.) and R35GM138283 (to M.K.), and a Praespero Innovation Award Alberta, Canada (to F.G. and K.K.). N. Carapanceanu and V. Carapanceanu are thankfully acknowledged for excellent technical support. L. Pennell (BioLegend) is gratefully acknowledged for advice with scRNA-seq techniques. V. Simon (Mayo Clinic) is gratefully acknowledged for assistance with scRNA-seq. A. V. Lucs (Eli Lilly) is thankfully acknowledged for providing the TGF-beta RI inhibitor LY3200882 and for scientific advice.	Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Barra MM, 2015, J IMMUNOL, V195, P3058, DOI 10.4049/jimmunol.1500821; Barra MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127038; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blatner NR, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23852; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Bos PD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005283; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapman NM, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00686; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kolinski T, 2016, CENT EUR J IMMUNOL, V41, P317, DOI 10.5114/ceji.2016.63133; Kovalovsky D, 2009, J IMMUNOL, V183, P3873, DOI 10.4049/jimmunol.0901369; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mielke LA, 2019, J EXP MED, V216, P1682, DOI 10.1084/jem.20181778; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Miyagawa I, 2017, J IMMUNOL, V199, P1616, DOI 10.4049/jimmunol.1600230; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Neumann C, 2019, NAT IMMUNOL, V20, P471, DOI 10.1038/s41590-019-0316-2; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pabbisetty SK, 2016, P NATL ACAD SCI USA, V113, pE4662, DOI 10.1073/pnas.1605849113; Pavelko KD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01532; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Pratama A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190428; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quandt J, 2021, NAT IMMUNOL, V22, P471, DOI 10.1038/s41590-021-00889-2; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sumida T, 2018, NAT IMMUNOL, V19, P1391, DOI 10.1038/s41590-018-0236-6; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van der Veeken J, 2020, IMMUNITY, V53, P971, DOI 10.1016/j.immuni.2020.10.010; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Weis AM, 2018, GUT MICROBES, V9, P458, DOI 10.1080/19490976.2018.1441662; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang YY, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0131-5; Zhou J, 2018, SEMIN IMMUNOL, V35, P19, DOI 10.1016/j.smim.2017.12.004; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	58	15	15	7	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1152	+		10.1038/s41590-021-00987-1	http://dx.doi.org/10.1038/s41590-021-00987-1		AUG 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34385712	Green Accepted, Green Submitted			2022-12-18	WOS:000684510900002
J	Cupovic, J; Ring, SS; Onder, L; Colston, JM; Lutge, M; Cheng, HW; De Martin, A; Provine, NM; Flatz, L; Oxenius, A; Scandella, E; Krebs, P; Engeler, D; Klenerman, P; Ludewig, B				Cupovic, Jovana; Ring, Sandra S.; Onder, Lucas; Colston, Julia M.; Lutge, Mechthild; Cheng, Hung-Wei; De Martin, Angelina; Provine, Nicholas M.; Flatz, Lukas; Oxenius, Annette; Scandella, Elke; Krebs, Philippe; Engeler, Daniel; Klenerman, Paul; Ludewig, Burkhard			Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							RETICULAR CELLS; RESPONSES; INFECTION; MATURATION; EFFECTOR; SAFETY; MOUSE	Pathogens and vaccines that produce persisting antigens can generate expanded pools of effector memory CD8(+) T cells, described as memory inflation. While properties of inflating memory CD8(+) T cells have been characterized, the specific cell types and tissue factors responsible for their maintenance remain elusive. Here, we show that clinically applied adenovirus vectors preferentially target fibroblastic stromal cells in cultured human tissues. Moreover, we used cell-type-specific antigen targeting to define critical cells and molecules that sustain long-term antigen presentation and T cell activity after adenovirus vector immunization in mice. While antigen targeting to myeloid cells was insufficient to activate antigen-specific CD8(+) T cells, genetic activation of antigen expression in Ccl19-cre-expressing fibroblastic stromal cells induced inflating CD8(+) T cells. Local ablation of vector-targeted cells revealed that lung fibroblasts support the protective function and metabolic fitness of inflating memory CD8(+) T cells in an interleukin (IL)-33-dependent manner. Collectively, these data define a critical fibroblastic niche that underpins robust protective immunity operating in a clinically important vaccine platform. Ludewig and colleagues show that adenovirus immunization fosters the formation of pulmonary immune-stimulating niches underpinned by fibroblastic stromal cells that maintain 'inflating' memory CD8(+) T cells through the provision of interleukin-33.	[Cupovic, Jovana; Ring, Sandra S.; Onder, Lucas; Lutge, Mechthild; Cheng, Hung-Wei; De Martin, Angelina; Flatz, Lukas; Scandella, Elke; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Cupovic, Jovana] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Colston, Julia M.; Provine, Nicholas M.; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Flatz, Lukas] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Krebs, Philippe] Univ Bern, Inst Pathol, Bern, Switzerland; [Engeler, Daniel] Kantonsspital St Gallen, Dept Urol, St Gallen, Switzerland; [Ludewig, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland	Kantonsspital St. Gallen; Max Planck Society; University of Oxford; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Kantonsspital St. Gallen; University of Zurich	Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland.; Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.; Ludewig, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	paul.klenerman@medawar.ox.ac.uk; burkhard.ludewig@kssg.ch		klenerman, paul/0000-0003-4307-9161; Colston, Julia/0000-0002-3337-2455; Oxenius, Annette/0000-0002-2079-2354; Lutge, Mechthild/0000-0001-9011-5319	Swiss National Science Foundation [166500, 159188]; Swiss Cancer Research [KFS-4162-02-2017-R]; Wellcome Trust [099897/Z/12/A, 109965MA]; British Infection Association	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer Research; Wellcome Trust(Wellcome Trust); British Infection Association	We thank S. Caviezel-Firner and C. Engetschwiler for excellent technical support. This study received financial support from the Swiss National Science Foundation (grants 166500 and 159188 to B.L.), Swiss Cancer Research (KFS-4162-02-2017-R to P. Krebs), the Wellcome Trust (109965MA to P. Klenerman) and research fellowship grants from the British Infection Association (to J.M.C.) and the Wellcome Trust (099897/Z/12/A to J.M.C.).	Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Bassett JD, 2011, BLOOD, V117, P1146, DOI 10.1182/blood-2010-03-272336; Baumann C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01833; Baumann NS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006993; Bolinger B, 2015, CELL REP, V13, P1578, DOI 10.1016/j.celrep.2015.10.034; Bolinger B, 2013, J IMMUNOL, V190, P4162, DOI 10.4049/jimmunol.1202665; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Busche A, 2013, J IMMUNOL, V190, P2767, DOI 10.4049/jimmunol.1200966; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Cheng HW, 2018, J ALLERGY CLIN IMMUN, V142, P1257, DOI 10.1016/j.jaci.2017.12.998; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Dominguez D, 2017, J IMMUNOL, V198, P1365, DOI 10.4049/jimmunol.1501399; Ewer K, 2017, HUM VACC IMMUNOTHER, V13, P3020, DOI 10.1080/21645515.2017.1383575; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gordon CL, 2018, CELL REP, V23, P768, DOI 10.1016/j.celrep.2018.03.074; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Grzimek NKA, 2001, J VIROL, V75, P2692, DOI 10.1128/JVI.75.6.2692-2705.2001; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Klenerman P, 2018, IMMUNOL REV, V283, P99, DOI 10.1111/imr.12653; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Komatsu H, 2003, CLIN EXP IMMUNOL, V134, P9, DOI 10.1046/j.1365-2249.2003.02266.x; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lee LN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006782; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Mager LF, 2015, J CLIN INVEST, V125, P2579, DOI 10.1172/JCI77347; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McLaren JE, 2019, J IMMUNOL, V202, P943, DOI 10.4049/jimmunol.1701757; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Novkovic M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002515; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Pikor NB, 2021, J IMMUNOL, V206, P257, DOI 10.4049/jimmunol.2000914; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Rego GNA, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030474; Rowe WP., 1954, RES REP NAVAL MED RE, V12, P167; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Silva-Sanchez A, 2020, CURR TOP MICROBIOL, V426, P21, DOI 10.1007/82_2019_191; Snook AE, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0576-2; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034	61	15	15	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					1042	+		10.1038/s41590-021-00969-3	http://dx.doi.org/10.1038/s41590-021-00969-3		JUL 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34267375	Green Accepted, Bronze			2022-12-18	WOS:000673826600002
J	Ma, FY; Hughes, TK; Teles, RMB; Andrade, PR; Silva, BJD; Plazyo, O; Tsoi, LC; Do, T; Wadsworth, MH; Oulee, A; Ochoa, MT; Sarno, EN; Iruela-Arispe, ML; Klechevsky, E; Bryson, B; Shalek, AK; Bloom, BR; Gudjonsson, JE; Pellegrini, M; Modlin, RL				Ma, Feiyang; Hughes, Travis K.; Teles, Rosane M. B.; Andrade, Priscila R.; de Andrade Silva, Bruno J.; Plazyo, Olesya; Tsoi, Lam C.; Do, Tran; Wadsworth, Marc H., II; Oulee, Aislyn; Ochoa, Maria Teresa; Sarno, Euzenir N.; Luisa Iruela-Arispe, M.; Klechevsky, Eynav; Bryson, Bryan; Shalek, Alex K.; Bloom, Barry R.; Gudjonsson, Johann E.; Pellegrini, Matteo; Modlin, Robert L.			The cellular architecture of the antimicrobial response network in human leprosy granulomas	NATURE IMMUNOLOGY			English	Article							IMMUNE LANDSCAPE; T-CELLS; RNA-SEQ; POPULATIONS; SUBSETS; GRANULYSIN; DISEASE; LESIONS	Granulomas are complex cellular structures composed predominantly of macrophages and lymphocytes that function to contain and kill invading pathogens. Here, we investigated the single-cell phenotypes associated with antimicrobial responses in human leprosy granulomas by applying single-cell and spatial sequencing to leprosy biopsy specimens. We focused on reversal reactions (RRs), a dynamic process whereby some patients with disseminated lepromatous leprosy (L-lep) transition toward self-limiting tuberculoid leprosy (T-lep), mounting effective antimicrobial responses. We identified a set of genes encoding proteins involved in antimicrobial responses that are differentially expressed in RR versus L-lep lesions and regulated by interferon-gamma and interleukin-1 beta. By integrating the spatial coordinates of the key cell types and antimicrobial gene expression in RR and T-lep lesions, we constructed a map revealing the organized architecture of granulomas depicting compositional and functional layers by which macrophages, T cells, keratinocytes and fibroblasts can each contribute to the antimicrobial response. Modlin and colleagues examined the skin lesions of human leprosy patients using single-cell RNA sequencing coupled to cellular spatial mapping. Their analysis maps the architecture of granulomas in leprosy lesions from patients with leprosy with localized disease (tuberculoid leprosy, reversal reaction) to those with progressive infection (lepromatous leprosy).	[Ma, Feiyang; Teles, Rosane M. B.; Andrade, Priscila R.; de Andrade Silva, Bruno J.; Do, Tran; Oulee, Aislyn; Modlin, Robert L.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90024 USA; [Ma, Feiyang; Modlin, Robert L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Ma, Feiyang; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Hughes, Travis K.; Shalek, Alex K.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Bryson, Bryan; Shalek, Alex K.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA USA; [Plazyo, Olesya; Tsoi, Lam C.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Ochoa, Maria Teresa] Univ Southern Calif, Dept Dermatol, Los Angeles, CA 90007 USA; [Sarno, Euzenir N.] Fundacao Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil; [Luisa Iruela-Arispe, M.] Northwestern Univ, Dept Cell & Dev Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Klechevsky, Eynav] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Bryson, Bryan] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bloom, Barry R.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Michigan System; University of Michigan; University of Southern California; Fundacao Oswaldo Cruz; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90024 USA.; Modlin, RL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	rmodlin@mednet.ucla.edu	Teles, Rosane/AAQ-3436-2020; Ma, Feiyang/GLN-6180-2022	Teles, Rosane/0000-0003-2908-3244; Ma, Feiyang/0000-0002-6260-0787; Oulee, Aislyn/0000-0003-1300-9840; Plazyo, Olesya/0000-0002-6859-7590	National Institutes of Health (NIH) [AI-22553, AR-073252, AR074302, AR-40312, NIH-P30 AR075043]; Searle Scholars Program; Beckman Young Investigator Program; Sloan Fellowship in Chemistry, NIH [5U24AI118672]; Bill and Melinda Gates Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Beckman Young Investigator Program; Sloan Fellowship in Chemistry, NIH; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported in part by National Institutes of Health (NIH) grant nos. AI-22553, AR-073252, AR074302 and AR-40312 to R.L.M.; no. NIH-P30 AR075043 to J.E.G.; the Searle Scholars Program, the Beckman Young Investigator Program, a Sloan Fellowship in Chemistry, NIH grant no. 5U24AI118672 and the Bill and Melinda Gates Foundation to A.K.S.	Andrade PR, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007589; Balin SJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7668; Busch M, 2016, AM J RESP CRIT CARE, V194, P345, DOI 10.1164/rccm.201509-1746OC; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen Y, 2010, CARDIOVASC RES, V87, P723, DOI 10.1093/cvr/cvq117; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; COOPER CL, 1989, J EXP MED, V169, P1565, DOI 10.1084/jem.169.5.1565; Dang AT, 2019, J CLIN INVEST, V129, P1926, DOI 10.1172/JCI99550; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esaulova E, 2021, CELL HOST MICROBE, V29, P165, DOI 10.1016/j.chom.2020.11.013; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Inkeles MS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88843; Iyer AM, 2007, HUM PATHOL, V38, P1065, DOI 10.1016/j.humpath.2006.12.017; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; MODLIN RL, 1983, J AM ACAD DERMATOL, V8, P182, DOI 10.1016/S0190-9622(83)70021-6; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Montoya DJ, 2019, CELL REP, V26, P3574, DOI 10.1016/j.celrep.2019.02.109; Ochoa MT, 2010, IMMUNOLOGY, V131, P405, DOI 10.1111/j.1365-2567.2010.03314.x; Ochoa MT, 2000, LEPROSY REV, V71, pS115; Ochoa MT, 2001, NAT MED, V7, P174, DOI 10.1038/84620; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Sole-Boldo L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0922-4; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Teles RMB, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007764; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Wang ECE, 2019, CELL STEM CELL, V24, P654, DOI 10.1016/j.stem.2019.01.011; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang HS, 2020, J INVEST DERMATOL, V140, P1824, DOI 10.1016/j.jid.2020.01.026; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Xue D, 2020, J DERMATOL SCI, V97, P41, DOI [10.1016/j.dermsci.2019.11.012, 10.1016/j.jdermsci.2019.11.012]; YAMAMURA M, 1992, J IMMUNOL, V149, P1470; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Young MD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa151	47	15	16	3	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					839	+		10.1038/s41590-021-00956-8	http://dx.doi.org/10.1038/s41590-021-00956-8		JUN 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34168371	Green Published, Green Accepted			2022-12-18	WOS:000665706700002
J	Hiltensperger, M; Beltraen, E; Kant, R; Tyystjaervi, S; Lepennetier, G; Moreno, HD; Bauer, IJ; Grassmann, S; Jarosch, S; Schober, K; Buchholz, VR; Kenet, S; Gasperi, C; Oellinger, R; Rad, R; Muschaweckh, A; Sie, C; Aly, L; Knier, B; Garg, G; Afzali, AM; Gerdes, LA; Kuempfel, T; Franzenburg, S; Kawakami, N; Hemmer, B; Busch, DH; Misgeld, T; Dornmair, K; Korn, T				Hiltensperger, Michael; Beltran, Eduardo; Kant, Ravi; Tyystjarvi, Sofia; Lepennetier, Gildas; Moreno, Helena Dominguez; Bauer, Isabel J.; Grassmann, Simon; Jarosch, Sebastian; Schober, Kilian; Buchholz, Veit R.; Kenet, Selin; Gasperi, Christiane; Ollinger, Rupert; Rad, Roland; Muschaweckh, Andreas; Sie, Christopher; Aly, Lilian; Knier, Benjamin; Garg, Garima; Afzali, Ali M.; Gerdes, Lisa Ann; Kumpfel, Tania; Franzenburg, Soren; Kawakami, Naoto; Hemmer, Bernhard; Busch, Dirk H.; Misgeld, Thomas; Dornmair, Klaus; Korn, Thomas			Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity	NATURE IMMUNOLOGY			English	Article							MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTORS; BINDING; ENCEPHALOMYELITIS; LYMPHOCYTES; MOUSE; HETEROGENEITY; COOPERATE; EFFECTOR; MODELS	Korn and colleagues demonstrate that the site of T cell priming (gut versus skin draining lymph nodes) dictates their effector phenotypes and homing to distal sites of immunopathology. Multidimensional single-cell analyses of T cells have fueled the debate about whether there is extensive plasticity or 'mixed' priming of helper T cell subsets in vivo. Here, we developed an experimental framework to probe the idea that the site of priming in the systemic immune compartment is a determinant of helper T cell-induced immunopathology in remote organs. By site-specific in vivo labeling of antigen-specific T cells in inguinal (i) or gut draining mesenteric (m) lymph nodes, we show that i-T cells and m-T cells isolated from the inflamed central nervous system (CNS) in a model of multiple sclerosis (MS) are distinct. i-T cells were Cxcr6(+), and m-T cells expressed P2rx7. Notably, m-T cells infiltrated white matter, while i-T cells were also recruited to gray matter. Therefore, we propose that the definition of helper T cell subsets by their site of priming may guide an advanced understanding of helper T cell biology in health and disease.	[Hiltensperger, Michael; Kant, Ravi; Tyystjarvi, Sofia; Lepennetier, Gildas; Moreno, Helena Dominguez; Muschaweckh, Andreas; Sie, Christopher; Aly, Lilian; Garg, Garima; Afzali, Ali M.; Korn, Thomas] Tech Univ Munich, Inst Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany; [Beltran, Eduardo; Bauer, Isabel J.; Gerdes, Lisa Ann; Kumpfel, Tania; Kawakami, Naoto; Dornmair, Klaus] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Clin Neuroimmunol, Planegg Martinsried, Germany; [Beltran, Eduardo; Bauer, Isabel J.; Gerdes, Lisa Ann; Kumpfel, Tania; Kawakami, Naoto; Dornmair, Klaus] Ludwig Maximilians Univ Munchen, Biomed Ctr, Planegg Martinsried, Germany; [Lepennetier, Gildas; Gasperi, Christiane; Aly, Lilian; Knier, Benjamin; Afzali, Ali M.; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Grassmann, Simon; Jarosch, Sebastian; Schober, Kilian; Buchholz, Veit R.; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Kenet, Selin; Misgeld, Thomas] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Ollinger, Rupert; Rad, Roland] Tech Univ Munich, TranslaTUM Canc Ctr, Inst Mol Oncol & Funct Genom, Munich, Germany; [Gerdes, Lisa Ann; Hemmer, Bernhard; Misgeld, Thomas; Dornmair, Klaus; Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Franzenburg, Soren] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Misgeld, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	Technical University of Munich; University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; University of Kiel; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Korn, T (corresponding author), Tech Univ Munich, Inst Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	thomas.korn@tum.de	Hemmer, Bernhard/AAT-8388-2021; Beltrán, Eduardo/G-4458-2012; Beltrán, Eduardo/AAF-4257-2021; Hemmer, Bernhard/AAU-3066-2021; Hemmer, Bernhard/GPX-8451-2022; Kümpfel, Tania/ABH-1780-2021	Beltrán, Eduardo/0000-0002-7266-4098; Beltrán, Eduardo/0000-0002-7266-4098; Hemmer, Bernhard/0000-0001-5985-6784; Bauer, Isabel Julia/0000-0001-9090-2072; Gasperi, Christiane/0000-0002-0524-6005; Jarosch, Sebastian/0000-0002-2908-8590; Kenet, Selin/0000-0001-5527-3442; Hiltensperger, Michael/0000-0003-4600-1394; Kawakami, Naoto/0000-0001-7693-3489; Lepennetier, Gildas/0000-0002-1899-3149	European Research Council (ERC) [CoG 647215]; Deutsche Forschungsgemeinschaft [SFB1054-B06, SFB1054-B05, SFB1371-P04, GA 2913/1-1, DO 420/7-1, EXC 2145, ID 390857198, TRR128-A07, TRR128-A12, TRR274-A01, TRR274-B03, TRR274-C02, TRR274-Z02]; Gemeinnutzige Hertie-Stiftung (Hertie Network of Excellence in Clinical Neuroscience); Langmatz-Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung (Hertie Network of Excellence in Clinical Neuroscience); Langmatz-Foundation	We thank V. Husterer and M. Pfaller for skillful technical assistance as well as A. Domadenik, V. Kavaka and M. Hammel for help with library preparation. This study was supported by funds from the European Research Council (ERC; CoG 647215 to T. Korn); the Deutsche Forschungsgemeinschaft (SFB1054-B06 (T. Korn), SFB1054-B05 (D.H.B., V.R.B. and S.G.), SFB1371-P04 (D.H.B., K.S. and S.J.), GA 2913/1-1 (C.G.), DO 420/7-1 (K.D.), EXC 2145 (SyNergy) ID 390857198 (T. Korn and K.D.), TRR128-A07 and TRR128-A12 (T. Korn), TRR274-A01 (T. Korn), TRR274-B03 (T.M.), TRR274-C02 (T.M.) and TRR274-Z02 (T. Korn and T.M.)); the Gemeinnutzige Hertie-Stiftung (Hertie Network of Excellence in Clinical Neuroscience to C.G. and T. Korn); and the Langmatz-Foundation (to C.G.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; AKDIS CA, NAT REV IMMUNOL; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Beltran E, 2019, J CLIN INVEST, V129, P4758, DOI 10.1172/JCI128475; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Biedermann T, 2006, J IMMUNOL, V177, P3763, DOI 10.4049/jimmunol.177.6.3763; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cano-Gamez E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15543-y; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; da Silva HB, 2020, IMMUNITY, V53, P158, DOI 10.1016/j.immuni.2020.06.010; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hashimoto-Hill S, 2017, MUCOSAL IMMUNOL, V10, P912, DOI 10.1038/mi.2016.109; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herich S, 2019, BRAIN, V142, P3411, DOI 10.1093/brain/awz301; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kadowaki A, 2020, TRENDS NEUROSCI, V43, P622, DOI 10.1016/j.tins.2020.06.002; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kyratsous NI, 2017, P NATL ACAD SCI USA, V114, pE6381, DOI 10.1073/pnas.1701806114; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nguyen P, 2010, J IMMUNOL, V185, P3895, DOI 10.4049/jimmunol.1001550; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Pavlidis NG., 2018, J MACH LEARN RES, V17, P1; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Rissiek B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00204; Roosendaal SD, 2015, NEUROIMAG CLIN N AM, V25, P83, DOI 10.1016/j.nic.2014.09.008; Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	64	15	15	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					880	+		10.1038/s41590-021-00948-8	http://dx.doi.org/10.1038/s41590-021-00948-8		JUN 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34099917	Green Accepted			2022-12-18	WOS:000658651000004
J	Bonnal, RJP; Rossetti, G; Lugli, E; De Simone, M; Gruarin, P; Brummelman, J; Drufuca, L; Passaro, M; Bason, R; Gervasoni, F; Della Chiara, G; D'Oria, C; Martinovic, M; Curti, S; Ranzani, V; Cordiglieri, C; Alvisi, G; Mazza, EMC; Oliveto, S; Silvestri, Y; Carelli, E; Mazzara, S; Bosotti, R; Sarnicola, ML; Godano, C; Bevilacqua, V; Lorenzo, M; Siena, S; Bonoldi, E; Sartore-Bianchi, A; Amatu, A; Veronesi, G; Novellis, P; Alloisio, M; Giani, A; Zucchini, N; Opocher, E; Ceretti, AP; Mariani, N; Biffo, S; Prati, D; Bardelli, A; Geginat, J; Lanzavecchia, A; Abrignani, S; Pagani, M				Bonnal, Raoul J. P.; Rossetti, Grazisa; Lugli, Enrico; De Simone, Marco; Gruarin, Paola; Brummelman, Jolanda; Drufuca, Lorenzo; Passaro, Marco; Bason, Ramona; Gervasoni, Federica; Della Chiara, Giulia; D'Oria, Claudia; Martinovic, Martina; Curti, Serena; Ranzani, Valeria; Cordiglieri, Chiara; Alvisi, Giorgia; Mazza, Emilia Maria Cristina; Oliveto, Stefania; Silvestri, Ylenia; Carelli, Elena; Mazzara, Saveria; Bosotti, Roberto; Sarnicola, Maria Lucia; Godano, Chiara; Bevilacqua, Valeria; Lorenzo, Mariangela; Siena, Salvatore; Bonoldi, Emanuela; Sartore-Bianchi, Andrea; Amatu, Alessio; Veronesi, Giulia; Novellis, Pierluigi; Alloisio, Marco; Giani, Alessandro; Zucchini, Nicola; Opocher, Enrico; Ceretti, Andrea Pisani; Mariani, Nicolo; Biffo, Stefano; Prati, Daniele; Bardelli, Alberto; Geginat, Jens; Lanzavecchia, Antonio; Abrignani, Sergio; Pagani, Massimiliano			Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; LYMPHOCYTES; POPULATION; PLASTICITY; LANDSCAPE; IL-10; GAMMA	Human primary and metastatic tumors harbor CD4(+) T-reg cells that can suppress antitumor immune responses. Bonnal et al. identify an intratumoral type 1 T-reg-like CD4(+) T cell subset that expresses the transcription factor EOMES, granzyme K and CHI3L2. This EOMES+ T cell subset correlates with disease progression but is responsive to PD-1 checkpoint blockade immunotherapy. Regulatory T (T-reg) cells are a barrier for tumor immunity and a target for immunotherapy. Using single-cell transcriptomics, we found that CD4(+) T cells infiltrating primary and metastatic colorectal cancer and non-small-cell lung cancer are highly enriched for two subsets of comparable size and suppressor function comprising forkhead box protein P3(+) T-reg and eomesodermin homolog (EOMES)(+) type 1 regulatory T (Tr1)-like cells also expressing granzyme K and chitinase-3-like protein 2. EOMES+ Tr1-like cells, but not T-reg cells, were clonally related to effector T cells and were clonally expanded in primary and metastatic tumors, which is consistent with their proliferation and differentiation in situ. Using chitinase-3-like protein 2 as a subset signature, we found that the EOMES+ Tr1-like subset correlates with disease progression but is also associated with response to programmed cell death protein 1-targeted immunotherapy. Collectively, these findings highlight the heterogeneity of T-reg cells that accumulate in primary tumors and metastases and identify a new prospective target for cancer immunotherapy.	[Bonnal, Raoul J. P.; Rossetti, Grazisa; De Simone, Marco; Gruarin, Paola; Drufuca, Lorenzo; Passaro, Marco; Bason, Ramona; Gervasoni, Federica; Della Chiara, Giulia; D'Oria, Claudia; Martinovic, Martina; Curti, Serena; Ranzani, Valeria; Cordiglieri, Chiara; Oliveto, Stefania; Silvestri, Ylenia; Carelli, Elena; Bosotti, Roberto; Sarnicola, Maria Lucia; Godano, Chiara; Bevilacqua, Valeria; Lorenzo, Mariangela; Biffo, Stefano; Geginat, Jens; Lanzavecchia, Antonio; Abrignani, Sergio; Pagani, Massimiliano] Ist Nazl Genet Mol Romeo Enrica Invernizzi, Milan, Italy; [Bonnal, Raoul J. P.; Rossetti, Grazisa; Drufuca, Lorenzo; Passaro, Marco; Bason, Ramona; Gervasoni, Federica; Della Chiara, Giulia; D'Oria, Claudia; Pagani, Massimiliano] FIRC Inst Mol Oncol IFOM, Milan, Italy; [Lugli, Enrico; Brummelman, Jolanda; Alvisi, Giorgia; Mazza, Emilia Maria Cristina] IRCCS Humanitas Res Hosp, Lab Translat Immunol, Milan, Italy; [Lugli, Enrico] IRCCS Humanitas Res Hosp, Flow Cytometry Core, Milan, Italy; [Mazzara, Saveria] IRCCS, European Inst Oncol IEO, Div Hematopathol, Milan, Italy; [Siena, Salvatore; Sartore-Bianchi, Andrea; Amatu, Alessio] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Milan, Italy; [Siena, Salvatore; Sartore-Bianchi, Andrea] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Bonoldi, Emanuela] Grande Osped Metropolitano Niguarda, Pathol & Cytogenet Unit, Milan, Italy; [Veronesi, Giulia] Univ Vita Salute San Raffaele, Fac Med, Milan, Italy; [Veronesi, Giulia; Novellis, Pierluigi] IRCCS San Raffaele Sci Inst, Div Thorac Surg, Milan, Italy; [Alloisio, Marco] IRCCS Humanitas Res Hosp, Div Thorac Surg, Milan, Italy; [Alloisio, Marco] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Giani, Alessandro] Bicocca Univ, San Gerardo Hosp, Dept Surg, Monza, Italy; [Zucchini, Nicola] San Gerardo Hosp, Dept Pathol, Monza, Italy; [Opocher, Enrico; Ceretti, Andrea Pisani; Mariani, Nicolo] Osped San Paolo, Unita Operativa Chirurgia Epatobiliopancrat Diges, Milan, Italy; [Opocher, Enrico] Univ Milan, Dept Hlth Sci, Milan, Italy; [Biffo, Stefano] Univ Milan, Dept Biosci, Milan, Italy; [Prati, Daniele] IRCCS Ca Granda Osped Maggiore Policlin, Dept Transfus Med & Hematol, Milan, Italy; [Bardelli, Alberto] Fdn Piemonte Oncol IRCCS, Candiolo Canc Inst, Turin, Italy; [Bardelli, Alberto] Univ Torino, Dept Oncol, Turin, Italy; [Geginat, Jens; Abrignani, Sergio] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Pagani, Massimiliano] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [De Simone, Marco] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA USA	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Humanitas University; San Gerardo Hospital; University of Milano-Bicocca; San Gerardo Hospital; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Milan; University of Milan; Cedars Sinai Medical Center	Geginat, J; Lanzavecchia, A; Abrignani, S; Pagani, M (corresponding author), Ist Nazl Genet Mol Romeo Enrica Invernizzi, Milan, Italy.; Pagani, M (corresponding author), FIRC Inst Mol Oncol IFOM, Milan, Italy.; Geginat, J; Abrignani, S (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.; Pagani, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.	geginat@ingm.org; lanzavecchia@ingm.org; abrignani@ingm.org; massimiliano.pagani@ifom.eu	alloisio, marco/GYV-1110-2022; Cordiglieri, Chiara/AAX-1638-2021; Oliveto, Stefania/AAW-9210-2021; Novellis, Pierluigi/AAC-4614-2022; Amatu, Alessio/K-2669-2018; Mariani, Nicolò Maria/AAO-5964-2020; Zucchini, Nicola/A-6916-2017; OPOCHER, ENRICO/H-9222-2012; Lugli, Enrico/AAB-7933-2019; Oliveto, Stefania/AAM-6752-2021; rossetti, grazisa/C-3722-2015	alloisio, marco/0000-0002-1415-5439; Cordiglieri, Chiara/0000-0002-2013-0043; Oliveto, Stefania/0000-0001-7765-1918; Mariani, Nicolò Maria/0000-0003-4360-187X; Zucchini, Nicola/0000-0003-4997-2807; OPOCHER, ENRICO/0000-0001-5668-3136; Lugli, Enrico/0000-0002-1964-7678; Bonnal, Raoul/0000-0002-2123-6536; Bevilacqua, Valeria/0000-0002-1291-3347; Della Chiara, Giulia/0000-0001-5211-3814; Gervasoni, Federica/0000-0002-0873-7563; mazzara, saveria/0000-0003-1799-2360; Pagani, Massimiliano/0000-0002-7017-9304; Brummelman, Jolanda/0000-0003-3581-4816; rossetti, grazisa/0000-0001-6361-311X; Abrignani, Sergio/0000-0002-0794-3285	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG2016-ID18575]; AIRC [23826, 20676, IG2018-ID21923, IG2015-ID17448, IG2019-ID23581]; Fondazione AIRC under 5 per mille 2019 [22759]; Cancer Research UK Accelerator Award [22794]; Fondazione AIRC under 5 per mille 2018 [21147, 21091]; Fondazione Romeo ed Enrica Invernizzi; Fondo di Beneficenza Intesa San Paolo fellowship from AIRC; 2017 Fondazione Umberto Veronesi postdoctoral fellowship; Italian Ministry of Health [82/2015]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione AIRC under 5 per mille 2019(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK Accelerator Award; Fondazione AIRC under 5 per mille 2018(Fondazione AIRC per la ricerca sul cancro); Fondazione Romeo ed Enrica Invernizzi; Fondo di Beneficenza Intesa San Paolo fellowship from AIRC; 2017 Fondazione Umberto Veronesi postdoctoral fellowship(Fondazione Umberto Veronesi); Italian Ministry of Health(Ministry of Health, Italy)	We thank M. Fakiola for discussions and critical revision of the manuscript, M. Moro and M. Crosti for technical assistance with cell sorting at Istituto Nazionale Genetica Molecolare and F. Colombo (Humanitas Flow Cytometry Core) for help with the FACSymphony A5 instrument setup. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) grant no. IG2016-ID18575, AIRC grant no. IG2019-ID 23826 and Fondazione AIRC under 5 per mille 2019 - ID 22759 program to M. Pagani; Cancer Research UK Accelerator Award no. 22794, Fondazione AIRC under 5 per mille 2018 - ID 21147 to S.A.; 21091 program to S.A., A.B. and S.S.; AIRC grant no. IG2017 - ID 20676 to E.L.; AIRC grant no. IG2018-ID21923 to A.B.; AIRC grant nos. IG2015-ID17448 and IG2019-ID23581 to J.G.; and by an unrestricted grant of the Fondazione Romeo ed Enrica Invernizzi. J.B. is a recipient of the Fondo di Beneficenza Intesa San Paolo fellowship from AIRC. E.M.C.M. is a recipient of the 2017 Fondazione Umberto Veronesi postdoctoral fellowship. Purchase of the FACSymphony A5 (BD Biosciences) has been in part defrayed by a grant from the Italian Ministry of Health (agreement no. 82/2015).	Alfen JS, 2018, J ALLERGY CLIN IMMUN, V142, P1537, DOI 10.1016/j.jaci.2017.12.984; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Alvisi G, 2020, J CLIN INVEST, V130, P3137, DOI 10.1172/JCI130426; Areshkov PO, 2012, INT J BIOL SCI, V8, P39, DOI 10.7150/ijbs.8.39; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Brummelman J, 2019, NAT PROTOC, V14, P1946, DOI 10.1038/s41596-019-0166-2; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; DELPRETE G, 1993, J IMMUNOL, V150, P353; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Dobrzanski MJ, 2012, CANCER IMMUNOL IMMUN, V61, P839, DOI 10.1007/s00262-011-1128-x; Facciotti F, 2020, P NATL ACAD SCI USA, V117, P7305, DOI 10.1073/pnas.1917834117; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Gruarin P, 2019, EUR J IMMUNOL, V49, P96, DOI 10.1002/eji.201847722; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Keller MD, 2019, BRIT J HAEMATOL, V187, P206, DOI 10.1111/bjh.16053; Kzhyshkowska J, 2016, BIOL CHEM, V397, P231, DOI 10.1515/hsz-2015-0269; Lee HO, 2020, NAT GENET, V52, P594, DOI 10.1038/s41588-020-0636-z; Libreros S, 2015, J LEUKOCYTE BIOL, V98, P931, DOI 10.1189/jlb.3VMR0415-142R; Liu D, 2019, NAT MED, V25, P1916, DOI 10.1038/s41591-019-0654-5; Lugli E, 2017, METHODS MOL BIOL, V1514, P31, DOI 10.1007/978-1-4939-6548-9_3; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedroza-Gonzalez A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008355; Petitprez F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00784; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2018, IMMUNITY, V49, P1004, DOI 10.1016/j.immuni.2018.12.001; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Webber W, 2010, ACM T INFORM SYST, V28, DOI 10.1145/1852102.1852106; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang P, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7152; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	56	15	15	3	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					735	+		10.1038/s41590-021-00930-4	http://dx.doi.org/10.1038/s41590-021-00930-4		MAY 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34017124				2022-12-18	WOS:000652579200001
J	Takahashi, M; Lio, CWJ; Campeau, A; Steger, M; Ay, F; Mann, M; Gonzalez, DJ; Jain, M; Sharma, S				Takahashi, Mariko; Lio, Chan-Wang J.; Campeau, Anaamika; Steger, Martin; Ay, Ferhat; Mann, Matthias; Gonzalez, David J.; Jain, Mohit; Sharma, Sonia			The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-beta pathway	NATURE IMMUNOLOGY			English	Article								Sharma and colleagues identify the kinase DAPK3 as a positive regulator of the STING-interferon-beta activation pathway. DAPK3 acts to modify E3 ubiquitin ligases that regulate STING K63-linked poly-ubiquitination. Evasion of host immunity is a hallmark of cancer; however, mechanisms linking oncogenic mutations and immune escape are incompletely understood. Through loss-of-function screening of 1,001 tumor suppressor genes, we identified death-associated protein kinase 3 (DAPK3) as a previously unrecognized driver of anti-tumor immunity through the stimulator of interferon genes (STING) pathway of cytosolic DNA sensing. Loss of DAPK3 expression or kinase activity impaired STING activation and interferon (IFN)-beta-stimulated gene induction. DAPK3 deficiency in IFN-beta-producing tumors drove rapid growth and reduced infiltration of CD103(+)CD8 alpha(+) dendritic cells and cytotoxic lymphocytes, attenuating the response to cancer chemo-immunotherapy. Mechanistically, DAPK3 coordinated post-translational modification of STING. In unstimulated cells, DAPK3 inhibited STING K48-linked poly-ubiquitination and proteasome-mediated degradation. After cGAMP stimulation, DAPK3 was required for STING K63-linked poly-ubiquitination and STING-TANK-binding kinase 1 interaction. Comprehensive phospho-proteomics uncovered a DAPK3-specific phospho-site on the E3 ligase LMO7, critical for LMO7-STING interaction and STING K63-linked poly-ubiquitination. Thus, DAPK3 is an essential kinase for STING activation that drives tumor-intrinsic innate immunity and tumor immune surveillance.	[Takahashi, Mariko; Lio, Chan-Wang J.; Ay, Ferhat; Sharma, Sonia] La Jolla Inst Immunol, La Jolla, CA 92037 USA; [Campeau, Anaamika; Gonzalez, David J.; Jain, Mohit] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Campeau, Anaamika; Gonzalez, David J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Steger, Martin; Mann, Matthias] Max Planck Inst Biochem, Martinsried, Germany; [Jain, Mohit] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Lio, Chan-Wang J.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Steger, Martin] Evotec Munchen GmbH, Martinsried, Germany	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Diego; University System of Ohio; Ohio State University; Evotec	Sharma, S (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.	soniasharma@lji.org	Ay, Ferhat/J-7800-2019	Ay, Ferhat/0000-0002-0708-6914; Lio, Jerry/0000-0003-3876-6741; Sharma, Sonia/0000-0002-6556-1963; Takahashi, Mariko/0000-0003-2465-7907	Shared Instrumentation Grant (SIG) program [S10 RR027366]; National Institutes of Health (NIH) [R01CA199376, U01DE028227, U54CA260591]; NIH [S10OD020025, R01ES027595]; Cancer Research Institute (CRI) Irvington Postdoc Fellowship; UCSD Microbial Sciences Initiative Graduate Research Fellowship; UCSD Graduate Training Program in Cellular and Molecular Pharmacology, through an institutional training grant from the National Institute of General Medical Sciences [T32 GM007752]	Shared Instrumentation Grant (SIG) program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute (CRI) Irvington Postdoc Fellowship; UCSD Microbial Sciences Initiative Graduate Research Fellowship; UCSD Graduate Training Program in Cellular and Molecular Pharmacology, through an institutional training grant from the National Institute of General Medical Sciences	We thank J. Huang (LJI) for support for the HUVEC siRNA screen; S. Shresta (LJI) for Ifnar1-null mice; C. Benedict (LJI) for MEFs, NHDFs and hCMV; N. P. Restifo (NCI) for MCA205; J. Schlom (NCI) for MC38; S. Schoenberger (LJI) for B16F10; C. C. Hedrick (LJI) for LLC-RFP; Y. C. Liu (LJI) for pEF-neo-HA-Ub; D. Zajonc (LJI) for pGEX-4T-2; J. Day and K. Tanguay (LJI) for shRNA and siRNA constructs, and siRNA screen support; D. Freeman, B. McDonald and R. El Morabiti (LJI) for hCMV propagation; M. Diep, K. Foos and M. Kaur (LJI) for technical assistance; Z. Mikulski (LJI Microscopy Core Facility) for confocal microscopy support; A. Sethi (LJI Bioinformatics Core Facility) for pathway analysis support; LJI Flow Cytometry Core Facility for cell sorting (FACSAria-II Cell Sorter; supported by the Shared Instrumentation Grant (SIG) program no. S10 RR027366); and D. Araujo (LJI) for proofreading the manuscript. This work was supported by National Institutes of Health (NIH) grant nos. R01CA199376, U01DE028227 and U54CA260591 (S.S.); and NIH grant no. S10OD020025 and grant no. R01ES027595 (M.J.). C.-W.J.L. was supported by a Cancer Research Institute (CRI) Irvington Postdoc Fellowship. A.C. was supported by the UCSD Microbial Sciences Initiative Graduate Research Fellowship and by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology, through an institutional training grant from the National Institute of General Medical Sciences, grant no. T32 GM007752.	Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Balka KR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.056; Bi J, 2009, INT J CANCER, V124, P1587, DOI 10.1002/ijc.24164; Brognard J, 2011, CANCER RES, V71, P3152, DOI 10.1158/0008-5472.CAN-10-3543; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Dhanwani R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3688; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fang J, 2008, BLOOD, V112, P886, DOI 10.1182/blood-2008-02-138909; Farag AK, 2019, MED RES REV, V39, P349, DOI 10.1002/med.21518; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hosoba K, 2015, BIOCHEM BIOPH RES CO, V459, P686, DOI 10.1016/j.bbrc.2015.03.005; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kocher BA, 2015, MOL CANCER RES, V13, P358, DOI 10.1158/1541-7786.MCR-14-0333; Kwon J, 2020, CANCER DISCOV, V10, P26, DOI 10.1158/2159-8290.CD-19-0761; Lapek JD, 2017, MOL CELL PROTEOMICS, V16, P1447, DOI 10.1074/mcp.M116.066019; Lio CWJ, 2016, J VIROL, V90, P7789, DOI 10.1128/JVI.01040-16; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lohard S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13689-y; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mallipeddi R, 2004, J INVEST DERMATOL, V122, P1302, DOI 10.1111/j.0022-202X.2004.22525.x; Mitchison TJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170182; Mullard A, 2018, NAT REV DRUG DISCOV, V17, P3, DOI 10.1038/nrd.2017.264; Nehru V, 2013, BIOCHEM BIOPH RES CO, V433, P163, DOI 10.1016/j.bbrc.2013.02.046; Ni GX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7119; Okamoto M, 2009, J MED CHEM, V52, P7323, DOI 10.1021/jm901191q; Pokatayev V, 2020, NAT IMMUNOL, V21, P158, DOI 10.1038/s41590-019-0569-9; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Seo GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02936-3; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sharma S, 2009, NAT IMMUNOL, V10, P799, DOI 10.1038/ni0809-799; Song SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39858; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Tsuchiya Y, 2016, EBIOMEDICINE, V9, P87, DOI 10.1016/j.ebiom.2016.05.039; Vanpouille-Box C, 2018, CANCER CELL, V34, P361, DOI 10.1016/j.ccell.2018.05.013; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wang ZN, 2019, J CLIN INVEST, V129, P4850, DOI 10.1172/JCI127471; Willemsen J, 2017, MOL CELL, V65, P403, DOI 10.1016/j.molcel.2016.12.021; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wozniak JM, 2019, PEERJ, V7, DOI 10.7717/peerj.7046; Xu ST, 2019, COMPUT STRUCT BIOTEC, V17, P430, DOI 10.1016/j.csbj.2019.03.008; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04759-8; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	60	15	16	5	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					485	+		10.1038/s41590-021-00896-3	http://dx.doi.org/10.1038/s41590-021-00896-3		MAR 2021	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33767426	Green Accepted			2022-12-18	WOS:000632800300002
J	Prados, A; Onder, L; Cheng, HW; Morbe, U; Lutge, M; Gil-Cruz, C; Perez-Shibayama, C; Koliaraki, V; Ludewig, B; Kollias, G				Prados, Alejandro; Onder, Lucas; Cheng, Hung-Wei; Morbe, Urs; Lutge, Mechthild; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Koliaraki, Vasiliki; Ludewig, Burkhard; Kollias, George			Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; STROMAL CELLS; DENDRITIC CELLS; INDUCER CELLS; MICE LACKING; B-CELL; RECEPTOR; IGA; INFLAMMATION; RESPONSES	Kollias and colleagues examine the development of fibroblastic reticular cells (FRCs) during lymphoid organogenesis in gut Peyer's patches (PPs). They show that PP FRCs develop from two separate mesenchymal cell lineages, which converge and form mosaic microenvironments that support immune cell activation and maintain intestinal homeostasis. Fibroblastic reticular cells (FRCs) determine the organization of lymphoid organs and control immune cell interactions. While the cellular and molecular mechanisms underlying FRC differentiation in lymph nodes and the splenic white pulp have been elaborated to some extent, in Peyer's patches (PPs) they remain elusive. Using a combination of single-cell transcriptomics and cell fate mapping in advanced mouse models, we found that PP formation in the mouse embryo is initiated by an expansion of perivascular FRC precursors, followed by FRC differentiation from subepithelial progenitors. Single-cell transcriptomics and cell fate mapping confirmed the convergence of perivascular and subepithelial FRC lineages. Furthermore, lineage-specific loss- and gain-of-function approaches revealed that the two FRC lineages synergistically direct PP organization, maintain intestinal microbiome homeostasis and control anticoronavirus immune responses in the gut. Collectively, this study reveals a distinct mosaic patterning program that generates key stromal cell infrastructures for the control of intestinal immunity.	[Prados, Alejandro; Koliaraki, Vasiliki; Kollias, George] BSRC Alexander Fleming, Inst Bioinnovat, Vari, Greece; [Onder, Lucas; Cheng, Hung-Wei; Morbe, Urs; Lutge, Mechthild; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Ludewig, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Kollias, George] Natl & Kapodistrian Univ Athens, Sch Med, Dept Physiol, Athens, Greece	Alexander Fleming Biomedical Sciences Research Center; Kantonsspital St. Gallen; University of Zurich; Athens Medical School; National & Kapodistrian University of Athens	Kollias, G (corresponding author), BSRC Alexander Fleming, Inst Bioinnovat, Vari, Greece.; Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland.; Ludewig, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.; Kollias, G (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Physiol, Athens, Greece.	burkhard.ludewig@kssg.ch; kollias@fleming.gr	Mörbe, Urs Michael/AAM-2757-2020; Koliaraki, Vasiliki/B-8618-2015; Mörbe, Urs/GPX-7383-2022; Prados, Alejandro/C-4987-2009	Mörbe, Urs Michael/0000-0001-8747-437X; Koliaraki, Vasiliki/0000-0003-1694-6987; Ludewig, Burkhard/0000-0002-7685-573X; Prados, Alejandro/0000-0002-8610-7559; Lutge, Mechthild/0000-0001-9011-5319	InfrafrontierGR Infrastructure; European Union (European Regional Development Fund) under NSRF 2014-2020 [MIS 5002135]; FP7 Advanced ERC Grant MCs-inTEST [340217]; Swiss National Science Foundation [166500, 182583]	InfrafrontierGR Infrastructure; European Union (European Regional Development Fund) under NSRF 2014-2020; FP7 Advanced ERC Grant MCs-inTEST; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank M. Meletiou and S. Lalos for technical assistance in mouse genotyping and histology. We thank K. Dagla and S. Grammenoudi for assistance in flow cytometry. The authors acknowledge support of this work by the InfrafrontierGR Infrastructure, cofunded by Greece and the European Union (European Regional Development Fund) under NSRF 2014-2020, MIS 5002135, which provided mouse hosting, transgenesis and phenotyping facilities, histopathology, flow cytometry and advanced microscopy facilities. This work was supported by the FP7 Advanced ERC Grant MCs-inTEST (grant no. 340217) to G.K. and the Swiss National Science Foundation (grant nos 166500 and 182583) to B.L.	Afanasyeva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098349; Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Amaya E, 2007, AQUACULTURE, V262, P419, DOI 10.1016/j.aquaculture.2006.11.001; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Brulois K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17291-5; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.1038/s41577-019-0268-7, 10.4161/gmic.20228]; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang JE, 2019, NAT IMMUNOL, V20, P1506, DOI 10.1038/s41590-019-0505-z; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Debard N, 2001, GASTROENTEROLOGY, V120, P1173, DOI 10.1053/gast.2001.22476; Denton AE, 2019, J EXP MED, V216, P2242, DOI 10.1084/jem.20181705; El Shikh MEM, 2007, J IMMUNOL, V179, P4444, DOI 10.4049/jimmunol.179.7.4444; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fujimoto N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000704; Gil-Cruz C, 2019, SCIENCE, V366, P881, DOI 10.1126/science.aav3487; Gil-Cruz C, 2016, NAT IMMUNOL, V17, P1388, DOI 10.1038/ni.3566; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hanson NB, 2008, DEV COMP IMMUNOL, V32, P980, DOI 10.1016/j.dci.2008.01.013; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Jeucken KCM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02700; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Lasry A, 2016, NAT IMMUNOL, V17, P230, DOI 10.1038/ni.3384; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Nagashima K, 2017, BIOCHEM BIOPH RES CO, V493, P437, DOI 10.1016/j.bbrc.2017.09.004; Nagashima K, 2017, NAT IMMUNOL, V18, P675, DOI 10.1038/ni.3732; Nakagawa R, 2013, J IMMUNOL, V190, P3309, DOI 10.4049/jimmunol.1202766; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Neurath MF, 2019, NAT IMMUNOL, V20, P970, DOI 10.1038/s41590-019-0415-0; Onder L, 2018, TRENDS IMMUNOL, V39, P775, DOI 10.1016/j.it.2018.08.003; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Perez-Shibayama C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb7066; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Prados A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33027; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Van Hauwermeiren F, 2013, J CLIN INVEST, V123, P2590, DOI 10.1172/JCI65624; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; ZHENG GX, 2017, NATURE, V0008	63	15	15	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					510	+		10.1038/s41590-021-00894-5	http://dx.doi.org/10.1038/s41590-021-00894-5		MAR 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33707780	Green Accepted, Bronze			2022-12-18	WOS:000627707900001
J	Tan, LV				Van Tan, Le			COVID-19 control in Vietnam	NATURE IMMUNOLOGY			English	Editorial Material								Early preparedness, contact tracing, isolation and testing, coupled with timely border closure, physical distancing and community adherence, have been key measures in controlling COVID-19 in Vietnam.	[Van Tan, Le] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford	Tan, LV (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.	tanlv@oucru.org		Le Van, Tan/0000-0002-1791-3901	Wellcome Trust [204904/Z/16/Z] Funding Source: Medline; Wellcome Trust (Wellcome) [204904/Z/16/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust (Wellcome)			0	15	15	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					261	261		10.1038/s41590-021-00882-9	http://dx.doi.org/10.1038/s41590-021-00882-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627879	Bronze			2022-12-18	WOS:000621567200005
J	Soon, MSF; Lee, HJ; Engel, JA; Straube, J; Thomas, BS; Pernold, CPS; Clarke, LS; Laohamonthonkul, P; Haldar, RN; Williams, CG; Lansink, LIM; Moreira, ML; Bramhall, M; Koufariotis, LT; Wood, S; Chen, X; James, KR; Lonnberg, T; Lane, SW; Belz, GT; Engwerda, CR; Khoury, DS; Davenport, MP; Svensson, V; Teichmann, SA; Haque, A				Soon, Megan S. F.; Lee, Hyun Jae; Engel, Jessica A.; Straube, Jasmin; Thomas, Bryce S.; Pernold, Clara P. S.; Clarke, Lachlan S.; Laohamonthonkul, Pawat; Haldar, Rohit N.; Williams, Cameron G.; Lansink, Lianne I. M.; Moreira, Marcela L.; Bramhall, Michael; Koufariotis, Lambros T.; Wood, Scott; Chen, Xi; James, Kylie R.; Lonnberg, Tapio; Lane, Steven W.; Belz, Gabrielle T.; Engwerda, Christian R.; Khoury, David S.; Davenport, Miles P.; Svensson, Valentine; Teichmann, Sarah A.; Haque, Ashraful			Transcriptome dynamics of CD4(+) T cells during malaria maps gradual transit from effector to memory	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER; R/BIOCONDUCTOR PACKAGE; DIFFERENTIAL EXPRESSION; SELF-RENEWAL; ACCESSIBILITY; COMMITMENT; INFECTION; RESPONSES; GENERATE; IMMUNITY	The dynamics of CD4(+) T cell memory development remain to be examined at genome scale. In malaria-endemic regions, anti-malarial chemoprevention protects long after its cessation and associates with effects on CD4(+) T cells. We applied single-cell RNA sequencing and computational modelling to track memory development during Plasmodium infection and treatment. In the absence of central memory precursors, two trajectories developed as T helper 1 (T(H)1) and follicular helper T (T-FH) transcriptomes contracted and partially coalesced over three weeks. Progeny of single clones populated T(H)1 and T-FH trajectories, and fate-mapping suggested that there was minimal lineage plasticity. Relationships between T-FH and central memory were revealed, with antimalarials modulating these responses and boosting T(H)1 recall. Finally, single-cell epigenomics confirmed that heterogeneity among effectors was partially reset in memory. Thus, the effector-to-memory transition in CD4(+) T cells is gradual during malaria and is modulated by antiparasitic drugs. Graphical user interfaces are presented for examining gene-expression dynamics and gene-gene correlations (http://haquelab.mdhs.unimelb.edu.au/cd4_memory/).	[Soon, Megan S. F.; Lee, Hyun Jae; Engel, Jessica A.; Straube, Jasmin; Thomas, Bryce S.; Pernold, Clara P. S.; Clarke, Lachlan S.; Laohamonthonkul, Pawat; Haldar, Rohit N.; Williams, Cameron G.; Lansink, Lianne I. M.; Koufariotis, Lambros T.; Wood, Scott; Lane, Steven W.; Engwerda, Christian R.; Haque, Ashraful] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Lee, Hyun Jae; Williams, Cameron G.; Lansink, Lianne I. M.; Moreira, Marcela L.; Bramhall, Michael; Haque, Ashraful] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Chen, Xi] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China; [Chen, Xi; James, Kylie R.; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Chen, Xi; James, Kylie R.; Teichmann, Sarah A.] Univ Cambridge, Cavendish Lab, Cambridge, England; [Lonnberg, Tapio] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Lonnberg, Tapio] Abo Akad Univ, Turku, Finland; [Belz, Gabrielle T.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Khoury, David S.; Davenport, Miles P.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Svensson, Valentine] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	QIMR Berghofer Medical Research Institute; University of Melbourne; Southern University of Science & Technology; Wellcome Trust Sanger Institute; University of Cambridge; University of Turku; Abo Akademi University; University of Queensland; Walter & Eliza Hall Institute; University of Melbourne; University of New South Wales Sydney; Kirby Institute; California Institute of Technology	Haque, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Haque, A (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia.; Teichmann, SA (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England.; Teichmann, SA (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge, England.	st9@sanger.ac.uk; ashraful.haque@unimelb.edu.au	Straube, Jasmin/Y-1355-2018; Belz, Gabrielle T/C-9350-2013; Lee, Hyun Jae/C-7975-2017	Straube, Jasmin/0000-0002-1748-0659; Belz, Gabrielle T/0000-0002-9660-9587; Davenport, Miles/0000-0002-4751-1831; Engwerda, Christian/0000-0003-2813-4804; Engel, Jessica/0000-0001-6175-1797; James, Kylie/0000-0002-7107-0650; Lee, Hyun Jae/0000-0002-9204-6078; Khoury, David/0000-0002-2663-1551; Lansink, Lianne/0000-0003-1965-1287; de Lima Moreira, Marcela/0000-0003-3477-0727	Australian National Health & Medical Research Council [1126399]; ERC Consolidator grant ThDEFINE	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ERC Consolidator grant ThDEFINE	This study was funded by the Australian National Health & Medical Research Council: Project Grant 1126399 (awarded to A.H. and S.A.T.). Smart-seq2 work was funded by ERC Consolidator grant ThDEFINE (awarded to S.A.T.). We are grateful to J. Moehrle at Medicines for Malaria Venture for providing sodium artesunate. We acknowledge the expertise and assistance of several QIMR Berghofer Medical Research Institute Core Staff: the Flow Cytometry and Microscopy Core, particularly M. Rist and T. Hong Nguyen, for single-cell sorting; the Histology Core, including C. Winterford; the Animal Facility, including all technicians involved with animal husbandry; the Next-Generation-Sequencing Core, including P. Collins for assistance with droplet-based scRNA-seq and Illumina sequencing. We acknowledge the Single-Cell Genomics Core Facility and sequencing pipeline at the Wellcome Sanger Institute for plate-based Smart-seq2 and scATAC-seq processing.	Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Akter J, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007599; Arroyo EN, 2020, J EXP MED, V217, DOI 10.1084/jem.20190849; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Carlson M., 2019, ORG MM EG DB GENOME; Chen X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07771-0; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fernandez-Ruiz D, 2017, J IMMUNOL, V199, P4165, DOI 10.4049/jimmunol.1700186; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Haque A, 2014, J CLIN INVEST, V124, P2483, DOI 10.1172/JCI70698; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Jagannathan P, 2016, J INFECT DIS, V214, P329, DOI 10.1093/infdis/jiw147; James KR, 2018, J IMMUNOL, V200, P1443, DOI 10.4049/jimmunol.1700782; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H., 2013, ALIGNING SEQUENCE RE; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Lopez R, 2018, NAT METHODS, V15, P1053, DOI 10.1038/s41592-018-0229-2; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Muhindo MK, 2019, LANCET INFECT DIS, V19, P962, DOI 10.1016/S1473-3099(19)30299-3; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Opata MM, 2015, J IMMUNOL, V194, P5346, DOI 10.4049/jimmunol.1403216; Page` s H., 2019, BIOSTRINGS EFFICIENT; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Perez-Mazliah D, 2017, EBIOMEDICINE, V24, P216, DOI 10.1016/j.ebiom.2017.08.030; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Senabouth A, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa034; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; SUSS G, 1988, INFECT IMMUN, V56, P3081; Svensson V, 2018, NAT METHODS, V15, P343, DOI 10.1038/nmeth.4636; Tan G, 2019, JASPAR2016 DATA PACK; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Waickman AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11634-7; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; WHO Global Malaria Programme, 2019, WHO GLOB MAL PROGR W; Yasuda K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08404-w; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	67	15	15	3	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1597	+		10.1038/s41590-020-0800-8	http://dx.doi.org/10.1038/s41590-020-0800-8		OCT 2020	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33046889	Bronze, Green Accepted			2022-12-18	WOS:000577043300001
J	Bartleson, JM; Milam, AAV; Donermeyer, DL; Horvath, S; Xia, Y; Egawa, T; Allen, PM				Bartleson, Juliet M.; Viehmann Milam, Ashley A.; Donermeyer, David L.; Horvath, Stephen; Xia, Yu; Egawa, Takeshi; Allen, Paul M.			Strength of tonic T cell receptor signaling instructs T follicular helper cell-fate decisions	NATURE IMMUNOLOGY			English	Article							B-CELLS; ANTIGEN PRESENTATION; POSITIVE SELECTION; TCR-ZETA; EXPRESSION; BCL6; SENSITIVITY; PEPTIDE; PROTEIN; PHOSPHORYLATION	The pathways controlling T follicular helper (T-FH) cell development are only partially understood. Allen and colleagues demonstrate the importance of the T cell receptor, with low tonic signaling promoting T(FH)cell development and high tonic signaling opposing it. T follicular helper (T-FH) cells are critical in adaptive immune responses to pathogens and vaccines; however, what drives the initiation of their developmental program remains unclear. Studies suggest that a T cell antigen receptor (TCR)-dependent mechanism may be responsible for the earliest T(FH)cell-fate decision, but a critical aspect of the TCR has been overlooked: tonic TCR signaling. We hypothesized that tonic signaling influences early T(FH)cell development. Here, two murine TCR-transgenic CD4(+)T cells, LLO56 and LLO118, which recognize the same antigenic peptide presented on major histocompatibility complex molecules but experience disparate strengths of tonic signaling, revealed low tonic signaling promotes T(FH)cell differentiation. Polyclonal T cells paralleled these findings, with naive Nur77 expression distinguishing T(FH)cell potential. Two mouse lines were also generated to both increase and decrease tonic signaling strength, directly establishing an inverse relationship between tonic signaling strength and T(FH)cell development. Our findings elucidate a central role for tonic TCR signaling in early T(FH)cell-lineage decisions.	[Bartleson, Juliet M.; Viehmann Milam, Ashley A.; Donermeyer, David L.; Horvath, Stephen; Xia, Yu; Egawa, Takeshi; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Viehmann Milam, Ashley A.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Washington University (WUSTL); Saint Louis University	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu		Allen, Paul/0000-0003-3796-6047; Bartleson, Juliet/0000-0003-2342-1839	National Institutes of Health [AI138393, AI130152-01A1, AI139875, AI139540]; Leukemia and Lymphoma Society Scholar Award; Washington University Rheumatic Diseases Research Resource-Based Center - NIH [P30AR073752]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Washington University Rheumatic Diseases Research Resource-Based Center - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Kreamalmeyer for mouse breeding and care, D. Brinja and E. Lantelme for assistance with sorting by flow cytometry, D. Oakley and M. Shih of the Washington University Center for Cellular Imaging for assistance with AxioScan use and image analysis, W. L. Lo for insights on the manuscript and M. White and the Genome Engineering and iPSC Center at Washington University for generation of the H2-DMa<SUP>f/f</SUP> mouse line. This work was supported by National Institutes of Health research grants AI138393 (to J.M.B.), AI130152-01A1 (to T.E.), AI139875 (to T.E.) and AI139540 (to P.M.A), the Leukemia and Lymphoma Society Scholar Award (to T.E.) and the Washington University Rheumatic Diseases Research Resource-Based Center, funded by NIH grant P30AR073752 (to P.M.A).	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Bocharov G, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/739706; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Daley SR, 2013, ELIFE, V2, DOI 10.7554/eLife.01020; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Keck S, 2014, P NATL ACAD SCI USA, V111, P14852, DOI 10.1073/pnas.1403271111; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Markegard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025540; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; Milam Ashley A Viehmann, 2020, Immunohorizons, V4, P485, DOI 10.4049/immunohorizons.2000055; Milam AAV, 2018, J IMMUNOL, V200, P3429, DOI 10.4049/jimmunol.1701422; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Myers DR, 2017, CELL REP, V19, P1558, DOI 10.1016/j.celrep.2017.04.076; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Ploquin MJY, 2011, J IMMUNOL, V187, P3321, DOI 10.4049/jimmunol.1101006; Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Valderrama C, 2017, EUR J IMMUNOL, V47, P830, DOI 10.1002/eji.201646856; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Webb LMC, 2017, IMMUNOLOGY, V152, P185, DOI 10.1111/imm.12778; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311; Zinzow-Kramer WM, 2019, P NATL ACAD SCI USA, V116, P15160, DOI 10.1073/pnas.1904096116	49	15	16	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1384	+		10.1038/s41590-020-0781-7	http://dx.doi.org/10.1038/s41590-020-0781-7		SEP 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32989327	Green Accepted			2022-12-18	WOS:000573447100004
J	Semenza, JC				Semenza, Jan C.			Cascading risks of waterborne diseases from climate change	NATURE IMMUNOLOGY			English	Article							DIARRHEAL DISEASE; OUTBREAKS; PRECIPITATION; ASSOCIATION; EVENTS	Climate change can trigger a sequence of events of significant magnitude with consequences for waterborne diseases. Heavy rainfall, flooding and hot weather are associated with waterborne diseases, but early warning systems could intercept these cascading risks.	[Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Sci Assessment Sect, Solna, Sweden	European Centre for Disease Prevention & Control	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control ECDC, Sci Assessment Sect, Solna, Sweden.	JanC.Semenza@ecdc.europa.eu						ADKINS HJ, 1987, J CLIN MICROBIOL, V25, P1143, DOI 10.1128/JCM.25.7.1143-1147.1987; Baker-Austin C, 2016, EMERG INFECT DIS, V22, P1216, DOI [10.32032/eid2207.151996, 10.3201/eid2207.151996]; Cherrie MPC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5931-6; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Damania R., 2017, UNCHARTED WATERS NEW; Desai S, 2009, CLIN INFECT DIS, V48, P691, DOI 10.1086/597036; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Djennad A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3840-7; Effler P, 2001, EMERG INFECT DIS, V7, P812; European Centre for Disease Prevention and Control, 2020, VIBR MAP VIEW E3 GEO; Herrador BG, 2016, J WATER HEALTH, V14, P1019, DOI 10.2166/wh.2016.071; Herrador BRG, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0014-y; Hume R, 1997, CELL, V90, P55, DOI [10.1016/S0092-8674(00)80313-X, DOI 10.1016/S0092-8674(00)80313-X]; IPCC, SPECIAL REPORT; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Lake IR, 2019, EUROSURVEILLANCE, V24, P35, DOI 10.2807/1560-7917.ES.2019.24.13.180028; Lake IR, 2017, ENVIRON HEALTH-GLOB, V16, P53, DOI 10.1186/s12940-017-0327-0; Levy K, 2016, ENVIRON SCI TECHNOL, V50, P4905, DOI 10.1021/acs.est.5b06186; Lo Iacono G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005659; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Schijven J, 2013, RISK ANAL, V33, P2154, DOI 10.1111/risa.12077; Semenza J C, 2007, Euro Surveill, V12, pE13; Semenza JC, 2019, TRANSBOUND EMERG DIS, V66, P1855, DOI 10.1111/tbed.13211; Semenza JC, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP2198; Semenza JC, 2012, CRIT REV ENV SCI TEC, V42, P857, DOI 10.1080/10643389.2010.534706; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shapiro RS, 2012, MBIO, V3, DOI 10.1128/mBio.00238-12; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Sterk A, 2016, WATER RES, V95, P90, DOI 10.1016/j.watres.2016.03.005; Suk JE, 2020, EUR J PUBLIC HEALTH, V30, P928, DOI 10.1093/eurpub/ckz111; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Yun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28442	32	15	16	2	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					484	487		10.1038/s41590-020-0631-7	http://dx.doi.org/10.1038/s41590-020-0631-7		APR 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	LG7GW	32313241				2022-12-18	WOS:000527507900001
J	Derecka, M; Herman, JS; Cauchy, P; Ramamoorthy, S; Lupar, E; Grun, D; Grosschedl, R				Derecka, Marta; Herman, Josip Stefan; Cauchy, Pierre; Ramamoorthy, Senthilkumar; Lupar, Ekaterina; Gruen, Dominic; Grosschedl, Rudolf			EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTORS; EMERGING CONCEPTS; READ ALIGNMENT; PROGENITORS; NICHE; EBF1; AP-1; PU.1; DIFFERENTIATION	Crosstalk between mesenchymal stromal cells (MSCs) and hematopoietic stem cells (HSCs) is essential for hematopoietic homeostasis and lineage output. Here, we investigate how transcriptional changes in bone marrow (BM) MSCs result in long-lasting effects on HSCs. Single-cell analysis of Cxcl12-abundant reticular (CAR) cells and PDGFR alpha(+)Sca1(+) (P alpha S) cells revealed an extensive cellular heterogeneity but uniform expression of the transcription factor gene Ebf1. Conditional deletion of Ebf1 in these MSCs altered their cellular composition, chromatin structure and gene expression profiles, including the reduced expression of adhesion-related genes. Functionally, the stromal-specific Ebf1 inactivation results in impaired adhesion of HSCs, leading to reduced quiescence and diminished myeloid output. Most notably, HSCs residing in the Ebf1-deficient niche underwent changes in their cellular composition and chromatin structure that persist in serial transplantations. Thus, genetic alterations in the BM niche lead to long-term functional changes of HSCs. Grosschedl and colleagues identify a role for the transcription factor EBF1 in bone marrow stromal cells that is required to maintain the niche to support hematopoietic stem cells and hematopoiesis.	[Derecka, Marta; Herman, Josip Stefan; Cauchy, Pierre; Ramamoorthy, Senthilkumar; Lupar, Ekaterina; Gruen, Dominic; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Herman, Josip Stefan] Univ Freiburg, Fac Biol, Freiburg, Germany; [Herman, Josip Stefan] Int Max Planck Res Sch Mol & Cellular Biol, Freiburg, Germany; [Gruen, Dominic] Univ Freiburg, Ctr Integrat Biol Signaling Studies, Freiburg, Germany	Max Planck Society; University of Freiburg; Max Planck Society; University of Freiburg	Derecka, M; Grosschedl, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	derecka@ie-freiburg.mpg.de; grosschedl@ie-freiburg.mpg.de	Ramamoorthy, Senthilkumar/AAT-1088-2021; Ramamoorthy, Senthilkumar/E-9325-2017	Derecka, Marta/0000-0001-6265-9781; Ramamoorthy, Senthilkumar/0000-0003-3468-4247; Cauchy, Pierre/0000-0002-0659-0799	Max Planck Society; German Research Foundation; German Research Foundation (DFG) [GR4980/1-1, GR4980/3-1, GRK2344 MeInBio]; DFG under Germany's Excellence Strategy [CIBSS-EXC-2189, 390939984]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG))	We are grateful to E. Trompouki for critical reading of the manuscript and M. Rott for assistance with the manuscript preparation. We thank S. Muellerke, I. Falk, K. Schlegel, D. Komandin and F. Ludin for technical assistance and members of the R. Grosschedl laboratory for discussions. We thank the Deep Sequencing, Imaging, FACS and Animal facilities of the Max Planck Insitute of Immunobiology and Epigenetics. This work was supported by the funds from the Max Planck Society and German Research Foundation. D. Grun was supported by the Max Planck Society, the German Research Foundation (DFG) (GR4980/1-1, GR4980/3-1, and GRK2344 MeInBio) and by the DFG under Germany's Excellence Strategy (CIBSS-EXC-2189 Project ID 390939984).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Comazzetto S, 2019, CELL STEM CELL, V24, P477, DOI 10.1016/j.stem.2018.11.022; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Fretz JA, 2010, ENDOCRINOLOGY, V151, P1611, DOI 10.1210/en.2009-0987; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Jones M, 2015, J CLIN INVEST, V125, P2007, DOI 10.1172/JCI78124; Joseph C, 2013, CELL STEM CELL, V13, P520, DOI 10.1016/j.stem.2013.10.010; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kurotaki D, 2018, CELL REP, V22, P2628, DOI 10.1016/j.celrep.2018.02.048; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2018, GENE DEV, V32, P96, DOI 10.1101/gad.309583.117; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Medyouf H, 2017, BLOOD, V129, P1617, DOI 10.1182/blood-2016-11-696070; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagasawa T, 2007, ADV EXP MED BIOL, V602, P69; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Obier N, 2016, DEVELOPMENT, V143, P4324, DOI 10.1242/dev.139857; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Pinho S, 2019, NAT REV MOL CELL BIO, V20, P303, DOI 10.1038/s41580-019-0103-9; Pinho S, 2018, DEV CELL, V44, P634, DOI 10.1016/j.devcel.2018.01.016; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Qian H, 2013, MOL CELL BIOL, V33, P661, DOI 10.1128/MCB.01287-12; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ruppert R, 2015, J EXP MED, V212, P1415, DOI 10.1084/jem.20150269; Sagar, 2018, METHODS MOL BIOL, V1766, P257, DOI 10.1007/978-1-4939-7768-0_15; Seike M, 2018, GENE DEV, V32, P359, DOI 10.1101/gad.311068.117; Tikhonova AN, 2019, NATURE, V572, pE6, DOI 10.1038/s41586-019-1394-x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	68	15	16	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					261	+		10.1038/s41590-020-0595-7	http://dx.doi.org/10.1038/s41590-020-0595-7		FEB 2020	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066955				2022-12-18	WOS:000514067400007
J	Fukada, T; Hojyo, S; Hara, T; Takagishi, T				Fukada, Toshiyuki; Hojyo, Shintaro; Hara, Takafumi; Takagishi, Teruhisa			Revisiting the old and learning the new of zinc in immunity	NATURE IMMUNOLOGY			English	Editorial Material									[Fukada, Toshiyuki; Hara, Takafumi; Takagishi, Teruhisa] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan; [Fukada, Toshiyuki] Showa Univ, Dept Oral Diagnost Sci, Sch Dent, Div Pathol, Tokyo, Japan; [Fukada, Toshiyuki] RIKEN Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan; [Hojyo, Shintaro] Deutsch Rheuma Forschungszentrum, Osteoimmunol, Berlin, Germany	Tokushima Bunri University; Showa University; RIKEN; Deutsches Rheuma-Forschungszentrum (DRFZ)	Fukada, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan.; Fukada, T (corresponding author), Showa Univ, Dept Oral Diagnost Sci, Sch Dent, Div Pathol, Tokyo, Japan.; Fukada, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan.	fukada@ph.bunri-u.ac.jp						Anzilotti C, 2019, NAT IMMUNOL, V20, P350, DOI 10.1038/s41590-018-0295-8; Bin BH, 2017, J INVEST DERMATOL, V137, P1682, DOI 10.1016/j.jid.2017.03.031; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; Hojyo S, 2014, P NATL ACAD SCI USA, V111, P11786, DOI 10.1073/pnas.1323557111; JANATIPOUR M, 1992, IMMUNOGENETICS, V35, P272, DOI 10.1007/BF00166833; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Ohashi W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006349; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183	12	15	15	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					248	250		10.1038/s41590-019-0319-z	http://dx.doi.org/10.1038/s41590-019-0319-z			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30718916				2022-12-18	WOS:000458893600007
J	Talay, O; Yan, DH; Brightbill, HD; Straney, EEM; Zhou, MJ; Ladi, E; Lee, WP; Egen, JG; Austin, CD; Xu, M; Wu, LC				Talay, Oezcan; Yan, Donghong; Brightbill, Hans D.; Straney, Elizabeth E. M.; Zhou, Meijuan; Ladi, Ena; Lee, Wyne P.; Egen, Jackson G.; Austin, Cary D.; Xu, Min; Wu, Lawren C.			IgE(+) memory B cells and plasma cells generated through a germinal-center pathway (vol 13, pg 396, 2012)	NATURE IMMUNOLOGY			English	Correction														Egen, Jackson/0000-0003-2053-0837				Lafaille JJ, 2012, NAT IMMUNOL, V13, P623, DOI 10.1038/ni.2313; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	3	15	15	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1302	1304		10.1038/ni.2770	http://dx.doi.org/10.1038/ni.2770			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24240161	Bronze			2022-12-18	WOS:000327149400016
J	Sen, R				Sen, Ranjan			The origins of NF-kappa B	NATURE IMMUNOLOGY			English	Article							DNA-BINDING SUBUNIT; IMMUNOGLOBULIN GENES; ENHANCER; TRANSCRIPTION; REL; INHIBITOR; SEQUENCES		NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, R (corresponding author), NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA.	rs465z@nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000384, ZIAAG000376] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; ELSON KJ, 1985, P NATL ACAD SCI USA, V82, P5305; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SEN R, 1987, MOL CELL BIOL, V7, P1989, DOI 10.1128/MCB.7.5.1989; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; WALL R, 1986, P NATL ACAD SCI USA, V83, P295, DOI 10.1073/pnas.83.2.295; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	15	15	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					686	688		10.1038/ni.2071	http://dx.doi.org/10.1038/ni.2071			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772276				2022-12-18	WOS:000292870700003
J	Garcia-Sastre, A				Garcia-Sastre, Adolfo			2 methylate or not 2 methylate: viral evasion of the type I interferon response	NATURE IMMUNOLOGY			English	Editorial Material							RIG-I; VIRUS-INFECTION; RNA; CELLS		[Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Garcia-Sastre, A (corresponding author), Mt Sinai Sch Med, Dept Med, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827				Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	10	15	18	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					114	115		10.1038/ni0211-114	http://dx.doi.org/10.1038/ni0211-114			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21245900	Green Published, Bronze			2022-12-18	WOS:000286378400003
J	Biron, CA				Biron, Christine A.			More things in heaven and earth: defining innate and adaptive immunity	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS	Natural killer cells have emerged as key components of innate immunity with critical antimicrobial functions. New work showing that they can also be accessed by vaccination to deliver antigen-specific memory responses and protect against subsequent viral infections challenges the traditional distinctions made between innate and adaptive immunity.	Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Biron, CA (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.							Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; MacFarlane AW, 2006, CURR TOP MICROBIOL, V298, P23; Makrigiannis AP, 2001, ARCH IMMUNOL THER EX, V49, P47; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665	12	15	15	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1080	1082		10.1038/ni1210-1080	http://dx.doi.org/10.1038/ni1210-1080			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079631				2022-12-18	WOS:000284262200006
J	Chaussabel, D; Ueno, H; Banchereau, J; Quinn, C				Chaussabel, Damien; Ueno, Hideki; Banchereau, Jacques; Quinn, Charles			Data management: it starts at the bench	NATURE IMMUNOLOGY			English	Editorial Material								Data management has been neglected but should be made an integral activity in all research laboratories. Chaussabel and colleagues discuss how to implement this at the bench.	[Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX USA; Baylor Res Inst, Dallas, TX USA	Baylor Scott & White Health; Baylor Scott & White Health; Baylor University Medical Center	Chaussabel, D (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	damienc@baylorhealth.edu	Ueno, Hideki/L-1237-2016; Chaussabel, Damien/AAX-1909-2020	Ueno, Hideki/0000-0001-7747-0738; Chaussabel, Damien/0000-0002-6131-7242	NCI NIH HHS [P01 CA084512-05A20005, P01 CA084512-040003, P01 CA084512-07, P01 CA084512-060005, P01 CA084512-069004, P01 CA084512-06, P01 CA084512, P01 CA084512-079004, P01 CA084512-05A2, P01 CA084512-020003, P01 CA084512-030003, P01 CA084512-070005, P01 CA084512-05A29002, P01 CA084512-01A10003, P01 CA084512-079002, P01 CA084512-069002, P01 CA084512-05A29004, P01 CA084512-07S1] Funding Source: Medline; NIAID NIH HHS [U19 AI057234-02, U19 AI057234, U19 AI057234-010004, U01 AI082110, U01 AI082110-01, U19 AI057234-010005, U19 AI057234-01] Funding Source: Medline; PHS HHS [U19 AIO57234-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, U01AI082110] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183	4	15	15	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1225	1227		10.1038/ni1209-1225	http://dx.doi.org/10.1038/ni1209-1225			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19915619	Green Accepted			2022-12-18	WOS:000271872800002
J	Malmberg, KJ; Ljunggren, HG				Malmberg, Karl-Johan; Ljunggren, Hans-Gustaf			Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELL		[Malmberg, Karl-Johan; Ljunggren, Hans-Gustaf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital	Malmberg, KJ (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden.	hans-gustaf.ljunggren@ki.se		Malmberg, Karl-Johan/0000-0002-8718-9373				Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	12	15	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					11	12		10.1038/ni0109-11	http://dx.doi.org/10.1038/ni0109-11			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088733				2022-12-18	WOS:000261788800004
J	Holt, PG; Strickland, DH				Holt, Patrick G.; Strickland, Deborah H.			The CD200-CD200R axis in local control of lung inflammation	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; CD200	Excessive lung inflammation in response to infection or allergens can lead to tissue damage and potentially loss of organ function. The CD200-CD200R interaction acts to limit such destructive immune responses in the lung.	[Holt, Patrick G.; Strickland, Deborah H.] Univ Western Australia, Telethon Inst Child Hlth Res, Fac Med Dent, Nedlands, WA 6009, Australia; [Holt, Patrick G.; Strickland, Deborah H.] Univ Western Australia, Ctr Child Hlth Res, Fac Med Dent, Nedlands, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia	Holt, PG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Fac Med Dent, Nedlands, WA 6009, Australia.	patrick@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011; strickland, deborah/K-4597-2019; Strickland, Deborah/AGV-6937-2022	Holt, Patrick G/0000-0003-1193-0935; Strickland, Deborah/0000-0003-0114-4201				Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Gorczynski R, 2008, J IMMUNOL, V180, P5946, DOI 10.4049/jimmunol.180.9.5946; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; Rijkers ESK, 2008, MOL IMMUNOL, V45, P1126, DOI 10.1016/j.molimm.2007.07.013; SCHONHEGRAD MA, 1991, J EXP MED, V173, P1345, DOI 10.1084/jem.173.6.1345; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637	10	15	15	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1011	1013		10.1038/ni0908-1011	http://dx.doi.org/10.1038/ni0908-1011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711441				2022-12-18	WOS:000258559600011
J	McAllister-Lucas, LM; Lucas, PC				McAllister-Lucas, Linda M.; Lucas, Peter C.			Finally, MALT1 is a protease!	NATURE IMMUNOLOGY			English	Editorial Material							KAPPA-B ACTIVATION; UBIQUITIN LIGASE; LYMPHOMA; BCL10; PATHWAY	Two groups demonstrate proteolytic activity for MALT1, a component of the signaling pathway mediating antigen receptor-dependent stimulation of the transcription factor NF-kappa B, and identify its first substrates.	[McAllister-Lucas, Linda M.] Univ Michigan, Sch Med, Dept Pediat, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Lucas, Peter C.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McAllister-Lucas, LM (corresponding author), Univ Michigan, Sch Med, Dept Pediat, Div Hematol & Oncol, Ann Arbor, MI 48109 USA.	lindaluc@umich.edu; plucas@umich.edu		Lucas, Peter/0000-0003-4880-7172	NCI NIH HHS [R01 CA124540] Funding Source: Medline; NHLBI NIH HHS [R01 HL082914] Funding Source: Medline; NIDDK NIH HHS [R01 DK079973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	11	15	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					231	233		10.1038/ni0308-231	http://dx.doi.org/10.1038/ni0308-231			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285772				2022-12-18	WOS:000253406700007
J	Tiemessen, CT; Kuhn, L				Tiemessen, Caroline T.; Kuhn, Louise			CC chemokines and protective immunity: insights gained from mother-to-child transmission of HIV	NATURE IMMUNOLOGY			English	Editorial Material							BETA-CHEMOKINES; RESPONSES; SUSCEPTIBILITY; NEWBORNS	Maternal-infant transmission provides a useful model for the study of immune factors associated with protection against the acquisition of human immunodeficiency virus and has emphasized the importance of CCL3 in protective immunity to this virus.	Natl Inst Communicable Dis, AIDS Virus Res Unit, ZA-2131 Johannesburg, South Africa; Univ Witwatersrand, ZA-2131 Johannesburg, South Africa; Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Columbia University; Columbia University	Tiemessen, CT (corresponding author), Natl Inst Communicable Dis, AIDS Virus Res Unit, ZA-2131 Johannesburg, South Africa.	carolinet@nicd.ac.za		Tiemessen, Caroline/0000-0002-0991-1690	NICHD NIH HHS [R01 HD042402] Funding Source: Medline; Wellcome Trust [076352/Z/05/Z, 076352] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042402] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Heeney JL, 1998, P NATL ACAD SCI USA, V95, P10803, DOI 10.1073/pnas.95.18.10803; Kuhn L, 2001, AIDS, V15, P1, DOI 10.1097/00002030-200101050-00003; Kuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Tiemessen Caroline T, 2006, Curr HIV/AIDS Rep, V3, P13, DOI 10.1007/s11904-006-0003-4; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Wasik TJ, 1999, J IMMUNOL, V162, P4355	13	15	16	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					219	222		10.1038/ni0307-219	http://dx.doi.org/10.1038/ni0307-219			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304227	Green Accepted			2022-12-18	WOS:000244275100004
J	Bauer, S				Bauer, S			Toll-erating self DNA	NATURE IMMUNOLOGY			English	Editorial Material							CPG-DNA; CELL ACTIVATION; RECOGNITION; RECEPTORS	Discrimination between self and bacterial DNA has been attributed in part to differential modification of prokaryotic and eukaryotic DNA. However, cellular localization of innate DNA receptors may be even more important.	Tech Univ Munich, Inst Med Microbiol & Immunol & Hyg, D-81675 Munich, Germany	Technical University of Munich	Bauer, S (corresponding author), Tech Univ Munich, Inst Med Microbiol & Immunol & Hyg, D-81675 Munich, Germany.	stefan.bauer@lrz.tu-muenchen.de		Bauer, Stefan/0000-0002-8462-1845				Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	13	15	16	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					13	15		10.1038/ni0106-13	http://dx.doi.org/10.1038/ni0106-13			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357851				2022-12-18	WOS:000234139700006
J	Silverstein, AM				Silverstein, AM			Paul Ehrlich, archives and the history of immunology	NATURE IMMUNOLOGY			English	Letter									Johns Hopkins Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), 38 Fells Rd, Falmouth, MA 02540 USA.	arts@jhmi.edu						MEDAWAR PB, 1969, INDUCTION I SCI AM P	1	15	16	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					639	639		10.1038/ni0705-639	http://dx.doi.org/10.1038/ni0705-639			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970932				2022-12-18	WOS:000229975500002
J	Shortman, K; Wu, L				Shortman, K; Wu, L			Are dendritic cells end cells?	NATURE IMMUNOLOGY			English	Editorial Material							MATURATION; GENERATION; CULTURES; ANTIGEN		Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Shortman, K (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	shortman@wehi.edu.au						Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Caux C, 1996, BLOOD, V87, P2376, DOI 10.1182/blood.V87.6.2376.bloodjournal8762376; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Wilson HL, 2000, P NATL ACAD SCI USA, V97, P4784, DOI 10.1073/pnas.080278897; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	12	15	15	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1105	1107		10.1038/ni1104-1105	http://dx.doi.org/10.1038/ni1104-1105			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496948				2022-12-18	WOS:000224692700006
J	Price, LS; Bos, JL				Price, LS; Bos, JL			RAPL: taking the Rap in immunity	NATURE IMMUNOLOGY			English	Editorial Material							CELL-ADHESION; EFFECTOR; IDENTIFICATION; INTEGRINS; GTPASES	Lymphocyte adhesion requires rapid responses. Lymphocytes from mice deficient in the Rap effector molecule RAPL lack this property and are therefore deficient in their immune responses.	Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Price, LS (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	l.s.price@med.uu.nl; j.l.bos@med.uu.nl		Price, Leo/0000-0002-4562-9086				Boettner B, 2003, GENETICS, V165, P159; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439	12	15	16	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1007	1008		10.1038/ni1004-1007	http://dx.doi.org/10.1038/ni1004-1007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454926				2022-12-18	WOS:000224156600014
J	Doherty, PC				Doherty, PC			On the nose: shared themes for the sensory and immune self	NATURE IMMUNOLOGY			English	Editorial Material							MAJOR HISTOCOMPATIBILITY COMPLEX; BINDING PROTEIN; FLY BRAIN; MHC; MICE; ODOR; REVEALS; MAP; INDIVIDUALITY; RECOGNITION	The immune system and the central nervous system operate in very different ways, but the dual use of the major histocompatibility complex for CD8(+) T cell monitoring and pheromone presentation indicates some commonalities exist.	Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	University of Melbourne	Doherty, PC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	pcd@unimelb.edu.au	Doherty, Peter Charles/C-4185-2013	Doherty, Peter Charles/0000-0002-5028-3489				Bard J, 2000, IMMUNOGENETICS, V51, P514, DOI 10.1007/s002510000165; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; de Groot NG, 2000, IMMUNOGENETICS, V51, P398, DOI 10.1007/s002510050638; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doherty PC, 2002, IMMUNOL REV, V185, P39, DOI 10.1034/j.1600-065X.2002.18505.x; Eggert F, 1998, GENETICA, V104, P265, DOI 10.1023/A:1026431303879; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Menashe I, 2002, HUM MOL GENET, V11, P1381, DOI 10.1093/hmg/11.12.1381; Montag S, 2001, P NATL ACAD SCI USA, V98, P9249, DOI 10.1073/pnas.161266398; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Potts WK, 2002, NAT GENET, V30, P130, DOI 10.1038/ng0202-130; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schaefer ML, 2002, J NEUROSCI, V22, P9513; Singh PB, 2001, REPRODUCTION, V121, P529, DOI 10.1530/reprod/121.4.529; Trachtulec Z, 1997, GENOMICS, V44, P1, DOI 10.1006/geno.1997.4839; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yamazaki K, 1999, P NATL ACAD SCI USA, V96, P1522, DOI 10.1073/pnas.96.4.1522; YAMAZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P5685, DOI 10.1073/pnas.80.18.5685; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	30	15	15	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1043	1045		10.1038/ni1103-1043	http://dx.doi.org/10.1038/ni1103-1043			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586418				2022-12-18	WOS:000186241100004
J	Davis, MM				Davis, MM			The problem of plain vanilla peptides	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; INFLUENZA-A; SPECIFICITY; RECOGNITION; MECHANISMS; COMPLEX; HLA-A2; CHAIN	The anti-influenza CD8(+) T cell response in HLA-A2 adults is dominated by a specific TCR. The crystal structure of the TCR and peptide-MHC complex show unusual interactions that help to explain the molecular basis of this dominant TCR selection.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Bankovich AJ, 2003, IMMUNITY, V18, P7, DOI 10.1016/S1074-7613(02)00517-4; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942	12	15	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					649	650		10.1038/ni0703-649	http://dx.doi.org/10.1038/ni0703-649			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830143				2022-12-18	WOS:000183952500010
J	Fugmann, SD; Schatz, DG				Fugmann, SD; Schatz, DG			RNA AIDs DNA	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; MECHANISM	Experiments based on the requirement for immunoglobulin gene transcription provide new insights into the elusive role played by AID in immunoglobulin class switching and hypermutation.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Fugmann, SD (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; DICKERSON SK, 2003, IN PRESS J EXP MED; EOI T, 2003, P NATL ACAD SCI USA, V100, P2634; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; RAMIRO AR, 2003, RAMIRO AROL, V4, P452; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	12	15	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					429	430		10.1038/ni0503-429	http://dx.doi.org/10.1038/ni0503-429			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719733				2022-12-18	WOS:000182665400007
J	Mueller, DL				Mueller, DL			Tuning the immune system: competing positive and negative feedback loops	NATURE IMMUNOLOGY			English	Editorial Material							CD4(+) T-CELLS; TOLERANCE; SHP-1	In a sea of potential suitors, it is important for T cells to discriminate between self and nonself ligands. New data provide a molecular understanding of how this may be achieved.	Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, DL (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.			Mueller, Daniel/0000-0003-1621-0419				Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176	11	15	15	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					210	211		10.1038/ni0303-210	http://dx.doi.org/10.1038/ni0303-210			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605227				2022-12-18	WOS:000181201000006
J	Bouillet, P; Strasser, A				Bouillet, P; Strasser, A			Bax and Bak: back-bone of T cell death	NATURE IMMUNOLOGY			English	Editorial Material							BH3-ONLY PROTEINS; BCL-2; APOPTOSIS; MICE	Apoptosis shapes T cell development and immune responses. The pro-apoptotic molecules Bax and Bak have overlapping essential functions in T cell development and homeostasis.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Bouillet, P (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058				Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	12	15	17	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					893	894		10.1038/ni1002-893	http://dx.doi.org/10.1038/ni1002-893			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352962				2022-12-18	WOS:000178242100005
J	Ezekowitz, RA				Ezekowitz, RA			Local opsonization for apoptosis?	NATURE IMMUNOLOGY			English	Editorial Material							PROGRAMMED CELL-DEATH; CLEARANCE; GROWTH	Classical opsonins are serum proteins that coat microorganisms and particles so as to enhance uptake by macrophages. A recent Nature paper has identified a macrophage-derived opsonin for apoptotic cells.	Harvard Univ, Sch Med, MassGen Hosp Children, Lab Dev Immunol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Ezekowitz, RA (corresponding author), Harvard Univ, Sch Med, MassGen Hosp Children, Lab Dev Immunol, Boston, MA 02114 USA.	ezekowitz.alan@mgh.harvard.edu						EZEKOWITZ RAB, 1984, J EXP MED, V159, P244, DOI 10.1084/jem.159.1.244; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Metchnikoff E., 1905, IMMUNITY INFECTIVE D; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4	13	15	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					510	512		10.1038/ni0602-510	http://dx.doi.org/10.1038/ni0602-510			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032563				2022-12-18	WOS:000175874700008
J	Nichols, KE; Koretzky, GA; June, CH				Nichols, KE; Koretzky, GA; June, CH			SAP: natural inhibitor or grand SLAM of T cell activation?	NATURE IMMUNOLOGY			English	News Item							ENCODING GENE; MUTATIONS; CDW150	Identification of SH2DIA as the defective gene in X-linked lymphoproliferative syndrome highlighted the importance of SAP in the regulation of T cell activation. New data suggest an alternative explanation for how SAP controls signaling.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Childrens Hosp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Nichols, KE (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Nichols, Kim/AAP-8592-2020; Nichols, Kim/E-9353-2016; Koretzky, Gary/AAU-5381-2021	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555; 				Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lewis J, 2001, CLIN IMMUNOL, V100, P15, DOI 10.1006/clim.2001.5035; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Takei M, 2001, INT IMMUNOL, V13, P559, DOI 10.1093/intimm/13.4.559; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	12	15	18	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					665	666		10.1038/90595	http://dx.doi.org/10.1038/90595			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477397				2022-12-18	WOS:000170230100004
J	Raines, LN; Zhao, HX; Wang, YZ; Chen, HY; Gallart-Ayala, H; Hsueh, PC; Cao, W; Koh, Y; Alamonte-Loya, A; Liu, PS; Ivanisevic, J; Lio, CWJ; Ho, PC; Huang, SCC				Raines, Lydia N.; Zhao, Haoxin; Wang, Yuzhu; Chen, Heng-Yi; Gallart-Ayala, Hector; Hsueh, Pei-Chun; Cao, Wei; Koh, Yeojung; Alamonte-Loya, Ana; Liu, Pu-Ste; Ivanisevic, Julijana; Lio, Chan-Wang Jerry; Ho, Ping-Chih; Huang, Stanley Ching-Cheng			PERK is a critical metabolic hub for immunosuppressive function in macrophages	NATURE IMMUNOLOGY			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALTERNATIVE ACTIVATION; T-CELLS; SERINE; IMMUNITY; INFLAMMATION; INHIBITOR; CANCER; TET2	Raines et al. examine the role of the PERK-mediated ER stress response in promoting and sustaining M2-like macrophages in type 2 immune response and in tumor immunity. Chronic inflammation triggers compensatory immunosuppression to stop inflammation and minimize tissue damage. Studies have demonstrated that endoplasmic reticulum (ER) stress augments the suppressive phenotypes of immune cells; however, the molecular mechanisms underpinning this process and how it links to the metabolic reprogramming of immunosuppressive macrophages remain elusive. In the present study, we report that the helper T cell 2 cytokine interleukin-4 and the tumor microenvironment increase the activity of a protein kinase RNA-like ER kinase (PERK)-signaling cascade in macrophages and promote immunosuppressive M2 activation and proliferation. Loss of PERK signaling impeded mitochondrial respiration and lipid oxidation critical for M2 macrophages. PERK activation mediated the upregulation of phosphoserine aminotransferase 1 (PSAT1) and serine biosynthesis via the downstream transcription factor ATF-4. Increased serine biosynthesis resulted in enhanced mitochondrial function and alpha-ketoglutarate production required for JMJD3-dependent epigenetic modification. Inhibition of PERK suppressed macrophage immunosuppressive activity and could enhance the efficacy of immune checkpoint programmed cell death protein 1 inhibition in melanoma. Our findings delineate a previously undescribed connection between PERK signaling and PSAT1-mediated serine metabolism critical for promoting immunosuppressive function in M2 macrophages.	[Raines, Lydia N.; Zhao, Haoxin; Wang, Yuzhu; Cao, Wei; Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chen, Heng-Yi; Alamonte-Loya, Ana] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Gallart-Ayala, Hector; Ivanisevic, Julijana] Univ Lausanne, Metabol Serv & Res Unit, Lausanne, Switzerland; [Hsueh, Pei-Chun; Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Epalinges, Switzerland; [Hsueh, Pei-Chun; Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland; [Liu, Pu-Ste] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wang, Yuzhu] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China	Case Western Reserve University; University System of Ohio; Ohio State University; University of Lausanne; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; National Health Research Institutes - Taiwan; Case Western Reserve University; Capital Medical University	Huang, SCC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.; Huang, SCC (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	stan.huang@case.edu		Chen, Heng-Yi/0000-0001-9283-6144; Koh, Yeo Jung/0000-0002-4294-7871; Raines, Lydia/0000-0001-5675-4854; Lio, Jerry/0000-0003-3876-6741	Immunology T32 Training Program [AI089474]; Ministry of Science and Technology, Taiwan; National Institutes of Health's National Cancer Institute K22 award [K22CA241290]; Department of Microbial Infection and Immunity at Ohio State University; Pelotonia Institute of Immuno-oncology at Ohio State University; UNIL interdisciplinary grant; European Research Council [802773-MitoGuide]; SNSF [31003A_182470]; Cancer Research Institute (CLIP investigator award); Cancer Research Institute (Lloyd J. Old STAR award); University of Lausanne (UNIL) interdisciplinary grant; Cancer Research Institute CLIP Investigator Award; VeloSano Pilot Award; Case Comprehensive Cancer Center American Cancer Society pilot grants [IRG-91-022-19, IRG-16-186-21]; Case GI SPORE DRP grant [5P50CA150964-08]; Cleveland Digestive Research Core Center pilot grant [1P30DK097948]	Immunology T32 Training Program; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health's National Cancer Institute K22 award; Department of Microbial Infection and Immunity at Ohio State University; Pelotonia Institute of Immuno-oncology at Ohio State University; UNIL interdisciplinary grant; European Research Council(European Research Council (ERC)European Commission); SNSF(Swiss National Science Foundation (SNSF)); Cancer Research Institute (CLIP investigator award); Cancer Research Institute (Lloyd J. Old STAR award); University of Lausanne (UNIL) interdisciplinary grant; Cancer Research Institute CLIP Investigator Award; VeloSano Pilot Award; Case Comprehensive Cancer Center American Cancer Society pilot grants; Case GI SPORE DRP grant; Cleveland Digestive Research Core Center pilot grant	We thank S. Adoro and A. Huang for providing Eif2ak3<SUP>fl/fl</SUP> and OT-I mice, respectively. We thank A. Huang, S. Adoro and G. Dubyak for helpful discussions, and H. Fujioka from the Cleveland Center for Membrane and Structural Biology for expert technical assistance. All the individuals above are affiliated with Case Western Reserve University. L.N.R is supported by the Immunology T32 Training Program (no. AI089474). P.-C.H. is supported in part by a postdoctoral fellowship provided by Ministry of Science and Technology, Taiwan. C.-W.J.L. is funded by the National Institutes of Health's National Cancer Institute K22 award (no. K22CA241290), and startup funds from the Department of Microbial Infection and Immunity and Pelotonia Institute of Immuno-oncology at Ohio State University. J.I. is supported by a UNIL interdisciplinary grant. P.-C.H. is funded by the European Research Council starting grant (no. 802773-MitoGuide), SNSF project grants (no. 31003A_182470), the Cancer Research Institute (CLIP investigator award and Lloyd J. Old STAR award) and University of Lausanne (UNIL) interdisciplinary grant. S.C.-C.H. is funded by the Cancer Research Institute CLIP Investigator Award, the VeloSano Pilot Award, Case Comprehensive Cancer Center American Cancer Society pilot grants (nos. IRG-91-022-19 and IRG-16-186-21), Case GI SPORE DRP grant (no. 5P50CA150964-08) and the Cleveland Digestive Research Core Center pilot grant (no. 1P30DK097948).	Batista A, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000687; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cao, 2019, NAT COMMUN, V10; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Di Conza G, 2021, NAT IMMUNOL, V22, P1403, DOI 10.1038/s41590-021-01047-4; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Gagnebin Y, 2017, ANAL CHIM ACTA, V955, P27, DOI 10.1016/j.aca.2016.12.029; Gallart-Ayala H, 2018, ANAL CHIM ACTA, V1037, P327, DOI 10.1016/j.aca.2018.04.002; Gao S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0648-4; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Guthrie LN, 2016, J BIOL CHEM, V291, P15830, DOI 10.1074/jbc.M116.738021; Halaby MJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8189; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hwang IY, 2016, CELL METAB, V24, P494, DOI 10.1016/j.cmet.2016.06.014; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kory N, 2018, SCIENCE, V362, P791, DOI 10.1126/science.aat9528; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Lio CWJ, 2020, IMMUNOLOGY, V161, P165, DOI 10.1111/imm.13207; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/nchembio.2070, 10.1038/NCHEMBIO.2070]; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pan W, 2017, IMMUNITY, V47, P284, DOI 10.1016/j.immuni.2017.07.020; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Roci I, 2016, ANAL CHEM, V88, P2707, DOI 10.1021/acs.analchem.5b04071; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Song M, 2019, TRENDS IMMUNOL, V40, P128, DOI 10.1016/j.it.2018.12.001; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Tsugawa H, 2014, BIOINFORMATICS, V30, P2379, DOI 10.1093/bioinformatics/btu203; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang CS, 2018, EMBO REP, V19, DOI 10.15252/embr.201643577; Yang FJ, 2019, CELL IMMUNOL, V336, P40, DOI 10.1016/j.cellimm.2018.12.008; Yang X, 2018, CELL REP, V23, P1754, DOI 10.1016/j.celrep.2018.04.032; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	66	14	14	16	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					431	+		10.1038/s41590-022-01145-x	http://dx.doi.org/10.1038/s41590-022-01145-x		FEB 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35228694				2022-12-18	WOS:000762163700003
J	Liston, A; Humblet-Baron, S; Duffy, D; Goris, A				Liston, Adrian; Humblet-Baron, Stephanie; Duffy, Darragh; Goris, An			Human immune diversity: from evolution to modernity	NATURE IMMUNOLOGY			English	Review							TRIVALENT INFLUENZA VACCINE; SYSTEMS-ANALYSIS; DOUBLE-BLIND; GENETIC ARCHITECTURE; CYTOKINE PRODUCTION; TOPICAL IMIQUIMOD; INNATE IMMUNITY; SEVERE COVID-19; CELL INDUCTION; GUT MICROBIOME	The extreme diversity of the human immune system, forged and maintained throughout evolutionary history, provides a potent defense against opportunistic pathogens. Liston and colleagues review the current state of play in the field, identify the key unknowns in the causality of immune variation and identify the multidisciplinary pathways toward an improved understanding. The extreme diversity of the human immune system, forged and maintained throughout evolutionary history, provides a potent defense against opportunistic pathogens. At the same time, this immune variation is the substrate upon which a plethora of immune-associated diseases develop. Genetic analysis suggests that thousands of individually weak loci together drive up to half of the observed immune variation. Intense selection maintains this genetic diversity, even selecting for the introgressed Neanderthal or Denisovan alleles that have reintroduced variation lost during the out-of-Africa migration. Variations in age, sex, diet, environmental exposure, and microbiome each potentially explain the residual variation, with proof-of-concept studies demonstrating both plausible mechanisms and correlative associations. The confounding interaction of many of these variables currently makes it difficult to assign definitive contributions. Here, we review the current state of play in the field, identify the key unknowns in the causality of immune variation, and identify the multidisciplinary pathways toward an improved understanding.	[Liston, Adrian] Babraham Inst, Immunol Programme, Babraham Res Campus, Cambridge, England; [Humblet-Baron, Stephanie] Univ Leuven, Dept Microbiol Immunol & Transplantat, KU Leuven, Leuven, Belgium; [Duffy, Darragh] Inst Pasteur, Dept Immunol, Translat Immunol Lab, Paris, France; [Goris, An] Univ Leuven, Leuven Brain Inst, Dept Neurosci, KU Leuven, Leuven, Belgium	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; KU Leuven; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; KU Leuven	Liston, A (corresponding author), Babraham Inst, Immunol Programme, Babraham Res Campus, Cambridge, England.; Humblet-Baron, S (corresponding author), Univ Leuven, Dept Microbiol Immunol & Transplantat, KU Leuven, Leuven, Belgium.; Duffy, D (corresponding author), Inst Pasteur, Dept Immunol, Translat Immunol Lab, Paris, France.; Goris, A (corresponding author), Univ Leuven, Leuven Brain Inst, Dept Neurosci, KU Leuven, Leuven, Belgium.	adrian.liston@babraham.ac.uk; stephanie.humbletbaron@kuleuven.be; darragh.duffy@pasteur.fr; an.goris@kuleuven.be	Goris, An/L-5852-2019; Liston, Adrian/G-8606-2013	Goris, An/0000-0002-1276-6682; Liston, Adrian/0000-0002-6272-4085; Duffy, Darragh/0000-0002-8875-2308	European Union's Horizon 2020 research and innovation program [874707]; Biotechnology and Biological Sciences Research Council through Institute Strategic Program Grant [BBS/E/B/000C0427, BBS/E/B/000C0428]; Research Fund KU Leuven [C24/16/045]; Research Foundation-Flanders [FWO G. 0734.15]; Belgian Charcot Foundation; Queen Elisabeth Medical Foundation; Horizon2020 'MultipleMS' consortium [733161]; Laboratoire d'Excellence 'Milieu Interieur' [ANR-10-LABX-69-01]; KU Leuven BOFZAP start-up grant; VLAIO (Flanders Innovation & Entrepreneurship) within the project entitled PRISMA; Stichting Alzheimer Onderzoek -Fondation Recherche Maladie Alzheimer (SAO-FMA)	European Union's Horizon 2020 research and innovation program; Biotechnology and Biological Sciences Research Council through Institute Strategic Program Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Fund KU Leuven(KU Leuven); Research Foundation-Flanders(FWO); Belgian Charcot Foundation; Queen Elisabeth Medical Foundation; Horizon2020 'MultipleMS' consortium; Laboratoire d'Excellence 'Milieu Interieur'; KU Leuven BOFZAP start-up grant; VLAIO (Flanders Innovation & Entrepreneurship) within the project entitled PRISMA; Stichting Alzheimer Onderzoek -Fondation Recherche Maladie Alzheimer (SAO-FMA)	This project was supported by the European Union's Horizon 2020 research and innovation program under grant agreement No 874707 (EXIMIOUS). This work was also supported by the Biotechnology and Biological Sciences Research Council through Institute Strategic Program Grant funding BBS/E/B/000C0427 and BBS/E/B/000C0428. AG is supported by the Research Fund KU Leuven (C24/16/045), the Research Foundation-Flanders (FWO G. 0734.15), the Belgian Charcot Foundation, the Queen Elisabeth Medical Foundation and the Horizon2020 'MultipleMS' consortium (grant EU RIA 733161). D. D. acknowledges support from the Laboratoire d'Excellence 'Milieu Interieur', managed by the Agence Nationale de la Recherche, (ANR-10-LABX-69-01). S. H. B. is supported by KU Leuven BOFZAP start-up grant, VLAIO (Flanders Innovation & Entrepreneurship) within the project entitled PRISMA and by a grant from Stichting Alzheimer Onderzoek -Fondation Recherche Maladie Alzheimer (SAO-FMA).	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Ahola-Olli AV, 2017, AM J HUM GENET, V100, P40, DOI 10.1016/j.ajhg.2016.11.007; Ansari MA, 2017, NAT GENET, V49, P666, DOI 10.1038/ng.3835; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Athale S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9194; Avey S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal4656; Awany D, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00637; Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920; Bergamaschi L, 2021, IMMUNITY, V54, P1257, DOI 10.1016/j.immuni.2021.05.010; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Byrd AL, 2021, J EXP MED, V218, DOI 10.1084/jem.20200606; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chen MH, 2020, CELL, V182, P1198, DOI 10.1016/j.cell.2020.06.045; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Choin J, 2021, NATURE, V592, P583, DOI 10.1038/s41586-021-03236-5; Clave E, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2966; Colbran LL, 2019, NAT ECOL EVOL, V3, P1598, DOI 10.1038/s41559-019-0996-x; Consonni D, 2008, AM J EPIDEMIOL, V167, P847, DOI 10.1093/aje/kwm371; Cortese A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01977-0; COVID Host-Genetics Initiative, NATURE, DOI [10.1038/s41586-021-03767-x(2021), DOI 10.1038/S41586-021-03767-X(2021)]; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; de Jong SE, 2021, NAT IMMUNOL, V22, P654, DOI 10.1038/s41590-021-00911-7; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; DIAZSANCHEZ D, 1994, J CLIN INVEST, V94, P1417, DOI 10.1172/JCI117478; Dumanski JP, 2021, CELL MOL LIFE SCI, V78, P4019, DOI 10.1007/s00018-021-03822-w; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Enard D, 2018, CELL, V175, P360, DOI 10.1016/j.cell.2018.08.034; Evans RDR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18184-3; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Geisberger S, 2021, CIRCULATION, V144, P144, DOI 10.1161/CIRCULATIONAHA.120.052788; Goncalves-Mendes N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00065; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hagen SH, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108485; Hansen LBS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07019-x; He HQ, 2020, BLOOD, V136, P183, DOI 10.1182/blood.2019003910; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Henrick BM, 2021, CELL, V184, P3884, DOI 10.1016/j.cell.2021.05.030; Hill DL, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw9522; Huffman J, ALTERNATIVE SPLICING, DOI [10.1101/2021.03.20.21254005(2021, DOI 10.1101/2021.03.20.21254005(2021]; Hung IFN, 2014, CLIN INFECT DIS, V59, P1246, DOI 10.1093/cid/ciu582; Hung IFN, 2016, LANCET INFECT DIS, V16, P209, DOI 10.1016/S1473-3099(15)00354-0; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jabara HH, 2016, NAT GENET, V48, P74, DOI 10.1038/ng.3465; Jonsson S, 2017, NAT GENET, V49, P1182, DOI 10.1038/ng.3897; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Kamdar S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14923-8; Kerner G, 2021, AM J HUM GENET, V108, P517, DOI 10.1016/j.ajhg.2021.02.009; Kerner G, 2019, P NATL ACAD SCI USA, V116, P10430, DOI 10.1073/pnas.1903561116; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243; Konturek PC, 2016, J PHYSIOL PHARMACOL, V67, P859; Kotliarov Y, 2020, NAT MED, V26, P618, DOI 10.1038/s41591-020-0769-8; Kwok AJ, 2021, NAT REV GENET, V22, P137, DOI 10.1038/s41576-020-00297-6; Lagou V, 2018, CELL REP, V25, P798, DOI 10.1016/j.celrep.2018.09.048; Lakshmikanth T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107923; Li HC, 2017, CIRCULATION, V136, P618, DOI [10.1161/CIRCULATIONAHA.116.026796, 10.1161/circulationaha.116.026796]; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Liu C, 2021, CELL, V184, P1836, DOI 10.1016/j.cell.2021.02.018; Liu YS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145728; Lundtoft C, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009199; Mangino M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13850; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Mohr AE, 2020, J ACAD NUTR DIET, V120, P548, DOI 10.1016/j.jand.2019.08.018; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Natrajan MS, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010004; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Orru V, 2020, NAT GENET, V52, P1036, DOI 10.1038/s41588-020-0684-4; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Ota M, 2021, CELL, V184, P3006, DOI 10.1016/j.cell.2021.03.056; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Penttila PA, 2021, CELL MOL LIFE SCI, V78, P3987, DOI 10.1007/s00018-021-03808-8; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Potluri T, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0124-6; Quach H, 2017, J EXP MED, V214, P877, DOI 10.1084/jem.20161942; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Quintana-Murci L, 2019, CELL, V177, P184, DOI 10.1016/j.cell.2019.02.033; Rechtien A, 2017, CELL REP, V20, P2251, DOI 10.1016/j.celrep.2017.08.023; Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053; Rinker DC, 2020, NAT ECOL EVOL, V4, P1332, DOI 10.1038/s41559-020-1261-z; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rotival M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09689-7; Sams AJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1098-6; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schluter J, 2020, NATURE, V588, DOI 10.1038/s41586-020-2971-8; Sliz E, 2019, J MED GENET, V56, P607, DOI 10.1136/jmedgenet-2018-105965; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Souyris M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8855; Stebegg M, 2020, ELIFE, V9, DOI 10.7554/eLife.52473; Stein MM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80145-z; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stoffel NU, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01313; Sullivan RJ, 2022, NAT REV DRUG DISCOV, V21, P495, DOI 10.1038/s41573-021-00259-5; Suzuki T, 2020, NAT IMMUNOL, V21, P1486, DOI 10.1038/s41590-020-0802-6; Temba GS, 2021, NAT IMMUNOL, V22, P287, DOI 10.1038/s41590-021-00867-8; Thompson DJ, 2019, NATURE, V575, P652, DOI 10.1038/s41586-019-1765-3; Toussirot E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00440; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Umans BD, 2021, TRENDS GENET, V37, P109, DOI 10.1016/j.tig.2020.08.009; Van Horebeek L, 2019, TRENDS GENET, V35, P935, DOI 10.1016/j.tig.2019.09.005; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Vanderbeke L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24360-w; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VOJDANI A, 1992, TOXICOL IND HEALTH, V8, P239; Vuckovic D, 2020, CELL, V182, P1214, DOI 10.1016/j.cell.2020.08.008; Wastyk HC, 2021, CELL, V184, P4137, DOI 10.1016/j.cell.2021.06.019; Webb LMC, 2021, AGING CELL, V20, DOI 10.1111/acel.13295; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Yang F, 2021, SCIENCE, V372, P738, DOI 10.1126/science.abf6648; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3; Zekavat SM, 2021, NAT MED, V27, P1012, DOI 10.1038/s41591-021-01371-0; Zheng H, 2021, IMMUNITY, V54, P753, DOI 10.1016/j.immuni.2021.03.002	134	14	14	7	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1479	1489		10.1038/s41590-021-01058-1	http://dx.doi.org/10.1038/s41590-021-01058-1		NOV 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34795445	Bronze, Green Published			2022-12-18	WOS:000720214500002
J	Fiancette, R; Finlay, CM; Willis, C; Bevington, SL; Soley, J; Ng, STH; Baker, SM; Andrews, S; Hepworth, MR; Withers, DR				Fiancette, Remi; Finlay, Conor M.; Willis, Claire; Bevington, Sarah L.; Soley, Jake; Ng, Sky T. H.; Baker, Syed Murtuza; Andrews, Simon; Hepworth, Matthew R.; Withers, David R.			Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; NK CELLS; REGULATORY NETWORK; GENE-EXPRESSION; DIFFERENTIATION; BET; ALPHA; FATE; ACTIVATION	Fiancette et al. utilize models of inducible transcription factor deletion in mature tissue-resident ILCs to reveal complementary and competing transcriptional networks that determine ILC3 phenotype and functional capacity. Innate lymphoid cells (ILCs) are guardians of mucosal immunity, yet the transcriptional networks that support their function remain poorly understood. We used inducible combinatorial deletion of key transcription factors (TFs) required for ILC development (ROR gamma t, ROR alpha and T-bet) to determine their necessity in maintaining ILC3 identity and function. Both ROR gamma t and ROR alpha were required to preserve optimum effector functions; however, ROR alpha was sufficient to support robust interleukin-22 production among the lymphoid tissue inducer (LTi)-like ILC3 subset, but not natural cytotoxicity receptor (NCR)(+) ILC3s. Lymphoid tissue inducer-like ILC3s persisted with only selective loss of phenotype and effector functions even after the loss of both TFs. In contrast, continued ROR gamma t expression was essential to restrain transcriptional networks associated with type 1 immunity within NCR+ ILC3s, which coexpress T-bet. Full differentiation to an ILC1-like population required the additional loss of ROR alpha. Together, these data demonstrate how TF networks integrate within mature ILCs after development to sustain effector functions, imprint phenotype and restrict alternative differentiation programs.	[Fiancette, Remi; Willis, Claire; Ng, Sky T. H.; Withers, David R.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Finlay, Conor M.; Baker, Syed Murtuza; Hepworth, Matthew R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat,Div Infect, Manchester, Lancs, England; [Bevington, Sarah L.; Soley, Jake] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Baker, Syed Murtuza] Univ Manchester, Div Informat Imaging & Data Sci, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England	University of Birmingham; University of Manchester; University of Birmingham; University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Withers, DR (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Hepworth, MR (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat,Div Infect, Manchester, Lancs, England.	matthew.hepworth@manchester.ac.uk; d.withers@bham.ac.uk	; Withers, David/C-7055-2015	Andrews, Simon/0000-0002-5006-3507; Soley, Jake/0000-0001-7131-2560; Baker, Syed Murtuza/0000-0002-6633-333X; Withers, David/0000-0003-3757-7594; Finlay, Conor/0000-0001-8285-0903; Hepworth, Matthew/0000-0002-9613-7858				Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bai L, 2021, SCIENCE, V371, P1332, DOI 10.1126/science.aba4177; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cella M, 2019, NAT IMMUNOL, V20, P980, DOI 10.1038/s41590-019-0425-y; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Ghaem-Maghami M, 2001, INFECT IMMUN, V69, P5597, DOI 10.1128/IAI.69.9.5597-5605.2001; Gokmen MR, 2013, J IMMUNOL, V191, P5925, DOI 10.4049/jimmunol.1202254; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huber D., 2019, SSEQ SHRINKAGE ESTIM; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Karagiannis F, 2020, IMMUNITY, V52, P885, DOI 10.1016/j.immuni.2020.04.021; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lo BC, 2019, J IMMUNOL, V203, P3209, DOI 10.4049/jimmunol.1900781; Lo BC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8864; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Melo-Gonzalez F, 2017, IMMUNOLOGY, V150, P265, DOI 10.1111/imm.12697; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stehle C, 2021, NAT IMMUNOL, V22, P1231, DOI 10.1038/s41590-021-01029-6; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Suo SB, 2018, CELL REP, V25, P1436, DOI 10.1016/j.celrep.2018.10.045; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; van de Sande B, 2020, NAT PROTOC, V15, P2247, DOI 10.1038/s41596-020-0336-2; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; WITHERS DR, 2017, FRONT IMMUNOL, V8; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; ZHENG GX, 2017, NATURE, V0008	60	14	14	3	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1245	+		10.1038/s41590-021-01024-x	http://dx.doi.org/10.1038/s41590-021-01024-x		SEP 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556884	Green Submitted, Green Accepted			2022-12-18	WOS:000751833700004
J	Hu, W; Wang, ZM; Feng, YQ; Schizas, M; Hoyos, BE; van der Veeken, J; Verter, JG; Bou-Puerto, R; Rudensky, AY				Hu, Wei; Wang, Zhong-Min; Feng, Yongqiang; Schizas, Michail; Hoyos, Beatrice E.; van der Veeken, Joris; Verter, Jacob G.; Bou-Puerto, Regina; Rudensky, Alexander Y.			Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity	NATURE IMMUNOLOGY			English	Article							MEDIATED SUPPRESSION; FOXP3; RECEPTOR; DISEASE; SCURFY; INFECTION; RESPONSES; IMMUNITY; MECHANISMS; PROMOTES	The immunosuppressive function of regulatory T (T-reg) cells is dependent on continuous expression of the transcription factor Foxp3. Foxp3 loss of function or induced ablation of T-reg cells results in a fatal autoimmune disease featuring all known types of inflammatory responses with every manifestation stemming from T-reg cell paucity, highlighting a vital function of T-reg cells in preventing fatal autoimmune inflammation. However, a major question remains whether T-reg cells can persist and effectively exert their function in a disease state, where a broad spectrum of inflammatory mediators can either inactivate T-reg cells or render innate and adaptive pro-inflammatory effector cells insensitive to suppression. By reinstating Foxp3 protein expression and suppressor function in cells expressing a reversible Foxp3 null allele in severely diseased mice, we found that the resulting single pool of rescued T-reg cells normalized immune activation, quelled severe tissue inflammation, reversed fatal autoimmune disease and provided long-term protection against them. Thus, T-reg cells are functional in settings of established broad-spectrum systemic inflammation and are capable of affording sustained reset of immune homeostasis. Regulatory T cells are functional in a broad-spectrum systemic autoimmune disease and are capable of suppressing innate and adaptive immune responses, reversing established tissue inflammation and enabling long-term restoration of immunological health.	[Hu, Wei; Wang, Zhong-Min; Feng, Yongqiang; Schizas, Michail; Hoyos, Beatrice E.; van der Veeken, Joris; Verter, Jacob G.; Bou-Puerto, Regina; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, Howard Hughes Med Inst, New York, NY 10065 USA; [Hu, Wei; Wang, Zhong-Min; Feng, Yongqiang; Schizas, Michail; Hoyos, Beatrice E.; van der Veeken, Joris; Verter, Jacob G.; Bou-Puerto, Regina; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Wang, Zhong-Min] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Bou-Puerto, Regina] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Feng, Yongqiang] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN USA; [van der Veeken, Joris] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; St Jude Children's Research Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Hu, W; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, Howard Hughes Med Inst, New York, NY 10065 USA.; Hu, W; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.	huw1@mskcc.org; rudenska@mskcc.org	Wang, Zhongmin/GLU-9473-2022; Hu, Wei/ABH-1470-2021; Feng, Yongqiang/N-2731-2018	Wang, Zhongmin/0000-0002-5538-1969; Hu, Wei/0000-0002-0392-6939; Bou Puerto, Regina/0000-0002-7546-3312; Feng, Yongqiang/0000-0002-2320-5063	National Institutes of Health [R01 AI034206]; Irvington-Cancer Research Institute Postdoctoral Fellowship; Ludwig Center at Memorial Sloan Kettering, Parker Institute for Cancer Immunotherapy (PICI); National Cancer Institute Cancer Center [P30 CA08748]; Bruce Charles Forbes Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington-Cancer Research Institute Postdoctoral Fellowship; Ludwig Center at Memorial Sloan Kettering, Parker Institute for Cancer Immunotherapy (PICI); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bruce Charles Forbes Fellowship	We thank E. Azizi for advice on scRNA-seq data analysis and members of the laboratory of A.Y.R. for technical support and discussion, Memorial Sloan Kettering Cancer Center (MSKCC) Single Cell Research Initiative and Integrated Genomics Operation Core facility for single-cell and bulk RNA-seq. This work was supported by the National Institutes of Health (grant R01 AI034206 to A.Y.R.), an Irvington-Cancer Research Institute Postdoctoral Fellowship (to W.H.), the Ludwig Center at Memorial Sloan Kettering, Parker Institute for Cancer Immunotherapy (PICI) (to A.Y.R.) and the National Cancer Institute Cancer Center (grant P30 CA08748). A.Y.R is an investigator with the Howard Hughes Medical Institute. Z.-M.W. is supported by a Bruce Charles Forbes Fellowship.	Allenspach E, 2016, J CLIN IMMUNOL, V36, pS57, DOI 10.1007/s10875-016-0294-1; Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Clough LE, 2008, J IMMUNOL, V180, P5393, DOI 10.4049/jimmunol.180.8.5393; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durant LR, 2013, J VIROL, V87, P10946, DOI 10.1128/JVI.01295-13; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gangaplara A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006985; Gao YY, 2015, P NATL ACAD SCI USA, V112, pE3246, DOI 10.1073/pnas.1421463112; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Georgiev P, 2019, J CLIN IMMUNOL, V39, P623, DOI 10.1007/s10875-019-00684-7; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Levine AG, 2017, J EXP MED, V214, P609, DOI 10.1084/jem.20161318; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nasrallah R, 2020, NATURE, V583, P447, DOI 10.1038/s41586-020-2296-7; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Park JH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102526; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pelly VS, 2017, J EXP MED, V214, P1809, DOI 10.1084/jem.20161104; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Pritykin Y, 2021, MOL CELL, V81, P2477, DOI 10.1016/j.molcel.2021.03.045; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Schmitz I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003362; Setty M, 2019, NAT BIOTECHNOL, V37, P451, DOI 10.1038/s41587-019-0068-4; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tahvildari M, 2019, J IMMUNOL, V203, P2749, DOI 10.4049/jimmunol.1900733; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang BH, 2019, CELL REP, V27, P3629, DOI 10.1016/j.celrep.2019.05.061; Ye J, 2017, CELL REP, V21, P2277, DOI 10.1016/j.celrep.2017.10.114; Zhao JX, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004279	81	14	16	5	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1163	+		10.1038/s41590-021-01001-4	http://dx.doi.org/10.1038/s41590-021-01001-4		AUG 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34426690	Green Submitted, Green Accepted			2022-12-18	WOS:000687501700004
J	Chen, DY; Wang, Y; Vijay, GKM; Fu, SJ; Nash, CW; Xu, D; He, DY; Salomonis, N; Singh, H; Xu, HP				Chen, Dianyu; Wang, Yan; Vijay, Godhev K. Manakkat; Fu, Shujie; Nash, Colt W.; Xu, Di; He, Danyang; Salomonis, Nathan; Singh, Harinder; Xu, Heping			Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation	NATURE IMMUNOLOGY			English	Article							B-CELL RECEPTOR; GERMINAL CENTER; RNA-SEQ; SELECTION; DYNAMICS; CYCLE; ACIDS; MYC	Antigen-activated B cells diversify variable regions of B cell antigen receptors by somatic hypermutation in germinal centers (GCs). The positive selection of GC B cells that acquire high-affinity mutations enables antibody affinity maturation. In spite of considerable progress, the genomic states underlying this process remain to be elucidated. Single-cell RNA sequencing and topic modeling revealed increased expression of the oxidative phosphorylation (OXPHOS) module in GC B cells undergoing mitoses. Coupled analysis of somatic hypermutation in immunoglobulin heavy chain (Igh) variable gene regions showed that GC B cells acquiring higher-affinity mutations had further elevated expression of OXPHOS genes. Deletion of mitochondrial Cox10 in GC B cells resulted in reduced cell division and impaired positive selection. Correspondingly, augmentation of OXPHOS activity with oltipraz promoted affinity maturation. We propose that elevated OXPHOS activity promotes B cell clonal expansion and also positive selection by tuning cell division times. Xu and colleagues use single-cell transcriptomic analyses to uncover distinct expression dynamics of metabolic programs in germinal center B cells. Coupled analysis of transcriptional states and Igh variable sequences revealed that OXPHOS metabolism is enhanced in GC B cells undergoing positive selection. Their findings suggest BCR signaling tunes GC B cell metabolism to accelerate the cell cycle of positively selected GC B cells.	[Chen, Dianyu; Wang, Yan] Zhejiang Univ, Coll Life Sci, Sch Med, Hangzhou, Peoples R China; [Chen, Dianyu; Wang, Yan; Fu, Shujie; Xu, Di; He, Danyang; Xu, Heping] Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou, Peoples R China; [Chen, Dianyu; Wang, Yan; Fu, Shujie; Xu, Di; He, Danyang; Xu, Heping] Westlake Lab Life Sci & Biomed, Hangzhou, Peoples R China; [Chen, Dianyu; Wang, Yan; Fu, Shujie; Xu, Di; He, Danyang; Xu, Heping] Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou, Peoples R China; [Vijay, Godhev K. Manakkat; Nash, Colt W.; Singh, Harinder] Univ Pittsburgh, Ctr Syst Immunol, Dept Immunol, Pittsburgh, PA 15261 USA; [Vijay, Godhev K. Manakkat; Nash, Colt W.; Singh, Harinder] Univ Pittsburgh, Ctr Syst Immunol, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA; [Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Dept Pediat, Cincinnati, OH 45229 USA	Zhejiang University; Westlake University; Westlake University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center	Xu, HP (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou, Peoples R China.; Xu, HP (corresponding author), Westlake Lab Life Sci & Biomed, Hangzhou, Peoples R China.; Xu, HP (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou, Peoples R China.; Singh, H (corresponding author), Univ Pittsburgh, Ctr Syst Immunol, Dept Immunol, Pittsburgh, PA 15261 USA.; Singh, H (corresponding author), Univ Pittsburgh, Ctr Syst Immunol, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA.	harinder@pitt.edu; xuheping@westlake.edu.cn		Xu, Heping/0000-0003-2149-7004; Manakkat Vijay, Godhev/0000-0003-3833-3057; He, Danyang/0000-0002-3613-4188; Singh, Harinder/0000-0002-6330-8526; Chen, Dianyu/0000-0002-4217-2279	National Natural Science Foundation of China [31970842, U20A20346]; National Key R&D Program of China [2020YFA0804200, 2019YFA0802900]; Education Foundation of Westlake University; UPMC ITTC fund; NIH [U01AI141990]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Education Foundation of Westlake University; UPMC ITTC fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Huang for discussions and technical advice; W. Zhu for mouse genotyping; the Laboratory Animal Resources Center, the High-Performance Computing Center, the Flow Cytometry Core and the Genomics Core in Westlake University; and the Division of Laboratory Animal Resources at the University of Pittsburgh. Research was supported by the National Natural Science Foundation of China (grant nos. 31970842 and U20A20346; H.X.), the National Key R&D Program of China (grant nos. 2020YFA0804200 and 2019YFA0802900; H.X.) and the Education Foundation of Westlake University (H.X.). H.S. acknowledges support from the UPMC ITTC fund and NIH grant no. U01AI141990.	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chamoto K, 2017, P NATL ACAD SCI USA, V114, pE761, DOI 10.1073/pnas.1620433114; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Hancock T, 2010, BIOINFORMATICS, V26, P2128, DOI 10.1093/bioinformatics/btq344; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Kennedy DE, 2020, NAT IMMUNOL, V21, P660, DOI 10.1038/s41590-020-0660-2; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; King HW, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe6291; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Raybuck AL, 2018, J IMMUNOL, V200, P2627, DOI 10.4049/jimmunol.1701321; Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; Temate-Tiagueu Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2823-y; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Turchaninova MA, 2016, NAT PROTOC, V11, P1599, DOI 10.1038/nprot.2016.093; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wagner A., 2020, J IMMUNOL, V204, p150.22; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Weiser AA, 2011, INT IMMUNOL, V23, P345, DOI 10.1093/intimm/dxr018; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	45	14	14	4	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					904	+		10.1038/s41590-021-00936-y	http://dx.doi.org/10.1038/s41590-021-00936-y		MAY 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34031613				2022-12-18	WOS:000653628400005
J	Cumpelik, A; Heja, D; Hu, Y; Varano, G; Ordikhani, F; Roberto, MP; He, ZX; Homann, D; Lira, SA; Dominguez-Sola, D; Heeger, PS				Cumpelik, Arun; Heja, David; Hu, Yuan; Varano, Gabriele; Ordikhani, Farideh; Roberto, Mark P.; He, Zhengxiang; Homann, Dirk; Lira, Sergio A.; Dominguez-Sola, David; Heeger, Peter S.			Dynamic regulation of B cell complement signaling is integral to germinal center responses	NATURE IMMUNOLOGY			English	Article							DECAY-ACCELERATING FACTOR; TRANSCRIPTION FACTOR; INTRACELLULAR COMPLEMENT; AFFINITY MATURATION; IMMUNE-RESPONSE; EXPRESSION; SELECTION; RECEPTOR; BCL6; DISRUPTION	Heeger and colleagues report that activated B cells dynamically regulate the expression of complement regulatory proteins via the transcription factor BCL6. C3 convertase activity and C3aR1-C5aR1 signaling were both necessary for optimal B cell activation and germinal center formation. Maturation of B cells within germinal centers (GCs) generates diversified B cell pools and high-affinity B cell antigen receptors (BCRs) for pathogen clearance. Increased receptor affinity is achieved by iterative cycles of T cell-dependent, affinity-based B cell positive selection and clonal expansion by mechanisms hitherto incompletely understood. Here we found that, as part of a physiologic program, GC B cells repressed expression of decay-accelerating factor (DAF/CD55) and other complement C3 convertase regulators via BCL6, but increased the expression of C5b-9 inhibitor CD59. These changes permitted C3 cleavage on GC B cell surfaces without the formation of membrane attack complex and activated C3a- and C5a-receptor signals required for positive selection. Genetic disruption of this pathway in antigen-activated B cells by conditional transgenic DAF overexpression or deletion of C3a and C5a receptors limited the activation of mechanistic target of rapamycin (mTOR) in response to BCR-CD40 signaling, causing premature GC collapse and impaired affinity maturation. These results reveal that coordinated shifts in complement regulation within the GC provide crucial signals underlying GC B cell positive selection.	[Cumpelik, Arun; Heja, David; Hu, Yuan; Ordikhani, Farideh; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Dept Med, Div Renal, New York, NY 10029 USA; [Cumpelik, Arun; Heja, David; Hu, Yuan; Ordikhani, Farideh; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, New York, NY 10029 USA; [Varano, Gabriele; Roberto, Mark P.; Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Ordikhani, Farideh; Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Roberto, Mark P.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [He, Zhengxiang; Homann, Dirk; Lira, Sergio A.; Dominguez-Sola, David; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Heja, David] eGenesis Inc, Cambridge, MA USA; [Varano, Gabriele] Univ Ferrara, Dept Translat Med, Lab Adv Therapy Technol, Ferrara, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Ferrara	Heeger, PS (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Renal, New York, NY 10029 USA.; Heeger, PS (corresponding author), Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Dominguez-Sola, D; Heeger, PS (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.	david.dominguez-sola@mssm.edu; peter.heeger@mssm.edu		He, Zhengxiang/0000-0002-8961-859X; Dominguez-Sola, David/0000-0001-9569-8402; Homann, Dirk/0000-0002-7622-5754				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Biram A, 2019, IMMUNOL REV, V288, P37, DOI 10.1111/imr.12737; Bird L, 2020, NAT REV IMMUNOL, DOI 10.1038/s41577-020-0294-5; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dernstedt A, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599647; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hovingh ES, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02004; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jacobson AC, 2008, J IMMUNOL, V181, P2953, DOI 10.4049/jimmunol.181.5.2953; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kennedy DE, 2020, NAT IMMUNOL, V21, P660, DOI 10.1038/s41590-020-0660-2; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kwan WH, 2012, J CLIN INVEST, V122, P2234, DOI 10.1172/JCI61019; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Llaudo I, 2019, AM J TRANSPLANT, V19, P633, DOI 10.1111/ajt.15072; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Lu YW, 2020, CELL, V180, P1081, DOI 10.1016/j.cell.2020.02.015; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; Pae J, 2021, J EXP MED, V218, DOI 10.1084/jem.20201699; Paiano J, 2019, J IMMUNOL, V203, P379, DOI 10.4049/jimmunol.1900276; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; Sivasankar B, 2007, MOL IMMUNOL, V44, P2978, DOI 10.1016/j.molimm.2006.12.025; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verghese DA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124646; Verghese DA, 2018, J IMMUNOL, V200, P2186, DOI 10.4049/jimmunol.1701638; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wentink MWJ, 2015, CLIN IMMUNOL, V161, P120, DOI 10.1016/j.clim.2015.08.010; West EE, 2018, ADV IMMUNOL, V138, P35, DOI 10.1016/bs.ai.2018.02.001; Wiede F, 2013, IMMUNOL CELL BIOL, V91, P335, DOI 10.1038/icb.2013.14; Wu YL, 2016, J CLIN INVEST, V126, P32, DOI 10.1172/JCI85627; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang M, 2006, J MOL CELL CARDIOL, V41, P62, DOI 10.1016/j.yjmcc.2006.02.006; Zhao RZ, 2020, NATURE, V577, P416, DOI 10.1038/s41586-019-1873-0	74	14	14	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					757	+		10.1038/s41590-021-00926-0	http://dx.doi.org/10.1038/s41590-021-00926-0		MAY 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34031614	Green Accepted			2022-12-18	WOS:000653628400004
J	Nathan, A; Beynor, JI; Baglaenko, Y; Suliman, S; Ishigaki, K; Asgari, S; Huang, CC; Luo, Y; Zhang, ZB; Lopez, K; Arlehamn, CSL; Ernst, JD; Jimenez, J; Calderon, RI; Lecca, L; Van Rhijn, I; Moody, DB; Murray, MB; Raychaudhuri, S				Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Suliman, Sara; Ishigaki, Kazuyoshi; Asgari, Samira; Huang, Chuan-Chin; Luo, Yang; Zhang, Zibiao; Lopez, Kattya; Lindestam Arlehamn, Cecilia S.; Ernst, Joel D.; Jimenez, Judith; Calderon, Roger I.; Lecca, Leonid; Van Rhijn, Ildiko; Moody, D. Branch; Murray, Megan B.; Raychaudhuri, Soumya			Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease	NATURE IMMUNOLOGY			English	Article							HUMAN IMMUNE-SYSTEM; TRANSCRIPTION FACTOR; INVARIANT T; TH17 CELLS; HELPER 17; MYCOBACTERIUM; EXPRESSION; DISTINCT; QUANTIFICATION; RESPONSES	Raychaudhuri and colleagues use high-dimensional single-cell analysis of T cells from a human tuberculosis progression cohort. They identify a T(H)17-like cluster reactive to Mycobacterium tuberculosis peptides that is reduced in people who previously progressed to active disease. Multimodal T cell profiling can enable more precise characterization of elusive cell states underlying disease. Here, we integrated single-cell RNA and surface protein data from 500,089 memory T cells to define 31 cell states from 259 individuals in a Peruvian tuberculosis (TB) progression cohort. At immune steady state >4 years after infection and disease resolution, we found that, after accounting for significant effects of age, sex, season and genetic ancestry on T cell composition, a polyfunctional type 17 helper T (T(H)17) cell-like effector state was reduced in abundance and function in individuals who previously progressed from Mycobacterium tuberculosis (M.tb) infection to active TB disease. These cells are capable of responding to M.tb peptides. Deconvoluting this state-uniquely identifiable with multimodal analysis-from public data demonstrated that its depletion may precede and persist beyond active disease. Our study demonstrates the power of integrative multimodal single-cell profiling to define cell states relevant to disease and other traits.	[Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Ishigaki, Kazuyoshi; Asgari, Samira; Luo, Yang; Raychaudhuri, Soumya] Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA; [Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Suliman, Sara; Ishigaki, Kazuyoshi; Asgari, Samira; Huang, Chuan-Chin; Luo, Yang; Zhang, Zibiao; Lopez, Kattya; Van Rhijn, Ildiko; Moody, D. Branch; Murray, Megan B.; Raychaudhuri, Soumya] Harvard Med Sch, Boston, MA 02115 USA; [Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Suliman, Sara; Ishigaki, Kazuyoshi; Asgari, Samira; Luo, Yang; Lopez, Kattya; Van Rhijn, Ildiko; Moody, D. Branch; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA; [Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Ishigaki, Kazuyoshi; Asgari, Samira; Luo, Yang; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Ishigaki, Kazuyoshi; Asgari, Samira; Luo, Yang; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Nathan, Aparna; Beynor, Jessica I.; Baglaenko, Yuriy; Ishigaki, Kazuyoshi; Asgari, Samira; Luo, Yang; Raychaudhuri, Soumya] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Huang, Chuan-Chin; Zhang, Zibiao; Lecca, Leonid; Murray, Megan B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Huang, Chuan-Chin; Zhang, Zibiao; Murray, Megan B.] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Lopez, Kattya; Jimenez, Judith; Calderon, Roger I.; Lecca, Leonid] Socios Salud Sucursal Peru, Lima, Peru; [Lindestam Arlehamn, Cecilia S.] La Jolla Inst Immunol, Ctr Infect Dis, La Jolla, CA USA; [Ernst, Joel D.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Calderon, Roger I.] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, Brazil; [Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Genet & Genom Versus Arthrit, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; La Jolla Institute for Immunology; University of California System; University of California San Francisco; Universidade Federal do Rio de Janeiro; Utrecht University; University of Manchester	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Genet & Genom Versus Arthrit, Manchester, Lancs, England.	soumya@broadinstitute.org	Ishigaki, Kazuyoshi/ABF-6926-2021	Nathan, Aparna/0000-0002-5975-2851; Asgari, Samira/0000-0002-2347-8985; Beynor, Jessica/0000-0001-9430-0271; Lecca, Leonid/0000-0003-1363-3985; Ishigaki, Kazuyoshi/0000-0003-2881-0657; Calderon, Roger I./0000-0001-8932-0489; Van Rhijn, Ildiko/0000-0002-1446-5701; Baglaenko, Yuriy/0000-0002-9020-6824; Luo, Yang/0000-0001-7385-6166	NHGRI NIH HHS [U01 HG009379, T32 HG002295] Funding Source: Medline; NIAID NIH HHS [R01 AI049313, U19 AI111211, U19 AI111224] Funding Source: Medline; NIAMS NIH HHS [R01 AR063759, UH2 AR067677, T32 AR007530] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; [Anonymous], 2020, MA STAT PUBL HLTH LA; Arlehamn CL, 2014, J IMMUNOL, V193, P2931, DOI 10.4049/jimmunol.1401151; Arlehamn CSL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005760; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Arrigucci R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02127; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Becerra MC, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5894; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Burel JG, 2018, J IMMUNOL, V200, P3283, DOI 10.4049/jimmunol.1800118; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Christophersen A, 2019, NAT MED, V25, P734, DOI 10.1038/s41591-019-0403-9; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Coulter F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01252; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; Day CL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01995; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Hashimoto K, 2019, P NATL ACAD SCI USA, V116, P24242, DOI 10.1073/pnas.1907883116; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002152, 10.1371/journal.pmed.1002119]; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lee JJ, 2017, J IMMUNOL, V199, P467, DOI 10.4049/jimmunol.1601815; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luo Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11664-1; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; McInnes L., 2018, ARXIV PREPRINT ARXIV, DOI DOI 10.21105/JOSS.00861; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Nathan A, 2019, CURR OPIN IMMUNOL, V61, P17, DOI 10.1016/j.coi.2019.07.002; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2012, EUR J IMMUNOL, V42, P2215, DOI 10.1002/eji.201242741; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Scriba TJ, 2017, AM J RESP CRIT CARE, V196, P772, DOI 10.1164/rccm.201706-1208OC; Shanmugasundaram U, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137858; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Suliman S, 2020, J INFECT DIS, V222, P995, DOI 10.1093/infdis/jiaa173; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28586; World Health Organization, 2022, GLOBAL TUBERCULOSIS; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	85	14	14	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					781	+		10.1038/s41590-021-00933-1	http://dx.doi.org/10.1038/s41590-021-00933-1		MAY 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34031617	Green Submitted, Green Accepted			2022-12-18	WOS:000653628400006
J	Wiedemann, GM; Santosa, EK; Grassmann, S; Sheppard, S; Le Luduec, JB; Adams, NM; Dang, C; Hsu, KC; Sun, JC; Lau, CM				Wiedemann, Gabriela M.; Santosa, Endi K.; Grassmann, Simon; Sheppard, Sam; Le Luduec, Jean-Benoit; Adams, Nicholas M.; Dang, Celeste; Hsu, Katharine C.; Sun, Joseph C.; Lau, Colleen M.			Deconvoluting global cytokine signaling networks in natural killer cells	NATURE IMMUNOLOGY			English	Article								Cytokine signaling via signal transducer and activator of transcription (STAT) proteins is crucial for optimal antiviral responses of natural killer (NK) cells. However, the pleiotropic effects of both cytokine and STAT signaling preclude the ability to precisely attribute molecular changes to specific cytokine-STAT modules. Here, we employed a multi-omics approach to deconstruct and rebuild the complex interaction of multiple cytokine signaling pathways in NK cells. Proinflammatory cytokines and homeostatic cytokines formed a cooperative axis to commonly regulate global gene expression and to further repress expression induced by type I interferon signaling. These cytokines mediated distinct modes of epigenetic regulation via STAT proteins, and collective signaling best recapitulated global antiviral responses. The most dynamically responsive genes were conserved across humans and mice, which included a cytokine-STAT-induced cross-regulatory program. Thus, an intricate crosstalk exists between cytokine signaling pathways, which governs NK cell responses. Sun and colleagues provide a new resource, multi-omics analysis of NK cell Jak-STAT signaling in response to the cytokines IL-2, IL-15, IL-12, IL-18 and IFN-alpha, showing synergistic and antagonistic interactions that govern NK cell activity.	[Wiedemann, Gabriela M.; Santosa, Endi K.; Grassmann, Simon; Sheppard, Sam; Le Luduec, Jean-Benoit; Adams, Nicholas M.; Dang, Celeste; Hsu, Katharine C.; Sun, Joseph C.; Lau, Colleen M.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Wiedemann, Gabriela M.] Tech Univ Munich, Dept Internal Med 2, Munich, Germany; [Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Technical University of Munich; Memorial Sloan Kettering Cancer Center; Cornell University	Sun, JC; Lau, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org; lauc2@mskcc.org		Hsu, Katharine/0000-0003-2827-5324; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941; Wiedemann, Gabriela/0000-0001-6138-9791; Grassmann, Simon/0000-0002-8336-3418; Sun, Joseph/0000-0001-8062-9033	National Cancer Institute Cancer Center Support Grant [P30CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Deutsche Forschungsgemeinschaft (DFG Forschungsstipendium) [WI-4927/1-2, GR 5503/1-1]; National Institute of General Medical Sciences [T32GM007739]; National Institute of Allergy and Infectious Diseases [F30 AI136239]; Francois Wallace Monahan Fellowship; National Institutes of Health [AI125651, HL129472, AI069197, AI100874, AI130043, P30CA008748]; Leukemia Lymphoma Society; Ludwig Center for Cancer Immunotherapy; American Cancer Society; Burroughs Wellcome Fund; Cancer Research Institute	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Deutsche Forschungsgemeinschaft (DFG Forschungsstipendium)(German Research Foundation (DFG)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francois Wallace Monahan Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Ludwig Center for Cancer Immunotherapy; American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute	We thank members of the Sun laboratory for comments, discussions, technical support and experimental assistance. We thank V. Pascual (Weill Cornell Medicine) for sharing reagents. We thank L. Lanier (University of California, San Francisco) for providing mice and critical feedback of our manuscript. We acknowledge the use of the Integrated Genomics Operation Core, funded by the National Cancer Institute Cancer Center Support Grant (P30CA08748); Cycle for Survival; and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. G.M.W. and S.G. were supported through research fellowships by the Deutsche Forschungsgemeinschaft (DFG Forschungsstipendium WI-4927/1-2 and GR 5503/1-1). N.M.A. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences (T32GM007739 to the Weill Cornell-Rockefeller-Sloan Kettering Tri-Institutional MD-PhD Program) and by an F30 Predoctoral Fellowship from the National Institute of Allergy and Infectious Diseases (F30 AI136239). J.B.L. was supported by the Francois Wallace Monahan Fellowship. K.C.H. was supported by the National Institutes of Health (AI125651, HL129472 and AI069197) and the Leukemia Lymphoma Society Scholar Award. J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the American Cancer Society, the Burroughs Wellcome Fund and the National Institutes of Health (AI100874, AI130043 and P30CA008748). C.M.L. was supported by the Cancer Research Institute as a Cancer Research Institute-Carson Family Fellow.	Ali AK, 2016, J IMMUNOL, V196, P1753, DOI 10.4049/jimmunol.1501593; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BIRON CA, 1990, J EXP MED, V171, P173, DOI 10.1084/jem.171.1.173; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Geary CD, 2018, CELL REP, V24, P1949, DOI 10.1016/j.celrep.2018.07.060; Gollob JA, 1998, BLOOD, V91, P1341, DOI 10.1182/blood.V91.4.1341; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennessy RJ, 2019, J LEUKOCYTE BIOL, V105, P1341, DOI 10.1002/JLB.MA0718-296R; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee SH, 2010, J IMMUNOL, V185, P917, DOI 10.4049/jimmunol.1000784; Lin JX, 2019, ANNU REV IMMUNOL, V37, P295, DOI 10.1146/annurev-immunol-042718-041447; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MEHROTRA PT, 1993, J IMMUNOL, V151, P2444; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Nabekura T, 2016, J EXP MED, V213, P2745, DOI 10.1084/jem.20160726; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Orange JS, 1996, J IMMUNOL, V156, P4746; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sadelain M, 2016, CURR OPIN IMMUNOL, V41, P68, DOI 10.1016/j.coi.2016.06.004; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Villarino AV, 2017, J EXP MED, V214, P2999, DOI 10.1084/jem.20150907; Wiedemann GM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108498; Wright MW, 2005, MAMM GENOME, V16, P827, DOI 10.1007/s00335-005-0103-2; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	67	14	14	4	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					627	+		10.1038/s41590-021-00909-1	http://dx.doi.org/10.1038/s41590-021-00909-1		APR 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33859404	Green Accepted			2022-12-18	WOS:000640493700004
J	Kato, H; Itoh-Nakadai, A; Matsumoto, M; Ishii, Y; Watanabe-Matsui, M; Ikeda, M; Ebina-Shibuya, R; Sato, Y; Kobayashi, M; Nishizawa, H; Suzuki, K; Muto, A; Fujiwara, T; Nannya, Y; Malcovati, L; Cazzola, M; Ogawa, S; Harigae, H; Igarashi, K				Kato, Hiroki; Itoh-Nakadai, Ari; Matsumoto, Mitsuyo; Ishii, Yusho; Watanabe-Matsui, Miki; Ikeda, Masatoshi; Ebina-Shibuya, Risa; Sato, Yuki; Kobayashi, Masahiro; Nishizawa, Hironari; Suzuki, Katsushi; Muto, Akihiko; Fujiwara, Tohru; Nannya, Yasuhito; Malcovati, Luca; Cazzola, Mario; Ogawa, Seishi; Harigae, Hideo; Igarashi, Kazuhiko			Infection perturbs Bach2-and Bach1-dependent erythroid lineage 'choice' to cause anemia	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; ALVEOLAR MACROPHAGE FUNCTION; TRANSCRIPTION FACTORS; REPRESSOR BACH2; SURFACTANT HOMEOSTASIS; GENE-EXPRESSION; DIFFERENTIATION; HEME; INDUCTION; ERYTHROPOIESIS	Elucidation of how the differentiation of hematopoietic stem and progenitor cells (HSPCs) is reconfigured in response to the environment is critical for understanding the biology and disorder of hematopoiesis. Here we found that the transcription factors (TFs) Bach2 and Bach1 promoted erythropoiesis by regulating heme metabolism in committed erythroid cells to sustain erythroblast maturation and by reinforcing erythroid commitment at the erythro-myeloid bifurcation step. Bach TFs repressed expression of the gene encoding the transcription factor C/EBP beta, as well as that of its target genes encoding molecules important for myelopoiesis and inflammation; they achieved the latter by binding to their regulatory regions also bound by C/EBP beta. Lipopolysaccharide diminished the expression of Bach TFs in progenitor cells and promoted myeloid differentiation. Overexpression of Bach2 in HSPCs promoted erythroid development and inhibited myelopoiesis. Knockdown of BACH1 or BACH2 in human CD34(+) HSPCs impaired erythroid differentiation in vitro. Thus, Bach TFs accelerate erythroid commitment by suppressing the myeloid program at steady state. Anemia of inflammation and myelodysplastic syndrome might involve reduced activity of Bach TFs.	[Kato, Hiroki; Itoh-Nakadai, Ari; Matsumoto, Mitsuyo; Ishii, Yusho; Watanabe-Matsui, Miki; Ikeda, Masatoshi; Ebina-Shibuya, Risa; Sato, Yuki; Nishizawa, Hironari; Suzuki, Katsushi; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi, Japan; [Kato, Hiroki; Ishii, Yusho; Kobayashi, Masahiro; Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Itoh-Nakadai, Ari] Tohoku Univ, Grad Sch Med, Dept Expt Immunol, Sendai, Miyagi, Japan; [Matsumoto, Mitsuyo; Fujiwara, Tohru; Harigae, Hideo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan; [Watanabe-Matsui, Miki] Japan Soc Promot Sci, Tokyo, Japan; [Nannya, Yasuhito; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Malcovati, Luca; Cazzola, Mario] Univ Pavia, Dept Mol Med, Pavia, Italy; [Malcovati, Luca; Cazzola, Mario] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy; [Kato, Hiroki] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Itoh-Nakadai, Ari] RIKEN, Lab Human Dis Models, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ebina-Shibuya, Risa] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ebina-Shibuya, Risa] NHLBI, Ctr Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sato, Yuki] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Society for the Promotion of Science; Kyoto University; University of Pavia; IRCCS Fondazione San Matteo; Harvard University; Massachusetts General Hospital; RIKEN; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Shinshu University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi, Japan.; Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan.	igarashi@med.tohoku.ac.jp	Cazzola, Mario/AAQ-8854-2021; Malcovati, Luca/CAJ-1695-2022; Ogawa, Seishi/AAE-7088-2019; Matsumoto, Mitsuyo/AAC-3065-2019; Nishizawa, Hironari/GQP-8164-2022; Fujiwara, Tohru/GOG-9775-2022	Cazzola, Mario/0000-0001-6984-8817; Malcovati, Luca/0000-0002-1460-1611; Nishizawa, Hironari/0000-0001-7024-9942; Ebina-Shibuya, Risa/0000-0001-9031-5070	Departments of Biochemistry and of Hematology and Rheumatology in Tohoku University Graduate School of Medicine; Japan Society for the Promotion of Science [17H06527, 25860203, 22134006, 26221308, 15H05909, 15H02506, 24390066, 21249014, 18H04021]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [JP16gm0510001]; Takeda Science Foundation; Associazione Italiana per la Ricerca sul Cancro [20125]; Special Program Molecular Clinical Oncology 5 per Mille [1005]; Fondazione Regionale Ricerca Biomedica (FRRB) [2015-0042]	Departments of Biochemistry and of Hematology and Rheumatology in Tohoku University Graduate School of Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology 5 per Mille(Fondazione AIRC per la ricerca sul cancro); Fondazione Regionale Ricerca Biomedica (FRRB)	We thank members of the Departments of Biochemistry and of Hematology and Rheumatology in Tohoku University Graduate School of Medicine for discussions and support; J Sun (Hiroshima University) for initial analysis of DKO mice; the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support; and S Shibahara (Tohoku University School of Medicine) for HO1 cDNA. Supported by Grants-in-Aid from the Japan Society for the Promotion of Science (17H06527 to H.K.; 25860203 to M.W.-M.; 22134006, 26221308 and 15H05909 to S.O.; and 15H02506, 24390066, 21249014 and 18H04021 to K.I.), Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST, JP16gm0510001 to K.I.), research grants from Takeda Science Foundation (S.O.), Associazione Italiana per la Ricerca sul Cancro (Individual Grant 20125 to L.M.; and Special Program Molecular Clinical Oncology 5 per Mille (project 1005) to M.C.), and Fondazione Regionale Ricerca Biomedica (FRRB, project no. 2015-0042 to M.C.).	Abraham NG, 1998, INT J MOL MED, V1, P657; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Aranda-Orgilles B, 2016, CELL STEM CELL, V19, P784, DOI 10.1016/j.stem.2016.08.004; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Ebina-Shibuya R, 2016, J BIOCHEM, V160, P333, DOI 10.1093/jb/mvw041; Feng XM, 2011, HAEMATOL-HEMATOL J, V96, P602, DOI 10.3324/haematol.2010.030536; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Fujiwara T, 2014, J BIOL CHEM, V289, P8121, DOI 10.1074/jbc.M114.548651; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Garcia-Santos D, 2014, BLOOD, V123, P2269, DOI 10.1182/blood-2013-04-496760; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hipp N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01475-7; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Igarashi K, 2016, CURR OPIN IMMUNOL, V39, P136, DOI 10.1016/j.coi.2016.01.012; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Itoh-Nakadai A, 2017, CELL REP, V18, P2401, DOI 10.1016/j.celrep.2017.02.029; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kawamoto H, 2010, INT IMMUNOL, V22, P65, DOI 10.1093/intimm/dxp125; Krzemien J, 2010, INT J DEV BIOL, V54, P1117, DOI 10.1387/ijdb.093053jk; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; McCullough J, 2014, HEMATOL-AM SOC HEMAT, P404, DOI 10.1182/asheducation-2014.1.404; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Mizuta S, 2014, GENES CELLS, V19, P28, DOI 10.1111/gtc.12104; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moudra A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1183860; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ota K, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/757901; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Perkins A, 2016, BLOOD, V127, P1856, DOI 10.1182/blood-2016-01-694331; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shiozawa Y, 2017, BLOOD, V130, P2642, DOI 10.1182/blood-2017-05-783050; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tanaka H, 2016, J BIOL CHEM, V291, P6316, DOI 10.1074/jbc.M116.713842; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Yamaguchi Y, 1998, BLOOD, V91, P450, DOI 10.1182/blood.V91.2.450.450_450_457; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Zaretsky AG, 2014, J IMMUNOL, V192, P27, DOI 10.4049/jimmunol.1302061; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	65	14	15	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1059	+		10.1038/s41590-018-0202-3	http://dx.doi.org/10.1038/s41590-018-0202-3			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30250186				2022-12-18	WOS:000445968600012
J	Grauwet, K; Chiocca, EA				Grauwet, Korneel; Chiocca, E. Antonio			Glioma and microglia, a double entendre	NATURE IMMUNOLOGY			English	Editorial Material								Microglia are important facilitators of glioma proliferation and invasion. An important component of this process seems to be glioma-mediated suppression of microglial activation via S-nitrosylation of microglial caspase-3.	[Grauwet, Korneel; Chiocca, E. Antonio] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chiocca, EA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA.	eachiocca@partners.org						Altieri R, 2015, TRANSL MED UNISA, V12, P54; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Granados-Principal S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0527-x; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Jahani-Asl A, 2013, CURR MOL MED, V13, P1241, DOI 10.2174/1566524011313080002; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Muller A, 2015, INT J CANCER, V137, P278, DOI 10.1002/ijc.29379; Shen XL, 2016, NAT IMMUNOL, V17, P1282, DOI 10.1038/ni.3545; Szabo C, 2016, NAT REV DRUG DISCOV, V15, P185, DOI 10.1038/nrd.2015.1; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Tran A.N., 2016, ANTIOXID REDOX SIGNA; Voisin Pierre, 2010, Front Neuroenergetics, V2, P131, DOI 10.3389/fnene.2010.00131	14	14	14	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1240	1242		10.1038/ni.3586	http://dx.doi.org/10.1038/ni.3586			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27760107				2022-12-18	WOS:000386193200003
J	Schultze, JL				Schultze, Joachim L.			Teaching 'big data' analysis to young immunologists	NATURE IMMUNOLOGY			English	Article							CHALLENGES; IMMUNITY; MODEL	Everyone and everything seems to go 'big data' these days. The task ahead will be to train young immunologists to formulate intelligent hypotheses using big data resources.	Univ Bonn, Dept Genom & Immunoregulat Life & Med Sci LIMES, Bonn, Germany	University of Bonn	Schultze, JL (corresponding author), Univ Bonn, Dept Genom & Immunoregulat Life & Med Sci LIMES, Bonn, Germany.	j.schultze@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011	Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853				[Anonymous], 2008, NAT METHODS, V5, P1, DOI 10.1038/NMETH1153; [Anonymous], 2014, NAT CHEM BIOL, V10, P605; [Anonymous], 2014, NAT METHODS, V11, P1; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gerstein M, 2012, NATURE, V489, P208, DOI 10.1038/489208b; Jaitin DA, 2015, SEMIN IMMUNOL, V27, P67, DOI 10.1016/j.smim.2015.01.002; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Lichtman JW, 2014, NAT NEUROSCI, V17, P1448, DOI 10.1038/nn.3837; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Marx V, 2013, NAT METHODS, V10, P293, DOI 10.1038/nmeth.2410; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Orchard S, 2013, PROTEOMICS, V13, P2931, DOI 10.1002/pmic.201370166; Su LF, 2013, COLD SH Q B, V78, P203, DOI 10.1101/sqb.2013.78.022905; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	21	14	14	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					902	905		10.1038/ni.3250	http://dx.doi.org/10.1038/ni.3250			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287590	hybrid			2022-12-18	WOS:000359876900007
J	Zhu, JF; Shevach, EM				Zhu, Jinfang; Shevach, Ethan M.			TCR signaling fuels T-reg cell suppressor function	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNITY; RESPONSES		[Zhu, Jinfang; Shevach, Ethan M.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov; eshevach@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	Intramural NIH HHS [ZIA AI001169-03, ZIA AI000959-04, ZIA AI000959-08] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, ZIAAI000959] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Churlaud G, 2014, CLIN IMMUNOL, V151, P114, DOI 10.1016/j.clim.2014.02.003; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Younes SA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001171; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	11	14	15	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1002	1003		10.1038/ni.3014	http://dx.doi.org/10.1038/ni.3014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25329180	Green Accepted			2022-12-18	WOS:000343640700003
J	Vivier, E; Ugolini, S; Nunes, JA				Vivier, Eric; Ugolini, Sophie; Nunes, Jacques A.			ADAPted secretion of cytokines in NK cells	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; NF-KAPPA-B; SIGNALING PATHWAYS; MEDIATED CYTOTOXICITY; T-CELLS; PROTEINS; ACTIVATION; CARMA1; KINASE	A signaling module consisting of the adaptor ADAP and the Carma1-Bcl-10-MALT1 (CBM)-TAK1 signalosome has been shown to selectively induce cytokine secretion but not cytotoxicity in natural killer cells.	[Vivier, Eric; Ugolini, Sophie] Ctr Immunol Marseille Luminy, INSERM, U1104, Marseille, France; [Vivier, Eric; Ugolini, Sophie] CNRS, UMR7280, Marseille, France; [Vivier, Eric; Ugolini, Sophie] Aix Marseille Univ, UM2, Marseille, France; [Vivier, Eric] Hop Conception, AP HP, Serv Immunol, Marseille, France; [Nunes, Jacques A.] Ctr Rech Cancerol Marseille, INSERM, U1068, Marseille, France; [Nunes, Jacques A.] CNRS, UMR7258, Marseille, France; [Nunes, Jacques A.] Aix Marseille Univ, UM105, Marseille, France; [Nunes, Jacques A.] Inst J Paoli I Calmettes, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Vivier, E (corresponding author), Ctr Immunol Marseille Luminy, INSERM, U1104, Marseille, France.	vivier@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010; NUNES, Jacques A/F-4952-2013	Vivier, Eric/0000-0001-7022-8287; NUNES, Jacques A/0000-0003-4865-0400; Ugolini, Sophie/0000-0003-4041-0103				Baessler T, 2010, BLOOD, V115, P3058, DOI 10.1182/blood-2009-06-227934; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kohrt HE, 2012, J CLIN INVEST, V122, P1066, DOI 10.1172/JCI61226; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rajasekaran K, 2011, J BIOL CHEM, V286, P31213, DOI 10.1074/jbc.M111.261917; Schmid JP, 2009, EMBO MOL MED, V1, P112, DOI 10.1002/emmm.200900009; Srivastava R, 2012, MOL CELL BIOL, V32, P1908, DOI 10.1128/MCB.06541-11; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	15	14	16	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1108	1110						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145781				2022-12-18	WOS:000326023400004
J	Weiss, A				Weiss, Arthur			The right team at the right time to go for a home run: tyrosine kinase activation by the TCR	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; PHOSPHATIDYL-INOSITOL PATHWAY; T3 SURFACE MOLECULES; SIGNAL-TRANSDUCTION; ZETA-CHAIN; MONOCLONAL-ANTIBODY; COMPLEX; ZAP-70; PHOSPHORYLATION	The TCR signals via cytoplasmic tyrosine kinases. Art Weiss recounts discoveries that led to early understanding of these events.	[Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Dept Med, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Dept Med, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu			National Institutes of Health; Rosalind Russell Medical Research Center for Arthritis; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalind Russell Medical Research Center for Arthritis; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	I thank M. Matloubian, J. Imboden and T. DeFranco for reading this essay and for suggestions; the students, postdoctoral fellows and technicians whom I have worked with over the years (and regret being unable to discuss all their work); M. Mollenauer and T. Kadlecek, who have worked with me for more than two decades and have ensured that the laboratory has been a welcoming, productive and fun place to do research; J. Stobo and F. Fitch for guidance and advice during my training; my colleagues at UCSF who have made this public institution a very special place; and the National Institutes of Health, Rosalind Russell Medical Research Center for Arthritis and the Howard Hughes Medical Institute for support that made this work possible.	ALLISON JP, 1982, J IMMUNOL, V129, P2293; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; MERCEP M, 1988, SCIENCE, V242, P571, DOI 10.1126/science.2845582; MEUER SC, 1983, J EXP MED, V157, P705, DOI 10.1084/jem.157.2.705; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; PETER ME, 1992, EMBO J, V11, P933, DOI 10.1002/j.1460-2075.1992.tb05132.x; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAN L, 1991, J EXP MED, V173, P1247, DOI 10.1084/jem.173.5.1247; VANDENELSEN P, 1984, NATURE, V312, P413, DOI 10.1038/312413a0; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	41	14	14	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					101	104		10.1038/ni0210-101	http://dx.doi.org/10.1038/ni0210-101			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084063				2022-12-18	WOS:000273730200002
J	Martin, AJ; Zhou, L; Miller, SD				Martin, Aaron J.; Zhou, Liang; Miller, Stephen D.			MicroRNA-managing the T-H-17 inflammatory response	NATURE IMMUNOLOGY			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; CELL-DIFFERENTIATION; CNS; AUTOIMMUNITY; ENTRY; EAE	The differentiation of interleukin 17-producing helper T cells is controlled by a complex network of cytokines, signaling pathways and transcription factors. Regulation by microRNA particles can now be added to this list.	[Martin, Aaron J.; Zhou, Liang; Miller, Stephen D.] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhou, Liang] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhou, Liang] Northwestern Univ, Interdepartmental Immunobiol Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Martin, AJ (corresponding author), Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu			NINDS NIH HHS [R01 NS030871-16, R01 NS048411, R01 NS026543-20, R01 NS030871, R01 NS048411-04, R01 NS026543] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543, R01NS030871, R01NS048411] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	13	14	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1229	1231		10.1038/ni1209-1229	http://dx.doi.org/10.1038/ni1209-1229			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19915620	Green Accepted			2022-12-18	WOS:000271872800003
J	Murray, PJ				Murray, Peter J.			Beyond peptidoglycan for Nod2	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME; RESPONSES; INNATE	Nod2 is a cytoplasmic Nod-like receptor protein that detects the peptidoglycan subfragment muramyl dipeptide. New work shows that Nod2 also has an important role in recognizing viruses and in triggering interferon production during viral infection.	[Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802				Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KRIEG A, 2009, P NATL ACAD IN PRESS; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Owen DM, 2009, IMMUNITY, V30, P476, DOI 10.1016/j.immuni.2009.03.011; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747	15	14	15	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1053	1054		10.1038/ni1009-1053	http://dx.doi.org/10.1038/ni1009-1053			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19767725				2022-12-18	WOS:000270006900007
J	Georgopoulos, K				Georgopoulos, Katia			From immunity to tolerance through HDAC	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION; INFLAMMATION		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Georgopoulos, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Biol Res Ctr, Charlestown, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA162092] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA162092] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282	8	14	18	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					13	14		10.1038/ni0109-13	http://dx.doi.org/10.1038/ni0109-13			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088734				2022-12-18	WOS:000261788800005
J	Auffray, C; Emre, Y; Geissmann, F				Auffray, Cedric; Emre, Yalin; Geissmann, Frederic			Homeostasis of dendritic cell pool in lymphoid organs	NATURE IMMUNOLOGY			English	Editorial Material							STIMULATING FACTOR-1 RECEPTOR; BONE-MARROW; MOUSE; OSTEOPETROSIS; MICE	A new study finds that local homeostatic expansion of conventional dendritic cells in the spleen is regulated by Fms-related tyrosine kinase-3 ligand.	[Auffray, Cedric; Emre, Yalin; Geissmann, Frederic] Univ Paris 05, Inst Federatif Rech Necker Enfants Malad, Lab Biol Mononucl Phagocyte Syst, INSERM U838, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Auffray, C (corresponding author), Univ Paris 05, Inst Federatif Rech Necker Enfants Malad, Lab Biol Mononucl Phagocyte Syst, INSERM U838, 156 Rue Vaugirard, F-75015 Paris, France.	geissmann@necker.fr	Emre, Yalin/L-6856-2017; Auffray, Cedric/M-3225-2017	Emre, Yalin/0000-0003-3125-9560; geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; NAILK SH, 2007, NAT IMMUNOL, V8, P1217; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; WIKTORJEDRZEJCZAK W, 1994, ENDOCRINOLOGY, V134, P1932, DOI 10.1210/en.134.4.1932	14	14	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					584	586		10.1038/ni0608-584	http://dx.doi.org/10.1038/ni0608-584			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490906				2022-12-18	WOS:000256067900006
J	Merad, M; Ginhoux, F				Merad, Miriam; Ginhoux, Florent			Dendritic cell genealogy: a new stem or just another branch?	NATURE IMMUNOLOGY			English	Editorial Material							STEADY-STATE; HEMATOPOIETIC PRECURSORS; FLT3 LIGAND; IN-VIVO; MONOCYTES; PROGENITORS; ORIGIN; MICE	Two papers in this issue report the isolation and characterization of a common clonal bone marrow precursor of plasmacytoid and conventional dendritic cells.	Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	miriam.merad@mssm.edu						D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Karsunky H, 2005, EXP HEMATOL, V33, P173, DOI 10.1016/j.exphem.2004.10.010; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; ONAI N, 2007, ANN NY ACAD SCI; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011	16	14	14	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1199	1201		10.1038/ni1107-1199	http://dx.doi.org/10.1038/ni1107-1199			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952047				2022-12-18	WOS:000250338900011
J	Greenspan, NS				Greenspan, Neil S.			Conceptualizing immune responsiveness	NATURE IMMUNOLOGY			English	Editorial Material							RECOGNITION	Communicating about and comprehending immune responses and immunity will be facilitated by greater attention to semantic precision and consistency and increased willingness to engage with the full dimensionality and quantitative nature of immunological phenomena.	Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Greenspan, NS (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	neil.greenspan@case.edu	Greenspan, Neil/AAJ-4795-2020					Alberts B., 2017, MOL BIOL CELL; BEAUCHAMP GK, 1994, IMMUNOGENETICS, V39, P109, DOI 10.1007/BF00188613; Beckner Morton, 1968, BIOL WAY THOUGHT; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; El-Sawy T, 2004, AM J PATHOL, V165, P147, DOI 10.1016/S0002-9440(10)63283-X; GREENSPAN NS, 1992, B I PASTEUR, V90, P267; Greenspan NS, 2001, ADV CANCER RES, V80, P147, DOI 10.1016/S0065-230X(01)80015-4; Greenspan NS, 2002, SCIENTIST, V16, P12; GREENSPAN NS, 2004, HUMANIST MATH NETWOR; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kosko B., 1993, FUZZY THINKING NEW S; Lewontin RC, 2001, SCIENCE, V291, P1263, DOI 10.1126/science.1057124; MAGOR KE, 1992, J IMMUNOL, V149, P2627; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; MAYR E, 1988, NEW PHILOS BIOL OBSE, P196; NARAYSZABO G, 1993, J MOL RECOGNIT, V6, P205, DOI 10.1002/jmr.300060409; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Pace NR, 2006, NATURE, V441, P289, DOI 10.1038/441289a; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI [10.1016/S0065-2601(08)60357-3, DOI 10.1016/S0065-2601(08)60357-3]; Sporn MB, 1997, KIDNEY INT, V51, P1352, DOI 10.1038/ki.1997.184; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003	24	14	15	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					5	7		10.1038/ni0107-5	http://dx.doi.org/10.1038/ni0107-5			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179961				2022-12-18	WOS:000242934400003
J	Fauci, AS				Fauci, AS			The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research	NATURE IMMUNOLOGY			English	Editorial Material							AIDS	The US has entered a new period of fiscal restraint. What does this mean for basic research? Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, discusses the way forward for research scientists in the US.	NIAID, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Atlas RM, 2002, ANNU REV MICROBIOL, V56, P167, DOI 10.1146/annurev.micro.56.012302.160616; *COORD COMM GLOB H, 2005, PLOS MED, V2, P111; Fauci AS, 1996, LANCET, V348, P1002; Fauci AS, 2003, NATURE, V421, P787, DOI 10.1038/nature01480; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Folkers GK, 1998, NAT MED, V4, P491, DOI 10.1038/nm0598supp-491; Folkers GK, 2001, JAMA-J AM MED ASSOC, V286, P458, DOI 10.1001/jama.286.4.458; Malakoff D, 2001, SCIENCE, V292, P1992, DOI 10.1126/science.292.5524.1992; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; *NAT I ALL INF DIS, 2006, FISC YEAR; *NIH, OFF AIDS RES NIH FIS; *NIH OFF SCI POL P, BRDPI OV ANN BUDG; *OFF MAN BUDG, 2003, BUDG US GOV; Rappuoli R, 2004, NAT MED, V10, P1177, DOI 10.1038/nm1129	14	14	14	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					743	747		10.1038/ni0805-743	http://dx.doi.org/10.1038/ni0805-743			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034426	Green Published, Bronze			2022-12-18	WOS:000230646200003
J	Trautmann, A				Trautmann, A			Chemokines as immunotransmitters?	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; DENDRITIC CELLS; ANTIGEN; ACTIVATION; RESPONSES; CALCIUM; TUNE	Chemokines not only act as chemotactic and chemokinetic molecules but also are inducers of integrin-dependent adhesion. Analysis of an immunological synapse now demonstrates an additional function for chemokines as costimulatory molecules.	INSERM, CNRS, Inst Cochin, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Trautmann, A (corresponding author), INSERM, CNRS, Inst Cochin, F-75014 Paris, France.	trautmann@cochin.inserm.fr						Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.0.CO;2-I; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Montes M, 1999, INT IMMUNOL, V11, P561, DOI 10.1093/intimm/11.4.561; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Real E, 2004, J IMMUNOL, V173, P50, DOI 10.4049/jimmunol.173.1.50; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Taub DD, 1996, J IMMUNOL, V156, P2095; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224	12	14	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					427	428		10.1038/ni0505-427	http://dx.doi.org/10.1038/ni0505-427			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843794				2022-12-18	WOS:000228634300003
J	Logue, EC; Sha, WC				Logue, EC; Sha, WC			CD28-B7 bidirectional signaling: a two-way street to activation	NATURE IMMUNOLOGY			English	Editorial Material							TRYPTOPHAN CATABOLISM; CRYSTAL-STRUCTURE; DENDRITIC CELLS; STIMULATION; COMPLEX; B7-2		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Logue, EC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bsha@berkeley.edu						Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Radhakrishnan S, 2003, J IMMUNOL, V170, P1830, DOI 10.4049/jimmunol.170.4.1830; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499	12	14	15	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1103	1105		10.1038/ni1104-1103	http://dx.doi.org/10.1038/ni1104-1103			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496947				2022-12-18	WOS:000224692700005
J	Alon, R; Luscinskas, FW				Alon, R; Luscinskas, FW			Crawling and INTEGRating apical cues	NATURE IMMUNOLOGY			English	Editorial Material							ENDOTHELIUM; MIGRATION; MONOCYTES; VCAM-1; ICAM-1	Leukocytes are arrested on endothelial cells before moving through vessel intercellular junctions. The identification of another beta(2) integrin-dependent step may provide insights into the events and signals required for transmigration.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA	Weizmann Institute of Science; Harvard University; Brigham & Women's Hospital	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronalon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369				Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Gopalan PK, 2000, J LEUKOCYTE BIOL, V68, P47; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; Marschel P, 2002, ANN BIOMED ENG, V30, P333, DOI 10.1114/1.1475342; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Weber C, 1998, J IMMUNOL, V161, P6825; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	12	14	14	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					351	353		10.1038/ni0404-351	http://dx.doi.org/10.1038/ni0404-351			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052260				2022-12-18	WOS:000220515900003
J	Schreiber, RD; Old, LJ; Hayday, AC; Smyth, MJ				Schreiber, RD; Old, LJ; Hayday, AC; Smyth, MJ			A cancer immunosurveillance controversy - Reply	NATURE IMMUNOLOGY			English	Letter							APOPTOSIS-INDUCING LIGAND; TUMOR-DEVELOPMENT; DEFICIENT MICE; GAMMA; SURVEILLANCE; METASTASIS; INITIATION; PERFORIN		Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA; Guys Hosp, Guys Kings & St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 8006, Australia	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Peter Maccallum Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Smyth, Mark J/H-8709-2014; Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Smyth, Mark J/0000-0001-7098-7240; Schreiber, Robert D/0000-0001-6311-0432; HAYDAY, ADRIAN/0000-0002-9495-5793				Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781	9	14	14	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					4	5		10.1038/ni0104-4	http://dx.doi.org/10.1038/ni0104-4			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL					2022-12-18	WOS:000187635800003
J	Schoenberger, SP				Schoenberger, SP			BLT for speed	NATURE IMMUNOLOGY			English	Editorial Material							CELL TRAFFICKING; LEUKOTRIENES; INFLAMMATION; RECEPTOR		La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.							Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970	10	14	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					937	939		10.1038/ni1003-937	http://dx.doi.org/10.1038/ni1003-937			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515122				2022-12-18	WOS:000185590100005
J	Silverstein, AM; Rose, NR				Silverstein, AM; Rose, NR			On the implications of polyclonal B cell activation	NATURE IMMUNOLOGY			English	Letter									Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Silverstein, AM (corresponding author), Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA.			Recher, Mike/0000-0002-9121-6936; Hunziker, Lukas/0000-0003-0081-8518					0	14	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					931	932		10.1038/ni1003-931	http://dx.doi.org/10.1038/ni1003-931			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515119				2022-12-18	WOS:000185590100002
J	Montecino-Rodriguez, E; Dorshkind, K				Montecino-Rodriguez, E; Dorshkind, K			To T or not to T: reassessing the common lymphoid progenitor	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW; STEM-CELLS; IDENTIFICATION; EXPRESSION	Common lymphoid progenitor cells are the earliest lymphoid progenitor cells assumed to give rise to B and T lineages. The identification of a novel early T lineage progenitor now challenges this model.	Univ Calif Los Angeles, Dept Pathol & Lab Med 173216, Jonsson Comprehens Canc Ctr, Ctr Hlth Sci, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Montecino-Rodriguez, E (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med 173216, Jonsson Comprehens Canc Ctr, Ctr Hlth Sci, Los Angeles, CA 90095 USA.			Montecino Rodriguez, Encarnacion/0000-0002-2826-7503				ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; DONSKOY E, 1992, J IMMUNOL, V148, P1604; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Kincade PW, 2002, SEMIN IMMUNOL, V14, P385, DOI 10.1016/S1044532302000738; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Payne KJ, 2002, IMMUNOL REV, V187, P48, DOI 10.1034/j.1600-065X.2002.18705.x; Prohaska SS, 2002, SEMIN IMMUNOL, V14, P377, DOI 10.1016/S1044532302000726; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	12	14	14	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					100	101		10.1038/ni0203-100	http://dx.doi.org/10.1038/ni0203-100			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555090				2022-12-18	WOS:000180686500004
J	Rothenberg, EV				Rothenberg, EV			Notchless T cell maturation?	NATURE IMMUNOLOGY			English	News Item							MYELOID DIFFERENTIATION; SPECIFICATION; PROMOTES; LINEAGES; MICE; FATE; CD4		CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.			Rothenberg, Ellen/0000-0002-3901-347X				Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; BELLAVIA, 2000, EMBO J, V19, P3337; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5; PUL JC, 1999, IMMUNITY, V11, P299; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Tan-Pertel HT, 2000, J IMMUNOL, V165, P4428, DOI 10.4049/jimmunol.165.8.4428; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2000, J IMMUNOL, V165, P5397, DOI 10.4049/jimmunol.165.10.5397; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	19	14	14	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					189	190		10.1038/85231	http://dx.doi.org/10.1038/85231			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224511				2022-12-18	WOS:000167413800005
J	Beutler, B; Poltorak, A				Beutler, B; Poltorak, A			Toll we meet again ...	NATURE IMMUNOLOGY			English	News Item							DROSOPHILA TOLL; GENE; TLR4		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Du X, 2000, EUR CYTOKINE NETW, V11, P362; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kuhns DB, 1997, J IMMUNOL, V158, P3959; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168	16	14	14	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					9	10		10.1038/83222	http://dx.doi.org/10.1038/83222			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135568				2022-12-18	WOS:000166261500005
J	Lustig, Y; Gonen, T; Meltzer, L; Gilboa, M; Indenbaum, V; Cohen, C; Amit, S; Jaber, H; Doolman, R; Asraf, K; Rubin, C; Fluss, R; Mendelson, E; Freedman, L; Regev-Yochay, G; Kreiss, Y				Lustig, Yaniv; Gonen, Tal; Meltzer, Lilac; Gilboa, Mayan; Indenbaum, Victoria; Cohen, Carmit; Amit, Sharon; Jaber, Hanaa; Doolman, Ram; Asraf, Keren; Rubin, Carmit; Fluss, Ronen; Mendelson, Ella; Freedman, Laurence; Regev-Yochay, Gili; Kreiss, Yitshak			Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose	NATURE IMMUNOLOGY			English	Article								As the effectiveness of a two-dose messenger RNA (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine regimen decreases with time, a third dose has been recommended. Here, we assessed immunogenicity, vaccine effectiveness and safety of the third BNT162b2 vaccine dose in a prospective cohort study of 12,413 healthcare workers (HCWs). Anti-RBD immunoglobulin G (IgG) levels were increased 1.7-fold after a third dose compared with following the second dose. Increased avidity from 61.1% (95% confidence interval (CI), 56.1-66.7) to 96.3% (95% CI, 94.2-98.5) resulted in a 6.1-fold increase in neutralization titer. Peri-infection humoral markers of 13 third-dose Delta variant of concern (VOC) breakthrough cases were lower compared with 52 matched controls. Vaccine effectiveness of the third dose relative to two doses was 85.6% (95% CI, 79.2-90.1). No serious adverse effects were reported. These results suggest that the third dose is superior to the second dose in both quantity and quality of IgG antibodies and safely boosts protection from infection. Around the world, governments are urging populations to receive a third COVID-19 vaccine dose. Here, the authors compare immunogenicity, reactogenicity and effectiveness of a third dose versus the second dose of the BNT162b2 vaccine in a large group of healthcare workers in Israel.	[Lustig, Yaniv; Indenbaum, Victoria; Mendelson, Ella] Minist Hlth, Publ Hlth Serv, Cent Virol Lab, Sheba Med Ctr, Tel Hashomer, Israel; [Lustig, Yaniv; Gonen, Tal; Meltzer, Lilac; Gilboa, Mayan; Mendelson, Ella; Regev-Yochay, Gili; Kreiss, Yitshak] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Lustig, Yaniv] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gonen, Tal; Meltzer, Lilac; Gilboa, Mayan; Cohen, Carmit; Jaber, Hanaa; Rubin, Carmit; Regev-Yochay, Gili] Sheba Med Ctr, Infect Prevent & Control Unit, Tel Hashomer, Israel; [Amit, Sharon] Sheba Med Ctr, Clin Microbiol, Tel Hashomer, Israel; [Doolman, Ram; Asraf, Keren] Sheba Med Ctr, Lab Div, Automated Megalab, Tel Hashomer, Israel; [Fluss, Ronen; Freedman, Laurence] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Biostat & Biomath Unit, Tel Hashomer, Israel; [Kreiss, Yitshak] Sheba Med Ctr, Sheba Med Ctr Management, Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Regev-Yochay, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Regev-Yochay, G (corresponding author), Sheba Med Ctr, Infect Prevent & Control Unit, Tel Hashomer, Israel.	gili.regev@sheba.health.gov.il			SMC; Nehemia Rubin Excellence in Biomedical Research; TELEM Program of Chaim, SMC	SMC; Nehemia Rubin Excellence in Biomedical Research; TELEM Program of Chaim, SMC	This study was funded by internal funds of the SMC. Y.L. is a recipient of the Nehemia Rubin Excellence in Biomedical Research, the TELEM Program of Chaim, SMC. We greatly acknowledge T. Levin, R. Koren, S. Kats-Likvornik, O. Halpern, Y. Kanaaneh, S. Abosiam, A. Aydenzon and M. Chiara Atias-Golbus for their devoted work in the laboratory; the Infection, Prevention and Control team for the extensive epidemiologic investigation; and Y. Beker-Ilani, E. Rozner and E. Steinberger for coordinating the study.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Arbel R, 2021, NEW ENGL J MED, V385, P2413, DOI 10.1056/NEJMoa2115624; Bar-On YM, 2021, NEW ENGL J MED, V385, P2421, DOI 10.1056/NEJMoa2115926; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Bernal J.L., 2021, EARLY EFFECTIVENESS, DOI [DOI 10.1101/2021.03.01.21252652, DOI 10.1016/j.autrev.2020.102524]; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Gilboa M, 2022, J INFECT DIS, V225, P785, DOI 10.1093/infdis/jiab584; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hause AM, 2021, MMWR-MORBID MORTAL W, V70, P1379, DOI 10.15585/mmwr.mm7039e4; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Lustig Y, 2021, LANCET RESP MED, V9, P999, DOI 10.1016/S2213-2600(21)00220-4; Menni C, 2021, LANCET INFECT DIS, V21, P939, DOI 10.1016/S1473-3099(21)00224-3; Pilishvili T, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2106599; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Saciuk Y, 2022, J INFECT DIS, V225, P30, DOI 10.1093/infdis/jiab556; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8	22	13	13	3	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					940	+		10.1038/s41590-022-01212-3	http://dx.doi.org/10.1038/s41590-022-01212-3		MAY 2022	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35534723	Bronze			2022-12-18	WOS:000792578900002
J	Dussupt, V; Sankhala, RS; Mendez-Rivera, L; Townsley, SM; Schmidt, F; Wieczorek, L; Lal, KG; Donofrio, GC; Tran, U; Jackson, ND; Zaky, WI; Zemil, M; Tritsch, SR; Chen, WH; Martinez, EJ; Ahmed, A; Choe, M; Chang, L; Hajduczki, A; Jian, NB; Peterson, CE; Rees, PA; Rutkowska, M; Slike, BM; Selverian, CN; Swafford, I; Teng, T; Thomas, PV; Zhou, TQ; Smith, CJ; Currier, JR; Kwong, PD; Rolland, M; Davidson, E; Doranz, BJ; Mores, CN; Hatziioannou, T; Reiley, WW; Bieniasz, PD; Paquin-Proulx, D; Gromowski, GD; Polonis, VR; Michael, NL; Modjarrad, K; Joyce, MG; Krebs, SJ				Dussupt, Vincent; Sankhala, Rajeshwer S.; Mendez-Rivera, Letzibeth; Townsley, Samantha M.; Schmidt, Fabian; Wieczorek, Lindsay; Lal, Kerri G.; Donofrio, Gina C.; Tran, Ursula; Jackson, Nathaniel D.; Zaky, Weam, I; Zemil, Michelle; Tritsch, Sarah R.; Chen, Wei-Hung; Martinez, Elizabeth J.; Ahmed, Aslaa; Choe, Misook; Chang, William C.; Hajduczki, Agnes; Jian, Ningbo; Peterson, Caroline E.; Rees, Phyllis A.; Rutkowska, Magdalena; Slike, Bonnie M.; Selverian, Christopher N.; Swafford, Isabella; Teng, I-Ting; Thomas, Paul, V; Zhou, Tongqing; Smith, Clayton J.; Currier, Jeffrey R.; Kwong, Peter D.; Rolland, Morgane; Davidson, Edgar; Doranz, Benjamin J.; Mores, Christopher N.; Hatziioannou, Theodora; Reiley, William W.; Bieniasz, Paul D.; Paquin-Proulx, Dominic; Gromowski, Gregory D.; Polonis, Victoria R.; Michael, Nelson L.; Modjarrad, Kayvon; Joyce, M. Gordon; Krebs, Shelly J.			Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations	NATURE IMMUNOLOGY			English	Article							HIGH-THROUGHPUT; X-RAY; CORONAVIRUS	Prevention of viral escape and increased coverage against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern require therapeutic monoclonal antibodies (mAbs) targeting multiple sites of vulnerability on the coronavirus spike glycoprotein. Here we identify several potent neutralizing antibodies directed against either the N-terminal domain (NTD) or the receptor-binding domain (RBD) of the spike protein. Administered in combinations, these mAbs provided low-dose protection against SARS-CoV-2 infection in the K18-human angiotensin-converting enzyme 2 mouse model, using both neutralization and Fc effector antibody functions. The RBD mAb WRAIR-2125, which targets residue F486 through a unique heavy-chain and light-chain pairing, demonstrated potent neutralizing activity against all major SARS-CoV-2 variants of concern. In combination with NTD and other RBD mAbs, WRAIR-2125 also prevented viral escape. These data demonstrate that NTD/RBD mAb combinations confer potent protection, likely leveraging complementary mechanisms of viral inactivation and clearance. Krebs and colleagues identify multiple mAbs that recognize either the RBD or the NTD of SARS-CoV-2 spike protein that have potent cross-neutralizing activities against variants of concern. Combinatorial mAb cocktails have complementary effects on viral neutralization and Fc effector functions and can protect against SARS-CoV-2 escape mutants.	[Dussupt, Vincent; Sankhala, Rajeshwer S.; Lal, Kerri G.; Jackson, Nathaniel D.; Chen, Wei-Hung; Martinez, Elizabeth J.; Choe, Misook; Chang, William C.; Hajduczki, Agnes; Peterson, Caroline E.; Rees, Phyllis A.; Thomas, Paul, V; Modjarrad, Kayvon; Joyce, M. Gordon; Krebs, Shelly J.] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Silver Spring, MD 20910 USA; [Dussupt, Vincent; Mendez-Rivera, Letzibeth; Townsley, Samantha M.; Wieczorek, Lindsay; Lal, Kerri G.; Donofrio, Gina C.; Tran, Ursula; Jackson, Nathaniel D.; Zaky, Weam, I; Zemil, Michelle; Jian, Ningbo; Slike, Bonnie M.; Swafford, Isabella; Rolland, Morgane; Paquin-Proulx, Dominic; Polonis, Victoria R.; Krebs, Shelly J.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Dussupt, Vincent; Sankhala, Rajeshwer S.; Mendez-Rivera, Letzibeth; Townsley, Samantha M.; Wieczorek, Lindsay; Lal, Kerri G.; Donofrio, Gina C.; Tran, Ursula; Jackson, Nathaniel D.; Zaky, Weam, I; Zemil, Michelle; Chen, Wei-Hung; Martinez, Elizabeth J.; Choe, Misook; Chang, William C.; Hajduczki, Agnes; Jian, Ningbo; Peterson, Caroline E.; Rees, Phyllis A.; Slike, Bonnie M.; Swafford, Isabella; Thomas, Paul, V; Rolland, Morgane; Paquin-Proulx, Dominic; Joyce, M. Gordon; Krebs, Shelly J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Schmidt, Fabian; Rutkowska, Magdalena; Hatziioannou, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, 1230 York Ave, New York, NY 10021 USA; [Tritsch, Sarah R.; Mores, Christopher N.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA; [Ahmed, Aslaa; Currier, Jeffrey R.; Gromowski, Gregory D.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Selverian, Christopher N.; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol, Philadelphia, PA USA; [Teng, I-Ting; Zhou, Tongqing; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Smith, Clayton J.] NCI, NIH, Bethesda, MD 20892 USA; [Reiley, William W.] Trudeau Inst, Saranac Lake, NY USA; [Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Rockefeller University; George Washington University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Trudeau Institute; Howard Hughes Medical Institute; Rockefeller University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Joyce, MG; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, Emerging Infect Dis Branch, Silver Spring, MD 20910 USA.; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Joyce, MG; Krebs, SJ (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	gjoyce@eidresearch.org; skrebs@hivresearch.org	Paquin-Proulx, Dominic/AFS-1852-2022	Paquin-Proulx, Dominic/0000-0003-1407-3414; Tran, Ursula/0000-0003-2891-2821; Jackson, Nathaniel/0000-0002-9654-6926; Selverian, Christopher/0000-0002-1047-4336; Swafford, Isabella/0000-0001-8638-2772; Dussupt, Vincent/0000-0002-8579-6356	US Department of Defense, Defense Health Agency through the CARES Act; Intramural Research Program of the Vaccine Research Center, NIAID; NIH; NIH [R01AI50111, R01AI78788, HHSN 75N93019C00073]; NIH NIGMS [P30 GM124165]; NIH-ORIP HEI grant [S10OD021527]; Advanced Photon Source, a US Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; National Cancer Institute Cryo-EM Facility at FNLCR [HSSN261200800001E]; Medical Research and Development Command of the Army Futures Command in the US Department of the Army [W81XWH-18-2-0040]; HJF [W81XWH-18-2-0040]	US Department of Defense, Defense Health Agency through the CARES Act(United States Department of Defense); Intramural Research Program of the Vaccine Research Center, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI grant; Advanced Photon Source, a US Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); National Cancer Institute Cryo-EM Facility at FNLCR; Medical Research and Development Command of the Army Futures Command in the US Department of the Army; HJF	We thank S. Vasan, P. Scott, S. Daye, J. Headley, and M. Amare for programmatic, administrative and regulatory support and planning within the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) and WRAIR. We sincerely thank the participants and staff of protocols EID029 and RV229H. The coding sequence for the SARS-CoV-2 stabilized trimer (S-2P) was a generous gift from J. McLellan, University of Texas at Austin. We also thank M. Creegan, and the MHRP FlowCore facility for help with FACS sorting, and E. Kavusak, S. Molnar, J. Heller, C. Kuklis, S. Soman, C. Kannadka, T. Lang, D. Duso, L. Kummer, S. Muncil, K. Lanzer, T. Cookenham, F. Szaba, M. Rao, D. Bolton and J. K. Williams for technical support within HJF/WRAIR. This work was primarily funded by the US Department of Defense, Defense Health Agency, through the CARES Act. Funding was executed through a cooperative agreement (W81XWH-18-2-0040) between the Medical Research and Development Command of the Army Futures Command in the US Department of the Army and the HJF. Additional support was provided by the Intramural Research Program of the Vaccine Research Center, NIAID and the NIH and by NIH grants R01AI50111 (to P.D.B.) and R01AI78788 (to T.H.) as well as NIH contract HHSN 75N93019C00073 (to B.J.D). The X-ray crystallographic work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, funded by the NIH NIGMS (P30 GM124165). The Eiger 16M detector on 24-ID-E is funded by an NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a US Department of Energy Office of Science User Facility under contract no. DE-AC02-06CH11357. EM data were collected at the Cryo-EM Facility of the National Cancer Institute. This research was supported by the National Cancer Institute Cryo-EM Facility at FNLCR under contract HSSN261200800001E (to C.J.S.). Material has been reviewed by the WRAIR. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense.	Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Andreano E, 2021, CELL, V184, P1821, DOI 10.1016/j.cell.2021.02.035; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; CERUTTI G, 2021, BIORXIV; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Dong Jinhui, 2021, bioRxiv, DOI 10.1101/2021.01.27.428529; Dussupt V, 2020, NAT MED, V26, P228, DOI 10.1038/s41591-019-0746-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Gorman MJ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100405; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsieh Ching-Lin, 2020, Science, V369, P1501, DOI [10.1101/2020.05.30.125484, 10.1126/science.abd0826]; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Joyce, CRYPTIC SITE VULNERA, DOI 10.1101/2020.03.15.992883(2020; Joyce, EFFICACY BROADLY NEU, DOI 10.1101/2021.03.24.436523(2021; Joyce, SARS COV 2 FERRITIN, DOI 10.1101/2021.05.09.443331(2021; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Liu HJ, 2021, CELL HOST MICROBE, V29, P806, DOI 10.1016/j.chom.2021.04.005; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Martinez DR, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109450; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; O'Brien Meagan P, 2021, medRxiv, DOI 10.1101/2021.06.14.21258567; Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Sholukh AM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00527-21; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun Y, 2021, CELL RES, V31, P597, DOI 10.1038/s41422-021-00497-7; Suryadevara Naveenchandra, 2021, bioRxiv, DOI [10.1016/j.cell.2021.03.029, 10.1101/2021.01.19.427324]; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Ullah Irfan, 2021, bioRxiv, DOI 10.1101/2021.03.22.436337; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Yan RH, 2021, CELL RES, V31, P517, DOI 10.1038/s41422-021-00487-9; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhou HX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10897-4; Zhou TQ, 2020, CELL REP, V33, DOI [10.1101/2020.06.22.166033, 10.1016/j.celrep.2020.108322]; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	67	13	14	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1503	+		10.1038/s41590-021-01068-z	http://dx.doi.org/10.1038/s41590-021-01068-z		OCT 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34716452	Green Published, hybrid			2022-12-18	WOS:000712793700001
J	Lee, H; Jeong, S; Shin, EC				Lee, Hoyoung; Jeong, Seongju; Shin, Eui-Cheol			Significance of bystander T cell activation in microbial infection	NATURE IMMUNOLOGY			English	Review							MEMORY CD8(+) T; IFN-GAMMA; INNATE-LIKE; INFLUENZA INFECTION; CYTOTOXIC FUNCTION; COGNATE ANTIGEN; GENE-EXPRESSION; CUTTING EDGE; IN-VIVO; VIRUS	During microbial infection, pre-existing memory CD8(+) T cells that are not specific for the infecting pathogens can be activated by cytokines without cognate antigens, termed bystander activation. Studies in mouse models and human patients demonstrate bystander activation of memory CD8(+) T cells, which exerts either protective or detrimental effects on the host, depending on the infection model or disease. Research has elucidated mechanisms underlying the bystander activation of CD8(+) T cells in terms of the responsible cytokines and the effector mechanisms of bystander-activated CD8(+) T cells. In this Review, we describe the history of research on bystander CD8(+) T cell activation as well as evidence of bystander activation. We also discuss the mechanisms and immunopathological roles of bystander activation in various microbial infections. T cell receptor-independent triggering of T cells is known as bystander activation. Shin and colleagues review the mechanisms and significance of bystander activation to homeostatic antimicrobial responses and immunopathology.	[Lee, Hoyoung; Jeong, Seongju; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Ctr Epidem Preparedness, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Shin, EC (corresponding author), Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea.; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Ctr Epidem Preparedness, Daejeon, South Korea.	ecshin@kaist.ac.kr		Jeong, Seongju/0000-0001-5866-7260; Lee, Hoyoung/0000-0003-1266-7147				Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Alanio C, 2015, ELIFE, V4, DOI 10.7554/eLife.07916; Balin SJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7668; Bastidas S, 2014, J IMMUNOL, V192, P1732, DOI 10.4049/jimmunol.1302027; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Belkaya S, 2019, J EXP MED, V216, P1777, DOI 10.1084/jem.20190669; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Chakir H, 2003, EUR J IMMUNOL, V33, P1788, DOI 10.1002/eji.200323398; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Chiu WK, 2006, J IMMUNOL, V177, P7802, DOI 10.4049/jimmunol.177.11.7802; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Correia MP, 2009, J IMMUNOL, V182, P6149, DOI 10.4049/jimmunol.0802470; Crosby EJ, 2015, J IMMUNOL, V195, P3301, DOI 10.4049/jimmunol.1500855; Crosby EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003970; Danahy DB, 2020, J IMMUNOL, V204, P1431, DOI 10.4049/jimmunol.1901172; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Erkes DA, 2017, J IMMUNOL, V198, P2979, DOI 10.4049/jimmunol.1601064; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Gangappa S, 2000, INVEST OPHTH VIS SCI, V41, P453; Gangappa S, 1999, EUR J IMMUNOL, V29, P3674, DOI 10.1002/(SICI)1521-4141(199911)29:11<3674::AID-IMMU3674>3.0.CO;2-7; Ge CH, 2019, CELL REP, V29, P4236, DOI 10.1016/j.celrep.2019.11.103; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Griffiths SJ, 2013, J IMMUNOL, V190, P5363, DOI 10.4049/jimmunol.1203267; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Herndler-Brandstetter D, 2011, HUM IMMUNOL, V72, P627, DOI 10.1016/j.humimm.2011.03.028; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hunter CA, 1997, EUR J IMMUNOL, V27, P2787, DOI 10.1002/eji.1830271107; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Jacomet F, 2015, EUR J IMMUNOL, V45, P1926, DOI 10.1002/eji.201545539; Jo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004210; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025; Kim Tae-Shin, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0316-1; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Lee HG, 2020, EXP MOL MED, V52, P1255, DOI 10.1038/s12276-020-00486-7; Lee HG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08482-w; Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110; Lee YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176484; Legoux F, 2017, ANNU REV CELL DEV BI, V33, P511, DOI 10.1146/annurev-cellbio-100616-060725; Lemon SM, 2018, J HEPATOL, V68, P167, DOI 10.1016/j.jhep.2017.08.034; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Lin JS, 2019, MUCOSAL IMMUNOL, V12, P258, DOI 10.1038/s41385-018-0100-x; Lindgren T, 2011, J VIROL, V85, P10252, DOI 10.1128/JVI.05548-11; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Low JS, 2020, J EXP MED, V217, DOI 10.1084/jem.20192291; Lu J, 2002, CLIN CANCER RES, V8, P3877; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Mao YM, 2016, BLOOD, V128, P1475, DOI 10.1182/blood-2016-02-698027; Martin MD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18022; Maurice NJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12980-2; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mittelbrunn M, 2021, NAT IMMUNOL, V22, P687, DOI 10.1038/s41590-021-00927-z; Morris SR, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132963; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Newman JH, 2020, P NATL ACAD SCI USA, V117, P1119, DOI 10.1073/pnas.1904022116; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nolz JC, 2014, J CLIN INVEST, V124, P1013, DOI 10.1172/JCI72039; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ostler T, 2003, EUR J IMMUNOL, V33, P1839, DOI 10.1002/eji.200323460; Paquin-Proulx D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006154; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Polley R, 2005, EUR J IMMUNOL, V35, P498, DOI 10.1002/eji.200425436; Port JR, 2020, J VIROL, V94, DOI 10.1128/JVI.01367-20; Quinn KM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16633-7; Quinn KM, 2016, P NATL ACAD SCI USA, V113, P1333, DOI 10.1073/pnas.1525167113; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Rehermann B, 2005, J EXP MED, V201, P667, DOI 10.1084/jem.20050220; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Rha MS, 2020, J HEPATOL, V73, P640, DOI 10.1016/j.jhep.2020.03.033; Richer MJ, 2015, J CLIN INVEST, V125, P3477, DOI 10.1172/JCI81261; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Rolot M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06978-5; Rosato PC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08534-1; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Salerno F, 2016, J IMMUNOL, V196, P3695, DOI 10.4049/jimmunol.1501997; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Sckisel GD, 2014, CLIN EXP IMMUNOL, V175, P79, DOI 10.1111/cei.12186; Seo IH, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109438; Setoguchi R, 2016, INT IMMUNOL, V28, P293, DOI 10.1093/intimm/dxw004; Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Sowell RT, 2017, J IMMUNOL, V199, P2536, DOI 10.4049/jimmunol.1501638; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tietze JK, 2012, BLOOD, V119, P3073, DOI 10.1182/blood-2011-07-369736; Tomura M, 1998, J IMMUNOL, V160, P4738; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Weng NP, 2002, ANN NY ACAD SCI, V975, P46, DOI 10.1111/j.1749-6632.2002.tb05940.x; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291; Whiteside SK, 2018, TRENDS IMMUNOL, V39, P1021, DOI 10.1016/j.it.2018.10.003; Whiteside SK, 2018, J IMMUNOL, V200, P1457, DOI 10.4049/jimmunol.1701248; Wong HC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26442; Younes SA, 2016, J CLIN INVEST, V126, P2745, DOI 10.1172/JCI85996; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906	136	13	13	1	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					13	22		10.1038/s41590-021-00985-3	http://dx.doi.org/10.1038/s41590-021-00985-3		AUG 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34354279				2022-12-18	WOS:000681536100002
J	Yamashita, M; Kuehn, HS; Okuyama, K; Okada, S; Inoue, Y; Mitsuiki, N; Imai, K; Takagi, M; Kanegane, H; Takeuchi, M; Shimojo, N; Tsumura, M; Padhi, AK; Zhang, KYJ; Boisson, B; Casanova, JL; Ohara, O; Rosenzweig, SD; Taniuchi, I; Morio, T				Yamashita, Motoi; Kuehn, Hye Sun; Okuyama, Kazuki; Okada, Satoshi; Inoue, Yuzaburo; Mitsuiki, Noriko; Imai, Kohsuke; Takagi, Masatoshi; Kanegane, Hirokazu; Takeuchi, Masahiro; Shimojo, Naoki; Tsumura, Miyuki; Padhi, Aditya K.; Zhang, Kam Y. J.; Boisson, Bertrand; Casanova, Jean-Laurent; Ohara, Osamu; Rosenzweig, Sergio D.; Taniuchi, Ichiro; Morio, Tomohiro			A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; MOLECULAR-DYNAMICS; STAT1 MUTATIONS; GENE; IKZF1; IMMUNODEFICIENCY; MATURATION; PACKAGE; SYSTEM; ALLELE	The zinc-finger transcription factor IKAROS is essential for B cell development. Taniuchi, Morio and colleagues identify a human kindred presenting with B cell immunodeficiency that was caused by a heterozygous missense mutation in IKZF3 encoding the related AIOLOS protein. AIOLOS(G159R) is a mutant protein that interferes with both wild-type AIOLOS and IKAROS by forming heterodimers that bind to aberrant DNA-binding sites and prevent normal expression of IKAROS-dependent genes. In the present study, we report a human-inherited, impaired, adaptive immunity disorder, which predominantly manifested as a B cell differentiation defect, caused by a heterozygous IKZF3 missense variant, resulting in a glycine-to-arginine replacement within the DNA-binding domain of the encoded AIOLOS protein. Using mice that bear the corresponding variant and recapitulate the B and T cell phenotypes, we show that the mutant AIOLOS homodimers and AIOLOS-IKAROS heterodimers did not bind the canonical AIOLOS-IKAROS DNA sequence. In addition, homodimers and heterodimers containing one mutant AIOLOS bound to genomic regions lacking both canonical motifs. However, the removal of the dimerization capacity from mutant AIOLOS restored B cell development. Hence, the adaptive immunity defect is caused by the AIOLOS variant hijacking IKAROS function. Heterodimeric interference is a new mechanism of autosomal dominance that causes inborn errors of immunity by impairing protein function via the mutation of its heterodimeric partner.	[Yamashita, Motoi; Mitsuiki, Noriko; Imai, Kohsuke; Takagi, Masatoshi; Kanegane, Hirokazu; Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan; [Yamashita, Motoi; Okuyama, Kazuki; Taniuchi, Ichiro] RIKEN Ctr Integrat Med Sci, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Kuehn, Hye Sun; Rosenzweig, Sergio D.] NIH, Immunol Serv, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Okada, Satoshi; Tsumura, Miyuki] Hiroshima Univ, Dept Pediat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Inoue, Yuzaburo; Shimojo, Naoki] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Inoue, Yuzaburo] Chiba Childrens Hosp, Dept Allergy & Rheumatol, Chiba, Japan; [Imai, Kohsuke] Tokyo Med & Dent Univ, Dept Community Pediat Perinatal & Maternal Med, Tokyo, Japan; [Kanegane, Hirokazu] Tokyo Med & Dent Univ, Dept Child Hlth & Dev, Tokyo, Japan; [Takeuchi, Masahiro] Chiba Univ Hosp, Dept Hematol, Chiba, Japan; [Takeuchi, Masahiro] Chiba Canc Ctr, Dept Hematol & Med Oncol, Chiba, Japan; [Shimojo, Naoki] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Padhi, Aditya K.; Zhang, Kam Y. J.] RIKEN Ctr Biosyst Dynam Res, Lab Struct Bioinformat, Yokohama, Kanagawa, Japan; [Boisson, Bertrand; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Boisson, Bertrand; Casanova, Jean-Laurent] Necker Hosp Sick Children, Lab Human Genet Infect Dis, Necker Branch, INSERM U1163,Imagine Inst, Paris, France; [Boisson, Bertrand; Casanova, Jean-Laurent] Univ Paris, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Appl Genom, Chiba, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; National Institutes of Health (NIH) - USA; Hiroshima University; Chiba University; Chiba Children's Hospital; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Chiba University; Chiba Cancer Center; Chiba University; RIKEN; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Kazusa DNA Research Institute	Morio, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan.; Taniuchi, I (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Transcript Regulat, Yokohama, Kanagawa, Japan.	ichiro.taniuchi@riken.jp; tmorio.ped@tmd.ac.jp	Inoue, Yuzaburo/E-3262-2019; Padhi, Aditya Kumar/AAU-7373-2021; Boisson, Bertrand/I-2485-2017; Ohara, Osamu/G-5448-2015; Yamashita, Motoi/ABB-5789-2021; Okada, Satoshi/B-8901-2011; Boisson, Bertrand/AAC-6058-2019; Imai, Kohsuke/Q-2602-2015	Inoue, Yuzaburo/0000-0001-5904-687X; Boisson, Bertrand/0000-0001-5240-3555; Ohara, Osamu/0000-0002-3328-9571; Okada, Satoshi/0000-0002-4622-5657; Boisson, Bertrand/0000-0001-5240-3555; Imai, Kohsuke/0000-0003-2132-8403; Okuyama, Kazuki/0000-0002-0262-9326; Padhi, Aditya Kumar/0000-0001-6732-2547; Yamashita, Motoi/0000-0002-9814-1033; Takagi, Masatoshi/0000-0002-7580-9184	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [P01 AI061093] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogaert DJ, 2018, J ALLERGY CLIN IMMUN, V141, P432, DOI 10.1016/j.jaci.2017.08.019; Boutboul D, 2018, J CLIN INVEST, V128, P3071, DOI 10.1172/JCI98164; Case D.A., 2014, AMBER 14; Churchman ML, 2018, CANCER CELL, V33, P937, DOI 10.1016/j.ccell.2018.03.021; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Bruin LMO, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00250; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eskandarian Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00568; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoshino A, 2017, J ALLERGY CLIN IMMUN, V140, P223, DOI 10.1016/j.jaci.2016.09.029; Hu YG, 2016, GENE DEV, V30, P1971, DOI 10.1101/gad.283762.116; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Kuehn HS, 2021, BLOOD, V137, P349, DOI 10.1182/blood.2020007292; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Patel A, 2017, J BIOL CHEM, V292, P15994, DOI 10.1074/jbc.M117.805754; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; Punwani D, 2016, NEW ENGL J MED, V375, P2165, DOI 10.1056/NEJMoa1509164; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stark R., 2011, R PACKAGE VERSION; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Van Nieuwenhove E, 2018, J ALLERGY CLIN IMMUN, V142, P699, DOI 10.1016/j.jaci.2018.04.008; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Yoshida N, 2017, LEUKEMIA, V31, P1221, DOI 10.1038/leu.2017.25; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	13	13	3	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					893	+		10.1038/s41590-021-00951-z	http://dx.doi.org/10.1038/s41590-021-00951-z		JUN 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34155405	Green Accepted			2022-12-18	WOS:000663993300001
J	Glimcher, LH; Lee, AH; Iwakoshi, NN				Glimcher, Laurie H.; Lee, Ann-Hwee; Iwakoshi, Neal N.			XBP-1 and the unfolded protein response (UPR)	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; ER STRESS; TRANSMEMBRANE PROTEIN; INDUCTION; REQUIRES; IRE1	Laurie Glimcher and colleagues recount their work that showed how the transcription factor XBP1 and the UPR signaling pathway are interconnected during plasma cell differentiation.	[Glimcher, Laurie H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Lee, Ann-Hwee] Regeneron Pharmaceut, Tarrytown, NY USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Regeneron	Glimcher, LH (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.	niwakos@gmail.com						Bettigole SE, 2015, NAT IMMUNOL, V16, P829, DOI 10.1038/ni.3225; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	22	13	14	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					963	965		10.1038/s41590-020-0708-3	http://dx.doi.org/10.1038/s41590-020-0708-3		JUL 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32616861				2022-12-18	WOS:000545059300001
J	[Anonymous]				[Anonymous]			Cytokines in the balance	NATURE IMMUNOLOGY			English	Editorial Material								Cytokines have context-dependent roles that dictate their normal physiological function; however, dysregulation or chronic activation of cytokine pathways can alter tissue balance away from a return to homeostatic quiescence toward disease-associated immunopathology.											0	13	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1557	1557		10.1038/s41590-019-0557-0	http://dx.doi.org/10.1038/s41590-019-0557-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745347	Bronze			2022-12-18	WOS:000497949800001
J	Cheng, D; Deobagkar-Lele, M; Zvezdova, E; Choi, S; Uehara, S; Baup, D; Bennett, SC; Bull, KR; Crockford, TL; Ferry, H; Warzecha, C; Marcellin, M; de Peredo, AG; Lesourne, R; Anzilotti, C; Love, PE; Cornall, RJ				Cheng, Daian; Deobagkar-Lele, Mukta; Zvezdova, Ekaterina; Choi, Seeyoung; Uehara, Shoji; Baup, Delphine; Bennett, Sophia C.; Bull, Katherine R.; Crockford, Tanya L.; Ferry, Helen; Warzecha, Claude; Marcellin, Marlene; de Peredo, Anne Gonzalez; Lesourne, Renaud; Anzilotti, Consuelo; Love, Paul E.; Cornall, Richard J.			Themis2 lowers the threshold for B cell activation during positive selection	NATURE IMMUNOLOGY			English	Article							THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; LYMPHOCYTES; PROTEIN; DOWNSTREAM; PATHWAY; DETERMINES; EXPRESSION; SURVIVAL; KINASE	The positive and negative selection of lymphocytes by antigen is central to adaptive immunity and self-tolerance, yet how this is determined by different antigens is not completely understood. We found that thymocyte-selection-associated family member 2 (Themis2) increased the positive selection of B1 cells and germinal center B cells by self and foreign antigens. Themis2 lowered the threshold for B-cell activation by low-avidity, but not high-avidity, antigens. Themis2 constitutively bound the adaptor protein Grb2, src-kinase Lyn and signal transducer phospholipase gamma 2 (PLC-gamma 2), and increased activation of PLC-gamma 2 and its downstream pathways following B cell receptor stimulation. Our findings identify a unique function for Themis2 in differential signaling and provide insight into how B cells discriminate between antigens of different quantity and quality.	[Cheng, Daian; Deobagkar-Lele, Mukta; Baup, Delphine; Bennett, Sophia C.; Bull, Katherine R.; Crockford, Tanya L.; Ferry, Helen; Anzilotti, Consuelo; Cornall, Richard J.] Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Zvezdova, Ekaterina; Choi, Seeyoung; Uehara, Shoji; Warzecha, Claude; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD USA; [Marcellin, Marlene; de Peredo, Anne Gonzalez] Inst Pharmacol & Biol Struct, Toulouse, France; [Marcellin, Marlene; de Peredo, Anne Gonzalez] Univ Paul Sabatier, Univ Toulouse, CNRS, Toulouse, France; [Lesourne, Renaud] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Lesourne, Renaud] INSERM, U1043, CNRS, Toulouse, France; [Cheng, Daian; Deobagkar-Lele, Mukta] Univ Paul Sabatier, Univ Toulouse, Toulouse, France	University of Oxford; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cornall, RJ (corresponding author), Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Love, PE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD USA.	lovep@mail.nih.gov; richard.cornall@ndm.ox.ac.uk	Bull, Katherine/AAC-2411-2019; Lesourne, Renaud/M-1855-2014	Bull, Katherine/0000-0003-0656-0917; Anzilotti, Consuelo/0000-0003-4528-0651; Warzecha, Claude/0000-0002-3659-2867; Deobagkar, Mukta/0000-0002-8543-6801; Lesourne, Renaud/0000-0003-3816-7087; Gonzalez de Peredo, Anne/0000-0001-6152-6311	Medical Research Council; Intramural Research Program of the Eunice Kennedy Shriver, NICHD (PEL: project) [1ZIAHD001803-19]; Wellcome Trust; Medical Research Council [MC_UU_00008/6, MC_UU_12010/6] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; MRC [MC_UU_00008/6] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the Eunice Kennedy Shriver, NICHD (PEL: project); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of Biomedical Services Unit, Oxford University for animal care and R. Brink (Garvan Institute) for HEL constructs. This work was supported by the Medical Research Council, Intramural Research Program of the Eunice Kennedy Shriver, NICHD (PEL: project number 1ZIAHD001803-19) and the Wellcome Trust (studentship to D.C.).	Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Ferry H, 2003, J EXP MED, V198, P1415, DOI 10.1084/jem.20030279; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hartweger H, 2014, J IMMUNOL, V193, P700, DOI 10.4049/jimmunol.1400943; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2012, J IMMUNOL, V189, P1154, DOI 10.4049/jimmunol.1200123; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Peirce MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011465; Quek LS, 2000, BLOOD, V96, P4246; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Zvezdova E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1576	36	13	13	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					205	213		10.1038/ni.3642	http://dx.doi.org/10.1038/ni.3642			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27992403	Green Submitted			2022-12-18	WOS:000392360900014
J	Stehle, C; Saikali, P; Romagnani, C				Stehle, Christina; Saikali, Philippe; Romagnani, Chiara			Putting the brakes on ILC2 cells	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; T-BET; INTERFERON; INFLAMMATION	Immune responses are characterized by the concerted actions of both effector mechanisms and regulatory mechanisms. Signaling via the transcription factor STAT1 downstream of receptors for interferons and interleukin 27 (IL-27) can suppress type 2 immune responses induced by group 2 innate lymphoid cells (ILCs).	[Stehle, Christina; Romagnani, Chiara] Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum Berlin, Dept Innate Immun, Berlin, Germany; [Saikali, Philippe] Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum Berlin, Dept Expt Immunol, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Deutsches Rheuma-Forschungszentrum (DRFZ)	Stehle, C (corresponding author), Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum Berlin, Dept Innate Immun, Berlin, Germany.	romagnani@drfz.de	Romagnani, Chiara/E-4708-2016	Romagnani, Chiara/0000-0002-5167-7463; Saikali, Philippe/0000-0002-4916-7376; Stehle, Christina/0000-0001-5016-0588				Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Duerr C.U., 2016, NAT IMMUNOL, V17, P65; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K., 2016, NAT IMMUNOL, V17, P76; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	16	13	13	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					43	44						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681462				2022-12-18	WOS:000366675800008
J	Ginhoux, F				Ginhoux, Florent			Fate PPAR-titioning: PPAR-gamma 'instructs' alveolar macrophage development	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; TISSUE MACROPHAGES; HOMEOSTASIS; MONOCYTES; EXPRESSION; PATHWAYS; DERIVE		Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.	florent_ginhoux@immunol.a-star.edu.sg						Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179	15	13	16	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1005	1007		10.1038/ni.3011	http://dx.doi.org/10.1038/ni.3011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25329182				2022-12-18	WOS:000343640700005
J	Salek-Ardakani, S; Schoenberger, SP				Salek-Ardakani, Shahram; Schoenberger, Stephen P.			T cell exhaustion: a means or an end?	NATURE IMMUNOLOGY			English	Editorial Material							CHRONIC VIRAL-INFECTION		[Salek-Ardakani, Shahram] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA	State University System of Florida; University of Florida; La Jolla Institute for Immunology	Salek-Ardakani, S (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	sps@liai.org			NIAID NIH HHS [R01 AI087734] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	10	13	13	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					531	533		10.1038/ni.2619	http://dx.doi.org/10.1038/ni.2619			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685816				2022-12-18	WOS:000319107600004
J	Goto, Y; Kiyono, H				Goto, Yoshiyuki; Kiyono, Hiroshi			Epithelial cell microRNAs in gut immunity	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION		[Goto, Yoshiyuki; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan	University of Tokyo	Goto, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Goto, Yoshiyuki/H-9860-2017	Goto, Yoshiyuki/0000-0001-8552-4839				Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Dahan S, 2007, IMMUNOL REV, V215, P243, DOI 10.1111/j.1600-065X.2006.00484.x; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267	12	13	16	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					195	197		10.1038/ni0311-195	http://dx.doi.org/10.1038/ni0311-195			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21321589				2022-12-18	WOS:000287354400003
J	McVicar, DW; Trinchieri, G				McVicar, Daniel W.; Trinchieri, Giorgio			CSF-1R, DAP12 and beta-catenin: a menage a trois	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION	DAP12-coupled receptors influence signals emanating from Toll-like receptors, integrins and receptors for cytokines and growth factors. New findings indicate that DAP12 also facilitates the ability of CSF-1R, the receptor for M-CSF, to induce the stabilization and nuclear translocation of beta-catenin.	[McVicar, Daniel W.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McVicar, DW (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.	trinchig@mail.nih.gov	Trinchieri, Giorgio/F-9369-2015; McVicar, Daniel/G-1970-2015	Trinchieri, Giorgio/0000-0001-5892-7464; McVicar, Daniel/0000-0002-1112-5111	NATIONAL CANCER INSTITUTE [ZIABC010793, ZIABC011152, ZIABC010300] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; TIANRU J, 2008, J CELL SIGNAL, V20, P1697; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; WHITTAKER GC, UCSD NATURE MOL, DOI DOI 10.1038/MP.A000750.01; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023	12	13	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					681	683		10.1038/ni0709-681	http://dx.doi.org/10.1038/ni0709-681			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536190				2022-12-18	WOS:000267142600004
J	Vilcek, J				Vilcek, Jan			From IFN to TNF: a journey into realms of lore	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA LEVELS; HUMAN-FIBROBLASTS; INNATE IMMUNITY; BINDING; PROTEIN; TSG-6; INFLAMMATION; LYMPHOTOXIN; CROSSROADS	Jan Vilcek relates how his work helped to identify some of the pleiotropic actions of tumor necrosis factor and contributed to the development of infliximab, the first medically useful tumor necrosis factor antagonist.	NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10012 USA	New York University; NYU Langone Medical Center	Vilcek, J (corresponding author), NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10012 USA.	jan.vilcek@med.nyu.edu						AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; KOHASE M, 1986, CELL, V45, P659, DOI 10.1016/0092-8674(86)90780-4; LEE GW, 1993, J IMMUNOL, V150, P1804; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; LIN JX, 1987, J BIOL CHEM, V262, P11908; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; REIS LFL, 1989, J BIOL CHEM, V264, P16351; SIEGEL SA, 1995, CYTOKINE, V7, P15, DOI 10.1006/cyto.1995.1003; STONEWOLFF DS, 1984, J EXP MED, V159, P828, DOI 10.1084/jem.159.3.828; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; Vilcek J, 2007, CURR TOP MICROBIOL, V316, P9; VILCEK J, 1960, NATURE, V187, P73, DOI 10.1038/187073a0; Vilcek J, 2007, J INTERF CYTOK RES, V27, P535, DOI 10.1089/jir.2007.9984; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049	23	13	13	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					555	557		10.1038/ni0609-555	http://dx.doi.org/10.1038/ni0609-555			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448652				2022-12-18	WOS:000266384100002
J	Takeuchi, O; Akira, S				Takeuchi, Osamu; Akira, Shizuo			RIG-I-like antiviral protein in flies	NATURE IMMUNOLOGY			English	Editorial Material							INNATE IMMUNITY; DROSOPHILA; RECOGNITION; INFECTION; VIRUSES	The function of gene expression in the response of drosophila to viral infection is poorly understood. A report now demonstrates that the helicase Dicer-2 controls antiviral gene expression in addition to RNA interference-mediated gene silencing.	[Takeuchi, Osamu] Osaka Univ, Dept Host Def, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Takeuchi, O (corresponding author), Osaka Univ, Dept Host Def, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; 				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; LIMDO H, 2008, BIOCHEM BIOPH RES CO, V371, P525; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	12	13	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1327	1328		10.1038/ni1208-1327	http://dx.doi.org/10.1038/ni1208-1327			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008930				2022-12-18	WOS:000260888700005
J	Spies, T				Spies, Thomas			Regulation of NKG2D ligands: a purposeful but delicate affair	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-SYSTEM; RECEPTOR	New findings show that cellular microRNAs 'calibrate' the baseline expression of mRNAs encoding stress-inducible ligands of the activating NKG2D receptor. This regulation serves to protect innocent cells but may be exploited by tumors and viruses to thwart immune attack.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Spies, T (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	tspies@fhcrc.org						Burgess SJ, 2008, IMMUNOL RES, V40, P18, DOI 10.1007/s12026-007-0060-9; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Coudert JD, 2006, SEMIN CANCER BIOL, V16, P333, DOI 10.1016/j.semcancer.2006.07.008; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961	12	13	19	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1013	1015		10.1038/ni0908-1013	http://dx.doi.org/10.1038/ni0908-1013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711442				2022-12-18	WOS:000258559600012
J	Tarlinton, D				Tarlinton, David			IL-17 drives germinal center B cells?	NATURE IMMUNOLOGY			English	Editorial Material							PATHOGENIC AUTOANTIBODIES; BXD2 MICE; MEMORY	The inflammatory cytokine interleukin 17, normally considered a T cell-associated factor, is now reported to be the central participant driving the development of germinal center-derived autoantibodies in a model disease setting.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Tarlinton, D (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	tarlinton@wehi.edu.au		Tarlinton, David/0000-0001-9928-686X				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Hsu HC, 2006, ARTHRITIS RHEUM-US, V54, P343, DOI 10.1002/art.21550; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938	9	13	14	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					124	126		10.1038/ni0208-124	http://dx.doi.org/10.1038/ni0208-124			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204425				2022-12-18	WOS:000252503000008
J	Beuder, B; Moresco, EMY				Beuder, Bruce; Moresco, Eva Marie Y.			Akirins versus infection	NATURE IMMUNOLOGY			English	Editorial Material							DROSOPHILA; EXPRESSION	Over 20 years have passed since the discovery of NF-kappa B and its signaling pathways, yet additional participants continue to be identified. The highly conserved protein Akirin is such an example.	[Beuder, Bruce; Moresco, Eva Marie Y.] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA	Scripps Research Institute	Beuder, B (corresponding author), Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA.	bruce@scripps.edu		Moresco, Eva Marie/0000-0002-2049-7291				DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Pena-Rangel MT, 2002, GENETICS, V160, P1035	8	13	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					7	9		10.1038/ni0108-7	http://dx.doi.org/10.1038/ni0108-7			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087247				2022-12-18	WOS:000251820800003
J	Hollander, GA				Hollaender, Georg A.			Claudins provide a breath of fresh Aire	NATURE IMMUNOLOGY			English	Editorial Material							PROMISCUOUS GENE-EXPRESSION; EPITHELIAL HETEROGENEITY; THYMIC EPITHELIUM; PROGENITOR	'Promiscuous' gene expression in medullary thymic epithelial cells positive for the autoimmune regulator Aire is critical for central T cell tolerance. Expression of the tight-junction components claudin-3 and claudin-4 'marks' Aire(+) epithelial cells in the postnatal thymus and their direct precursors in the embryo.	Univ Basel, Dept Clin Biol Sci, Lab Pediat Immunol, Ctr Biomed, CH-4058 Basel, Switzerland; Univ Basel, Childrens Hosp, CH-4058 Basel, Switzerland	University of Basel; University of Basel	Hollander, GA (corresponding author), Univ Basel, Dept Clin Biol Sci, Lab Pediat Immunol, Ctr Biomed, CH-4058 Basel, Switzerland.	georg-a.hollaender@unibas.ch						Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Gillard GO, 2005, J EXP MED, V202, P15, DOI 10.1084/jem.20050976; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404	12	13	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					234	236		10.1038/ni0307-234	http://dx.doi.org/10.1038/ni0307-234			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304232				2022-12-18	WOS:000244275100008
J	Cao, W; Liu, YJ				Cao, W; Liu, YJ			Opn: key regulator of pDC interferon production	NATURE IMMUNOLOGY			English	Editorial Material							OSTEOPONTIN; IMMUNITY; COMPONENT; CELLS	Plasmacytoid dendritic cells selectively express Toll-like receptors 7 and 9 and respond to virus infection by triggering massive interferon production, a pathway regulated by osteopontin expressed in plasmacytoid dendritic cells.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Cao, W (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org		Cao, Wei/0000-0002-8952-9159				Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	12	13	15	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					441	443		10.1038/ni0506-441	http://dx.doi.org/10.1038/ni0506-441			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622428				2022-12-18	WOS:000237008800006
J	Posey, JE; Brandt, VL; Roth, DB				Posey, JE; Brandt, VL; Roth, DB			Paradigm switching in the germinal center	NATURE IMMUNOLOGY			English	Editorial Material							DNA-REPAIR; RECOMBINATION; MICE	Antigen receptor genes are assembled by a sequence of lineage-specific recombinatorial events, in which DNA breaks must be properly repaired to ensure cell survival and further developmental maturation. B lymphocytes, it seems, use multiple unique pathways to repair their DNA.	NYU, Sch Med, Skirball Inst, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	New York University; New York University; Baylor College of Medicine	Posey, JE (corresponding author), NYU, Sch Med, Skirball Inst, Program Mol Pathogenesis, New York, NY 10016 USA.	roth@saturn.med.nyu.edu	Brandt, Vicky L/J-5202-2014; Posey, Jennifer E./J-3048-2019	Posey, Jennifer E./0000-0003-4814-6765; Brandt, Vicky/0000-0002-5512-3724				Bassing CH, 2004, CELL CYCLE, V3, P149; Bogue MA, 1998, P NATL ACAD SCI USA, V95, P15559, DOI 10.1073/pnas.95.26.15559; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; LEE GS, 2004, CELL            0401, DOI DOI 10.1016/S0092867404003010; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; O'Driscoll M, 2002, MUTAT RES-FUND MOL M, V509, P109, DOI 10.1016/S0027-5107(02)00221-X; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; van Engelen BGM, 2001, HUM IMMUNOL, V62, P1324, DOI 10.1016/S0198-8859(01)00345-7	11	13	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					476	477		10.1038/ni0504-476	http://dx.doi.org/10.1038/ni0504-476			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116114				2022-12-18	WOS:000221101100010
J	Greene, WC				Greene, WC			How resting T cells deMURR HIV infection	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSION; GENE	Murr1, a protein linked to copper homeostasis, is shown in a recent Nature paper to inhibit the degradation of IkappaBalpha. This unexpected action of Murr1, which blunts both basal and stimulus-coupled activation of the NF-kappaB transcription factor, is key in making resting CD4 T lymphocytes nonpermissive for HIV infection.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	wgreene@gladstone.ucsf.edu						Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; KRACKLAUER MP, 2003, MOL CANC; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	12	13	14	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					18	19		10.1038/ni0104-18	http://dx.doi.org/10.1038/ni0104-18			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699403				2022-12-18	WOS:000187635800009
J	Eaves, CJ				Eaves, CJ			Manipulating hematopoietic stem cell amplification with Wnt	NATURE IMMUNOLOGY			English	Editorial Material							IN-VITRO; RECONSTITUTING ABILITY; EXPANSION; VIVO	The mechanisms that regulate self-renewal of hematopoietic stem cells have remained elusive. Recent papers in Nature point to an important role of the Wnt-beta-catenin signaling pathway in promoting this process.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.							Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Audet J, 2002, BIOTECHNOL BIOENG, V80, P393, DOI 10.1002/bit.10399; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Iscove N, 2002, EXP HEMATOL, V30, P38; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; REYA T, 2003, NATURE; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; Willert K, 2003, NATURE; Yonemura Y, 1996, P NATL ACAD SCI USA, V93, P4040, DOI 10.1073/pnas.93.9.4040	13	13	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					511	512		10.1038/ni0603-511	http://dx.doi.org/10.1038/ni0603-511			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774072				2022-12-18	WOS:000183175500007
J	Pugliese, A; Diez, J				Pugliese, A; Diez, J			Lymphoid organs contain diverse cells expressing self-molecules	NATURE IMMUNOLOGY			English	Letter							THYMIC MEDULLA; TOLERANCE		Univ Miami, Sch Med, Diabet Res Inst, Immunogenet Program, Miami, FL 33136 USA	University of Miami	Pugliese, A (corresponding author), Univ Miami, Sch Med, Diabet Res Inst, Immunogenet Program, Miami, FL 33136 USA.							Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Diez J, 2001, DIABETES, V50, P895, DOI 10.2337/diabetes.50.4.895; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Sospedra M, 1998, J IMMUNOL, V161, P5918; Throsby M, 1998, ENDOCRINOLOGY, V139, P2399, DOI 10.1210/en.139.5.2399	8	13	13	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					335	336		10.1038/ni0402-335b	http://dx.doi.org/10.1038/ni0402-335b			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919571				2022-12-18	WOS:000174623600008
J	Nomoto, A; Arita, I				Nomoto, A; Arita, I			Eradication of poliomyelitis	NATURE IMMUNOLOGY			English	Editorial Material									Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, Tokyo 1130033, Japan; Agcy Cooperat Int Hlth, Kumamoto 8620901, Japan	University of Tokyo	Nomoto, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	anomoto@m.u-tokyo.ac.jp						*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P147; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P874; *CDCP, 2001, MMOWR MORB MORTAL WK, V50, P141; DOMOK I, 1962, BMJ-BRIT MED J, P743, DOI 10.1136/bmj.1.5280.743; Fenner F, 1988, SMALLPOX ITS ERADICA; MASLAGO P, 2001, INT J EPIDEMIOL, V20, P1029; MELNICK JL, 1984, REV INFECT DIS, V6, pS323; Orenstein W, 2002, CLIN INFECT DIS, V34, P72, DOI 10.1086/338262; PULLI T, 1995, VIROLOGY, V212, P30, DOI 10.1006/viro.1995.1450; REDER E, 2001, PROGR POLIO ERADICAT, V105, P111; SABIN A. B., 1973, Journal of Biology, V1, P115, DOI 10.1016/0092-1157(73)90048-6; SALK JE, 1960, LANCET, V2, P714; STUTTER RW, 1999, VACCINES, P364; *WHO, 1998, WKLY EPIDEMIOL REC, V73, P113; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; World Health Assembly, 1988, GLOB ER POL YEAR 200; YONEYAMA T, 2001, PROGR POLIO ERADICAT, V105, P93	17	13	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					205	208		10.1038/ni0302-205	http://dx.doi.org/10.1038/ni0302-205			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875454				2022-12-18	WOS:000174074000003
J	Kranz, DM				Kranz, DM			Incompatible differences: view of an allogeneic pMHC-TCR complex	NATURE IMMUNOLOGY			English	News Item							T-CELL RECEPTORS; STRUCTURAL BASIS; RECOGNITION; ANTIGEN; ALLORECOGNITION; ALLOREACTIVITY; PEPTIDES		Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.							BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manning TC, 1999, IMMUNOL TODAY, V20, P417, DOI 10.1016/S0167-5699(99)01508-X; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; RESIER JB, 2000, NATURE IMMUNOL, V1, P291; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272	13	13	13	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					277	278		10.1038/79716	http://dx.doi.org/10.1038/79716			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017095				2022-12-18	WOS:000089869700007
J	Serhan, CN				Serhan, CN			Preventing injury from within, using selective cPLA(2) inhibitors	NATURE IMMUNOLOGY			English	News Item							CYTOSOLIC PHOSPHOLIPASE A(2)	The enzyme cPLA(2) plays a pivotal role in adult respiratory distress syndrome (ARDS). Specific blocking of cPLA(2) may present a useful therapeutic target for treating ARDS.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu						Bigby TD, 1998, LUNG BIOL HEALTH DIS, V120, P125; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Dennis EA, 2000, AM J RESP CRIT CARE, V161, pS32, DOI 10.1164/ajrccm.161.supplement_1.ltta-7; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Farber SA, 1999, J BIOL CHEM, V274, P19338, DOI 10.1074/jbc.274.27.19338; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Ohara M, 1998, ANESTHESIOLOGY, V88, P1014, DOI 10.1097/00000542-199804000-00022; Pang L, 1998, CLIN EXP ALLERGY, V28, P1050; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; SAMUELSSON B, 1982, BIOGRAPHIES LECT, P153; SURETTE ME, 1993, J EXP MED, V178, P1347, DOI 10.1084/jem.178.4.1347	15	13	15	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					13	15		10.1038/76865	http://dx.doi.org/10.1038/76865			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881166				2022-12-18	WOS:000089814800006
J	Triana, S; Vonficht, D; Jopp-Saile, L; Raffel, S; Lutz, R; Leonce, D; Antes, M; Hernandez-Malmierca, P; Ordonez-Rueda, D; Ramasz, B; Boch, T; Jann, JC; Nowak, D; Hofmann, WK; Muller-Tidow, C; Hubschmann, D; Alexandrov, T; Benes, V; Trumpp, A; Paulsen, M; Velten, L; Haas, S				Triana, Sergio; Vonficht, Dominik; Jopp-Saile, Lea; Raffel, Simon; Lutz, Raphael; Leonce, Daniel; Antes, Magdalena; Hernandez-Malmierca, Pablo; Ordonez-Rueda, Diana; Ramasz, Beata; Boch, Tobias; Jann, Johann-Christoph; Nowak, Daniel; Hofmann, Wolf-Karsten; Mueller-Tidow, Carsten; Huebschmann, Daniel; Alexandrov, Theodore; Benes, Vladimir; Trumpp, Andreas; Paulsen, Malte; Velten, Lars; Haas, Simon			Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states	NATURE IMMUNOLOGY			English	Article							RNA-SEQ DATA; STEM-CELLS; LINEAGE COMMITMENT; MYELOID PROGENITOR; STEPPING-STONE; IDENTIFICATION; NICHE	Single-cell genomics technology has transformed our understanding of complex cellular systems. However, excessive cost and a lack of strategies for the purification of newly identified cell types impede their functional characterization and large-scale profiling. Here, we have generated high-content single-cell proteo-genomic reference maps of human blood and bone marrow that quantitatively link the expression of up to 197 surface markers to cellular identities and biological processes across all main hematopoietic cell types in healthy aging and leukemia. These reference maps enable the automatic design of cost-effective high-throughput cytometry schemes that outperform state-of-the-art approaches, accurately reflect complex topologies of cellular systems and permit the purification of precisely defined cell states. The systematic integration of cytometry and proteo-genomic data enables the functional capacities of precisely mapped cell states to be measured at the single-cell level. Our study serves as an accessible resource and paves the way for a data-driven era in cytometry. Haas, Velten and colleagues use single-cell multiomics of human blood and bone marrow to generate a reference map allowing the quantitative linking of cytometry and proteo-genomic information.	[Triana, Sergio; Alexandrov, Theodore] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Triana, Sergio] Fac Biosci, Collaborat Joint PhD Degree European Mol Biol Lab, Heidelberg, Germany; [Triana, Sergio; Velten, Lars] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain; [Vonficht, Dominik; Jopp-Saile, Lea; Lutz, Raphael; Antes, Magdalena; Hernandez-Malmierca, Pablo; Huebschmann, Daniel; Trumpp, Andreas; Haas, Simon] Heidelberg Inst Stem Cell Technol & Expt Med HIST, Heidelberg, Germany; [Vonficht, Dominik; Jopp-Saile, Lea; Lutz, Raphael; Antes, Magdalena; Hernandez-Malmierca, Pablo; Huebschmann, Daniel; Trumpp, Andreas; Haas, Simon] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Heidelberg, Germany; [Vonficht, Dominik; Jopp-Saile, Lea; Lutz, Raphael; Antes, Magdalena; Hernandez-Malmierca, Pablo; Huebschmann, Daniel; Trumpp, Andreas; Haas, Simon] DKFZ ZMBH Alliance, Heidelberg, Germany; [Vonficht, Dominik; Jopp-Saile, Lea; Antes, Magdalena; Hernandez-Malmierca, Pablo] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Jopp-Saile, Lea; Haas, Simon] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany; [Jopp-Saile, Lea; Haas, Simon] Berlin Inst Med Syst Biol, Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Raffel, Simon; Lutz, Raphael; Antes, Magdalena] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany; [Leonce, Daniel] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Ordonez-Rueda, Diana; Ramasz, Beata; Paulsen, Malte] European Mol Biol Lab, Flow Cytometry Core Facil, Heidelberg, Germany; [Boch, Tobias; Jann, Johann-Christoph; Nowak, Daniel; Hofmann, Wolf-Karsten] Heidelberg Univ, Med Fac Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Huebschmann, Daniel] Natl Ctr Tumor Dis NCT Heidelberg, Computat Oncol Mol Diagnost Program, Heidelberg, Germany; [Huebschmann, Daniel] German Canc Res Ctr, Heidelberg, Germany; [Huebschmann, Daniel; Trumpp, Andreas; Haas, Simon] German Canc Consortium DKTK, Heidelberg, Germany; [Huebschmann, Daniel] Univ Hosp Heidelberg, Dept Pediat Immunol Hematol & Oncol, Heidelberg, Germany; [Alexandrov, Theodore] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Benes, Vladimir] European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Paulsen, Malte] Novo Nordisk Fdn, Ctr Stem Cell Biol, DanStem, Fac Hlth & Med Sci, Blegdamsvej, Copenhagen, Denmark; [Mueller-Tidow, Carsten; Velten, Lars] Univ Pompeu Fabra UPF, Barcelona, Spain; [Haas, Simon] Charite, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of California System; University of California San Diego; European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation; Pompeu Fabra University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Velten, L (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain.; Haas, S (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HIST, Heidelberg, Germany.; Haas, S (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Heidelberg, Germany.; Haas, S (corresponding author), DKFZ ZMBH Alliance, Heidelberg, Germany.; Haas, S (corresponding author), Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany.; Haas, S (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Velten, L (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.; Haas, S (corresponding author), Charite, Berlin, Germany.	lars.velten@crg.eu; simon.haas@bih-charite.de		Triana Sierra, Sergio Heli/0000-0003-0370-7821; Hernandez-Malmierca, Pablo/0000-0003-4529-384X; Ordonez-Rueda, Diana/0000-0002-8387-6707; Velten, Lars/0000-0002-1233-5874; Antes, Magdalena/0000-0001-6773-6109; Haas, Simon/0000-0001-9227-2051				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Sabah J, 2020, CURR OPIN ONCOL, V32, P146, DOI 10.1097/CCO.0000000000000602; Argelaguet R, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178124; Baccin C, 2020, NAT CELL BIOL, V22, P38, DOI 10.1038/s41556-019-0439-6; Baron CS, 2019, CELL, V179, P527, DOI 10.1016/j.cell.2019.08.006; Becht E, 2019, BIOINFORMATICS, V35, P301, DOI 10.1093/bioinformatics/bty491; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Erickson Jami R, 2020, STAR Protoc, V1, DOI 10.1016/j.xpro.2020.100092; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Gorgens A, 2014, STEM CELL REP, V3, P1058, DOI 10.1016/j.stemcr.2014.09.016; Haas S, 2020, CURR STEM CELL REP, V6, P67, DOI 10.1007/s40778-020-00174-2; Haas S, 2018, CELL STEM CELL, V22, P627, DOI 10.1016/j.stem.2018.04.003; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hanekamp D, 2017, INT J HEMATOL, V105, P549, DOI 10.1007/s12185-017-2221-5; Hennig BP, 2018, G3-GENES GENOM GENET, V8, P79, DOI 10.1534/g3.117.300257; Hie B, 2019, NAT BIOTECHNOL, V37, P685, DOI 10.1038/s41587-019-0113-3; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Hua P, 2019, BLOOD, V134, P2111, DOI 10.1182/blood.2019002301; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Kiselev VY, 2018, NAT METHODS, V15, P359, DOI 10.1038/nmeth.4644; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Loughran SJ, 2020, EXP HEMATOL, V88, P1, DOI 10.1016/j.exphem.2020.07.002; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Macaulay IC, 2016, CELL REP, V14, P966, DOI 10.1016/j.celrep.2015.12.082; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Psaila B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0939-7; Risso D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02554-5; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schraivogel D, 2020, NAT METHODS, V17, P629, DOI 10.1038/s41592-020-0837-5; Shahi P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44447; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Van den Berge K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14766-3; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; van Galen P, 2019, CELL, V176, P1265, DOI 10.1016/j.cell.2019.01.031; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041	65	12	12	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1577	+		10.1038/s41590-021-01059-0	http://dx.doi.org/10.1038/s41590-021-01059-0		NOV 2021	39	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811546	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-18	WOS:000722315400004
J	Yao, JF; Wu, DM; Zhang, CY; Yan, T; Zhao, YH; Shen, HY; Xue, KL; Huang, X; Wang, ZH; Qiu, YF				Yao, Jingfei; Wu, Dongmei; Zhang, Chunyan; Yan, Ting; Zhao, Yiheng; Shen, Hongyu; Xue, Kaili; Huang, Xun; Wang, Zihao; Qiu, Yifu			Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation	NATURE IMMUNOLOGY			English	Article							BROWN ADIPOSE-TISSUE; FTO GENE; TRANSCRIPTION-FACTORS; SIGNAL-TRANSDUCTION; FAT-CELL; THERMOGENESIS; SUPPRESSES; EXPRESSION; VARIANT; ADIPOCYTES	Metabolic inflammation is closely linked to obesity, and is implicated in the pathogenesis of metabolic diseases. FTO harbors the strongest genetic association with polygenic obesity, and IRX3 mediates the effects of FTO on body weight. However, in what cells and how IRX3 carries out this control are poorly understood. Here we report that macrophage IRX3 promotes metabolic inflammation to accelerate the development of obesity and type 2 diabetes. Mice with myeloid-specific deletion of Irx3 were protected against diet-induced obesity and metabolic diseases via increasing adaptive thermogenesis. Mechanistically, macrophage IRX3 promoted proinflammatory cytokine transcription and thus repressed adipocyte adrenergic signaling, thereby inhibiting lipolysis and thermogenesis. JNK1/2 phosphorylated IRX3, leading to its dimerization and nuclear translocation for transcription. Further, lipopolysaccharide stimulation stabilized IRX3 by inhibiting its ubiquitination, which amplified the transcriptional capacity of IRX3. Together, our findings identify a new player, macrophage IRX3, in the control of body weight and metabolic inflammation, implicating IRX3 as a therapeutic target. Adipose tissue macrophages are intimately involved with adipocytes to orchestrate whole-body energy metabolism. Qiu and colleagues show that myeloid-specific deletion of the homeobox protein IRX3 protects against diet-induced obesity, excessive proinflammatory cytokine secretion and metabolic diseases via increasing adaptive thermogenesis.	[Yao, Jingfei; Wu, Dongmei; Zhang, Chunyan; Zhao, Yiheng; Shen, Hongyu; Xue, Kaili; Huang, Xun; Wang, Zihao; Qiu, Yifu] Peking Univ, Coll Future Technol, Inst Mol Med, Beijing Key Lab Cardiometab Mol Med, Beijing, Peoples R China; [Wu, Dongmei; Zhao, Yiheng; Shen, Hongyu; Huang, Xun; Qiu, Yifu] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Yan, Ting] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing, Peoples R China; [Zhao, Yiheng; Shen, Hongyu; Huang, Xun] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China	Peking University; Peking University; Tsinghua University; Peking University	Qiu, YF (corresponding author), Peking Univ, Coll Future Technol, Inst Mol Med, Beijing Key Lab Cardiometab Mol Med, Beijing, Peoples R China.; Qiu, YF (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.	yifu.qiu@pku.edu.cn		Qiu, Yifu/0000-0001-5645-3189; Shen, Hongyu/0000-0002-2146-9997				Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; de Araujo TM, 2020, TRENDS ENDOCRIN MET, V31, P368, DOI 10.1016/j.tem.2020.01.002; de Araujo TM, 2019, EBIOMEDICINE, V39, P448, DOI 10.1016/j.ebiom.2018.11.048; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson JM, 2001, BBA-MOL CELL RES, V1538, P206, DOI 10.1016/S0167-4889(01)00070-2; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Goto T, 2016, CYTOKINE, V77, P107, DOI 10.1016/j.cyto.2015.11.001; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Qiu YF, 2016, SCI CHINA LIFE SCI, V59, P1232, DOI 10.1007/s11427-016-0155-1; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wang CW, 2020, GENOM PROTEOM BIOINF, V18, P72, DOI 10.1016/j.gpb.2020.01.001; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhi XH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00085; Zou YY, 2017, EBIOMEDICINE, V24, P64, DOI 10.1016/j.ebiom.2017.09.010	51	12	12	5	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1268	+		10.1038/s41590-021-01023-y	http://dx.doi.org/10.1038/s41590-021-01023-y		SEP 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556885				2022-12-18	WOS:000751833700003
J	Hangai, S; Kawamura, T; Kimura, Y; Chang, CY; Hibino, S; Yamamoto, D; Nakai, Y; Tateishi, R; Oshima, M; Oshima, H; Kodama, T; Moriya, K; Koike, K; Yanai, H; Taniguchi, T				Hangai, Sho; Kawamura, Takeshi; Kimura, Yoshitaka; Chang, Ching-Yun; Hibino, Sana; Yamamoto, Daisuke; Nakai, Yousuke; Tateishi, Ryosuke; Oshima, Masanobu; Oshima, Hiroko; Kodama, Tatsuhiko; Moriya, Kyoji; Koike, Kazuhiko; Yanai, Hideyuki; Taniguchi, Tadatsugu			Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells	NATURE IMMUNOLOGY			English	Article							CANCER; EXPRESSION; METASTASIS; INDUCTION; RESPONSES; CORRELATE; IMMUNITY; THERAPY	Cell death in the context of cancer therapies is often associated with immunogenicity. Taniguchi and colleagues instead find that release of the cellular protein TCTP following cell death triggers an immunosuppressive pathway in the tumor microenvironment. One of most challenging issues in tumor immunology is a better understanding of the dynamics in the accumulation of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TIME), as this would lead to the development of new cancer therapeutics. Here, we show that translationally controlled tumor protein (TCTP) released by dying tumor cells is an immunomodulator crucial to full-blown MDSC accumulation in the TIME. We provide evidence that extracellular TCTP mediates recruitment of the polymorphonuclear MDSC (PMN-MDSC) population in the TIME via activation of Toll-like receptor-2. As further proof of principle, we show that inhibition of TCTP suppresses PMN-MDSC accumulation and tumor growth. In human cancers, we find an elevation of TCTP and an inverse correlation of TCTP gene dosage with antitumor immune signatures and clinical prognosis. This study reveals the hitherto poorly understood mechanism of the MDSC dynamics in the TIME, offering a new rationale for cancer immunotherapy.	[Hangai, Sho; Kimura, Yoshitaka; Chang, Ching-Yun; Hibino, Sana; Yanai, Hideyuki; Taniguchi, Tadatsugu] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Inflammol, Meguro Ku, Tokyo, Japan; [Kawamura, Takeshi] Univ Tokyo, Isotope Sci Ctr, Bunkyo Ku, Tokyo, Japan; [Yamamoto, Daisuke; Oshima, Masanobu; Oshima, Hiroko] Kanazawa Univ, Canc Res Inst, Divis Genet, Kanazawa, Ishikawa, Japan; [Yamamoto, Daisuke] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa, Japan; [Nakai, Yousuke; Tateishi, Ryosuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Nucl Receptor Med, Labs Syst Biol & Med, Tokyo, Japan; [Moriya, Kyoji] Univ Tokyo, Fac Med, Dept Infect Dis, Tokyo, Japan	University of Tokyo; University of Tokyo; Kanazawa University; Ishikawa Prefectural Central Hospital; University of Tokyo; University of Tokyo; University of Tokyo	Yanai, H (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Inflammol, Meguro Ku, Tokyo, Japan.	yanai@inflammology.rcast.u-tokyo.ac.jp; tada@m.u-tokyo.ac.jp	Tateishi, Ryosuke/G-7758-2014; Nakai, Yousuke/H-2964-2019; Yanai, Hideyuki/AGK-5933-2022	Tateishi, Ryosuke/0000-0003-3021-2517; Nakai, Yousuke/0000-0001-7411-1385; Yanai, Hideyuki/0000-0002-0115-9000; Hangai, Sho/0000-0003-3657-9731; Yamamoto, Daisuke/0000-0002-3539-7728; Hibino, Sana/0000-0002-2296-0200	Ministry of Education, Culture, Sports, Science of Japan (MEXT) [18030848, 15638461, 20298458, 19J00887]; Grant AMED-PRIME from the Japan Agency for Medical Research and Development [JP20gm6110008]; Uehara Memorial Foundation; Takeda Science Foundation; Naito Foundation; BONAC Corporation	Ministry of Education, Culture, Sports, Science of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant AMED-PRIME from the Japan Agency for Medical Research and Development; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); BONAC Corporation	We thank H.-F. Yang-Yen and S. Robine for providing Tctpflox mice and Villin-Cre-ERT2 mice, respectively. We also thank T. Nitta, T. Tanoue and K. Honda for providing materials. We thank M. Sugahara for technical assistance. This work was supported part by a Grant-In-Aid for Young Scientists 18030848 (S. Hangai); Scientific Research (S) 15638461 (T.T.); Scientific Research (A) 20298458 (T.T.); and a Research Fellowship for Young Scientists 19J00887 (S. Hibino) from the Ministry of Education, Culture, Sports, Science of Japan (MEXT); Grant AMED-PRIME JP20gm6110008 (H.Y.) from the Japan Agency for Medical Research and Development; the Uehara Memorial Foundation (S. Hangai); the Takeda Science Foundation (S. Hangai); and the Naito Foundation (H.Y.). The Department of Inflammology is supported by the BONAC Corporation.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Butcher SK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00933; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Du JH, 2017, ONCOTARGET, V8, P101922, DOI 10.18632/oncotarget.21747; Epperly R, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00262; Fujita T, 2008, FEBS LETT, V582, P1055, DOI 10.1016/j.febslet.2008.02.055; Galluzzi L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000337; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Gorgulho CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01561; Hangai S, 2016, P NATL ACAD SCI USA, V113, P3844, DOI 10.1073/pnas.1602023113; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hiraoka N, 2010, BRIT J CANCER, V103, P1057, DOI 10.1038/sj.bjc.6605854; Jiang HH, 2015, INT J CANCER, V136, P2352, DOI 10.1002/ijc.29297; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Kimura Y, 2016, P NATL ACAD SCI USA, V113, P14097, DOI 10.1073/pnas.1617903113; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Limagne E, 2016, CANCER RES, V76, P5241, DOI 10.1158/0008-5472.CAN-15-3164; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Munn DH, 2016, CURR OPIN IMMUNOL, V39, P1, DOI 10.1016/j.coi.2015.10.009; Ninomiya S, 2015, BLOOD, V125, P3905, DOI 10.1182/blood-2015-01-621474; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; REVESZ L, 1956, NATURE, V178, P1391, DOI 10.1038/1781391a0; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tiberio L, 2018, CELL MOL IMMUNOL, V15, P346, DOI 10.1038/s41423-018-0005-3; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; WALSH BJ, 1995, J LEUKOCYTE BIOL, V57, P507, DOI 10.1002/jlb.57.3.507; Weber R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01310; Weiss JM, 2010, J EXP MED, V207, P2455, DOI 10.1084/jem.20100670; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Zhang F, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0531-3; Zhang J, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1258504	56	12	12	2	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					947	+		10.1038/s41590-021-00967-5	http://dx.doi.org/10.1038/s41590-021-00967-5		JUL 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34239121				2022-12-18	WOS:000670876900001
J	London, M; Bilate, AM; Castro, TBR; Sujino, T; Mucida, D				London, Mariya; Bilate, Angelina M.; Castro, Tiago B. R.; Sujino, Tomohisa; Mucida, Daniel			Stepwise chromatin and transcriptional acquisition of an intraepithelial lymphocyte program	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; CD4(+); LINEAGE; EXPRESSION; INDUCTION; BINDING; THPOK; DIFFERENTIATION; REPRESSION; LANDSCAPE	Mesenteric lymph node (mLN) T cells undergo tissue adaptation upon migrating to intestinal lamina propria and epithelium, ensuring appropriate balance between tolerance and resistance. By combining mouse genetics with single-cell and chromatin analyses, we uncovered the molecular imprinting of gut epithelium on T cells. Transcriptionally, conventional and regulatory (T-reg) CD4(+) T cells from mLN, lamina propria and intestinal epithelium segregate based on the gut layer they occupy; trajectory analysis suggests a stepwise loss of CD4 programming and acquisition of an intraepithelial profile. T-reg cell fate mapping coupled with RNA sequencing and assay for transposase-accessible chromatin followed by sequencing revealed that the T-reg cell program shuts down before an intraepithelial program becomes fully accessible at the epithelium. Ablation of CD4-lineage-defining transcription factor ThPOK results in premature acquisition of an intraepithelial lymphocyte profile by mLN T-reg cells, partially recapitulating epithelium imprinting. Thus, coordinated replacement of the circulating lymphocyte program with site-specific transcriptional and chromatin changes is necessary for tissue imprinting. Mucida and colleagues examine how the gut epithelial microenvironment alters CD4(+) T cells during their conversion into intraepithelial lymphocytes. They reveal a stepwise process involving chromatin accessibility and transcription changes triggered by ThPOK downregulation.	[London, Mariya; Bilate, Angelina M.; Castro, Tiago B. R.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Sujino, Tomohisa] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Rockefeller University; Keio University	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.	mucida@rockefeller.edu	TBR, Castro/K-4014-2018	TBR, Castro/0000-0002-0359-0611; Mucida, Daniel/0000-0002-0000-0452	Leona M. and Harry B. Helmsley Charitable Trust; Black Family Metastasis Center; Kavli Foundation; Burroughs Wellcome Fund PATH Award; National Institute of Health [AI144827, DK113375, DK093674]	Leona M. and Harry B. Helmsley Charitable Trust; Black Family Metastasis Center; Kavli Foundation; Burroughs Wellcome Fund PATH Award(Burroughs Wellcome Fund); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to A. Rogoz and S. Gonzalez for exceptional animal care, mouse colony management and genotyping and the Rockefeller University employees for continuous assistance. We thank K. Gordon and K. Chhosphel for assistance with cell sorting. We thank C. Zhao and the entire Genomics Core of Rockefeller University for library preparation for 10X Genomics and assistance with all sequencing platforms used in this paper. We are grateful to U. Schaefer (The Rockefeller University) for help with ChIP protocols and guidance and S. Larsen for help with the ATAC-seq. We thank T. Egawa (Washington University in St. Louis) for providing anti-ThPOK ChIP antibody. We thank B. Reis and G. Victora for suggestions and critical reading of the manuscript and all the members of the Mucida laboratory for fruitful discussions. This work was supported by the Leona M. and Harry B. Helmsley Charitable Trust, the Black Family Metastasis Center, the Kavli Foundation, the Burroughs Wellcome Fund PATH Award and National Institute of Health grants no. AI144827, no. DK113375 and no. DK093674 (D.M.).	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bilate AM, 2020, IMMUNITY, V53, P1001, DOI 10.1016/j.immuni.2020.09.003; Bilate AM, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf7471; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Carpenter AC, 2017, J IMMUNOL, V199, P1716, DOI 10.4049/jimmunol.1700181; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; R Development Core Team, 2018, R LANG ENV STAT COMP; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sergushichev S.A., 2016, ALGORITHM FAST PRERA, DOI 10.1101/060012; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0	62	12	12	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					449	+		10.1038/s41590-021-00883-8	http://dx.doi.org/10.1038/s41590-021-00883-8		MAR 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33686285	Green Accepted, Green Submitted			2022-12-18	WOS:000626403800001
J	Geoghegan, JL; Moreland, NJ; Le Gros, G; Ussher, JE				Geoghegan, Jemma L.; Moreland, Nicole J.; Le Gros, Graham; Ussher, James E.			New Zealand's science-led response to the SARS-CoV-2 pandemic	NATURE IMMUNOLOGY			English	Editorial Material								New Zealand has avoided the major health impacts of the SARS-CoV-2 pandemic due to a strict country-wide lockdown, the end-goal of which was elimination rather than mitigation and suppression. The New Zealand government's use of scientific expertise, spanning public health, infectious diseases, genomics, modeling and immunology, has been one of the keys to the success of its SARS-CoV-2 elimination and control strategy.	[Geoghegan, Jemma L.; Ussher, James E.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Geoghegan, Jemma L.] Inst Environm Sci & Res, Wellington, New Zealand; [Geoghegan, Jemma L.; Moreland, Nicole J.; Ussher, James E.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Moreland, Nicole J.] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand; [Le Gros, Graham] Malaghan Inst Med Res, Wellington, New Zealand; [Le Gros, Graham; Ussher, James E.] Vaccine Alliance Aoteoroa New Zealand, Ohu Kaupare Huaketo, Wellington, New Zealand; [Ussher, James E.] Southern Community Labs, Dunedin, New Zealand	University of Otago; Institute of Environmental Science & Research (ESR) - New Zealand; University of Auckland; University of Auckland; Malaghan Institute; Victoria University Wellington	Le Gros, G (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.; Le Gros, G (corresponding author), Vaccine Alliance Aoteoroa New Zealand, Ohu Kaupare Huaketo, Wellington, New Zealand.	glegros@malaghan.org.nz		Le Gros, Graham/0000-0002-5721-0442; Moreland, Nicole/0000-0001-6548-637X; Geoghegan, Jemma/0000-0003-0970-0153				Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Binny R.N, PREPRINT MEDRXIV, DOI [10.1101/2020.08.10.20172320, DOI 10.1101/2020.08.10.20172320]; Craigie A, PREPRINT MEDRXIV, DOI [10.1101/2020.10.20.20215616, DOI 10.1101/2020.10.20.20215616]; Fox-Lewis S, 2020, NEW ZEAL MED J, V133, P127; Geoghegan J.L., PREPRINT MEDRXIV, DOI [10.1101/2020.10.28.20221853, DOI 10.1101/2020.10.28.20221853]; Geoghegan JL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20235-8; Jefferies S, 2020, LANCET PUBLIC HEALTH, V5, pE612, DOI 10.1016/S2468-2667(20)30225-5; McGregor R, 2020, PEERJ, V8, DOI 10.7717/peerj.9863; Swadi T, 2021, EMERG INFECT DIS, V27, P687, DOI 10.3201/eid2703.204714; The Treasury, WEEKLY EC UPDATE 18; Whitcombe A.L, PREPRINT MEDRXIV, DOI [10.1101/2020.12.10.20246751, DOI 10.1101/2020.12.10.20246751]	11	12	12	3	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					262	263		10.1038/s41590-021-00872-x	http://dx.doi.org/10.1038/s41590-021-00872-x			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627881	Bronze			2022-12-18	WOS:000621567200006
J	Kimura, MY; Thomas, J; Tai, XG; Guinter, TI; Shinzawa, M; Etzensperger, R; Li, ZH; Love, P; Nakayama, T; Singer, A				Kimura, Motoko Y.; Thomas, Julien; Tai, Xuguang; Guinter, Terry I.; Shinzawa, Miho; Etzensperger, Ruth; Li, Zhenhu; Love, Paul; Nakayama, Toshinori; Singer, Alfred			Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASE; RUNX PROTEINS; CD4; THYMOCYTES; DIFFERENTIATION; EXPRESSION; ANTIGENS; REPERTOIRE; RECEPTORS; PROMOTES	Major histocompatibility complex class I (MHC I) positive selection of CD8(+) T cells in the thymus requires that T cell antigen receptor (TCR) signaling end in time for cytokines to induce Runx3d, the CD8-lineage transcription factor. We examined the time required for these events and found that the overall duration of positive selection was similar for all CD8(+) thymocytes in mice, despite markedly different TCR signaling times. Notably, prolonged TCR signaling times were counter-balanced by accelerated Runx3d induction by cytokines and accelerated differentiation into CD8(+) T cells. Consequently, lineage errors did not occur except when MHC I TCR signaling was so prolonged that the CD4-lineage-specifying transcription factor ThPOK was expressed, preventing Runx3d induction. Thus, our results identify a compensatory signaling mechanism that prevents lineage-fate errors by dynamically modulating Runx3d induction rates during MHC I positive selection.	[Kimura, Motoko Y.; Thomas, Julien; Tai, Xuguang; Guinter, Terry I.; Shinzawa, Miho; Etzensperger, Ruth; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Li, Zhenhu; Love, Paul] Eunice Kennedy Schriver Natl Inst Child Hlth & Hu, Lab Mammalian Genes & Dev, NIH, Bethesda, MD USA; [Kimura, Motoko Y.; Nakayama, Toshinori] Chiba Univ, Dept Immunol, Chiba, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chiba University	Kimura, MY; Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.; Kimura, MY (corresponding author), Chiba Univ, Dept Immunol, Chiba, Japan.	kimuramo@chiba-u.jp; singera@nih.gov	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; Ministry of Education, Culture, Science and Technology [26893033, 15K08524]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011106] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K08524, 26221305] Funding Source: KAKEN	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; Ministry of Education, Culture, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Park, D. Singer and N. Taylor for critical reading of the manuscript; M. Nussenzweig (Rockefeller University) for Rag2<SUP>GFP</SUP>Tg mice; D. Littman (New York University) for Runx3d<SUP>YFP</SUP> knock-in reporter mice; R. Bosselut (National Cancer Institute) for Thpok<SUP>GFP</SUP> mice; M. Kubo (Tokyo University of Science, Japan) for SOCS1<SUP>Tg</SUP> mice; and S. Sharrow and L. Granger for flow cytometry. Supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research, and the Ministry of Education, Culture, Science and Technology (Grant-in-Aid for Research Activity Start-up 26893033; and Scientific Research (C) 15K08524).	BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Katz G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005221; Littman DR, 2016, J IMMUNOL, V196, P1983, DOI 10.4049/jimmunol.1600032; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Yin XY, 2007, J IMMUNOL, V179, P7358, DOI 10.4049/jimmunol.179.11.7358; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	42	12	13	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1415	1423		10.1038/ni.3560	http://dx.doi.org/10.1038/ni.3560			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27668801	Green Accepted			2022-12-18	WOS:000388056400012
J	Ting, JPY; Harton, JA				Ting, Jenny P. Y.; Harton, Jonathan A.			NLRP3 moonlights in T(H)2 polarization	NATURE IMMUNOLOGY			English	Editorial Material							CELLS; INFLAMMASOME	As the cytosolic guardian for many microbial and sterile inflammatory insults, NLRP3 is best appreciated for its innate immunological role mediating inflammasome activation. Now NLRP3 debuts as a transcription factor key for T(H)2 polarization.	[Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	University of North Carolina; University of North Carolina Chapel Hill; Albany Medical College	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu; hartonj@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan A/0000-0002-0350-1877				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2012, J IMMUNOL, V188, P2884, DOI 10.4049/jimmunol.1102488; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Kobayashi M, 1998, J IMMUNOL, V160, P5869; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921	9	12	12	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					794	796		10.1038/ni.3223	http://dx.doi.org/10.1038/ni.3223			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194278				2022-12-18	WOS:000358299200004
J	Veldhoen, M; Veiga-Fernandes, H				Veldhoen, Marc; Veiga-Fernandes, Henrique			Feeding immunity: skepticism, delicacies and delights	NATURE IMMUNOLOGY			English	Article							VITAMIN-A-DEFICIENCY; INNATE LYMPHOID-CELLS; RETINOIC ACID; RESPONSES; RECEPTOR; BUTYRATE; CHILDREN; INFANTS; HISTORY; DIET		[Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Universidade de Lisboa	Veldhoen, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	marc.veldhoen@babraham.ac.uk; jhfernandes@medicina.ulisboa.pt	Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021	Veldhoen, Marc/0000-0002-1478-9562; Veiga-Fernandes, Henrique/0000-0001-6216-1836	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S042] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E021638/1, BBS/E/B/000C0409] Funding Source: Medline; European Research Council [280307, 647274] Funding Source: Medline; BBSRC [BBS/E/B/0000S042, BB/E021638/1, BBS/E/B/000C0409] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; BEISEL WR, 1992, J NUTR, V122, P591, DOI 10.1093/jn/122.suppl_3.591; Benn CS, 2007, VACCINE, V25, P777, DOI 10.1016/j.vaccine.2006.09.044; Benn CS, 2005, BMJ-BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Chanarin I, 2000, BRIT J HAEMATOL, V111, P407, DOI 10.1046/j.1365-2141.2000.02238.x; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Diness BR, 2011, BRIT J NUTR, V105, P1819, DOI 10.1017/S0007114510005532; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Ferreira M, 2014, BIOESSAYS, V36, P1213, DOI 10.1002/bies.201400115; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Kaufman DR, 2011, J IMMUNOL, V187, P1877, DOI 10.4049/jimmunol.1101248; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lind J., 1772, TREATISE SCURVY, V3rd; Martini E, 2003, LANCET, V361, P1480, DOI 10.1016/S0140-6736(03)13131-5; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Newton S, 2005, J NUTR, V135, P2669, DOI 10.1093/jn/135.11.2669; Otten JJ, 2006, DIETARY REFERENCE IN; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Simon J, 1845, PHYSL ESSAY THYMUS G; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; SOMMER A, 1984, AM J CLIN NUTR, V40, P1090, DOI 10.1093/ajcn/40.5.1090; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Vlasova AN, 2013, J IMMUNOL, V190, P4742, DOI 10.4049/jimmunol.1203575; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; WHO, 2009, GLOB PREV VIT A DEF; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	38	12	13	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					215	219		10.1038/ni.3100	http://dx.doi.org/10.1038/ni.3100			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689432	Green Accepted			2022-12-18	WOS:000349842100001
J	Coloma, J; Harris, E				Coloma, Josefina; Harris, Eva			Broad and strong: the ultimate antibody to dengue virus	NATURE IMMUNOLOGY			English	Editorial Material							NEUTRALIZING ANTIBODIES; INFECTION; EPITOPES; BIND		[Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Coloma, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	eharris@berkeley.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085607] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI085607] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13; VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761; Wahala WMPB, 2012, J VIROL, V86, P4019, DOI 10.1128/JVI.06871-11; Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688	15	12	12	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					135	137		10.1038/ni.3081	http://dx.doi.org/10.1038/ni.3081			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594456				2022-12-18	WOS:000348143100003
J	Muallem, G; Hunter, CA				Muallem, Gala; Hunter, Christopher A.			ParadYm shift: Ym1 and Ym2 as innate immunological regulators of IL-17	NATURE IMMUNOLOGY			English	Editorial Material							GAMMA-DELTA; T-CELLS; RESPONSES; CHITIN; ASTHMA		[Muallem, Gala; Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Muallem, Gala] Univ Penn, Dept Nephrol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Muallem, G (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Simpson JL, 2014, EUR RESPIR J, V43, P1067, DOI 10.1183/09031936.00105013; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Williams GR, 2014, J EXP MED, V211, P1019, DOI 10.1084/jem.20131768	12	12	13	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1099	1100		10.1038/ni.3032	http://dx.doi.org/10.1038/ni.3032			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25396344				2022-12-18	WOS:000344841900005
J	Broderick, L; Hoffman, HM				Broderick, Lori; Hoffman, Hal M.			cASCading specks	NATURE IMMUNOLOGY			English	Editorial Material							ASC; APOPTOSIS; PROTEIN	Inflammasome-driven inflammation extends into the extracellular space and to neighboring cells through the passive release of specks consisting of the adaptor ASC; this perpetuates the innate immune response and adds a dimension beyond interleukin 1 to autoinflammation.	[Broderick, Lori; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Broderick, Lori; Hoffman, Hal M.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Hoffman, Hal M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Broderick, L (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	hahoffman@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075830] Funding Source: NIH RePORTER; NICHD NIH HHS [K08 HD075830] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512	10	12	12	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					698	700		10.1038/ni.2942	http://dx.doi.org/10.1038/ni.2942			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	25045869				2022-12-18	WOS:000339323000002
J	Wulfing, C; Tunbridge, HM; Wraith, DC				Wuelfing, Christoph; Tunbridge, Helen M.; Wraith, David C.			New inhibitory signaling by CTLA-4	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-ACTIVATION; POLARIZATION		[Wuelfing, Christoph; Tunbridge, Helen M.; Wraith, David C.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol	Wulfing, C (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	christoph.wuelfing@bristol.ac.uk		Wraith, David/0000-0003-2147-5614; Tunbridge, Helen/0000-0002-8802-5979				Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Sinai P, 2010, P NATL ACAD SCI USA, V107, P11912, DOI 10.1073/pnas.0913422107; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Valk E, 2008, TRENDS IMMUNOL, V29, P272, DOI 10.1016/j.it.2008.02.011; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818	12	12	13	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					408	409		10.1038/ni.2870	http://dx.doi.org/10.1038/ni.2870			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747703				2022-12-18	WOS:000334667900003
J	Randolph, G; Merad, M				Randolph, Gwen; Merad, Miriam			Can DCs be distinguished from macrophages by molecular signatures? respond	NATURE IMMUNOLOGY			English	Letter							CD103(+) DENDRITIC CELLS; IN-VIVO; T-CELLS; EXPRESSION; CD8(+); ANTIGENS; LINEAGE; ZBTB46		[Randolph, Gwen] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Merad, Miriam] Mt Sinai Sch Med, Immunol Inst, New York, NY USA; [Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Randolph, G (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.							Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778	16	12	12	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					189	190		10.1038/ni.2517	http://dx.doi.org/10.1038/ni.2517			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416665				2022-12-18	WOS:000315065400002
J	Ombrello, MJ; Kastner, DL; Milner, JD				Ombrello, Michael J.; Kastner, Daniel L.; Milner, Joshua D.			HOIL and water: the two faces of HOIL-1 deficiency	NATURE IMMUNOLOGY			English	News Item							AUTOINFLAMMATORY DISEASE; IMMUNODEFICIENCY; PLCG2	Autoinflammation and immunodeficiency are rare in humans, but the rate of discovery of these conditions has increased. Three patients have now been characterized in whom deficiency in HOIL-1, a component of the LUBAC complex, leads to these conditions.	[Ombrello, Michael J.; Kastner, Daniel L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Milner, Joshua D.] NIAID, Lab Allerg Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ombrello, MJ (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	ombrellomj@mail.nih.gov; kastnerd@arb.niams.nih.gov		Ombrello, Michael/0000-0003-3322-4089	Intramural NIH HHS [Z99 AR999999] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001183] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	10	12	12	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1133	1135		10.1038/ni.2471	http://dx.doi.org/10.1038/ni.2471			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160206				2022-12-18	WOS:000311217900002
J	Lahouassa, H; Daddacha, W; Hofmann, H; Ayinde, D; Logue, EC; Dragin, L; Bloch, N; Maudet, C; Bertrand, M; Gramberg, T; Pancino, G; Priet, S; Canard, B; Laguette, N; Benkirane, M; Transy, C; Landau, NR; Kim, B; Margottin-Goguet, F				Lahouassa, Hichem; Daddacha, Waaqo; Hofmann, Henning; Ayinde, Diana; Logue, Eric C.; Dragin, Loic; Bloch, Nicolin; Maudet, Claire; Bertrand, Matthieu; Gramberg, Thomas; Pancino, Gianfranco; Priet, Stephane; Canard, Bruno; Laguette, Nadine; Benkirane, Monsef; Transy, Catherine; Landau, Nathaniel R.; Kim, Baek; Margottin-Goguet, Florence			SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates (vol 13, pg 223, 2012)	NATURE IMMUNOLOGY			English	Correction													Margottin-Goguet, Florence/F-9272-2013; Laguette, Nadine/A-2764-2019; Gramberg, Thomas/AAW-8706-2020; Priet, Stéphane/N-7952-2017; Maudet, Claire/AAH-1728-2019; Priet, Stéphane/ABD-4869-2020	Margottin-Goguet, Florence/0000-0002-3124-6690; Priet, Stéphane/0000-0001-7102-3654; Maudet, Claire/0000-0001-8856-0819; Priet, Stéphane/0000-0001-7102-3654				Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236	1	12	12	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					621	621		10.1038/ni0612-621c	http://dx.doi.org/10.1038/ni0612-621c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO		Bronze			2022-12-18	WOS:000304203900019
J	Mattarollo, SR; Smyth, MJ				Mattarollo, Stephen R.; Smyth, Mark J.			A novel axis of innate immunity in cancer	NATURE IMMUNOLOGY			English	Editorial Material							MESSENGER-RNA EXPRESSION; INVARIANT NKT CELLS; SERUM AMYLOID-A; KILLER T-CELLS; ALPHA; NEUTROPHILS; ACTIVATION; RELEASE		[Mattarollo, Stephen R.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia	Peter Maccallum Cancer Center	Mattarollo, SR (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia.	mark.smyth@petermac.org	Mattarollo, Stephen/B-3671-2011; Smyth, Mark J/H-8709-2014	Mattarollo, Stephen/0000-0003-3659-6507; Smyth, Mark J/0000-0001-7098-7240				Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; COSTANTINI C, J LEUKOC BIOL; Costantini C, 2010, INT IMMUNOL, V22, P827, DOI 10.1093/intimm/dxq434; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Hatanaka E, 2004, IMMUNOL LETT, V91, P33, DOI 10.1016/j.imlet.2003.09.011; Hegde S, 2010, IMMUNOLOGY, V130, P471, DOI 10.1111/j.1365-2567.2010.03293.x; Hwang SJ, 2006, J IMMUNOL, V177, P5258, DOI 10.4049/jimmunol.177.8.5258; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Paret C, 2010, EUR UROL, V57, P859, DOI 10.1016/j.eururo.2009.08.014; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097	14	12	12	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					981	982		10.1038/ni1110-981	http://dx.doi.org/10.1038/ni1110-981			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959800				2022-12-18	WOS:000283127800005
J	Engel, A; Barton, GM				Engel, Alex; Barton, Gregory M.			Unfolding new roles for XBP1 in immunity	NATURE IMMUNOLOGY			English	Editorial Material							PROTEIN RESPONSE; STRESS-RESPONSE; ACTIVATION; INDUCTION		[Engel, Alex; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Engel, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu		Barton, Gregory/0000-0002-3793-0100				Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359	11	12	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					365	367		10.1038/ni0510-365	http://dx.doi.org/10.1038/ni0510-365			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20404847				2022-12-18	WOS:000276852200003
J	Augustine, AD; Hall, BF; Leitner, WW; Mo, AX; Wali, TM; Fauci, AS				Augustine, Alison Deckhut; Hall, B. Fenton; Leitner, Wolfgang W.; Mo, Annie X.; Wali, Tonu M.; Fauci, Anthony S.			NIAID workshop on immunity to malaria: addressing immunological challenges	NATURE IMMUNOLOGY			English	Editorial Material							CELL EXHAUSTION; RESISTANCE	The US National Institute of Allergy and Infectious Diseases convened a workshop of malaria investigators and immunologists to foster collaborations and attract more immunologists into malaria research. Discussions highlighted research gaps and underscored the incomplete understanding of basic immune mechanisms that contribute to the pathogenesis of or protection against malaria.	[Augustine, Alison Deckhut; Hall, B. Fenton; Leitner, Wolfgang W.; Mo, Annie X.; Wali, Tonu M.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Augustine, AD (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fauci@niaid.nih.gov	Leitner, Wolfgang W/F-5741-2011	Leitner, Wolfgang W/0000-0003-3125-5922				Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; *NAT I ALL INF DIS, 2009, LIF CYCL MAL PAR; Papathanasiou P, 2005, ANNU REV GENET, V39, P241, DOI 10.1146/annurev.genet.39.110304.095817; Pierce SK, 2009, J IMMUNOL, V182, P5171, DOI 10.4049/jimmunol.0804153; Pierce SK, 2009, IMMUNOL RES, V43, P85, DOI 10.1007/s12026-008-8052-y; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; World Health Organization, 2008, WHO WORLD MAL REP 20	17	12	15	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					673	678		10.1038/ni0709-673	http://dx.doi.org/10.1038/ni0709-673			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536188				2022-12-18	WOS:000267142600002
J	Yano, T; Kurata, S				Yano, Tamaki; Kurata, Shoichiro			An unexpected twist for autophagy in Crohn's disease	NATURE IMMUNOLOGY			English	Editorial Material							ATG16L1; PATHOGENESIS; RECEPTORS; IMMUNITY; INNATE	Autophagy has been linked to inflammatory bowel disease. Studies of two different mouse strains deficient in the autophagy-related gene product Atg16L1 now show that autophagy is important in regulating the secretory function of Paneth cells and the production of inflammatory cytokines in the intestine.	[Yano, Tamaki; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Yano, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	kurata@mail.pharm.tohoku.ac.jp	Yano, Tamaki/AHB-5620-2022	Yano, Tamaki/0000-0002-5576-1128				Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	10	12	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					134	136		10.1038/ni0209-134	http://dx.doi.org/10.1038/ni0209-134			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148195				2022-12-18	WOS:000263178500004
J	Bowie, AG				Bowie, Andrew G.			TRIM-ing down tolls	NATURE IMMUNOLOGY			English	Editorial Material							TAB3	Activation of the transcription factor NF-kappa B by Toll-like receptors must be controlled to avoid excessive inflammation. The tripartite-motif protein family member. TRIM30 alpha has now been shown to mediate a negative regulatory feedback mechanism curtailing such responses.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026	13	12	15	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					348	350		10.1038/ni0408-348	http://dx.doi.org/10.1038/ni0408-348			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349813				2022-12-18	WOS:000254123200009
J	Hoffmann, J				Hoffmann, Jules			Antifungal defense in drosophila	NATURE IMMUNOLOGY			English	Article							INSECT IMMUNITY; ANTIBACTERIAL PROTEINS; TOLL; RECOGNITION; SEQUENCE; ACTIVATION; BACTERIA; FUNGAL; DORSAL; FAMILY	Innate immunity has come to the forefront in immunology, aided by the discovery of antifungal defense in drosophila. Here Jules Hoffmann recounts his team's pioneering work on insect immunity.	Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France		Hoffmann, J (corresponding author), Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.	j.hoffmann@ibmc.u-strasbg.fr						Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; DIMARCQ JL, 1988, EUR J BIOCHEM, V171, P17, DOI 10.1111/j.1432-1033.1988.tb13752.x; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; HOFFMANN JA, 1972, J INSECT PHYSIOL, V18, P1639, DOI 10.1016/0022-1910(72)90094-7; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	20	12	12	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					543	545		10.1038/ni0607-543	http://dx.doi.org/10.1038/ni0607-543			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514202				2022-12-18	WOS:000246703300002
J	Ravetch, JV; Nussenzweig, M				Ravetch, Jeffrey V.; Nussenzweig, Michel			Killing some to make way for others	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY B-CELLS; FC-GAMMA-RII; DEFICIENT MICE; PLASMA-CELL; RECEPTOR; EXPRESSION	Limited niche availability restricts the number of long-lived plasma cells that can reside in the bone marrow. New research describes homeostatic regulatory mechanisms that allow newly 'minted' plasma cells to gain entry to such niches.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@mail.rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Nussenzweig, Michel/AAE-7292-2019	Ravetch, Jeffrey/0000-0003-2024-9041; 				Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; DAVENPORT FM, 1957, T ASSOC AM PHYSICIAN, V70, P81; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	16	12	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					337	339		10.1038/ni0407-337	http://dx.doi.org/10.1038/ni0407-337			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375094				2022-12-18	WOS:000245075900007
J	Mebius, RE				Mebius, Reina E.			Vitamins in control of lymphocyte migration	NATURE IMMUNOLOGY			English	Editorial Material							INTESTINAL DENDRITIC CELLS; T-CELLS; GENERATION	Localized vitamin metabolism by dendritic cells generates homing cues that direct lymphocytes to specific tissues. Gut tropism is linked to vitamin A and now epidermal skin tropism is linked to vitamin D processing.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Mebius, RE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands.	r.mebius@vumc.nl		Mebius, Reina/0000-0003-0451-7464				Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E	11	12	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					229	230		10.1038/ni0307-229	http://dx.doi.org/10.1038/ni0307-229			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304229				2022-12-18	WOS:000244275100005
J	Dziarski, R				Dziarski, Roman			Deadly plague versus mild-mannered TLR4	NATURE IMMUNOLOGY			English	Editorial Material							YERSINIA; INFECTION; MUTATIONS	Yersinia pestis evades lipopolysaccharide (LPS)-induced inflammation and establishes deadly infection mediated by myriad virulence factors. Virulence can be completely neutralized, however, if Y. pestis expresses a Toll-like receptor 4-stimulating LPS.	Indiana Univ, Sch Med, Gary, IN 46408 USA	Indiana University System; Indiana University Northwest	Dziarski, R (corresponding author), Indiana Univ, Sch Med, NW Campus, Gary, IN 46408 USA.	rdziar@iun.edu						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vogel SN, 2005, J ENDOTOXIN RES, V11, P333, DOI 10.1179/096805105X58724	10	12	15	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1017	1019		10.1038/ni1006-1017	http://dx.doi.org/10.1038/ni1006-1017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985495				2022-12-18	WOS:000241437100004
J	Walzer, T; Vivier, E				Walzer, Thierry; Vivier, Eric			NK cell development: Gas matters	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; RECEPTORS; SUBSET; MOLECULES; FEATURES; FAMILY; MHC	The mechanisms governing natural killer cell development are not well understood. Activation of the tyrosine kinase receptors Tyro3, Axl and Mer on pre-natural killer cells by stromal cell-produced ligands now seems to be critical.	Univ Mediterranee, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; INSERM, U631, F-13288 Marseille, France; CNRS, UMR6102, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Walzer, T (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr	Walzer, Thierry/L-9418-2014; Vivier, Eric/F-8939-2010	Walzer, Thierry/0000-0002-0857-8179; Vivier, Eric/0000-0001-7022-8287				Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; CHIESA S, 2005, BLOOD; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Vely F, 1997, J IMMUNOL, V159, P2075; Vosshenrich CAJ, 2005, CURR OPIN IMMUNOL, V17, P151, DOI 10.1016/j.coi.2005.01.005	13	12	13	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					702	704		10.1038/ni0706-702	http://dx.doi.org/10.1038/ni0706-702			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785886				2022-12-18	WOS:000238377700007
J	Roy, CR; Zamboni, DS				Roy, Craig R.; Zamboni, Dario S.			Cytosolic detection of flagellin: a deadly twist	NATURE IMMUNOLOGY			English	Editorial Material							MACROPHAGE APOPTOSIS; LEGIONELLA; INFLAMMASOME; RECOGNITION; ACTIVATION; CASPASE-1; SECRETION; BINDING	Immune responses to bacterial infection occur by host cell detection of bacterial components. Monomeric flagellin can be elicited directly by host cells and then are 'sensed' by the cytosolic protein Ipaf.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	craig.roy@yale.edu	Zamboni, Dario S/D-3024-2012	Zamboni, Dario S/0000-0002-7856-7512; Roy, Craig/0000-0003-4490-440X				Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Subramanian N, 2006, NAT IMMUNOL, V7, P583, DOI 10.1038/ni1336; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	14	12	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					549	551		10.1038/ni0606-549	http://dx.doi.org/10.1038/ni0606-549			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715062				2022-12-18	WOS:000237751200005
J	Ip, YT				Ip, YT			Drosophila innate immunity goes viral	NATURE IMMUNOLOGY			English	Editorial Material							MELANOGASTER; INFECTION; VIRUSES; TOLL	Insects are capable of fighting viral infection even though they do not have B and T cells. Genetic analysis of drosophila C virus infection provides a glimpse of this unexplored area of innate immunity.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ip, YT (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	tony.ip@umassmed.edu						Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Marks H, 2005, J GEN VIROL, V86, P2081, DOI 10.1099/vir.0.80895-0; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; THOMASORILLARD M, 1995, GENETICS, V140, P1289; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	12	12	12	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					863	864		10.1038/ni0905-863	http://dx.doi.org/10.1038/ni0905-863			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116462				2022-12-18	WOS:000231369800005
J	Flynn, JL				Flynn, JL			Mutual attraction: Does it benefit the host or the bug?	NATURE IMMUNOLOGY			English	Editorial Material							TUBERCULOSIS; REINFECTION	Granulomas are thought to be immunological barriers that effectively contain mycobacteria. This hypothesis is now challenged by data that show granulomas are dynamic entities permissive to bacterial latency and reinfection.	Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Flynn, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA.	joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020					Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DEVIEDMA DG, 2002, ARCH INTERN MED, V162, P1873; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; MYERS JA, 1966, DIS CHEST, V50, P120, DOI 10.1378/chest.50.2.120; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Repique CJ, 2002, INFECT IMMUN, V70, P3318, DOI 10.1128/IAI.70.7.3318-3323.2002; van Helden PD, 2002, IUBMB LIFE, V53, P219, DOI 10.1080/15216540212653; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC	9	12	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					778	779		10.1038/ni0804-778	http://dx.doi.org/10.1038/ni0804-778			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282559	Bronze			2022-12-18	WOS:000222955600007
J	Takai, D; Nagase, T; Shimizu, T				Takai, D; Nagase, T; Shimizu, T			New therapeutic key for cystic fibrosis: a role for lipoxins	NATURE IMMUNOLOGY			English	Editorial Material							CYTOSOLIC PHOSPHOLIPASE A(2); LUNG; BIOSYNTHESIS	One of the hallmarks of cystic fibrosis is the propensity of patients to develop lung infections with Pseudomonas aeruginosa, which eventually compromises lung function. New data suggest loss of CFTR impairs lipoxin production, thus preventing resolution of lung inflammation and creating an environment susceptible to further infection.	Univ Tokyo, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Takai, D (corresponding author), Univ Tokyo, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	tshimizu@m-tokyo.ac.jp						Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; NAGASE T, 1990, BIOCHEM BIOPH RES CO, V168, P485, DOI 10.1016/0006-291X(90)92347-3; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002	12	12	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					357	358		10.1038/ni0404-357	http://dx.doi.org/10.1038/ni0404-357			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052263				2022-12-18	WOS:000220515900006
J	Silverstein, AM				Silverstein, AM			Splitting the difference: the germline-somatic mutation debate on generating antibody diversity	NATURE IMMUNOLOGY			English	Article							BENCE-JONES PROTEINS; DNA-RNA HYBRIDIZATION; INBRED MICE; ANTIGENIC-STIMULATION; IMMUNOGLOBULIN GENES; MOUSE IMMUNOGLOBULIN; POLYPEPTIDE CHAINS; NATURAL-SELECTION; VARIABLE REGIONS; MYELOMA PROTEINS	In the debate about the mechanism for the generation of immunological diversity, the initial positions of both 'somaticists' and 'germliners' were diametrically opposed. Then, as data developed favoring first one and then the other side, concessions were made, until the final solution showed that each had been at least partially correct.	Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	arts@jhmi.edu						[Anonymous], 1984, ANTIBODY ENIGMA; Bock G.R., 1997, IMMUNOLOGICAL TOLERA; Breinl F., 1930, Z PHYSL CHEM, V192, P45; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; BRILES DE, 1982, J EXP MED, V156, P1177, DOI 10.1084/jem.156.4.1177; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cantor H., 1984, REGULATION IMMUNE SY; Capra J. D., 1976, GENERATION ANTIBODY, P75; CAPRA JD, 1975, IMMUNOGENETICS, V1, P417; COHN M, 1994, ANNU REV IMMUNOL, V12, P1; Cohn M, 1970, Cell Immunol, V1, P461, DOI 10.1016/0008-8749(70)90034-1; Cohn M., 1980, PROGR IMMUNOLOGY, V4, P153; CUNNINGHAM AJ, 1974, SCAND J IMMUNOL, V3, P5, DOI 10.1111/j.1365-3083.1974.tb01227.x; DELOVITCH TL, 1973, P NATL ACAD SCI USA, V70, P173, DOI 10.1073/pnas.70.1.173; DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; DUPASQUIER L, 1970, IMMUNOLOGY, V19, P353; DUPASQUIER L, 1976, GENERATION ANTIBODY; EDELMAN GM, 1967, P NATL ACAD SCI USA, V57, P353, DOI 10.1073/pnas.57.2.353; EDELMAN GM, 1959, J AM CHEM SOC, V81, P3155, DOI 10.1021/ja01521a071; EDELMAN GM, 1962, J EXP MED, V116, P207; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; EICHMANN K, 1971, J EXP MED, V134, P532, DOI 10.1084/jem.134.2.532; EICHMANN K, 1975, IMMUNOGENETICS, V2, P491, DOI 10.1007/BF01572318; EICHMANN K, 1972, EUR J IMMUNOL, V2, P301, DOI 10.1002/eji.1830020402; FEINSTEIN A, 1963, NATURE, V199, P1197, DOI 10.1038/1991197b0; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FRANEK F, 1961, BIOCHEM BIOPH RES CO, V4, P28, DOI 10.1016/0006-291X(61)90249-2; FRIED M, 1960, J BIOL CHEM, V193, P1086; GELL PGH, 1964, NATURE, V201, P687, DOI 10.1038/201687a0; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P195; GRUBER M, 1901, MUNCHEN MED WOCHEN, V48, P1214; GRUBER M, 1903, WIEN KLIN WOCHENSCHR, V16, P791; HILSCHMANN N, 1965, P NATL ACAD SCI USA, V53, P1403, DOI 10.1073/pnas.53.6.1403; Hood L, 1971, Adv Immunol, V14, P291, DOI 10.1016/S0065-2776(08)60287-4; HOOD L, 1970, SCIENCE, V168, P325, DOI 10.1126/science.168.3929.325; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KEHOE JM, 1971, P NATL ACAD SCI USA, V68, P2019, DOI 10.1073/pnas.68.9.2019; Klinman N.R., 1976, P127; KLINMAN NR, 1976, COLD SPRING HARB SYM, V41, P165, DOI 10.1101/SQB.1977.041.01.022; KLINMAN NR, 1972, J EXP MED, V136, P241, DOI 10.1084/jem.136.2.241; KRETH HW, 1973, EUR J IMMUNOL, V3, P141, DOI 10.1002/eji.1830030306; KUETTNER MG, 1972, J EXP MED, V135, P579, DOI 10.1084/jem.135.3.579; KUNKEL HENRY G., 1965, HARVEY LECT, V59, P219; KUNKEL HG, 1963, SCIENCE, V140, P1218, DOI 10.1126/science.140.3572.1218; LANDSTEINER K, 1962, SPECIFICTY SEROLOGIC; Langman R, 2002, SEMIN IMMUNOL, V14, P153, DOI 10.1016/S1044-5323(02)00039-8; LANGMAN RE, 1987, MOL IMMUNOL, V24, P675, DOI 10.1016/0161-5890(87)90050-2; LEDER P, 1974, P NATL ACAD SCI USA, V71, P5109, DOI 10.1073/pnas.71.12.5109; LEDER P, 1982, SCI AM, V246, P102, DOI 10.1038/scientificamerican0582-102; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LIEBERMAN R, 1974, J EXP MED, V139, P983, DOI 10.1084/jem.139.4.983; Max E.E., 1998, FUNDAMENTAL IMMUNOLO, P111; Metchnikoff E., 1893, LECT COMP PATHOLOGY; Metchnikoff E., 1905, IMMUNITY INFECT DIS; NISONOFF A, 1959, BIOCHEM BIOPH RES CO, V1, P318, DOI 10.1016/0006-291X(59)90046-4; OHNO S, 1976, PERSPECT BIOL MED, V19, P527, DOI 10.1353/pbm.1976.0074; OUDIN J, 1956, CR HEBD ACAD SCI, V242, P2606; OUDIN J, 1963, CR HEBD ACAD SCI, V257, P805; Pasteur L, 1880, CR HEBD ACAD SCI, V90, P239; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Pick E.P., 1906, WIEN KLIN WOCHENSCHR, V19, P327; Pick E.P., 1912, HDB PATHOGENEN MIKRO, V1, P685; PINK JRL, 1974, EUR J IMMUNOL, V4, P426, DOI 10.1002/eji.1830040608; PORTER RR, 1950, BIOCHEM J, V46, P479, DOI 10.1042/bj0460479; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; POTTER M, 1972, PHYSIOL REV, V52, P631, DOI 10.1152/physrev.1972.52.3.631; PREMKUMAR E, 1974, P NATL ACAD SCI USA, V71, P99, DOI 10.1073/pnas.71.1.99; PUTNAM FW, 1967, COLD SPRING HARB SYM, V32, P9, DOI 10.1101/SQB.1967.032.01.006; PUTNAM FW, 1955, J BIOL CHEM, V212, P361; SHERWIN WK, 1974, J IMMUNOL, V113, P1353; Sigal N H, 1978, Adv Immunol, V26, P255, DOI 10.1016/S0065-2776(08)60232-1; Silverstein A. M., 1973, PHYLOGENIC ONTOGENIC, P221; SILVERSTEIN AM, 1979, CELL IMMUNOL, V48, P208, DOI 10.1016/0008-8749(79)90113-8; Silverstein AM, 2003, NAT IMMUNOL, V4, P3, DOI 10.1038/ni0103-3; SILVERSTEIN AM, 1970, DEVELOPMENTAL ASPECT, V1, P69; SILVERSTEIN J, 1967, ADV IMMUNOL, V6, P337; SLATER RJ, 1955, J EXP MED, V101, P85, DOI 10.1084/jem.101.1.85; SMITHIES O, 1967, COLD SPRING HARB SYM, V32, P161, DOI 10.1101/SQB.1967.032.01.023; SOLOMON JB, 1971, FOETAL NEONATAL IMMU; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; TITANI K, 1966, SCIENCE, V152, P1513, DOI 10.1126/science.152.3728.1513; TODD CW, 1963, BIOCHEM BIOPH RES CO, V11, P170, DOI 10.1016/0006-291X(63)90329-2; TONEGAWA S, 1974, FEBS LETT, V40, P92, DOI 10.1016/0014-5793(74)80901-4; TONEGAWA S, 1976, COLD SPRING HARB SYM, V41, P877; TOPLEY WC, 1938, PRINCIPLES BACTERIOL; WEIGERT M, 1978, NATURE, V276, P785, DOI 10.1038/276785a0; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; WEILER E, 1965, P NATL ACAD SCI USA, V54, P1765, DOI 10.1073/pnas.54.6.1765; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YOUNG LLL, 1973, EUR J IMMUNOL, V3, P224; Zinsser H., 1914, INFECT RESISTANCE, P1	96	12	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					829	833		10.1038/ni0903-829	http://dx.doi.org/10.1038/ni0903-829			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942083				2022-12-18	WOS:000185002200008
J	O'Neill, LAJ; Brown, Z; Ward, SG				O'Neill, LAJ; Brown, Z; Ward, SG			Toll-like receptors in the spotlight	NATURE IMMUNOLOGY			English	Letter									Trinity Coll Dublin, Dept Biochem, Dublin, Ireland; Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; Trinity Coll Dublin, Inst Biotechnol, Dublin, Ireland; Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England	Trinity College Dublin; University of Bath; Trinity College Dublin; Novartis	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Dept Biochem, Dublin, Ireland.		Ward, Stephen/AAE-4341-2020	Ward, Stephen G./0000-0002-6795-6002; O'Neill, Luke/0000-0002-4333-2748				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; OSIUMI H, 2002, NATURE IMMUNOLOGY, V4, P161; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	5	12	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					299	299		10.1038/ni0403-299	http://dx.doi.org/10.1038/ni0403-299			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660723				2022-12-18	WOS:000181987700002
J	Aspinall, R; Henson, SM; Pido-Lopez, J				Aspinall, R; Henson, SM; Pido-Lopez, J			My T's gone cold, I'm wondering why	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC OUTPUT; CELLS; MEMORY; AGE; CD4(+); CENTENARIANS; LYMPHOCYTES; EXPRESSION; LIFE		Chelsea & Westminster Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London SW10 9NH, England	Imperial College London	Aspinall, R (corresponding author), Chelsea & Westminster Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, 369 Fulham Rd, London SW10 9NH, England.	r.aspinall@ic.ac.uk	Aspinall, Richard/E-4924-2013	Aspinall, Richard/0000-0002-1648-1887; Henson, Sian/0000-0003-1893-4912				Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Fry TJ, 2002, SPRINGER SEMIN IMMUN, V24, P7, DOI 10.1007/s00281-001-0092-5; Garcia GG, 2002, J IMMUNOL, V169, P5021, DOI 10.4049/jimmunol.169.9.5021; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; HIROKAWA K, 1984, MECH AGEING DEV, V28, P111, DOI 10.1016/0047-6374(84)90157-X; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; KENDALL MD, 1990, CELL TISSUE RES, V261, P555, DOI 10.1007/BF00313535; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Lin J, 2001, J CELL SCI, V114, P243; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Nociari MM, 1999, J IMMUNOL, V162, P3327; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Pido-Lopez J, 2002, EUR J IMMUNOL, V32, P2827, DOI 10.1002/1521-4141(2002010)32:10<2827::AID-IMMU2827>3.0.CO;2-X; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; SHUTTER J, 1995, MOL CELL BIOL, V15, P7022; Timm JA, 1999, J IMMUNOL, V162, P711; Tinkle CW, 1998, CELL IMMUNOL, V186, P154, DOI 10.1006/cimm.1998.1313; UTSUYAMA M, 1993, INT IMMUNOL, V5, P1177, DOI 10.1093/intimm/5.9.1177; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Whisler RL, 1996, CELL IMMUNOL, V168, P201, DOI 10.1006/cimm.1996.0067; Whisler RL, 1997, MECH AGEING DEV, V98, P57, DOI 10.1016/S0047-6374(97)00073-0; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792	27	12	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					203	205		10.1038/ni0303-203	http://dx.doi.org/10.1038/ni0303-203			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605224				2022-12-18	WOS:000181201000003
J	Pietropaolo, M; Giannoukakis, N; Trucco, M				Pietropaolo, M; Giannoukakis, N; Trucco, M			Cellular environment and freedom of gene expression	NATURE IMMUNOLOGY			English	Letter							DENDRITIC CELLS		Univ Pittsburgh, Sch Med, Dept Pediat, Diabet Inst,Div Immunogenet, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pietropaolo, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Diabet Inst,Div Immunogenet, Pittsburgh, PA 15213 USA.							Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; FARATIAN D, 2000, GRAFT, V3, P54; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Lo D, 1997, IMMUNOL RES, V16, P3, DOI 10.1007/BF02786320; PIETROPAOLO M, 1993, J CLIN INVEST, V92, P359, DOI 10.1172/JCI116574; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Radinsky R, 1995, CANCER METAST REV, V14, P323, DOI 10.1007/BF00690601; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Savino W, 1995, NEUROIMMUNOMODULAT, V2, P313, DOI 10.1159/000097210; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Throsby M, 1998, ENDOCRINOLOGY, V139, P2399, DOI 10.1210/en.139.5.2399	12	12	12	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					335	335		10.1038/ni0402-335a	http://dx.doi.org/10.1038/ni0402-335a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919570	Bronze			2022-12-18	WOS:000174623600007
J	Bonneville, M; Lang, F				Bonneville, M; Lang, F			CD8: from coreceptor to comodulator	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN; RECOGNITION; MOLECULES		INSERM, U463, Inst Biol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonneville, M (corresponding author), INSERM, U463, Inst Biol, Nantes, France.	bonnevil@nantes.inserm.fr	LANG, François/K-7403-2015	LANG, François/0000-0002-0762-4647				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Bahram S, 2001, ADV IMMUNOL, V76, P1, DOI 10.1016/S0065-2776(01)76018-X; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; TEITELL M, 1994, CRIT REV IMMUNOL, V14, P1; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	11	12	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					12	14		10.1038/ni0102-12	http://dx.doi.org/10.1038/ni0102-12			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753402				2022-12-18	WOS:000173148700007
J	Lehner, PJ; Wilkinson, GWG				Lehner, PJ; Wilkinson, GWG			Cytomegalovirus: from evasion to suppression?	NATURE IMMUNOLOGY			English	News Item							DENDRITIC CELLS; IMMUNITY; PROTEIN		Addenbrookes Hosp, Cambridge Inst Med Res, Div Immunol, Cambridge CB2 2XY, England; Univ Wales Coll Cardiff, Coll Med, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales	Addenbrooke's Hospital; University of Cambridge; Cardiff University	Wilkinson, GWG (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Div Immunol, Hills Rd, Cambridge CB2 2XY, England.		Wilkinson, Gavin WG/J-6388-2015	Wilkinson, Gavin WG/0000-0002-5623-0126; Lehner, Paul Joseph/0000-0001-9383-1054				Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; REDDEHASE MJ, 1987, J VIROL, V61, P3102, DOI 10.1128/JVI.61.10.3102-3108.1987; Rescigno M, 2001, CELL, V106, P267, DOI 10.1016/S0092-8674(01)00454-8; RIEGLER S, 2001, 26 INT HERP WORKSH A; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Tabi Z, 2001, J IMMUNOL, V166, P5695, DOI 10.4049/jimmunol.166.9.5695; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	13	12	12	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					993	994		10.1038/ni1101-993	http://dx.doi.org/10.1038/ni1101-993			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685220				2022-12-18	WOS:000172049800010
J	Kirberg, J; von Boehmer, H; Brocker, T; Rodewald, HR; Takeda, S				Kirberg, J; von Boehmer, H; Brocker, T; Rodewald, HR; Takeda, S			Class II essential for CD4 survival	NATURE IMMUNOLOGY			English	Letter							CELLS; MOLECULES; THYMUS		Basel Inst Immunol, CH-4005 Basel, Switzerland; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Ulm, Dept Immunol, D-89081 Ulm, Germany; Kyoto Univ, Sch Med, Dept Radiat Med, Sakyo Ku, JP-6068501 Kyoto, Japan	Harvard University; Dana-Farber Cancer Institute; University of Munich; Ulm University; Kyoto University	Kirberg, J (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Brocker, Thomas/0000-0001-7060-5433				Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	10	12	12	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					136	136		10.1038/84229	http://dx.doi.org/10.1038/84229			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175806				2022-12-18	WOS:000166778700009
J	Concepcion, AR; Wagner, LE; Zhu, JJ; Tao, AY; Yang, J; Khodadadi-Jamayran, A; Wang, YH; Liu, MH; Rose, RE; Jones, DR; Coetzee, WA; Yule, DI; Feske, S				Concepcion, Axel R.; Wagner, Larry E., II; Zhu, Jingjie; Tao, Anthony Y.; Yang, Jun; Khodadadi-Jamayran, Alireza; Wang, Yin-Hu; Liu, Menghan; Rose, Rebecca E.; Jones, Drew R.; Coetzee, William A.; Yule, David, I; Feske, Stefan			The volume-regulated anion channel LRRC8C suppresses T cell function by regulating cyclic dinucleotide transport and STING-p53 signaling	NATURE IMMUNOLOGY			English	Article							LEUCINE-RICH REPEAT; ESSENTIAL COMPONENT; CRAC CHANNELS; ACTIVATION; RESPONSES; P53; INNATE; RESISTANCE; EXPRESSION; INDUCTION	The volume-regulated anion channel (VRAC) is formed by LRRC8 proteins and is responsible for the regulatory volume decrease (RVD) after hypotonic cell swelling. Besides chloride, VRAC transports other molecules, for example, immunomodulatory cyclic dinucleotides (CDNs) including 2 ' 3 ' cGAMP. Here, we identify LRRC8C as a critical component of VRAC in T cells, where its deletion abolishes VRAC currents and RVD. T cells of Lrrc8c(-/-) mice have increased cell cycle progression, proliferation, survival, Ca2+ influx and cytokine production-a phenotype associated with downmodulation of p53 signaling. Mechanistically, LRRC8C mediates the transport of 2 ' 3 ' cGAMP in T cells, resulting in STING and p53 activation. Inhibition of STING recapitulates the phenotype of LRRC8C-deficient T cells, whereas overexpression of p53 inhibits their enhanced T cell function. Lrrc8c(-/-) mice have exacerbated T cell-dependent immune responses, including immunity to influenza A virus infection and experimental autoimmune encephalomyelitis. Our results identify cGAMP uptake through LRRC8C and STING-p53 signaling as a new inhibitory signaling pathway in T cells and adaptive immunity. Concepcion et al. show that the volume-regulated anion channel LRRC8C mediates the transport of cGAMP in T cells, resulting in a noncanonical STING-p53-dependent suppression of Ca2+ influx, T cell proliferation and cytokine production.	[Concepcion, Axel R.; Zhu, Jingjie; Tao, Anthony Y.; Yang, Jun; Wang, Yin-Hu; Liu, Menghan; Coetzee, William A.; Feske, Stefan] NYU, Dept Pathol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Wagner, Larry E., II; Yule, David, I] Univ Rochester, Dept Pharmacol & Physiol, Rochester, NY USA; [Khodadadi-Jamayran, Alireza] NYU, Appl Bioinformat Labs, Grossman Sch Med, New York, NY USA; [Rose, Rebecca E.; Jones, Drew R.] NYU, Grossman Sch Med, Metabol Core Resource Lab, New York, NY USA	New York University; University of Rochester; New York University; New York University	Feske, S (corresponding author), NYU, Dept Pathol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.	feskes01@nyumc.org		Khodadadi-Jamayran, Alireza/0000-0003-2495-7504; Jones, Rebecca/0000-0002-5056-9292; Concepcion, Axel R./0000-0003-2971-3488	National Institutes of Health (NIH) [AI097302, AI130143, AI137004, AI125997, R01DE014756]; Irma T. Hirsch career development grant; Alfonso Martin Escudero Foundation; Bernard Levine postdoctoral fellowship in Immunology; T32 training program in Immunology and Inflammation [AI100853]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirsch career development grant; Alfonso Martin Escudero Foundation; Bernard Levine postdoctoral fellowship in Immunology; T32 training program in Immunology and Inflammation	This work was funded by National Institutes of Health (NIH) grant nos. AI097302, AI130143, AI137004 and AI125997 to S.F., and R01DE014756 to D.I.Y, an Irma T. Hirsch career development grant to S.F., a postdoctoral fellowship from the Alfonso Martin Escudero Foundation and the Bernard Levine postdoctoral fellowship in Immunology to A.R.C. and a predoctoral fellowship by the T32 training program in Immunology and Inflammation (AI100853) to A.Y.T. We thank M. Imagawa (Nagoya City University, Japan) for providing Lrrc8c<SUP>-/-</SUP> mice and P.G. Thomas (St. Jude Children's Research Hospital) for the gift of influenza A/PR8 viral stocks. We thank P. Schwarzberg (NIH) and M. Pipkin (Scripps Research) for providing us with plasmids for expression of sgRNA and shRNA, respectively. We thank B. Desai (University of Virginia School of Medicine) for critical reading of the manuscript and members of the Feske laboratory for helpful discussions.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balka KR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.056; Bouis D, 2019, J ALLERGY CLIN IMMUN, V143, P712, DOI 10.1016/j.jaci.2018.04.034; Burow P, 2015, PFLUG ARCH EUR J PHY, V467, P1215, DOI 10.1007/s00424-014-1561-8; Cerboni S, 2017, J EXP MED, V214, P1769, DOI 10.1084/jem.20161674; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Chen X, 2021, J IMMUNOL, V206, P2061, DOI 10.4049/jimmunol.2000989; Choi J, 2019, NUCLEIC ACIDS RES, V47, pD780, DOI 10.1093/nar/gky1020; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Diercks BP, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat0358; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang Bonnie, 2019, Curr Protoc Immunol, V124, pe62, DOI 10.1002/cpim.62; Imanishi T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800282; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Kar P, 2014, CURR BIOL, V24, P1361, DOI 10.1016/j.cub.2014.04.046; Kaufmann U, 2016, J IMMUNOL, V196, P573, DOI 10.4049/jimmunol.1501406; Kern DM, 2019, ELIFE, V8, DOI 10.7554/eLife.42636; Konig B, 2019, BIOPHYS J, V116, P1185, DOI 10.1016/j.bpj.2019.02.014; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lahey LJ, 2020, MOL CELL, V80, P578, DOI 10.1016/j.molcel.2020.10.021; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Li WW, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay9013; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luck JC, 2018, J BIOL CHEM, V293, P11796, DOI 10.1074/jbc.RA118.003853; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Ma Z, 2018, ANNU REV VIROL, V5, P341, DOI 10.1146/annurev-virology-092917-043244; Madapura HS, 2012, CELL CYCLE, V11, P4563, DOI 10.4161/cc.22810; Motwani M, 2019, P NATL ACAD SCI USA, V116, P7941, DOI 10.1073/pnas.1818281116; Nguyen TAT, 2018, NUCLEIC ACIDS RES, V46, P8153, DOI 10.1093/nar/gky720; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Platt CD, 2017, J ALLERGY CLIN IMMUN, V140, P1651, DOI 10.1016/j.jaci.2016.12.974; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Shaw PJ, 2013, CELL MOL LIFE SCI, V70, P2637, DOI 10.1007/s00018-012-1175-2; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Vaeth M, 2020, TRENDS IMMUNOL, V41, P878, DOI 10.1016/j.it.2020.06.012; Vaeth M, 2016, IMMUNITY, V44, P1350, DOI 10.1016/j.immuni.2016.04.013; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JJ, 2020, IMMUNITY, V53, P115, DOI 10.1016/j.immuni.2020.06.009; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016	66	11	11	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					287	+		10.1038/s41590-021-01105-x	http://dx.doi.org/10.1038/s41590-021-01105-x		FEB 2022	39	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35105987	Green Accepted			2022-12-18	WOS:000749438000001
J	Zhang, JJ; Qiu, JX; Zhou, WY; Cao, JP; Hu, XF; Mi, WL; Su, B; He, B; Qiu, J; Shen, L				Zhang, Jingjing; Qiu, Jinxin; Zhou, Wenyong; Cao, Jianping; Hu, Xuefei; Mi, Wenli; Su, Bing; He, Bin; Qiu, Ju; Shen, Lei			Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; TGF-BETA; PULMONARY-FIBROSIS; MACROPHAGES; TGF-BETA(1); RECEPTOR; ID2	ILC2s are heterogeneous, dependent on tissue location. Here the authors show that TGF beta-induced neuropilin-1 specifically marks lung ILC2s and controls their function in pulmonary fibrosis by inducing expression of the ST2 IL-33 receptor. Group 2 innate lymphoid cells (ILC2s) are highly heterogeneous tissue-resident lymphocytes that regulate inflammation and tissue homeostasis in health and disease. However, how these cells integrate into the tissue microenvironment to perform tissue-specific functions is unclear. Here, we show neuropilin-1 (Nrp1), which is induced postnatally and sustained by lung-derived transforming growth factor beta-1 (TGF beta 1), is a tissue-specific marker of lung ILC2s. Genetic ablation or pharmacological inhibition of Nrp1 suppresses IL-5 and IL-13 production by ILC2s and protects mice from the development of pulmonary fibrosis. Mechanistically, TGF beta 1-Nrp1 signaling enhances ILC2 function and type 2 immunity by upregulating IL-33 receptor ST2 expression. These findings identify Nrp1 as a tissue-specific regulator of lung-resident ILC2s and highlight Nrp1 as a potential therapeutic target for pulmonary fibrosis.	[Zhang, Jingjing; Su, Bing; Shen, Lei] Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Shanghai Inst Immunol,Dept Immunol & Microbiol, Shanghai, Peoples R China; [Zhang, Jingjing; Su, Bing; Shen, Lei] Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Shanghai, Peoples R China; [Zhang, Jingjing; Shen, Lei] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai, Peoples R China; [Qiu, Jinxin; Qiu, Ju] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai, Peoples R China; [Zhou, Wenyong] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Cao, Jianping] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, NHC Key Lab Parasite & Vector Biol, Shanghai, Peoples R China; [Cao, Jianping] Shanghai Jiao Tong Univ, Chinese Ctr Trop Dis Res, Sch Global Hlth, Sch Med, Shanghai, Peoples R China; [Hu, Xuefei] Tongji Univ, Shanghai Pulm Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China; [Mi, Wenli] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Integrat Med & Neurobiol, Shanghai, Peoples R China; [Mi, Wenli] Fudan Univ, Shanghai Med Coll, Inst Integrat Med, Shanghai, Peoples R China; [He, Bin] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Crit Care Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Shanghai Jiao Tong University; Tongji University; Fudan University; Fudan University; Shanghai Jiao Tong University	Shen, L (corresponding author), Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Shanghai Inst Immunol,Dept Immunol & Microbiol, Shanghai, Peoples R China.; Shen, L (corresponding author), Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Shanghai, Peoples R China.; Shen, L (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai, Peoples R China.; Qiu, J (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai, Peoples R China.; He, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Crit Care Med, Shanghai, Peoples R China.	bin_he@sjtu.edu.cn; qiuju@sibs.ac.cn; lshen@shsmu.edu.cn	Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047; Zhang, Jingjing/0000-0002-4707-415X; , qiu ju/0000-0002-1543-5678; , he bin/0000-0001-8468-7492; Shen, Lei/0000-0003-2811-7094	Ministry of Science and Technology of China [2020YFA0509200, 2020YFA0509103]; National Natural Science Foundation of China [81971487, 32022027, 31970860]; Science and Technology Commission of Shanghai Municipality [20ZR1430200, 20142202300, 20ZR1466900]; Shanghai Jiao Tong University School of Medicine Innovation Team on Pediatric Research	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Jiao Tong University School of Medicine Innovation Team on Pediatric Research	We thank members of L. Shen's laboratory for their help and suggestions on this project. We thank the National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention for help with N. brasiliensis infection experiments. We thank the Flow Cytometry Facility and Animal Facility at Shanghai Jiao Tong University School of Medicine for service and assistance. We thank J. Zhou and T. Hong for helping with human samples collection. We thank E. Engleman for editing the manuscript. This study was supported by grant 2020YFA0509200 (to L.S.) and 2020YFA0509103 (to J.Q.) from the Ministry of Science and Technology of China, grant 81971487 (to L.S.), 32022027 and 31970860 (to J.Q.) from the National Natural Science Foundation of China, grant 20ZR1430200, 20142202300 (to L.S.) and 20ZR1466900 (to J.Q.) from Science and Technology Commission of Shanghai Municipality, and Shanghai Jiao Tong University School of Medicine Innovation Team on Pediatric Research (to L.S.).	Bi JC, 2017, J IMMUNOL, V198, P3336, DOI 10.4049/jimmunol.1601830; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Evren E, 2021, IMMUNITY, V54, P259, DOI 10.1016/j.immuni.2020.12.003; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Lichtman MK, 2016, WOUND REPAIR REGEN, V24, P215, DOI 10.1111/wrr.12398; Liu C, 2020, NAT IMMUNOL, V21, P1010, DOI 10.1038/s41590-020-0733-2; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Passalacqua G, 2017, PULM PHARMACOL THER, V45, P95, DOI 10.1016/j.pupt.2017.05.007; Qiu JX, 2021, MUCOSAL IMMUNOL, V14, P1306, DOI 10.1038/s41385-021-00431-5; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Shikhagaie MM, 2017, CELL REP, V18, P1761, DOI 10.1016/j.celrep.2017.01.063; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14876-y; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012	48	11	11	14	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					237	+		10.1038/s41590-021-01097-8	http://dx.doi.org/10.1038/s41590-021-01097-8		JAN 2022	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35075279	hybrid			2022-12-18	WOS:000746478500003
J	Ma, KY; Schonnesen, AA; He, CF; Xia, AY; Sun, E; Chen, E; Sebastian, KR; Guo, YW; Balderas, R; Kulkarni-Date, M; Jiang, N				Ma, Ke-Yue; Schonnesen, Alexandra A.; He, Chenfeng; Xia, Amanda Y.; Sun, Eric; Chen, Eunise; Sebastian, Katherine R.; Guo, Yu-Wan; Balderas, Robert; Kulkarni-Date, Mrinalini; Jiang, Ning			High-throughput and high-dimensional single-cell analysis of antigen-specific CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							DISCOVERY; EPITOPES; QUANTIFICATION	Jiang and colleagues describe a high-dimensional, high-throughput tetramer-associated TCR sequencing (TetTCR-SeqHD) method to simultaneously profile TCR sequences, cognate antigen specificities, targeted gene expression and surface-protein expression from tens of thousands of single cells. Although critical to T cell function, antigen specificity is often omitted in high-throughput multiomics-based T cell profiling due to technical challenges. We describe a high-dimensional, tetramer-associated T cell antigen receptor (TCR) sequencing (TetTCR-SeqHD) method to simultaneously profile cognate antigen specificities, TCR sequences, targeted gene expression and surface-protein expression from tens of thousands of single cells. Using human polyclonal CD8(+) T cells with known antigen specificity and TCR sequences, we demonstrate over 98% precision for detecting the correct antigen specificity. We also evaluate gene expression and phenotypic differences among antigen-specific CD8(+) T cells and characterize phenotype signatures of influenza- and Epstein-Barr virus-specific CD8(+) T cells that are unique to their pathogen targets. Moreover, with the high-throughput capacity of profiling hundreds of antigens simultaneously, we apply TetTCR-SeqHD to identify antigens that preferentially enrich cognate CD8(+) T cells in patients with type 1 diabetes compared to healthy controls and discover a TCR that cross-reacts with diabetes-related and microbiome antigens. TetTCR-SeqHD is a powerful approach for profiling T cell responses in humans and mice.	[Ma, Ke-Yue; Jiang, Ning] Univ Texas Austin, Interdisciplinary Life Sci Grad Programs, Austin, TX 78712 USA; [Schonnesen, Alexandra A.; He, Chenfeng; Sun, Eric; Jiang, Ning] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Xia, Amanda Y.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Chen, Eunise] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Sebastian, Katherine R.; Kulkarni-Date, Mrinalini] Univ Texas Austin, Dell Med Sch, Dept Internal Med, Austin, TX 78712 USA; [Guo, Yu-Wan] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA; [Guo, Yu-Wan; Jiang, Ning] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Balderas, Robert] Becton Dickinson, San Jose, CA USA; [Jiang, Ning] Univ Texas Austin, Dept Oncol, Dell Med Sch, Austin, TX 78712 USA; [Jiang, Ning] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Pennsylvania; Becton Dickinson; University of Texas System; University of Texas Austin; University of Pennsylvania; Pennsylvania Medicine	Jiang, N (corresponding author), Univ Texas Austin, Interdisciplinary Life Sci Grad Programs, Austin, TX 78712 USA.; Jiang, N (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Jiang, N (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Jiang, N (corresponding author), Univ Texas Austin, Dept Oncol, Dell Med Sch, Austin, TX 78712 USA.; Jiang, N (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	jnjiang@upenn.edu	Ma, Kevin/ABB-9237-2020					Abreu JRF, 2012, CLIN EXP IMMUNOL, V170, P57, DOI 10.1111/j.1365-2249.2012.04635.x; Bender C, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.606434; Blancou P, 2007, J IMMUNOL, V178, P7458, DOI 10.4049/jimmunol.178.11.7458; Cole DK, 2016, J CLIN INVEST, V126, P3626, DOI 10.1172/JCI89919; Culina S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4013; Davis MM, 2019, CURR OPIN IMMUNOL, V59, P109, DOI 10.1016/j.coi.2019.05.012; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Fernandez DM, 2019, NAT MED, V25, P1576, DOI 10.1038/s41591-019-0590-4; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Gayoso A, 2021, NAT METHODS, V18, P272, DOI 10.1038/s41592-020-01050-x; Granja JM, 2019, NAT BIOTECHNOL, V37, P1458, DOI 10.1038/s41587-019-0332-7; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Joglekar AV, 2019, NAT METHODS, V16, P191, DOI 10.1038/s41592-018-0304-8; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Keating R, 2018, IMMUNOL CELL BIOL, V96, P1104, DOI 10.1111/imcb.12189; Kisielow J, 2019, NAT IMMUNOL, V20, P652, DOI 10.1038/s41590-019-0335-z; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Kula T, 2019, CELL, V178, P1016, DOI 10.1016/j.cell.2019.07.009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li GD, 2019, NAT METHODS, V16, P183, DOI 10.1038/s41592-018-0305-7; Pita-Lopez ML, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00616; Ma KY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00033; Mair F, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.063; McInnes L., 2018, ARXIV PREPRINT ARXIV, DOI DOI 10.21105/JOSS.00861; Men Y, 1999, J IMMUNOL, V162, P3566; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Pulendran B, 2020, SCIENCE, V369, P1582, DOI 10.1126/science.aay4014; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Satpathy AT, 2018, NAT MED, V24, P580, DOI 10.1038/s41591-018-0008-8; Shahi P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44447; Sharma G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12444-7; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Shum EY, 2019, ADV EXP MED BIOL, V1129, P63, DOI 10.1007/978-981-13-6037-4_5; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Wendel BS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00645-x; Wiedeman AE, 2020, J CLIN INVEST, V130, P480, DOI 10.1172/JCI126595; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zhang SQ, 2018, NAT BIOTECHNOL, V36, P1156, DOI 10.1038/nbt.4282	46	11	11	7	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1590	+		10.1038/s41590-021-01073-2	http://dx.doi.org/10.1038/s41590-021-01073-2		NOV 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM		Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000722315400009
J	Dai, LP; Xu, K; Li, JH; Huang, QR; Song, J; Han, YX; Zheng, TY; Gao, P; Lu, XC; Yang, HB; Liu, KF; Xia, QF; Wang, QH; Chai, Y; Qi, JX; Yan, JH; Gao, GF				Dai, Lianpan; Xu, Kun; Li, Jinhe; Huang, Qingrui; Song, Jian; Han, Yuxuan; Zheng, Tianyi; Gao, Ping; Lu, Xuancheng; Yang, Huabing; Liu, Kefang; Xia, Qianfeng; Wang, Qihui; Chai, Yan; Qi, Jianxun; Yan, Jinghua; Gao, George F.			Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch	NATURE IMMUNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; VIRUS-INFECTION; STRUCTURAL BASIS; RECOGNITION; DISEASE; NEUTRALIZATION; FLAVIVIRUSES; DETERMINANTS; PROTEIN; POTENT	Antibody-dependent enhancement (ADE) is an important safety concern for vaccine development against dengue virus (DENV) and its antigenically related Zika virus (ZIKV) because vaccine may prime deleterious antibodies to enhance natural infections. Cross-reactive antibodies targeting the conserved fusion loop epitope (FLE) are known as the main sources of ADE. We design ZIKV immunogens engineered to change the FLE conformation but preserve neutralizing epitopes. Single vaccination conferred sterilizing immunity against ZIKV without ADE of DENV-serotype 1-4 infections and abrogated maternal-neonatal transmission in mice. Unlike the wild-type-based vaccine inducing predominately cross-reactive ADE-prone antibodies, B cell profiling revealed that the engineered vaccines switched immunodominance to dispersed patterns without DENV enhancement. The crystal structure of the engineered immunogen showed the dimeric conformation of the envelope protein with FLE disruption. We provide vaccine candidates that will prevent both ZIKV infection and infection-/vaccination-induced DENV ADE. Antibody-dependent enhancement (ADE) is an important safety concern for vaccine development against dengue virus (DENV) and the antigenically related Zika virus (ZIKV). Gao and colleagues designed a ZIKV vaccine that induced sterilizing immunity and fetal protection in mice challenged with ZIKV and did not induce ADE following subsequent DENV infection.	[Dai, Lianpan; Song, Jian; Wang, Qihui; Chai, Yan; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Dai, Lianpan; Li, Jinhe; Han, Yuxuan; Zheng, Tianyi; Gao, Ping; Gao, George F.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dai, Lianpan; Xu, Kun; Xia, Qianfeng] Hainan Med Univ, Affiliated Hosp 1, Sch Trop Med & Lab Med, Key Lab Trop Translat Med,Minist Educ, Haikou, Hainan, Peoples R China; [Li, Jinhe; Zheng, Tianyi; Gao, Ping; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing, Peoples R China; [Huang, Qingrui; Yang, Huabing; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China; [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent China CDC, Lab Anim Ctr, Beijing, Peoples R China; [Liu, Kefang] Univ Macau, Fac Hlth Sci, Macau, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hainan Medical University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Center for Disease Control & Prevention; University of Macau	Dai, LP; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Dai, LP; Gao, GF (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Dai, LP (corresponding author), Hainan Med Univ, Affiliated Hosp 1, Sch Trop Med & Lab Med, Key Lab Trop Translat Med,Minist Educ, Haikou, Hainan, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing, Peoples R China.; Yan, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.	dailp@im.ac.cn; yanjh@im.ac.cn; gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021	Song, Jian/0000-0003-2004-9250	National Science and Technology Major Project [2016YFE0205800, 2020YFA0907100]; National Natural Science Foundation of China (NSFC) [81991494, 81801648]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29010202]; Youth Innovation Promotion Association CAS [2018113]	National Science and Technology Major Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association CAS	We thank the staff of BL17U and BL19U beamlines at National Center for Protein Sciences Shanghai and Shanghai Synchrotron Radiation Facility (Shanghai, China) for assistance during data collection. We are grateful to J. Jia (Institute of Biophysics, Chinese Academy of Sciences (CAS), China) for technical support during BD FACSAria II manipulation. We thank Y. Chen (Institute of Biophysics, CAS, China) for technical support with BIAcore experiments. We thank D. Zhou (Institut Pasteur of Shanghai, CAS, China) for providing us with the AdC7 vector. We thank G. Cheng (Tsinghua University, Beijing, China) and Q. Leng (Institut Pasteur of Shanghai, CAS, China) for providing AG6 mice for breeding. We thank R. Gong (Wuhan Institute of Virology, CAS) for providing ZIKV-sE dimer protein. We thank Y. Chen (China CDC) for breeding of AG6 and Ifnar1<SUP>-/-</SUP> mice. We thank C. Liu (Guangxi University, China) for technical support. This work is supported by the National Science and Technology Major Project (2016YFE0205800 and 2020YFA0907100) (L.D. and G.F.G.), the National Natural Science Foundation of China (NSFC) (81991494 and 81801648) (L.D.) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010202) (G.F.G). L.D. is supported by Youth Innovation Promotion Association CAS (2018113).	Aad G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.161801; Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bennett KM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0194-0; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Dai LP, 2018, SUBCELL BIOCHEM, V88, P147, DOI 10.1007/978-981-10-8456-0_7; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002; Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015; George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089; Howley P.M., 2013, PETER FIELDS VIROLOG, V6th; Katzelnick LC, 2020, SCIENCE, V369, P1123, DOI 10.1126/science.abb6143; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z; Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]; Yang CP, 2019, J BIOL CHEM, V294, P10638, DOI 10.1074/jbc.RA119.007443; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; York Ashley, 2020, Nat Rev Microbiol, V18, P605, DOI 10.1038/s41579-020-00455-x; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	59	11	11	10	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					958	+		10.1038/s41590-021-00966-6	http://dx.doi.org/10.1038/s41590-021-00966-6		JUL 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34267374	Bronze			2022-12-18	WOS:000673826600001
J	Rose, SA; Wroblewska, A; Dhainaut, M; Yoshida, H; Shaffer, JM; Bektesevic, A; Ben-Zvi, B; Rhoads, A; Kim, EY; Yu, BF; Lavin, Y; Merad, M; Buenrostro, JD; Brown, BD				Rose, Samuel A.; Wroblewska, Aleksandra; Dhainaut, Maxime; Yoshida, Hideyuki; Shaffer, Jonathan M.; Bektesevic, Anela; Ben-Zvi, Benjamin; Rhoads, Andrew; Kim, Edy Y.; Yu, Bingfei; Lavin, Yonit; Merad, Miriam; Buenrostro, Jason D.; Brown, Brian D.		Immunological Genome Consortium	A microRNA expression and regulatory element activity atlas of the mouse immune system	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM; TRANSCRIPTION; MACROPHAGE; CHROMATIN; TISSUE; DIFFERENTIATION; IDENTIFICATION; ANNOTATION; EVOLUTION; PROFILES	To better define the control of immune system regulation, we generated an atlas of microRNA (miRNA) expression from 63 mouse immune cell populations and connected these signatures with assay for transposase-accessible chromatin using sequencing (ATAC-seq), chromatin immunoprecipitation followed by sequencing (ChIP-seq) and nascent RNA profiles to establish a map of miRNA promoter and enhancer usage in immune cells. miRNA complexity was relatively low, with >90% of the miRNA compartment of each population comprising <75 miRNAs; however, each cell type had a unique miRNA signature. Integration of miRNA expression with chromatin accessibility revealed putative regulatory elements for differentially expressed miRNAs, including miR-21a, miR-146a and miR-223. The integrated maps suggest that many miRNAs utilize multiple promoters to reach high abundance and identified dominant and divergent miRNA regulatory elements between lineages and during development that may be used by clustered miRNAs, such as miR-99a/let-7c/miR-125b, to achieve distinct expression. These studies, with web-accessible data, help delineate the cis-regulatory elements controlling miRNA signatures of the immune system. Brown and colleagues generated an atlas of miRNA expression profiles from primary mouse immune cell populations and connected these signatures with ATAC-seq, ChIP-seq and nascent RNA profiles to establish a map of miRNA promoter and enhancer usage in immune cells.	[Rose, Samuel A.; Wroblewska, Aleksandra; Dhainaut, Maxime; Bektesevic, Anela; Ben-Zvi, Benjamin; Lavin, Yonit; Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Rose, Samuel A.; Wroblewska, Aleksandra; Bektesevic, Anela; Ben-Zvi, Benjamin; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Yoshida, Hideyuki] RIKEN Ctr Integrat Med Sci, YCI Lab Immunol Transcript, Yokohama, Kanagawa, Japan; [Shaffer, Jonathan M.] Qiagen, Frederick, MA USA; [Rhoads, Andrew] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Kim, Edy Y.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Kim, Edy Y.] Harvard Med Sch, Boston, MA 02115 USA; [Yu, Bingfei] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Ontol Sci, New York, NY 10029 USA; [Buenrostro, Jason D.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Buenrostro, Jason D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	brian.brown@mssm.edu	Kim, Edy/ABF-7592-2021; Grieshaber-Bouyer, Dr. Ricardo/R-7512-2016; Nutt, Stephen/C-9256-2013	Kim, Edy/0000-0002-9095-3109; Lareau, Caleb/0000-0003-4179-4807; Lavin, Yonit/0000-0003-0593-3910; Grieshaber-Bouyer, Dr. Ricardo/0000-0002-2873-5135; Omilusik, Kyla/0000-0003-3675-048X; Nutt, Stephen/0000-0002-0020-6637; Allan, Rhys/0000-0003-0906-2980	NIH [R01AI113221, R01AT011326, R01CA257195, R01CA254104, R24AI072073]; Cancer Research Institute; Alliance for Cancer Gene Therapy; NIH Director's New Innovator Award [DP2HL151353];  [T32AI007605]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Alliance for Cancer Gene Therapy; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We thank all members of the ImmGen Consortium for their comments and advice throughout this work and for their critical feedback on the manuscript, especially C. Benoist (Harvard), L. Lanier (UCSF), S. Nutt (WEHI), P. Monach (Boston U), S. Turley (Genetech) and D. Hasson (Mount Sinai). B.D.B. was supported by the NIH (nos. R01AI113221 and R01AT011326), the Cancer Research Institute and the Alliance for Cancer Gene Therapy. M.M. was supported by the NIH (nos. R01CA257195 and R01CA254104), and S.A.R. by no. T32AI007605. J.D.B. acknowledges support from the NIH Director's New Innovator Award (no. DP2HL151353). This work was also supported by the NIH (no. R24AI072073) to the ImmGen Consortium.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Baccarini A, 2010, METHODS MOL BIOL, V667, P215, DOI 10.1007/978-1-60761-811-9_15; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonelt P, 2019, EMBO J, V38, DOI 10.15252/embj.2018100010; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Bouvy-Liivrand M, 2017, NUCLEIC ACIDS RES, V45, P12054, DOI 10.1093/nar/gkx909; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chang TC, 2015, GENOME RES, V25, P1401, DOI 10.1101/gr.193607.115; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Danko CG, 2018, NAT ECOL EVOL, V2, P537, DOI 10.1038/s41559-017-0447-5; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; DebRoy S, 2021, BIOSTRINGS EFFICIENT; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gasperini M, 2020, NAT REV GENET, V21, P292, DOI 10.1038/s41576-019-0209-0; Georgakilas G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6700; Giraldez MD, 2018, NAT BIOTECHNOL, V36, P746, DOI 10.1038/nbt.4183; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Johanson TM, 2018, NAT IMMUNOL, V19, P1257, DOI 10.1038/s41590-018-0234-8; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kalvari I, 2021, NUCLEIC ACIDS RES, V49, pD192, DOI 10.1093/nar/gkaa1047; Kingston ER, 2019, GENOME RES, V29, P1777, DOI 10.1101/gr.251421.119; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin M., 2011, EMBNET J, V17, P5, DOI 10.14806/ej.17.1.200; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Montagner S, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-14; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mui ALF, 2015, JOVE-J VIS EXP, V100, P52807; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nair SJ, 2019, NAT STRUCT MOL BIOL, V26, P193, DOI 10.1038/s41594-019-0190-5; Nelson VL, 2018, GENE DEV, V32, P1035, DOI 10.1101/gad.312355.118; Nussing S, 2020, J IMMUNOL, V204, P2308, DOI 10.4049/jimmunol.1901396; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Quinlan AR, 2010, BEDTOOLS MANUAL; Ribas J, 2012, NUCLEIC ACIDS RES, V40, P6821, DOI 10.1093/nar/gks308; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Nogales A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00468; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; van Buuren S, 2011, J STAT SOFTW, V45, P1; Venables W.N., 2002, MODERN APPL STAT S, V4th ed., DOI DOI 10.1198/TECH.2003.S33; Wei CL, 2015, CELL REP, V10, P1521, DOI 10.1016/j.celrep.2015.02.013; Wroblewska A, 2018, CELL, V175, P1141, DOI 10.1016/j.cell.2018.09.022; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Ye ZD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05552-3; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhu YN, 2017, GENE DEV, V31, P141, DOI 10.1101/gad.293910.116	81	11	11	6	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					914	+		10.1038/s41590-021-00944-y	http://dx.doi.org/10.1038/s41590-021-00944-y		JUN 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34099919	Green Accepted			2022-12-18	WOS:000658651000005
J	Jagannathan, P; Wang, TT				Jagannathan, Prasanna; Wang, Taia T.			Immunity after SARS-CoV-2 infections	NATURE IMMUNOLOGY			English	Editorial Material								T cell responses probably play important roles in the control of SARS-CoV-2 infection, but they have been relatively understudied. Data now suggest that the majority of infected individuals develop robust and long-lasting T cell immunity, which has implications for the durability of immunity and future vaccine approaches.	[Jagannathan, Prasanna; Wang, Taia T.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Jagannathan, Prasanna; Wang, Taia T.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Wang, Taia T.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Stanford University; Stanford University	Jagannathan, P; Wang, TT (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.; Jagannathan, P; Wang, TT (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Wang, TT (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	prasj@stanford.edu; taiawang@stanford.edu	Jagannathan, Prasanna/AAC-4176-2022	Jagannathan, Prasanna/0000-0001-6305-758X; , Taia/0000-0002-3894-685X	Stanford University; Searle Scholars Program; CEND COVID Catalyst Fund; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI111825, U54CA260517, U01AI150741-01S1, R01AI139119]; Fast Grants; Chan Zuckerberg Biohub	Stanford University(Stanford University); Searle Scholars Program; CEND COVID Catalyst Fund; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fast Grants; Chan Zuckerberg Biohub	Support was received from Stanford University, the Chan Zuckerberg Biohub and the Searle Scholars Program. Research reported in this publication was supported by Fast Grants, CEND COVID Catalyst Fund and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award nos. U19AI111825, U54CA260517, U01AI150741-01S1 and R01AI139119.	Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Sattler A, 2020, J CLIN INVEST, V130, DOI 10.1172/JCI140965; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	9	11	13	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					539	540		10.1038/s41590-021-00923-3	http://dx.doi.org/10.1038/s41590-021-00923-3		APR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33875881	Bronze			2022-12-18	WOS:000641210500001
J	van Beek, JJP; Rescigno, M; Lugli, E				van Beek, Jasper J. P.; Rescigno, Maria; Lugli, Enrico			A fresh look at the T helper subset dogma	NATURE IMMUNOLOGY			English	Article							HETEROGENEITY	Single-cell-sequencing techniques enable the decades-old T helper subset dogma to be re-examined in an unsupervised manner, bringing nuance to the definition of known subsets while simultaneously identifying interesting new cell states.	[van Beek, Jasper J. P.; Rescigno, Maria; Lugli, Enrico] IRCCS, Humanitas Cinical & Res Ctr, Milan, Italy; [Rescigno, Maria] Humanitas Univ, Dept Biomed Sci, Milan, Italy	Humanitas University	Lugli, E (corresponding author), IRCCS, Humanitas Cinical & Res Ctr, Milan, Italy.	enrico.lugli@humanitasresearch.it	Lugli, Enrico/AAB-7933-2019; van Beek, Jasper J. P./ABG-6679-2020; Rescigno, Maria/J-9704-2012	Lugli, Enrico/0000-0002-1964-7678; van Beek, Jasper J. P./0000-0001-5888-0125; Rescigno, Maria/0000-0002-6464-509X	European Research Council [ERC-StG-2014 PERSYST 640511, ERC_CoG 615735]; Associazione Italiana per la Ricerca sul Cancro [AIRC IG 20676, AIRC 5x1000 UniCanVax 22757]; AIRC [IG 22026 2018, 5x1000 UniCanVax 22757]	European Research Council(European Research Council (ERC)European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	E.L. is funded by grants from the European Research Council (ERC-StG-2014 PERSYST 640511) and by the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 20676 and AIRC 5x1000 UniCanVax 22757). M.R. is funded by grants from the European Research Council (ERC_CoG 615735 Homeogut), AIRC IG 22026 2018 and AIRC 5x1000 UniCanVax 22757.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Faria AMC, 2017, J EXP MED, V214, P1211, DOI 10.1084/jem.20162014; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Magen A, 2019, CELL REP, V29, P3019, DOI 10.1016/j.celrep.2019.10.131; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Soon MSF, 2020, NAT IMMUNOL, V21, P1597, DOI 10.1038/s41590-020-0800-8; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014	13	11	11	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					104	105		10.1038/s41590-020-00858-1	http://dx.doi.org/10.1038/s41590-020-00858-1		JAN 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33462455	Green Accepted			2022-12-18	WOS:000608675100003
J	Ozen, A; Kasap, N; Vujkovic-Cvijin, I; Apps, R; Cheung, F; Karakoc-Aydiner, E; Akkelle, B; Sari, S; Tutar, E; Ozcay, F; Uygun, DK; Islek, A; Akgun, G; Selcuk, M; Sezer, OB; Zhang, Y; Kutluk, G; Topal, E; Sayar, E; Celikel, C; Houwen, RHJ; Bingol, A; Ogulur, I; Eltan, SB; Snow, AL; Lake, C; Fantoni, G; Alba, C; Sellers, B; Chauvin, SD; Dalgard, CL; Harari, O; Ni, YG; Wang, MD; Devalaraja-Narashimha, K; Subramanian, P; Ergelen, R; Artan, R; Guner, SN; Dalgic, B; Tsang, J; Belkaid, Y; Ertem, D; Baris, S; Lenardo, MJ				Ozen, Ahmet; Kasap, Nurhan; Vujkovic-Cvijin, Ivan; Apps, Richard; Cheung, Foo; Karakoc-Aydiner, Elif; Akkelle, Bilge; Sari, Sinan; Tutar, Engin; Ozcay, Figen; Uygun, Dilara Kocacik; Islek, Ali; Akgun, Gamze; Selcuk, Merve; Sezer, Oya Balci; Zhang, Yu; Kutluk, Gunsel; Topal, Erdem; Sayar, Ersin; Celikel, Cigdem; Houwen, Roderick H. J.; Bingol, Aysen; Ogulur, Ismail; Eltan, Sevgi Bilgic; Snow, Andrew L.; Lake, Camille; Fantoni, Giovanna; Alba, Camille; Sellers, Brian; Chauvin, Samuel D.; Dalgard, Clifton L.; Harari, Olivier; Ni, Yan G.; Wang, Ming-Dauh; Devalaraja-Narashimha, Kishor; Subramanian, Poorani; Ergelen, Rabia; Artan, Reha; Guner, Sukru Nail; Dalgic, Buket; Tsang, John; Belkaid, Yasmine; Ertem, Deniz; Baris, Safa; Lenardo, Michael J.			Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease	NATURE IMMUNOLOGY			English	Article							DECAY-ACCELERATING FACTOR; PROTEIN-LOSING ENTEROPATHY; HEMOLYTIC-UREMIC SYNDROME; LUPUS-ERYTHEMATOSUS SLE; ENDOTHELIAL-CELLS; CD55 DEFICIENCY; SINGLE-CELL; COPY-NUMBER; COMPLEMENT; ECULIZUMAB	CHAPLE disease is a lethal syndrome caused by genetic loss of the complement regulatory protein CD55. Lenardo, Ozen and their colleagues report that blockade of C5 complement activation in a small cohort of pediatric patients with CHAPLE disease reduced gastrointestinal pathology and restored their immunity and growth. Complement hyperactivation, angiopathic thrombosis and protein-losing enteropathy (CHAPLE disease) is a lethal disease caused by genetic loss of the complement regulatory protein CD55, leading to overactivation of complement and innate immunity together with immunodeficiency due to immunoglobulin wasting in the intestine. We report in vivo human data accumulated using the complement C5 inhibitor eculizumab for the medical treatment of patients with CHAPLE disease. We observed cessation of gastrointestinal pathology together with restoration of normal immunity and metabolism. We found that patients rapidly renormalized immunoglobulin concentrations and other serum proteins as revealed by aptamer profiling, re-established a healthy gut microbiome, discontinued immunoglobulin replacement and other treatments and exhibited catch-up growth. Thus, we show that blockade of C5 by eculizumab effectively re-establishes regulation of the innate immune complement system to substantially reduce the pathophysiological manifestations of CD55 deficiency in humans.	[Ozen, Ahmet; Kasap, Nurhan; Karakoc-Aydiner, Elif; Ogulur, Ismail; Baris, Safa] Marmara Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Istanbul, Turkey; [Ozen, Ahmet; Kasap, Nurhan; Karakoc-Aydiner, Elif; Akgun, Gamze; Ogulur, Ismail; Eltan, Sevgi Bilgic; Baris, Safa] Istanbul Jeffrey Modell Diagnost Ctr Primary Immu, Istanbul, Turkey; [Ozen, Ahmet; Kasap, Nurhan; Karakoc-Aydiner, Elif; Akgun, Gamze; Ogulur, Ismail; Eltan, Sevgi Bilgic; Baris, Safa] Isil Berat Barlan Ctr Translat Med, Istanbul, Turkey; [Vujkovic-Cvijin, Ivan; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Apps, Richard; Cheung, Foo; Fantoni, Giovanna; Sellers, Brian; Tsang, John; Belkaid, Yasmine] Trans NIH Ctr Human Immunol Autoimmun & Inflammat, NIH, Bethesda, MD USA; [Akkelle, Bilge; Tutar, Engin; Ertem, Deniz] Marmara Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Istanbul, Turkey; [Sari, Sinan; Dalgic, Buket] Gazi Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Ozcay, Figen; Sezer, Oya Balci] Baskent Univ Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Uygun, Dilara Kocacik; Bingol, Aysen] Akdeniz Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Antalya, Turkey; [Islek, Ali] Ataturk Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Erzurum, Turkey; [Akgun, Gamze; Eltan, Sevgi Bilgic] Marmara Univ, Dept Pediat, Div Allergy & Immunol, Minist Hlth, Istanbul, Turkey; [Selcuk, Merve] Marmara Univ, Sch Med, Dept Pediat, Istanbul, Turkey; [Zhang, Yu] NIAID, Human Immunol Dis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhang, Yu; Chauvin, Samuel D.; Lenardo, Michael J.] NIAID, Clin Genom Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kutluk, Gunsel] Hlth Sci Univ, Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Istanbul, Turkey; [Topal, Erdem] Inonu Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Malatya, Turkey; [Sayar, Ersin] Alanya Alaaddin Keykubat Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Alanya, Turkey; [Celikel, Cigdem] Marmara Univ, Sch Med, Dept Pathol, Istanbul, Turkey; [Houwen, Roderick H. J.] Wilhelmina Childrens Hosp, Dept Pediat Gastroenterol, Univ Med Ctr, Utrecht, Netherlands; [Snow, Andrew L.; Lake, Camille] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Alba, Camille] Uniformed Serv Univ Hlth Sci, Henry Jackson Fdn, Amer Genome Ctr, Bethesda, MD USA; [Chauvin, Samuel D.; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chauvin, Samuel D.; Lenardo, Michael J.] NIAID, NIAID Clin Genom Program, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Amer Genome Ctr, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Harari, Olivier; Ni, Yan G.; Wang, Ming-Dauh; Devalaraja-Narashimha, Kishor] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Subramanian, Poorani] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ergelen, Rabia] Marmara Univ, Sch Med, Dept Radiol, Istanbul, Turkey; [Artan, Reha] Akdeniz Univ, Sch Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Antalya, Turkey; [Guner, Sukru Nail] Necmettin Erbakan Univ, Meram Med Fac, Div Pediat Allergy & Immunol, Konya, Turkey	Marmara University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Marmara University; Gazi University; Baskent University; Akdeniz University; Ataturk University; Marmara University; Ministry of Health - Turkey; Marmara University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Istanbul Kanuni Sultan Suleyman Training & Research Hospital; University of Health Sciences Turkey; Inonu University; Alanya Alaaddin Keykubat University; Marmara University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Uniformed Services University of the Health Sciences - USA; Regeneron; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Marmara University; Akdeniz University; Necmettin Erbakan University; Selcuk University	Ozen, A (corresponding author), Marmara Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Istanbul, Turkey.; Ozen, A (corresponding author), Istanbul Jeffrey Modell Diagnost Ctr Primary Immu, Istanbul, Turkey.; Ozen, A (corresponding author), Isil Berat Barlan Ctr Translat Med, Istanbul, Turkey.; Lenardo, MJ (corresponding author), NIAID, Clin Genom Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Lenardo, MJ (corresponding author), NIAID, NIAID Clin Genom Program, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ahmet.ozen@marmara.edu.tr; lenardo@nih.gov	Guner, Sukru Nail/A-9841-2018; Sari, Sinan/AAP-5671-2021; Sezer, Oya Balci/AAI-9346-2021; celikel, cigdem/AAB-6540-2021; Özçay, Figen/ABG-5684-2020; Akkelle, Bilge/AAQ-1629-2021; Islek, Ali/A-6996-2016; eltan, Sevgi Bilgic/ABF-6314-2020; Ogulur, Ismail/GYV-4415-2022; artan, reha/I-6332-2015; Ozen, Ahmet/R-6749-2017; Ertem, Deniz/C-2285-2015	Guner, Sukru Nail/0000-0002-8860-6132; Sezer, Oya Balci/0000-0002-8402-8208; celikel, cigdem/0000-0002-9360-8116; Özçay, Figen/0000-0002-5214-516X; Islek, Ali/0000-0001-6172-7797; artan, reha/0000-0001-6114-9210; Ozen, Ahmet/0000-0002-9065-1901; Ertem, Deniz/0000-0002-4427-0569; Chauvin, Samuel/0000-0003-0232-751X; Harari, Olivier/0000-0001-8214-489X; Dalgard, Clifton/0000-0003-2025-8239; Subramanian, Poorani/0000-0003-4371-7290; Vujkovic-Cvijin, Ivan/0000-0002-8611-4900; Bingol, Aysen/0000-0002-0886-3332	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, BCBB Support Services [HHSN316201300006W/HHSN27200002]; Marmara University, Scientific Research Projects Committee (BAPKO) [SAG-C-TUP-230119-0018]; NIAID Microbiome Program, NIAID, NIH; NIH [R01-GM129325]	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, BCBB Support Services; Marmara University, Scientific Research Projects Committee (BAPKO)(Marmara University); NIAID Microbiome Program, NIAID, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, BCBB Support Services Contract HHSN316201300006W/HHSN27200002, and The Marmara University, Scientific Research Projects Committee (BAPKO, grant no. SAG-C-TUP-230119-0018). We thank the Turkish National Society of Allergy and Clinical Immunology (TNSACI) for supporting travel expenses for the screening studies. We thank C. Kemper of the National Heart, Lung and Blood Institute for thoughtful editing of the final manuscript. We thank M. Quinones, the Center for Human Immunology and the NIAID Microbiome Program, NIAID, NIH, for research support. We also thank A. Kiykim for patient care, A. Dalga and I. Tatli for technical assistance and H. Su and X. He for advice and assistance; D. Comrie, S. Kubo and J. Ravell for critical reading of the manuscript; and R. Kissinger for artwork. We thank important colleagues at Regeneron: A. N. Thomas for sample processing; C. Huang for biomarker analysis; H. Qiu, and E. Sook Yen for eculizumab analysis; and C. H. Lai, L. DeStefano and K. Donohue for total C5 analysis. Molecular graphics and analyses were performed with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization and Informatics at the University of California, San Francisco, with support from NIH R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, NIAID.	Ardissino G, 2018, PEDIATR NEPHROL, V33, P457, DOI 10.1007/s00467-017-3813-2; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Brucker WJ, 2020, J INHERIT METAB DIS, V43, P880, DOI 10.1002/jimd.12225; Candia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14755-5; Cheung F., 2017, J OPEN RES SOFTWARE, V5, P20, DOI [DOI 10.5334/jors.166, 10.5334/jors.166, DOI 10.5334/JORS.166]; Dahm AEA, 2019, THROMB HAEMOSTASIS, V119, P1481, DOI 10.1055/s-0039-1692426; Di Narzo AF, 2019, J CROHNS COLITIS, V13, P462, DOI 10.1093/ecco-jcc/jjy190; Ding H, 2016, CLIN EXP IMMUNOL, V184, P11, DOI 10.1111/cei.12743; Eiseman JL, 2007, CLIN CANCER RES, V13, P2121, DOI 10.1158/1078-0432.CCR-06-2286; Elvington M, 2016, IMMUNOL REV, V274, P9, DOI 10.1111/imr.12474; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Eser E, 2008, TURK PSIKIYATR DERG, V19, P409; Fukuzawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01087-7; Giles JL, 2015, J IMMUNOL, V194, P3029, DOI 10.4049/jimmunol.1402956; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Harris CL, 2018, MOL IMMUNOL, V102, P89, DOI 10.1016/j.molimm.2018.06.008; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; HOMBURGER F, 1949, BLOOD, V4, P1085, DOI 10.1182/blood.V4.10.1085.1085; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaskowski TD, 1999, CLIN DIAGN LAB IMMUN, V6, P137, DOI 10.1128/CDLI.6.1.137-139.1999; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kurolap A, 2019, J PEDIATR GASTR NUTR, V68, P325, DOI 10.1097/MPG.0000000000002198; Kurolap A, 2017, NEW ENGL J MED, V377, P87, DOI 10.1056/NEJMc1707173; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Lintner KE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00036; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mason JC, 2002, AM J PHYSIOL-CELL PH, V282, pC578, DOI 10.1152/ajpcell.00339.2001; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; Notaro R, 2018, SEMIN HEMATOL, V55, P130, DOI 10.1053/j.seminhematol.2018.05.014; Olm MR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5727; Ozen A, 2019, IMMUNOL REV, V287, P20, DOI 10.1111/imr.12715; Ozen A, 2017, NEW ENGL J MED, V377, P1499, DOI 10.1056/NEJMc1710011; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; PARFITT AM, 1966, ARCH DIS CHILD, V41, P54, DOI 10.1136/adc.41.215.54; Park SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094781; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sauter RJ, 2018, CIRCULATION, V138, P1720, DOI 10.1161/CIRCULATIONAHA.118.034600; Savelli SL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00885; Saxena K, 2009, MOL IMMUNOL, V46, P1289, DOI 10.1016/j.molimm.2008.11.018; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Srinivasan M, 2005, CURR PROTEIN PEPT SC, V6, P185, DOI 10.2174/1389203053545426; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tezcan I., 1996, COCUK SAGLIGI HASTAL, V39, P649; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; WALDMANN TA, 1961, GASTROENTEROLOGY, V41, P197; Wong EKS, 2013, MOL IMMUNOL, V56, P199, DOI 10.1016/j.molimm.2013.05.224; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Zaneveld JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.121; Zelek WM, 2019, IMMUNOLOGY, V157, P283, DOI 10.1111/imm.13083; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	70	11	11	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					128	U24		10.1038/s41590-020-00830-z	http://dx.doi.org/10.1038/s41590-020-00830-z		JAN 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398182	Green Accepted			2022-12-18	WOS:000604865800004
J	Liang, GX; Zhao, L; Qiao, Y; Geng, WQ; Zhang, XW; Liu, M; Dong, JX; Ding, HB; Sun, H; Shang, H				Liang, Guoxin; Zhao, Li; Qiao, Ying; Geng, Wenqing; Zhang, Xiaowei; Liu, Mei; Dong, Jinxiu; Ding, Haibo; Sun, Hong; Shang, Hong			Membrane metalloprotease TRABD2A restricts HIV-1 progeny production in resting CD4(+) T cells by degrading viral Gag polyprotein	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPLICATION; INFECTION; SAMHD1; TRANSCRIPTS; INHIBITION; ACTIVATION; REVEALS; RELEASE; ENTRY	Resting CD4(+) T cells are highly resistant to the production of human immunodeficiency virus type 1 (HIV-1). However, the mechanism by which resting CD4(+) T cells restrict such production in the late viral replication phase of infection has remained unclear. In this study, we found that the cell membrane metalloprotease TRAB domain-containing protein 2A (TRABD2A) inhibited this production in resting CD4(+) T cells by degrading the virion structural precursor polyprotein Gag at the plasma membrane. Depletion or inhibition of metalloprotease activity by TRABD2A profoundly enhanced HIV-1 production in resting CD4(+) T cells. TRABD2A expression was much higher in resting CD4(+) T cells than in activated CD4(+) T cells and was considerably reduced by T cell activation. Moreover, reexpressing TRABD2A reinforced the resistance of activated CD4(+) T cells to the production of HIV-1 progeny. Collectively, these results elucidate the molecular mechanism employed by resting CD4(+) T cells to potently restrict the assembly and production of HIV-1 progeny.	[Liang, Guoxin; Zhao, Li; Geng, Wenqing; Liu, Mei; Dong, Jinxiu; Ding, Haibo; Sun, Hong; Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Natl Hlth & Family Planning, Shenyang, Liaoning, Peoples R China; [Liang, Guoxin; Zhao, Li; Geng, Wenqing; Liu, Mei; Dong, Jinxiu; Ding, Haibo; Sun, Hong; Shang, Hong] Chinese Acad Med Sci, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China; [Qiao, Ying; Zhang, Xiaowei] China Med Univ, Affiliated Hosp 1, Core Lab Publ Hlth Sci & Practice, Shenyang, Liaoning, Peoples R China; [Shang, Hong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; China Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Liang, GX; Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Natl Hlth & Family Planning, Shenyang, Liaoning, Peoples R China.; Liang, GX; Shang, H (corresponding author), Chinese Acad Med Sci, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China.; Shang, H (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	gxliang@cmu.edu.cn; hshang@cmu.edu.cn		Liang, Guoxin/0000-0003-1789-9094	Mega Projects of National Science Research for the 13th Five-Year Plan [2017ZX10201101]; Development Plan of Innovative Group of the Ministry of Education 2016 [IRT_16R70]; National Natural Science Foundation of China [81273238]	Mega Projects of National Science Research for the 13th Five-Year Plan; Development Plan of Innovative Group of the Ministry of Education 2016; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all our laboratory members for contributing to this study. We also thank S. Yu, Y. Xiong, J. Ouyang and R. Wang for their technical support. This study was supported by the Mega Projects of National Science Research for the 13th Five-Year Plan (grant no. 2017ZX10201101), Development Plan of Innovative Group of the Ministry of Education 2016 (grant no. IRT_16R70) and the National Natural Science Foundation of China (grant no. 81273238).	Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015; Bouldin CM, 2012, CELL RES, V22, P1621, DOI 10.1038/cr.2012.104; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; DeMaster LK, 2016, J VIROL, V90, P2165, DOI 10.1128/JVI.01913-15; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Graf EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071879; Hatziioannou T, 2005, J VIROL, V79, P15586, DOI 10.1128/JVI.79.24.15586-15589.2005; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Li RH, 2014, MOL CELL BIOCHEM, V392, P109, DOI 10.1007/s11010-014-2023-5; Liang GX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004780; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Plesa G, 2007, J VIROL, V81, P13938, DOI 10.1128/JVI.01745-07; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanchez-Pulido L, 2013, BIOINFORMATICS, V29, P2371, DOI 10.1093/bioinformatics/btt412; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; TANG SB, 1995, J VIROL, V69, P5659, DOI 10.1128/JVI.69.9.5659-5665.1995; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Q, 2016, PEANUTS: PROCESSING TECHNOLOGY AND PRODUCT DEVELOPMENT, P1, DOI 10.1016/B978-0-12-809595-9.00001-6; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang XJ, 2016, J BIOL CHEM, V291, P2435, DOI 10.1074/jbc.M115.677807; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	41	11	13	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					711	+		10.1038/s41590-019-0385-2	http://dx.doi.org/10.1038/s41590-019-0385-2			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31061530				2022-12-18	WOS:000468505100014
J	Meyts, I; Casanova, JL				Meyts, Isabelle; Casanova, Jean-Laurent			A human inborn error connects the alpha's	NATURE IMMUNOLOGY			English	Editorial Material							RNADNA HYBRIDS; VASCULOPATHY; MUTATIONS	Patients with XLPDR are found to carry an intronic hypomorphic mutation in the gene encoding the catalytic subunit of DNA polymerase-alpha. Patients' cells display low levels of cytoplasmic RNA: DNA hybrids, which increases the expression of interferon-alpha-induced genes, a hallmark of monogenic 'type I interferonopathies'.	[Meyts, Isabelle] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Meyts, Isabelle] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Casanova, Jean-Laurent] Rockefeller Univ, Giles Lab Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM, Lab Human Genet Infect Dis, Necker Branch,U1163, Paris, France; [Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol & Immunol Unit, Paris, France	KU Leuven; University Hospital Leuven; KU Leuven; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Meyts, I (corresponding author), Univ Hosp Leuven, Dept Pediat, Leuven, Belgium.; Meyts, I (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	isabelle.meyts@uzleuven.be	Casanova, Jean-Laurent/I-3418-2017; Meyts, Isabelle/Z-3295-2019	Casanova, Jean-Laurent/0000-0002-7782-4169				Belot A, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-44; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Frugoni F, 2016, J ALLERGY CLIN IMMUN, V137, P635, DOI 10.1016/j.jaci.2015.06.049; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; PARTINGTON MW, 1981, AM J MED GENET, V10, P65, DOI 10.1002/ajmg.1320100109; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Schmid JP, 2012, J EXP MED, V209, P2323, DOI 10.1084/jem.20121303; Starokadomskyy P, 2016, NAT IMMUNOL, V17, P495, DOI 10.1038/ni.3409; Van Eyck L, 2015, J ALLERGY CLIN IMMUN, V135, P283, DOI 10.1016/j.jaci.2014.10.010; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	13	11	11	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					472	474		10.1038/ni.3420	http://dx.doi.org/10.1038/ni.3420			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092795				2022-12-18	WOS:000374323100002
J	Dejnirattisai, W; Wongwiwat, W; Supasa, S; Zhang, XK; Dai, XH; Rouvinsky, A; Jumnainsong, A; Edwards, C; Quyen, NTH; Duangchinda, T; Grimes, JM; Tsai, WY; Lai, CY; Wang, WK; Malasit, P; Farrar, J; Simmons, CP; Zhou, ZH; Rey, FA; Mongkolsapaya, J; Screaton, GR				Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Supasa, Sunpetchuda; Zhang, Xiaokang; Dai, Xinghong; Rouvinsky, Alexander; Jumnainsong, Amonrat; Edwards, Carolyn; Nguyen Than Ha Quyen; Duangchinda, Thaneeya; Grimes, Jonathan M.; Tsai, Wen-Yang; Lai, Chih-Yun; Wang, Wei-Kung; Malasit, Prida; Farrar, Jeremy; Simmons, Cameron P.; Zhou, Z. Hong; Rey, Felix A.; Mongkolsapaya, Juthathip; Screaton, Gavin R.			A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus (vol 16, pg 171, 2015)	NATURE IMMUNOLOGY			English	Correction									[Supasa, Sunpetchuda; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Grad Program Immunol,Dept Immunol, Bangkok 10700, Thailand	Mahidol University	Dejnirattisai, W (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Grad Program Immunol,Dept Immunol, Bangkok 10700, Thailand.		Zhou, Z Hong/HDN-0747-2022; Simmons, Cameron P/ABA-3896-2021; Wongwiwat, Wiyada/AAJ-8936-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X; Grimes, Jonathan Mark/0000-0001-9698-0389; Dai, Xinghong/0000-0002-4102-3175; Wongwiwat, Wiyada/0000-0002-5889-0929	MRC [G0600000] Funding Source: UKRI; Medical Research Council [G0600000] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058	1	11	11	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					785	785		10.1038/ni0715-785a	http://dx.doi.org/10.1038/ni0715-785a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086146	Bronze			2022-12-18	WOS:000356445600015
J	Starkl, P; Marichal, T; Galli, SJ				Starkl, Philipp; Marichal, Thomas; Galli, Stephen J.			PLA2G3 promotes mast cell maturation and function	NATURE IMMUNOLOGY			English	Editorial Material							SECRETED PHOSPHOLIPASE A(2); DEGRANULATION; ENZYMES; DISEASE		[Starkl, Philipp; Marichal, Thomas; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Starkl, P (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	sgalli@stanford.edu		Starkl, Philipp/0000-0001-7521-129X	NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, U19AI104209, R37AI023990] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3399] Funding Source: researchfish; Austrian Science Fund FWF [J 3399] Funding Source: Medline; NCI NIH HHS [R01 CA072074] Funding Source: Medline; NIAID NIH HHS [U19 AI104209, R01 AI023990, R37 AI023990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; MURAKAMI M, 1992, EUR J BIOCHEM, V209, P257, DOI 10.1111/j.1432-1033.1992.tb17284.x; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; Varsani M, 1997, INFLAMM RES, V46, pS9	12	11	11	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					527	529		10.1038/ni.2612	http://dx.doi.org/10.1038/ni.2612			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685814	Green Submitted, Green Accepted			2022-12-18	WOS:000319107600002
J	Feinberg, MB; Ahmed, R				Feinberg, Mark B.; Ahmed, Rafi			Born this way? Understanding the immunological basis of effective HIV control	NATURE IMMUNOLOGY			English	Editorial Material							MECHANISMS; INFECTION	'Elite controllers' of human immunodeficiency virus (HIV) maintain a long-term disease-free status after infection with HIV. A comparison of elite controllers and people who progress to disease after infection with HIV now suggests that clonotypic profiles of HIV-specific CD8(+) T cells may underlie elite control.	[Feinberg, Mark B.] Merck, Merck Vaccines, West Point, PA USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Merck & Company; Emory University	Feinberg, MB (corresponding author), Merck, Merck Vaccines, West Point, PA USA.	mark_feinberg@merck.com						Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036	8	11	12	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					632	634		10.1038/ni.2351	http://dx.doi.org/10.1038/ni.2351			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713821				2022-12-18	WOS:000305483800006
J	Lafaille, JJ; Xiong, HZ; de Lafaille, MAC				Lafaille, Juan J.; Xiong, Huizhong; de Lafaille, Maria A. Curotto			On the differentiation of mouse IgE(+) cells	NATURE IMMUNOLOGY			English	Letter									[Lafaille, Juan J.; Xiong, Huizhong] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA; [Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Xiong, Huizhong] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA; [de Lafaille, Maria A. Curotto] Singapore Immunol Network, Singapore, Singapore	New York University; New York University; New York University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Lafaille, JJ (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA.	juan.lafaille@med.nyu.edu		Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777				Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Karnowski A, 2006, EUR J IMMUNOL, V36, P1917, DOI 10.1002/eji.200535495; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	6	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					623	623		10.1038/ni.2313	http://dx.doi.org/10.1038/ni.2313			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713817	Bronze			2022-12-18	WOS:000305483800001
J	Pelzer, C; Thome, M				Pelzer, Christiane; Thome, Margot			IKK alpha takes control of canonical NF-kappa B activation	NATURE IMMUNOLOGY			English	Editorial Material							EDITING ENZYME A20; TAX1BP1	The kinase IKK alpha has a well-described activating role in the noncanonical transcription factor NF-kappa B pathway. Evidence now suggests that IKK alpha also inhibits the canonical NF-kappa B pathway by phosphorylating the scaffold protein TAX1BP1 to promote the assembly of the A20 ubiquitin-editing complex.	[Pelzer, Christiane; Thome, Margot] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Pelzer, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	margot.thomemiazza@unil.ch	Thome, Margot/F-8167-2011	Thome, Margot/0000-0002-5656-2139				HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Verstrepen L, 2011, TRENDS BIOCHEM SCI, V36, P347, DOI 10.1016/j.tibs.2011.03.004; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	14	11	12	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					815	816		10.1038/ni.2082	http://dx.doi.org/10.1038/ni.2082			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21852778				2022-12-18	WOS:000294461200004
J	O'Neill, LAJ				O'Neill, Luke A. J.			Outfoxing Foxo1 with miR-182	NATURE IMMUNOLOGY			English	Editorial Material									Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945	4	11	11	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					983	984		10.1038/ni1110-983	http://dx.doi.org/10.1038/ni1110-983			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959801				2022-12-18	WOS:000283127800006
J	Di Santo, JP				Di Santo, James P.			A defining factor for natural killer cell development	NATURE IMMUNOLOGY			English	Editorial Material							PROGENITORS; GENERATION; RHYTHMS; ROLES; ID2	Transcription factors are critical regulators of cell fate in the hemato-lymphoid system. New evidence indicates that the basic leucine zipper transcription factor E4BP4 (also known as NFIL3) is essential for natural killer cell specification.	[Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France; [Di Santo, James P.] INSERM, U668, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Santo, JP (corresponding author), Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France.	disanto@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862				Arjona A, 2008, NEUROCHEM RES, V33, P708, DOI 10.1007/s11064-007-9501-z; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Eberl G, 2007, TRENDS IMMUNOL, V28, P423, DOI 10.1016/j.it.2007.07.009; Fujimoto S, 2007, INT IMMUNOL, V19, P1175, DOI 10.1093/intimm/dxm085; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	13	11	11	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1051	1052		10.1038/ni1009-1051	http://dx.doi.org/10.1038/ni1009-1051			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19767724				2022-12-18	WOS:000270006900006
J	Hemmers, S; Mowen, KA				Hemmers, Saskia; Mowen, Kerri A.			T(H)2 bias: Mina tips the balance	NATURE IMMUNOLOGY			English	Editorial Material							IL-4 GENE-TRANSCRIPTION; T-CELL; DIFFERENTIATION; EXPRESSION; MECHANISM; NFAT1	Tipping the balance of early cytokine production can lead to lineage bias and, potentially, immune-mediated pathology. Mapping of a leishmania-susceptibility region has identified a gene that may determine the extent of T helper type 2 bias in naive helper T cells.	[Hemmers, Saskia; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Hemmers, Saskia; Mowen, Kerri A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Hemmers, S (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	kmowen@scripps.edu	Hu, Ruogu/B-2203-2008					Affolter M, 2008, DEV CELL, V15, P11, DOI 10.1016/j.devcel.2008.06.006; Baguet A, 2004, J EXP MED, V200, P1605, DOI 10.1084/jem.20040334; Bix M, 1998, J EXP MED, V188, P2289, DOI 10.1084/jem.188.12.2289; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1	11	11	13	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					806	808		10.1038/ni0809-806	http://dx.doi.org/10.1038/ni0809-806			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621039				2022-12-18	WOS:000268141400005
J	Kuijl, C; Neefjes, J				Kuijl, Coenraad; Neefjes, Jacques			New insight into the everlasting host-pathogen arms race	NATURE IMMUNOLOGY			English	Editorial Material							TUBERCULOSIS; RESISTANCE; PROTEINS	New work explains how the interferon-gamma-regulated GTPase Irgm1 on phagosomes responds to intracellular signaling and recruits the 'machinery' for fusion with lysosomes. This pathway overlaps a signaling route controlled by bacteria to prevent the fusion of phagosomes with lysosomes.	[Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute	Kuijl, C (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Kuijl, Coen/0000-0003-4378-1428				Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; CARROLL L, 1871, LOOKING GLASS WHAT A, P46; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Raupach B, 2001, CURR OPIN IMMUNOL, V13, P417, DOI 10.1016/S0952-7915(00)00236-3; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Van Valen L, 1973, EVOL THEORY, V1, P1	11	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					808	809		10.1038/ni0809-808	http://dx.doi.org/10.1038/ni0809-808			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621040				2022-12-18	WOS:000268141400006
J	Lefrancois, L; Masopust, D				Lefrancois, Leo; Masopust, David			The road not taken: memory T cell fate 'decisions'	NATURE IMMUNOLOGY			English	Editorial Material							EFFECTOR; RESPONSES; SUBSETS	Two papers published recently in Science exploit new transgenic mouse systems to explore the path that activated CD8(+) T cells take on the way to memory differentiation.	[Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA.	llefranc@neuron.uchc.edu	masopust, david/B-5027-2008		NIAID NIH HHS [R01 AI041576-14, R01 AI076457-04, R01 AI041576, P01 AI056172, R01 AI078289-05, P01 AI056172-07, R01 AI041576-15, R01 AI076457, R01 AI078289] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, R01AI076457, P01AI056172, R01AI078289] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Marsland BJ, 2005, P NATL ACAD SCI USA, V102, P14374, DOI 10.1073/pnas.0506250102; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2003, MICROBES INFECT, V5, P221, DOI 10.1016/S1286-4579(03)00014-5; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612	10	11	11	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					369	370		10.1038/ni0409-369	http://dx.doi.org/10.1038/ni0409-369			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295636	Green Accepted			2022-12-18	WOS:000264425800009
J	Honjo, T				Honjo, Tasuku			A memoir of AID, which engraves antibody memory on DNA	NATURE IMMUNOLOGY			English	Editorial Material							INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY-CHAIN; V(D)J RECOMBINATION; EXPRESSION; GENES; ORGANIZATION; FAMILY; CELLS; RAG-1; IGM	Tasuku Honjo recounts his work aimed at unraveling the molecular mystery of how antibodies undergo antigen-induced maturation.	Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Mehravaran, Ahmad/S-3958-2017; Honjo, Tasuku/N-4470-2016	Mehravaran, Ahmad/0000-0002-2079-7972; 				DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WANG AC, 1969, IMMUNOCHEMISTRY, V6, P451, DOI 10.1016/0019-2791(69)90301-2; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235	21	11	11	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					335	337		10.1038/ni0408-335	http://dx.doi.org/10.1038/ni0408-335			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349808				2022-12-18	WOS:000254123200004
J	Unutmaz, D; Vilcek, J				Unutmaz, Derya; Vilcek, Jan			IRF1: a deus ex machina in T(H)1 differentiation	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-RESPONSES; TRANSCRIPTION; ANTIBODY; EFFECTOR; FAMILY	The cytokines IFN-gamma and IL-12, a long with the transcription factors STAT4 and T-bet, are necessary for driving T(H)1 development. Fresh data now indicate that the transcription factor IRF1 is also essential in this process.	[Unutmaz, Derya; Vilcek, Jan] NYU Med Ctr, Dept Microbiol, New York, NY 10016 USA	New York University	Vilcek, J (corresponding author), NYU Med Ctr, Dept Microbiol, New York, NY 10016 USA.	jan.vilcek@med.nyu.edu						Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557	11	11	12	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					9	10		10.1038/ni0108-9	http://dx.doi.org/10.1038/ni0108-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087248				2022-12-18	WOS:000251820800004
J	Alon, R; Rosen, S				Alon, Ronen; Rosen, Steven			Rolling on N-linked glycans: a new way to present L-selectin binding sites	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL RECRUITMENT; NONLYMPHOID TISSUES; LIGAND; INFLAMMATION; LYMPHOCYTES; ADHESION; DISTINCT; FLOW	Recruitment of lymphocytes to the lymph nodes requires L-selectin-mediated recognition of carbohydrate determinants presented by O-glycans. New work shows that N-glycans 'decorated' with the same determinants also contribute to lymphocyte homing.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA	Weizmann Institute of Science; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il; rosen@ucsf.edu	ALON, RONEN/GRX-6987-2022	Rosen, Steven/0000-0002-6245-701X; Alon, Ronen/0000-0001-9161-6369				Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MITOMA, 2007, NAT IMMUNOL, V8, P409; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638	12	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					339	341		10.1038/ni0407-339	http://dx.doi.org/10.1038/ni0407-339			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375095				2022-12-18	WOS:000245075900008
J	Zhang, F; Thomas, LR; Oltz, EM; Aune, TM				Zhang, Feng; Thomas, Lance R.; Oltz, Eugene M.; Aune, Thomas M.			Control of thymocyte development and recombination activating gene expression by the zinc finger protein Zfp608	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; MURINE RAG-2 PROMOTER; IMMATURE B-CELLS; C-MYB; IMMUNE-RESPONSE; RECEPTOR-BETA; ELEMENTS 5'; NKT CELLS; MICE; REARRANGEMENT	The products of recombination-activating gene 1 (Rag1) and Rag2 are required for T cell receptor gene assembly and thymocyte maturation, yet their transcriptional control mechanisms remain unclear. A congenic strain (called 'ZORI' here) with defects in Rag1 and Rag2 expression, thymocyte maturation and peripheral T cell homeostasis has been developed. Here, we mapped the mutation in this strain to a chromosome 18 locus containing a single known gene encoding the zinc finger protein Zfp608. This gene (Zfp608) was highly expressed in neonatal thymus but was extinguished thereafter. In contrast to wild-type mice, ZORI mice had sustained thymocyte expression of Zfp608 throughout life. The ZORI mutation produced a thymocyte-intrinsic developmental defect. Overexpression of Zfp608 in BALB/c thymocytes substantially impaired Rag1 and Rag2 expression, indicating the underlying mechanism for the defect in ZORI thymocyte development. Thus, the normal function of Zfp608 may be to prevent Rag1 and Rag2 expression in utero.	Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Immunol & Microbiol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Aune, TM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol, 221 Kirkland Hall, Nashville, TN 37232 USA.	thomas.aune@vanderbilt.edu			NCI NIH HHS [CA100905] Funding Source: Medline; NHLBI NIH HHS [5T32 HL069765, P01 HL68744] Funding Source: Medline; NIAID NIH HHS [AI 44924, F32 AI066691] Funding Source: Medline; NIDDK NIH HHS [5 T32 DK07563] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100905] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044924, R56AI044924, F32AI066691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; AMAGAI T, 1995, EUR J IMMUNOL, V25, P757, DOI 10.1002/eji.1830250320; BLUMBERG H, 1991, GENE, V107, P101, DOI 10.1016/0378-1119(91)90302-R; Brown ST, 1997, J IMMUNOL, V158, P5071; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Cipollina C, 2005, YEAST, V22, P385, DOI 10.1002/yea.1218; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003; Fong IC, 2000, MOL IMMUNOL, V37, P391, DOI 10.1016/S0161-5890(00)00056-0; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hoebeke I, 2006, BLOOD, V107, P2879, DOI 10.1182/blood-2005-05-1815; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; Kishi H, 2000, BLOOD, V95, P3845; Kurioka H, 1996, MOL IMMUNOL, V33, P1059, DOI 10.1016/S0161-5890(96)00062-4; Lauring J, 1999, MOL CELL BIOL, V19, P2601; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monroe RJ, 1999, P NATL ACAD SCI USA, V96, P12713, DOI 10.1073/pnas.96.22.12713; PIGUET PF, 1981, J EXP MED, V154, P581, DOI 10.1084/jem.154.3.581; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sikes ML, 1998, J IMMUNOL, V161, P1399; SPEAR PG, 1974, J EXP MED, V139, P249, DOI 10.1084/jem.139.2.249; SPEAR PG, 1973, J EXP MED, V138, P557, DOI 10.1084/jem.138.3.557; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Xu ZH, 1998, GENETICS, V150, P1419; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080; Zarrin AA, 1997, J IMMUNOL, V159, P4382; Zhang F, 2003, J IMMUNOL, V171, P4613, DOI 10.4049/jimmunol.171.9.4613	49	11	14	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1309	1316		10.1038/ni1397	http://dx.doi.org/10.1038/ni1397			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17057722				2022-12-18	WOS:000242125200013
J	Intlekofer, AM; Takemoto, N; Wherry, EJ; Longworth, SA; Northrup, JT; Palanivel, VR; Mullen, AC; Gasink, CR; Kaech, SM; Miller, JD; Gapin, L; Ryan, K; Russ, AP; Lindsten, T; Orange, JS; Goldrath, AW; Ahmed, R; Reiner, SL				Intlekofer, AM; Takemoto, N; Wherry, EJ; Longworth, SA; Northrup, JT; Palanivel, VR; Mullen, AC; Gasink, CR; Kaech, SM; Miller, JD; Gapin, L; Ryan, K; Russ, AP; Lindsten, T; Orange, JS; Goldrath, AW; Ahmed, R; Reiner, SL			Effector and memory CD8(+) T cell fate coupled by T-bet and eomesodermin (vol 6, pg 1236, 2005)	NATURE IMMUNOLOGY			English	Correction													Wherry, John/ABI-1280-2020	orange, jordan/0000-0001-7117-7725; Mullen, Alan/0000-0002-4096-3106				Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268	1	11	11	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					113	113		10.1038/ni0106-113	http://dx.doi.org/10.1038/ni0106-113			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ		Bronze			2022-12-18	WOS:000234139700025
J	Schneider, K; Benedict, CA; Ware, CF				Schneider, K; Benedict, CA; Ware, CF			A TRAFfic cop for host defense	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; ACTIVATION	The function of TRAF3, a member of the family of tumor necrosis factor receptor-associated factors, has remained an enigma. Two recent Nature papers now show that TRAF3 regulates interferon and interleukin 10 production.	Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA		Schneider, K (corresponding author), Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	cware@liai.org						Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; HACKER H, 2005, NATURE          1123, DOI DOI 10.1038/NATURE04369; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; OGANESYAN G, 2005, NATURE          1123, DOI DOI 10.1038/NATURE04374; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wu H, 2004, ADV PROTEIN CHEM, V68, P225	12	11	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					15	16		10.1038/ni0106-15	http://dx.doi.org/10.1038/ni0106-15			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357852				2022-12-18	WOS:000234139700007
J	MacDonald, HR				MacDonald, HR			NK cell tolerance: revisiting the central dogma	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; RECEPTORS	Physiological tolerance of natural killer ( NK) cells to self tissues is believed to require the expression of at least one inhibitory receptor specific for self MHC. This dogma may require revision with the identification of self- tolerant NK cells lacking self MHC - specific receptors.	Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research	MacDonald, HR (corresponding author), Ludwig Inst Canc Res, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.							Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Lowin-Kropf B, 2000, J IMMUNOL, V165, P91, DOI 10.4049/jimmunol.165.1.91; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Wu MF, 1997, J IMMUNOL, V158, P1628; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	10	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					868	869		10.1038/ni0905-868	http://dx.doi.org/10.1038/ni0905-868			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116465				2022-12-18	WOS:000231369800008
J	Malissen, B; Ewbank, JJ				Malissen, B; Ewbank, JJ			'TaiLoRing' the response of dendritic cells to pathogens	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; IMMUNITY; INDUCTION; INNATE	Cells of the innate and adaptive immune systems often require signals emanating from diverse cell surface receptors for full activation. For dendritic cells, synergistic stimulation by different pairs of Toll-like receptors provides the host with a mechanism to react rapidly and specifically to different pathogens.	Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, CNRS, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, CNRS, Parc Sci Luminy,Case 906, F-13288 Marseille, France.	bernardm@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010; Malissen, Bernard/AAK-4659-2020	Ewbank, Jonathan J/0000-0002-1257-6862; Malissen, Bernard/0000-0003-1340-9342				Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Millet ACM, 2004, CURR OPIN IMMUNOL, V16, P4, DOI 10.1016/j.coi.2003.11.005; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153	10	11	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					749	750		10.1038/ni0805-749	http://dx.doi.org/10.1038/ni0805-749			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034427				2022-12-18	WOS:000230646200004
J	Gerard, C				Gerard, C			Inflammatory chemokines: tuned in, turned on, dropped out	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; PROTEIN; C5L2; C5A	Inflammatory signals must be resolved to avoid excessive tissue damage. The D6 chemokine receptor acts in this process by 'mopping up' proinflammatory beta-chemokines.	Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Gerard, C (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA.	craig.gerard@childrens.harvard.edu						ABONIA PJ, IN PRESS BLOOD; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554	8	11	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					366	368		10.1038/ni0405-366	http://dx.doi.org/10.1038/ni0405-366			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785765				2022-12-18	WOS:000227860000009
J	Lipp, M; Muller, G				Lipp, M; Muller, G			Lymphoid organogenesis: getting the green light from ROR gamma t	NATURE IMMUNOLOGY			English	Editorial Material							ORPHAN RECEPTOR; CELLS; PROGENITORS; EXPRESSION; SURVIVAL; LIGAND; NK	Lymphoid tissue inducer (LTi) cells are central to the development of lymphoid organs during embryonic development. Only these cells express the nuclear receptor RORgammat, which turns out to be indispensable for LTi cell survival and function.	Max Delbruck Ctr Mol Med, MDC, Dept Mol Tumor Genet & Immunogenet, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Lipp, M (corresponding author), Max Delbruck Ctr Mol Med, MDC, Dept Mol Tumor Genet & Immunogenet, Robert Roessle Str 10, D-13092 Berlin, Germany.	mlipp@mdc-berlin.de	Lipp, Martin/G-2235-2010	Lipp, Martin/0000-0002-0087-2672				Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Muller G, 2003, IMMUNOL REV, V195, P117, DOI 10.1034/j.1600-065X.2003.00073.x; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	12	11	16	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					12	14		10.1038/ni0104-12	http://dx.doi.org/10.1038/ni0104-12			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699400				2022-12-18	WOS:000187635800006
J	Parry, RV; June, CH				Parry, RV; June, CH			Calcium-independent calcineurin regulation	NATURE IMMUNOLOGY			English	Editorial Material							PHOSPHATASE-ACTIVITY; T-LYMPHOCYTES; PROTEIN; EXPRESSION; INHIBITION	Calcineurin is negatively regulated by calcipressin 1. Analysis of calcipressin-deficient mice shows that survival of T helper type 1 cells is dependent on calcipressin, demonstrating another function for the regulation of calcineurin activity in T cells.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Parry, RV (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	cjune@mail.med.upenn.edu						CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	13	11	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					821	823		10.1038/ni0903-821	http://dx.doi.org/10.1038/ni0903-821			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942079				2022-12-18	WOS:000185002200005
J	Pinkoski, MJ; Green, DR				Pinkoski, MJ; Green, DR			Granzyme A: the road less traveled	NATURE IMMUNOLOGY			English	Editorial Material							CELLS	Cellular parasites have evolved clever antiapoptosis strategies to avoid being killed by CTLs. However, CTL release of granzyme A inactivates a key repair enzyme, Ape1, ensuring death of infected cells.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Pinkoski, MJ (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA.	michael@liai.org; doug@liai.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; D'Amours D, 2001, J CELL SCI, V114, P3771; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23	12	11	11	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					106	108		10.1038/ni0203-106	http://dx.doi.org/10.1038/ni0203-106			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555094				2022-12-18	WOS:000180686500008
J	Zasloff, M				Zasloff, M			Trypsin, for the defense	NATURE IMMUNOLOGY			English	Editorial Material								The alpha-defensins from Paneth cells in intestinal crypts need processing to be fully functional. Unlike for mice, the cleaving enzyme for human HD5 turns out to be trypsin.	Georgetown Univ, Med Ctr, Washington, DC 20007 USA	Georgetown University	Zasloff, M (corresponding author), Georgetown Univ, Med Ctr, Med Dent Bldg 103 NW,3900 Reservoir Rd NW, Washington, DC 20007 USA.							Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Ganz T, 1997, Curr Opin Hematol, V4, P53; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; PORTER EM, 2001, CELL MOL LIFE SCI, V58, P1; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	10	11	11	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					508	510		10.1038/ni0602-508	http://dx.doi.org/10.1038/ni0602-508			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032562				2022-12-18	WOS:000175874700007
J	Wulfing, C; Rupp, F				Wulfing, C; Rupp, F			Neuropilin-I: another neuronal molecule in the "immunological synapse"	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ACTIVATION; SYNAPTOGENESIS; RECEPTOR; ADHESION		Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Hyseq Inc, Sunnyvale, CA 94085 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wulfing, C (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA.							Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Chang CH, 1996, PLASMA CHEM PLASMA P, V16, P17, DOI 10.1007/BF01465215; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	17	11	12	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					418	419		10.1038/ni0502-418	http://dx.doi.org/10.1038/ni0502-418			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976715				2022-12-18	WOS:000175411200006
J	Guo, LY; Hu-Li, J; Zhu, JF; Pannetier, C; Watson, C; McKenzie, GJ; McKenzie, ANJ; Paul, WE				Guo, LY; Hu-Li, J; Zhu, JF; Pannetier, C; Watson, C; McKenzie, GJ; McKenzie, ANJ; Paul, WE			Disrupting III3 impairs production of IL-4 specified by the linked allele	NATURE IMMUNOLOGY			English	Article							INTERLEUKIN-4 RECEPTOR; T-CELLS; IMMUNE-RESPONSES; BINDING SUBUNIT; GAMMA-CHAIN; B-CELLS; COMPONENT; SEQUENCE; REGION; GENE	Interleukin 13-deficient (IL-13(-/-)) mice express a defect in priming for IL-4 production that is not corrected by adding IL-13 to the priming culture. This is partly accounted for by the consumption of IL-4 without endogenous replacement during culture of IL-13(-/-) CD4(+) T cells. We examined cells from mice in which disrupted Il13 was linked to wild-type Il4 on one chromosome and wild-type Il13 was linked to a "knocked-in" green fluorescent protein (GfP) gene in the Il4 locus. Our results show that the deficit in IL-4 production was due, at least in part, to a cis effect, in which disrupted Il13 diminished IL-4 production from the linked Il14 gene.	NIAID, NIH, Immunol Lab, Bethesda, MD 20892 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Lorantis, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MRC Laboratory Molecular Biology	Paul, WE (corresponding author), NIAID, NIH, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; KIM JM, 1992, J IMMUNOL, V148, P3618; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; Poudrier J, 1999, J IMMUNOL, V163, P1153; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	18	11	11	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					461	466		10.1038/87778	http://dx.doi.org/10.1038/87778			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323701				2022-12-18	WOS:000168549800020
J	Linsley, PS				Linsley, PS			T cell activation: you can't get good help	NATURE IMMUNOLOGY			English	News Item							ICOS		Rosetta Inpharmat, Kirkland, WA USA	Merck & Company	Linsley, PS (corresponding author), Rosetta Inpharmat, 12040 115th Ave NE, Kirkland, WA USA.							Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Ling V, 2000, FASEB J, V14, pA1169; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	13	11	16	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					139	140		10.1038/84233	http://dx.doi.org/10.1038/84233			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175808				2022-12-18	WOS:000166778700011
J	Huby, R; Chowdhury, F; Lombardi, G				Huby, R; Chowdhury, F; Lombardi, G			Rafts for antigen presentation?	NATURE IMMUNOLOGY			English	Letter							GPI-ANCHORED PROTEINS		AstraZeneca, Safety Assessment, Mol Toxicol, Macclesfield SK10 4TG, Cheshire, England; Hammersmith Hosp, Imperial Coll, Dept Immunol, London W12 0NN, England	AstraZeneca; Imperial College London	Huby, R (corresponding author), AstraZeneca, Safety Assessment, Mol Toxicol, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.							Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Huby RDJ, 1999, J BIOL CHEM, V274, P22591, DOI 10.1074/jbc.274.32.22591; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563	4	11	11	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					3	3		10.1038/83154	http://dx.doi.org/10.1038/83154			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135565				2022-12-18	WOS:000166261500002
J	Yeo, AT; Rawal, S; Delcuze, B; Christofides, A; Atayde, A; Strauss, L; Balaj, L; Rogers, VA; Uhlmann, EJ; Varma, H; Carter, BS; Boussiotis, VA; Charest, A				Yeo, Alan T.; Rawal, Shruti; Delcuze, Bethany; Christofides, Anthos; Atayde, Agata; Strauss, Laura; Balaj, Leonora; Rogers, Vaughn A.; Uhlmann, Erik J.; Varma, Hemant; Carter, Bob S.; Boussiotis, Vassiliki A.; Charest, Al			Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression	NATURE IMMUNOLOGY			English	Article							PERIVASCULAR MACROPHAGES; SUPPRESSOR-CELLS; CROSS-TALK; EXPRESSION; MOUSE; RECEPTOR; IMMUNOTHERAPY; PROLIFERATION; ANGIOGENESIS; TEMOZOLOMIDE	Glioblastoma (GBM) is an incurable primary malignant brain cancer hallmarked with a substantial protumorigenic immune component. Knowledge of the GBM immune microenvironment during tumor evolution and standard of care treatments is limited. Using single-cell transcriptomics and flow cytometry, we unveiled large-scale comprehensive longitudinal changes in immune cell composition throughout tumor progression in an epidermal growth factor receptor-driven genetic mouse GBM model. We identified subsets of proinflammatory microglia in developing GBMs and anti-inflammatory macrophages and protumorigenic myeloid-derived suppressors cells in end-stage tumors, an evolution that parallels breakdown of the blood-brain barrier and extensive growth of epidermal growth factor receptor(+) GBM cells. A similar relationship was found between microglia and macrophages in patient biopsies of low-grade glioma and GBM. Temozolomide decreased the accumulation of myeloid-derived suppressor cells, whereas concomitant temozolomide irradiation increased intratumoral GranzymeB(+) CD8(+)T cells but also increased CD4(+) regulatory T cells. These results provide a comprehensive and unbiased immune cellular landscape and its evolutionary changes during GBM progression. Single-cell RNAseq during initiation and progression of mouse glioblastoma reveals a dynamic immune microenvironment transitioning from pro-inflammatory microglia in early tumors towards an infiltrating macrophage and suppressor cell-centric immune landscape in late-stage tumors.	[Yeo, Alan T.; Rawal, Shruti; Delcuze, Bethany; Christofides, Anthos; Atayde, Agata; Strauss, Laura; Rogers, Vaughn A.; Boussiotis, Vassiliki A.; Charest, Al] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Yeo, Alan T.; Delcuze, Bethany] Tufts Univ, Sch Med, Sackler Sch Grad Studies, Boston, MA 02111 USA; [Balaj, Leonora; Carter, Bob S.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Uhlmann, Erik J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Varma, Hemant] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Boussiotis, Vassiliki A.; Charest, Al] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Boussiotis, VA; Charest, A (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.; Boussiotis, VA; Charest, A (corresponding author), Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.	vboussio@bidmc.harvard.edu; acharest@bidmc.harvard.edu		Rogers, Vaughn A./0000-0002-6423-5197	National Institutes of Health [R01 CA229784, P01 CA069246, U01 CA230697, R01 CA239078, R01 CA237500]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank P. Zhang and H. Jung Jun for critical review of the manuscript and H. Pan and J. Dreyfuss of the Joslin Bioinformatics Core (Harvard Medical School) for their technical contribution. This work was supported by National Institutes of Health grant R01 CA229784 to V.A.B. and A.C., P01 CA069246 to B.S.C. and A.C., U01 CA230697, R01 CA239078, R01 CA237500 to B.S.C.	Acquaviva J, 2011, CANCER RES, V71, P7198, DOI 10.1158/0008-5472.CAN-11-1514; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Azzaoui I, 2016, BLOOD, V128, P1081, DOI 10.1182/blood-2015-08-662783; Bais AS, 2020, BIOINFORMATICS, V36, P1150, DOI 10.1093/bioinformatics/btz698; Bajetto A, 2006, NEUROCHEM INT, V49, P423, DOI 10.1016/j.neuint.2006.03.003; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Boussiotis VA, 2018, ONCOGENE, V37, P1121, DOI 10.1038/s41388-017-0024-z; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cao YH, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00490; Cen L, 2013, NEURO-ONCOLOGY, V15, P735, DOI 10.1093/neuonc/not010; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feng PH, 2012, AM J RESP CRIT CARE, V186, P1025, DOI 10.1164/rccm.201204-0636OC; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Gutmann DH, 2019, NEURON, V104, P442, DOI 10.1016/j.neuron.2019.08.028; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Herting CJ, 2017, GLIA, V65, P1914, DOI 10.1002/glia.23203; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Johnson KC, 2021, NAT GENET, V53, P1456, DOI 10.1038/s41588-021-00926-8; Jun HJ, 2012, ONCOGENE, V31, P3039, DOI 10.1038/onc.2011.474; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Khalafallah AM, 2021, NEUROSURGERY, V88, P477, DOI 10.1093/neuros/nyaa305; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Knudsen SLJ, 2014, GROWTH FACTORS, V32, P155, DOI 10.3109/08977194.2014.952410; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Mayoux M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aav7431; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rossi F, 2018, NAT NEUROSCI, V21, P455, DOI 10.1038/s41593-018-0123-3; Salmaggi A, 2004, J NEURO-ONCOL, V67, P305, DOI 10.1023/B:NEON.0000024241.05346.24; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Srivastava A, 2016, BIOINFORMATICS, V32, P192, DOI 10.1093/bioinformatics/btw277; Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Veglia F, 2021, NAT REV IMMUNOL, V21, P485, DOI 10.1038/s41577-020-00490-y; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Woolfenden S, 2009, GENESIS, V47, P659, DOI 10.1002/dvg.20545; Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144; Yeo AT, 2021, ONCOGENE, V40, P2682, DOI 10.1038/s41388-021-01721-9; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	79	10	10	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					971	+		10.1038/s41590-022-01215-0	http://dx.doi.org/10.1038/s41590-022-01215-0		MAY 2022	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624211	Green Published, hybrid			2022-12-18	WOS:000805549900002
J	Schloss, MJ; Hulsmans, M; Rohde, D; Lee, IH; Severe, N; Foy, BH; Pulous, FE; Zhang, S; Kokkaliaris, KD; Frodermann, V; Courties, G; Yang, CB; Iwamoto, Y; Knudsen, AS; McAlpine, CS; Yamazoe, M; Schmidt, SP; Wojtkiewicz, GR; Masson, GS; Gustafsson, K; Capen, D; Brown, D; Higgins, JM; Scadden, DT; Libby, P; Swirski, FK; Naxerova, K; Nahrendorf, M				Schloss, Maximilian J.; Hulsmans, Maarten; Rohde, David; Lee, I-Hsiu; Severe, Nicolas; Foy, Brody H.; Pulous, Fadi E.; Zhang, Shuang; Kokkaliaris, Konstantinos D.; Frodermann, Vanessa; Courties, Gabriel; Yang, Chongbo; Iwamoto, Yoshiko; Knudsen, Anders Steen; McAlpine, Cameron S.; Yamazoe, Masahiro; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Gustafsson, Karin; Capen, Diane; Brown, Dennis; Higgins, John M.; Scadden, David T.; Libby, Peter; Swirski, Filip K.; Naxerova, Kamila; Nahrendorf, Matthias			B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis	NATURE IMMUNOLOGY			English	Article							AUTONOMIC NERVOUS-SYSTEM; STEM-CELLS; SIGNALS	Nahrendorf and colleagues show that B cells in the bone marrow are an important source of the neurotransmitter acetylcholine, which limits hematopoiesis through modulating the signals produced by the bone marrow stromal niche during steady-state and emergency hematopoiesis. Autonomic nerves control organ function through the sympathetic and parasympathetic branches, which have opposite effects. In the bone marrow, sympathetic (adrenergic) nerves promote hematopoiesis; however, how parasympathetic (cholinergic) signals modulate hematopoiesis is unclear. Here, we show that B lymphocytes are an important source of acetylcholine, a neurotransmitter of the parasympathetic nervous system, which reduced hematopoiesis. Single-cell RNA sequencing identified nine clusters of cells that expressed the cholinergic alpha 7 nicotinic receptor (Chrna7) in the bone marrow stem cell niche, including endothelial and mesenchymal stromal cells (MSCs). Deletion of B cell-derived acetylcholine resulted in the differential expression of various genes, including Cxcl12 in leptin receptor(+) (LepR(+)) stromal cells. Pharmacologic inhibition of acetylcholine signaling increased the systemic supply of inflammatory myeloid cells in mice and humans with cardiovascular disease.	[Schloss, Maximilian J.; Hulsmans, Maarten; Rohde, David; Lee, I-Hsiu; Foy, Brody H.; Pulous, Fadi E.; Zhang, Shuang; Frodermann, Vanessa; Courties, Gabriel; Yang, Chongbo; Iwamoto, Yoshiko; Knudsen, Anders Steen; McAlpine, Cameron S.; Yamazoe, Masahiro; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Higgins, John M.; Swirski, Filip K.; Naxerova, Kamila; Nahrendorf, Matthias] Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA; [Schloss, Maximilian J.; Hulsmans, Maarten; Rohde, David; Lee, I-Hsiu; Foy, Brody H.; Pulous, Fadi E.; Zhang, Shuang; Frodermann, Vanessa; Courties, Gabriel; Yang, Chongbo; Iwamoto, Yoshiko; Knudsen, Anders Steen; McAlpine, Cameron S.; Yamazoe, Masahiro; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Higgins, John M.; Libby, Peter; Swirski, Filip K.; Naxerova, Kamila; Nahrendorf, Matthias] Harvard Med Sch, Boston, MA 02115 USA; [Schloss, Maximilian J.; Hulsmans, Maarten; Rohde, David; Lee, I-Hsiu; Pulous, Fadi E.; Zhang, Shuang; Frodermann, Vanessa; Courties, Gabriel; Yang, Chongbo; Iwamoto, Yoshiko; Knudsen, Anders Steen; McAlpine, Cameron S.; Yamazoe, Masahiro; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Swirski, Filip K.; Naxerova, Kamila; Nahrendorf, Matthias] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Severe, Nicolas; Kokkaliaris, Konstantinos D.; Gustafsson, Karin; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA; [Severe, Nicolas; Kokkaliaris, Konstantinos D.; Gustafsson, Karin; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Severe, Nicolas; Kokkaliaris, Konstantinos D.; Gustafsson, Karin; Scadden, David T.] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [McAlpine, Cameron S.; Swirski, Filip K.] Icahn Sch Med Mt Sinai, Cardiovasc Res Inst, New York, NY 10029 USA; [Gustafsson, Karin; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA USA; [Capen, Diane; Brown, Dennis] Harvard Med Sch, Dept Med, Div Nephrol, Program Membrane Biol, Boston, MA 02115 USA; [Capen, Diane; Brown, Dennis] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Nahrendorf, Matthias] Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Wurzburg	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany.	mnahrendorf@mgh.harvard.edu	Kokkaliaris, Konstantinos/GWQ-3400-2022	KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463; Rohde, David/0000-0002-3785-9375; McAlpine, Cameron/0000-0002-9832-6345; Pulous, Fadi/0000-0002-0794-8078	National Institutes of Health [HL142494, NS108419, HL139598, HL125428, HL155097, HL149647, HL158040, T32HL076136]; MGH Research Scholar program; Deutsche Forschungsgemeinschaft [SCHL 2221/1-1, RO5071/1-1]; American Heart Association Career Development Award [19CDA34490005]; NIH [K99HL151750, P30 GM127607]; Canadian Institutes of Health Research Banting Fellowship; One Brave Idea Initiative.; Fundacao Lemann; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease grant [DK43351]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Research Scholar program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Heart Association Career Development Award(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Banting Fellowship(Canadian Institutes of Health Research (CIHR)); One Brave Idea Initiative.; Fundacao Lemann; Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease grant	We thank M. Handley, D. Daly, J. Kauffman, P. Sen, G. Lima, J. Choi and E. Surette of the HSCI-CRM Flow Cytometry Core Facility, Massachusetts General Hospital, for their assistance with cell sorting; the Bioanalytics Core at the Diabetes and Obesity Center, Christina Lee Brown Envirome Institute, University of Louisville, for mass spectrometry analysis; the BPF Next-Gen Sequencing Core Facility at Harvard Medical School for their expertise and instrument availability in support of this work and the Partners Healthcare Research Patient Data Registry group for facilitating the use of their database. We thank K. Joyes for editing the article. Figures were designed using Servier Medical Art (http://www.servier.com).This work was supported in part by the National Institutes of Health grants HL142494, NS108419, HL139598, HL125428, HL155097, HL149647, HL158040 and T32HL076136 and the MGH Research Scholar program. M.J.S. and D.R. were funded by Deutsche Forschungsgemeinschaft (SCHL 2221/1-1 and RO5071/1-1). M.H. was supported by an American Heart Association Career Development Award (19CDA34490005). C.S.M. was funded by NIH K99HL151750 and a Canadian Institutes of Health Research Banting Fellowship. J.M.H. and B.H.F. were supported by a grant from the One Brave Idea Initiative. G.S.M. was funded by the Fundacao Lemann. The University of Louisville Diabetes and Obesity Center was supported by NIH P30 GM127607 and user fees. The Microscopy Core facility of the Massachusetts General Hospital Program in Membrane Biology receives support from Boston Area Diabetes and Endocrinology Research Center grant DK57521 and Center for the Study of Inflammatory Bowel Disease grant DK43351.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Artico M, 2002, INT J MOL MED, V10, P77; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Costantini TW, 2019, P NATL ACAD SCI USA, V116, P7932, DOI 10.1073/pnas.1821853116; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Fujii T, 2017, J PHARMACOL SCI, V134, P1, DOI 10.1016/j.jphs.2017.05.002; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Herring N, 2019, NAT REV CARDIOL, V16, P707, DOI 10.1038/s41569-019-0221-2; Hirsch NP, 2007, BRIT J ANAESTH, V99, P132, DOI 10.1093/bja/aem144; Jiang W, 2017, P NATL ACAD SCI USA, V114, pE6202, DOI 10.1073/pnas.1705491114; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Maryanovich M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031344; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Reardon C, 2013, P NATL ACAD SCI USA, V110, P1410, DOI 10.1073/pnas.1221655110; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Santisteban MM, 2013, CURR HYPERTENS REP, V15, P377, DOI 10.1007/s11906-013-0361-4; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	39	10	10	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					605	+		10.1038/s41590-022-01165-7	http://dx.doi.org/10.1038/s41590-022-01165-7		MAR 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35352063	Green Accepted			2022-12-18	WOS:000774648400001
J	Sumida, TS; Dulberg, S; Schupp, J; Lincoln, M; Stillwell, HA; Axisa, PP; Comi, M; Unterman, A; Kaminski, N; Madi, A; Kuchroo, VK; Hafler, DA				Sumida, Tomokazu S.; Dulberg, Shai; Schupp, Jonas; Lincoln, Matthew; Stillwell, Helen A.; Axisa, Pierre-Paul; Comi, Michela; Unterman, Avraham; Kaminski, Naftali; Madi, Asaf; Kuchroo, Vijay K.; Hafler, David A.			Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells	NATURE IMMUNOLOGY			English	Article							INFECTION; IMMUNOTHERAPY; DYSFUNCTION; CHROMATIN; PATHWAYS; BLOCKADE; SAMHD1; TIM-3; LAG-3; MICE	Although inhibition of T cell coinhibitory receptors has revolutionized cancer therapy, the mechanisms governing their expression on human T cells have not been elucidated. In the present study, we show that type 1 interferon (IFN-I) regulates coinhibitory receptor expression on human T cells, inducing PD-1/TIM-3/LAG-3 while inhibiting TIGIT expression. High-temporal-resolution mRNA profiling of IFN-I responses established the dynamic regulatory networks uncovering three temporal transcriptional waves. Perturbation of key transcription factors (TFs) and TF footprint analysis revealed two regulator modules with different temporal kinetics that control expression of coinhibitory receptors and IFN-I response genes, with SP140 highlighted as one of the key regulators that differentiates LAG-3 and TIGIT expression. Finally, we found that the dynamic IFN-I response in vitro closely mirrored T cell features in acute SARS-CoV-2 infection. The identification of unique TFs controlling coinhibitory receptor expression under IFN-I response may provide targets for enhancement of immunotherapy in cancer, infectious diseases and autoimmunity. Sumida et al. resolve the human T cell transcriptional response to type I interferon stimulation at high temporal resolution and reveal a genetic network controlling coinhibitory receptor expression.	[Sumida, Tomokazu S.; Lincoln, Matthew; Stillwell, Helen A.; Axisa, Pierre-Paul; Comi, Michela; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sumida, Tomokazu S.; Lincoln, Matthew; Stillwell, Helen A.; Axisa, Pierre-Paul; Comi, Michela; Hafler, David A.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Dulberg, Shai; Madi, Asaf] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel; [Schupp, Jonas; Unterman, Avraham; Kaminski, Naftali] Yale Sch Med, Sect Pulm, Crit Care & Sleep Med Sect, Dept Internal Med, New Haven, CT USA; [Schupp, Jonas] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Schupp, Jonas] German Lung Res Ctr, Biomed Res End Stage & Obstruct Lung Dis Hannover, Hannover, Germany; [Lincoln, Matthew] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Unterman, Avraham] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Pulm Inst, Tel Aviv, Israel; [Madi, Asaf; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Madi, Asaf; Kuchroo, Vijay K.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Madi, Asaf; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kuchroo, Vijay K.; Hafler, David A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Yale University; Yale University; Tel Aviv University; Sackler Faculty of Medicine; Yale University; Hannover Medical School; University of Toronto; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sumida, TS (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Sumida, TS (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Madi, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel.; Madi, A (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Madi, A (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Madi, A (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	tomokazu.sumida@yale.edu; asafmadi@tauex.tau.ac.il		Unterman, Avraham/0000-0003-0965-3326; Lincoln, Matthew/0000-0003-2962-6253; Axisa, Pierre-Paul/0000-0003-1446-3922; Kaminski, Naftali/0000-0001-5917-4601; Dulberg, Shai/0000-0001-8304-5324; Madi, Asaf/0000-0003-3441-3228; Sumida, Tomokazu/0000-0002-9806-2642; Schupp, Jonas/0000-0002-7714-8076	Race to Erase MS; National MS Society; Consortium of MS Centers; National Institutes of Health (NIH) [U19 AI089992, R25 NS079193, P01 AI073748, P01 AI039671, P50 CA121974]; National Multiple Sclerosis Society [CA 1061-A-18, RG-1802-30153]; Nancy Taylor Foundation for Chronic Diseases and Erase MS; NIH [P01 AI073748, P01 AI039671, R01HL127349, R01HL141852, U01HL145567, R01 NS045937, R01 NS030843, R01 AI144166, P01 AI056299]; Klarman Cell Observatory; Alon fellowship for outstanding young scientists; Israel Science Foundation [1700/21]; Israel Cancer Association [01028753]; Israel Cancer Research Fund Research Career Development Awards; DoD [W81XWH-19-1-0131]; Connecticut Regenerative Medicine Research Fund; Li Ka Shing Foundation; Israel Council for Higher Education	Race to Erase MS; National MS Society(National Multiple Sclerosis Society); Consortium of MS Centers; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Nancy Taylor Foundation for Chronic Diseases and Erase MS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; Alon fellowship for outstanding young scientists; Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israel Cancer Research Fund Research Career Development Awards; DoD(United States Department of Defense); Connecticut Regenerative Medicine Research Fund; Li Ka Shing Foundation; Israel Council for Higher Education	We thank L. Devine and C. Wang for assistance with FACS-based cell sorting, G. Wang, M. Machado and C. Castaldi at Yale Center for Genome Analysis for support with 10x Genomics library and ATAC-seq library preparation and sequencing, P. Coish for his diligent proofreading of this paper, K. Raddassi and L. Zhang for processing scRNA-seq samples, L. Geng and M. Zhang for preparation of the bulk RNA-seq libraries and sequencing, M. Taura for assistance developing Vpx-VLP-based lentiviral transduction and N. Chihara and H. Asashima for useful discussions and input on the manuscript. This work was supported by grants to T.S.S. from Race to Erase MS, to M.R.L. from the National MS Society and the Consortium of MS Centers (Career Transition Award), to D.A.H. from the National Institutes of Health (NIH) (grant nos. U19 AI089992, R25 NS079193, P01 AI073748, P01 AI039671 and P50 CA121974), the National Multiple Sclerosis Society (grant nos. CA 1061-A-18 and RG-1802-30153), the Nancy Taylor Foundation for Chronic Diseases and Erase MS, to V.K.K. from NIH (grant nos. R01 NS045937, R01 NS030843, R01 AI144166, P01 AI073748, P01 AI039671 and P01 AI056299) and the Klarman Cell Observatory, to N.K. from NIH (grant nos. R01HL127349, R01HL141852 and U01HL145567), to A.M. from The Alon fellowship for outstanding young scientists, Israel Council for Higher Education, the Israel Science Foundation (1700/21), the Israel Cancer Association (01028753) and the Israel Cancer Research Fund Research Career Development Awards, and to J.C.S. from DoD (grant no. W81XWH-19-1-0131). The RNA-seq service was conducted at Yale Center for Genome Analysis and Yale Stem Cell Center Genomics Core facility, the latter supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation.	Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bentsen M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18035-1; Bojnordi MN, 2017, MOL NEUROBIOL, V54, P5676, DOI 10.1007/s12035-016-0097-7; Bosi E, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04864-4; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen YM, 2017, J BIOPHARM STAT, V27, P308, DOI 10.1080/10543406.2016.1265542; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Christensen AP, 2018, R J, V10, P422; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crow MK, 2019, LUPUS SCI MED, V6, DOI 10.1136/lupus-2019-000336; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; De Vico Fallani Fabrizio, 2017, PLoS Comput Biol, V13, pe1005305, DOI 10.1371/journal.pcbi.1005305; DeLong Jonathan H, 2019, Immunohorizons, V3, P13, DOI 10.4049/immunohorizons.1800083; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El-Sherbiny Y M, 2018, Sci Rep, V8, P5793, DOI 10.1038/s41598-018-24198-1; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gennert DG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104758118; Ghiboub, 2020, MODULATION MACROPHAG, DOI 2020.2008.2010.239475; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grunwell JR, 2018, J IMMUNOL, V200, P2115, DOI 10.4049/jimmunol.1701325; Hagberg Aric., 2008, EXPLORING NETWORK ST; Hofer MJ, 2012, J VIROL, V86, P6932, DOI 10.1128/JVI.07147-11; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leong HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4947; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Luoma AM, 2020, CELL, V182, P655, DOI 10.1016/j.cell.2020.06.001; Ly A, 2018, STAT NEERL, V72, P4, DOI 10.1111/stan.12111; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Musella M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1314424; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Orchard P, 2020, CELL SYST, V10, P298, DOI 10.1016/j.cels.2020.02.009; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Piraveenan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053095; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinstein ML, 2018, DIAGNOSIS, V5, P205, DOI 10.1515/dx-2018-0061; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Szalkai B, 2019, BRAIN IMAGING BEHAV, V13, P1185, DOI 10.1007/s11682-018-9937-6; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Unterman A, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27716-4; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang WS, 2017, TRENDS MICROBIOL, V25, P574, DOI 10.1016/j.tim.2017.01.001; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yevshin I, 2019, NUCLEIC ACIDS RES, V47, pD100, DOI 10.1093/nar/gky1128; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488	69	10	10	6	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					632	+		10.1038/s41590-022-01152-y	http://dx.doi.org/10.1038/s41590-022-01152-y		MAR 2022	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35301508	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000770206000002
J	Li, ZH; Li, SH; Zhang, G; Peng, WY; Chang, Z; Zhang, X; Fan, Z; Chai, Y; Wang, FR; Zhao, X; Li, DD; Zhang, R; He, ZL; Zou, WW; Xu, K; Lei, WN; Liu, PP; Hao, JF; Zhang, JJ; Sun, LT; Wu, GZ; Tan, SG; Gao, GF; Gao, F; Wu, Y				Li, Zhaohui; Li, Shihua; Zhang, Gen; Peng, Weiyu; Chang, Zhen; Zhang, Xue; Fan, Zheng; Chai, Yan; Wang, Feiran; Zhao, Xin; Li, Dedong; Zhang, Rong; He, Zhanlong; Zou, Weiwei; Xu, Ke; Lei, Wenwen; Liu, Peipei; Hao, Junfeng; Zhang, Jingjing; Sun, Litao; Wu, Guizhen; Tan, Shuguang; Gao, George Fu; Gao, Feng; Wu, Yan			An engineered bispecific human monoclonal antibody against SARS-CoV-2	NATURE IMMUNOLOGY			English	Article							VIRUS-INFECTION; SPIKE PROTEIN; MUTATIONS	The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires effective therapies against coronavirus disease 2019 (COVID-19), and neutralizing antibodies are a promising therapy. A noncompeting pair of human neutralizing antibodies (B38 and H4) blocking SARS-CoV-2 binding to its receptor, ACE2, have been described previously. Here, we develop bsAb15, a bispecific monoclonal antibody (bsAb) based on B38 and H4. bsAb15 has greater neutralizing efficiency than these parental antibodies, results in less selective pressure and retains neutralizing ability to most SARS-CoV-2 variants of concern (with more potent neutralizing activity against the Delta variant). We also selected for escape mutants of the two parental mAbs, a mAb cocktail and bsAb15, demonstrating that bsAb15 can efficiently neutralize all single-mAb escape mutants. Furthermore, prophylactic and therapeutic application of bsAb15 reduced the viral titer in infected nonhuman primates and human ACE2 transgenic mice. Therefore, this bsAb is a feasible and effective strategy to treat and prevent severe COVID-19. Although COVID-19 vaccines are proving to be generally effective, new therapeutics to neutralize SARS-CoV-2 are required. Here, the authors engineer bispecific antibodies from ACE2-blocking B38 and H4 SARS-CoV-2 neutralizing antibodies and demonstrate their superiority in mice and nonhuman primates.	[Li, Zhaohui; Li, Shihua; Zhang, Gen; Peng, Weiyu; Fan, Zheng; Chai, Yan; Wang, Feiran; Zhao, Xin; Li, Dedong; Zhang, Rong; Tan, Shuguang; Gao, George Fu; Wu, Yan] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Li, Zhaohui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Peng, Weiyu; Li, Dedong] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Chang, Zhen; Zhang, Xue; Zou, Weiwei; Wu, Yan] Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Microbiol, Beijing, Peoples R China; [Wang, Feiran] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Rong] Guangxi Univ, Coll Anim Sci & Vet Med, Lab Anim Infect Dis, Nanning, Peoples R China; [He, Zhanlong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Xu, Ke; Lei, Wenwen; Liu, Peipei; Wu, Guizhen] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing, Peoples R China; [Hao, Junfeng] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China; [Zhang, Jingjing; Sun, Litao] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Peoples R China; [Gao, Feng] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China; [Gao, Feng] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Struct Biol, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Capital Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Guangxi University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Biophysics, CAS; Sun Yat Sen University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Tan, SG; Gao, GF; Wu, Y (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Wu, Y (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Microbiol, Beijing, Peoples R China.; Gao, F (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China.; Gao, F (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Struct Biol, Tianjin, Peoples R China.	tansg@im.ac.cn; gaof@im.ac.cn; gaofeng@tib.cas.cn; wuyan@ccmu.edu.cn	Li, Shi-Hua/GQH-6298-2022	SUN, LITAO/0000-0002-8415-989X	National Natural Science Foundation of China [82022042, 32090014, 31872745]; National Key R&D Program of China [2020YFA0907104]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (82022042, 32090014 and 31872745), the National Key R&D Program of China (2020YFA0907104) and the intramural special grant for SARS-CoV-2 research from the Chinese Academy of Sciences.	Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bournazos S, 2016, CELL, V165, P1609, DOI 10.1016/j.cell.2016.04.050; Brown KA, 2021, JAMA-J AM MED ASSOC, V325, P2115, DOI 10.1001/jama.2021.5607; Chakraborty S, 2021, BIOCHEM BIOPH RES CO, V538, P97, DOI 10.1016/j.bbrc.2021.01.035; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Dai LP, 2020, CELL, V182, P722, DOI 10.1016/j.cell.2020.06.035; De Gasparo R, 2021, NATURE, V593, P424, DOI 10.1038/s41586-021-03461-y; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Demanet C, 1996, BLOOD, V87, P4390, DOI 10.1182/blood.V87.10.4390.bloodjournal87104390; Du LY, 2016, EXPERT REV VACCINES, V15, P1123, DOI 10.1586/14760584.2016.1167603; Edara Venkata-Viswanadh, 2021, bioRxiv, DOI 10.1101/2021.05.09.443299; Frei JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19193; Hirotsu Y, 2021, J INFECTION, V82, P307, DOI 10.1016/j.jinf.2021.03.013; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hohdatsu T, 1998, J VET MED SCI, V60, P49, DOI 10.1292/jvms.60.49; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Jiang HH, 2020, MBIO, V11, DOI 10.1128/mBio.02315-20; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Labrijn AF, 2019, NAT REV DRUG DISCOV, V18, P585, DOI 10.1038/s41573-019-0028-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JF, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20171278; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Lum LG, 2012, BIOL BLOOD MARROW TR, V18, P1012, DOI 10.1016/j.bbmt.2012.01.022; Moshoette T, 2019, RETROVIROLOGY, V16, DOI 10.1186/s12977-019-0493-y; Ozer E. A., HIGH PREVALENCE SARS, DOI [10.1101/2021.04.09.21255206(2021), DOI 10.1101/2021.04.09.21255206(2021), 10.1101/2021.04.09.21255206 (2021)]; Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w; Pereira F, 2021, J MED VIROL, V93, P5523, DOI 10.1002/jmv.27086; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002; Wang N, 2021, CELL RES, V31, P101, DOI 10.1038/s41422-020-00446-w; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang QH, 2019, NAT MICROBIOL, V4, P1231, DOI 10.1038/s41564-019-0411-z; Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yao HP, 2021, CELL RES, V31, P25, DOI 10.1038/s41422-020-00444-y; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou W., 2020, N439K VARIANT SPIKE, DOI 10.1101/2020.11.21.392407; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	49	10	10	10	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					423	+		10.1038/s41590-022-01138-w	http://dx.doi.org/10.1038/s41590-022-01138-w		FEB 2022	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35228696	Bronze			2022-12-18	WOS:000762163700004
J	McKenzie, DR; Hart, R; Bah, N; Ushakov, DS; Munoz-Ruiz, M; Feederle, R; Hayday, AC				McKenzie, Duncan R.; Hart, Rosie; Bah, Nourdine; Ushakov, Dmitry S.; Munoz-Ruiz, Miguel; Feederle, Regina; Hayday, Adrian C.			Normality sensing licenses local T cells for innate-like tissue surveillance	NATURE IMMUNOLOGY			English	Article							LYMPHOID STRESS-SURVEILLANCE; GAMMA-DELTA TCR; UP-REGULATION; GENOME-WIDE; RECEPTOR; SKINT-1; GROWTH; KERATINOCYTES; AMPHIREGULIN; MAINTENANCE	Hayday and colleagues show that sustained Skint1-dependent interactions between murine intraepidermal gamma delta T cells and keratinocytes are required to maintain the homeostatic barrier function and phenotype of the intraepidermal gamma delta T cells, including their preparedness to respond appropriately to epidermal challenges. The increasing implication of lymphocytes in general physiology and immune surveillance outside of infection poses the question of how their antigen receptors might be involved. Here, we show that macromolecular aggregates of intraepidermal gamma delta T cell antigen receptors (TCRs) in the mouse skin aligned with and depended on Skint1, a butyrophilin-like (BTNL) protein expressed by differentiated keratinocytes (KCs) at steady state. Interruption of TCR-mediated 'normality sensing' had no impact on gamma delta T cell numbers but altered their signature phenotype, while the epidermal barrier function was compromised. In addition to the regulation of steady-state physiology, normality sensing licensed intraepidermal T cells to respond rapidly to subsequent tissue perturbation by using innate tumor necrosis factor (TNF) superfamily receptors. Thus, interfering with Skint1-dependent interactions between local gamma delta T cells and KCs at steady state increased the susceptibility to ultraviolet B radiation (UVR)-induced DNA damage and inflammation, two cancer-disposing factors.	[McKenzie, Duncan R.; Hart, Rosie; Bah, Nourdine; Ushakov, Dmitry S.; Munoz-Ruiz, Miguel; Hayday, Adrian C.] Francis Crick Inst, London, England; [Ushakov, Dmitry S.; Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London, England; [Feederle, Regina] Helmholtz Zentrum Munchen, Monoclonal Antibody Core Facil, Neuherberg, Germany; [Ushakov, Dmitry S.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany	Francis Crick Institute; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Friedrich Loeffler Institute	Hayday, AC (corresponding author), Francis Crick Inst, London, England.; Hayday, AC (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, London, England.	adrian.hayday@kcl.ac.uk	Muñoz-Ruiz, Miguel/AAC-3549-2021	Muñoz-Ruiz, Miguel/0000-0001-7986-3527; HAYDAY, ADRIAN/0000-0002-9495-5793	Francis Crick Institute - Cancer Research UK [FC001093]; MRC [FC001093]; Wellcome Trust [FC001093, 106292/Z/14/Z and 100156/Z/12/Z]; Cancer Research UK, King's and City of London Cancer Centre; Cancer Research Institute Irvington fellowship; Cancer Research UK postdoctoral fellowship	Francis Crick Institute - Cancer Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK, King's and City of London Cancer Centre; Cancer Research Institute Irvington fellowship; Cancer Research UK postdoctoral fellowship(Cancer Research UK)	We thank J. Strid (Imperial College London) and T. Zal (UT Southwestern) for advice; M. Battilocci and F. Watt (KCL) for advice and equipment and D. Calado (Francis Crick Institute) and T. Nitta, T. Narita and H. Takayanagi (University of Tokyo) for mice. We thank present and past members of our laboratory and the laboratory of D. Gibbons for discussions and advice, in particular O. Sobolev, A. Jandke, L. Monin, D. Moreno-Vicencio, V. Sofra, F. Cano and N. Roberts. We thank staff from the following Francis Crick Institute science technology platforms: biological research facility, flow cytometry, experimental histopathology, light microscopy, advanced sequencing, genomics equipment park (particularly O. O'Neill) and cell services and staff at the Nikon Imaging Centre at KCL Guy's Hospital campus. This work was supported by The Francis Crick Institute, which receives core funding from Cancer Research UK (FC001093), the MRC (FC001093) and the Wellcome Trust (FC001093) (A.C.H.); by the Cancer Research UK, King's and City of London Cancer Centre; by the Wellcome Trust (106292/Z/14/Z and 100156/Z/12/Z; A.C.H.); by a Cancer Research Institute Irvington fellowship to D.R.M. and by a Cancer Research UK postdoctoral fellowship to R.H.	Abeler-Dorner L, 2020, NAT IMMUNOL, V21, P86, DOI 10.1038/s41590-019-0549-0; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; DEBENEDETTE MA, 1995, J EXP MED, V181, P985, DOI 10.1084/jem.181.3.985; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ghilas S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103059; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jandke A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17557-y; Kadow S, 2011, J IMMUNOL, V187, P3104, DOI 10.4049/jimmunol.1100912; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Komori HK, 2012, J IMMUNOL, V188, P2972, DOI 10.4049/jimmunol.1100887; KYES S, 1989, P NATL ACAD SCI USA, V86, P5527, DOI 10.1073/pnas.86.14.5527; LANDAU SB, 1995, IMMUNOL INVEST, V24, P947, DOI 10.3109/08820139509060719; Lee HJ, 2019, J INVEST DERMATOL, V139, P1182, DOI 10.1016/j.jid.2018.10.036; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacLeod AS, 2014, J IMMUNOL, V192, P5695, DOI 10.4049/jimmunol.1303297; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Mohamadzadeh M, 1996, J INVEST DERMATOL, V107, P738, DOI 10.1111/1523-1747.ep12365634; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Narita T, 2018, INT IMMUNOL, V30, P301, DOI 10.1093/intimm/dxy030; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Salim M, 2016, J BIOL CHEM, V291, P9310, DOI 10.1074/jbc.M116.722066; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shi L, 2009, CELL DEATH DIFFER, V16, P1694, DOI 10.1038/cdd.2009.101; Shipman WD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9527; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Willcox CR, 2019, IMMUNITY, V51, P813, DOI 10.1016/j.immuni.2019.09.006; Wollenberg A, 2019, J ALLERGY CLIN IMMUN, V143, P135, DOI 10.1016/j.jaci.2018.05.029; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhang BJ, 2015, J IMMUNOL, V195, P4282, DOI 10.4049/jimmunol.1501220; Zmora N, 2017, CELL METAB, V25, P506, DOI 10.1016/j.cmet.2017.02.006	63	10	10	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					411	+		10.1038/s41590-021-01124-8	http://dx.doi.org/10.1038/s41590-021-01124-8		FEB 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35165446	Green Published, hybrid			2022-12-18	WOS:000754956300001
J	Amorim, A; De Feo, D; Friebel, E; Ingelfinger, F; Anderfuhren, CD; Krishnarajah, S; Andreadou, M; Welsh, CA; Liu, ZY; Ginhoux, F; Greter, M; Becher, B				Amorim, Ana; De Feo, Donatella; Friebel, Ekaterina; Ingelfinger, Florian; Anderfuhren, Cyrill Dimitri; Krishnarajah, Sinduya; Andreadou, Myrto; Welsh, Christina A.; Liu, Zhaoyuan; Ginhoux, Florent; Greter, Melanie; Becher, Burkhard			IFN gamma and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; HIGH-DIMENSIONAL CYTOMETRY; CENTRAL-NERVOUS-SYSTEM; LY6C(HI) MONOCYTES; EFFECTOR PHASE; MYELOID CELLS; MICE; MACROPHAGES; POPULATION; DEFICIENT	During inflammation, Ly6C(hi) monocytes are rapidly mobilized from the bone marrow (BM) and are recruited into inflamed tissues, where they undergo monocyte-to-phagocyte transition (MTPT). The in vivo developmental trajectories of the MTPT and the contribution of individual cytokines to this process remain unclear. Here, we used a murine model of neuroinflammation to investigate how granulocyte-macrophage colony-stimulating factor (GM-CSF) and interferon-gamma (IFN gamma), two type 1 cytokines, controlled MTPT. Using genetic fate mapping, gene targeting and high-dimensional single-cell multiomics analyses, we found that IFN gamma was essential for the gradual acquisition of a mature inflammatory phagocyte phenotype in Ly6C(hi) monocytes, while GM-CSF was required to license interleukin-1 beta (IL-1 beta) production, phagocytosis and oxidative burst. These results suggest that the proinflammatory cytokine environment guided MTPT trajectories in the inflamed central nervous system (CNS) and indicated that GM-CSF was the most prominent target for the disarming of monocyte progenies during neuroinflammation. Becher and colleagues use a mouse model of multiple sclerosis to show that IFN gamma is essential for the acquisition of a mature inflammatory phagocyte phenotype, while GM-CSF is required for phagocytosis and the production of IL-1 beta and ROS in Ly6C(hi) monocytes during neuroinflammation.	[Amorim, Ana; De Feo, Donatella; Friebel, Ekaterina; Ingelfinger, Florian; Anderfuhren, Cyrill Dimitri; Krishnarajah, Sinduya; Andreadou, Myrto; Welsh, Christina A.; Greter, Melanie; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Liu, Zhaoyuan; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China; [Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Ginhoux, Florent] Singhlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Amorim, Ana] Roche Glycart, Schlieren, Switzerland	University of Zurich; Chinese Academy of Sciences; Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Roche Holding	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Friebel, Ekaterina/0000-0003-1419-2376; Ingelfinger, Florian/0000-0001-6890-9753; Greter, Melanie/0000-0002-7220-5369	Swiss National Science Foundation [733 310030_170320, 310030_188450, CRSII5_183478, BSSGI0_155832, 310030_184915]; University of Zurich postdoctoral fellowship; Swiss Multiple Sclerosis Society; European Research Council (ERC) under the European Union [882424]; Clinical Research Priority Program ImmunoCure	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich postdoctoral fellowship; Swiss Multiple Sclerosis Society; European Research Council (ERC) under the European Union(European Research Council (ERC)); Clinical Research Priority Program ImmunoCure	We thank M. Lutz and P. Zwicky for technical assistance. We wish to thank L. Robinson of Insight Editing London for critical review of the manuscript. This work was supported by the Swiss National Science Foundation (733 310030_170320, 310030_188450 and CRSII5_183478 to B.B. and BSSGI0_155832, 310030_184915 to M.G.), the Clinical Research Priority Program ImmunoCure (B.B.), the University of Zurich postdoctoral fellowship (D.D.F.), the Swiss Multiple Sclerosis Society (B.B. and D.D.F.) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme grant agreement No 882424 (B.B.).	Abdi Kaveh, 2020, Immunohorizons, V4, P415, DOI 10.4049/immunohorizons.2000011; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Barin JG, 2013, J IMMUNOL, V191, P4038, DOI 10.4049/jimmunol.1301282; Bastian M., 2009, P 3 INT AAAI C WEBLO, V3, P361, DOI DOI 10.1609/ICWSM.V3I1.13937; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brummelman J, 2019, NAT PROTOC, V14, P1946, DOI 10.1038/s41596-019-0166-2; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Codarri L, 2013, TRENDS IMMUNOL, V34, P114, DOI 10.1016/j.it.2012.09.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Croxford AL, 2011, IMMUNOLOGY, V132, P1, DOI 10.1111/j.1365-2567.2010.03372.x; Ferber IA, 1996, J IMMUNOL, V156, P5; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Kageyama Y, 1998, J IMMUNOL, V161, P1542; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Locatelli G, 2018, NAT NEUROSCI, V21, P1196, DOI 10.1038/s41593-018-0212-3; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mendiola AS, 2020, NAT IMMUNOL, V21, P513, DOI 10.1038/s41590-020-0654-0; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mrdjen D, 2017, METHODS MOL BIOL, V1559, P321, DOI 10.1007/978-1-4939-6786-5_22; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; See P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02425; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tuzlak S, 2021, NAT IMMUNOL, V22, P1210, DOI 10.1038/s41590-021-01009-w; Weinreb C, 2020, SCIENCE, V367, DOI 10.1126/science.aaw3381; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	56	10	10	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					217	+		10.1038/s41590-021-01117-7	http://dx.doi.org/10.1038/s41590-021-01117-7		JAN 2022	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35102344				2022-12-18	WOS:000750323300003
J	Wu, BW; Zhao, TV; Jin, K; Hu, ZL; Abdel, MP; Warrington, KJ; Goronzy, JJ; Weyand, CM				Wu, Bowen; Zhao, Tuantuan, V; Jin, Ke; Hu, Zhaolan; Abdel, Matthew P.; Warrington, Ken J.; Goronzy, Jorg J.; Weyand, Cornelia M.			Mitochondrial aspartate regulates TNF biogenesis and autoimmune tissue inflammation	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; RHEUMATOID-ARTHRITIS; T-CELLS; BIOSYNTHESIS; RESPIRATION; XBP1	Mitochondrial aspartate regulates ER morphology and co-translational translocation via BiP ADP ribosylation. In T cells from patients with rheumatoid arthritis, mitochondrial aspartate is deficient, resulting in ER expansion and excessive production of the pro-inflammatory cytokine TNF. Misdirected immunity gives rise to the autoimmune tissue inflammation of rheumatoid arthritis, in which excess production of the cytokine tumor necrosis factor (TNF) is a central pathogenic event. Mechanisms underlying the breakdown of self-tolerance are unclear, but T cells in the arthritic joint have a distinctive metabolic signature of ATP(lo) acetyl-CoA(hi) proinflammatory effector cells. Here we show that a deficiency in the production of mitochondrial aspartate is an important abnormality in these autoimmune T cells. Shortage of mitochondrial aspartate disrupted the regeneration of the metabolic cofactor nicotinamide adenine dinucleotide, causing ADP deribosylation of the endoplasmic reticulum (ER) sensor GRP78/BiP. As a result, ribosome-rich ER membranes expanded, promoting co-translational translocation and enhanced biogenesis of transmembrane TNF. ERrich T cells were the predominant TNF producers in the arthritic joint. Transfer of intact mitochondria into T cells, as well as supplementation of exogenous aspartate, rescued the mitochondria-instructed expansion of ER membranes and suppressed TNF release and rheumatoid tissue inflammation.	[Wu, Bowen; Zhao, Tuantuan, V; Jin, Ke; Hu, Zhaolan; Warrington, Ken J.; Goronzy, Jorg J.; Weyand, Cornelia M.] Mayo Clin, Dept Med, Coll Med & Sci, Rochester, MN 55905 USA; [Abdel, Matthew P.] Mayo Clin, Dept Orthoped Surg, Coll Med & Sci, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Weyand, CM (corresponding author), Mayo Clin, Dept Med, Coll Med & Sci, Rochester, MN 55905 USA.	cweyand@stanford.edu	Warrington, Kenneth/CAG-1626-2022; Zhao, Tuantuan/GSD-8599-2022; Hu, Zhaolan/GYU-4213-2022; Wu, Bowen/GVR-9161-2022	Goronzy, Jorg/0000-0001-7670-1856; Warrington, Kenneth/0000-0001-7708-2487				Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Bovensiepen CS, 2019, J IMMUNOL, V203, P3148, DOI 10.4049/jimmunol.1900124; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chinopoulos C, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113218; Davila A, 2018, ELIFE, V7, DOI 10.7554/eLife.33246; Deane KD, 2010, RHEUM DIS CLIN N AM, V36, P213, DOI 10.1016/j.rdc.2010.02.001; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Jain A, 2020, NAT IMMUNOL, V21, P65, DOI 10.1038/s41590-019-0559-y; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Knupp J, 2019, CELL DEATH DIFFER, V26, P487, DOI 10.1038/s41418-018-0133-4; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Li YY, 2019, CELL METAB, V30, P477, DOI 10.1016/j.cmet.2019.06.016; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; PROBERT L, 1993, J IMMUNOL, V151, P1894; Rubbert-Roth A, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102398; Rubbert-Roth A, 2018, AUTOIMMUN REV, V17, P24, DOI 10.1016/j.autrev.2017.11.005; Schreurs RRCE, 2019, IMMUNITY, V50, P462, DOI 10.1016/j.immuni.2018.12.010; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Slowikowski K, 2018, CURR OPIN RHEUMATOL, V30, P65, DOI 10.1097/BOR.0000000000000455; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Voorhees RM, 2016, CURR OPIN CELL BIOL, V41, P91, DOI 10.1016/j.ceb.2016.04.009; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Weyand CM, 2006, NAT CLIN PRACT RHEUM, V2, P201, DOI 10.1038/ncprheum0142; Weyand CM, 2021, NAT IMMUNOL, V22, P10, DOI 10.1038/s41590-020-00816-x; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49; Wu BW, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.025; Wu Bowen, 2020, Immunometabolism, V2, DOI 10.20900/immunometab20200017; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Zaslona Z, 2020, MOL CELL, V78, P814, DOI 10.1016/j.molcel.2020.04.002; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	48	10	10	7	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1551	+		10.1038/s41590-021-01065-2	http://dx.doi.org/10.1038/s41590-021-01065-2		NOV 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811544	Green Accepted			2022-12-18	WOS:000722315400001
J	Snell, LM; Xu, WX; Abd-Rabbo, D; Boukhaled, G; Guo, MD; Macleod, BL; Elsaesser, HJ; Hezaveh, K; Alsahafi, N; Lukhele, S; Nejat, S; Prabhakaran, R; Epelman, S; McGaha, TL; Brooks, DG				Snell, Laura M.; Xu, Wenxi; Abd-Rabbo, Diala; Boukhaled, Giselle; Guo, Mengdi; Macleod, Bethany L.; Elsaesser, Heidi J.; Hezaveh, Kebria; Alsahafi, Nirmin; Lukhele, Sabelo; Nejat, Sara; Prabhakaran, Ramanandan; Epelman, Slava; McGaha, Tracy L.; Brooks, David G.			Dynamic CD4(+) T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FOLLICULAR HELPER-CELLS; BLOCKADE; PROGENITOR; EXPANSION; RESPONSES; STRENGTH; SUSTAIN; PD-1	Inhibiting PD-1:PD-L1 signaling has transformed therapeutic immune restoration. CD4(+) T cells sustain immunity in chronic infections and cancer, yet little is known about how PD-1 signaling modulates CD4(+) helper T (T-H) cell responses or the ability to restore CD4(+) T-H-mediated immunity by checkpoint blockade. We demonstrate that PD-1:PD-L1 specifically suppressed CD4(+) T(H)1 cell amplification, prevents CD4(+) T(H)1 cytokine production and abolishes CD4(+) cytotoxic killing capacity during chronic infection in mice. Inhibiting PD-L1 rapidly restored these functions, while simultaneously amplifying and activating T(H)1-like T regulatory cells, demonstrating a system-wide CD4-T(H)1 recalibration. This effect coincided with decreased T cell antigen receptor signaling, and re-directed type I interferon (IFN) signaling networks towards dominant IFN-gamma-mediated responses. Mechanistically, PD-L1 blockade specifically targeted defined populations with pre-established, but actively suppressed proliferative potential, with limited impact on minimally cycling TCF-1(+) follicular helper T cells, despite high PD-1 expression. Thus, CD4(+) T cells require unique differentiation and functional states to be targets of PD-L1-directed suppression and therapeutic restoration. Snell et al. examine the heterogeneity of CD4(+) T cells in chronic viral infection, showing that PD-L1 blockade enhances a cytotoxic gene program in antigen-specific T(H)1 cells and can restore antiviral CD4(+) T cell killer function.	[Snell, Laura M.; Xu, Wenxi; Abd-Rabbo, Diala; Boukhaled, Giselle; Guo, Mengdi; Macleod, Bethany L.; Elsaesser, Heidi J.; Hezaveh, Kebria; Alsahafi, Nirmin; Lukhele, Sabelo; Prabhakaran, Ramanandan; McGaha, Tracy L.; Brooks, David G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Snell, Laura M.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Guo, Mengdi; Epelman, Slava; McGaha, Tracy L.; Brooks, David G.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Nejat, Sara; Epelman, Slava] Univ Hlth Network UHN, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Epelman, Slava] Ted Rogers Ctr Heart Res, Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Peter Munk Cardiac Centre	Snell, LM; Brooks, DG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Snell, LM (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.; Brooks, DG (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	lausnell@iu.edu; dbrooks@uhnresearch.ca	Epelman, Slava/AAO-1728-2020	Epelman, Slava/0000-0003-3400-4475; McGaha, Tracy/0000-0003-4721-9301; Snell, Laura/0000-0001-9890-6588	Canadian Institutes of Health Research (CIHR) Foundation [FDN148386]; National Institutes of Health (NIH) [AI085043]; Scotiabank Research Chair; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR) Foundation(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scotiabank Research Chair; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	We thank past and present members of the Brooks laboratory for technical help and discussion. This work was supported by the Canadian Institutes of Health Research (CIHR) Foundation Grant FDN148386 (D.G.B.), the National Institutes of Health (NIH) grant AI085043 (D.G.B.), the Scotiabank Research Chair to D.G.B, and a training grant from the Fonds de la Recherche en Sante du Quebec (L.M.S.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Barber DL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2702; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cader FZ, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1006-1; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Feng JY, 2012, J GASTROENTEROL, V47, P1048, DOI 10.1007/s00535-012-0568-1; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Griffith M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004393; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Macleod BL, 2020, J EXP MED, V217, DOI 10.1084/jem.20191473; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roemer MGM, 2018, J CLIN ONCOL, V36, P942, DOI 10.1200/JCO.2017.77.3994; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sledzinska A, 2020, IMMUNITY, V52, P151, DOI 10.1016/j.immuni.2019.12.007; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Snell LM, 2016, CELL REP, V16, P3286, DOI 10.1016/j.celrep.2016.08.065; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Weber LM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0415-5; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	68	10	10	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1524	+		10.1038/s41590-021-01060-7	http://dx.doi.org/10.1038/s41590-021-01060-7		NOV 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34795443				2022-12-18	WOS:000720214500003
J	Holtkamp, SJ; Ince, LM; Barnoud, C; Schmitt, MT; Sinturel, F; Pilorz, V; Pick, R; Jemelin, S; Muhlstadt, M; Boehncke, WH; Weber, J; Laubender, D; Philippou-Massier, J; Chen, CS; Holtermann, L; Vestweber, D; Sperandio, M; Schraml, BU; Halin, C; Dibner, C; Oster, H; Renkawitz, J; Scheiermann, C				Holtkamp, Stephan J.; Ince, Louise M.; Barnoud, Coline; Schmitt, Madeleine T.; Sinturel, Flore; Pilorz, Violetta; Pick, Robert; Jemelin, Stephane; Muehlstaedt, Michael; Boehncke, Wolf-Henning; Weber, Jasmin; Laubender, David; Philippou-Massier, Julia; Chen, Chien-Sin; Holtermann, Leonie; Vestweber, Dietmar; Sperandio, Markus; Schraml, Barbara U.; Halin, Cornelia; Dibner, Charna; Oster, Henrik; Renkawitz, Joerg; Scheiermann, Christoph			Circadian clocks guide dendritic cells into skin lymphatics	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSE; TRAFFICKING; CCL21; INFLAMMATION; EXPRESSION; MIGRATION	Scheiermann and colleagues show that circadian clocks control the infiltration of dendritic cells into skin lymphatics in mice and humans, with a peak migration to the lymph nodes during the rest phase. Migration of leukocytes from the skin to lymph nodes (LNs) via afferent lymphatic vessels (LVs) is pivotal for adaptive immune responses(1,2). Circadian rhythms have emerged as important regulators of leukocyte trafficking to LNs via the blood(3,4). Here, we demonstrate that dendritic cells (DCs) have a circadian migration pattern into LVs, which peaks during the rest phase in mice. This migration pattern is determined by rhythmic gradients in the expression of the chemokine CCL21 and of adhesion molecules in both mice and humans. Chronopharmacological targeting of the involved factors abrogates circadian migration of DCs. We identify cell-intrinsic circadian oscillations in skin lymphatic endothelial cells (LECs) and DCs that cogovern these rhythms, as their genetic disruption in either cell type ablates circadian trafficking. These observations indicate that circadian clocks control the infiltration of DCs into skin lymphatics, a process that is essential for many adaptive immune responses and relevant for vaccination and immunotherapies.	[Holtkamp, Stephan J.; Schmitt, Madeleine T.; Weber, Jasmin; Chen, Chien-Sin; Sperandio, Markus; Schraml, Barbara U.; Renkawitz, Joerg; Scheiermann, Christoph] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med WBex, Inst Cardiovasc Physiol & Pathophysiol, Biomed Ctr BMC,Fac Med, Planegg Martinsried, Germany; [Ince, Louise M.; Barnoud, Coline; Pick, Robert; Jemelin, Stephane; Boehncke, Wolf-Henning; Scheiermann, Christoph] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Schmitt, Madeleine T.; Renkawitz, Joerg] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med WBex, Inst Cardiovasc Physiol & Pathophysiol, Lab Cell Biol Immune Syst,Biomed Ctr BMC,Fac Med, Planegg Martinsried, Germany; [Sinturel, Flore; Dibner, Charna] Univ Hosp Geneva, Dept Med, Div Endocrinol Diabet Nutr & Patient Educ, Geneva, Switzerland; [Sinturel, Flore; Dibner, Charna] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Sinturel, Flore; Dibner, Charna] Univ Geneva, Fac Med, Diabet Ctr, Geneva, Switzerland; [Sinturel, Flore; Dibner, Charna] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Pilorz, Violetta; Oster, Henrik] Univ Lubeck, Inst Neurobiol, Lubeck, Germany; [Muehlstaedt, Michael; Boehncke, Wolf-Henning] Univ Hosp Geneva, Dept Med, Div Dermatol & Venereol, Geneva, Switzerland; [Laubender, David] Max Planck Inst Neurobiol, Martinsried, Germany; [Philippou-Massier, Julia] Ludwig Maximilians Univ Munchen, Gene Ctr Munich, Lab Funct Genome Anal, Munich, Germany; [Holtermann, Leonie; Vestweber, Dietmar] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany; [Halin, Cornelia] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland	University of Munich; University of Geneva; University of Munich; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lubeck; University of Geneva; Max Planck Society; University of Munich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Scheiermann, C (corresponding author), Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med WBex, Inst Cardiovasc Physiol & Pathophysiol, Biomed Ctr BMC,Fac Med, Planegg Martinsried, Germany.; Scheiermann, C (corresponding author), Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland.	christoph.scheiermann@unige.ch	Ince, Louise/K-6149-2019; Renkawitz, Jörg/AAD-5932-2022; Mühlstädt, Michael/AAN-2158-2021; Scheiermann, Christoph/B-8261-2014	Ince, Louise/0000-0002-2093-0876; Renkawitz, Jörg/0000-0003-2856-3369; Schraml, Barbara/0000-0002-5801-0151; Barnoud, Coline/0000-0001-5500-0217; Pick, Robert/0000-0001-9785-8481; Sperandio, Markus/0000-0002-7689-3613; Scheiermann, Christoph/0000-0002-9212-0995; Sinturel, Flore/0000-0003-3210-0113	European Research Council [635872]; Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) [SCHE 1645/2-1, SFB914]; Swiss National Science Foundation [SNF 310030_182417/1, 310030_184708/1, 310030_182528]; Novartis foundation [20A019]; International Max Planck Research School for Molecular Life Sciences (IMPRS-LS); SGED/SSED Young Investigator grant; Vontobel Foundation; Novartis Consumer Health Foundation; Swiss Life Foundation; EFSD/Novo Nordisk Program for Diabetes Research in Europe; Leenaards Foundation; Olga Mayenfisch Foundation; Fondation pour l'innovation sur le cancer et la biologie; DFG [SFB914, SFB1009, OS353-7/1, OS353-10/1]; Stiftung Experimentelle Biomedizin; LMU Institutional Strategy LMU-Excellent	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis foundation(Novartis); International Max Planck Research School for Molecular Life Sciences (IMPRS-LS); SGED/SSED Young Investigator grant; Vontobel Foundation; Novartis Consumer Health Foundation; Swiss Life Foundation; EFSD/Novo Nordisk Program for Diabetes Research in Europe; Leenaards Foundation; Olga Mayenfisch Foundation; Fondation pour l'innovation sur le cancer et la biologie; DFG(German Research Foundation (DFG)); Stiftung Experimentelle Biomedizin; LMU Institutional Strategy LMU-Excellent	This study received support from the European Research Council (Starting grant 635872, CIRCODE to C.S.), the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) (Emmy-Noether grant SCHE 1645/2-1 and SFB914 projects B09 and Z03 to C.S.), the Swiss National Science Foundation (SNF 310030_182417/1 to C.S.), the Novartis foundation (20A019 to C.S.) and the International Max Planck Research School for Molecular Life Sciences (IMPRS-LS to C.S.). F.S. was supported by an SGED/SSED Young Investigator grant. Work in the laboratory of C.D. was supported by a Swiss National Science Foundation grant (310030_184708/1), the Vontobel Foundation, the Novartis Consumer Health Foundation, Swiss Life Foundation, the EFSD/Novo Nordisk Program for Diabetes Research in Europe, the Leenaards Foundation, the Olga Mayenfisch Foundation and Fondation pour l'innovation sur le cancer et la biologie. D.V. received support from the DFG (SFB1009, project A1). C.H. gratefully acknowledges financial support from the Swiss National Science Foundation (310030_182528). H.O. received support from the DFG (OS353-7/1 and OS353-10/1). J.R. received support from the Peter Hans Hofschneider Professorship of the Stiftung Experimentelle Biomedizin, the DFG (grant SFB914, project A12) and the LMU Institutional Strategy LMU-Excellent within the framework of the German Excellence Initiative. We thank the Ludwig-Maximilian University flow cytometry core facility, especially L. Richter and the University of Geneva flow cytometry core facility for their services as well as the core facility for animal models (CAM) of the BMC and the animal facility in Geneva. We thank J. Arasa Aparici for helping us set up the GM-CSF hybridoma culture, V. Petrenko for providing BM from Bmal1<SUP>-/-</SUP> animals and J. Ripperger and U. Albrecht for providing BM from Per1<SUP>-/-</SUP>/Per2<SUP>-/-</SUP> mice.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hopwood TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22021-5; Jackson DG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00471; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kiermaier E, 2016, SCIENCE, V351, P186, DOI 10.1126/science.aad0512; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; Nobis CC, 2019, P NATL ACAD SCI USA, V116, P20077, DOI 10.1073/pnas.1905080116; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palomino-Segura M, 2021, J EXP MED, V218, DOI 10.1084/jem.20200798; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Renkawitz J, 2019, NATURE, V568, P546, DOI 10.1038/s41586-019-1087-5; Russo E, 2016, CELL REP, V14, P1723, DOI 10.1016/j.celrep.2016.01.048; Saeki H, 1999, J IMMUNOL, V162, P2472; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Sutton CE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02111-0; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Torzicky M, 2012, J INVEST DERMATOL, V132, P1149, DOI 10.1038/jid.2011.420; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	33	10	10	3	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1375	+		10.1038/s41590-021-01040-x	http://dx.doi.org/10.1038/s41590-021-01040-x		OCT 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34663979	Green Published, hybrid			2022-12-18	WOS:000708376800003
J	Mastorakos, P; Russo, MV; Zhou, TZ; Johnson, K; McGavern, DB				Mastorakos, Panagiotis; Russo, Matthew, V; Zhou, Tianzan; Johnson, Kory; McGavern, Dorian B.			Antimicrobial immunity impedes CNS vascular repair following brain injury	NATURE IMMUNOLOGY			English	Article							ACUTE ISCHEMIC-STROKE; INFECTION; MACROPHAGES; INTERFERONS; MECHANISMS; RESPONSES; VIRUS; ANGIOGENESIS; RECRUITMENT; INDUCTION	Traumatic brain injury and stroke are commonly complicated by systemic infections, which impede recovery and lead to poor clinical outcomes. Using a mouse model, McGavern and colleagues show systemic microbial infections impair central nervous system revascularization and repair by a mechanism involving type I interferon signaling. Traumatic brain injury (TBI) and cerebrovascular injury are leading causes of disability and mortality worldwide. Systemic infections often accompany these disorders and can worsen outcomes. Recovery after brain injury depends on innate immunity, but the effect of infections on this process is not well understood. Here, we demonstrate that systemically introduced microorganisms and microbial products interfered with meningeal vascular repair after TBI in a type I interferon (IFN-I)-dependent manner, with sequential infections promoting chronic disrepair. Mechanistically, we discovered that MDA5-dependent detection of an arenavirus encountered after TBI disrupted pro-angiogenic myeloid cell programming via induction of IFN-I signaling. Systemic viral infection similarly blocked restorative angiogenesis in the brain parenchyma after intracranial hemorrhage, leading to chronic IFN-I signaling, blood-brain barrier leakage and a failure to restore cognitive-motor function. Our findings reveal a common immunological mechanism by which systemic infections deviate reparative programming after central nervous system injury and offer a new therapeutic target to improve recovery.	[Mastorakos, Panagiotis; Russo, Matthew, V; Zhou, Tianzan; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Mastorakos, Panagiotis] NINDS, Dept Surg Neurol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Mastorakos, Panagiotis/ABG-1157-2021; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X				Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Ahmed NA, 1999, CRIT CARE MED, V27, P2459, DOI 10.1097/00003246-199911000-00023; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Andraweera N, 2016, AUST HEALTH REV, V40, P114, DOI 10.1071/AH15062; Angus DC, 2016, JAMA-J AM MED ASSOC, V315, P1457, DOI 10.1001/jama.2016.2762; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Becker KJ, 2005, J CEREBR BLOOD F MET, V25, P1634, DOI 10.1038/sj.jcbfm.9600160; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crane MJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007212; Cumming TB, 2011, INT J STROKE, V6, P416, DOI 10.1111/j.1747-4949.2011.00666.x; Davis FM, 2019, ARTERIOSCL THROM VAS, V39, P2353, DOI 10.1161/ATVBAHA.119.312754; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Erdur H, 2015, STROKE, V46, P1031, DOI 10.1161/STROKEAHA.114.006886; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Gorelick PB, 2015, JAMA-J AM MED ASSOC, V314, P29, DOI 10.1001/jama.2015.7149; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; KENYON AJ, 1983, AM J VET RES, V44, P652; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kliper E, 2013, STROKE, V44, P1433, DOI 10.1161/STROKEAHA.111.000536; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Manglani Monica, 2018, Curr Protoc Immunol, V120, DOI 10.1002/cpim.46; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moseman EA, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb1817; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; Nitkunan A, 2011, STROKE, V42, P133, DOI 10.1161/STROKEAHA.110.594267; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Prigge JR, 2015, J IMMUNOL, V195, P5347, DOI 10.4049/jimmunol.1501553; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothenburg LS, 2010, J GERIATR PSYCH NEUR, V23, P199, DOI 10.1177/0891988710373598; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shim R, 2018, BRAIN BEHAV IMMUN, V70, P10, DOI 10.1016/j.bbi.2018.03.019; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Traub E, 1936, J EXP MED, V63, P847, DOI 10.1084/jem.63.6.847; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; VOLKERT M, 1965, ACTA PATHOL MIC SC, V63, P161, DOI 10.1111/apm.1965.63.2.161; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Welsh Raymond M, 2008, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15a01s8; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	75	10	10	4	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1280	+		10.1038/s41590-021-01012-1	http://dx.doi.org/10.1038/s41590-021-01012-1		SEP 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556874	Green Accepted			2022-12-18	WOS:000751833700001
J	Tomalka, JA; Pelletier, AN; Fourati, S; Latif, MB; Sharma, A; Furr, K; Carlson, K; Lifton, M; Gonzalez, A; Wilkinson, P; Franchini, G; Parks, R; Letvin, N; Yates, N; Seaton, K; Tomaras, G; Tartaglia, J; Robb, ML; Michael, NL; Koup, R; Haynes, B; Santra, S; Sekaly, RP				Tomalka, Jeffrey Alan; Pelletier, Adam Nicolas; Fourati, Slim; Latif, Muhammad Bilal; Sharma, Ashish; Furr, Kathryn; Carlson, Kevin; Lifton, Michelle; Gonzalez, Ana; Wilkinson, Peter; Franchini, Genoveffa; Parks, Robert; Letvin, Norman; Yates, Nicole; Seaton, Kelly; Tomaras, Georgia; Tartaglia, Jim; Robb, Merlin L.; Michael, Nelson L.; Koup, Richard; Haynes, Barton; Santra, Sampa; Sekaly, Rafick Pierre			The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination	NATURE IMMUNOLOGY			English	Article							YELLOW-FEVER VACCINE; INTERFERON RESPONSE; DEPENDENT INNATE; EFFICACY; BINDING; PROTEIN; CELLS; DIFFERENTIATION; CHEMOKINES; EXPRESSION	Understanding the mechanistic basis of vaccine efficacy is crucial to the development of next-generation vaccines. Sekaly and colleagues find that activation of the transcription factor CREB1 by the RV144 HIV-1 vaccine underpins the induction of robust adaptive immunity. Development of effective human immunodeficiency virus 1 (HIV-1) vaccines requires synergy between innate and adaptive immune cells. Here we show that induction of the transcription factor CREB1 and its target genes by the recombinant canarypox vector ALVAC + Alum augments immunogenicity in non-human primates (NHPs) and predicts reduced HIV-1 acquisition in the RV144 trial. These target genes include those encoding cytokines/chemokines associated with heightened protection from simian immunodeficiency virus challenge in NHPs. Expression of CREB1 target genes probably results from direct cGAMP (STING agonist)-modulated p-CREB1 activity that drives the recruitment of CD4(+) T cells and B cells to the site of antigen presentation. Importantly, unlike NHPs immunized with ALVAC + Alum, those immunized with ALVAC + MF59, the regimen in the HVTN702 trial that showed no protection from HIV infection, exhibited significantly reduced CREB1 target gene expression. Our integrated systems biology approach has validated CREB1 as a critical driver of vaccine efficacy and highlights that adjuvants that trigger CREB1 signaling may be critical for efficacious HIV-1 vaccines.	[Tomalka, Jeffrey Alan; Pelletier, Adam Nicolas; Fourati, Slim; Latif, Muhammad Bilal; Wilkinson, Peter; Sekaly, Rafick Pierre] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Tomalka, Jeffrey Alan; Fourati, Slim; Latif, Muhammad Bilal; Sharma, Ashish; Sekaly, Rafick Pierre] Emory Univ, Sch Med, Dept Pathol & Lab Med, Pathol Adv Translat Res Unit, Atlanta, GA 30322 USA; [Furr, Kathryn; Carlson, Kevin; Lifton, Michelle; Gonzalez, Ana; Letvin, Norman; Santra, Sampa] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Franchini, Genoveffa] NCI, Ctr Canc Res, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Parks, Robert; Yates, Nicole; Seaton, Kelly; Tomaras, Georgia; Haynes, Barton] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Tartaglia, Jim] Sanofi Pasteur, Swiftwater, PA USA; [Robb, Merlin L.; Michael, Nelson L.] Henry Jackson Fdn, Mil HIV Res Program, Bethesda, MD USA; [Robb, Merlin L.; Michael, Nelson L.] Walter Reed Army Inst Res, Bethesda, MD USA; [Robb, Merlin L.; Michael, Nelson L.] Henry Jackson Fdn, Mil HIV Res Program, Silver Spring, MD USA; [Robb, Merlin L.; Michael, Nelson L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Koup, Richard] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA	Case Western Reserve University; Emory University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; Sanofi-Aventis; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA	Sekaly, RP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.; Sekaly, RP (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Pathol Adv Translat Res Unit, Atlanta, GA 30322 USA.; Santra, S (corresponding author), Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	ssantra@bidmc.harvard.edu; rafick.sekaly@emory.edu		Lifton, Michelle/0000-0003-0279-2198; Fourati, Slim/0000-0001-6609-7587				Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bracci L, 2008, EXPERT REV VACCINES, V7, P373, DOI 10.1586/14760584.7.3.373; Delaloye J, 2015, J VIROL, V89, P3819, DOI 10.1128/JVI.03061-14; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Gray GE, 2021, NEW ENGL J MED, V384, P1089, DOI 10.1056/NEJMoa2031499; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hara S, 2011, TOXICOLOGY, V288, P49, DOI 10.1016/j.tox.2011.07.001; Harenberg A, 2008, VACCINE, V26, P5004, DOI 10.1016/j.vaccine.2008.07.050; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horb ME, 1999, DEVELOPMENT, V126, P1739; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kearney CJ, 2017, CELL MOL IMMUNOL, V14, P406, DOI 10.1038/cmi.2017.9; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Liu QH, 1999, FEBS LETT, V445, P402, DOI 10.1016/S0014-5793(99)00161-1; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Mohan T, 2018, IMMUNOBIOLOGY, V223, P477, DOI 10.1016/j.imbio.2017.12.001; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Offield MF, 1996, DEVELOPMENT, V122, P983; Ogilvie P, 2003, BLOOD, V102, P789, DOI 10.1182/blood-2002-09-2773; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Roth V, 2004, IEEE T NEURAL NETWOR, V15, P16, DOI 10.1109/TNN.2003.809398; Sahoo A, 2011, J IMMUNOL, V186, P4098, DOI 10.4049/jimmunol.1002620; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tassi I, 2014, J IMMUNOL, V193, P4303, DOI 10.4049/jimmunol.1401505; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Vaccari M, 2018, NAT MED, V24, P847, DOI 10.1038/s41591-018-0025-7; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; Yu QG, 2006, VACCINE, V24, P6376, DOI 10.1016/j.vaccine.2006.06.011; Zaal A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00818; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160	50	10	10	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1294	+		10.1038/s41590-021-01026-9	http://dx.doi.org/10.1038/s41590-021-01026-9		SEP 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556879	Green Accepted, Bronze			2022-12-18	WOS:000751833700012
J	Zemmour, D; Charbonnier, LM; Leon, J; Six, E; Keles, S; Delville, M; Benamar, M; Baris, S; Zuber, J; Chen, KR; Neven, B; Garcia-Lloret, MI; Ruemmele, FM; Brugnara, C; Cerf-Bensussan, N; Rieux-Laucat, F; Cavazzana, M; Andre, I; Chatila, TA; Mathis, D; Benoist, C				Zemmour, David; Charbonnier, Louis-Marie; Leon, Juliette; Six, Emmanuelle; Keles, Sevgi; Delville, Marianne; Benamar, Mehdi; Baris, Safa; Zuber, Julien; Chen, Karin; Neven, Benedicte; Garcia-Lloret, Maria I.; Ruemmele, Frank M.; Brugnara, Carlo; Cerf-Bensussan, Nadine; Rieux-Laucat, Frederic; Cavazzana, Marina; Andre, Isabelle; Chatila, Talal A.; Mathis, Diane; Benoist, Christophe			Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4(+) T cell perturbations	NATURE IMMUNOLOGY			English	Article							X-LINKED SYNDROME; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; EXPRESSION; ENTEROPATHY; HETEROGENEITY; DIFFERENTIATION; AUTOIMMUNITY; INDUCTION; LANDSCAPE	FOXP3 deficiency in mice and in patients with immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome results in fatal autoimmunity by altering regulatory T (T-reg) cells. CD4(+) T cells in patients with IPEX syndrome and Foxp3-deficient mice were analyzed by single-cell cytometry and RNA-sequencing, revealing heterogeneous T-reg-like cells, some very similar to normal T-reg cells, others more distant. Conventional T cells showed no widespread activation or helper T cell bias, but a monomorphic disease signature affected all CD4(+) T cells. This signature proved to be cell extrinsic since it was extinguished in mixed bone marrow chimeric mice and heterozygous mothers of patients with IPEX syndrome. Normal T-reg cells exerted dominant suppression, quenching the disease signature and revealing in mutant T-reg-like cells a small cluster of genes regulated cell-intrinsically by FOXP3, including key homeostatic regulators. We propose a two-step pathogenesis model: cell-intrinsic downregulation of core FOXP3-dependent genes destabilizes T-reg cells, de-repressing systemic mediators that imprint the disease signature on all T cells, furthering T-reg cell dysfunction. Accordingly, interleukin-2 treatment improved the T-reg-like compartment and survival. FOXP3 deficiency leads to dramatic loss of immune homeostasis. This multicenter collaborative group finds that loss of FOXP3 function only disrupts a few core genes, but this unmasks a degree of systemic inflammation, and it is this environment that then strongly perturbs T-reg cells.	[Zemmour, David; Leon, Juliette; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Zemmour, David] Harvard Med Sch, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Charbonnier, Louis-Marie; Benamar, Mehdi; Brugnara, Carlo; Chatila, Talal A.] Harvard Med Sch, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Charbonnier, Louis-Marie; Benamar, Mehdi; Brugnara, Carlo; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Leon, Juliette; Six, Emmanuelle; Delville, Marianne; Zuber, Julien; Neven, Benedicte; Ruemmele, Frank M.; Cerf-Bensussan, Nadine; Rieux-Laucat, Frederic; Andre, Isabelle] Univ Paris, Imagine Inst, INSERM UMR 1163, Paris, France; [Keles, Sevgi] Necmettin Erbakan Univ, Meram Med Fac, Div Pediat Allergy & Immunol, Konya, Turkey; [Delville, Marianne; Zuber, Julien; Neven, Benedicte; Ruemmele, Frank M.; Cerf-Bensussan, Nadine] Necker Childrens Hosp, Assistance Publ Hop Paris AP HP, Paris, France; [Baris, Safa] Marmara Univ, Div Pediat Allergy & Immunol, Sch Med, Istanbul, Turkey; [Baris, Safa] Istanbul Jeffrey Modell Diagnost & Res Ctr Primar, Istanbul, Turkey; [Chen, Karin] Univ Utah, Sch Med, Dept Pediat, Div Allergy & Immunol, Salt Lake City, UT USA; [Chen, Karin] Univ Washington, Dept Pediat, Div Immunol, Seattle, WA 98195 USA; [Chen, Karin] Seattle Childrens Res Inst, Seattle, WA USA; [Garcia-Lloret, Maria I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, Los Angeles, CA 90095 USA; [Cavazzana, Marina] INSERM, Assistance Publ Hop Paris, Biotherapy Dept, Paris, France; [Cavazzana, Marina] INSERM, Assistance Publ Hop Paris, Clin Invest Ctr, Paris, France; [Cavazzana, Marina] Univ Paris, Paris, France; [Cavazzana, Marina; Andre, Isabelle] Inst Imagine, Paris, France	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Necmettin Erbakan University; Selcuk University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Marmara University; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Andre, Isabelle/F-6263-2013; ZUBER, Julien/HGD-9815-2022; Rieux-Laucat, Frederic/A-7916-2017; Six, Emmanuelle/H-7891-2017	Andre, Isabelle/0000-0002-3905-9910; Baris, Safa/0000-0002-4730-9422; Keles, Sevgi/0000-0001-7344-8947; Zemmour, David/0000-0002-0990-217X; Zuber, Julien/0000-0001-6741-9330; Rieux-Laucat, Frederic/0000-0001-7858-7866; Six, Emmanuelle/0000-0001-7806-0968; Charbonnier, Louis-Marie/0000-0002-4594-7893; Benamar, Mehdi/0000-0003-1532-8642	National Institutes of Health [AI116834, AI150686, AI085090, AI153174]; Institut National de la Sante et Recherche Medicale; European Union Seventh Framework [269037, 261387]; Horizon 2020 [693762]; Agence Nationale pour la Recherche (Investissement d'Avenir) [ANR-10-IAHU-01]; INSERM Poste d'Accueil; Arthur Sachs scholarship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut National de la Sante et Recherche Medicale; European Union Seventh Framework; Horizon 2020; Agence Nationale pour la Recherche (Investissement d'Avenir)(French National Research Agency (ANR)); INSERM Poste d'Accueil(Institut National de la Sante et de la Recherche Medicale (Inserm)); Arthur Sachs scholarship	We thank M. Levings and A. Rudensky for insightful discussions and K. Hattori, C. Araneo, K. Seddu and the Klarman Cell Observatory team for help with mice, cell sorting and single-cell profiling. This work was funded by grants from the National Institutes of Health to C. Benoist and D.M. (AI116834 and AI150686), T.A.C. (AI085090) and L.M.C. (AI153174); the Institut National de la Sante et Recherche Medicale; the European Union Seventh Framework (269037 and 261387) and Horizon 2020 (693762); and the Agence Nationale pour la Recherche (Investissement d'Avenir ANR-10-IAHU-01) to I.A., E.S., M.D., J.L., M.C., B.N., F.R.L., F.R. and N.C.B. J.L. was supported by an INSERM Poste d'Accueil and an Arthur Sachs scholarship.	ALLAN SE, 2007, INT IMMUNOL; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bakke AC, 2004, CLIN EXP IMMUNOL, V137, P373, DOI 10.1111/j.1365-2249.2004.02537.x; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boldt A, 2014, CLIN IMMUNOL, V153, P109, DOI 10.1016/j.clim.2014.04.001; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Duclaux-Loras R, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0064-x; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02411; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johansen N, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1766-4; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; MALEK TR, 1985, J EXP MED, V161, P1575, DOI 10.1084/jem.161.6.1575; McMurchy AN, 2013, BLOOD, V121, P1265, DOI 10.1182/blood-2012-05-431023; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Ono M, 2020, IMMUNOLOGY, V160, P24, DOI 10.1111/imm.13178; Otsubo K, 2011, CLIN IMMUNOL, V141, P111, DOI 10.1016/j.clim.2011.06.006; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pesenacker AM, 2016, DIABETES, V65, P1031, DOI 10.2337/db15-0572; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Remedios KA, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau2042; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sitrin J, 2013, J EXP MED, V210, P1153, DOI 10.1084/jem.20122248; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Van Gool F, 2019, IMMUNITY, V50, P362, DOI 10.1016/j.immuni.2018.12.016; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wing JB, 2019, IMMUNITY, V50, P302, DOI 10.1016/j.immuni.2019.01.020; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zemmour D, 2017, P NATL ACAD SCI USA, V114, pE3472, DOI 10.1073/pnas.1700946114; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	61	10	10	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					607	+		10.1038/s41590-021-00910-8	http://dx.doi.org/10.1038/s41590-021-00910-8		APR 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33833438	Green Submitted, Green Accepted			2022-12-18	WOS:000638036600001
J	Schneider, C; Shen, C; Gopal, AA; Douglas, T; Forestell, B; Kauffman, KD; Rogers, D; Artusa, P; Zhang, Q; Jing, H; Freeman, AF; Barber, DL; King, IL; Saleh, M; Wiseman, PW; Su, HC; Mandl, JN				Schneider, Caitlin; Shen, Connie; Gopal, Angelica A.; Douglas, Todd; Forestell, Benjamin; Kauffman, Keith D.; Rogers, Dakota; Artusa, Patricio; Zhang, Qian; Jing, Huie; Freeman, Alexandra F.; Barber, Daniel L.; King, Irah L.; Saleh, Maya; Wiseman, Paul W.; Su, Helen C.; Mandl, Judith N.			Migration-induced cell shattering due to DOCK8 deficiency causes a type 2-biased helper T cell response	NATURE IMMUNOLOGY			English	Article							GM-CSF; ALLERGIC SENSITIZATION; MACROPHAGES; DEDICATOR; INNATE; IMMUNE; ROLES; MICE; HOMEOSTASIS; ACTIVATION	Humans with inherited defects inDOCK8expression are prone to allergic, type 2 CD4(+)T cell responses. Mandl and colleagues reveal an important role for cell death in driving such type 2 signals during infection. Mutations that impact immune cell migration and result in immune deficiency illustrate the importance of cell movement in host defense. In humans, loss-of-function mutations inDOCK8, a guanine exchange factor involved in hematopoietic cell migration, lead to immunodeficiency and, paradoxically, allergic disease. Here, we demonstrate that, like humans,Dock8(-/-)mice have a profound type 2 CD4(+)helper T (T(H)2) cell bias upon pulmonary infection withCryptococcus neoformansand other non-T(H)2 stimuli. We found that recruitedDock8(-/-)CX3CR1(+)mononuclear phagocytes are exquisitely sensitive to migration-induced cell shattering, releasing interleukin (IL)-1 beta that drives granulocyte-macrophage colony-stimulating factor (GM-CSF) production by CD4(+)T cells. Blocking IL-1 beta, GM-CSF or caspase activation eliminated the type-2 skew in mice lackingDock8. Notably, treatment of infected wild-type mice with apoptotic cells significantly increased GM-CSF production and T(H)2 cell differentiation. This reveals an important role for cell death in driving type 2 signals during infection, which may have implications for understanding the etiology of type 2 CD4(+)T cell responses in allergic disease.	[Schneider, Caitlin; Shen, Connie; Douglas, Todd; Forestell, Benjamin; Mandl, Judith N.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Schneider, Caitlin; Shen, Connie; Gopal, Angelica A.; Douglas, Todd; Forestell, Benjamin; Rogers, Dakota; Artusa, Patricio; Mandl, Judith N.] McGill Univ, McGill Res Ctr Complex Traits, Montreal, PQ, Canada; [Gopal, Angelica A.; Rogers, Dakota; Artusa, Patricio; Mandl, Judith N.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Kauffman, Keith D.; Barber, Daniel L.] NIAID, T Lymphocyte Biol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhang, Qian; Jing, Huie; Freeman, Alexandra F.; Su, Helen C.] NIAID, Human Immunol Dis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [King, Irah L.] McGill Univ, Hlth Ctr, Res Inst, Meakins Christie Labs,Dept Microbiol & Immunol, Montreal, PQ, Canada; [Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Gopal, Angelica A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zhang, Qian] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Saleh, Maya] Univ Bordeaux, Bordeaux, France	McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McGill University; McGill University; McGill University; McGill University; Harvard University; Massachusetts General Hospital; Rockefeller University; UDICE-French Research Universities; Universite de Bordeaux	Mandl, JN (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Mandl, JN (corresponding author), McGill Univ, McGill Res Ctr Complex Traits, Montreal, PQ, Canada.; Mandl, JN (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	judith.mandl@mcgill.ca		Saleh, Maya/0000-0003-1538-9146; Schneider, Caitlin/0000-0001-8931-4847; Douglas, Todd/0000-0002-6053-9345; Shen, Connie/0000-0001-9495-6086; Rogers, Dakota/0000-0001-5574-3088	McGill University Faculty of Medicine; Fonds de recherche Sante Quebec fellowship; Tomlinson Doctoral Fellowship; Canadian Institutes of Health Research (CIHR) [201603PJT-364017]; McGill start-up funds; NSERC [2017-05005]; CIHR; NSERC; CIHR [MOP-130579]; NIAID, NIH	McGill University Faculty of Medicine; Fonds de recherche Sante Quebec fellowship; Tomlinson Doctoral Fellowship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill start-up funds; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. D'Arcy, G. Perreault and animal facility staff at McGill for their excellent care of our animal colony; K. Mayer-Barber (NIH) for technical advice on myeloid cell stimulations; N. van Panhuys (Sidra Medical and Research Center, Qatar) for helpful discussions; J. Lee (Mayo Clinic) for providing Eo-cre mice; J. Burkhardt (U Penn) for the LifeAct-GFP mice; and D. Malo (McGill) for sharing the LysM-cre mice. Influenza A virus was provided by S. Vidal at The Centre for Phenogenomics McGill. A stock of C.neoformans H99 was shared by K. Kwon-Chung (NIH). We thank H. Matthews and P. Angelus for clinical support at NIH. R. Germain (NIH), S. Schwab (NYU), M. Richer (McGill), H. Melichar (University of Montreal), S. Gruenheid (McGill) and Mandl laboratory members provided critical feedback and advice on previous manuscript drafts. We thank the McGill University Cell Vision Core Facility for flow cytometry and single-cell analysis, the Life Sciences Complex Advanced BioImaging Facility and the Goodman Cancer Research Centre Histology Core Facility. C. Schneider was funded by the Max E. Binz Fellowship, McGill University Faculty of Medicine; C. Shen and P.A. were funded by a Fonds de recherche Sante Quebec fellowship; and D.R. was funded by a Tomlinson Doctoral Fellowship. J.N.M. is a Canada Research Chair for immune cell dynamics. M.S. is a McGill William Dawson Scholar. This research was supported by a Canadian Institutes of Health Research (CIHR) project grant (201603PJT-364017) and McGill start-up funds to J.N.M.; an NSERC Discovery Grant to P.W.W. (2017-05005), two CIHR project grants and an NSERC Discovery Grant to M.S.; a CIHR grant (MOP-130579) to I.L.K.; and by the Intramural Research Programme of the NIAID, NIH (D.L.B., A.F.F. and H.C.S.).	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Aydin SE, 2015, J CLIN IMMUNOL, V35, P189, DOI 10.1007/s10875-014-0126-0; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cates EC, 2003, J ALLERGY CLIN IMMUN, V111, P1076, DOI 10.1067/mai.2003.1460; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Happel CS, 2016, J ALLERGY CLIN IMMUN, V137, P1895, DOI 10.1016/j.jaci.2015.11.017; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Janssen E, 2016, J CLIN INVEST, V126, P3837, DOI 10.1172/JCI85774; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Keles S, 2016, J ALLERGY CLIN IMMUN, V138, P1384, DOI 10.1016/j.jaci.2016.04.023; Khameneh HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023025; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Kunimura K, 2020, INT IMMUNOL, V32, P5, DOI 10.1093/intimm/dxz067; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McCubbrey AL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01618; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Ohta K, 1999, J ALLERGY CLIN IMMUN, V104, P1024, DOI 10.1016/S0091-6749(99)70084-9; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Renkawitz J, 2019, NATURE, V568, P546, DOI 10.1038/s41586-019-1087-5; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Rodero MP, 2015, ELIFE, V4, DOI 10.7554/eLife.07847; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Sachet M, 2017, APOPTOSIS, V22, P1189, DOI 10.1007/s10495-017-1413-z; Saijo T, 2014, MBIO, V5, DOI 10.1128/mBio.00912-14; Singh AK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5603; Sionov E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005040; Sixt M., 2011, CELL MIGRATION DEV M; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Su HC, 2019, IMMUNOL REV, V287, P9, DOI 10.1111/imr.12723; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tangye SG, 2017, J ALLERGY CLIN IMMUN, V139, P933, DOI 10.1016/j.jaci.2016.07.016; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; van Panhuys N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00006; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307	63	10	10	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1528	+		10.1038/s41590-020-0795-1	http://dx.doi.org/10.1038/s41590-020-0795-1		OCT 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33020661				2022-12-18	WOS:000575347200001
J	Aksoylar, HI; Boussiotis, VA				Aksoylar, Halil-Ibrahim; Boussiotis, Vassiliki A.			PD-1(+)T(reg)cells: a foe in cancer immunotherapy?	NATURE IMMUNOLOGY			English	Article							IMMUNE TOLERANCE; DIFFERENTIATION	The mechanisms that drive responses to PD-1-blocking immunotherapy in some but not all patients have been puzzling. A new study suggests that the balance of PD-1 expression levels between CD8(+)T cells and T(reg)cells might provide an answer.	[Aksoylar, Halil-Ibrahim; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Aksoylar, Halil-Ibrahim; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA.; Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	vboussio@bidmc.harvard.edu			National Institutes of Health [RO1CA212605, RO1CA238263, RO1CA229784]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health awards RO1CA212605, RO1CA238263 and RO1CA229784 (V.A.B.).	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Wing JB, 2019, IMMUNITY, V50, P302, DOI 10.1016/j.immuni.2019.01.020; Zhang BH, 2016, P NATL ACAD SCI USA, V113, P8490, DOI 10.1073/pnas.1608873113	12	10	10	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1311	1312		10.1038/s41590-020-0801-7	http://dx.doi.org/10.1038/s41590-020-0801-7		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32973361				2022-12-18	WOS:000572604400001
J	Gioulbasani, M; Galaras, A; Grammenoudi, S; Moulos, P; Dent, AL; Sigvardsson, M; Hatzis, P; Kee, BL; Verykokakis, M				Gioulbasani, Marianthi; Galaras, Alexandros; Grammenoudi, Sofia; Moulos, Panagiotis; Dent, Alexander L.; Sigvardsson, Mikael; Hatzis, Pantelis; Kee, Barbara L.; Verykokakis, Mihalis			The transcription factor BCL-6 controls early development of innate-like T cells	NATURE IMMUNOLOGY			English	Article							GAMMA-DELTA T; NKT CELLS; B-CELLS; PLZF; GENE; PROGRAM; DIFFERENTIATION; GENERATION; PRECURSOR; IMMUNITY	Verykokakis and colleagues show that the transcription factor BCL-6 is highly expressed in stage 0 NKT and is absolutely required for innate T cell lineage development. BCL-6 acts to modify the chromatin landscape and is needed to promote the ST0-ST1 transition and PLZF expression. Innate T cells, including invariant natural killer T (iNKT) and mucosal-associated innate T (MAIT) cells, are a heterogeneous T lymphocyte population with effector properties preprogrammed during their thymic differentiation. How this program is initiated is currently unclear. Here, we show that the transcription factor BCL-6 was transiently expressed in iNKT cells upon exit from positive selection and was required for their proper development beyond stage 0. Notably, development of MAIT cells was also impaired in the absence ofBcl6. BCL-6-deficient iNKT cells had reduced expression of genes that were associated with the innate T cell lineage, includingZbtb16, which encodes PLZF, and PLZF-targeted genes. BCL-6 contributed to a chromatin accessibility landscape that was permissive for the expression of development-related genes and inhibitory for genes associated with naive T cell programs. Our results revealed new functions for BCL-6 and illuminated how this transcription factor controls early iNKT cell development.	[Gioulbasani, Marianthi; Galaras, Alexandros; Grammenoudi, Sofia; Moulos, Panagiotis; Hatzis, Pantelis; Verykokakis, Mihalis] BSRC Alexander Fleming, Inst Fundamental Biomed Res, Vari, Greece; [Galaras, Alexandros] Univ Thessaly, Dept Biochem & Biotechnol, Biopolis, Greece; [Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Hematopoiesis Unit, Linkoping, Sweden; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	Alexander Fleming Biomedical Sciences Research Center; University of Thessaly; Indiana University System; Indiana University Bloomington; Linkoping University; University of Chicago; University of Chicago	Verykokakis, M (corresponding author), BSRC Alexander Fleming, Inst Fundamental Biomed Res, Vari, Greece.; Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu; verykokakis@fleming.gr	Moulos, Panagiotis/E-2335-2018	Moulos, Panagiotis/0000-0002-4199-0333; Kee, Barbara/0000-0001-7014-1982; Verykokakis, Mihalis/0000-0002-2780-5007; Sigvardsson, Mikael/0000-0001-8527-7276	European Commission H2020-MSCA-IF grant [655271]; Hellenic Foundation for Research and Innovation grant [486]; National Institute of Allergy and Infectious Diseases [R56 AI104303, R01 AI123396]; Stavros Niarchos Foundation [GRA-14451]; Knut and Alice Wallenbergs Foundation; Cancerfonden; NIH [5R01 AI32771]; Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF) [MIS 5002562]; European Union	European Commission H2020-MSCA-IF grant; Hellenic Foundation for Research and Innovation grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stavros Niarchos Foundation; Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Cancerfonden(Swedish Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF); European Union(European Commission)	This work was supported by a European Commission H2020-MSCA-IF grant (no. 655271) and a Hellenic Foundation for Research and Innovation grant (no. 486) to M.V. and grants from the National Institute of Allergy and Infectious Diseases (R56 AI104303 and R01 AI123396) to B.L.K. M.V. and P.M. were supported by a Stavros Niarchos Foundation start-up grant to BSRC Alexander Fleming (GRA-14451), as part of the Foundation's initiative to support the Greek research ecosystem. M.S. was supported by Knut and Alice Wallenbergs Foundation and Cancerfonden. A.L.D. was supported by NIH 5R01 AI32771. This work benefited from the project "Strategic Development of the Biomedical Research Institute Alexander Fleming" (MIS 5002562) to P.H., which was implemented under "Action for the Strategic Development on the Research and Technological Sector", funded by the Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and co-financed by Greece and the European Union. We thank A. Melnick (Weill Cornell Medicine) for advice and C. Dagla, G. van der Voort, A. Rao and L. Lenner for technical support. We also thank the InfrafrontierGR Infrastructure for providing mouse and flow cytometry facilities, BSRC Fleming Flow Facility, the University of Chicago Genomics Core Facility and the Cytometry and Antibodies Core Facility, the University of Chicago Comprehensive Cancer Center (P30 CA014599) and the NIH Tetramer Facility.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bunting KL, 2013, CURR OPIN IMMUNOL, V25, P339, DOI 10.1016/j.coi.2013.05.003; Carr T, 2015, J EXP MED, V212, P793, DOI 10.1084/jem.20141849; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; D'Cruz LM, 2010, CURR OPIN IMMUNOL, V22, P199, DOI 10.1016/j.coi.2010.01.014; Dickgreber N, 2012, J LEUKOCYTE BIOL, V92, P999, DOI 10.1189/jlb.0512242; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Enders A, 2012, J IMMUNOL, V189, P5240, DOI 10.4049/jimmunol.1201486; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Engel I, 2010, J EXP MED, V207, P1015, DOI 10.1084/jem.20090557; FUKUDA T, 1995, ONCOGENE, V11, P1657; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Hosoya T, 2018, SCI REP, V8; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee YJ, 2016, J IMMUNOL, V197, P1460, DOI 10.4049/jimmunol.1600643; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Mao AP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00882-0; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Mathew R, 2014, J EXP MED, V211, P1137, DOI 10.1084/jem.20132267; Moulos P, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1273; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Verykokakis M, 2018, CURR OPIN IMMUNOL, V51, P39, DOI 10.1016/j.coi.2018.01.006; Verykokakis M, 2013, J IMMUNOL, V191, P5973, DOI 10.4049/jimmunol.1301521; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	58	10	11	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1058	+		10.1038/s41590-020-0737-y	http://dx.doi.org/10.1038/s41590-020-0737-y		JUL 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32719520	Green Submitted, Green Accepted			2022-12-18	WOS:000553242700003
J	Mahoney, KM; Freeman, GJ				Mahoney, Kathleen M.; Freeman, Gordon J.			Acidity changes immunology: a new VISTA pathway	NATURE IMMUNOLOGY			English	Editorial Material							PSGL-1; LIGAND		[Mahoney, Kathleen M.; Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mahoney, Kathleen M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Freeman, GJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	gordon_freeman@dfci.harvard.edu		Freeman, Gordon/0000-0002-7210-5616	U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH) [AI056299] Funding Source: Medline; Kidney Cancer Association (KCA) [Advanced Discovery Award, Advanced Discovery Award] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI) [P50CA101942] Funding Source: Medline	U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney Cancer Association (KCA); U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)		Damgaci S, 2018, IMMUNOLOGY, V154, P354, DOI 10.1111/imm.12917; Deng J, 2019, CANCER IMMUNOL RES, V7, P1079, DOI 10.1158/2326-6066.CIR-18-0507; El-Kenawi A, 2019, BRIT J CANCER, V121, P556, DOI 10.1038/s41416-019-0542-2; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Johnston RJ, 2019, NATURE, V574, P565, DOI 10.1038/s41586-019-1674-5; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Mehta N, 2019, CELL REP, V28, P2509, DOI 10.1016/j.celrep.2019.07.073; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Sergent PA, 2018, LUPUS, V27, P210, DOI 10.1177/0961203317716322; Tinoco R, 2016, IMMUNITY, V44, P1190, DOI 10.1016/j.immuni.2016.04.015; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619	14	10	10	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					13	16		10.1038/s41590-019-0563-2	http://dx.doi.org/10.1038/s41590-019-0563-2			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31822869				2022-12-18	WOS:000515136500009
J	Bruno, L; Ramlall, V; Studer, RA; Sauer, S; Bradley, D; Dharmalingam, G; Carroll, T; Ghoneim, M; Chopin, M; Nutt, SL; Elderkin, S; Rueda, DS; Fisher, AG; Siggers, T; Beltrao, P; Merkenschlager, M				Bruno, Ludovica; Ramlall, Vijendra; Studer, Romain A.; Sauer, Stephan; Bradley, David; Dharmalingam, Gopuraja; Carroll, Thomas; Ghoneim, Mohamed; Chopin, Michael; Nutt, Stephen L.; Elderkin, Sarah; Rueda, David S.; Fisher, Amanda G.; Siggers, Trevor; Beltrao, Pedro; Merkenschlager, Matthias			Selective deployment of transcription factor paralogs with submaximal strength facilitates gene regulation in the immune system	NATURE IMMUNOLOGY			English	Article							RUNT DOMAIN; DUPLICATE GENES; BINDING SITES; EXPRESSION; AML1; MICROARRAYS; MECHANISMS; PROTEINS; COMPLEX; CELLS	In multicellular organisms, duplicated genes can diverge through tissue-specific gene expression patterns, as exemplified by highly regulated expression of RUNX transcription factor paralogs with apparent functional redundancy. Here we asked what cell-type-specific biologies might be supported by the selective expression of RUNX paralogs during Langerhans cell and inducible regulatory T cell differentiation. We uncovered functional nonequivalence between RUNX paralogs. Selective expression of native paralogs allowed integration of transcription factor activity with extrinsic signals, while non-native paralogs enforced differentiation even in the absence of exogenous inducers. DNA binding affinity was controlled by divergent amino acids within the otherwise highly conserved RUNT domain and evolutionary reconstruction suggested convergence of RUNT domain residues toward submaximal strength. Hence, the selective expression of gene duplicates in specialized cell types can synergize with the acquisition of functional differences to enable appropriate gene expression, lineage choice and differentiation in the mammalian immune system.	[Bruno, Ludovica; Sauer, Stephan; Fisher, Amanda G.; Merkenschlager, Matthias] MRC London Inst Med Sci, Lymphocyte Dev Grp, London, England; [Ramlall, Vijendra; Siggers, Trevor] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Studer, Romain A.; Bradley, David; Beltrao, Pedro] European Bioinformat Inst, EMBL, Wellcome Genome Campus, Cambridge, England; [Dharmalingam, Gopuraja; Carroll, Thomas] MRC London Inst Med Sci, London, England; [Ghoneim, Mohamed; Rueda, David S.] Imperial Coll London, Dept Med, Mol Virol, London, England; [Ghoneim, Mohamed; Rueda, David S.] MRC London Inst Med Sci, Single Mol Imaging Grp, London, England; [Chopin, Michael; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Elderkin, Sarah] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Studer, Romain A.] BenevolentAI, London, England	Boston University; European Molecular Biology Laboratory (EMBL); Imperial College London; Walter & Eliza Hall Institute; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Merkenschlager, M (corresponding author), MRC London Inst Med Sci, Lymphocyte Dev Grp, London, England.	matthias.merkenschlager@lms.mrc.ac.uk	Chopin, Michael/AAD-3661-2020; Nutt, Stephen L/C-9256-2013; Rueda, David S./F-9065-2014; Beltrao, Pedro/B-3342-2010	Nutt, Stephen L/0000-0002-0020-6637; Rueda, David S./0000-0003-4657-6323; Beltrao, Pedro/0000-0002-2724-7703; Studer, Romain A/0000-0003-0687-9848; Ghoneim, Mohamed/0000-0003-2889-1039; Michael, Chopin/0000-0001-8812-2763; Bradley, David/0000-0002-5530-1789; Ramlall, Vijendra/0000-0002-2318-7184	Medical Research Council UK; Wellcome [099276/Z/12/Z]; NIH [R01A116829]; BBSRC [BBS/E/B/000C0404, BBS/E/B/000C0405] Funding Source: UKRI; MRC [MC_U120027516, MC_UP_1102/5] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116829] Funding Source: NIH RePORTER	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Warren (University of Cambridge), F. Kondrashov (Institute of Science and Technology Austria), D. Odom (CRUK Cambridge), T. Warnecke, P. Sarkies, S. Santos and B. Lenhard for discussion and advice; N. Speck (University of Pennsylvania) for conditional Runx1 mutants; J. Elliott, B. Patel and T. Adejumo for cell sorting; P. Leung for assistance; D. Djeghloul for help with immunofluorescence; and L. Game and her team for sequencing. This work was funded by the Medical Research Council UK (M.M. and A.G.F.), by Wellcome (grant 099276/Z/12/Z to M. M.) and the NIH (R01A116829 to T. S.).	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Boucheron N, 2014, NAT IMMUNOL, V15, P439, DOI 10.1038/ni.2864; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Cannavo E, 2017, NATURE, V541, P402, DOI 10.1038/nature20802; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Crocker J, 2016, CURR TOP DEV BIOL, V117, P455, DOI 10.1016/bs.ctdb.2015.11.018; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Force A, 1999, GENETICS, V151, P1531; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Goyama S, 2004, BLOOD, V104, P3558, DOI 10.1182/blood-2004-04-1535; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HENTSCH B, 1992, NUCLEIC ACIDS RES, V20, P2657, DOI 10.1093/nar/20.11.2657; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lan X, 2016, SCIENCE, V352, P1009, DOI 10.1126/science.aad8411; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lin HW, 2004, VIROLOGY, V324, P412, DOI 10.1016/j.virol.2004.04.015; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Nah GSS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093816; Nuzhdin SV, 2010, TRENDS GENET, V26, P51, DOI 10.1016/j.tig.2009.12.005; Ohno S., 1970, EVOLUTION GENE DUPLI; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schreiber F, 2014, NUCLEIC ACIDS RES, V42, pD922, DOI 10.1093/nar/gkt1055; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Tenno M, 2017, J EXP MED, V214, P2933, DOI 10.1084/jem.20170729; Voon DCC, 2015, IMMUNOLOGY, V146, P523, DOI 10.1111/imm.12535; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wheeler JC, 2000, SEMIN CELL DEV BIOL, V11, P369, DOI 10.1006/scdb.2000.0184; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	66	10	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1372	+		10.1038/s41590-019-0471-5	http://dx.doi.org/10.1038/s41590-019-0471-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31451789	Green Accepted			2022-12-18	WOS:000486615900020
J	Marino, E; Richards, JL; McLeod, KH; Stanley, D; Yap, YA; Knight, J; McKenzie, C; Kranich, J; Oliveira, AC; Rossello, FJ; Krishnamurthy, B; Nefzger, CM; Macia, L; Thorburn, A; Baxter, AG; Morahan, G; Wong, LH; Polo, JM; Moore, RJ; Lockett, TJ; Clarke, JM; Topping, DL; Harrison, LC; Mackay, CR				Marino, Eliana; Richards, James L.; McLeod, Keiran H.; Stanley, Dragana; Yap, Yu Anne; Knight, Jacinta; McKenzie, Craig; Kranich, Jan; Oliveira, Ana Carolina; Rossello, Fernando J.; Krishnamurthy, Balasubramanian; Nefzger, Christian M.; Macia, Laurence; Thorburn, Alison; Baxter, Alan G.; Morahan, Grant; Wong, Lee H.; Polo, Jose M.; Moore, Robert J.; Lockett, Trevor J.; Clarke, Julie M.; Topping, David L.; Harrison, Leonard C.; Mackay, Charles R.			Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes (vol 18, pg 552, 2017)	NATURE IMMUNOLOGY			English	Correction													Rossello, Fernando/B-1208-2015; Oliveira, Ana Carolina/O-6791-2014; Lockett, Trevor J/H-8970-2013; Macia, laurence/D-5983-2016; Oliveira, Ana Carolina/GRF-1435-2022; Mariño, Eliana/GPK-6544-2022; Stanley, Dragana/AAC-2596-2020; Moore, Robert J/D-8352-2011	Rossello, Fernando/0000-0003-3885-8777; Oliveira, Ana Carolina/0000-0002-0036-3720; Lockett, Trevor J/0000-0002-8063-071X; Macia, laurence/0000-0003-0835-851X; Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861				Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713	1	10	12	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1271	1271		10.1038/ni1117-1271c	http://dx.doi.org/10.1038/ni1117-1271c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044240	Bronze			2022-12-18	WOS:000413457300019
J	Sidwell, T; Kallies, A				Sidwell, Tom; Kallies, Axel			Bach2 is required for B cell and T cell memory differentiation	NATURE IMMUNOLOGY			English	Editorial Material							PLASMA-CELLS; BLIMP-1; SWITCH	B cell and T cell memory differentiation requires the transcription factor Bach2, which inhibits the effector-cell fate by limiting antigen-receptor-stimulation-induced gene expression and restricting premature expression of the transcriptional regulator Blimp-1.	[Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au		Kallies, Axel/0000-0002-6312-6968				Grotsch B, 2014, J EXP MED, V211, P2199, DOI 10.1084/jem.20130795; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Tanaka H, 2016, J BIOL CHEM, V291, P6316, DOI 10.1074/jbc.M116.713842; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	12	10	12	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					744	745		10.1038/ni.3493	http://dx.doi.org/10.1038/ni.3493			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27327995				2022-12-18	WOS:000378283200003
J	Belz, GT				Belz, Gabrielle T.			ILC2s masquerade as ILC1s to drive chronic disease	NATURE IMMUNOLOGY			English	Editorial Material							T-BET	Tissue-resident innate lymphoid cells (ILCs) perform diverse roles in regulating mucosal homeostasis and inflammation. The transdifferentiation of ILC2s into interferon-gamma (IFN-gamma)-producing ILC1-like cells generates a highly inflammatory immune cell.	[Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013	Belz, Gabrielle T/0000-0002-9660-9587				Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443	5	10	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					611	612		10.1038/ni.3467	http://dx.doi.org/10.1038/ni.3467			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27196511				2022-12-18	WOS:000376162200003
J	Hons, M; Sixt, M				Hons, Miroslav; Sixt, Michael			The lymph node filter revealed	NATURE IMMUNOLOGY			English	Editorial Material							CONDUITS; CORTEX; CELLS		[Hons, Miroslav; Sixt, Michael] IST Austria, Klosterneuburg, Austria	Institute of Science & Technology - Austria	Hons, M (corresponding author), IST Austria, Klosterneuburg, Austria.	michael.sixt@ist.ac.at	Hons, Miroslav/AAK-5115-2021; Hons, Miroslav/I-2197-2018; Pinos, Jakub/D-6536-2015	Hons, Miroslav/0000-0002-6625-3348; Hons, Miroslav/0000-0002-6625-3348; Sixt, Michael/0000-0002-6620-9179; Pinos, Jakub/0000-0001-6993-8660				ANDERSON AO, 1975, AM J PATHOL, V80, P387; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203	11	10	10	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					338	340		10.1038/ni.3126	http://dx.doi.org/10.1038/ni.3126			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789676				2022-12-18	WOS:000351333700005
J	Zipfel, C				Zipfel, Cyril			A new receptor for LPS	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-SYSTEM; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; RECOGNITION; RESISTANCE		Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	cyril.zipfel@tsl.ac.uk	ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011	ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583	Biotechnology and Biological Sciences Research Council [BB/G024936/1] Funding Source: Medline; BBSRC [BB/G024936/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Cole SJ, 2013, NEW PHYTOL, V200, P172, DOI 10.1111/nph.12368; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Erbs G, 2012, MOL PLANT PATHOL, V13, P95, DOI 10.1111/j.1364-3703.2011.00730.x; Iwano M, 2012, CURR OPIN PLANT BIOL, V15, P78, DOI 10.1016/j.pbi.2011.09.003; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Liu XK, 2014, ELIFE, V3, DOI 10.7554/eLife.01990; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	12	10	14	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					340	341		10.1038/ni.3127	http://dx.doi.org/10.1038/ni.3127			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789677	Green Accepted			2022-12-18	WOS:000351333700006
J	Ray, JP; Craft, J				Ray, John P.; Craft, Joe			PTENtiating autoimmunity through T-reg cell deregulation	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; ACTIVATION; STAT5		[Ray, John P.; Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT USA	Yale University; Yale University	Ray, JP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	joseph.craft@yale.edu	Ray, John/F-3187-2015	Ray, John/0000-0001-7294-4260	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068662, R01AR040072, P30AR053495] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR040072, P30 AR053495, R21 AR068662] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kato H, 2014, J IMMUNOL, V192, P4134, DOI 10.4049/jimmunol.1301859; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Liu XH, 2010, J CLIN INVEST, V120, P2497, DOI 10.1172/JCI42382; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Scalapino KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006031; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057	13	10	11	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					139	140		10.1038/ni.3082	http://dx.doi.org/10.1038/ni.3082			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594458	Green Accepted			2022-12-18	WOS:000348143100005
J	Hufford, MM; Kaplan, MH				Hufford, Matthew M.; Kaplan, Mark H.			A gut reaction to IL-9	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ULCERATIVE-COLITIS; TGF-BETA; DIFFERENTIATION; DISEASE	The pathogenesis of inflammatory bowel disease is orchestrated by specific subsets of cytokine-secreting T cells. The interleukin 9-producing subset of helper T cells contributes to the pathogenesis of inflammatory bowel disease in part by disrupting intestinal barrier function and impairing tissue-repair mechanisms.	[Hufford, Matthew M.; Kaplan, Mark H.] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Hufford, MM (corresponding author), Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu		Kaplan, Mark/0000-0002-2923-8245	NIAID NIH HHS [T32 AI060519, R01 AI057459] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519, R01AI057459] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Uyttenhove C, 2010, EUR J IMMUNOL, V40, P2230, DOI 10.1002/eji.200940281; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659	13	10	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					599	600		10.1038/ni.2916	http://dx.doi.org/10.1038/ni.2916			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940947	Green Accepted			2022-12-18	WOS:000337715600005
J	Donath, MY				Donath, Marc Y.			When metabolism met immunology	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; PROTEIN	Obesity induces metabolic stress and is associated with inflammation. A cellular pathway now links SIRT2, a deacetylase involved in metabolic processes, to cytoskeleton remodelling and activation of the NLRP3 inflammasome.	Univ Basel Hosp, Dept Diabet Endocrinol & Metab, CH-4031 Basel, Switzerland	University of Basel	Donath, MY (corresponding author), Univ Basel Hosp, Dept Diabet Endocrinol & Metab, CH-4031 Basel, Switzerland.	marc.donath@usb.ch						BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Biason-Lauber A, 2013, CELL METAB, V17, P448, DOI 10.1016/j.cmet.2013.02.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	13	10	10	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					421	422		10.1038/ni.2591	http://dx.doi.org/10.1038/ni.2591			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598389				2022-12-18	WOS:000317732100004
J	Heath, WR; Mueller, SN				Heath, William R.; Mueller, Scott N.			Hair follicles: gatekeepers to the epidermis	NATURE IMMUNOLOGY			English	Editorial Material							LANGERHANS CELLS; T-CELLS; SKIN; DISTINCT; SUBSETS	Substantial depletion of Langerhans cells leads to their replenishment by bone marrow-derived precursors that access the epidermis through hair follicles, a site of crucial chemokine production.	[Heath, William R.; Mueller, Scott N.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	wrheath@unimelb.edu.au; smue@unimelb.edu.au	Mueller, Scott N/B-1918-2012	Mueller, Scott N/0000-0002-3838-3989; Heath, William/0000-0001-9670-259X				Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Thennes T, 2012, MICROVASC RES, V83, P31, DOI 10.1016/j.mvr.2011.05.004	12	10	10	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					715	717		10.1038/ni.2374	http://dx.doi.org/10.1038/ni.2374			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814342				2022-12-18	WOS:000306569600004
J	Surh, CD; Sprent, J				Surh, Charles D.; Sprent, Jonathan			TGF-beta puts the brakes on homeostatic proliferation	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; NAIVE; MECHANISMS; MICE	The cellular mechanism by which the cytokine TGF-beta maintains the homeostasis of mature T cells and prevents the emergence of severe lethal lymphoproliferative disease has remained obscure. It is now shown that TGF-b restrains the homeostatic T cell proliferation driven by self ligands from erupting into overt autoimmunity.	[Surh, Charles D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Surh, Charles D.; Sprent, Jonathan] Pohang Univ Sci & Technol, World Class Univ Program, Div Intergrat Biosci & Biotechnol, Pohang, South Korea; [Sprent, Jonathan] Garvan Inst Med Res, Sydney, NSW, Australia	Scripps Research Institute; Pohang University of Science & Technology (POSTECH); Garvan Institute of Medical Research	Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	csurh@scripps.edu						Boivin GP, 1997, TRANSGENIC RES, V6, P197, DOI 10.1023/A:1018490007745; Bommireddy R, 2006, LAB INVEST, V86, P1008, DOI 10.1038/labinvest.3700460; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319	12	10	11	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					628	630		10.1038/ni.2345	http://dx.doi.org/10.1038/ni.2345			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713819				2022-12-18	WOS:000305483800004
J	Young, MJ; Sisti, DA; Rimon-Greenspan, H; Schwartz, JL; Caplan, AL				Young, Michael J.; Sisti, Dominic A.; Rimon-Greenspan, Hila; Schwartz, Jason L.; Caplan, Arthur L.			Immune to addiction: the ethical dimensions of vaccines against substance abuse	NATURE IMMUNOLOGY			English	Article							COCAINE VACCINE; DEPENDENCE; FUTURE; ISSUES; TRIAL; RISK		[Young, Michael J.] Univ Cambridge, Fac Philosophy, Cambridge, England; [Sisti, Dominic A.; Rimon-Greenspan, Hila] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Scattergood Program Appl Eth Behav Healthcare, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] NYU Langone Med Ctr, Div Med Eth, New York, NY USA	University of Cambridge; University of Pennsylvania; NYU Langone Medical Center	Young, MJ (corresponding author), Univ Cambridge, Fac Philosophy, Cambridge, England.	mjy25@cam.ac.uk	Schwartz, Jason L./ABA-8718-2020	Sisti, Dominic/0000-0002-2282-9253				Ashcroft RE, 2004, J MED ETHICS, V30, P341, DOI 10.1136/jme.2003.005017; Buka SL, 2002, PUBLIC HEALTH REP, V117, pS118; Caplan A, 2008, ADDICTION, V103, P1919, DOI 10.1111/j.1360-0443.2008.02369.x; Caplan Arthur L., 2009, HUMAN ENHANCEMENT, P199; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; Christakis N.A., 2009, CONNECTED SURPRISING; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Francis A., 2012, SOCIOL HLTH ILLN, V20, P1; Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x; Hall W, 2004, J MED ETHICS, V30, P337, DOI 10.1136/jme.2003.004739; Haney M, 2010, BIOL PSYCHIAT, V67, P59, DOI 10.1016/j.biopsych.2009.08.031; Hasman A, 2004, J MED ETHICS, V30, P344, DOI 10.1136/jme.2002.001602; Hyman SE, 2007, AM J BIOETHICS, V7, P8, DOI 10.1080/15265160601063969; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Kosten TR, 2002, VACCINE, V20, P1196, DOI 10.1016/S0264-410X(01)00425-X; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Newman PA, 2008, VACCINE, V26, P2528, DOI 10.1016/j.vaccine.2008.03.004; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Osburn A., 2008, CLEVELAND STATE LAW, V55, P159; Stevenson Dru, 2005, RUTGERS J LAW URBAN, V3, P4; [U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration rug Abuse Warning Network], 2011, DAWN SER D; Volkow ND, 2012, NEUROPSYCHOPHARMACOL, V37, P290, DOI 10.1038/npp.2011.84; Yaffe G, 2001, PHILOS PUBLIC AFF, V30, P178, DOI 10.1111/j.1088-4963.2001.00178.x	25	10	10	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					521	524		10.1038/ni.2321	http://dx.doi.org/10.1038/ni.2321			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22610239				2022-12-18	WOS:000304203900002
J	Khader, SA				Khader, Shabaana A.			Restraining IL-17: Del-1 deals the blow	NATURE IMMUNOLOGY			English	Editorial Material							TH17 CELLS; RECRUITMENT	Interleukin-17 (IL-17) induces the recruitment of neutrophils to sites of inflammation. In a model of periodontitis, Del-1 is now described to be an inhibitor of IL-17 expression that suppresses the recruitment of neutrophils and the associated inflammation-mediated pathology.	Univ Pittsburgh, Sch Med, Dept Pediat & Immunol, Div Infect Dis, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khader, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat & Immunol, Div Infect Dis, Pittsburgh, PA 15260 USA.	shabaana.khader@chp.edu		A Khader, Shabaana/0000-0002-9545-4982				Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Liang S, 2010, J PERIODONTAL RES, V45, P574, DOI 10.1111/j.1600-0765.2009.01245.x; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116	8	10	13	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					433	435		10.1038/ni.2290	http://dx.doi.org/10.1038/ni.2290			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513326				2022-12-18	WOS:000303048400005
J	Lawrence, BP; Sherr, DH				Lawrence, B. Paige; Sherr, David H.			You AhR what you eat?	NATURE IMMUNOLOGY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; T-CELLS; ACTIVATION; INFECTION; MICE	AhR is more than just a receptor for pollutants. Studies have now identified crucial roles for this environment-sensing transcription factor in the development and maintenance of gut-associated lymphoid tissues.	[Lawrence, B. Paige] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA; [Lawrence, B. Paige] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Sherr, David H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	University of Rochester; University of Rochester; Boston University	Lawrence, BP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA.	paige_lawrence@urmc.rochester.edu		Sherr, David/0000-0003-3353-0553	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017250] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES017250] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allan LL, 2005, MOL PHARMACOL, V67, P1740, DOI 10.1124/mol.104.009100; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lahvis GP, 1998, BIOCHEM PHARMACOL, V56, P781, DOI 10.1016/S0006-2952(98)00134-8; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lu HT, 2011, TOXICOL APPL PHARM, V255, P251, DOI 10.1016/j.taap.2011.06.026; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Schlezinger JJ, 2010, ENVIRON HEALTH PERSP, V118, P693, DOI 10.1289/ehp.0901113; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Simones T, 2011, TOXICOL SCI, V119, P293, DOI 10.1093/toxsci/kfq354; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vorderstrasse BA, 2001, TOXICOL APPL PHARM, V171, P157, DOI 10.1006/taap.2000.9122	15	10	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					117	119		10.1038/ni.2213	http://dx.doi.org/10.1038/ni.2213			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261961				2022-12-18	WOS:000299315000007
J	Geijtenbeek, TBH				Geijtenbeek, Teunis B. H.			Host DNase TREX1 hides HIV from DNA sensors	NATURE IMMUNOLOGY			English	Editorial Material							EXONUCLEASE TREX1; DENDRITIC CELLS; RECOGNITION; MUTATIONS		[Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl						Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941	10	10	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					979	980		10.1038/ni1110-979	http://dx.doi.org/10.1038/ni1110-979			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959799				2022-12-18	WOS:000283127800004
J	Bauernfeind, F; Hornung, V				Bauernfeind, Franz; Hornung, Veit			TLR2 joins the interferon gang	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; ANTIVIRAL RESPONSE; DENDRITIC CELLS; INDUCTION; BETA	The induction of type I interferon is a critical checkpoint in antiviral immunity. Toll-like receptor 2 can unexpectedly induce type I interferon in the subset of inflammatory monocytes during infection with vaccinia virus.	[Bauernfeind, Franz; Hornung, Veit] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany	University of Bonn	Bauernfeind, F (corresponding author), Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany.	veit.hornung@uni-bonn.de	Bauernfeind, Franz-Georg/ABF-1148-2020; Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Uematsu Satoshi, 2008, V183, P1; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	14	10	11	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1139	1141		10.1038/ni1109-1139	http://dx.doi.org/10.1038/ni1109-1139			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841644				2022-12-18	WOS:000270955900003
J	Chung, Y; Dong, C				Chung, Yeonseok; Dong, Chen			Don't leave home without it: the IL-23 visa to T-H-17 cells	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INFLAMMATION; CYTOKINE; PATHOLOGY; DRIVE	Interleukin 23 is tightly associated with T-H-17 cell-mediated inflammation and autoimmunity. A new study of mice deficient in its receptor shows that interleukin 23 is required for the terminal differentiation of T-H-17 cells in vivo.	[Chung, Yeonseok; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Chung, Y (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841				Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; NURIEVA R, J IMMUNOL IN PRESS; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	13	10	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					236	238		10.1038/ni0309-236	http://dx.doi.org/10.1038/ni0309-236			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221553				2022-12-18	WOS:000263456500006
J	Tato, CM; Cua, DJ				Tato, Cristina M.; Cua, Daniel J.			Alternative lifestyles of T cells	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; T(H)17	T cells are intrinsically more malleable than previously thought. Two studies now show that existing T helper type 2 cells can be converted into alternative CD4(+) T helper cells that coexpress interleukins 9 and 10.	[Tato, Cristina M.; Cua, Daniel J.] Schering Plough Biopharma, DNAX Res, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Tato, CM (corresponding author), Schering Plough Biopharma, DNAX Res, Palo Alto, CA 94304 USA.	daniel.cua@spcorp.com		Tato, Cristina M./0000-0002-0614-756X				Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	10	10	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1323	1325		10.1038/ni1208-1323	http://dx.doi.org/10.1038/ni1208-1323			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008928				2022-12-18	WOS:000260888700003
J	Willingham, SB; Ting, JPY				Willingham, Stephen B.; Ting, Jenny P-Y			NLRs and the dangers of pollution and aging	NATURE IMMUNOLOGY			English	Editorial Material							NALP3 INFLAMMASOME; CELL-DEATH; ACTIVATION	The production of inflammatory interleukin 1 beta after uptake of silica crystals and alum salt or amyloid-beta occurs by a process that involves lysosomal destabilization and release of cathepsin B that activates the NLRP3 inflammasome.	[Willingham, Stephen B.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Ting, Jenny P-Y] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Willingham, SB (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	panyun@med.unc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI077437-019001, U19 AI077437-010001, U19 AI077437] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	13	10	11	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					831	U16		10.1038/ni0808-831	http://dx.doi.org/10.1038/ni0808-831			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645588	Green Accepted, Green Submitted			2022-12-18	WOS:000257780700003
J	Gotch, F; Gilmour, J				Gotch, Frances; Gilmour, Jill			Science, medicine and research in the developing world: a perspective	NATURE IMMUNOLOGY			English	Editorial Material							HIV VACCINE TRIALS; UGANDAN COHORT; INFECTIONS; RESPONSES; SUBTYPE; AFRICA	As part of the Global Theme Issue on Poverty and Human Development, Frances Gotch and Jill Gilmour describe the development of laboratory capacity to support HIV vaccine trials as a model for technology transfer in the developing world.	Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England; Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Core Lab, London SW10 9NH, England	Imperial College London; Imperial College London	Gotch, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England.	f.gotch@imperial.ac.uk			MRC [G0501957] Funding Source: UKRI; Medical Research Council [G0501957] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAJUNIRWE F, 2004, AFR HLTH SCI, V4, P144; Cohen Jonathan, 2005, HIV AIDS Policy Law Rev, V10, P23; Davies A., 2006, J SOCIO-ECON, V35, P868, DOI DOI 10.1016/J.S0CEC.2005.11.048; Fast PE, 2006, CURR OPIN HIV AIDS, V1, P267, DOI 10.1097/01.COH.0000232340.77790.7a; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gilmour JW, 2007, CURR OPIN HIV AIDS, V2, P201, DOI 10.1097/COH.0b013e3280eec77a; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kebba A, 2005, J LEUKOCYTE BIOL, V78, P37, DOI 10.1189/jlb.0105049; Kebba A, 2004, J INFECT DIS, V189, P1705, DOI 10.1086/383227; Kebba A, 2004, AIDS RES HUM RETROV, V20, P67, DOI 10.1089/088922204322749512; Kebba A, 2007, PHARMACOGENOMICS, V8, P409, DOI 10.2217/14622416.8.4.409; Khurana S, 2006, J VIROL, V80, P2092, DOI 10.1128/JVI.80.5.2092-2099.2006; KLASSE PJ, IN PRESS ANN REV MED; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; MAYANJA V, 2007, MAIL GAURDIAN   0818; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Rutebemberwa A, 2004, AIDS RES HUM RETROV, V20, P763, DOI 10.1089/0889222041524643; Stiles T, 2003, GOOD CLIN LAB PRACTI; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4	22	10	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1273	1276		10.1038/ni1531	http://dx.doi.org/10.1038/ni1531			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17952077				2022-12-18	WOS:000251267000003
J	Spilianakis, CG; Flavell, RA				Spilianakis, Charalampos G.; Flavell, Richard A.			Epigenetic regulation of Ifng expression	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; ELEMENTS; GENES	Intensive characterization of the locus encoding interferon-gamma provides new insight into how proper gene expression is achieved in polarizing T cells.	Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Spilianakis, CG (corresponding author), Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Glimcher LH, 2000, GENE DEV, V14, P1693; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474	8	10	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					681	684		10.1038/ni0707-681	http://dx.doi.org/10.1038/ni0707-681			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579645				2022-12-18	WOS:000247718100008
J	Singh, H				Singh, Harinder			Shaping a helper T cell identity	NATURE IMMUNOLOGY			English	Editorial Material							COMMITMENT; EXPRESSION	Cell fate 'decisions' involving multipotential progenitors seem to be 'dictated' by threshold activities of lineage-determining transcription factors. Such 'decisions' are now shown to be reinforced by the induction of secondary transcription factors that act in concert with the primary regulators.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hsingh@uchicago.edu						DJURETIC, 2007, NAT IMMUNOL, V8, P145; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103	10	10	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					119	120		10.1038/ni0207-119	http://dx.doi.org/10.1038/ni0207-119			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242680				2022-12-18	WOS:000243597600004
J	Rudd, CE				Rudd, Christopher E.			Cell cycle 'check points' T cell anergy	NATURE IMMUNOLOGY			English	Editorial Material							CLONAL ANERGY; SMAD3; EXPANSION; P27(KIP1)		Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England	University of Cambridge	Rudd, CE (corresponding author), Univ Cambridge, Dept Pathol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; 				Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Colombetti S, 2002, J IMMUNOL, V169, P6178, DOI 10.4049/jimmunol.169.11.6178; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Powell JD, 1999, J IMMUNOL, V162, P2775; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197	12	10	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1130	1132		10.1038/ni1106-1130	http://dx.doi.org/10.1038/ni1106-1130			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053794				2022-12-18	WOS:000241437200004
J	Van Kaer, L; Joyce, S				Van Kaer, Luc; Joyce, Sebastian			Viral evasion of antigen presentation: not just for peptides anymore	NATURE IMMUNOLOGY			English	Editorial Material							NKT CELLS; CD1D; EXPRESSION; VIRUS; INFECTION; IMMUNITY	Viruses have evolved several strategies to subvert host defenses. New evidence indicates that herpes simplex virus 1 prevents glycolipid antigen presentation to natural killer T cells by downregulating CD1d expression.	Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Van Kaer, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	luc.van.kaer@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; JOYCE, Sebastian/0000-0002-3183-1451				Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Joyce S, 2003, CURR OPIN IMMUNOL, V15, P95, DOI 10.1016/S0952-7915(02)00012-2; Levy O, 2003, J INFECT DIS, V188, P948, DOI 10.1086/378503; Renukaradhya GJ, 2005, J IMMUNOL, V175, P4301, DOI 10.4049/jimmunol.175.7.4301; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364	12	10	11	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					795	797		10.1038/ni0806-795	http://dx.doi.org/10.1038/ni0806-795			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855602				2022-12-18	WOS:000239147200006
J	Hickman-Miller, HD; Yewdell, JW				Hickman-Miller, HD; Yewdell, JW			Youth has its privileges: maturation inhibits DC cross-priming	NATURE IMMUNOLOGY			English	Editorial Material							CELLS IN-VIVO; DENDRITIC CELLS; ANTIGEN PRESENTATION	Naive CD8(+) T cells can be activated via dendritic cell 'cross-priming' of antigens obtained exogenously. Dendritic cells cannot cross-prime, however, after systemic activation in vivo, potentially contributing to immunosuppression associated with severe infections.	NIAID, Lab Viral Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hickman-Miller, HD (corresponding author), NIAID, Lab Viral Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Hickman, Heather/0000-0003-4168-4894	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000814] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Pierre P, 2005, IMMUNOL REV, V207, P184, DOI 10.1111/j.0105-2896.2005.00300.x; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	8	10	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					125	126		10.1038/ni0206-125	http://dx.doi.org/10.1038/ni0206-125			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424887	Bronze			2022-12-18	WOS:000234801700005
J	Moser, M				Moser, M			Balancing life and death	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; LYMPH-NODE; T-CELLS; IMMUNITY; SYSTEM	Dendritic cells induce and control immunity in the lymphoid organs. Signals derived from the innate and acquired immune systems seem to control dendritic cell lifespan and function by distinct molecular mechanisms.	Free Univ Brussels, Dept Mol Biol, B-6041 Gosselies, Belgium		Moser, M (corresponding author), Free Univ Brussels, Dept Mol Biol, B-6041 Gosselies, Belgium.	mmoser@ulb.ac.be						Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065	12	10	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					559	560		10.1038/ni0604-559	http://dx.doi.org/10.1038/ni0604-559			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164011				2022-12-18	WOS:000221664000003
J	Kobayashi, KS; Eynon, EE; Flavell, RA				Kobayashi, KS; Eynon, EE; Flavell, RA			Intracellular debugging	NATURE IMMUNOLOGY			English	Editorial Material							INNATE; NOD1; PEPTIDOGLYCAN; DETECTS	A family of intracellular molecules called NODs has been proposed to sense bacteria within the cell. New data now show that NOD1 senses a distinct bacterial component and may thus be important in responding to bacteria with this molecular signature.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Kobayashi, KS (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	Richard.flavell@yale.edu		Kobayashi, Koichi/0000-0003-2930-0114				Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Holt BF, 2003, CURR OPIN IMMUNOL, V15, P20, DOI 10.1016/S0952-7915(02)00014-6; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013	12	10	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					652	654		10.1038/ni0703-652	http://dx.doi.org/10.1038/ni0703-652			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830145				2022-12-18	WOS:000183952500012
J	Miyazaki, T; Kim, HR; Godzik, A; Krajewski, S; Reed, JC				Miyazaki, T; Kim, HR; Godzik, A; Krajewski, S; Reed, JC			Interaction of DAP3 and FADD only after cellular disruption - Response	NATURE IMMUNOLOGY			English	Letter							PROTEIN; MEDIATOR		Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org	Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X				Berger T, 2000, J CELL SCI, V113, P3603; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Morgan CJ, 2001, BIOCHEM BIOPH RES CO, V280, P177, DOI 10.1006/bbrc.2000.4119; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135	10	10	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					4	5		10.1038/ni0102-4	http://dx.doi.org/10.1038/ni0102-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF					2022-12-18	WOS:000173148700003
J	Luscinskas, FW; Lim, YC; Lichtman, AH				Luscinskas, FW; Lim, YC; Lichtman, AH			Wall shear stress: the missing step for T cell transmigration?	NATURE IMMUNOLOGY			English	News Item							LEUKOCYTE	Our current understanding of lymphocyte migration across the endothelium includes four steps: attachment, rolling, arrest and diapedesis. New evidence suggests the involvement of another step, chemorheotaxis.	Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luscinskas, FW (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA.							ARNAOUT MA, 1990, IMMUNOL REV, V114, P147; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; GOLDSMITH HL, 1984, MICROVASC RES, V27, P204, DOI 10.1016/0026-2862(84)90054-2; Kitayama J, 2000, CELL IMMUNOL, V203, P39, DOI 10.1006/cimm.2000.1671; LAWRENCE MB, 1991, CELL, V65, P1; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; SHAW S, 2001, IN PRESS J IMMUNOL; TOZEREN A, 1992, BIOPHYS J, V63, P700, DOI 10.1016/S0006-3495(92)81660-0	11	10	12	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					478	480		10.1038/88663	http://dx.doi.org/10.1038/88663			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376329				2022-12-18	WOS:000169078000006
J	Kaul, R; Makadzange, T; Rowland-Jones, S				Kaul, R; Makadzange, T; Rowland-Jones, S			AIDS in Africa: a disaster no longer waiting to happen	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; DIFFERENT SUBTYPES; IMMUNE ACTIVATION; RANDOMIZED TRIAL; HIV-1; TRANSMISSION; TYPE-1; PATHOGENESIS; INFECTION; ADULTS		John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	University of Oxford; University of Nairobi	Kaul, R (corresponding author), John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England.			Makadzange, Azure Tariro/0000-0001-5330-1470; Kaul, Rupert/0000-0002-1586-4093				Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; Anzala AO, 2000, J INFECT DIS, V182, P459, DOI 10.1086/315733; BARKER E, 1995, P NATL ACAD SCI USA, V92, P11135, DOI 10.1073/pnas.92.24.11135; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Gregson S, 1998, SOC SCI MED, V46, P321, DOI 10.1016/S0277-9536(97)00165-2; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hu DJ, 1999, AIDS, V13, P873, DOI 10.1097/00002030-199905280-00002; Infante-Duarte C, 1999, SPRINGER SEMIN IMMUN, V21, P317, DOI 10.1007/s002810050070; Janssens W, 1997, AIDS, V11, P705, DOI 10.1097/00002030-199706000-00002; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; Long EM, 2000, NAT MED, V6, P71; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; MULDER D, 1995, BRIT MED J, V311, P833, DOI 10.1136/bmj.311.7009.833; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NGHATANGA M, 2000, 13 INT AIDS C; Plummer FA, 1998, AIDS RES HUM RETROV, V14, pS5; Pope M, 1997, SCIENCE, V278, P786; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Rizzardini G, 1998, AIDS, V12, P2387, DOI 10.1097/00002030-199818000-00007; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Whittle HC, 1998, CURR OPIN IMMUNOL, V10, P382, DOI 10.1016/S0952-7915(98)80108-8; Wolffers I, 1998, LANCET, V351, P1652, DOI 10.1016/S0140-6736(97)10237-9; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400; ZLON D, 2000, NAT MED, V6, P615; 2000, UNAIDS REPORT GLOBAL	35	10	10	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					267	270		10.1038/79703	http://dx.doi.org/10.1038/79703			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017091				2022-12-18	WOS:000089869700003
J	Qi, H; Liu, B; Wang, XQ; Zhang, LQ				Qi, Hai; Liu, Bo; Wang, Xinquan; Zhang, Linqi			The humoral response and antibodies against SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Review							CONVALESCENT PLASMA THERAPY; RECEPTOR-BINDING DOMAIN; NEUTRALIZING ANTIBODIES; SPIKE PROTEIN; COVID-19; CORONAVIRUS; MATURATION; IMMUNITY; POTENCY; IMMUNOGENICITY	Two and a half years into the COVID-19 pandemic, we have gained many insights into the human antibody response to the causative SARS-CoV-2 virus. In this Review, we summarize key observations of humoral immune responses in people with COVID-19, discuss key features of infection- and vaccine-induced neutralizing antibodies, and consider vaccine designs for inducing antibodies that are broadly protective against different variants of the SARS-CoV-2 virus. Qi et al. provide an in-depth analysis of antibody responses generated in response to SARS-CoV-2.	[Qi, Hai; Liu, Bo] Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Qi, Hai; Liu, Bo] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China; [Qi, Hai; Liu, Bo; Zhang, Linqi] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China; [Qi, Hai; Zhang, Linqi] Tsinghua Univ, NexVac Res Ctr, Beijing, Peoples R China; [Qi, Hai] Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China; [Qi, Hai; Wang, Xinquan; Zhang, Linqi] Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Ctr Global Hlth & Infect Dis, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Qi, H (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China.; Qi, H; Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China.; Qi, H; Zhang, LQ (corresponding author), Tsinghua Univ, NexVac Res Ctr, Beijing, Peoples R China.; Qi, H (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China.; Qi, H; Zhang, LQ (corresponding author), Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Ctr Global Hlth & Infect Dis, Beijing, Peoples R China.	qihai@tsinghua.edu.cn; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022	Qi, Hai/0000-0001-5475-3989	National Natural Science Foundation of China [81621002, 31830023]; Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission; National Key Plan for Scientific Research and Development of China [2020YFC0848800, 2020YFC08499, 2021YFC0864500, 2020YFC0861200]; National Natural Science Foundation [9216920007]; Beijing Municipal Science and Technology Commission [Z201100005420019]; Tsinghua University Scientific Research Program [20201080053, 2020Z99CFG004]; Tencent Foundation; Beijing Frontier Research Center for Biological Structure; Shuidi Foundation; TH Capital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Key Plan for Scientific Research and Development of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Tsinghua University Scientific Research Program; Tencent Foundation; Beijing Frontier Research Center for Biological Structure; Shuidi Foundation; TH Capital	The authors thank S. Shan for help with preparation of Table 1. Work of H.Q. is funded in part by National Natural Science Foundation of China (grant 81621002, 31830023), the Tsinghua-Peking Center for Life Sciences, the Beijing Municipal Science & Technology Commission, and the Beijing Frontier Research Center for Biological Structure. H.Q. is an HHMI-Gates International Research Scholar. L.Z. is funded by the National Key Plan for Scientific Research and Development of China (2020YFC0848800, 2020YFC08499, 2021YFC0864500, 2020YFC0861200), the National Natural Science Foundation (9216920007), Beijing Municipal Science and Technology Commission (Z201100005420019), Tsinghua University Scientific Research Program (20201080053 and 2020Z99CFG004), and Tencent Foundation, Shuidi Foundation, and TH Capital. The findings and conclusions within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or the Howard Hughes Medical Institute.	Ai JW, 2022, CELL RES, V32, P103, DOI 10.1038/s41422-021-00590-x; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Anand SP, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100290; Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; Atmar RL, 2022, NEW ENGL J MED, V386, P1046, DOI 10.1056/NEJMoa2116414; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bonometti R, 2020, EUR REV MED PHARMACO, V24, P9695, DOI 10.26355/eurrev_202009_23060; Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Carreno JM, 2022, NATURE, V602, P682, DOI 10.1038/s41586-022-04399-5; Carvalho T, 2021, NAT REV IMMUNOL, V21, P245, DOI 10.1038/s41577-021-00522-1; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Cervia C, 2021, J ALLERGY CLIN IMMUN, V147, P545, DOI 10.1016/j.jaci.2020.10.040; Cevik M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3862; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Che XY, 2005, J INFECT DIS, V191, P2033, DOI 10.1086/430355; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen XY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00301-9; Chen XM, 2021, VIROLOGY, V559, P1, DOI 10.1016/j.virol.2021.03.009; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Mesquita RD, 2021, WIEN KLIN WOCHENSCHR, V133, P377, DOI 10.1007/s00508-020-01760-4; Dai LP, 2021, NAT REV IMMUNOL, V21, P73, DOI 10.1038/s41577-020-00480-0; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Du S, 2020, CELL, V183, P1013, DOI 10.1016/j.cell.2020.09.035; Duan YQ, 2020, CURR MED SCI, V40, P618, DOI 10.1007/s11596-020-2225-x; Dufloo J, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100275; Dugan HL, 2021, IMMUNITY, V54, P1290, DOI 10.1016/j.immuni.2021.05.001; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Finsterer J, 2021, EUR J NEUROL, V28, pE10, DOI 10.1111/ene.14544; Froberg J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25949-x; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gagne M, 2022, CELL, V185, P1556, DOI 10.1016/j.cell.2022.03.038; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Ge JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20501-9; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gigli GL, 2020, NEUROL SCI, V41, P3391, DOI 10.1007/s10072-020-04787-7; Graham C, 2021, IMMUNITY, V54, P1276, DOI 10.1016/j.immuni.2021.03.023; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guo L, 2021, EMERG MICROBES INFEC, V10, P664, DOI 10.1080/22221751.2021.1905488; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hansen KE, 1998, SEMIN ARTHRITIS RHEU, V27, P263, DOI 10.1016/S0049-0172(98)80047-4; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; He WT, 2022, NAT IMMUNOL, V23, P960, DOI 10.1038/s41590-022-01222-1; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hueso T, 2020, BLOOD, V136, P2290, DOI 10.1182/blood.2020008423; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Hurlburt NK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19231-9; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Jensen Christopher E, 2020, Clin Infect Pract, V7, P100041, DOI 10.1016/j.clinpr.2020.100041; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Junqueira C, 2022, NATURE, V606, P576, DOI 10.1038/s41586-022-04702-4; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kim C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20602-5; Klassen SA, 2021, MAYO CLIN PROC, V96, P1262, DOI 10.1016/j.mayocp.2021.02.008; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Lam JH, 2020, VIRAL IMMUNOL, V33, P294, DOI 10.1089/vim.2019.0207; Lee WS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100296; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Li D, BIORXIV, DOI [10.1101/2022.01.26.477915(2022, DOI 10.1101/2022.01.26.477915(2022]; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Li JX, 2022, NAT MED, V28, P401, DOI 10.1038/s41591-021-01677-z; Lippi G, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3989; Liu HJ, 2020, IMMUNITY, V53, P1272, DOI 10.1016/j.immuni.2020.10.023; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Liu Y, 2021, CURR OPIN RHEUMATOL, V33, P155, DOI 10.1097/BOR.0000000000000776; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; Majdoubi A, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.146316; Mangalmurti N, 2020, IMMUNITY, V53, P19, DOI 10.1016/j.immuni.2020.06.017; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McCallum M, 2022, SCIENCE, V375, P864, DOI 10.1126/science.abn8652; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Moriyama S, 2021, IMMUNITY, V54, P1841, DOI 10.1016/j.immuni.2021.06.015; Muecksch F, 2022, NATURE, V607, P128, DOI 10.1038/s41586-022-04778-y; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Muecksch F, 2021, J INFECT DIS, V223, P389, DOI 10.1093/infdis/jiaa659; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Ortega N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24979-9; Pajon R, 2022, NEW ENGL J MED, V386, P1088, DOI 10.1056/NEJMc2119912; Palm AKE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01787; Patil Neha R, 2020, Hematol Oncol Stem Cell Ther, DOI 10.1016/j.hemonc.2020.06.005; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poon MML, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl9105; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Qu L, 2022, CELL, V185, P1728, DOI 10.1016/j.cell.2022.03.044; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Rivera-Correa J, 2018, TRENDS IMMUNOL, V39, P515, DOI 10.1016/j.it.2018.04.003; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Russell MW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.611337; Sakharkar M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6916; Saunders KO, 2021, NATURE, V594, P553, DOI 10.1038/s41586-021-03594-0; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shan SS, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.766821; Shenoy Santosh, 2021, World J Crit Care Med, V10, P132, DOI 10.5492/wjccm.v10.i4.132; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Song Ge, 2020, bioRxiv, DOI [10.1038/s41467-021-23074-3, 10.1101/2020.09.22.308965]; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Tan CW, 2021, NEW ENGL J MED, V385, P1401, DOI 10.1056/NEJMoa2108453; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Tong JY, 2020, OTOLARYNG HEAD NECK, V163, P3, DOI 10.1177/0194599820926473; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Tso FY, 2021, INT J INFECT DIS, V102, P577, DOI 10.1016/j.ijid.2020.10.104; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; VanBlargan LA, 2021, IMMUNITY, V54, P2399, DOI 10.1016/j.immuni.2021.08.016; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Walls AC, 2021, CELL, V184, P5432, DOI 10.1016/j.cell.2021.09.015; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21968-w; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Wang K, 2021, CLIN INFECT DIS, V73, pE531, DOI 10.1093/cid/ciaa1143; Wang K, 2022, NATURE, V603, P919, DOI 10.1038/s41586-022-04466-x; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang RK, 2021, IMMUNITY, V54, P1611, DOI 10.1016/j.immuni.2021.06.003; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wang ZJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1555; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Westendorf K, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110812; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu NC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108274; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Wuertz KM, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00392-7; Yamin R, 2021, NATURE, V599, P465, DOI 10.1038/s41586-021-04017-w; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yin WC, 2022, SCIENCE, V375, P1048, DOI 10.1126/science.abn8863; Yorsaeng R, 2022, VACCINE, V40, P524, DOI 10.1016/j.vaccine.2021.11.083; Yu YL, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00759-1; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1101/2021.08.17.456689, 10.1126/science.abl9463]; Zhang Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24514-w; Zhou DM, 2020, NAT STRUCT MOL BIOL, V27, P950, DOI 10.1038/s41594-020-0480-y; Zhou TQ, 2022, SCIENCE, V376, P369, DOI 10.1126/science.abn8897; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu FC, 2022, CLIN INFECT DIS, V75, pE783, DOI 10.1093/cid/ciab845; Zhu YM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc9999; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	191	9	9	15	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1008	1020		10.1038/s41590-022-01248-5	http://dx.doi.org/10.1038/s41590-022-01248-5		JUN 2022	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761083	Bronze			2022-12-18	WOS:000817057200001
J	He, WT; Musharrafieh, R; Song, G; Dueker, K; Tse, LV; Martinez, DR; Schafer, A; Callaghan, S; Yong, P; Beutler, N; Torres, JL; Volk, RM; Zhou, PP; Yuan, M; Liu, HJ; Anzanello, F; Capozzola, T; Parren, M; Garcia, E; Rawlings, SA; Smith, DM; Wilson, IA; Safonova, Y; Ward, AB; Rogers, TF; Baric, RS; Gralinski, LE; Burton, DR; Andrabi, R				He, Wan-ting; Musharrafieh, Rami; Song, Ge; Dueker, Katharina; Tse, Longping V.; Martinez, David R.; Schafer, Alexandra; Callaghan, Sean; Yong, Peter; Beutler, Nathan; Torres, Jonathan L.; Volk, Reid M.; Zhou, Panpan; Yuan, Meng; Liu, Hejun; Anzanello, Fabio; Capozzola, Tazio; Parren, Mara; Garcia, Elijah; Rawlings, Stephen A.; Smith, Davey M.; Wilson, Ian A.; Safonova, Yana; Ward, Andrew B.; Rogers, Thomas F.; Baric, Ralph S.; Gralinski, Lisa E.; Burton, Dennis R.; Andrabi, Raiees			Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses	NATURE IMMUNOLOGY			English	Article							HIV; IDENTIFICATION; CORONAVIRUSES; RESPONSES; VACCINES; BREADTH; DESIGN	The emergence of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy. Development of broadly effective coronavirus vaccines that can mitigate these threats is needed. Here, we utilized a targeted donor selection strategy to isolate a large panel of human broadly neutralizing antibodies (bnAbs) to sarbecoviruses. Many of these bnAbs are remarkably effective in neutralizing a diversity of sarbecoviruses and against most SARS-CoV-2 VOCs, including the Omicron variant. Neutralization breadth is achieved by bnAb binding to epitopes on a relatively conserved face of the receptor-binding domain (RBD). Consistent with targeting of conserved sites, select RBD bnAbs exhibited protective efficacy against diverse SARS-like coronaviruses in a prophylaxis challenge model in vivo. These bnAbs provide new opportunities and choices for next-generation antibody prophylactic and therapeutic applications and provide a molecular basis for effective design of pan-sarbecovirus vaccines. A broadly neutralizing antibody (bnAb) response is required to combat SARS-CoV-2 variants of concern (VOCs). The authors isolated and characterized a large panel of sarbecovirus bnAbs from vaccinated individuals who had recovered from COVID-19, finding that many of these antibodies were able to neutralize all VOCs, including Omicron, and demonstrate prophylaxis in mice infected with diverse sarbecoviruses.	[He, Wan-ting; Musharrafieh, Rami; Song, Ge; Dueker, Katharina; Callaghan, Sean; Yong, Peter; Beutler, Nathan; Zhou, Panpan; Anzanello, Fabio; Capozzola, Tazio; Parren, Mara; Garcia, Elijah; Rogers, Thomas F.; Burton, Dennis R.; Andrabi, Raiees] Scripps Res Inst, Dept Immunol & MicroBiol, La Jolla, CA 92037 USA; [He, Wan-ting; Musharrafieh, Rami; Song, Ge; Dueker, Katharina; Callaghan, Sean; Yong, Peter; Zhou, Panpan; Anzanello, Fabio; Capozzola, Tazio; Wilson, Ian A.; Ward, Andrew B.; Burton, Dennis R.; Andrabi, Raiees] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [He, Wan-ting; Musharrafieh, Rami; Song, Ge; Dueker, Katharina; Callaghan, Sean; Yong, Peter; Zhou, Panpan; Anzanello, Fabio; Capozzola, Tazio; Wilson, Ian A.; Ward, Andrew B.; Burton, Dennis R.; Andrabi, Raiees] Scripps Res Inst, Consortium HIV, AIDS Vaccine Dev, La Jolla, CA 92037 USA; [Tse, Longping V.; Martinez, David R.; Schafer, Alexandra; Baric, Ralph S.; Gralinski, Lisa E.] Univ N Carolina, Dept Epidmiol, Chapel Hill, NC 92037 USA; [Torres, Jonathan L.; Volk, Reid M.; Yuan, Meng; Liu, Hejun; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA USA; [Rawlings, Stephen A.; Smith, Davey M.; Rogers, Thomas F.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA USA; [Wilson, Ian A.] Skaggs Inst Chem Biol, Scripps Res Inst, La Jolla, CA USA; [Safonova, Yana] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27515 USA; [Baric, Ralph S.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27515 USA; [Burton, Dennis R.] MIT, Ragon Inst Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02138 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; University of California System; University of California San Diego; Scripps Research Institute; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Burton, DR; Andrabi, R (corresponding author), Scripps Res Inst, Dept Immunol & MicroBiol, La Jolla, CA 92037 USA.; Burton, DR; Andrabi, R (corresponding author), Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Burton, DR; Andrabi, R (corresponding author), Scripps Res Inst, Consortium HIV, AIDS Vaccine Dev, La Jolla, CA 92037 USA.; Baric, RS; Gralinski, LE (corresponding author), Univ N Carolina, Dept Epidmiol, Chapel Hill, NC 92037 USA.; Baric, RS (corresponding author), Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27515 USA.; Baric, RS (corresponding author), Univ N Carolina, Dept Immunol, Chapel Hill, NC 27515 USA.; Burton, DR (corresponding author), MIT, Ragon Inst Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Burton, DR (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	rbaric@email.unc.edu; lgralins@email.unc.edu; burton@scripps.edu; andrabi@scripps.edu	martinez, david/GQI-0849-2022; Liu, Hejun/L-9969-2014; Zhou, Panpan/GPC-8938-2022	Liu, Hejun/0000-0002-2412-7853; Zhou, Panpan/0000-0001-5740-4303; Tse, Longping Victor/0000-0001-7582-8396; Safonova, Yana/0000-0002-9634-4216; Dueker, Katharina/0000-0003-0426-468X; Martinez, David/0000-0002-2940-8961; Yong, Peter/0000-0002-4899-3270; Beutler, Nathan/0000-0003-3240-9524; Garcia, Elijah/0000-0002-1097-6723	National Institutes of Health (NIH) [CHAVD UM1 AI44462]; International AIDS Vaccine Initiative Neutralizing Antibody Center; Bill and Melinda Gates Foundation [INV-004923]; Translational Virology Core of the San Diego Center for AIDS research grant NIH [NIH AI036214, NIH 5T32AI007384, NIH AI149644, AI157155, NIH R21 AI145372]; John and Mary Tu Foundation; James B. Pendleton Charitable Trust; Pfizer NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; Howard Hughes Medical Institute	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Center; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Translational Virology Core of the San Diego Center for AIDS research grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Mary Tu Foundation; James B. Pendleton Charitable Trust; Pfizer NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank all the human cohort participants for donating samples. This work was supported by National Institutes of Health (NIH) CHAVD UM1 AI44462 (D.R.B.), the International AIDS Vaccine Initiative Neutralizing Antibody Center, Bill and Melinda Gates Foundation INV-004923 (I.A.W., A.B.W. and D.R.B.), Translational Virology Core of the San Diego Center for AIDS research grant NIH AI036214 (D.M.S.), NIH 5T32AI007384 (S.A.R.), NIH AI149644 and AI157155 (R.S.B), NIH R21 AI145372 (L.E.G.) and the John and Mary Tu Foundation and the James B. Pendleton Charitable Trust (D.M.S. and D.R.B.). L.V.T. is supported by the Pfizer NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy. D.R.M. is currently supported by a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award and a Hanna H. Gray Fellowship from the Howard Hughes Medical Institute.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Andrabi R, 2018, CURR OPIN IMMUNOL, V53, P143, DOI 10.1016/j.coi.2018.04.025; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bates TA, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abn8014; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bradley T, 2021, NEW ENGL J MED, V384, P1959, DOI 10.1056/NEJMc2102051; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Burton DR, 2020, CELL HOST MICROBE, V27, P695, DOI 10.1016/j.chom.2020.04.022; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Crotty S, 2021, SCIENCE, V372, P1392, DOI 10.1126/science.abj2258; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Feldman J, 2021, SCI IMMUNOL, V6, DOI [10.1126/sciimmunol.abl5842, 10.1101/2021.02.02.429458]; Gidoni M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08489-3; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hauser BM, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110561; Hurt AC, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040628; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jennewein MF, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109353; Jette CA, 2021, CELL REP, V36, DOI [10.1016/j.celrep.2021.109760, 10.1101/2021.04.23.441195]; Joyce MG, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi5735; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Konrath KM, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110318; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Liu H., 2021, BIORXIV, DOI [10.1101/2021.12.15.472864, DOI 10.1101/2021.12.15.472864]; Liu HJ, 2020, IMMUNITY, V53, P1272, DOI 10.1016/j.immuni.2020.10.023; Liu LH, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abn6859; Martinez DR, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj7125; Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]; Mascola JR, 2021, JAMA-J AM MED ASSOC, V325, P1261, DOI 10.1001/jama.2021.2088; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Menachery VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131451; Mishra P. K., 2021, VACCINATION BOOSTS P, DOI [10.1101/2021.04.11.21255153, DOI 10.1101/2021.04.11.21255153]; Moore RM, 2020, PEERJ, V8, DOI 10.7717/peerj.8584; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Roskin KM, 2020, NAT IMMUNOL, V21, P199, DOI 10.1038/s41590-019-0581-0; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Sakharkar M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6916; Saunders KO, 2021, NATURE, V594, P553, DOI 10.1038/s41586-021-03594-0; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0; Shlemov A, 2017, J IMMUNOL, V199, P3369, DOI 10.4049/jimmunol.1700485; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; Song Ge, 2020, bioRxiv, DOI [10.1038/s41467-021-23074-3, 10.1101/2020.09.22.308965]; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan CW, 2021, NEW ENGL J MED, V385, P1401, DOI 10.1056/NEJMoa2108453; Tauzin A, 2021, CELL HOST MICROBE, V29, P1137, DOI 10.1016/j.chom.2021.06.001; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; W.-t. He, 2021, bioRxiv, DOI 10.1101/2021.07.05.451222; Walls AC, 2020, CELL, V183, P1367, DOI 10.1016/j.cell.2020.10.043; Wang K, 2022, NATURE, V603, P919, DOI 10.1038/s41586-022-04466-x; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhou PP, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi9215	93	9	9	10	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					960	+		10.1038/s41590-022-01222-1	http://dx.doi.org/10.1038/s41590-022-01222-1		JUN 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35654851	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000805086500001
J	Kansler, ER; Dadi, S; Krishna, C; Nixon, BG; Stamatiades, EG; Liu, M; Kuo, FS; Zhang, J; Zhang, X; Capistrano, K; Blum, KA; Weiss, K; Kedl, RM; Cui, GW; Ikuta, K; Chan, TA; Leslie, CS; Hakimi, AA; Li, MO				Kansler, Emily R.; Dadi, Saida; Krishna, Chirag; Nixon, Briana G.; Stamatiades, Efstathios G.; Liu, Ming; Kuo, Fengshen; Zhang, Jing; Zhang, Xian; Capistrano, Kristelle; Blum, Kyle A.; Weiss, Kate; Kedl, Ross M.; Cui, Guangwei; Ikuta, Koichi; Chan, Timothy A.; Leslie, Christina S.; Hakimi, A. Ari; Li, Ming O.			Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER; TRANS PRESENTATION; NK CELLS; T-CELLS; IL-15; PHENOTYPE; GRANZYME	How the immune system responds to epithelial cancers beyond neoantigen-driven adaptive immunity is poorly understood. Kansler et al. reveal an innate immune surveillance response mediated by cytotoxic ILC1 sensing of cancer cell-expressed IL-15. Malignancy can be suppressed by the immune system. However, the classes of immunosurveillance responses and their mode of tumor sensing remain incompletely understood. Here, we show that although clear cell renal cell carcinoma (ccRCC) was infiltrated by exhaustion-phenotype CD8(+) T cells that negatively correlated with patient prognosis, chromophobe RCC (chRCC) had abundant infiltration of granzyme A-expressing intraepithelial type 1 innate lymphoid cells (ILC1s) that positively associated with patient survival. Interleukin-15 (IL-15) promoted ILC1 granzyme A expression and cytotoxicity, and IL-15 expression in chRCC tumor tissue positively tracked with the ILC1 response. An ILC1 gene signature also predicted survival of a subset of breast cancer patients in association with IL-15 expression. Notably, ILC1s directly interacted with cancer cells, and IL-15 produced by cancer cells supported the expansion and anti-tumor function of ILC1s in a murine breast cancer model. Thus, ILC1 sensing of cancer cell IL-15 defines an immunosurveillance mechanism of epithelial malignancies.	[Kansler, Emily R.; Dadi, Saida; Nixon, Briana G.; Stamatiades, Efstathios G.; Liu, Ming; Zhang, Jing; Zhang, Xian; Capistrano, Kristelle; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Kansler, Emily R.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Krishna, Chirag; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Nixon, Briana G.; Li, Ming O.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10044 USA; [Kuo, Fengshen; Blum, Kyle A.; Weiss, Kate; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Kedl, Ross M.] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Cui, Guangwei; Ikuta, Koichi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Immune Regulat, Kyoto, Japan; [Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Kyoto University; Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA.; Li, MO (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10044 USA.	lim@mskcc.org		Zhang, Xian/0000-0001-9674-7886; Stamatiades, Efstathios/0000-0002-2785-9005; Kuo, Fengshen/0000-0003-1797-2896	National Institutes of Health [F31CA210332, R01CA243904-01A1, P30 CA008748]; Department of Defense [KC19008.e001]; Howard Hughes Medical Institute Faculty Scholar Award; Cancer Research Institute CLIP grant; the Ludwig Center for Cancer Immunotherapy; Functional Genomic Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute Faculty Scholar Award; Cancer Research Institute CLIP grant; the Ludwig Center for Cancer Immunotherapy; Functional Genomic Initiative	We thank members of the Li laboratory for helpful discussions, N. Cheung for providing us with the human IL-15/IL-15Ra complex reagent, M. Huse for help with the single-cell killing microwell assay and K. Hsu for providing us with the K562 cell line. This work was supported by National Institutes of Health grants F31CA210332 (B.G.N.), R01CA243904-01A1 (M.O.L.) and P30 CA008748 (the Memorial Sloan Kettering Cancer Center Support Grant); Department of Defense grant KC19008.e001 (M.O.L.); a Howard Hughes Medical Institute Faculty Scholar Award (M.O.L.); a Cancer Research Institute CLIP grant (M.O.L.); the Ludwig Center for Cancer Immunotherapy (M.O.L.); and the Functional Genomic Initiative (M.O.L.).	Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Borcherding N, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01625-6; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Cichocki F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02078; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Di Censo C, 2021, EUR J IMMUNOL, V51, P2568, DOI 10.1002/eji.202149209; Diaz-Montero CM, 2020, NAT REV NEPHROL, V16, P721, DOI 10.1038/s41581-020-0316-3; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eckl J, 2012, J MOL MED, V90, P55, DOI 10.1007/s00109-011-0806-7; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Freytag Saskia, 2018, F1000Res, V7, P1297, DOI 10.12688/f1000research.15809.2; Friedrich C, 2021, NAT IMMUNOL, V22, P1256, DOI 10.1038/s41590-021-01013-0; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Guan Yue, 2020, Oncotarget, V11, P2571, DOI 10.18632/oncotarget.27654; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hoffmann JC, 2021, CANCERS, V13, DOI 10.3390/cancers13246211; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Liu M, 2020, NATURE, V587, P115, DOI 10.1038/s41586-020-2836-1; Loibl S, 2021, LANCET, V397, P1750, DOI 10.1016/S0140-6736(20)32381-3; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; McFarland AP, 2021, IMMUNITY, V54, P1320, DOI 10.1016/j.immuni.2021.03.024; McGregor BA, 2020, J CLIN ONCOL, V38, P63, DOI 10.1200/JCO.19.01882; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Motzer RJ, 2018, NEW ENGL J MED, V379, P92, DOI 10.1056/NEJMc1805988; Nixon BG, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi8642; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Swonger JM, 2016, DIFFERENTIATION, V92, P66, DOI 10.1016/j.diff.2016.05.009; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wagner JA, 2017, J CLIN INVEST, V127, P4042, DOI 10.1172/JCI90387; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Yomogida K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2117965118; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang YY, 2021, CANCER CELL, V39, P1578, DOI 10.1016/j.ccell.2021.09.010; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	48	9	9	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					904	+		10.1038/s41590-022-01213-2	http://dx.doi.org/10.1038/s41590-022-01213-2		MAY 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35618834	Green Accepted			2022-12-18	WOS:000805552300006
J	Guy, C; Mitrea, DM; Chou, PC; Temirov, J; Vignali, KM; Liu, XY; Zhang, H; Kriwacki, R; Bruchez, MP; Watkins, SC; Workman, CJ; Vignali, DAA				Guy, Clifford; Mitrea, Diana M.; Chou, Po-Chien; Temirov, Jamshid; Vignali, Kate M.; Liu, Xueyan; Zhang, Hui; Kriwacki, Richard; Bruchez, Marcel P.; Watkins, Simon C.; Workman, Creg J.; Vignali, Dario A. A.			LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation	NATURE IMMUNOLOGY			English	Article							ACIDIC AMINO-ACIDS; CUTTING EDGE; PROTEIN; CD4; EXPANSION; SURFACE; CD223; MOLECULES; DYNAMICS; CLUSTER	Vignali and colleagues show that the inhibitory receptor LAG3 interferes with TCR signaling and T cell activation by lowering the pH at the immune synapse, which causes the dissociation of the tyrosine kinase Lck from the CD4 or CD8 co-receptor. LAG3 is an inhibitory receptor that is highly expressed on exhausted T cells. Although LAG3-targeting immunotherapeutics are currently in clinical trials, how LAG3 inhibits T cell function remains unclear. Here, we show that LAG3 moved to the immunological synapse and associated with the T cell receptor (TCR)-CD3 complex in CD4(+) and CD8(+) T cells, in the absence of binding to major histocompatibility complex class II-its canonical ligand. Mechanistically, a phylogenetically conserved, acidic, tandem glutamic acid-proline repeat in the LAG3 cytoplasmic tail lowered the pH at the immune synapse and caused dissociation of the tyrosine kinase Lck from the CD4 or CD8 co-receptor, which resulted in a loss of co-receptor-TCR signaling and limited T cell activation. These observations indicated that LAG3 functioned as a signal disruptor in a major histocompatibility complex class II-independent manner, and provide insight into the mechanism of action of LAG3-targeting immunotherapies.	[Guy, Clifford; Chou, Po-Chien; Vignali, Kate M.; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mitrea, Diana M.; Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Temirov, Jamshid; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vignali, Kate M.; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Vignali, Kate M.; Workman, Creg J.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Liu, Xueyan; Zhang, Hui] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kriwacki, Richard] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA; [Mitrea, Diana M.] Dewpoint Therapeut, Boston, MA USA; [Liu, Xueyan] Univ New Orleans, Dept Math, New Orleans, LA 70148 USA; [Zhang, Hui] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Louisiana System; University of New Orleans; Northwestern University; Feinberg School of Medicine	Workman, CJ; Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Workman, CJ; Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Workman, CJ; Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Workman, CJ; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	cworkman@pitt.edu; dvignali@pitt.edu	; Kriwacki, Richard/N-8154-2018	Liu, Xueyan/0000-0001-8365-5675; watkins, simon/0000-0003-4092-1552; Kriwacki, Richard/0000-0002-9798-6018	SJCRH; National Institutes of Health [P01 AI108545, R01 AI129893, R01 AI144422]; NCI Comprehensive Cancer Center Support CORE grant [CA047904]; ALSAC; NCI [P30 CA021765]	SJCRH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank everyone in the Vignali laboratory (Vignali-lab.com; @Vignali_Lab) for all their constructive comments and advice during this project. The authors would like to thank G. Lennon, R. Cross and P. Ingle of the St. Jude Immunology Flow Lab for cell sorting and valuable assistance; A. Yates, D. Falkner and H. Shen from the Immunology Flow Core at the University of Pittsburgh for cell sorting; A. McKenna and K. Forbes for maintenance, breeding and genotyping of mouse colonies at St. Jude Children's Research Hospital; E. Brunazzi for maintenance, breeding and genotyping of mouse colonies at the University of Pittsburgh; and the staffs of the Shared Animal Resource Center and the Division of Laboratory Animal Services for the animal husbandry A. Philips for assistance with NMR data analysis. Images were acquired, in part, at the Cell and Tissue Imaging Center, and peptide synthesis was performed by the Hartwell Center for Macromolecular Synthesis, which are supported by SJCRH and NCI P30 CA021765. This work was supported by the National Institutes of Health (P01 AI108545, R01 AI129893 to D.A.A.V.; R01 AI144422 to D.A.A.V and C.J.W.), NCI Comprehensive Cancer Center Support CORE grant (CA047904, to D.A.A.V. and R.K.), and ALSAC (to D.A.A.V. and R.K.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Cho I, 2018, J MICROSC-OXFORD, V271, P123, DOI 10.1111/jmi.12712; Fu GT, 2021, NATURE, V595, P724, DOI 10.1038/s41586-021-03692-z; Grebinoski S, 2020, CURR OPIN IMMUNOL, V67, P1, DOI 10.1016/j.coi.2020.06.001; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Horkova V, 2020, CELL REP, V30, P1504, DOI 10.1016/j.celrep.2020.01.008; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang WYC, 2017, J AM CHEM SOC, V139, P18009, DOI 10.1021/jacs.7b09387; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Keller RLJ, 2004, COMPUTER AIDED RESON; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Liedmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6645; Maeda TK, 2019, J BIOL CHEM, V294, P6017, DOI 10.1074/jbc.RA119.007455; Maruhashi T, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001014; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Perkins LA, 2018, MOL PHARMACEUT, V15, P759, DOI 10.1021/acs.molpharmaceut.7b00928; Rigo A, 2004, J INORG BIOCHEM, V98, P1495, DOI 10.1016/j.jinorgbio.2004.06.008; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Ruffo E, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101305; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Singh SK, 2012, FEBS J, V279, P3705, DOI 10.1111/j.1742-4658.2012.08732.x; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wassie AT, 2019, NAT METHODS, V16, P33, DOI 10.1038/s41592-018-0219-4; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Woo SR, 2010, EUR J IMMUNOL, V40, P1768, DOI 10.1002/eji.200939874; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	46	9	9	8	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					757	+		10.1038/s41590-022-01176-4	http://dx.doi.org/10.1038/s41590-022-01176-4		APR 2022	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35437325	Green Accepted			2022-12-18	WOS:000784104500002
J	Fischer, A; Wannemacher, J; Christ, S; Koopmans, T; Kadri, S; Zhao, JK; Gouda, M; Ye, HF; Muck-Hausl, M; Krenn, PW; Machens, HG; Fassler, R; Neumann, PA; Hauck, SM; Rinkevich, Y				Fischer, Adrian; Wannemacher, Juliane; Christ, Simon; Koopmans, Tim; Kadri, Safwen; Zhao, Jiakuan; Gouda, Mahesh; Ye, Haifeng; Mueck-Haeusl, Martin; Krenn, Peter W.; Machens, Hans-Guenther; Faessler, Reinhard; Neumann, Philipp-Alexander; Hauck, Stefanie M.; Rinkevich, Yuval			Neutrophils direct preexisting matrix to initiate repair in damaged tissues	NATURE IMMUNOLOGY			English	Article							IRREVERSIBLE ELECTROPORATION; ADHESION; EXPRESSION; MIGRATION; CELLS	Internal organs heal injuries with new connective tissue, but the cellular and molecular events of this process remain obscure. By tagging extracellular matrix around the mesothelium lining in mouse peritoneum, liver and cecum, here we show that preexisting matrix was transferred across organs into wounds in various injury models. Using proteomics, genetic lineage-tracing and selective injury in juxtaposed organs, we found that the tissue of origin for the transferred matrix likely dictated the scarring or regeneration of the healing tissue. Single-cell RNA sequencing and genetic and chemical screens indicated that the preexisting matrix was transferred by neutrophils dependent on the HSF-integrin AM/B2-kindlin3 cascade. Pharmacologic inhibition of this axis prevented matrix transfer and the formation of peritoneal adhesions. Matrix transfer was thus an early event of wound repair and provides a therapeutic window to dampen scaring across a range of conditions. Rinkevich and colleagues show that preexisting matrix is transferred by neutrophils across organs into injured sites in a manner dependent on integrin activation.	[Fischer, Adrian; Wannemacher, Juliane; Christ, Simon; Kadri, Safwen; Zhao, Jiakuan; Gouda, Mahesh; Ye, Haifeng; Mueck-Haeusl, Martin; Rinkevich, Yuval] Helmholtz Zentrum Munchen, Inst Regenerat Biol & Med, Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Munich, Germany; [Koopmans, Tim] Hubrecht Inst, Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Krenn, Peter W.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany; [Krenn, Peter W.] Paris Lodron Univ Salzburg, Dept Biosci & Med Biol, Salzburg, Austria; [Machens, Hans-Guenther] Tech Univ Munich, Sch Med, Dept Plast & Hand Surg, Klinikum Rechts Isar, Munich, Germany; [Neumann, Philipp-Alexander] Tech Univ Munich, Sch Med, Dept Surg, Klinikum Rechts Isar, Munich, Germany; [Hauck, Stefanie M.] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Metabol & Prote Core & Res Unit Prot Sci, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Max Planck Society; Salzburg University; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rinkevich, Y (corresponding author), Helmholtz Zentrum Munchen, Inst Regenerat Biol & Med, Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Munich, Germany.	yuval.rinkevich@helmholtz-muenchen.de	Fischer, Adrian/GQI-4457-2022	Christ, Simon/0000-0003-2978-6548; Krenn, Peter/0000-0002-8896-8387; Fischer, Adrian/0000-0001-7810-1176	Helmholtz Zentrum Munchen -Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)	Helmholtz Zentrum Munchen -Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)	Open access funding provided by Helmholtz Zentrum Munchen -Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH).	Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Avishai E, 2017, EPMA J, V8, P23, DOI 10.1007/s13167-017-0081-y; Bellaye PS, 2014, PHARMACOL THERAPEUT, V143, P119, DOI 10.1016/j.pharmthera.2014.02.009; Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Calve S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32377; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; Curaj A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103685; Daseke MJ, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0746-x; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Fischer A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700475; Flanagan M., 1998, J WOUND CARE, V7, P508, DOI [10.12968/jowc.1998.7.10.508, DOI 10.12968/JOWC.1998.7.10.508, DOI 10.12968/JOWC.1998.7.10.50821]; Garcia-Touchard A, 2005, ARTERIOSCL THROM VAS, V25, P1119, DOI 10.1161/01.ATV.0000164311.48592.da; Golberg A, 2016, PEERJ, V4, DOI 10.7717/peerj.1571; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Iismaa SE, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0044-5; Jiang DS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19425-1; Kechagia JZ, 2019, NAT REV MOL CELL BIO, V20, P457, DOI 10.1038/s41580-019-0134-2; Krenn PW, 2020, P NATL ACAD SCI USA, V117, P24326, DOI 10.1073/pnas.2009078117; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maxson, 2016, PHYSIOL BEHAV, V176, P139; Miyazaki S, 2004, CLIN DIAGN LAB IMMUN, V11, P452, DOI 10.1128/CDLI.11.3.452-457.2004; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Park AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148998; Rosales C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00113; Ruppert R, 2015, J EXP MED, V212, P1415, DOI 10.1084/jem.20150269; Scheraga RG, 2016, AM J PHYSIOL-LUNG C, V311, pL941, DOI 10.1152/ajplung.00262.2016; Schiller HB, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156123; Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001; Shao XH, 2020, NUCLEIC ACIDS RES, V48, pD1136, DOI 10.1093/nar/gkz849; Shetty Akshay, 2019, Fed Pract, V36, P14; Silvestre-Roig C, 2019, TRENDS IMMUNOL, V40, P565, DOI 10.1016/j.it.2019.04.012; Stepensky PY, 2015, J PEDIAT HEMATOL ONC, V37, P264, DOI 10.1097/MPH.0000000000000228; Tomcik M, 2014, ANN RHEUM DIS, V73, P1215, DOI 10.1136/annrheumdis-2012-203095; Tsai JM, 2019, BLOOD ADV, V3, P2713, DOI 10.1182/bloodadvances.2018024026; Wagstaff PGK, 2016, ONCOTARGETS THER, V9, P2437, DOI [10.2147/OTT.586086, 10.2147/OTT.S88086]; Wang G, 2016, DEV CELL, V38, P453, DOI 10.1016/j.devcel.2016.07.014; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yamakoshi Y., 2014, DENT ORAL BIOL BIOCH; Zhang XL, 2021, BIOMED PHARMACOTHER, V135, DOI 10.1016/j.biopha.2020.111067	47	9	9	7	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					518	+		10.1038/s41590-022-01166-6	http://dx.doi.org/10.1038/s41590-022-01166-6		MAR 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35354953	Green Published, hybrid			2022-12-18	WOS:000775781500003
J	Zhou, L; Zhou, WQ; Joseph, AM; Chu, CC; Putzel, GG; Fang, BB; Teng, F; Lyu, M; Yano, H; Andreasson, KI; Mekada, E; Eberl, G; Sonnenberg, GF				Zhou, Lei; Zhou, Wenqing; Joseph, Ann M.; Chu, Coco; Putzel, Gregory G.; Fang, Beibei; Teng, Fei; Lyu, Mengze; Yano, Hiroshi; Andreasson, Katrin I.; Mekada, Eisuke; Eberl, Gerard; Sonnenberg, Gregory F.			Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation	NATURE IMMUNOLOGY			English	Article							FACTOR RECEPTOR; APOPTOSIS; CYTOKINE; PROMOTES; ACTIVATION; INFECTION; NECROSIS; PATHWAY; BIOLOGY; ALPHA	Tumor necrosis factor (TNF) drives chronic inflammation and cell death in the intestine, and blocking TNF is a therapeutic approach in inflammatory bowel disease (IBD). Despite this knowledge, the pathways that protect the intestine from TNF are incompletely understood. Here we demonstrate that group 3 innate lymphoid cells (ILC3s) protect the intestinal epithelium from TNF-induced cell death. This occurs independent of interleukin-22 (IL-22), and we identify that ILC3s are a dominant source of heparin-binding epidermal growth factor-like growth factor (HB-EGF). ILC3s produce HB-EGF in response to prostaglandin E2 (PGE2) and engagement of the EP2 receptor. Mice lacking ILC3-derived HB-EGF exhibit increased susceptibility to TNF-mediated epithelial cell death and experimental intestinal inflammation. Finally, human ILC3s produce HB-EGF and are reduced from the inflamed intestine. These results define an essential role for ILC3-derived HB-EGF in protecting the intestine from TNF and indicate that disruption of this pathway contributes to IBD. TNF is an important driver of many inflammatory diseases. Zhou et al. demonstrate ILC3 production of the growth factor HB-EGF protects against TNF-mediated injury of the gut epithelium in inflammatory bowel disease.	[Zhou, Lei; Zhou, Wenqing; Joseph, Ann M.; Teng, Fei; Lyu, Mengze; Sonnenberg, Gregory F.] Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA; [Zhou, Lei; Zhou, Wenqing; Joseph, Ann M.; Teng, Fei; Lyu, Mengze; Sonnenberg, Gregory F.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Zhou, Lei; Zhou, Wenqing; Joseph, Ann M.; Chu, Coco; Putzel, Gregory G.; Teng, Fei; Lyu, Mengze; Yano, Hiroshi; Sonnenberg, Gregory F.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Fang, Beibei] Weill Cornell Med, Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Andreasson, Katrin I.] Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford Neurosci Inst, Stanford Immunol Program, Stanford, CA 94305 USA; [Mekada, Eisuke] Osaka Univ, Res Inst Microbial Dis, Dept Cell Biol, Osaka, Japan; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France	Cornell University; Cornell University; Cornell University; Cornell University; Stanford University; Osaka University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zhou, L; Sonnenberg, GF (corresponding author), Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA.; Zhou, L; Sonnenberg, GF (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA.; Zhou, L; Sonnenberg, GF (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.	lez2004@med.cornell.edu; gfsonnenberg@med.cornell.edu	Chu, Coco/HGC-0804-2022; Lyu, Mengze/GXV-3779-2022	Chu, Coco/0000-0002-5466-7252; Yano, Hiroshi/0000-0002-3098-2629; Zhou, Wenqing/0000-0002-8800-3745; Lyu, Mengze/0000-0002-8509-7969	National Institutes of Health [R01AI143842, R01AI123368, R01AI145989, U01AI095608, R21CA249274, R01AI162936]; National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team; Searle Scholars Program; American Asthma Foundation Scholar Award; Burroughs Wellcome Fund; Meyer Cancer Center Collaborative Research Initiative, Linda and Glenn Greenberg; Dalton Family Foundation; Roberts Institute for Research in IBD; Crohn's and Colitis Foundation [608975, 831404]; Sackler Brain and Spine Institute research grant; National Institute of Diabetes and Digestive and Kidney Diseases [T32DK116970]; Cancer Research Institute Lloyd J. Old STAR Program; Wade F.B. Thompson/Cancer Research Institute CLIP Investigator grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team; Searle Scholars Program; American Asthma Foundation Scholar Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Meyer Cancer Center Collaborative Research Initiative, Linda and Glenn Greenberg; Dalton Family Foundation; Roberts Institute for Research in IBD; Crohn's and Colitis Foundation; Sackler Brain and Spine Institute research grant; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research Institute Lloyd J. Old STAR Program; Wade F.B. Thompson/Cancer Research Institute CLIP Investigator grant	We thank members of the Sonnenberg Laboratory for discussions and critical reading of the manuscript, the Epigenomics Core of Weill Cornell Medicine and R.C. Harris for sharing critical mouse lines. Research in the Sonnenberg Laboratory is supported by the National Institutes of Health (R01AI143842, R01AI123368, R01AI145989, U01AI095608, R21CA249274 and R01AI162936), the National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team, the Searle Scholars Program, the American Asthma Foundation Scholar Award, an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, a Wade F.B. Thompson/Cancer Research Institute CLIP Investigator grant, the Meyer Cancer Center Collaborative Research Initiative, Linda and Glenn Greenberg, the Dalton Family Foundation and the Roberts Institute for Research in IBD. L.Z. and W.Z. are supported by fellowships from the Crohn's and Colitis Foundation (608975 and 831404, respectively). C.C. is supported by a Sackler Brain and Spine Institute research grant. A.M.J. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (T32DK116970). G.F.S. is supported by the Cancer Research Institute Lloyd J. Old STAR Program.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chen JC, 2016, PHYSIOL REV, V96, P1025, DOI 10.1152/physrev.00030.2015; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Dao DT, 2018, AM J PATHOL, V188, P2446, DOI 10.1016/j.ajpath.2018.07.016; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Eberl G, 2017, MUCOSAL IMMUNOL, V10, P27, DOI 10.1038/mi.2016.86; El-Assal ON, 2005, GASTROENTEROLOGY, V129, P609, DOI 10.1053/j.gastro.2005.05.054; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Goc J, 2021, CELL, V184, P5015, DOI 10.1016/j.cell.2021.07.029; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Gunasekera DC, 2020, MUCOSAL IMMUNOL, V13, P493, DOI 10.1038/s41385-019-0252-3; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hilliard VC, 2011, AM J PHYSIOL-GASTR L, V301, pG338, DOI 10.1152/ajpgi.00057.2011; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Johansson JU, 2013, J NEUROSCI, V33, P16016, DOI 10.1523/JNEUROSCI.2203-13.2013; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Leppkes M, 2014, INT IMMUNOL, V26, P509, DOI 10.1093/intimm/dxu051; Michalsky MP, 2001, J PEDIATR SURG, V36, P1130, DOI 10.1053/jpsu.2001.25730; Miyoshi H, 2017, EMBO J, V36, P5, DOI 10.15252/embj.201694660; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; Parker A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1275-5; Patankar JV, 2021, NAT CELL BIOL, V23, P796, DOI 10.1038/s41556-021-00708-8; Patankar JV, 2020, NAT REV GASTRO HEPAT, V17, P543, DOI 10.1038/s41575-020-0326-4; Perkins DJ, 2018, NAT IMMUNOL, V19, P1309, DOI 10.1038/s41590-018-0243-7; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Powell N, 2020, GUT, V69, P578, DOI 10.1136/gutjnl-2019-318483; Singh Bhuminder, 2016, F1000Res, V5, DOI 10.12688/f1000research.9025.1; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Song-Zhao GX, 2014, METHODS MOL BIOL, V1193, P199, DOI 10.1007/978-1-4939-1212-4_18; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Teng F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1215; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Van Hauwermeiren F, 2015, MUCOSAL IMMUNOL, V8, P828, DOI 10.1038/mi.2014.112; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x; Zhou L, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1605	53	9	9	8	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					251	+		10.1038/s41590-021-01110-0	http://dx.doi.org/10.1038/s41590-021-01110-0		JAN 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35102343	Green Accepted			2022-12-18	WOS:000750323300001
J	Wang, YF; Tian, Q; Hao, YX; Yao, W; Lu, JJ; Chen, C; Chen, XY; Lin, Y; Huang, QZ; Xu, LF; Hu, JJ; Lei, S; Wei, ZP; Luo, Y; Li, ZR; Hu, L; Tang, JF; Wu, Q; Zhou, XY; Wu, YZ; Yin, ZN; Xu, JQ; Ye, LL				Wang, Yifei; Tian, Qin; Hao, Yaxing; Yao, Wei; Lu, Jinjin; Chen, Cheng; Chen, Xiangyu; Lin, Yao; Huang, Qizhao; Xu, Lifan; Hu, Jianjun; Lei, Shun; Wei, Zhengping; Luo, Yuan; Li, Zhirong; Hu, Li; Tang, Jianfang; Wu, Qing; Zhou, Xinyuan; Wu, Yuzhang; Yin, Zhinan; Xu, Jianqing; Ye, Lilin			The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4(+) T cells by preventing ferroptosis	NATURE IMMUNOLOGY			English	Article							LIPID-PEROXIDATION; DIFFERENTIATION; METABOLISM; MITOCHONDRIA; DEGRADATION; EFFECTOR; DEATH; NRF2; ACTIVATION; IMMUNITY	Wang et al. show that the Rictor-dependent mTORC2-Akt pathway is needed to maintain CD4(+) memory cells. This axis acts, in part, by suppressing mitoROS generation and subsequent oxidation of membrane phospholipids, which then triggers cell death by ferroptosis. Antigen-specific memory CD4(+) T cells can persist and confer rapid and efficient protection from microbial reinfection. However, the mechanisms underlying the long-term maintenance of the memory CD4(+) T cell pool remain largely unknown. Here, using a mouse model of acute infection with lymphocytic choriomeningitis virus (LCMV), we found that the serine/threonine kinase complex mammalian target of rapamycin complex 2 (mTORC2) is critical for the long-term persistence of virus-specific memory CD4(+) T cells. The perturbation of mTORC2 signaling at memory phase led to an enormous loss of virus-specific memory CD4(+) T cells by a unique form of regulated cell death (RCD), ferroptosis. Mechanistically, mTORC2 inactivation resulted in the impaired phosphorylation of downstream AKT and GSK3 beta kinases, which induced aberrant mitochondrial reactive oxygen species (ROS) accumulation and ensuing ferroptosis-causative lipid peroxidation in virus-specific memory CD4(+) T cells; furthermore, the disruption of this signaling cascade also inhibited glutathione peroxidase 4 (GPX4), a major scavenger of lipid peroxidation. Thus, the mTORC2-AKT-GSK3 beta axis functions as a key signaling hub to promote the longevity of virus-specific memory CD4(+) T cells by preventing ferroptosis.	[Wang, Yifei; Lu, Jinjin; Chen, Xiangyu; Huang, Qizhao] Southern Med Univ, Sch Lab Med & Biotechnol, Guangdong Prov Key Lab Immune Regulat & Immunothe, Guangzhou, Guangdong, Peoples R China; [Wang, Yifei] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Tian, Qin; Hao, Yaxing; Yao, Wei; Lu, Jinjin; Chen, Cheng; Lin, Yao; Xu, Lifan; Hu, Jianjun; Lei, Shun; Wei, Zhengping; Luo, Yuan; Li, Zhirong; Hu, Li; Tang, Jianfang; Wu, Qing; Zhou, Xinyuan; Wu, Yuzhang; Ye, Lilin] PLA Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China; [Huang, Qizhao] Gen Hosp Western Theater Command, Ctr Canc, Chengdu, Peoples R China; [Yin, Zhinan] Jinan Univ, Guangdong Prov Key Lab Tumor Intervent Diag & Tr, Zhuhai Inst Translat Med, Zhuhai Peoples Hosp, Zhuhai, Guangdong, Peoples R China; [Xu, Jianqing] Jinan Univ, Biomed Translat Res Inst, Fac Med Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Jianqing] Fudan Univ, Shanghai Key Lab Organ Transplantat, Zhongshan Hosp Inst Biomed Sci, Shanghai, Peoples R China	Southern Medical University - China; Jinan University; Army Medical University; Jinan University; Jinan University; Fudan University	Ye, LL (corresponding author), PLA Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China.; Yin, ZN (corresponding author), Jinan Univ, Guangdong Prov Key Lab Tumor Intervent Diag & Tr, Zhuhai Inst Translat Med, Zhuhai Peoples Hosp, Zhuhai, Guangdong, Peoples R China.; Xu, JQ (corresponding author), Jinan Univ, Biomed Translat Res Inst, Fac Med Sci, Guangzhou, Guangdong, Peoples R China.; Xu, JQ (corresponding author), Fudan Univ, Shanghai Key Lab Organ Transplantat, Zhongshan Hosp Inst Biomed Sci, Shanghai, Peoples R China.	tzhinan@jnu.edu.cn; xujianqing@fudan.edu.cn; yelilinlcmv@tmmu.edu.cn	Zhou, Xinyuan/AFS-9817-2022	Tian, Qin/0000-0002-7681-2115	National Key Research Development Plan [SQ2021YFC2300059]; National Natural Science Fund for Distinguished Young Scholars [31825011]; National Natural Science Foundation of China [32030041, 31800748, 31800742, 31900642]; China Postdoctoral Science Foundation [2019M663389]; Chongqing Special Postdoctoral Science Foundation [XmT2018021]	National Key Research Development Plan; National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Special Postdoctoral Science Foundation	We thank R. Ahmed (Emory University) for SMARTA transgenic mice and retroviral vectors. We thank CapitalBio Corporation (Beijing, China) for performing microarray experiments and data analysis, and we thank the core facility center of Third Military Medical University for cell sorting and TEM. This study was supported by grants from the National Key Research Development Plan (SQ2021YFC2300059 to L.Y.), the National Natural Science Fund for Distinguished Young Scholars (31825011 to L.Y.), the National Natural Science Foundation of China (32030041 to L.Y, 31800748 to Y.W., 31800742 to Q.T. and 31900642 to Y.H.), the China Postdoctoral Science Foundation (2019M663389 to Y.W.) and Chongqing Special Postdoctoral Science Foundation (XmT2018021 to Q.T.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872; Bantug GR, 2018, IMMUNITY, V48, P542, DOI 10.1016/j.immuni.2018.02.012; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Camara AKS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00460; Chen X, 2021, NAT REV CLIN ONCOL, V18, P280, DOI 10.1038/s41571-020-00462-0; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cuadrado A, 2015, FREE RADICAL BIO MED, V88, P147, DOI 10.1016/j.freeradbiomed.2015.04.029; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Hao YX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01127; Hayes JD, 2015, BIOCHEM SOC T, V43, P611, DOI 10.1042/BST20150011; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Huang HL, 2020, IMMUNOL REV, V295, P15, DOI 10.1111/imr.12845; Imai H, 2017, CURR TOP MICROBIOL, V403, P143, DOI 10.1007/82_2016_508; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Liu H, 2013, AUTOPHAGY, V9, P730, DOI 10.4161/auto.24039; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Liu XJ, 2018, CELL, V175, P502, DOI 10.1016/j.cell.2018.08.040; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Paramasivan P, 2019, CANCER DRUG RESIST, V2, P490, DOI 10.20517/cdr.2019.57; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Ursini F, 2020, FREE RADICAL BIO MED, V152, P175, DOI 10.1016/j.freeradbiomed.2020.02.027; Venditti P, 2013, MITOCHONDRION, V13, P71, DOI 10.1016/j.mito.2013.01.008; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Weldy CS, 2012, FREE RADICAL BIO MED, V53, P1264, DOI 10.1016/j.freeradbiomed.2012.07.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Ye LL, 2017, J VIROL, V91, DOI 10.1128/JVI.01653-16; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	58	9	10	13	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					303	+		10.1038/s41590-021-01090-1	http://dx.doi.org/10.1038/s41590-021-01090-1		DEC 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	34949833				2022-12-18	WOS:000733694100002
J	Tyler, PM; Bucklin, ML; Zhao, M; Maher, TJ; Rice, AJ; Ji, WZ; Warner, N; Pan, J; Morotti, R; McCarthy, P; Griffiths, A; van Rossum, AMC; Hollink, IHIM; Dalm, VASH; Catanzaro, J; Lakhani, SA; Muise, AM; Lucas, CL				Tyler, Paul M.; Bucklin, Molly L.; Zhao, Mengting; Maher, Timothy J.; Rice, Andrew J.; Ji, Weizhen; Warner, Neil; Pan, Jie; Morotti, Raffaella; McCarthy, Paul; Griffiths, Anne; van Rossum, Annemarie M. C.; Hollink, Iris H. I. M.; Dalm, Virgil A. S. H.; Catanzaro, Jason; Lakhani, Saquib A.; Muise, Aleixo M.; Lucas, Carrie L.			Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation	NATURE IMMUNOLOGY			English	Article							I INTERFERON; T-CELLS; INDUCTION; MEF; DIFFERENTIATION; EXPRESSION; FRAMEWORK; COLITIS; PATHWAY; DOMAIN	Transcription factors specialized to limit the destructive potential of inflammatory immune cells remain ill-defined. We discovered loss-of-function variants in the X-linked ETS transcription factor gene ELF4 in multiple unrelated male patients with early onset mucosal autoinflammation and inflammatory bowel disease (IBD) characteristics, including fevers and ulcers that responded to interleukin-1 (IL-1), tumor necrosis factor or IL-12p40 blockade. Using cells from patients and newly generated mouse models, we uncovered ELF4-mutant macrophages having hyperinflammatory responses to a range of innate stimuli. In mouse macrophages, Elf4 both sustained the expression of anti-inflammatory genes, such as Il1rn, and limited the upregulation of inflammation amplifiers, including S100A8, Lcn2, Trem1 and neutrophil chemoattractants. Blockade of Trem1 reversed inflammation and intestine pathology after in vivo lipopolysaccharide challenge in mice carrying patient-derived variants in Elf4. Thus, ELF4 restrains inflammation and protects against mucosal disease, a discovery with broad translational relevance for human inflammatory disorders such as IBD. Lucas and colleagues describe loss-of-function variants in the X-linked ETS transcription factor ELF4 in multiple unrelated male patients with early onset mucosal autoinflammation and inflammatory bowel disease (IBD)-like features.	[Tyler, Paul M.; Bucklin, Molly L.; Zhao, Mengting; Maher, Timothy J.; Rice, Andrew J.; Lucas, Carrie L.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA; [Ji, Weizhen; Lakhani, Saquib A.; Lucas, Carrie L.] Yale Univ, Sch Med, Pediat Genom Discovery Program, New Haven, CT 06510 USA; [Ji, Weizhen; McCarthy, Paul; Catanzaro, Jason; Lakhani, Saquib A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Warner, Neil; Pan, Jie; Griffiths, Anne; Muise, Aleixo M.] Univ Toronto, SickKids Inflammatory Bowel Dis Ctr, Res Inst, Hosp Sick Children,Dept Pediat & Biochem, Toronto, ON, Canada; [Warner, Neil; Pan, Jie; Griffiths, Anne; Muise, Aleixo M.] Univ Toronto, Cell Biol Program, Res Inst, Hosp Sick Children,Dept Pediat & Biochem, Toronto, ON, Canada; [Morotti, Raffaella] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [van Rossum, Annemarie M. C.] Erasmus MC, Dept Pediat, Div Pediat Infect Dis & Immunol, Rotterdam, Netherlands; [Hollink, Iris H. I. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Dalm, Virgil A. S. H.] Erasmus MC, Dept Internal Med, Div Clin Immunol, Rotterdam, Netherlands; [Dalm, Virgil A. S. H.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands	Yale University; Yale University; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Lucas, CL (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA.; Lucas, CL (corresponding author), Yale Univ, Sch Med, Pediat Genom Discovery Program, New Haven, CT 06510 USA.	C.arne.Lucas@yale.edu		Bucklin, Molly/0000-0003-1388-686X	Yale Cancer Center; Yale New Haven Hospital; Mathers Foundation; National Institute of Allergy and Infectious Diseases/National Institutes of Health [R01AI150913]; Immune Deficiency Foundation; Hood Foundation; Yale University; Canada Research Chair (Tier 1) in Pediatric IBD; Canadian Institute of Health Research Foundation Grant; National Institute of Diabetes and Digestive and Kidney Diseases [RC2DK118640]; Leona M. and Harry B. Helmsley Charitable Trust	Yale Cancer Center; Yale New Haven Hospital; Mathers Foundation; National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Immune Deficiency Foundation; Hood Foundation; Yale University; Canada Research Chair (Tier 1) in Pediatric IBD; Canadian Institute of Health Research Foundation Grant(Canadian Institutes of Health Research (CIHR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leona M. and Harry B. Helmsley Charitable Trust	We thank the patients and their families for participating in the research and all clinical care staff for their contributions. We also thank P. Schwartzberg, P.-P. Axisa and J.-M. Carpier for critical feedback. We thank Prometheus for providing recombinant IL-2 used in T cell culture experiments and the Yale Cancer Center for support. We thank Yale New Haven Hospital and S. Bluell and J. Buell for their support of the Pediatric Genomics Discovery Program. C.L.L. is funded by the Mathers Foundation, National Institute of Allergy and Infectious Diseases/National Institutes of Health (grant no. R01AI150913), Immune Deficiency Foundation, Hood Foundation and Yale University. A.M.M. is funded by a Canada Research Chair (Tier 1) in Pediatric IBD, Canadian Institute of Health Research Foundation Grant, National Institute of Diabetes and Digestive and Kidney Diseases (grant no. RC2DK118640) and the Leona M. and Harry B. Helmsley Charitable Trust.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Cao LL, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau4604; Crowley E, 2020, GASTROENTEROLOGY, V158, P2208, DOI 10.1053/j.gastro.2020.02.023; Curina A, 2017, GENE DEV, V31, P399, DOI 10.1101/gad.293134.116; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Flannigan KL, 2017, MUCOSAL IMMUNOL, V10, P673, DOI 10.1038/mi.2016.80; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lee PH, 2014, J IMMUNOL, V192, P178, DOI 10.4049/jimmunol.1301372; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Manda P, 2018, IMMUNITY, V49, P42, DOI 10.1016/j.immuni.2018.06.011; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyazaki Y, 1996, ONCOGENE, V13, P1721; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pan J, 2016, MODERN PATHOL, V29, P557, DOI 10.1038/modpathol.2016.52; Poon GMK, 2017, TRANSCR-AUSTIN, V8, P193, DOI 10.1080/21541264.2017.1302901; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Revu S, 2018, CELL REP, V22, P2642, DOI 10.1016/j.celrep.2018.02.044; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Seifert LL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007634; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stewart DM, 2005, CURR OPIN ALLERGY CL, V5, P510, DOI 10.1097/01.all.0000191235.35879.29; Takeda AJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12311-5; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Uhlig HH, 2014, GASTROENTEROLOGY, V147, P990, DOI 10.1053/j.gastro.2014.07.023; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756	44	9	9	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1118	+		10.1038/s41590-021-00984-4	http://dx.doi.org/10.1038/s41590-021-00984-4		JUL 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34326534	Green Accepted			2022-12-18	WOS:000679302800002
J	Barbet, G; Nair-Gupta, P; Schotsaert, M; Yeung, ST; Moretti, J; Seyffer, F; Metreveli, G; Gardner, T; Choi, A; Tortorella, D; Tampe, R; Khanna, KM; Garcia-Sastre, A; Blander, JM				Barbet, Gaetan; Nair-Gupta, Priyanka; Schotsaert, Michael; Yeung, Stephen T.; Moretti, Julien; Seyffer, Fabian; Metreveli, Giorgi; Gardner, Thomas; Choi, Angela; Tortorella, Domenico; Tampe, Robert; Khanna, Kamal M.; Garcia-Sastre, Adolfo; Blander, J. Magarian			TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming	NATURE IMMUNOLOGY			English	Article								Viral pathogens frequently target host cell antigen-processing pathways, including MHC-I-TAP peptide transporters, to evade host immunity. Blander and colleagues describe how MHC-I molecules can still cross-present antigen by re-routing ERGIC-resident MHC molecules to phagosomal vesicles, where phagolysosomal proteases act to shape the peptide repertoire for MHC-I presentation. Classic major histocompatibility complex class I (MHC-I) presentation relies on shuttling cytosolic peptides into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). Viruses disable TAP to block MHC-I presentation and evade cytotoxic CD8(+) T cells. Priming CD8(+) T cells against these viruses is thought to rely solely on cross-presentation by uninfected TAP-functional dendritic cells. We found that protective CD8(+) T cells could be mobilized during viral infection even when TAP was absent in all hematopoietic cells. TAP blockade depleted the endosomal recycling compartment of MHC-I molecules and, as such, impaired Toll-like receptor-regulated cross-presentation. Instead, MHC-I molecules accumulated in the ER-Golgi intermediate compartment (ERGIC), sequestered away from Toll-like receptor control, and coopted ER-SNARE Sec22b-mediated vesicular traffic to intersect with internalized antigen and rescue cross-presentation. Thus, when classic MHC-I presentation and endosomal recycling compartment-dependent cross-presentation are impaired in dendritic cells, cell-autonomous noncanonical cross-presentation relying on ERGIC-derived MHC-I counters TAP dysfunction to nevertheless mediate CD8(+) T cell priming.	[Barbet, Gaetan; Moretti, Julien; Blander, J. Magarian] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Barbet, Gaetan; Moretti, Julien; Blander, J. Magarian] Weill Cornell Med, Div Gastroenterol & Hepatol, Dept Med, New York, NY USA; [Nair-Gupta, Priyanka] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Nair-Gupta, Priyanka] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Schotsaert, Michael; Metreveli, Giorgi; Choi, Angela; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Schotsaert, Michael; Metreveli, Giorgi; Choi, Angela; Tortorella, Domenico; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Yeung, Stephen T.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Seyffer, Fabian; Khanna, Kamal M.] NYU, Perlmutter Canc Ctr, Langone Hlth, New York, NY USA; [Gardner, Thomas] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA; [Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, Frankfurt, Germany; [Khanna, Kamal M.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Blander, J. Magarian] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Blander, J. Magarian] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Blander, J. Magarian] Weill Cornell Med, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Barbet, Gaetan] Rutgers State Univ, Child Hlth Inst New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Barbet, Gaetan] Rutgers State Univ, Dept Pediat, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Nair-Gupta, Priyanka] Janssen Res & Dev LLC, Spring House, PA USA; [Yeung, Stephen T.] Weill Cornell Med, Div Infect Dis, Dept Med, New York, NY USA; [Gardner, Thomas] ArsenalBio, San Francisco, CA USA; [Choi, Angela] Moderna Inc, Cambridge, MA USA	Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; Memorial Sloan Kettering Cancer Center; Goethe University Frankfurt; New York University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Cornell University	Blander, JM (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Weill Cornell Med, Div Gastroenterol & Hepatol, Dept Med, New York, NY USA.; Blander, JM (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA.; Blander, JM (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA.; Blander, JM (corresponding author), Weill Cornell Med, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA.	jmblander@med.cornell.edu		Moretti, Julien/0000-0002-3415-9058; Barbet, Gaetan/0000-0002-0152-3650	NIH [F32CA224438, 5R24 CA095823-04, S10 RR0 9145-01, AI073899, AI123284, DK111862, AI127658]; NSF [DBI-9724504]; NIH/NIAID Center for Research on Influenza Pathogenesis contract, CEIRS Network [HHSN266200700010C, AI101820, AI112318, AI143861]; German Research Foundation [SFB 807, TA157/7]; European Research Council (ERC) [789121]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Crohn's and Colitis Foundation; American Heart Association pre-doctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH/NIAID Center for Research on Influenza Pathogenesis contract, CEIRS Network; German Research Foundation(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation; American Heart Association pre-doctoral fellowship(American Heart Association)	We thank V. Gillespie for expert pathology on mouse lung tissues. We thank S. Trombetta (Boehringer Ingelheim); K. Rock (University of Massachusetts); P. Cresswell (Yale University); and W. Li, T. M. Moran, D. B. Rubiov and A. Fernandez-Sesma (Icahn School of Medicine at Mount Sinai) for reagents and technical advice. We are grateful to current Blander laboratory members and to H. Gupta, M. A. Blander and S. J. Blander for discussions and support. The ISMMS-Microscopy Shared Resource Facility was supported by grants no. NIH 5R24 CA095823-04, no. S10 RR0 9145-01 and no. NSF DBI-9724504. This work was supported by NIH grants no. AI073899 and no. AI123284 to J.M.B.; an NIH/NIAID Center for Research on Influenza Pathogenesis contract as part of the CEIRS Network no. HHSN266200700010C to A.G.-S., grant nos. AI101820 and AI112318 to D.T., and grant no. AI143861 to K.M.K.; German Research Foundation grants no. SFB 807-Membrane Transport and Communication and no. TA157/7; and by the European Research Council (ERC Advanced Grant no. 789121) to R.T. Support to J.M.B. was also provided by NIH grants no. DK111862 and no. AI127658, the Burroughs Wellcome Fund, and the Leukemia and Lymphoma Society. G.B. has been supported by a fellowship and is currently supported by a career development award from the Crohn's and Colitis Foundation. T.G. was supported by an American Heart Association pre-doctoral fellowship and NIH grant no. F32CA224438.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; ALDRICH CJ, 1994, P NATL ACAD SCI USA, V91, P6525, DOI 10.1073/pnas.91.14.6525; Alloatti A, 2017, J EXP MED, V214, P2231, DOI 10.1084/jem.20170229; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; Bertholet S, 2006, J IMMUNOL, V177, P3525, DOI 10.4049/jimmunol.177.6.3525; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Garrido G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11728-2; Geng J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007171; Gutierrez-Martinez E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00363; Halenius A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472978; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lawand M, 2016, J IMMUNOL, V197, P3454, DOI 10.4049/jimmunol.1501925; Marijt KA, 2020, CURR OPIN IMMUNOL, V64, P15, DOI 10.1016/j.coi.2019.12.004; Marijt KA, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1599639; Mayerhofer PU, 2015, J MOL BIOL, V427, P1102, DOI 10.1016/j.jmb.2014.09.006; Merzougui N, 2011, EMBO REP, V12, P1257, DOI 10.1038/embor.2011.203; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Montealegre S, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900464; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Noriega V, 2012, IMMUNOL RES, V54, P140, DOI 10.1007/s12026-012-8304-8; Noriega VM, 2014, J VIROL, V88, P9391, DOI 10.1128/JVI.00934-14; Oliveira CC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00298; PARHAM P, 1979, J IMMUNOL, V123, P342; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Praest P, 2019, MOL IMMUNOL, V113, P103, DOI 10.1016/j.molimm.2018.03.020; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Sengupta D, 2019, EMBO J, V38, DOI 10.15252/embj.201899266; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Silvin A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8071; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Uger RA, 1997, J IMMUNOL, V158, P685; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Whitney PG, 2018, J VIROL, V92, DOI 10.1128/JVI.01508-17; Wu SJ, 2017, CELL REP, V19, P2645, DOI 10.1016/j.celrep.2017.06.013; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	59	9	9	1	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					497	+		10.1038/s41590-021-00903-7	http://dx.doi.org/10.1038/s41590-021-00903-7		MAR 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33790474	Green Accepted			2022-12-18	WOS:000635521900001
J	Malarkannan, S				Malarkannan, Subramaniam			NKG7 makes a better killer	NATURE IMMUNOLOGY			English	Editorial Material							CELLS; EXPRESSION; PROTEIN; GENES	New studies suggest that NKG7 is essential for NK and CD8(+)T cell cytotoxic degranulation and CD4(+)T cell activation and proinflammatory responses. While the mechanism is yet to be determined, the functional relevance is exciting and opens the possibility of a new target for cellular immunotherapies.	[Malarkannan, Subramaniam] Versiti, Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI 53233 USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Malarkannan, S (corresponding author), Versiti, Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI 53233 USA.; Malarkannan, S (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.; Malarkannan, S (corresponding author), Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.; Malarkannan, S (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	smalarkannan@versiti.org		Malarkannan, Subramaniam/0000-0002-7511-2731	NCI NIH HHS [R01 CA179363] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Hahtola S, 2006, CLIN CANCER RES, V12, P4812, DOI 10.1158/1078-0432.CCR-06-0532; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Ng SS, 2020, NAT IMMUNOL, V21, P1205, DOI 10.1038/s41590-020-0758-6; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; SHIMANE M, 1994, BIOCHEM BIOPH RES CO, V199, P26, DOI 10.1006/bbrc.1994.1187; Shimane M, 1999, J LEUKOCYTE BIOL, V65, P109, DOI 10.1002/jlb.65.1.109; TURMAN MA, 1993, HUM IMMUNOL, V36, P34, DOI 10.1016/0198-8859(93)90006-M; van Es LA, 2008, KIDNEY INT, V73, P1426, DOI 10.1038/ki.2008.66; Yang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11947-7	10	9	9	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1139	1140		10.1038/s41590-020-0767-5	http://dx.doi.org/10.1038/s41590-020-0767-5		AUG 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32839609				2022-12-18	WOS:000562393000003
J	Gong, T; Zhou, RB				Gong, Tao; Zhou, Rongbin			ApoC3: an 'alarmin' triggering sterile inflammation	NATURE IMMUNOLOGY			English	Editorial Material							DYSFUNCTION		[Gong, Tao; Zhou, Rongbin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Sch Basic Med Sci,Div Life Sci & Med, Hefei, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, RB (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Sch Basic Med Sci,Div Life Sci & Med, Hefei, Peoples R China.; Zhou, RB (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei, Peoples R China.	zrb1980@ustc.edu.cn	Zhou, Rongbin/B-1430-2013	Gong, Tao/0000-0002-9414-6902				Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Gong T, 2018, TRENDS IMMUNOL, V39, P393, DOI 10.1016/j.it.2018.01.009; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Luo L, 2020, J LEUKOCYTE BIOL, V107, P251, DOI 10.1002/JLB.2MA0819-138RR; Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022; Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; Tang TT, 2018, TRENDS PHARMACOL SCI, V39, P798, DOI 10.1016/j.tips.2018.07.002; Zewinger S, 2020, NAT IMMUNOL, V21, P30, DOI 10.1038/s41590-019-0548-1	12	9	9	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					9	11		10.1038/s41590-019-0562-3	http://dx.doi.org/10.1038/s41590-019-0562-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31822868				2022-12-18	WOS:000515136500007
J	Winkler, R; Gillis, E; Lasman, L; Safra, M; Geula, S; Soyris, C; Nachshon, A; Tai-Schmiedel, J; Friedman, N; Vu, TKLT; Trilling, M; Mandelboim, M; Hanna, JH; Schwartz, S; Stern-Ginossar, N				Winkler, Roni; Gillis, Ella; Lasman, Lior; Safra, Modi; Geula, Shay; Soyris, Clara; Nachshon, Aharon; Tai-Schmiedel, Julie; Friedman, Nehemya; Vu Thuy Khanh Le-Trilling; Trilling, Mirko; Mandelboim, Michal; Hanna, Jacob H.; Schwartz, Schraga; Stern-Ginossar, Noam			m6A modification controls the innate immune response to infection by targeting type I interferons (vol 20, pg 173, 2018)	NATURE IMMUNOLOGY			English	Correction													Lasman, Lior/ABH-9947-2020; Trilling, Mirko/AAL-3533-2021	Trilling, Mirko/0000-0003-3659-3541				Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z	1	9	9	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					243	243		10.1038/s41590-019-0314-4	http://dx.doi.org/10.1038/s41590-019-0314-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7AY	30635652	Bronze			2022-12-18	WOS:000458890300002
J	Schultze, JL				Schultze, Joachim L.			Myocardial infarction cell by cell	NATURE IMMUNOLOGY			English	Editorial Material							CARDIAC MACROPHAGES; STEADY-STATE	While important evidence for the role of myeloid cells in myocardial infarction has accumulated in recent years, single-cell transcriptomics fully delineates the functional heterogeneity of the myeloid cell compartment.	[Schultze, Joachim L.] Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci LIMES Inst, Bonn, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis, PRECISE Platform Single Cell Genom & Epigen, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, West German Genome Ctr, Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Schultze, JL (corresponding author), Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci LIMES Inst, Bonn, Germany.; Schultze, JL (corresponding author), German Ctr Neurodegenerat Dis, PRECISE Platform Single Cell Genom & Epigen, Bonn, Germany.; Schultze, JL (corresponding author), Univ Bonn, Bonn, Germany.; Schultze, JL (corresponding author), Univ Bonn, West German Genome Ctr, Bonn, Germany.	j.schultze@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020	Schultze, Joachim L./0000-0003-2812-9853				Adlung L, 2018, NAT REV IMMUNOL, V18, P597, DOI 10.1038/s41577-018-0050-2; Dick S. A., 2018, NAT IMMUNOL, DOI [10.1038/s41559-018-0272-2, DOI 10.1038/S41559-018-0272-2]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gomez Ingrid, 2018, Front Cardiovasc Med, V5, P134, DOI 10.3389/fcvm.2018.00134; Ma YG, 2018, TRANSL RES, V191, P15, DOI 10.1016/j.trsl.2017.10.001; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a; Schultze JL, 2019, SEMIN CELL DEV BIOL, V86, P15, DOI 10.1016/j.semcdb.2018.02.017; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009	10	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					7	9		10.1038/s41590-018-0277-x	http://dx.doi.org/10.1038/s41590-018-0277-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538327				2022-12-18	WOS:000456273900009
J	Zhu, JF				Zhu, Jinfang			Mysterious ILC2 tissue adaptation	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; SUBSETS		[Zhu, Jinfang] NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Nakanishi K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00763; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012	12	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1042	1044		10.1038/s41590-018-0214-z	http://dx.doi.org/10.1038/s41590-018-0214-z			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30201993				2022-12-18	WOS:000445968600008
J	Manz, MG				Manz, Markus G.			Plasmacytoid dendritic cells: origin matters	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW; IN-VIVO; MACROPHAGES; PROGENITOR; HOMEOSTASIS; MONOCYTES; IMMUNITY; TISSUE	Plasmacytoid dendritic cells (pDCs) are type I interferon-producing cells with antigen-presenting potential. pDC populations are composed of transcriptionally and functionally heterogeneous cellular subsets with distinct hematopoietic precursor origin.	[Manz, Markus G.] Univ Zurich, Dept Hematol & Oncol, Zurich, Switzerland; [Manz, Markus G.] Univ Hosp Zurich, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Manz, MG (corresponding author), Univ Zurich, Dept Hematol & Oncol, Zurich, Switzerland.; Manz, MG (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	markus.manz@usz.ch		Manz, Markus/0000-0002-4676-7931				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Fernandes P. R., 2018, NAT IMMUNOL, DOI [10.1038/s41590-018-0136-9, DOI 10.1038/S41590-018-0136-9]; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020	13	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					652	654		10.1038/s41590-018-0143-x	http://dx.doi.org/10.1038/s41590-018-0143-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925994				2022-12-18	WOS:000436341300009
J	Yang, C; Suda, T				Yang, Chong; Suda, Toshio			Hyperactivated mitophagy in hematopoietic stem cells	NATURE IMMUNOLOGY			English	Editorial Material							PARKIN; MITOCHONDRIA; CLEARANCE; AUTOPHAGY; INTERACTS; PROMOTES		[Yang, Chong; Suda, Toshio] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore, Singapore; [Suda, Toshio] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan	National University of Singapore; Kumamoto University	Suda, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore, Singapore.; Suda, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	csits@nus.edu.sg		Yang, Chong/0000-0003-0325-3970	Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Baudier J, 2017, BIOL REV CAMB PHILOS; Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Jin G., 2017, NAT IMMUNOL; Joshi A, 2013, AUTOPHAGY, V9, P1737, DOI 10.4161/auto.26681; Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1; Kohli L, 2014, TRENDS CELL BIOL, V24, P479, DOI 10.1016/j.tcb.2014.04.001; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Vazquez-Martin A, 2016, AGING-US, V8, P1330, DOI 10.18632/aging.100976; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022	16	9	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					2	3		10.1038/s41590-017-0008-8	http://dx.doi.org/10.1038/s41590-017-0008-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242545				2022-12-18	WOS:000419765300005
J	Togashi, Y; Nishikawa, H				Togashi, Yosuke; Nishikawa, Hiroyoshi			Suppression from beyond the grave	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; IMMUNOTHERAPY; CANCER	Adenosine produced by apoptotic regulatory T cells (T-reg cells) has a more important immunosuppressive role in the tumor microenvironment than that of live Treg cells. This discovery raises the possibility of novel strategies for cancer immunotherapy.	[Togashi, Yosuke; Nishikawa, Hiroyoshi] Natl Canc Ctr, Div Canc Immunol, Res Inst, EPOC, Tokyo, Japan; [Nishikawa, Hiroyoshi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan	National Cancer Center - Japan; Nagoya University	Nishikawa, H (corresponding author), Natl Canc Ctr, Div Canc Immunol, Res Inst, EPOC, Tokyo, Japan.; Nishikawa, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan.	hnishika@ncc.go.jp	Nishikawa, Hiroyoshi/AAI-7044-2020		Grants-in-Aid for Scientific Research [17J09900] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Dahan R, 2016, CANCER CELL, V30, P369, DOI 10.1016/j.ccell.2016.08.007; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Togashi Y, 2017, CURR TOP MICROBIOL I; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003	13	9	9	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1285	1286		10.1038/ni.3870	http://dx.doi.org/10.1038/ni.3870			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144496				2022-12-18	WOS:000415324900006
J	Hinterleitner, R; Jabri, B				Hinterleitner, Reinhard; Jabri, Bana			A dendritic cell subset designed for oral tolerance	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; REG-CELLS	Studies using genetic tools have identified the distinct dendritic cell subsets that ensure tolerance to oral antigens in the antigen-rich environment of the gut and suggest a 'division of labor' for protective immunity.	[Hinterleitner, Reinhard; Jabri, Bana] Univ Chicago, Dept Med, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Hinterleitner, Reinhard/N-7091-2019					Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Du Pre MF, 2011, GASTROENTEROLOGY, V141, P610, DOI 10.1053/j.gastro.2011.04.048; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Martinez-Lopez M, 2015, EUR J IMMUNOL, V45, P119, DOI 10.1002/eji.201444651; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Veenbergen S, 2016, MUCOSAL IMMUNOL, V9, P894, DOI 10.1038/mi.2015.118; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	12	9	11	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					474	476		10.1038/ni.3435	http://dx.doi.org/10.1038/ni.3435			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092796				2022-12-18	WOS:000374323100003
J	[Anonymous]				[Anonymous]			The lungs at the frontlines of immunity	NATURE IMMUNOLOGY			English	Editorial Material																			0	9	9	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					17	17		10.1038/ni.3069	http://dx.doi.org/10.1038/ni.3069			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521680	Bronze			2022-12-18	WOS:000346494200004
J	Dustin, ML; Davis, SJ				Dustin, Michael L.; Davis, Simon J.			TCR signaling: the barrier within	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-ACTIVATION; TRANSMEMBRANE ADAPTER; KINASE CSK; PROTEIN; MOTIF; CBP	Acute inhibition of the regulatory kinase Csk reveals additional checkpoints for full activation of thymocytes via the T cell antigen receptor.	[Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Dustin, Michael L.] Univ Oxford, Nuffield Dept Orthoped & Musculoskeletal Sci, Oxford, England; [Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford, England; [Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Clin Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.	michael.dustin@kennedy.ox.ac.uk	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	Medical Research Council [MC_UU_12010/4] Funding Source: Medline; NIAID NIH HHS [R37 AI043542] Funding Source: Medline; Wellcome Trust [100262, 098274] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013	17	9	9	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					136	137		10.1038/ni.2811	http://dx.doi.org/10.1038/ni.2811			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448571	Green Accepted			2022-12-18	WOS:000330150600005
J	Kaur, S; Platanias, LC				Kaur, Surinder; Platanias, Leonidas C.			IFN-beta-specific signaling via a unique IFNAR1 interaction	NATURE IMMUNOLOGY			English	Editorial Material							I INTERFERON RECEPTOR; TYROSINE PHOSPHORYLATION; PROTEIN; SUBUNITS; ALPHA		[Kaur, Surinder; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kaur, Surinder; Platanias, Leonidas C.] Jesse Brown Virginia Med Ctr, Dept Med, Chicago, IL USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kaur, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	l-platanias@northwestern.edu						ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Ezella SA, 2012, P NATL ACAD SCI USA, V109, pE613, DOI 10.1073/pnas.1115029109; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P23630, DOI 10.1074/jbc.271.39.23630; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014	15	9	10	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					884	885		10.1038/ni.2686	http://dx.doi.org/10.1038/ni.2686			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959176				2022-12-18	WOS:000323377700002
J	Hayden, MS				Hayden, Matthew S.			A less-canonical, canonical NF-kappa B pathway in DCs	NATURE IMMUNOLOGY			English	News Item							RELB; LIPOPOLYSACCHARIDE	Mathematical modeling shows that two members of the NF-kappa B family of transcription factors, RelB and p50, form heterodimers and participate in the canonical NF-kappa B pathway in dendritic cells.	[Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA; [Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA	Columbia University; Columbia University	Hayden, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA.	mh3046@columbia.edu		Hayden, Matthew/0000-0003-1670-6430	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR058886] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hofer S, 2001, MICROBES INFECT, V3, P259, DOI 10.1016/S1286-4579(01)01378-8; Neumann M, 1996, J IMMUNOL, V157, P4862; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x	10	9	11	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1139	1141		10.1038/ni.2476	http://dx.doi.org/10.1038/ni.2476			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160209				2022-12-18	WOS:000311217900005
J	Bram, RJ				Bram, Richard J.			TBK1 suppression of IgA in the NIK of time	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNITY	The kinase TBK1 participates in signaling pathways that induce antimicrobial responses. TBK1 is also necessary for the suppression of excessive production of immunoglobulin A by accelerating destruction of the kinase NIK.	Mayo Clin Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA	Mayo Clinic	Bram, RJ (corresponding author), Mayo Clin Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	bramr@mayo.edu						Chorny A, 2010, ADV IMMUNOL, V107, P31, DOI [10.1016/S0065-2776(10)07006-9, 10.1016/B978-0-12-381300-8.00002-2]; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362	13	9	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1027	1029		10.1038/ni.2451	http://dx.doi.org/10.1038/ni.2451			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23080194				2022-12-18	WOS:000310091700002
J	Takeuchi, O				Takeuchi, Osamu			IRF3: a molecular switch in pathogen responses	NATURE IMMUNOLOGY			English	Editorial Material							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; LISTERIA-MONOCYTOGENES; RESISTANCE; INFECTION; INDUCTION; IMMUNITY	Antiviral innate immunity often has deleterious effects on the course of bacterial infection. Activation of the transcription factor IRF3 induced by the recognition of double-stranded RNA by RIG-I-like receptors suppresses the Toll-like receptor-induced expression of interleukins 12 and 23 and antibacterial responses.	Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 606, Japan	Kyoto University	Takeuchi, O (corresponding author), Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 606, Japan.	otake@virus.kyoto-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019	Takeuchi, Osamu/0000-0002-1260-6232				Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	15	9	12	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					634	635		10.1038/ni.2346	http://dx.doi.org/10.1038/ni.2346			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713822				2022-12-18	WOS:000305483800007
J	Moynagh, PN				Moynagh, Paul N.			Peli1 (rel)ieves autoimmunity	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION	T cell tolerance is essential to the prevention of autoimmunity. The ubiquitin E3 ligase Peli1 acts as a negative regulator of T cell activation and contributes to the maintenance of self-tolerance.	Natl Univ Ireland, Inst Immunol, Maynooth, Kildare, Ireland	Maynooth University	Moynagh, PN (corresponding author), Natl Univ Ireland, Inst Immunol, Maynooth, Kildare, Ireland.	paul.moynagh@nuim.ie		Moynagh, Paul/0000-0002-4139-3061				Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Liu YL, 2004, J BIOL CHEM, V279, P37436, DOI 10.1074/jbc.M400241200; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; SMITH H, 2009, BIOCHEM J, V434, P537; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Venuprasad K, 2010, CANCER RES, V70, P3009, DOI 10.1158/0008-5472.CAN-09-4076	11	9	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					927	929		10.1038/ni.2108	http://dx.doi.org/10.1038/ni.2108			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934671	Green Accepted			2022-12-18	WOS:000295084500006
J	Bjorkhem, I; Diczfalusy, U; Olsson, T; Russell, DW; McDonald, JG; Wang, YQ; Griffiths, WJ				Bjorkhem, Ingemar; Diczfalusy, Ulf; Olsson, Tomas; Russell, David W.; McDonald, Jeffery G.; Wang, Yuqin; Griffiths, William J.			Detecting oxysterols in the human circulation	NATURE IMMUNOLOGY			English	Letter									[Bjorkhem, Ingemar; Diczfalusy, Ulf] Karolinska Univ Hosp Huddinge, Dept Lab Med, Karolinska Inst, Huddinge, Sweden; [Olsson, Tomas] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Solna, Sweden; [Russell, David W.; McDonald, Jeffery G.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Wang, Yuqin; Griffiths, William J.] Swansea Univ, Inst Mass Spectrometry, Sch Med, Swansea, W Glam, Wales	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Swansea University	Bjorkhem, I (corresponding author), Karolinska Univ Hosp Huddinge, Dept Lab Med, Karolinska Inst, Huddinge, Sweden.	ingemar.bjorkhem@karolinska.se	Griffiths, William/N-4641-2016; Diczfalusy, Ulf/A-5336-2008	Griffiths, William/0000-0002-4129-6616; Bjorkhem, Ingemar/0000-0002-0575-9425; Olsson, Tomas/0000-0002-2938-1877; Bjorkhem, Ingemar/0000-0001-6087-9190; wang, yuqin/0000-0002-3063-3066; Russell, David/0000-0002-0277-403X; Diczfalusy, Ulf/0000-0001-6643-3763				Bjorkhem I, 2011, J LIPID RES, V52, P170, DOI 10.1194/jlr.D011072; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Griffiths WJ, 2008, J PROTEOME RES, V7, P3602, DOI 10.1021/pr8001639; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5	5	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					577	577		10.1038/ni0711-577a	http://dx.doi.org/10.1038/ni0711-577a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685947	Bronze			2022-12-18	WOS:000291936400001
J	Van Stry, M; Bix, M				Van Stry, Melanie; Bix, Mark			Explaining discordant coordination	NATURE IMMUNOLOGY			English	Editorial Material							LOCUS ACCESSIBILITY; HISTONE ACETYLATION; CYTOKINE GENES; MAST-CELLS; EXPRESSION; IL-4; DIFFERENTIATION; GATA-3	T(H)2 cells control immune responses to helminth infection and contribute to the development of allergic asthma. A single intronic enhancer element in Il4 can regulate T(H)2 differentiation and susceptibility to allergic asthma via interaction with the transcription factor GATA-3.	[Van Stry, Melanie; Bix, Mark] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Van Stry, M (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	mark.bix@stjude.org		Bix, Mark/0000-0003-4617-0497; Van Stry, Melanie/0000-0002-4722-2407				Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Kelso A, 1999, INT IMMUNOL, V11, P617, DOI 10.1093/intimm/11.4.617; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966	13	9	9	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					16	17		10.1038/ni0111-16	http://dx.doi.org/10.1038/ni0111-16			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21170001				2022-12-18	WOS:000285465100008
J	[Anonymous]				[Anonymous]			Reduce, Refine, Replace	NATURE IMMUNOLOGY			English	Editorial Material																			0	9	9	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					971	971		10.1038/ni1110-971	http://dx.doi.org/10.1038/ni1110-971			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959796	Bronze			2022-12-18	WOS:000283127800001
J	Sims, JE				Sims, John E.			Accessory to inflammation	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTORS; IL-1RACP	IL-1 signaling requires a heterotrimeric complex of IL-1 receptor, its homolog IL-1RAcP and ligand. The crystal structure of this complex has now been solved, with implications for signaling by many IL-1 family members.	Inflammat Res, Seattle, WA USA		Sims, JE (corresponding author), Inflammat Res, Seattle, WA USA.	sims@amgen.com		Sims, John/0000-0002-5667-9185				Boraschi Diana, 1996, Frontiers in Bioscience (online), V1, pD270; Casadio R, 2001, FEBS LETT, V499, P65, DOI 10.1016/S0014-5793(01)02515-7; Guo CM, 1999, BIOCHEMISTRY-US, V38, P1618, DOI 10.1021/bi982068l; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925	7	9	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					883	885		10.1038/ni1010-883	http://dx.doi.org/10.1038/ni1010-883			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20856217				2022-12-18	WOS:000281926900005
J	Godfrey, DI; Rossjohn, J; McCluskey, J				Godfrey, Dale I.; Rossjohn, Jamie; McCluskey, James			Fighting infection with your MAITs	NATURE IMMUNOLOGY			English	Editorial Material							INVARIANT T-CELLS; REPERTOIRE; CERAMIDE; TCR	Mucosal-associated invariant T cells are evolutionarily conserved T lymphocytes with undefined antigen specificity. These cells are now shown to have a unique role in host defense by targeting highly conserved microbial antigens.	[Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem, Clayton, Vic 3168, Australia	University of Melbourne; Monash University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	godfrey@unimelb.edu.au	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Godfrey, Dale/0000-0002-3009-5472				Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Okamoto N, 2005, CHEM BIOL, V12, P677, DOI 10.1016/j.chembiol.2005.04.014; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Peterfalvi A, 2008, INT IMMUNOL, V20, P1517, DOI 10.1093/intimm/dxn111; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013	12	9	9	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					693	695		10.1038/ni0810-693	http://dx.doi.org/10.1038/ni0810-693			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644577				2022-12-18	WOS:000280149400008
J	Bousso, P; Albert, ML				Bousso, Philippe; Albert, Matthew L.			Signal 0 for guided priming of CTLs: NKT cells do it too	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; HELP; ANTIGENS	The cross-priming of antigen-specific CD8(+) T cells requires help. The mechanism by which natural killer T cells provide such help is now characterized.	[Bousso, Philippe; Albert, Matthew L.] Inst Pasteur, Dept Immunol, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bousso, P (corresponding author), Inst Pasteur, Dept Immunol, F-75724 Paris, France.	albertm@pasteur.fr	BOUSSO, Philippe/M-6547-2014; Albert, Matthew L/C-9782-2009	BOUSSO, Philippe/0000-0002-6362-561X; 				Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Blachere NE, 2006, J IMMUNOL, V176, P7288, DOI 10.4049/jimmunol.176.12.7288; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	13	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					284	286		10.1038/ni0410-284	http://dx.doi.org/10.1038/ni0410-284			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300136				2022-12-18	WOS:000275849500006
J	Cruz-Munoz, ME; Veillette, A				Cruz-Munoz, Mario-Ernesto; Veillette, Andre			Do NK cells always need a license to kill?	NATURE IMMUNOLOGY			English	Editorial Material							INHIBITORY RECEPTORS; SELF-TOLERANCE; CLASS-I; MOLECULES	The ability of natural killer cells to eliminate abnormal cells has been shown to be enhanced by triggering of certain inhibitory receptors during their maturation. New data show that sometimes the opposite can happen.	[Cruz-Munoz, Mario-Ernesto; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Cruz-Munoz, ME (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca						Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478	8	9	10	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					279	280		10.1038/ni0410-279	http://dx.doi.org/10.1038/ni0410-279			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300133				2022-12-18	WOS:000275849500003
J	Lee-Theilen, M; Chaudhuri, J				Lee-Theilen, Mieun; Chaudhuri, Jayanta			Walking the AID tightrope	NATURE IMMUNOLOGY			English	Editorial Material							GENE-EXPRESSION; B-CELLS; DEAMINASE; TRANSLOCATIONS; PROMOTER	The mutator activation-induced cytidine deaminase is essential for immunoglobulin diversification but can be detrimental in other settings. A new comprehensive analysis investigates how its gene expression is regulated.	[Lee-Theilen, Mieun; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Lee-Theilen, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	chaudhuj@mskcc.org			NIAID NIH HHS [R01 AI072194] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen-Mahrt SK, 2009, J MOL MED, V87, P893, DOI 10.1007/s00109-009-0496-6; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007	15	9	10	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					107	109		10.1038/ni0210-107	http://dx.doi.org/10.1038/ni0210-107			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084065				2022-12-18	WOS:000273730200004
J	Saveliev, A; Tybulewicz, VLJ				Saveliev, Alexander; Tybulewicz, Victor L. J.			Lymphocyte signaling: beyond knockouts	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; PHOSPHOINOSITIDE 3-KINASE P85-ALPHA; ADAPTER PROTEIN SLP-76; IMPAIRED B-CELL; THYMOCYTE DEVELOPMENT; MUTATION; MICE; LAT; ZAP-70; ACTIVATION	The analysis of lymphocyte signaling was greatly enhanced by the advent of gene targeting, which allows the selective inactivation of a single gene. Although this gene 'knockout' approach is often informative, in many cases, the phenotype resulting from gene ablation might not provide a complete picture of the function of the corresponding protein. If a protein has multiple functions within a single or several signaling pathways, or stabilizes other proteins in a complex, the phenotypic consequences of a gene knockout may manifest as a combination of several different perturbations. In these cases, gene targeting to 'knock in' subtle point mutations might provide more accurate insight into protein function. However, to be informative, such mutations must be carefully based on structural and biophysical data.	[Saveliev, Alexander; Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Tybulewicz, VLJ (corresponding author), Natl Inst Med Res, MRC, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	vtybule@nimr.mrc.ac.uk		Saveliev, Alexander/0000-0003-0840-4774; Tybulewicz, Victor/0000-0003-2439-0798	MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Okkenhaug K, 2002, SCIENCE, V297, P1031; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Zha YY, 2008, J IMMUNOL METHODS, V331, P94, DOI 10.1016/j.jim.2007.11.013; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	37	9	9	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					361	364		10.1038/ni.1709	http://dx.doi.org/10.1038/ni.1709			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295633	Green Accepted			2022-12-18	WOS:000264425800007
J	Freitas, AA; Rocha, B				Freitas, Antonio A.; Rocha, Benedita			Homeostasis of naive T cells: the Foxo that fixes	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTORS; MIGRATION	The transcription factor Foxo1 regulates the homeostasis of naive peripheral T cells by 'translating' nutrient-availability signals into the expression of lymphoid tissue-homing molecules and the receptor for interleukin 7.	[Freitas, Antonio A.] Inst Pasteur, Unites Rech Associees 1961, CNRS, Lymphocyte Populat Biol Unit, F-75015 Paris, France; [Rocha, Benedita] Univ Paris 05, Inst Federatif Rech 94, U591, INSERM, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Freitas, AA (corresponding author), Inst Pasteur, Unites Rech Associees 1961, CNRS, Lymphocyte Populat Biol Unit, 25 Rue Dr Roux, F-75015 Paris, France.	benedita.rocha@inserm.fr	freitas, antonio/A-2482-2013	Hedrick, Stephen/0000-0002-6345-8751; freitas, antonio/0000-0001-6392-7178				Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017	12	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					133	134		10.1038/ni0209-133	http://dx.doi.org/10.1038/ni0209-133			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148194				2022-12-18	WOS:000263178500003
J	Burrows, PD; Fischer, A				Burrows, Peter D.; Fischer, Alain			Building networks for immunodeficiency diseases and immunology training	NATURE IMMUNOLOGY			English	Editorial Material							MICE	The RIKEN Research Center for Allergy and Immunology in Japan is reaching out regionally to the primary immunodeficiency disease community and internationally to graduate students and postdoctoral fellows.	[Burrows, Peter D.] Univ Alabama, Birmingham, AL 35294 USA; [Fischer, Alain] Univ Paris 05, Hop Necker Enfants Malad, Inst Natl Sante & Rech Med, Unit 768, F-75015 Paris, France	University of Alabama System; University of Alabama Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Burrows, PD (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.	peterb@uab.edu						Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; Gordon CJ, 2001, CURR OPIN PHARMACOL, V1, P431, DOI DOI 10.1016/S1471-4892(01)00074-1; Ishikawa F, 2008, CURR TOP MICROBIOL, V324, P87; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017	8	9	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1005	1007		10.1038/ni0908-1005	http://dx.doi.org/10.1038/ni0908-1005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711439				2022-12-18	WOS:000258559600009
J	Hume, DA				Hume, David A.			Bring out your dead	NATURE IMMUNOLOGY			English	Editorial Material							APOPTOTIC CELLS; DROSOPHILA; RECEPTOR	Phagocytosis of apoptotic cells by macrophages occurs through recognition of specific molecules on the surfaces of apoptotic cells by receptors on macrophages. Three recent studies add to the understanding of this process.	[Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.	d.hume@imb.uq.edu.au	Hume, David A/C-7695-2013	Hume, David/0000-0002-2615-1478				AITCUFELLA H, 2007, CIRCULATION, V115, P2168; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huh JR, 2007, J BIOL CHEM, V282, P2056, DOI 10.1074/jbc.M608051200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; OVCHINNIKOV DA, 2007, J LEUKOC BIOL; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; SCHLEGEL RA, 2007, SCI STKE, pPE57; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016	13	9	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					12	14		10.1038/ni0108-12	http://dx.doi.org/10.1038/ni0108-12			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087250				2022-12-18	WOS:000251820800006
J	Lederman, MM; Sieg, SF				Lederman, Michael M.; Sieg, Scott F.			CCR5 and its ligands: a new axis of evil?	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE ACTIVATION; HIV-INFECTION; CCL3L1	Many additional effects in HIV pathogenesis are now described for the chemokine receptor CCR5, long recognized as an important coreceptor for HIV, and its ligand CCL3L1.	Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Lederman, MM (corresponding author), Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA.	mxl6@case.edu	Sieg, Scott/AAV-2429-2021					Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Murphy, 2003, FUNDAMENTAL IMMUNOLO, P801; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; SILVESTRI G, IN PRESS J CLIN INVE	11	9	10	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1283	1285		10.1038/ni1207-1283	http://dx.doi.org/10.1038/ni1207-1283			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026077				2022-12-18	WOS:000251267000006
J	Unanue, ER				Unanue, Emil R.			From antigen processing to peptide-MHC binding	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL HYBRIDOMAS; IMMUNOGENIC PEPTIDES; OVALBUMIN PEPTIDE; IMMUNE RESPONSE; LYMPHOCYTES-T; IA; MACROPHAGES; IDENTIFICATION; RECOGNITION	Emil R. Unanue recounts his seminal work 25 years ago demonstrating that antigens are phagocytosed and processed by antigen-presenting cells and that class 11 major histocompatibility complex molecules are peptide-binding proteins.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	unanue@pathbox.wustl.edu						Allen PM, 2006, J IMMUNOL, V177, P1369, DOI 10.4049/jimmunol.177.3.1369; ALLEN PM, 1984, J IMMUNOL, V132, P1077; ALLEN PM, 1984, P NATL ACAD SCI-BIOL, V81, P2489, DOI 10.1073/pnas.81.8.2489; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; ASKONAS BA, 1968, B SOC CHIM BIOL, V50, P1113; BABBITT BP, 1986, P NATL ACAD SCI USA, V83, P4509, DOI 10.1073/pnas.83.12.4509; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BENACERRAF B, 1981, SCIENCE, V212, P1229, DOI 10.1126/science.6165083; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; BUUS S, 1986, P NATL ACAD SCI USA, V83, P3968, DOI 10.1073/pnas.83.11.3968; KATZ ME, 1982, EUR J IMMUNOL, V12, P535, DOI 10.1002/eji.1830120702; MCDEVITT HO, 1969, SCIENCE, V163, P1207, DOI 10.1126/science.163.3872.1207; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; ZIEGLER K, 1981, J IMMUNOL, V127, P1869; ZINKERNAGEL RM, 1974, NATURE, V251, P230, DOI 10.1038/251230a0	21	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1277	1279		10.1038/ni1206-1277	http://dx.doi.org/10.1038/ni1206-1277			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110945				2022-12-18	WOS:000242125200007
J	Goutagny, N; Severa, M; Fitzgerald, KA				Goutagny, Nadege; Severa, Martina; Fitzgerald, Katherine A.			Pin-ning down immune responses to RNA viruses	NATURE IMMUNOLOGY			English	Editorial Material							PROLYL ISOMERIZATION; PHOSPHORYLATION; PATHWAY; LGP2	To prevent RNA virus-dependent tissue damage caused by interferon-regulatory factor 3 (IRF3)-induced type I interferons, proteasome-dependent destruction of IRF3 is orchestrated by the cytoplasmic prolyl isomerase Pin1.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Goutagny, N (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	SEVERA, MARTINA/J-8782-2016; Fitzgerald, Katherine/ABE-6317-2020	SEVERA, MARTINA/0000-0002-0411-4545; Fitzgerald, Kate/0000-0003-3175-609X				Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Obata Y, 2005, J BIOL CHEM, V280, P18355, DOI 10.1074/jbc.M501684200; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	12	9	10	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					555	557		10.1038/ni0606-555	http://dx.doi.org/10.1038/ni0606-555			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715065				2022-12-18	WOS:000237751200008
J	Spies, T; Groh, V				Spies, T; Groh, V			Natural cytotoxicity receptors: influenza virus in the spotlight	NATURE IMMUNOLOGY			English	Editorial Material							KILLER-CELLS; RECOGNITION; ACTIVATION; INFECTION; NKP46; NKP30	NKp46, an activating receptor expressed on natural killer cells, protects from lethal influenza virus infection. Contrary to prevailing views, involvement of NKp46 in tumor immunity is uncertain.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Spies, T (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	tspies@fhcrc.org						ALSHEIKHLY AR, 1985, SCAND J IMMUNOL, V22, P529, DOI 10.1111/j.1365-3083.1985.tb01912.x; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Bot A, 1996, J VIROL, V70, P5668, DOI 10.1128/JVI.70.8.5668-5672.1996; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Siren J, 2004, J GEN VIROL, V85, P2357, DOI 10.1099/vir.0.80105-0; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207	12	9	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					443	444		10.1038/ni0506-443	http://dx.doi.org/10.1038/ni0506-443			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622429	Bronze			2022-12-18	WOS:000237008800007
J	Fontenot, JD; Rasmussen, JP; Gavin, MA; Rudensky, AY				Fontenot, JD; Rasmussen, JP; Gavin, MA; Rudensky, AY			A function for interleukin 2 in Foxp3-expressing regulatory T cells (vol 6, pg 1142, 2005)	NATURE IMMUNOLOGY			English	Correction																		Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263	1	9	9	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					427	427		10.1038/ni0406-427b	http://dx.doi.org/10.1038/ni0406-427b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX		Bronze			2022-12-18	WOS:000236171000018
J	Peterlin, BM				Peterlin, BM			Nef: out and in?	NATURE IMMUNOLOGY			English	Editorial Material							HIV-1 NEF; INFECTED CELLS; T-CELLS; REPLICATION; EXPRESSION		Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.	matija@itsa.ucsf.edu						Choi J, 2005, J VIROL, V79, P264, DOI 10.1128/JVI.79.1.264-276.2005; Costa LJ, 2004, J VIROL, V78, P5311, DOI 10.1128/JVI.78.10.5311-5323.2004; Das SR, 2005, INDIAN J MED RES, V121, P315; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Harrer E, 2005, ANTIVIR THER, V10, P285; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7	13	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					229	230		10.1038/ni0306-229	http://dx.doi.org/10.1038/ni0306-229			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482168				2022-12-18	WOS:000235360400005
J	Jacobsen, SEW				Jacobsen, SEW			Defining 'stemness': Notch and Wnt join forces?	NATURE IMMUNOLOGY			English	Editorial Material							IN-VIVO; CELLS; EXPANSION	Self-renewal of hematopoietic stem cells allows life-long production of blood cells. Notch signaling is critically involved in this process by maintaining a pool of self-renewing hematopoietic stem cells.	Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden	Lund University	Jacobsen, SEW (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden.	sten.jacobsen@stemcell.lu.se	Jacobsen, Sten Eirik W/D-3974-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659				Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; YANG L, 2004, BLOOD           1130	12	9	10	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					234	236		10.1038/ni0305-234	http://dx.doi.org/10.1038/ni0305-234			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716971				2022-12-18	WOS:000227117400007
J	Poland, GA; Marcuse, EK				Poland, GA; Marcuse, EK			Vaccine availability in the US: problems and solutions	NATURE IMMUNOLOGY			English	Editorial Material								The present shortage in the US influenza vaccine supply has finally focused public attention on recurrent problems faced by public health officials in ensuring the availability of many vaccines.	Mayo Clin, Coll Med, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Program Translat Immunovirol & Biodefense, Rochester, MN 55905 USA; Univ Washington, Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Univ Washington, Dept Pediat, Seattle, WA 98105 USA	Mayo Clinic; Mayo Clinic; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Poland, GA (corresponding author), Mayo Clin, Coll Med, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu						Batson A, 2003, VACCINE BOOK, P345; *I MED DIV HLTH PR, 2000, CALL SHOTS IMM FIN P; *I MED NAT AC BOAR, 2003, FIN VACC 21 CENT ASS; *I MED NAT AC SCI, 2000, VACC 21 CENT TOOL DE; PAULEY M, 1996, SUPPLYING VACCINE EC; Peter G, 2003, JAMA-J AM MED ASSOC, V290, P3122; STEFFY CAP, 2004, BIOPROCESS INT, V2, P48; Wilson CB, 2001, NAT REV IMMUNOL, V1, P160, DOI 10.1038/35100585; 2002, NAT IMMUNOL, V3, P695	9	9	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1195	1198		10.1038/ni1204-1195	http://dx.doi.org/10.1038/ni1204-1195			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549115				2022-12-18	WOS:000225353500003
J	Watanabe, Y				Watanabe, Y			Fifty years of interference	NATURE IMMUNOLOGY			English	Letter									Kyoto Univ, Dept Mol Microbiol, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Watanabe, Y (corresponding author), Kyoto Univ, Dept Mol Microbiol, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	watanabe@pharm.kyoto-u.ac.jp						ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; NAGANO Y, 1954, CR SOC BIOL, V148, P1700; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981	4	9	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1193	1193		10.1038/ni1204-1193	http://dx.doi.org/10.1038/ni1204-1193			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549114	Bronze			2022-12-18	WOS:000225353500002
J	Ashton-Rickardt, PG				Ashton-Rickardt, PG			A license to remember	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; CD40 EXPRESSION; DENDRITIC CELLS; CUTTING EDGE; MEMORY; IMMUNITY; HELP		Univ Chicago, Ben May Inst Canc Res, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Dept Pathol, Comm Dev Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ashton-Rickardt, PG (corresponding author), Univ Chicago, Ben May Inst Canc Res, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	pashtonr@midway.uchicago.edu						Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105	12	9	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1097	1098		10.1038/ni1104-1097	http://dx.doi.org/10.1038/ni1104-1097			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496944				2022-12-18	WOS:000224692700002
J	Silverman, N; Fitzgerald, K				Silverman, N; Fitzgerald, K			DUBbing down innate immunity	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; ACTIVATION; UBIQUITINATION; PATHWAY; KINASE; RIP1; A20	The innate inflammatory immune response must be finely tuned to avoid excessive damage to the host. One molecule, A20, is intricately involved in dampening inflammatory signals mediated by both tumor necrosis factor and multiple Toll-like receptors.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; Silverman, Neal/0000-0002-4259-456X				Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lakhani SR, 2004, NEW ENGL J MED, V350, P187, DOI 10.1056/NEJMcibr032650; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	12	9	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1010	1012		10.1038/ni1004-1010	http://dx.doi.org/10.1038/ni1004-1010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454928				2022-12-18	WOS:000224156600016
J	Davis, M; Ben-Neriah, Y				Davis, M; Ben-Neriah, Y			Behind the scenes of anergy: a tale of three E3s	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; UBIQUITIN	Anergy induction initiates a transcription program involving the upregulation of several ubiquitin ligases (E3s). New data show how these E3s contribute to the establishment of anergy.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Davis, M (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel.	yinon@cc.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019					Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Krawczyk C, 2001, TRENDS CELL BIOL, V11, P212, DOI 10.1016/S0962-8924(01)01981-X; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110	12	9	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					238	240		10.1038/ni0304-238	http://dx.doi.org/10.1038/ni0304-238			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985708				2022-12-18	WOS:000189344600004
J	Springer, TA				Springer, TA			Cesar Milstein, the father of modern immunology - In memoriam	NATURE IMMUNOLOGY			English	Biographical-Item									Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.							MILSTEIN C, PUBLICATION LIST	1	9	9	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					501	503		10.1038/ni0602-501	http://dx.doi.org/10.1038/ni0602-501			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032559				2022-12-18	WOS:000175874700004
J	Bendelac, A; Teyton, L; Savage, PB				Bendelac, A; Teyton, L; Savage, PB			Lipid presentation by CDI: the short and the long lipid story	NATURE IMMUNOLOGY			English	Editorial Material							LIPOGLYCAN ANTIGENS; MOLECULES; CD1B; GLYCOLIPIDS		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Princeton University; Scripps Research Institute; Brigham Young University	Bendelac, A (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Savage, Paul B/HGB-3414-2022; Savage, Paul B/E-1448-2011	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109				Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Mukherjee S, 2000, TRAFFIC, V1, P203, DOI 10.1034/j.1600-0854.2000.010302.x; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X	9	9	11	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					421	422		10.1038/ni0502-421	http://dx.doi.org/10.1038/ni0502-421			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976717				2022-12-18	WOS:000175411200008
J	Schaller, M; Benoit, VM; Ditzel, HJ				Schaller, M; Benoit, VM; Ditzel, HJ			Few human autoimmune sera detect GPI - Response	NATURE IMMUNOLOGY			English	Letter							ARTHRITIS		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Schaller, M (corresponding author), Scripps Res Inst, Dept Immunol, IMM2,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hditzel@scripps.edu		Ditzel, Henrik J./0000-0003-3927-5135				Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696	2	9	10	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					412	413		10.1038/ni0502-412	http://dx.doi.org/10.1038/ni0502-412			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU					2022-12-18	WOS:000175411200004
J	Rocha, B				Rocha, B			Requirements for memory maintenance	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL MEMORY; ANTIGEN; EXPRESSION; NAIVE	Maintenance of a memory cell population is thought to be independent of antigen. However, it has now been shown that unless memory cells get some signals via MHC, they become functionally defective.	Inst Necker, INSERM, U345, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rocha, B (corresponding author), Inst Necker, INSERM, U345, F-75015 Paris, France.							HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; OFF GS, 1998, SCIENCE, V279, P2103; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907	13	9	9	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					209	210		10.1038/ni0302-209	http://dx.doi.org/10.1038/ni0302-209			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875455				2022-12-18	WOS:000174074000004
J	Gavin, MA; Rudensky, AY				Gavin, MA; Rudensky, AY			Dual TCRT cells: gaining entry into the periphery	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL; RECEPTOR; EXPRESSION; ACTIVATION; INCLUSION; COMPLEX; PEPTIDE	T cells bearing two different TCRs can be detrimental because the unselected TCR has the potential to cause autoimmunity. Evidence is now emerging that the unselected TCR may also be beneficial by expanding the TCR repertoire for foreign antigens.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Gavin, MA (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.							BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; MURRAY JS, 1992, EUR J IMMUNOL, V22, P559, DOI 10.1002/eji.1830220239; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	12	9	9	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					109	110		10.1038/ni0202-109	http://dx.doi.org/10.1038/ni0202-109			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812982				2022-12-18	WOS:000173562400006
J	Silverstein, AM				Silverstein, AM			Whatever happened to cell-bound antibodies? On the overriding influence of dogma	NATURE IMMUNOLOGY			English	Editorial Material								For over 75 years, only humoral antibodies were known to mediate immunological specificity. The apparent absence of these in delayed-type hypersensitivity reactions was perplexing, and the dominant dogma of antibodies led to some curious hypotheses.	Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Silverstein, AM (corresponding author), Johns Hopkins Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.							Amos Bernard, 1963, CELL BOUND ANTIBODIE; Behring E., 1892, Z HYG, V12, P45; BEHRING E, 1892, Z HYG, V12, P10; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; BENACERRAF B, 1962, J EXP MED, V115, P1023, DOI 10.1084/jem.115.5.1023; BENACERRAF B, 1959, IMMUNOLOGY, V2, P53; BILLINGHAM RE, 1954, PROC R SOC SER B-BIO, V143, P58, DOI 10.1098/rspb.1954.0054; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BOREK E, 1963, P SOC EXP BIOL MED, V114, P266; Brent L., 1997, HIST TRANSPLANTATION, P74; BRUTON OC, 1952, PEDIATRICS, V9, P722; CHASE MW, 1945, P SOC EXP BIOL MED, V59, P134, DOI 10.3181/00379727-59-15006P; Claman H N, 1969, Transplant Rev, V1, P92; CONE RE, 1974, BIOCHEM J, V1430, P345; Cooper M.D., 1967, IMMUNOLOGICAL DEFICI, P7; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DIENES L., 1929, AMER REV TUBERC, V20, P92; Dienes L, 1929, J IMMUNOL, V17, P531; Dienes L, 1932, AM J PATHOL, V8, P689; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; FELDMANN M, 1972, IMMUNOL REV, V13, P3; Freund J, 1942, P SOC EXP BIOL MED, V49, P548; GELL PGH, 1962, J EXP MED, V115, P1037; GELL PGH, 1959, IMMUNOLOGY, V2, P64; GELL PGH, 1961, ADV IMMUNOL, V1, P319, DOI 10.1016/S0065-2776(08)60768-3; GELL PGH, 1954, INT ARCH ALLER A IMM, V5, P23, DOI 10.1159/000228084; GELL PGH, 1951, BRIT J EXP PATHOL, V32, P516; GLANZMANN E, 1950, Ann Paediatr, V175, P1; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; GOOD RA, 1956, PEDIATRICS, V18, P109; GOOD RA, 1962, J EXP MED, V116, P773, DOI 10.1084/jem.116.5.773; GOOD RA, 1959, MECHANISMS HYPERSENS, P467; JANEWAY CA, 1957, ADV PEDIATR, V9, P65; JANKOVIC BD, 1962, J EXP MED, P159; Kabat E.A., 1968, STRUCTURAL CONCEPTS; KARUSH F, 1962, SCIENCE, V136, P1032, DOI 10.1126/science.136.3521.1032; Kuhn T, 2012, STRUCTURE SCI REVOLU, V4th, DOI DOI 10.7208/CHICAGO/9780226458144.001.0001; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; Landsteiner K., 1962, SPECIFICITY SEROLOGI; LAWRENCE HS, 1955, J CLIN INVEST, V34, P219, DOI 10.1172/JCI103075; MARCHALONIS JJ, 1972, NATURE-NEW BIOL, V235, P240, DOI 10.1038/newbio235240a0; Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X; MEDAWAR P B, 1956, Harvey Lect, P144; MEDAWAR PB, 1959, CELLULAR HUMORAL ASP, P504; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Metchnikoff I., 1884, VIRCHOWS ARCH, V96, P177; MILLER JF, 1961, LANCET, V2, P748; MITCHISON NA, 1954, PROC R SOC SER B-BIO, V142, P72, DOI 10.1098/rspb.1954.0007; MITCHISON NA, 1969, IMMUNOLOGICAL TOLERA, P115; NEZELOF C., 1964, ARCH FRANC PEDIAT, V21, P897; PAPPENHEIMER AM, 1959, MECHANISMS HYPERSENS, P417; Pressman D, 1968, STRUCTURAL BASIS ANT; RICH A, 1944, PATHOGENESIS TUBERCU, P404; Rich AR, 1940, B JOHNS HOPKINS HOSP, V66, P106; RICH AR, 1946, HARVEY LECT, V42, P106; Rich AR., 1944, PATHOGENESIS TUBERCU; Rich Arnold, 1944, PATHOGENESIS TUBERCU, P509; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; SELVIN SB, 1958, J EXP MED, V107, P109; SELVIN SF, 1960, J EXP MED, V111, P465; Silverstein AM, 2000, SEMIN IMMUNOL, V12, P173, DOI 10.1006/smim.2000.0228; SILVERSTEIN AM, 1979, CELL IMMUNOL, V48, P208, DOI 10.1016/0008-8749(79)90113-8; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; SILVERSTEIN AM, 1966, J IMMUNOL, V96, P953; SILVERSTEIN AM, 1962, J EXP MED, V115, P1053, DOI 10.1084/jem.115.5.1053; TURK JL, 1967, DELAYED HYPERSENSITI; UHR JW, 1958, J EXP MED, V108, P891, DOI 10.1084/jem.108.6.891; VITTETA ES, 1973, P NATL ACAD SCI USA, V70, P834; VITTETA ES, 1972, J EXP MED, V136, P81; WAKSMAN BH, 1958, J IMMUNOL, V81, P220; WAKSMAN BH, 1959, INT ARCH ALLER A I S, V4, P10; WEAVER JM, 1955, J NATL CANCER I, V15, P1737; Weiser R.S., 1963, CELL BOUND ANTIBODIE, P72; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X; Zinsser H., 1914, INFECT RESISTANCE, P443; ZINSSER H, 1914, INFECT RESISTANCE, P366	77	9	9	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					105	108		10.1038/ni0202-105	http://dx.doi.org/10.1038/ni0202-105			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812981				2022-12-18	WOS:000173562400005
J	Anderson, H; Hiltbold, E; Roche, P				Anderson, H; Hiltbold, E; Roche, P			Rafts for antigen presentation? Response	NATURE IMMUNOLOGY			English	Letter									NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anderson, H (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.							Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Huby R, 2001, NAT IMMUNOL, V2, P3, DOI 10.1038/83154; Huby RDJ, 1999, J BIOL CHEM, V274, P22591, DOI 10.1074/jbc.274.32.22591	3	9	9	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					3	3		10.1038/83156	http://dx.doi.org/10.1038/83156			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135566	Bronze			2022-12-18	WOS:000166261500003
J	Dower, SK				Dower, SK			Cytokines, virokines and the evolution of immunity	NATURE IMMUNOLOGY			English	News Item							SOLUBLE RECEPTOR; VACCINIA VIRUS; PROTEIN; INTERLEUKIN-1; HOMOLOG		Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Dower, SK (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England.			dower, steve/0000-0002-4675-4225				ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; SYMONS JA, 1991, J EXP MED, V174, P1251, DOI 10.1084/jem.174.5.1251	10	9	9	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					367	368		10.1038/80799	http://dx.doi.org/10.1038/80799			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062490				2022-12-18	WOS:000165076100004
J	van der Merwe, PA				van der Merwe, PA			Modeling costimulation	NATURE IMMUNOLOGY			English	News Item							T-CELL RECEPTOR; CD28-DEFICIENT MICE; ANTIGEN	T cell activation usually requires TCR engagement by antigen and another, costimulatory, signal. Modeling studies now indicate that this second signal may only slightly enhance TCR signaling, but nevertheless results in an exponential increase in cell numbers.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		van der Merwe, P. Anton/F-8539-2011					Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; BLUESTONE JA, 2000, FUNDAMENTAL IMMUNOLO; Detours V, 2000, J IMMUNOL, V164, P121, DOI 10.4049/jimmunol.164.1.121; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	17	9	9	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					194	195		10.1038/79729	http://dx.doi.org/10.1038/79729			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973274				2022-12-18	WOS:000089815100009
J	Christofides, A; Strauss, L; Yeo, A; Cao, C; Charest, A; Boussiotis, VA				Christofides, Anthos; Strauss, Laura; Yeo, Alan; Cao, Carol; Charest, Alain; Boussiotis, Vassiliki A.			The complex role of tumor-infiltrating macrophages	NATURE IMMUNOLOGY			English	Review							MYELOID CELLS; PATROLLING MONOCYTES; IMMUNE CHECKPOINT; PD-1 EXPRESSION; INFLAMMATION; ACTIVATION; METASTASIS; REVEALS; POLARIZATION; HOMEOSTASIS	Boussiotis and colleagues review the hallmarks of tumor-associated macrophages and discuss the mechanisms that contribute to their pathophysiological adaptations to the tumor microenvironment. Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being re-discovered as regulators of several diseases, including cancer. Tumor-associated macrophages (TAMs) represent the most abundant innate immune population in the tumor microenvironment (TME). Macrophages are professional phagocytic cells of the hematopoietic system specializing in the detection, phagocytosis and destruction of bacteria and other harmful micro-organisms, apoptotic cells and metabolic byproducts. In contrast to these healthy macrophage functions, TAMs support cancer cell growth and metastasis and mediate immunosuppressive effects on the adaptive immune cells of the TME. Cancer is one of the most potent insults on macrophage physiology, inducing changes that are intimately linked with disease progression. In this Review, we outline hallmarks of TAMs and discuss the emerging mechanisms that contribute to their pathophysiological adaptations and the vulnerabilities that provide attractive targets for therapeutic exploitation in cancer.	[Christofides, Anthos; Strauss, Laura; Cao, Carol; Boussiotis, Vassiliki A.] Harvard Med Sch, Div Hematol Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Christofides, Anthos; Strauss, Laura; Cao, Carol; Charest, Alain; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Christofides, Anthos; Strauss, Laura; Yeo, Alan; Charest, Alain; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Ctr, Boston, MA 02115 USA; [Cao, Carol] Harvard Univ, Cambridge, MA USA; [Strauss, Laura] Sanofi Tidal, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Boussiotis, VA (corresponding author), Harvard Med Sch, Div Hematol Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.; Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.; Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Ctr, Boston, MA 02115 USA.	vboussio@bidmc.harvard.edu			NIH [R01CA238263, R01CA229784]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01CA238263 (V.A.B.) and R01CA229784 (A. Charest and V.A.B.).	Artyomov MN, 2020, CELL METAB, V32, P710, DOI 10.1016/j.cmet.2020.09.013; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Ban Y, 2017, CANCER RES, V77, P2857, DOI 10.1158/0008-5472.CAN-16-2913; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bene K, 2021, FEBS OPEN BIO, V11, P3218, DOI 10.1002/2211-5463.13269; Boussiotis VA, 2018, ONCOGENE, V37, P1121, DOI 10.1038/s41388-017-0024-z; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen L, 2016, CANCER RES, V76, P6828, DOI 10.1158/0008-5472.CAN-16-1114; Chen W, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.33; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Cho EA, 2021, STRUCTURE, V29, P320, DOI 10.1016/j.str.2020.11.011; Christofides A, 2021, METABOLISM, V114, DOI 10.1016/j.metabol.2020.154338; Dangaj D, 2013, CANCER RES, V73, P4820, DOI 10.1158/0008-5472.CAN-12-3457; Di Conza G, 2021, NAT IMMUNOL, V22, P1403, DOI 10.1038/s41590-021-01047-4; Di Virgilio F, 2018, NAT REV CANCER, V18, P601, DOI 10.1038/s41568-018-0037-0; Dixon KO, 2021, NATURE, V595, P101, DOI 10.1038/s41586-021-03626-9; Donadon M, 2020, J EXP MED, V217, DOI 10.1084/jem.20191847; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Friebel E, 2020, CELL, V181, P1626, DOI 10.1016/j.cell.2020.04.055; Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841; Geeraerts X, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110171; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Gui P, 2018, CANCER IMMUNOL RES, V6, P1337, DOI 10.1158/2326-6066.CIR-17-0746; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hartley GP, 2018, CANCER IMMUNOL RES, V6, P1260, DOI 10.1158/2326-6066.CIR-17-0537; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hubel P, 2019, NAT IMMUNOL, V20, P493, DOI 10.1038/s41590-019-0323-3; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Jayasingam SD, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01512; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Kubo H, 2017, CANCER IMMUNOL RES, V5, P812, DOI 10.1158/2326-6066.CIR-17-0082; Kumar V, 2016, IMMUNITY, V44, P303, DOI 10.1016/j.immuni.2016.01.014; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lecoultre M, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001408; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Libreros S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.631319; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Ma RY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191820; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2021, CELL MOL IMMUNOL, V18, P566, DOI 10.1038/s41423-020-00613-4; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matlung HL, 2017, IMMUNOL REV, V276, P145, DOI 10.1111/imr.12527; Matsumura H, 2014, INT J ONCOL, V45, P2303, DOI 10.3892/ijo.2014.2662; Mehta AK, 2021, NAT CANCER, V2, P66, DOI 10.1038/s43018-020-00148-7; Menga A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911210; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Mowat C, 2021, J EXP MED, V218, DOI 10.1084/jem.20210108; Nakamura K, 2017, IMMUNOL CELL BIOL, V95, P325, DOI 10.1038/icb.2016.126; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oh MH, 2020, J CLIN INVEST, V130, P3865, DOI 10.1172/JCI131859; Parada D, 2018, TUMOUR BIOL, V40, DOI [10.1177/1010428318810059, DOI 10.1177/1010428318810059]; Patsoukis N, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8298; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qorraj M, 2017, LEUKEMIA, V31, P470, DOI 10.1038/leu.2016.214; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Robinson A, 2021, TRENDS IMMUNOL, V42, P104, DOI 10.1016/j.it.2020.12.001; Schmid MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07387-4; Schmid MC, 2011, CANCER RES, V71, P6965, DOI 10.1158/0008-5472.CAN-11-0588; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seo WI, 2021, CANCER IMMUNOL IMMUN, V70, P3113, DOI 10.1007/s00262-021-02906-7; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sharma SK, 2015, J IMMUNOL, V194, P5529, DOI 10.4049/jimmunol.1403215; Shen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38362; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863; Su SC, 2018, CELL, V175, P442, DOI 10.1016/j.cell.2018.09.007; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Twum DYF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124267; Ubertini V, 2015, ONCOGENE, V34, P2493, DOI 10.1038/onc.2014.191; Veglia F, 2021, NAT REV IMMUNOL, V21, P485, DOI 10.1038/s41577-020-00490-y; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; West AJ, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.830350; WHO Classification of Tumours Editorial Board, 2021, CENTRAL NERVOUS SYST, V6; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhivaki D, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108381; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	120	8	8	45	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1148	1156		10.1038/s41590-022-01267-2	http://dx.doi.org/10.1038/s41590-022-01267-2		JUL 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35879449				2022-12-18	WOS:000829717100003
J	Bresser, K; Kok, L; Swain, AC; King, LA; Jacobs, L; Weber, TS; Perie, L; Duffy, KR; de Boer, RJ; Scheeren, FA; Schumacher, TN				Bresser, Kaspar; Kok, Lianne; Swain, Arpit C.; King, Lisa A.; Jacobs, Laura; Weber, Tom S.; Perie, Leila; Duffy, Ken R.; de Boer, Rob J.; Scheeren, Ferenc A.; Schumacher, Ton N.			Replicative history marks transcriptional and functional disparity in the CD8(+) T cell memory pool	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; PRECURSOR FREQUENCY; LINEAGE RELATIONSHIP; SELF-RENEWAL; EFFECTOR; DIFFERENTIATION; HOMEOSTASIS; GENERATION; SUBSETS; NUMBERS	Clonal expansion is a core aspect of T cell immunity. However, little is known with respect to the relationship between replicative history and the formation of distinct CD8(+) memory T cell subgroups. To address this issue, we developed a genetic-tracing approach, termed the DivisionRecorder, that reports the extent of past proliferation of cell pools in vivo. Using this system to genetically 'record' the replicative history of different CD8(+) T cell populations throughout a pathogen-specific immune response, we demonstrate that the central memory T (T-CM) cell pool is marked by a higher number of prior divisions than the effector memory T cell pool, owing to the combination of strong proliferative activity during the acute immune response and selective proliferative activity after pathogen clearance. Furthermore, by combining DivisionRecorder analysis with single-cell transcriptomics and functional experiments, we show that replicative history identifies distinct cell pools within the T-CM compartment. Specifically, we demonstrate that lowly divided T-CM cells display enriched expression of stem-cell-associated genes, exist in a relatively quiescent state, and are superior in eliciting a proliferative recall response upon activation. These data provide the first evidence that a stem-cell-like memory T cell pool that reconstitutes the CD8(+) T cell effector pool upon reinfection is marked by prior quiescence. Schumacher and colleagues have designed a reporter system that allows in vivo tracking of replicative history over many cell generations. Using this system to study acute T cell responses, they uncover substantial diversity in past division of central memory CD8(+) T cells and its link to cell state and recall potential.	[Bresser, Kaspar; Kok, Lianne; King, Lisa A.; Jacobs, Laura; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Swain, Arpit C.; de Boer, Rob J.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands; [Weber, Tom S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Weber, Tom S.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Perie, Leila] Univ PSL, Sorbonne Univ, Inst Curie, Lab Phys Chim Curie,CNRS,UMR168, Paris, France; [Duffy, Ken R.] Maynooth Univ, Hamilton Inst, Maynooth, Kildare, Ireland; [Scheeren, Ferenc A.] Leiden Univ, Dept Dermatol, Med Ctr, Leiden, Netherlands; [Schumacher, Ton N.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [King, Lisa A.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam UMC, Amsterdam, Netherlands	Netherlands Cancer Institute; Utrecht University; Walter & Eliza Hall Institute; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Maynooth University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Vrije Universiteit Amsterdam	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Scheeren, FA (corresponding author), Leiden Univ, Dept Dermatol, Med Ctr, Leiden, Netherlands.; Schumacher, TN (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	f.a.scheeren@lumc.nl; t.schumacher@nki.nl	Duffy, Ken/D-7955-2011; De Boer, Rob/B-6050-2011	Duffy, Ken/0000-0001-5587-9356; Scheeren, Ferenc/0000-0002-8304-9023; Kok, Lianne/0000-0002-0445-7548; De Boer, Rob/0000-0002-2130-691X; Bresser, Kaspar/0000-0001-7113-0476; Weber, Tom S/0000-0003-3836-3299; Swain, Arpit Chandan/0000-0002-7816-1053	ERC AdG Life-his-T [268733]; NWO [ALWOP.265]	ERC AdG Life-his-T; NWO(Netherlands Organization for Scientific Research (NWO))	We would like to thank M. C. Wolkers (Sanquin, Amsterdam), C. Gerlach (Karolinska Institute, Stockholm), and K. van Gisbergen (Sanquin, Amsterdam) for helpful discussions regarding experimental procedures and sharing biological material, and D. Merkler (University of Geneva, Geneva) for kindly providing the artLCMV-OVA. In addition, we would like to thank the NKI Genomics Core Facility and Flow Cytometry Core Facility for providing experimental support. This work was supported by ERC AdG Life-his-T (Grant agreement ID: 268733) to T.N.S. and an NWO grant (ALWOP.265) to R.J.d.B.	Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; An ZW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02785-6; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Davis FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13053; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Grassmann S, 2020, NAT IMMUNOL, V21, P1563, DOI 10.1038/s41590-020-00807-y; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Hwang LN, 2006, CANCER RES, V66, P1132, DOI 10.1158/0008-5472.CAN-05-1679; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Kok L, 2020, J EXP MED, V217, DOI 10.1084/jem.20191711; Koole W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt615; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kretschmer L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13788-w; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sergushichev AA., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shlush LI, 2012, BLOOD, V120, P603, DOI 10.1182/blood-2011-10-388629; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Tempany JC, 2018, IMMUNOL CELL BIOL, V96, P149, DOI 10.1111/imcb.1020; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Weber TS, 2016, J MATH BIOL, V73, P491, DOI 10.1007/s00285-015-0963-3; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144	53	8	8	3	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					791	+		10.1038/s41590-022-01171-9	http://dx.doi.org/10.1038/s41590-022-01171-9		APR 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35393592	Green Submitted, Green Accepted			2022-12-18	WOS:000779779200001
J	Choe, K; Hontani, Y; Wang, TY; Hebert, E; Ouzounov, DG; Lai, K; Singh, A; Beguelin, W; Melnick, AM; Xu, C				Choe, Kibaek; Hontani, Yusaku; Wang, Tianyu; Hebert, Eric; Ouzounov, Dimitre G.; Lai, Kristine; Singh, Ankur; Beguelin, Wendy; Melnick, Ari M.; Xu, Chris			Intravital three-photon microscopy allows visualization over the entire depth of mouse lymph nodes	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; IN-VIVO; CELL TRAFFICKING; FLUORESCENCE MICROSCOPY; DEEP; EXPRESSION; STRATEGIES; DYNAMICS; MOTILITY; IMMUNITY	Intravital confocal microscopy and two-photon microscopy are powerful tools to explore the dynamic behavior of immune cells in mouse lymph nodes (LNs), with penetration depth of similar to 100 and similar to 300 mu m, respectively. Here, we used intravital three-photon microscopy to visualize the popliteal LN through its entire depth (600-900 mu m). We determined the laser average power and pulse energy that caused measurable perturbation in lymphocyte migration. Long-wavelength three-photon imaging within permissible parameters was able to image the entire LN vasculature in vivo and measure CD8(+) T cells and CD4(+) T cell motility in the T cell zone over the entire depth of the LN. We observed that the motility of naive CD4(+) T cells in the T cell zone during lipopolysaccharide-induced inflammation was dependent on depth. As such, intravital three-photon microscopy had the potential to examine immune cell behavior in the deeper regions of the LN in vivo.	[Choe, Kibaek; Hontani, Yusaku; Wang, Tianyu; Hebert, Eric; Ouzounov, Dimitre G.; Xu, Chris] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Lai, Kristine; Singh, Ankur] Cornell Univ, Coll Engn, Sch Mech Engn, Ithaca, NY USA; [Singh, Ankur] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Singh, Ankur] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Singh, Ankur] Emory Univ, Sch Med, Atlanta, GA USA; [Beguelin, Wendy; Melnick, Ari M.] Cornell Univ, Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Hontani, Yusaku] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Cornell University; Cornell University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Cornell University; University of Zurich	Choe, K; Xu, C (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	kc987@cornell.edu; cx10@cornell.edu	Xu, Chris/F-2703-2010; Choe, Kibaek/C-8027-2019	Xu, Chris/0000-0002-3493-6427; Wang, Tianyu/0000-0002-6087-6376; Singh, Ankur/0000-0002-3501-2277; Lai, Kristine/0000-0002-1950-0668; Choe, Kibaek/0000-0002-3068-6088; Hontani, Yusaku/0000-0001-8853-9454	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2019R1A6A3A03033817]; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [5R01AI132738-05]; NIH/National Cancer Institute [1R01CA238745-01A1]; University of Rochester School of Medicine and Dentistry; University of Rochester Program for Advanced Immune Bioimaging Pilot (NIH/National Institute of Allergy and Infectious Diseases ) [P01AI102851]; NSF [DBI1707312]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Rochester School of Medicine and Dentistry; University of Rochester Program for Advanced Immune Bioimaging Pilot (NIH/National Institute of Allergy and Infectious Diseases ); NSF(National Science Foundation (NSF))	We thank members of the Xu research group (B. Li, X. Yang, F. Xia, C. Wu, N. Akbari, A. T. Mok, A. K. LaViolette and S. Zhao) and H. M. Isles (Weill Cornell Medicine) for their help with valuable discussions. We thank N. Nishimura (Cornell University) and C.-Y. Eom (Cornell University) for providing the facility for performing lymphocyte isolation and cryosection. We thank K. A. Strednak and the Cornell Center for Animal Resources and Education for their animal care service. This research was supported from Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2019R1A6A3A03033817 to K.C.), NSF DBI1707312 Cornell NeuroNex Hub (to C.X.), National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases 5R01AI132738-05 (to A.S. and A.M.M.), NIH/National Cancer Institute 1R01CA238745-01A1 (to C.X. and A.S.), the University of Rochester Program for Advanced Immune Bioimaging Pilot (NIH/National Institute of Allergy and Infectious Diseases P01AI102851 to C.X.) and the University of Rochester School of Medicine and Dentistry.	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Baptista AP, 2019, IMMUNITY, V50, P1188, DOI 10.1016/j.immuni.2019.04.001; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chen BY, 2018, BIOMED OPT EXPRESS, V9, P1992, DOI 10.1364/BOE.9.001992; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Choe K, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202101086; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Guesmi K, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/s41377-018-0012-2; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Hontani Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf3531; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Horton NG, 2015, BIOMED OPT EXPRESS, V6, P1392, DOI 10.1364/BOE.6.001392; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Kim J, 2020, CYTOM PART A, V97, P496, DOI 10.1002/cyto.a.23937; Klioutchnikov A, 2020, NAT METHODS, V17, P509, DOI 10.1038/s41592-020-0817-9; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Li B, 2020, NAT METHODS, V17, P163, DOI 10.1038/s41592-019-0663-9; Liu HJ, 2019, NANO LETT, V19, P5260, DOI 10.1021/acs.nanolett.9b01708; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Park C, 2012, BLOOD, V119, P978, DOI 10.1182/blood-2011-06-364273; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodriguez C, 2018, OPT LETT, V43, P1914, DOI 10.1364/OL.43.001914; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Stoler-Barak L, 2019, J EXP MED, V216, P2515, DOI 10.1084/jem.20190789; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Takasaki K, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0255-19.2019; Tsai CK, 2012, BIOMED OPT EXPRESS, V3, P2234, DOI 10.1364/BOE.3.002234; Veerman K, 2019, CELL REP, V26, P3116, DOI 10.1016/j.celrep.2019.02.042; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wang MR, 2018, BIOMED OPT EXPRESS, V9, DOI 10.1364/BOE.9.003534; Wang TY, 2020, OPTICA, V7, P947, DOI 10.1364/OPTICA.395825; Wang TY, 2020, ELIFE, V9, DOI 10.7554/eLife.53205; Wang TY, 2018, NAT METHODS, V15, P789, DOI 10.1038/s41592-018-0115-y; Weigelin B, 2016, J CELL SCI, V129, P245, DOI 10.1242/jcs.152272; Weisenburger S, 2019, CELL, V177, P1050, DOI 10.1016/j.cell.2019.03.011; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Xu C., 2002, TOPICS FLUORESCENCE, V6, P471; Yildirim M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08179-6	54	8	8	12	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					330	+		10.1038/s41590-021-01101-1	http://dx.doi.org/10.1038/s41590-021-01101-1		JAN 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35087231				2022-12-18	WOS:000747646500001
J	Ayukawa, S; Kamoshita, N; Nakayama, J; Teramoto, R; Pishesha, N; Ohba, K; Sato, N; Kozawa, K; Abe, H; Semba, K; Goda, N; Fujita, Y; Maruyama, T				Ayukawa, Shiyu; Kamoshita, Nagisa; Nakayama, Jun; Teramoto, Ryohei; Pishesha, Novalia; Ohba, Kenji; Sato, Nanami; Kozawa, Kei; Abe, Hikari; Semba, Kentaro; Goda, Nobuhito; Fujita, Yasuyuki; Maruyama, Takeshi			Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; CLASS-I; TRANSFORMED-CELLS; CRYSTAL-STRUCTURE; HLA-G; PROMOTES; DIFFERENTIATION; MECHANISMS; MOLECULES; EXTRUSION	Epithelial cells have an ability termed 'cell competition', which is an immune surveillance-like function that extrudes precancerous cells from the epithelial layer, leading to apoptosis and clearance. However, it remains unclear how epithelial cells recognize and extrude transformed cells. Here, we discovered that a PirB family protein, leukocyte immunoglobulin-like receptor B3 (LILRB3), which is expressed on non-transformed epithelial cells, recognizes major histocompatibility complex class I (MHC class I) that is highly expressed on transformed cells. MHC class I interaction with LILRB3 expressed on normal epithelial cells triggers an SHP2-ROCK2 pathway that generates a mechanical force to extrude transformed cells. Removal of transformed cells occurs independently of natural killer (NK) cell or CD8(+) cytotoxic T cell-mediated activity. This is a new mechanism in that the immunological ligand-receptor system generates a mechanical force in non-immune epithelial cells to extrude precancerous cells in the same epithelial layer. Epithelial cells can use an immune-like mechanism to extrude neighboring precancerous cells; however, the recognition and control mechanisms of this process are unclear. Maruyama and colleagues demonstrate that LILRB3 on normal epithelial cells recognizes elevated MHC class I on transformed cells and triggers the extrusion process.	[Ayukawa, Shiyu; Nakayama, Jun; Teramoto, Ryohei; Abe, Hikari; Semba, Kentaro] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Kamoshita, Nagisa; Maruyama, Takeshi] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Pishesha, Novalia] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Ohba, Kenji] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan; [Sato, Nanami; Kozawa, Kei; Fujita, Yasuyuki] Hokkaido Univ, Inst Genet Med, Div Mol Oncol, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Fujita, Yasuyuki] Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Kyoto, Japan	Waseda University; Waseda University; Harvard University; Jichi Medical University; Hokkaido University; Kyoto University	Maruyama, T (corresponding author), Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.	tmaru@aoni.waseda.jp	Maruyama, Takeshi/T-7568-2019; Ohba, Kenji/D-8072-2015	Maruyama, Takeshi/0000-0003-0331-4702; Ohba, Kenji/0000-0002-4936-8186; Nakayama, Jun/0000-0001-8844-4295	Advanced Research & Development Programs for Medical Innovation (Prime) from the Japan Agency for Medical Research and Development (AMED) [21gm6210019h0001]; Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Agency, Japan Society for the Promotion of Science (JSPS) [JPMJPR168C, 18H02675]; Kato Memorial Bioscience Foundation; Naito Foundation; Takeda Science Foundation; Mitsubishi Foundation; Terumo Life Science Foundation; SGH Foundation; MSD Life Science Foundation	Advanced Research & Development Programs for Medical Innovation (Prime) from the Japan Agency for Medical Research and Development (AMED); Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Agency, Japan Society for the Promotion of Science (JSPS); Kato Memorial Bioscience Foundation; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation); SGH Foundation; MSD Life Science Foundation	This work was supported by Advanced Research & Development Programs for Medical Innovation (Prime) (grant number 21gm6210019h0001) from the Japan Agency for Medical Research and Development (AMED), the Precursory Research for Embryonic Science and Technology (PRESTO) (grant number JPMJPR168C) from the Japan Science and Technology Agency, Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) 18H02675, the Kato Memorial Bioscience Foundation, the Naito Foundation, the Takeda Science Foundation, the Mitsubishi Foundation, Terumo Life Science Foundation, SGH Foundation and MSD Life Science Foundation (to T.M.). We acknowledge J. Livet (Sorbonne University) for providing pPB infinity CAG-MCS vector.	Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; BICKNELL DC, 1994, P NATL ACAD SCI USA, V91, P4751, DOI 10.1073/pnas.91.11.4751; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chellaiah, 2012, MOL CANCER, V11; Douglass J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd5515; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Hilton HG, 2017, IMMUNOGENETICS, V69, P567, DOI 10.1007/s00251-017-1001-y; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isakov N, 1997, IMMUNOL RES, V16, P85, DOI 10.1007/BF02786325; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Javaherian A, 1998, CANCER RES, V58, P2200; Kajita M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5428; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kang XL, 2016, CELL CYCLE, V15, P25, DOI 10.1080/15384101.2015.1121324; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kon S, 2017, NAT CELL BIOL, V19, P530, DOI 10.1038/ncb3509; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li SQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15660-8; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Lin QB, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22755-3; Liu XY, 2015, ONCOTARGET, V6, P21004, DOI 10.18632/oncotarget.4217; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Maruyama T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101327; Maruyama T, 2017, CURR OPIN CELL BIOL, V48, P106, DOI 10.1016/j.ceb.2017.06.007; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miyamae J, 2018, IMMUNOGENETICS, V70, P237, DOI 10.1007/s00251-017-1031-5; Nakayama J, 2017, INT J ONCOL, V50, P497, DOI 10.3892/ijo.2016.3809; O'Donnell EP, 2006, CANCER LETT, V241, P197, DOI 10.1016/j.canlet.2005.10.012; Paul S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01124; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Schwartz M, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01398-y; Shao HF, 2018, BIOCHEM BIOPH RES CO, V506, P243, DOI 10.1016/j.bbrc.2018.09.114; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; STEINDOUGLAS KE, 1976, J EXP MED, V143, P822, DOI 10.1084/jem.143.4.822; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van der Touw W, 2017, CANCER IMMUNOL IMMUN, V66, P1079, DOI 10.1007/s00262-017-2023-x; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Watanabe H, 2018, CELL REP, V23, P3721, DOI 10.1016/j.celrep.2018.05.081; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Yamamoto M, 2017, NATURE, V542, P246, DOI 10.1038/nature21033; Yoh KE, 2016, P NATL ACAD SCI USA, V113, pE6107, DOI 10.1073/pnas.1613417113	55	8	8	2	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1391	+		10.1038/s41590-021-01045-6	http://dx.doi.org/10.1038/s41590-021-01045-6		OCT 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686865				2022-12-18	WOS:000710077900005
J	Liechti, T; Weber, LM; Ashhurst, TM; Stanley, N; Prlic, M; Van Gassen, S; Mair, F				Liechti, Thomas; Weber, Lukas M.; Ashhurst, Thomas M.; Stanley, Natalie; Prlic, Martin; Van Gassen, Sofie; Mair, Florian			An updated guide for the perplexed: cytometry in the high-dimensional era	NATURE IMMUNOLOGY			English	Article							FLOW-CYTOMETRY; VISUALIZATION	High-dimensional cytometry experiments measuring 20-50 cellular markers have become routine in many laboratories. The increased complexity of these datasets requires added rigor during the experimental planning and the subsequent manual and computational data analysis to avoid artefacts and misinterpretation of results. Here we discuss pitfalls frequently encountered during high-dimensional cytometry data analysis and aim to provide a basic framework and recommendations for reporting and analyzing these datasets.	[Liechti, Thomas] NIAID, NIH, Vaccine Res Ctr, Immunotechnol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Weber, Lukas M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Ashhurst, Thomas M.] Univ Sydney, Sydney Cytomet Core Res Facil, Charles Perkins Ctr, Sydney, NSW, Australia; [Ashhurst, Thomas M.] Cent Inst, Sydney, NSW, Australia; [Ashhurst, Thomas M.] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia; [Stanley, Natalie] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Prlic, Martin; Mair, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Van Gassen, Sofie] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Van Gassen, Sofie] VIB, Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Sydney; University of Sydney; Centenary Institute; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Ghent University; Flanders Institute for Biotechnology (VIB)	Mair, F (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	fmair@fredhutch.org		Liechti, Thomas/0000-0001-8738-6679; Weber, Lukas M./0000-0002-3282-1730; Mair, Florian/0000-0001-6732-5449; Ashhurst, Thomas/0000-0001-7269-7773; Van Gassen, Sofie/0000-0002-7119-5330; Prlic, Martin/0000-0002-0685-9321	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; National Institutes of Health (NIH) grant from the National Cancer Institute [R01CA237170]; NIH grant from the National Institute of Mental Health [U01MH122849]; Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation [CZF2019-002443]; NIH [R01AI123323, R21AI144677]; AAI Intersect Fellowship; FWO postdoctoral research grant (Research Foundation, Flanders)	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH) grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant from the National Institute of Mental Health; Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAI Intersect Fellowship; FWO postdoctoral research grant (Research Foundation, Flanders)	We thank M. Roederer (Vaccine Research Center, NIH) for critical reading and feedback. We thank D. Shinko and N. J. C. King for assistance in generating flow, spectral and mass cytometry data. T.L was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. L.M.W. was supported by the National Institutes of Health (NIH) grant R01CA237170 from the National Cancer Institute; NIH grant U01MH122849 from the National Institute of Mental Health to the Lieber Institute for Brain Development; and CZF2019-002443 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. M.P was supported by NIH grants R01AI123323 and R21AI144677. F.M was supported by an AAI Intersect Fellowship. S.V.G. was supported by an FWO postdoctoral research grant (Research Foundation, Flanders). T.L., T.M.A., S.V.G. and F.M. are ISAC Marylou Ingram Scholars.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Amezquita RA, 2020, NAT METHODS, V17, P137, DOI 10.1038/s41592-019-0654-x; Ashhurst T. M, CYTOM PART A, DOI [10.1002/cyto.a.24350(2021, DOI 10.1002/CYTO.A.24350(2021]; Ashhurst Thomas Myles, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.37; Brinkman RR, 2016, CYTOM PART A, V89A, P13, DOI 10.1002/cyto.a.22810; Ferrer-Font Laura, 2020, Curr Protoc Cytom, V92, pe70, DOI 10.1002/cpcy.70; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Kobak D, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-00809-z; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liechti T, 2019, CYTOM PART A, V95, P1129, DOI 10.1002/cyto.a.23853; Lucas F, 2020, CYTOM PART A, V97, P148, DOI 10.1002/cyto.a.23940; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mair F, 2019, METHODS MOL BIOL, V2032, P1, DOI 10.1007/978-1-4939-9650-6_1; Mair F, 2018, CYTOM PART A, V93A, P402, DOI 10.1002/cyto.a.23331; Nguyen R, 2013, CYTOM PART A, V83A, P306, DOI 10.1002/cyto.a.22251; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; O'Neill K, 2016, CYTOM PART A, V89A, P10, DOI 10.1002/cyto.a.22805; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Schuyler RP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02367; Van Gassen S, 2020, CYTOM PART A, V97, P268, DOI 10.1002/cyto.a.23904; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030	25	8	8	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1190	1197		10.1038/s41590-021-01006-z	http://dx.doi.org/10.1038/s41590-021-01006-z		SEP 2021	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34489590				2022-12-18	WOS:000692967100001
J	Alsuwaidi, AR; Al Hosani, FI; ElGhazli, G; al-Ramadi, BK				Alsuwaidi, Ahmed R.; Al Hosani, Farida I.; ElGhazli, Gehad; al-Ramadi, Basel K.			The COVID-19 response in the United Arab Emirates: challenges and opportunities	NATURE IMMUNOLOGY			English	Editorial Material								Like other countries in the region, the United Arab Emirates (UAE) was deeply affected by the pandemic. However, its foresight and proactive policies helped to create opportunities out of the challenges and spurred the development of trilateral collaborations involving government, academia and industry.	[Alsuwaidi, Ahmed R.] United Arab Emirates Univ, Dept Pediat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Al Hosani, Farida I.] Abu Dhabi Publ Hlth Ctr, Abu Dhabi, U Arab Emirates; [ElGhazli, Gehad] Sheikh Khalifa Med City Union 71, Abu Dhabi, U Arab Emirates; [ElGhazli, Gehad; al-Ramadi, Basel K.] United Arab Emirates Univ, Dept Med Microbiol & Immunol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [al-Ramadi, Basel K.] United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Alsuwaidi, AR (corresponding author), United Arab Emirates Univ, Dept Pediat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.; al-Ramadi, BK (corresponding author), United Arab Emirates Univ, Dept Med Microbiol & Immunol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.; al-Ramadi, BK (corresponding author), United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain, U Arab Emirates.	alsuwaidia@uaeu.ac.ae; ramadi.b@uaeu.ac.ae		Alsuwaidi, Ahmed/0000-0002-1187-522X					0	8	8	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1066	1067		10.1038/s41590-021-01000-5	http://dx.doi.org/10.1038/s41590-021-01000-5		JUL 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34316063	Bronze			2022-12-18	WOS:000677922000001
J	de Jong, SE; van Unen, V; Manurung, MD; Stam, KA; Goeman, JJ; Jochems, SP; Hollt, T; Pezzotti, N; Mouwenda, YD; Ongwe, MEB; Lorenz, FR; Kruize, YCM; Azimi, S; Konig, MH; Vilanova, A; Eisemann, E; Lelieveldt, BPF; Roestenberg, M; Sim, BKL; Reinders, MJT; Fendel, R; Hoffman, SL; Kremsner, PG; Koning, F; Mordmuller, B; Lell, B; Yazdanbakhsh, M				de Jong, Sanne E.; van Unen, Vincent; Manurung, Mikhael D.; Stam, Koen A.; Goeman, Jelle J.; Jochems, Simon P.; Hollt, Thomas; Pezzotti, Nicola; Mouwenda, Yoanne D.; Betouke Ongwe, Madeleine Eunice; Lorenz, Freia-Raphaella; Kruize, Yvonne C. M.; Azimi, Shohreh; Konig, Marion H.; Vilanova, Anna; Eisemann, Elmar; Lelieveldt, Boudewijn P. F.; Roestenberg, Meta; Sim, B. Kim Lee; Reinders, Marcel J. T.; Fendel, Rolf; Hoffman, Stephen L.; Kremsner, Peter G.; Koning, Frits; Mordmuller, Benjamin; Lell, Bertrand; Yazdanbakhsh, Maria			Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity	NATURE IMMUNOLOGY			English	Article							PLASMODIUM-FALCIPARUM SPOROZOITES; DIRECT VENOUS INOCULATION; DELTA-T-CELLS; PROTECTIVE EFFICACY; DENDRITIC CELLS; ACTIVATION; EXPRESSION; RESPONSES; IMMUNOGENICITY; ACCUMULATE	Controlled human infections provide opportunities to study the interaction between the immune system and malaria parasites, which is essential for vaccine development. Here, we compared immune signatures of malaria-naive Europeans and of Africans with lifelong malaria exposure using mass cytometry, RNA sequencing and data integration, before and 5 and 11 days after venous inoculation with Plasmodium falciparum sporozoites. We observed differences in immune cell populations, antigen-specific responses and gene expression profiles between Europeans and Africans and among Africans with differing degrees of immunity. Before inoculation, an activated/differentiated state of both innate and adaptive cells, including elevated CD161(+)CD4(+) T cells and interferon-gamma production, predicted Africans capable of controlling parasitemia. After inoculation, the rapidity of the transcriptional response and clusters of CD4(+) T cells, plasmacytoid dendritic cells and innate T cells were among the features distinguishing Africans capable of controlling parasitemia from susceptible individuals. These findings can guide the development of a vaccine effective in malaria-endemic regions. Malaria immunity can be acquired through natural infection, but the correlates of protection are still being determined. Yazdanbakhsh and colleagues combine experimental infection of volunteers with Plasmodium falciparum with systems analysis to throw light on the nature of protective immune responses.	[de Jong, Sanne E.; van Unen, Vincent; Manurung, Mikhael D.; Stam, Koen A.; Jochems, Simon P.; Mouwenda, Yoanne D.; Betouke Ongwe, Madeleine Eunice; Kruize, Yvonne C. M.; Azimi, Shohreh; Konig, Marion H.; Roestenberg, Meta; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Leiden Univ Ctr Infect Dis LU CID, Dept Parasitol, Leiden, Netherlands; [van Unen, Vincent; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands; [Goeman, Jelle J.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Hollt, Thomas; Pezzotti, Nicola; Vilanova, Anna; Eisemann, Elmar; Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Hollt, Thomas] Leiden Univ, Med Ctr, Computat Biol Ctr CBC, Leiden, Netherlands; [Mouwenda, Yoanne D.; Betouke Ongwe, Madeleine Eunice; Kremsner, Peter G.; Mordmuller, Benjamin; Lell, Bertrand] Ctr Med Res Lambarene CERMEL, Lambarene, Gabon; [Betouke Ongwe, Madeleine Eunice] Natl Ctr Sci & Technol Res CENAREST, Res Inst Trop Ecol IRET, Libreville, Gabon; [Lorenz, Freia-Raphaella; Fendel, Rolf; Kremsner, Peter G.; Mordmuller, Benjamin] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Lorenz, Freia-Raphaella; Fendel, Rolf; Kremsner, Peter G.; Mordmuller, Benjamin] German Ctr Infect Res, Partner Site Tubingen, Tubingen, Germany; [Lelieveldt, Boudewijn P. F.] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc LKEB, Leiden, Netherlands; [Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Reinders, Marcel J. T.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Lell, Bertrand] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [van Unen, Vincent] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Mordmuller, Benjamin] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; German Center for Infection Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Sanaria Inc.; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Medical University of Vienna; Stanford University; Radboud University Nijmegen	Yazdanbakhsh, M (corresponding author), Leiden Univ, Med Ctr, Leiden Univ Ctr Infect Dis LU CID, Dept Parasitol, Leiden, Netherlands.	M.Yazdanbakhsh@lumc.nl	Mordmüller, Benjamin/A-5749-2010; Manurung, Mikhael/AHE-1294-2022; Fendel, Rolf/K-3985-2013; Jochems, Simon/AAT-9156-2021; van Unen, Vincent/L-9105-2019; Roestenberg, Meta/AAP-9413-2021; Jochems, Simon/FFT-0345-2022; de Jong, Sanne/K-2242-2015; Goeman, Jelle/C-2260-2012	Mordmüller, Benjamin/0000-0001-9101-2768; Manurung, Mikhael/0000-0003-2728-1829; Fendel, Rolf/0000-0003-4716-0311; Jochems, Simon/0000-0002-4835-1032; van Unen, Vincent/0000-0001-9339-8430; Roestenberg, Meta/0000-0002-5052-2830; /0000-0001-8125-1650; de Jong, Sanne/0000-0002-6696-7359; Goeman, Jelle/0000-0003-4283-0259; Mouwenda, Yoanne Darelle/0000-0002-5827-419X; Betouke Ongwe, Madeleine Eunice/0000-0002-4206-1333; Stam, Koen/0000-0003-0982-4439; Koning, Frits/0000-0002-4007-5715	Leiden University Medical Center; German Ministry of Education and Research; Indonesian Endowment Fund for Education (Lembaga Pengelola Dana Pendidikan) of the Ministry of Finance, Republic of Indonesia [S-1598/LPDP.3/2016]; Bontius Stichting; Stichting Tabernaleporis; Leiden University Medical Center Strategic Fund; Sanaria Inc.; National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR [R01GM9987654]; EDCTP strategic primer grant [SP.2011.41304.062]; European Union [707404]	Leiden University Medical Center; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Indonesian Endowment Fund for Education (Lembaga Pengelola Dana Pendidikan) of the Ministry of Finance, Republic of Indonesia; Bontius Stichting; Stichting Tabernaleporis; Leiden University Medical Center Strategic Fund; Sanaria Inc.; National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR; EDCTP strategic primer grant; European Union(European Commission)	We thank the volunteers who participated in the trial; the trial staff, in particular A. A. Adegnika, J. Honkpehedji, J. Zinsou and C. Dejon-Agobe; and the LUMC Flow Cytometry Core Facility staff. We also thank the manufacturing, quality systems, regulatory, logistics, pharmaceutical operations, clinical, operations and legal teams at Sanaria for their contributions to the clinical trial. Furthermore, we thank H. Lima Mbenkep and N. Li for their help with the study and B. Everts, S. Khan, A. Luty and H. Smits for critically reading the manuscript. This work was supported by the Leiden University Medical Center excellent student funding (S.E.J.); the German Ministry of Education and Research in the framework of the German Center for Infection Research (P.G.K., B.M. and B.L.); the Indonesian Endowment Fund for Education (Lembaga Pengelola Dana Pendidikan) of the Ministry of Finance, Republic of Indonesia (reference no. S-1598/LPDP.3/2016) (M.D.M.); the Bontius Stichting (M.Y.); Stichting Tabernaleporis (M.Y.); Leiden University Medical Center Strategic Fund for Leiden Controlled Human Infection Center (M.Y. and M.R.); and Sanaria Inc. (B.K.L.S. and S.L.H.). Production of PfSPZ Challenge (NF54) by Sanaria was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR award no. R01GM9987654 (B.K.L.S. and S.L.H.). Slide reading training was provided through the EDCTP strategic primer grant SP.2011.41304.062 (S.L.H.). This project also received funding from LEaDing Fellows and the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement no. 707404 (S.P.J.). The opinions expressed in this document reflect only the authors' views. The European Commission is not responsible for any use that may be made of the information it contains. B.K.L.S. and S.L.H. have a financial interest in Sanaria Inc., which is the developer and owner of PfSPZ Challenge and the sponsor of the clinical trial. All other authors declare no competing interests.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bandyopadhyay K, 2016, CELL MOL IMMUNOL, V13, P337, DOI 10.1038/cmi.2015.115; Borrmann, 2020, MAPPING SAFE EARLY C, DOI 10.1101/2020.09.14.296152; Bowyer G, 2020, J EXP MED, V217, DOI 10.1084/jem.20200004; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; de Jong SE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09099-z; Dent AE, 2015, J INFECT DIS, V212, P1429, DOI 10.1093/infdis/jiv224; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Duffy PE, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0196-3; Felgner PL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03549; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Forconi CS, 2018, BLOOD ADV, V2, P1101, DOI 10.1182/bloodadvances.2017015404; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gomez-Perez GP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0817-x; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hollt T, 2016, COMPUT GRAPH FORUM, V35, P171, DOI 10.1111/cgf.12893; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Hur YG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-184; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jagannathan P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10624-3; Jongo SA, 2021, AM J TROP MED HYG, V104, P283, DOI 10.4269/ajtmh.20-0435; Jongo SA, 2018, AM J TROP MED HYG, V99, P338, DOI 10.4269/ajtmh.17-1014; Krasselt M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4321; Kurup SP, 2019, NAT REV IMMUNOL, V19, P457, DOI 10.1038/s41577-019-0158-z; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lell B, 2018, AM J TROP MED HYG, V98, P508, DOI 10.4269/ajtmh.17-0343; Mamedov MR, 2018, IMMUNITY, V48, P350, DOI 10.1016/j.immuni.2018.01.009; McCall MBB, 2018, SEMIN IMMUNOL, V39, P52, DOI 10.1016/j.smim.2018.08.002; McCall MBB, 2010, EUR J IMMUNOL, V40, P3472, DOI 10.1002/eji.201040587; McGee M, 2006, STAT APPL GENET MOL, V5, DOI 10.2202/1544-6115.1237; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Mordmuller B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0628-0; Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; OBIERO JM, 2019, MS PHERE; Obiero JM, 2015, INFECT IMMUN, V83, P2185, DOI 10.1128/IAI.03069-14; Pezzotti N, 2017, IEEE T VIS COMPUT GR, V23, P1739, DOI 10.1109/TVCG.2016.2570755; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rothen J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199392; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Shimizu K, 2014, P NATL ACAD SCI USA, V111, P12474, DOI 10.1073/pnas.1406240111; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Singh A, 2019, BIOINFORMATICS, V35, P3055, DOI 10.1093/bioinformatics/bty1054; Sundling C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126492; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Teirlinck AC, 2015, INFECT IMMUN, V83, P3732, DOI 10.1128/IAI.00473-15; Tran TM, 2019, IMMUNITY, V51, P750, DOI 10.1016/j.immuni.2019.08.009; Tran TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31291; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Urban EM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-50; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wager LE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02239; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wichers, 2020, COMMON VIRULENCE GEN, DOI 10.1101/2020.11.13.381137; Yang C, 2008, CELL DEATH DIFFER, V15, P530, DOI 10.1038/sj.cdd.4402287; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001; Zaidi I, 2017, J IMMUNOL, V199, P3781, DOI 10.4049/jimmunol.1700314	67	8	8	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					654	+		10.1038/s41590-021-00911-7	http://dx.doi.org/10.1038/s41590-021-00911-7		APR 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33888898	Bronze, Green Published			2022-12-18	WOS:000642385400002
J	Lopes, MF				F. Lopes, Marcela			From denial to hope: Brazil deals with a prolonged COVID-19 epidemic course	NATURE IMMUNOLOGY			English	Editorial Material								Brazil must strengthen science-based education to improve human development and responses to future public health threats.	[F. Lopes, Marcela] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Lopes, MF (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil.	marcelal@biof.ufrj.br	Lopes, Marcela Freitas/E-2201-2012	Lopes, Marcela Freitas/0000-0002-4508-0505					0	8	8	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					256	257		10.1038/s41590-021-00875-8	http://dx.doi.org/10.1038/s41590-021-00875-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627878	Bronze			2022-12-18	WOS:000621567200002
J	Johnson, RMG; Wen, T; Dong, HD				Johnson, Rachel M. Gibbons; Wen, Ti; Dong, Haidong			Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells	NATURE IMMUNOLOGY			English	Editorial Material							B7-H1	PD-L1 expressed by T cells provides backward and forward signals to restrain both innate and adaptive immune responses in tumor tissues.	[Johnson, Rachel M. Gibbons] Univ Minnesota, Biol Discipline, Morris, MN 56267 USA; [Wen, Ti; Dong, Haidong] Mayo Clin, Coll Med & Sci, Dept Urol, Rochester, MN 55905 USA; [Wen, Ti; Dong, Haidong] Mayo Clin, Coll Med & Sci, Dept Immunol, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Morris; Mayo Clinic; Mayo Clinic	Dong, HD (corresponding author), Mayo Clin, Coll Med & Sci, Dept Urol, Rochester, MN 55905 USA.; Dong, HD (corresponding author), Mayo Clin, Coll Med & Sci, Dept Immunol, Rochester, MN 55905 USA.	dong.haidong@mayo.edu		Dong, Haidong/0000-0002-5782-2983; Wen, Ti/0000-0002-6688-211X				Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 1999, NAT MED, V5, P1365; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Pulko V, 2011, J IMMUNOL, V187, P5606, DOI 10.4049/jimmunol.1003976; Saha A, 2016, J CLIN INVEST, V126, P2642, DOI 10.1172/JCI85796; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Tu XY, 2019, MOL CELL, V74, P1215, DOI 10.1016/j.molcel.2019.04.005	12	8	8	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					365	366		10.1038/s41590-020-0599-3	http://dx.doi.org/10.1038/s41590-020-0599-3		MAR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32152507				2022-12-18	WOS:000518737000001
J	Miller, BC; Sen, DR; Al Abosy, R; Bi, K; Virkud, YV; LaFleur, MW; Yates, KB; Lako, A; Felt, K; Naik, GS; Manos, M; Gjini, E; Kuchroo, JR; Ishizuka, JJ; Collier, JL; Griffin, GK; Maleri, S; Comstock, DE; Weiss, SA; Brown, FD; Panda, A; Zimmer, MD; Manguso, RT; Hodi, FS; Rodig, SJ; Sharpe, AH; Haining, WN				Miller, Brian C.; Sen, Debattama R.; Al Abosy, Rose; Bi, Kevin; Virkud, Yamini V.; LaFleur, Martin W.; Yates, Kathleen B.; Lako, Ana; Felt, Kristen; Naik, Girish S.; Manos, Michael; Gjini, Evisa; Kuchroo, Juhi R.; Ishizuka, Jeffrey J.; Collier, Jenna L.; Griffin, Gabriel K.; Maleri, Seth; Comstock, Dawn E.; Weiss, Sarah A.; Brown, Flavian D.; Panda, Arpit; Zimmer, Margaret D.; Manguso, Robert T.; Hodi, F. Stephen; Rodig, Scott J.; Sharpe, Arlene H.; Haining, W. Nicholas			Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade (vol 20, pg 326, 2019)	NATURE IMMUNOLOGY			English	Correction														Al Abosy, Rose/0000-0001-5400-1306; Miller, Brian/0000-0001-5931-4184; Comstock, Dawn/0000-0002-3718-8372	G. Harold and Leila Y. Mathers Charitable Foundation	G. Harold and Leila Y. Mathers Charitable Foundation	The G. Harold and Leila Y. Mathers Charitable Foundation.	Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6	1	8	8	3	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1556	1556		10.1038/s41590-019-0528-5	http://dx.doi.org/10.1038/s41590-019-0528-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31582823	Bronze, Green Accepted			2022-12-18	WOS:000492309600027
J	Visan, I				Visan, Ioana			New ligand for LAG-3	NATURE IMMUNOLOGY			English	Editorial Material																			0	8	8	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					111	111		10.1038/s41590-018-0307-8	http://dx.doi.org/10.1038/s41590-018-0307-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30664758	Bronze			2022-12-18	WOS:000456279100002
J	Wang, FS; Zhang, LQ; Douek, D; McMichael, A; Xu, XN; Lewin, SR				Wang, Fu Sheng; Zhang, Linqi; Douek, Daniel; McMichael, Andrew; Xu, Xiao-Ning; Lewin, Sharon R.			Strategies for an HIV cure: progress and challenges	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INFECTION; PREVALENCE	The 'Strategies for an HIV Cure' conference was held 27-28 April 2018 in Beijing, China, and was hosted by The People's Republic of China Ministry of Science and Technology and the Chinese Academy of Sciences.	[Wang, Fu Sheng] Beijing 302 Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China; [Wang, Fu Sheng] Chinese Ctr Dis Control & Prevent, Div Treatment & Care, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing, Peoples R China; [Douek, Daniel] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McMichael, Andrew] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Xu, Xiao-Ning] Imperial Coll London, Chelsea & Westminster Hosp, Dept Med, London, England; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia	Fifth Medical Center of Chinese PLA General Hospital; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Imperial College London; University of Melbourne; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; Monash University	Wang, FS (corresponding author), Beijing 302 Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China.; Wang, FS (corresponding author), Chinese Ctr Dis Control & Prevent, Div Treatment & Care, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.; Lewin, SR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Royal Melbourne Hosp, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Monash Univ, Melbourne, Vic, Australia.	sfswang302@163.com; sharon.lewin@unimelb.edu.au	Lewin, Sharon/Z-3297-2019; ZHANG, LIN/GYD-9123-2022	Lewin, Sharon Ruth/0000-0002-0330-8241				Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Beyrer C, 2017, NEW ENGL J MED, V377, P1605, DOI 10.1056/NEJMp1710608; Billman M. R., 2017, WELLCOME OPEN RES, V2, P87, DOI DOI 10.12688/WELLC0ME0PENRES.12469.2; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Chang CC, 2018, AIDS, V32, P2119, DOI 10.1097/QAD.0000000000001937; Cheng L, 2017, J CLIN INVEST, V127, P269, DOI 10.1172/JCI90745; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Huang Y, 2012, J AIDS CLIN RES, V3, pe106; Ma Y, 2018, CLIN INFECT DIS, V66, P833, DOI 10.1093/cid/cix911; Pitman MC, 2018, LANCET HIV, V5, pE317, DOI 10.1016/S2352-3018(18)30039-0; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; UNAIDS, 2020, GLOB HIV AIDS STAT F; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wiegand A, 2017, P NATL ACAD SCI USA, V114, pE3659, DOI 10.1073/pnas.1617961114; World Health Organization, 2016, WHO GUID APPR GUID R, V2016; Wu XL, 2018, J CLIN INVEST, V128, P2239, DOI 10.1172/JCI96764; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7	20	8	9	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1155	1158		10.1038/s41590-018-0242-8	http://dx.doi.org/10.1038/s41590-018-0242-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333614				2022-12-18	WOS:000447632200010
J	Patin, E; Hasan, M; Bergstedt, J; Rouilly, V; Libri, V; Urrutia, A; Alanio, C; Scepanovic, P; Hammer, C; Jonsson, F; Beitz, B; Quach, H; Lim, YW; Hunkapiller, J; Zepeda, M; Green, C; Piasecka, B; Leloup, C; Rogge, L; Huetz, F; Peguillet, I; Lantz, O; Fontes, M; Di Santo, JP; Thomas, S; Fellay, J; Duffy, D; Quintana-Murci, L; Albert, ML				Patin, Etienne; Hasan, Milena; Bergstedt, Jacob; Rouilly, Vincent; Libri, Valentina; Urrutia, Alejandra; Alanio, Cecile; Scepanovic, Petar; Hammer, Christian; Joensson, Friederike; Beitz, Benoit; Quach, Helene; Lim, Yoong Wearn; Hunkapiller, Julie; Zepeda, Magge; Green, Cherie; Piasecka, Barbara; Leloup, Claire; Rogge, Lars; Huetz, Francois; Peguillet, Isabelle; Lantz, Olivier; Fontes, Magnus; Di Santo, James P.; Thomas, Stephanie; Fellay, Jacques; Duffy, Darragh; Quintana-Murci, Lluis; Albert, Matthew L.		Milieu Interieur Consortium	Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors (vol 19, pg 302, 2018)	NATURE IMMUNOLOGY			English	Correction													Di Santo, James P/M-4298-2014; Jönsson, Friederike/H-7525-2014; Rogge, Lars/GYJ-6142-2022; Quintana-Murci, Lluis/AAB-7468-2022; Hasan, Milena/AAO-6610-2021	Di Santo, James P/0000-0002-7146-1862; Jönsson, Friederike/0000-0002-1667-8065; Hasan, Milena/0000-0002-0879-7099; Scepanovic, Petar/0000-0002-4686-7422; Patin, Etienne/0000-0002-9911-4459; Huetz, Francois/0000-0001-8704-1881; Lantz, olivier/0000-0003-3161-7719; Alanio, Cecile/0000-0003-2785-7445; Bergstedt, Jacob/0000-0002-9279-6936; Libri, Valentina/0000-0002-2080-1089				Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7	1	8	8	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					645	645		10.1038/s41590-018-0105-3	http://dx.doi.org/10.1038/s41590-018-0105-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29725081	Bronze			2022-12-18	WOS:000433041500031
J	Kesavardhana, S; Kanneganti, TD				Kesavardhana, Sannula; Kanneganti, Thirumala-Devi			Stressed-out ROS take a silent death route	NATURE IMMUNOLOGY			English	Editorial Material							PATHWAYS	Detrimental levels of intracellular reactive oxygen species engage a caspase-independent and non-inflammatory cell death called 'oxeiptosis' that serves as an important mechanism in diminishing inflammation.	[Kesavardhana, Sannula; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Holze C., 2017, NAT IMMUNOL; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Mealey GB, 2017, J CELL SCI, V130, P3467, DOI 10.1242/jcs.203216; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030	11	8	8	6	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					103	105		10.1038/s41590-017-0034-6	http://dx.doi.org/10.1038/s41590-017-0034-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348507				2022-12-18	WOS:000423435200009
J	Zheng, QL; Hou, J; Zhou, Y; Li, ZY; Cao, XT				Zheng, Qingliang; Hou, Jin; Zhou, Ye; Li, Zhenyang; Cao, Xuetao			The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus (vol 18, pg 1094, 2017)	NATURE IMMUNOLOGY			English	Correction													Hou, Jin/GRY-4960-2022					Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	1	8	9	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1361	1361		10.1038/ni1217-1361a	http://dx.doi.org/10.1038/ni1217-1361a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144498	Bronze			2022-12-18	WOS:000415324900014
J	Heink, S; Yogev, N; Garbers, C; Herwerth, M; Aly, L; Gasperi, C; Husterer, V; Croxford, AL; Moller-Hackbarth, K; Bartsch, HS; Sotlar, K; Krebs, S; Regen, T; Blum, H; Hemmer, B; Misgeld, T; Wunderlich, TF; Hidalgo, J; Oukka, M; Rose-John, S; Schmidt-Supprian, M; Waisman, A; Korn, T				Heink, Sylvia; Yogev, Nir; Garbers, Christoph; Herwerth, Marina; Aly, Lilian; Gasperi, Christiane; Husterer, Veronika; Croxford, Andrew L.; Moller-Hackbarth, Katja; Bartsch, Harald S.; Sotlar, Karl; Krebs, Stefan; Regen, Tommy; Blum, Helmut; Hemmer, Bernhard; Misgeld, Thomas; Wunderlich, Thomas F.; Hidalgo, Juan; Oukka, Mohamed; Rose-John, Stefan; Schmidt-Supprian, Marc; Waisman, Ari; Korn, Thomas			Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T(H)17 cells (vol 18, pg 74, 2017)	NATURE IMMUNOLOGY			English	Correction													Hidalgo, Juan/C-9082-2011; Gasperi, Christiane/AAB-3628-2021; Korn, Thomas/AAE-6960-2019; Hemmer, Bernhard/AAT-8388-2021; Garbers, Christoph/D-9932-2015; Hemmer, Bernhard/GPX-8451-2022; Regen, Tommy/GQH-6929-2022; Rose-John, Stefan/A-7998-2010	Hidalgo, Juan/0000-0003-0921-1122; Korn, Thomas/0000-0002-3633-0955; Garbers, Christoph/0000-0003-4939-6950; Hemmer, Bernhard/0000-0001-5985-6784; Regen, Tommy/0000-0002-7275-3330; Rose-John, Stefan/0000-0002-7519-3279; Herwerth, Marina/0000-0001-5125-4594				Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632	1	8	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					474	474		10.1038/ni0417-474b	http://dx.doi.org/10.1038/ni0417-474b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323263	Bronze			2022-12-18	WOS:000396815800016
J	Baxter, AE; Kaufmann, DE				Baxter, Amy E.; Kaufmann, Daniel E.			Tumor-necrosis factor is a master of T cell exhaustion	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PERSISTENT LCMV INFECTION; FACTOR-ALPHA; ACTIVATION; EXPRESSION; BLOCKADE	Chronic viral infections are characterized by ongoing inflammation and a dysfunctional T cell response, which results in a failure of the host to clear the pathogen. Now these two hallmarks of infection have been linked by the classic pro-inflammatory cytokine tumor-necrosis factor.	[Baxter, Amy E.; Kaufmann, Daniel E.] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Baxter, Amy E.; Kaufmann, Daniel E.] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Kaufmann, DE (corresponding author), Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada.; Kaufmann, DE (corresponding author), Univ Montreal, Montreal, PQ, Canada.	daniel.kaufmann@umontreal.ca		Baxter, Amy/0000-0002-1555-0713				Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Beyer M, 2016, NAT IMMUNOL, V17, P593, DOI 10.1038/ni.3399; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Gallitano SM, 2016, J AM ACAD DERMATOL, V74, P974, DOI 10.1016/j.jaad.2015.11.043; Klatt NR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007153; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	11	8	9	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					476	478		10.1038/ni.3436	http://dx.doi.org/10.1038/ni.3436			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092797				2022-12-18	WOS:000374323100004
J	Champion, BR; Fisher, K; Seymour, L				Champion, Brian R.; Fisher, Kerry; Seymour, Len			A PTENtial cause for the selectivity of oncolytic viruses?	NATURE IMMUNOLOGY			English	Editorial Material							MUTATIONS; INDUCTION; GENE	An important new function for the phosphatase PTEN in regulating interferon responses to viral infection has been delineated. This finding could help explain the remarkable cancer selectivity of many oncolytic viruses.	[Champion, Brian R.; Fisher, Kerry] PsiOxus Therapeut, Abingdon, Oxon, England; [Fisher, Kerry; Seymour, Len] Univ Oxford, Dept Oncol, Oxford, England	University of Oxford	Champion, BR (corresponding author), PsiOxus Therapeut, Abingdon, Oxon, England.	brian.champion@psioxus.com		seymour, len/0000-0003-3825-0841; fisher, kerry/0000-0001-9521-2134	Cancer Research UK [17720] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Bauzon M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00074; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; KIRCHHOFF S, 1995, ONCOGENE, V11, P439; Li S, 2016, NAT IMMUNOL, V17, P241, DOI 10.1038/ni.3311; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Nagy E, 2014, BRIT J CANCER, V110, P2874, DOI 10.1038/bjc.2014.263; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Song M., 2013, PLOS ONE, V8, P1; Twigger K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-368; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	13	8	8	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					225	226		10.1038/ni.3394	http://dx.doi.org/10.1038/ni.3394			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882253				2022-12-18	WOS:000370469300005
J	Sanin, DE; Pearce, EJ				Sanin, David E.; Pearce, Edward J.			The cell identity of cytotoxic T lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							EFFECTOR	Understanding cytotoxic T cells has been a major focus of immunology research for decades. Proteomic profiling of these cells now brings them into unprecedented and revealing focus.	[Sanin, David E.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometabol, Freiburg, Germany	Max Planck Society	Sanin, DE (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometabol, Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Sanin, David E/CAA-0373-2022; Sanin, David E/CAA-0391-2022	Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267				Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Gastello A., 2015, TRENDS ENDOCRIN MET, DOI [http://dx.doi.org/10.1016/j.tem.2015.09.012, DOI 10.1016/J.TEM.2015.09.012]; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005	12	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					45	46		10.1038/ni.3350	http://dx.doi.org/10.1038/ni.3350			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681463				2022-12-18	WOS:000366675800009
J	Quezada, SA; Peggs, KS				Quezada, Sergio A.; Peggs, Karl S.			An antitumor boost to T(H)9 cells	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; BETA	Cells of the T(H)9 subset of helper T cells differentiated in the presence of interleukin 1 beta (IL-1 beta) produce large amounts of IL-9 and IL-21 in a manner dependent on the transcription factors STAT1 and IRF1 and exhibit potent anticancer effects.	[Quezada, Sergio A.; Peggs, Karl S.] UCL, Inst Canc, Dept Res Haematol, Canc Immunol Unit, London, England	University of London; University College London	Quezada, SA (corresponding author), UCL, Inst Canc, Dept Res Haematol, Canc Immunol Unit, London, England.	s.quezada@ucl.ac.uk	Quezada, Sergio/ABF-6466-2020	Quezada, Sergio/0000-0002-9763-1700	Cancer Research UK [12100] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659	14	8	8	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					703	705		10.1038/ni.2945	http://dx.doi.org/10.1038/ni.2945			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	25045872				2022-12-18	WOS:000339323000005
J	McDonald, BD; Constantinides, MG; Bendelac, A				McDonald, Benjamin D.; Constantinides, Michael G.; Bendelac, Albert			Polarized effector programs for innate-like thymocytes	NATURE IMMUNOLOGY			English	Editorial Material							NKT CELLS	Distinct lineages of natural killer T cells arise in the thymus and are characterized by the signature transcription factors T-bet, GATA-3 or ROR gamma t.	[McDonald, Benjamin D.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McDonald, BD (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Constantinides, Michael/0000-0003-4770-7751	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007090] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418	12	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1110	1111						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145782				2022-12-18	WOS:000326023400005
J	Sallusto, F				Sallusto, Federica			DCs: a dual bridge to protective immunity	NATURE IMMUNOLOGY			English	Editorial Material							CD8-ALPHA(+) DENDRITIC CELLS; INFECTION; LINEAGE; DEFENSE		Inst Res Biomed, Bellinzona, Switzerland	Universita della Svizzera Italiana	Sallusto, F (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	federica.sallusto@irb.usi.ch						Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	15	8	8	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					890	891		10.1038/ni.2693	http://dx.doi.org/10.1038/ni.2693			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959179				2022-12-18	WOS:000323377700005
J	Geijtenbeek, TBH; Gringhuis, SI				Geijtenbeek, Teunis B. H.; Gringhuis, Sonja I.			An inside job for antibodies: tagging pathogens for intracellular sensing	NATURE IMMUNOLOGY			English	Editorial Material								Antibodies bound to pathogens that invade cells are sensed in the cytosol by the receptor TRIM21, which triggers innate signaling that leads to protective immunity.	[Geijtenbeek, Teunis B. H.; Gringhuis, Sonja I.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl		Gringhuis, Sonja/0000-0003-0383-4978				Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Fuchs R, 2010, REV MED VIROL, V20, P281, DOI 10.1002/rmv.654; Hauler F, 2012, P NATL ACAD SCI USA, V109, P19733, DOI 10.1073/pnas.1210659109; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022	10	8	8	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					309	311		10.1038/ni.2574	http://dx.doi.org/10.1038/ni.2574			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23507635				2022-12-18	WOS:000316648700002
J	Rayamajhi, M; Miao, EA				Rayamajhi, Manira; Miao, Edward A.			Just say NO to NLRP3	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMASOME ACTIVATION; RECOGNITION	Feedback inhibition by interferon-gamma blocks the NLRP3 inflammasome by triggering inducible nitric oxide synthase (iNOS), and the resulting nitric oxide (NO) thio-nitrosylates NLRP3, shutting it down. This prevents excessive immunopathology during chronic infection with Mycobacterium tuberculosis.	[Rayamajhi, Manira] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rayamajhi, M (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu	Rayamajhi, Manira/M-8416-2014	Miao, Edward/0000-0001-7295-3490	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097518, U54AI057141] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI097518, U54 AI057141] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020	12	8	11	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					12	14						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23238751				2022-12-18	WOS:000312433800003
J	Hogenbirk, MA; Velds, A; Kerkhoven, RM; Jacobs, H				Hogenbirk, Marc A.; Velds, Arno; Kerkhoven, Ron M.; Jacobs, Heinz			Reassessing genomic targeting of AID	NATURE IMMUNOLOGY			English	Letter							CHIP-SEQ		[Hogenbirk, Marc A.; Jacobs, Heinz] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Velds, Arno; Kerkhoven, Ron M.] Netherlands Canc Inst, Genom Core Facil, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Hogenbirk, MA (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	m.hogenbirk@nki.nl; h.jacobs@nki.nl		Velds, Arno/0000-0003-4333-8872; Jacobs, Heinz/0000-0001-6227-9850				Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	10	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					797	798		10.1038/ni.2367	http://dx.doi.org/10.1038/ni.2367			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910380				2022-12-18	WOS:000307863600001
J	Cannons, JL; Lu, KT; Schwartzberg, PL				Cannons, Jennifer L.; Lu, Kristina T.; Schwartzberg, Pamela L.			Lymph node choreography: B cells take the lead	NATURE IMMUNOLOGY			English	Editorial Material							FOLLICULAR HELPER-CELLS; T-CELLS; HELMINTH INFECTION; DIFFERENTIATION; ANTIBODIES; IMMUNITY	The role of T cells in providing help to B cells is well established; however, the converse-that B cells provide signals to help initiate T cell-mediated immunity-is less well appreciated. New data now show B cells modulate the earliest stages of T cell activation in a T helper type 2 response.	[Cannons, Jennifer L.; Lu, Kristina T.; Schwartzberg, Pamela L.] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Cannons, JL (corresponding author), NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA.	pams@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barr Tom A., 2012, Infectious Disorders - Drug Targets, V12, P222; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fritz JH, 2011, J INTERF CYTOK RES, V31, P277, DOI 10.1089/jir.2010.0121; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Leon Beatriz, 2012, Infectious Disorders - Drug Targets, V12, P213; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	16	8	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					630	632		10.1038/ni.2349	http://dx.doi.org/10.1038/ni.2349			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713820				2022-12-18	WOS:000305483800005
J	Dustin, ML				Dustin, Michael L.			PKC-theta: hitting the bull's eye	NATURE IMMUNOLOGY			English	Editorial Material							KINASE-C-THETA; T-CELL-ACTIVATION; PROTEIN-KINASE; IMMUNOLOGICAL SYNAPSE; MICROCLUSTERS; PHOSPHORYLATION; SEGREGATION; CLUSTERS; P56(LCK); COMPLEX	How the kinase PKC-theta is targeted to the immunological synapse and is activated once there remains unclear. A targeting motif in PKC-theta and the previously unsuspected kinase GLK identified in two separate papers now explains this.	NYU, Sch Med, Kimmel Ctr, Skirball Inst, New York, NY 10003 USA	New York University	Dustin, ML (corresponding author), NYU, Sch Med, Kimmel Ctr, Skirball Inst, New York, NY 10003 USA.	michael.dustin@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BAIER G, 1993, J BIOL CHEM, V268, P4997; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; HATZ P, 1994, J BIOL CHEM, V269, P16802; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; MINAMI Y, 1991, J BIOL CHEM, V266, P9222; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; So T, 2011, P NATL ACAD SCI USA, V108, P2903, DOI 10.1073/pnas.1008765108; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; Valenzuela JO, 2009, J CLIN INVEST, V119, P3774, DOI 10.1172/JCI39692; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Yankee TM, 2004, J IMMUNOL, V173, P1711, DOI 10.4049/jimmunol.173.3.1711; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	32	8	10	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1031	1032		10.1038/ni.2141	http://dx.doi.org/10.1038/ni.2141			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012436				2022-12-18	WOS:000296500100007
J	Dorshkind, K				Dorshkind, Kenneth			Not a split decision for human hematopoiesis	NATURE IMMUNOLOGY			English	Editorial Material							STEM-CELLS; LINEAGE COMMITMENT; LYMPHOID-CELLS; PROGENITORS; IDENTIFICATION; SYSTEM; GENE; MICE		Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu						ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Baba Y, 2004, TRENDS IMMUNOL, V25, P645, DOI 10.1016/j.it.2004.09.010; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; FIALKOW PJ, 1978, J CLIN INVEST, V62, P815, DOI 10.1172/JCI109193; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334	12	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					569	570		10.1038/ni0710-569	http://dx.doi.org/10.1038/ni0710-569			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562840				2022-12-18	WOS:000278926400010
J	Martin, CE; Kim, DM; Sprent, J; Surh, CD				Martin, Christopher E.; Kim, David M.; Sprent, Jonathan; Surh, Charles D.			Is IL-7 from dendritic cells essential for the homeostasis of CD4(+) T cells?	NATURE IMMUNOLOGY			English	Letter							PROLIFERATION; NAIVE; SURVIVAL		[Martin, Christopher E.; Kim, David M.; Surh, Charles D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sprent, Jonathan] Garvan Inst Med Res, Sydney, NSW, Australia; [Sprent, Jonathan; Surh, Charles D.] Pohang Univ Sci & Technol, World Class Univ Integrat Biosci & Biotechnol Pro, Pohang, South Korea	Scripps Research Institute; Garvan Institute of Medical Research; Pohang University of Science & Technology (POSTECH)	Martin, CE (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	csurh@scripps.edu						Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868	7	8	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					547	548		10.1038/ni0710-547	http://dx.doi.org/10.1038/ni0710-547			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562832				2022-12-18	WOS:000278926400002
J	Rathinam, VAK; Sharma, S; Fitzgerald, KA				Rathinam, Vijay A. K.; Sharma, Shruti; Fitzgerald, Katherine A.			Catenin' on to nucleic acid sensing	NATURE IMMUNOLOGY			English	Editorial Material							PATTERN-RECOGNITION RECEPTORS; BACTERIA		[Rathinam, Vijay A. K.; Sharma, Shruti; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rathinam, VAK (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X				Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; Wilson SA, 1998, NUCLEIC ACIDS RES, V26, P3460, DOI 10.1093/nar/26.15.3460; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876	14	8	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					466	468		10.1038/ni0610-466	http://dx.doi.org/10.1038/ni0610-466			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485273				2022-12-18	WOS:000277821300006
J	Allen, PM				Allen, Paul M.			Themis imposes new law and order on positive selection	NATURE IMMUNOLOGY			English	Editorial Material								The molecular mechanism by which thymocytes are positively selected remains incompletely understood. Three studies add a new piece to the positive selection puzzle.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu						Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768	3	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					805	806		10.1038/ni0809-805	http://dx.doi.org/10.1038/ni0809-805			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621038				2022-12-18	WOS:000268141400004
J	Ohkura, N; Sakaguchi, S				Ohkura, Naganari; Sakaguchi, Shimon			A novel modifier of regulatory T cells	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTORS; FTY720	The receptor for the lipid mediator sphingosine 1-phosphate is critical for T cell trafficking. New data show that signaling mediated by this receptor critically controls the development, maintenance and suppressive activity of natural regulatory T cells that express the transcription factor Foxp3.	[Ohkura, Naganari; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan; [Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka, Japan	Kyoto University; Osaka University	Ohkura, N (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	12	8	9	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					685	686		10.1038/ni0709-685	http://dx.doi.org/10.1038/ni0709-685			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536192				2022-12-18	WOS:000267142600006
J	Malissen, B				Malissen, Bernard			Revisiting the follicular helper T cell paradigm	NATURE IMMUNOLOGY			English	Editorial Material							INTERLEUKIN-21; GENERATION; PLASTICITY; LINEAGE	Antibody responses are critical for host protection against many pathogens. By reporting what actually occurs in vivo, two new studies provide important clues about follicular helper T cells that are dedicated to providing help to B cells.	Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, INSERM,U631, CNRS,UMR 6102, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, INSERM,U631, CNRS,UMR 6102, Marseille, France.	bernardm@ciml.univ-mrs.fr	Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342				Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; KING C, 2008, NAT IMMUNOL, V26, P741; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	12	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					371	372		10.1038/ni0409-371	http://dx.doi.org/10.1038/ni0409-371			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295637				2022-12-18	WOS:000264425800010
J	Hogquist, KA				Hogquist, Kristin A.			Immunodeficiency: when T cells are stuck at home	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOCYTE TRAFFICKING	A flurry of studies has suggested the importance of the actin regulator coronin 1A in lymphocyte development. Now, mutants of this regulator are shown to cause immunodeficiency in both mice and humans.	Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687	NIAID NIH HHS [R01 AI039560, R01 AI039560-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039560] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; YAGI H, 1990, IMMUNOL INVEST, V19, P493, DOI 10.3109/08820139009052975; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	8	8	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1207	1208		10.1038/ni1108-1207	http://dx.doi.org/10.1038/ni1108-1207			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936778	Green Accepted			2022-12-18	WOS:000260248600005
J	Natoli, G; Austenaa, LMI				Natoli, Gioacchino; Austenaa, Liv M. I.			A birthday gift for TRADD	NATURE IMMUNOLOGY			English	Editorial Material							KAPPA-B ACTIVATION; NECROSIS-FACTOR RECEPTOR; CELL-DEATH; MEDIATED APOPTOSIS; SIGNALING COMPLEX; KINASE RIP; PROTEIN; DOMAIN; MICE	Definitive new data solidify and clarify the function of the adaptor TRADD in tumor necrosis factor receptor 1 signaling and show that in some situations, TRADD is also required for the transmission of Toll-like receptor signals.	[Natoli, Gioacchino; Austenaa, Liv M. I.] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Natoli, G (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM European Inst Oncol Campus, I-20139 Milan, Italy.	gioacchino.natoli@iform-ieo-campus.it	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Natoli, Gioacchino/0000-0003-0711-2411				Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	15	8	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1015	1016		10.1038/ni0908-1015	http://dx.doi.org/10.1038/ni0908-1015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711443				2022-12-18	WOS:000258559600013
J	Reith, W; Boss, JM				Reith, Walter; Boss, Jeremy M.			New dimensions of CIITA	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-II EXPRESSION; INTERFERON-GAMMA; GENE-EXPRESSION; PROMOTER-IV; TRANSCRIPTION; CELLS		[Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University of Geneva; Emory University	Reith, W (corresponding author), Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland.	walter.reith@medecine.unige.ch			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI034000-14, R01 AI034000] Funding Source: Medline; NIGMS NIH HHS [R01 GM047310, R01 GM047310-11] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007	13	8	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					713	714		10.1038/ni0708-713	http://dx.doi.org/10.1038/ni0708-713			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18563077	Green Accepted			2022-12-18	WOS:000256904900004
J	Nagasawa, T				Nagasawa, Takashi			New niches for B cells	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM; BONE-MARROW; RECEPTORS	The bone marrow contains specialized microenvironments that maintain blood cells and supply the requisite factors for their development. Newly identified bone marrow-resident dendritic cells create unique niches for mature B cells.	Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Nagasawa, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Sakyo Ku, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Nagasawa, Takashi/0000-0002-1085-0960				BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	10	8	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					345	346		10.1038/ni0408-345	http://dx.doi.org/10.1038/ni0408-345			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349811				2022-12-18	WOS:000254123200007
J	Kraal, G				Kraal, Georg			Antigens take the shuttle	NATURE IMMUNOLOGY			English	Editorial Material							FOLLICULAR DENDRITIC CELLS; ZONE B-CELLS; MARGINAL ZONE; IMMUNE-COMPLEXES; LOCALIZATION; TRANSPORT	Splenic marginal zone B cells take up blood-borne antigens. These B cells are now reported to continuously transport antigens to the follicles, a process that ensures efficient delivery of blood-borne antigens to follicular dendritic cells.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Kraal, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands.	g.kraal@vumc.nl						Bende RJ, 2007, J EXP MED, V204, P2655, DOI 10.1084/jem.20071006; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; GRAY D, 1984, IMMUNOLOGY, V52, P659; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494	7	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					11	12		10.1038/ni0108-11	http://dx.doi.org/10.1038/ni0108-11			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087249				2022-12-18	WOS:000251820800005
J	De Libero, G; MacDonald, HR; Dellabona, P				De Libero, Gennaro; MacDonald, H. Robson; Dellabona, Paolo			T cell recognition of lipids: quo vadis? (vol 8, pg 223, 2007)	NATURE IMMUNOLOGY			English	Correction													Dellabona, Paolo/G-5416-2012; De Libero, Gennaro/P-2694-2017	Dellabona, Paolo/0000-0002-1414-633X; De Libero, Gennaro/0000-0003-0853-7868				De Libero G, 2007, NAT IMMUNOL, V8, P438, DOI 10.1038/ni0407-438	1	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					438	438		10.1038/ni0407-438	http://dx.doi.org/10.1038/ni0407-438			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17304228	Bronze			2022-12-18	WOS:000245075900019
J	Marodi, L; Notarangelo, LD				Marodi, Laszlo; Notarangelo, Luigi D.			Education and worldwide collaboration pays off	NATURE IMMUNOLOGY			English	Letter							DEFICIENCY; IMMUNODEFICIENCIES; MUTATIONS; DISEASE		Univ Debrecen, Dept Infect & Pediat Immunol, H-4012 Debrecen, Hungary; Hlth Sci Ctr, H-4012 Debrecen, Hungary; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	University of Debrecen; Harvard University; Boston Children's Hospital; Harvard Medical School	Marodi, L (corresponding author), Univ Debrecen, Dept Infect & Pediat Immunol, H-4012 Debrecen, Hungary.	lmarodi@jaguar.dote.hu; luigi.notarangelo@childrens.harvard.edu	Marodi, Laszlo/AAU-9915-2020; Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262				Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Eades-Perner AM, 2007, CLIN EXP IMMUNOL, V147, P306, DOI 10.1111/j.1365-2249.2006.03292.x; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Roscioli T, 2006, NAT GENET, V38, P620, DOI 10.1038/ng1780	9	8	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					323	324		10.1038/ni0407-323	http://dx.doi.org/10.1038/ni0407-323			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375089				2022-12-18	WOS:000245075900002
J	Blander, JM; Medzhitov, R				Blander, J. Magarian; Medzhitov, Ruslan			Toll-like receptors and phagosome maturation - Reply	NATURE IMMUNOLOGY			English	Letter									CUNY Mt Sinai Sch Med, Ctr Immunobiol, New York, NY 10029 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Yale University; Yale University	Blander, JM (corresponding author), CUNY Mt Sinai Sch Med, Ctr Immunobiol, New York, NY 10029 USA.	ruslan.medzhitov@yale.edu						Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	6	8	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					217	218		10.1038/ni0307-217b	http://dx.doi.org/10.1038/ni0307-217b			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF					2022-12-18	WOS:000244275100003
J	Smyth, MJ; Nutt, SL				Smyth, Mark J.; Nutt, Stephen L.			IL-7 and the thymus dictate the NK cell 'labor market'	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; LYMPH-NODES; IFN-GAMMA; T-CELLS; IN-VIVO; MATURATION; LIVER		Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 3002, Australia; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; Walter & Eliza Hall Institute	Smyth, MJ (corresponding author), Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 3002, Australia.	mark.smyth@petermac.org; nutt@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Smyth, Mark J/H-8709-2014	Nutt, Stephen L/0000-0002-0020-6637; Smyth, Mark J/0000-0001-7098-7240				Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Farag SS, 2003, INT J HEMATOL, V78, P7, DOI 10.1007/BF02983234; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395	13	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1134	1136		10.1038/ni1106-1134	http://dx.doi.org/10.1038/ni1106-1134			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053796				2022-12-18	WOS:000241437200006
J	O'Neill, LAJ				O'Neill, Luke A. J.			DisSARMing toll-like receptor signaling	NATURE IMMUNOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; ADAPTER MOLECULE; PROTEIN; TRIF; SARM; TRANSDUCTION	Toll-like receptor (TLR) signaling must be tightly regulated to avoid uncontrolled inflammation. A fifth Toll interleukin 1 receptor adaptor domain, SARM, has been identified as an inhibitor of TLR3 and TLR4 signaling.	Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415	13	8	9	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1023	1025		10.1038/ni1006-1023	http://dx.doi.org/10.1038/ni1006-1023			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985498				2022-12-18	WOS:000241437100007
J	Bottaro, A; Inlay, MA; Matzke, NJ				Bottaro, A; Inlay, MA; Matzke, NJ			Immunology in the spotlight at the Dover 'Intelligent Design' trial	NATURE IMMUNOLOGY			English	Editorial Material							V(D)J RECOMBINATION; IMMUNE-SYSTEM; MEDIATED TRANSPOSITION; TRANSPOSABLE ELEMENTS; EVOLUTION; RAG1; COMPLEXITY; SEQUENCES; GENE	Immunology had an unexpected and decisive part in challenging the claims of 'Intelligent Design' proponents at the US trial on the teaching of evolution in public schools in Dover, Pennsylvania.	Univ Rochester, Sch Med & Dent, Dept Med, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; Stanford Univ, Beckman Ctr, Dept Pathol, Stanford, CA 94305 USA; Natl Ctr Sci Educ, Oakland, CA 94609 USA	University of Rochester; University of Rochester; Stanford University	Bottaro, A (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	andrea_bottaro@urmc.rochester.edu	Bottaro, Andrea/L-1831-2017; Matzke, Nicholas/L-4109-2015	Bottaro, Andrea/0000-0003-1712-6796; Matzke, Nicholas/0000-0002-8698-7656				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Aird WC, 2003, J THROMB HAEMOST, V1, P227, DOI 10.1046/j.1538-7836.2003.00062.x; BARTL S, 1994, P NATL ACAD SCI USA, V91, P10769, DOI 10.1073/pnas.91.23.10769; Behe MJ., 1996, DARWINS BLACK BOX BI; Bernstein RM, 1996, P NATL ACAD SCI USA, V93, P9454, DOI 10.1073/pnas.93.18.9454; Cavalier-Smith Tom, 1997, TRENDS ECOL EVOL, V12, P162; Clatworthy AE, 2003, MOL CELL, V12, P489, DOI 10.1016/S1097-2765(03)00305-8; Coyne JA, 1996, NATURE, V383, P227, DOI 10.1038/383227a0; DREYFUS DH, 1992, MOL IMMUNOL, V29, P807, DOI 10.1016/0161-5890(92)90191-Y; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Keller EF, 2002, ANN NY ACAD SCI, V981, P189; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; METCHNIKOFF E, 1968, LECT COMP PATH INFL; Orr H. A., 1996, BOSTON REV, V21, P28; Pennock RT, 2003, ANNU REV GENOM HUM G, V4, P143, DOI 10.1146/annurev.genom.4.070802.110400; POMIANKOWSKI A, 1996, NEW SCI, V151, P44; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Shanks N, 1999, PHILOS SCI, V66, P268, DOI 10.1086/392687; Thornhill RH, 2000, J THEOR BIOL, V203, P111, DOI 10.1006/jtbi.2000.1070; Vaandrager JW, 2000, BLOOD, V96, P1947, DOI 10.1182/blood.V96.5.1947.h8001947_1947_1952; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Weber BH, 1999, BIOL PHILOS, V14, P593, DOI 10.1023/A:1006575823752; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	24	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					433	435		10.1038/ni0506-433	http://dx.doi.org/10.1038/ni0506-433			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622425				2022-12-18	WOS:000237008800003
J	Miller, JFAP				Miller, JFAP			Vestigial no more	NATURE IMMUNOLOGY			English	Editorial Material							NEONATAL THYMECTOMY; CELL INTERACTION; IMMUNE-RESPONSE; THYMUS; MICE; LYMPHOCYTES; MOUSE	Historical accounts of important experiments in Immunology provide insight and continuity to present areas of research. Jacques F. A. P. Miller inaugurates the Essay format with his seminal work on the thymus.	Walter & Eliza Hall Inst Med Res, Dept Immunol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute	Miller, JFAP (corresponding author), Walter & Eliza Hall Inst Med Res, Dept Immunol, 1G Royal Parade, Parkville, Vic 3050, Australia.	miller@wehi.edu.edu						BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BURNET FM, 1971, GENES DREAMS REALITI; CHEERS C, 1972, J EXP MED, V136, P1661, DOI 10.1084/jem.136.6.1661; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; GROSS L, 1951, P SOC EXP BIOL MED, V78, P342; LAW LW, 1962, WISTAR I S, P105; MCINTIRE KR, 1964, NATURE, V204, P151, DOI 10.1038/204151a0; MILLER JF, 1961, LANCET, V2, P748; MILLER JF, 1961, NATURE, V191, P248, DOI 10.1038/191248a0; MILLER JFA, 1967, NATURE, V216, P659, DOI 10.1038/216659a0; MILLER JFA, 1959, NATURE, V184, P1809, DOI 10.1038/1841809a0; MILLER JFA, 1963, NATURE, V199, P921, DOI 10.1038/199920a0; MILLER JFA, 1962, NATURE, V195, P1318, DOI 10.1038/1951318a0; MILLER JFA, 1964, P SOC EXP BIOL MED, V116, P323; MILLER JFAP, 1962, PROC R SOC SER B-BIO, V156, P415, DOI 10.1098/rspb.1962.0048; MILLER JFAP, 1959, NATURE, V183, P1069, DOI 10.1038/1831069a0; MILLER JFAP, 1960, NATURE, V187, P703, DOI 10.1038/187703a0; MITCHELL BG, 1968, P NATL ACAD SCI USA, V59, P296, DOI 10.1073/pnas.59.1.296; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821	19	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					3	5		10.1038/ni0106-3	http://dx.doi.org/10.1038/ni0106-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357847				2022-12-18	WOS:000234139700002
J	Anderson, P				Anderson, P			Pin1: a proline isomerase that makes you wheeze?	NATURE IMMUNOLOGY			English	Editorial Material							MESSENGER-RNAS; AUF1; PHOSPHORYLATION; ISOFORMS; BINDING; DEGRADATION; PROTEINS		Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Anderson, P (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu						Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001	13	8	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1211	1212		10.1038/ni1205-1211	http://dx.doi.org/10.1038/ni1205-1211			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369562				2022-12-18	WOS:000233371900006
J	Trautmann, A				Trautmann, A			Microclusters initiate and sustain T cell signaling	NATURE IMMUNOLOGY			English	Editorial Material							SYNAPSE FORMATION; ACTIVATION; CD3-ZETA		INSERM, U567, F-75005 Paris, France; Ctr Natl Rech Sci, UMR 8104, Paris, France; Univ Paris Descartes, UMR S 8104, Paris, France; Inst Cochin, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Trautmann, A (corresponding author), INSERM, U567, F-75005 Paris, France.	trautmann@cochin.inserm.fr						Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	12	8	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1213	1214		10.1038/ni1205-1213	http://dx.doi.org/10.1038/ni1205-1213			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369563				2022-12-18	WOS:000233371900007
J	Colonna, M				Colonna, M			Fine-tuning NK cell responses: it's a family affair	NATURE IMMUNOLOGY			English	Editorial Material							LINKED LYMPHOPROLIFERATIVE DISEASE; CUTTING EDGE; 2B4 CD244; SAP; RECEPTOR; CYTOTOXICITY	The adaptor SAP mediates activation signals in natural killer cells. However, its family members EAT-2 and ERT are negative regulators that help to fine-tune natural killer cell recognition of viruses and tumors.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.	mcolonna@wustl.edu		Colonna, Marco/0000-0001-5222-4987				Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Tangye SG, 1999, J IMMUNOL, V162, P6981; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4	12	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					961	962		10.1038/ni1005-961	http://dx.doi.org/10.1038/ni1005-961			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177799				2022-12-18	WOS:000232027200003
J	Melief, CJM				Melief, CJM			Escort service for cross-priming	NATURE IMMUNOLOGY			English	Editorial Material							CELLS		Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Melief, CJM (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands.	cmelief@lumc.nl						Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Chandawarkar RY, 1999, J EXP MED, V189, P1437, DOI 10.1084/jem.189.9.1437; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	13	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					543	544		10.1038/ni0605-543	http://dx.doi.org/10.1038/ni0605-543			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908932				2022-12-18	WOS:000229385900005
J	[Anonymous]				[Anonymous]			Essence of harmony	NATURE IMMUNOLOGY			English	Editorial Material																			0	8	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					325	325		10.1038/ni0405-325	http://dx.doi.org/10.1038/ni0405-325			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785756	Bronze			2022-12-18	WOS:000227860000001
J	Hamilton, SE; Prlic, M; Jameson, SC				Hamilton, SE; Prlic, M; Jameson, SC			Environmental conservation: bystander CD4 T cells keep CD8 memories fresh	NATURE IMMUNOLOGY			English	Editorial Material							ABSENCE	CD4(+) T cells reportedly program CD8(+) T cells to develop into suitable memory cells during the primary immune response. However, new data indicate that the maintenance of CD8(+) memory T cells requires continuous exposure to bystander CD4(+) T cells.	Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hamilton, SE (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Prlic, Martin/0000-0002-0685-9321				Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Johansen P, 2004, EUR J IMMUNOL, V34, P91, DOI 10.1002/eji.200324231; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105	11	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					873	874		10.1038/ni0904-873	http://dx.doi.org/10.1038/ni0904-873			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334079				2022-12-18	WOS:000223612500005
J	Marsland, BJ; Kopf, M; Le Gros, G				Marsland, BJ; Kopf, M; Le Gros, G			Viral infection and allergy	NATURE IMMUNOLOGY			English	Letter							AIRWAY INFLAMMATION; CELLS		Malaghan Inst Med Res, Wellington, New Zealand; Swiss Fed Inst Technol, CH-8952 Zurich, Switzerland	Malaghan Institute; Victoria University Wellington; Swiss Federal Institutes of Technology Domain; ETH Zurich	Marsland, BJ (corresponding author), Malaghan Inst Med Res, POB 7060, Wellington, New Zealand.	mars1and@env.ethz.ch	Le Gros, Graham/C-6725-2011; Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Le Gros, Graham/0000-0002-5721-0442				Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Marsland BJ, 2004, CLIN EXP ALLERGY, V34, P1299, DOI 10.1111/j.1365-2222.2004.02021.x; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101	4	8	8	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					865	865		10.1038/ni0904-865a	http://dx.doi.org/10.1038/ni0904-865a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334076				2022-12-18	WOS:000223612500002
J	Makar, KW; Wilson, CB				Makar, KW; Wilson, CB			Sounds of a silent Blimp-1	NATURE IMMUNOLOGY			English	Editorial Material							V(D)J RECOMBINATION; HISTONE; METHYLATION	When acetyl or methyl groups are added to histones, chromatin structure and gene expression are altered. The methyltransferase G9a can target the specific silencing of IFNB gene expression and blocking of V(D)J recombination.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Makar, KW (corresponding author), Univ Washington, Dept Immunol, Box 357650, Seattle, WA 98195 USA.	cbwilson@u.washington.edu						Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2	11	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					241	242		10.1038/ni0304-241	http://dx.doi.org/10.1038/ni0304-241			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985709				2022-12-18	WOS:000189344600005
J	Riese, RJ; Finn, PW; Shapiro, SD				Riese, RJ; Finn, PW; Shapiro, SD			Influenza and asthma: adding to the respiratory burden	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; INFECTION; IMMUNITY	Viral T(H)1 responses can positively regulate T(H)2 responses in a mouse model of allergen-induced lung inflammation. This helps explain why respiratory viral infections can exacerbate allergic T(H)2-type diseases.	Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Riese, RJ (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	sshapiro@rics.bwh.harvard.edu						Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Cohen Lance, 2003, Semin Respir Infect, V18, P3, DOI 10.1053/srin.2003.50001; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Holtzman MJ, 2002, PHYSIOL REV, V82, P19, DOI 10.1152/physrev.00020.2001; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x	12	8	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					243	244		10.1038/ni0304-243	http://dx.doi.org/10.1038/ni0304-243			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985710				2022-12-18	WOS:000189344600006
J	Houghton, AN				Houghton, AN			LIGHTing the way for tumor immunity	NATURE IMMUNOLOGY			English	Editorial Material							STROMA; CELLS	Stroma in tumors forms a barrier to immunity against cancer. New findings show that stimulating both stroma and T lymphocytes together leads to potent immunity against established tumors.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Houghton, AN (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	a-houghton@ski.mskcc.org						DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; PERDRIZET GA, 1990, J EXP MED, V171, P1205, DOI 10.1084/jem.171.4.1205; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029	6	8	10	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					123	124		10.1038/ni0204-123	http://dx.doi.org/10.1038/ni0204-123			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14749779				2022-12-18	WOS:000188512000004
J	Zaim, J; Kierzek, AM				Zaim, J; Kierzek, AM			Domain organization of activation-induced cytidine deaminase	NATURE IMMUNOLOGY			English	Letter							MECHANISM		Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zaim, J (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.			Kierzek, Andrzej/0000-0002-2605-9057				Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964	5	8	8	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1153	1153		10.1038/ni1203-1153	http://dx.doi.org/10.1038/ni1203-1153			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639459	Bronze			2022-12-18	WOS:000186769500002
J	Wills-Karp, M; Belkaid, Y; Karp, CL				Wills-Karp, M; Belkaid, Y; Karp, CL			I-Tim-izing the pathways of counter-regulation	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE; RESPONSES	Tim-3, a member of the T cell immunoglobulin mucin family, is expressed by T H 1 cells. Analysis of Tim-3- Tim3 ligand signaling now shows this pathway is intimately involved in the counter-regulation of T helper type 1 immune responses.	Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45208 USA; Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45208 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Wills-Karp, M (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45208 USA.	wildc7@chmcc.org		Belkaid, Yasmine/0000-0001-9962-3571; Karp, Christopher/0000-0002-0832-2659				Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821	9	8	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1050	1052		10.1038/ni1103-1050	http://dx.doi.org/10.1038/ni1103-1050			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586421				2022-12-18	WOS:000186241100007
J	Durum, SK				Durum, SK			Bcl11: sibling rivalry in lymphoid development	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTIONAL REPRESSION; FAMILY; GENE	Lymphocyte development is a complex process that involves the coordinated action of many transcription factors. The puzzle of B cell and T cell development gains an additional clue with the discovery of two critical factors.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Durum, SK (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	durums@mail.ncifcrf.gov		durum, scott/0000-0003-1307-9582	NATIONAL CANCER INSTITUTE [Z01BC009287] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shinbo T, 1999, ONCOGENE, V18, P4131, DOI 10.1038/sj.onc.1202767; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927	12	8	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					512	514		10.1038/ni0603-512	http://dx.doi.org/10.1038/ni0603-512			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774073				2022-12-18	WOS:000183175500008
J	Kurosaki, T				Kurosaki, T			Checks and balances on developing B cells	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; RECEPTOR; SYK	Signals through the pre-BCR play key roles in B cell development. New data reveal how two downstream components, SLP-65 and the tyrosine kinase Abl, regulate pre-BCR surface expression and immunoglobulin light chain expression.	Kansai Med Univ, Dept Mol Genet, Inst Liver Res, Moriguchi, Osaka 5708506, Japan; Res Ctr Allergy & Immunol, RIKEN, Lab Lymphocyte Differentiat, Moriguchi, Osaka 5708506, Japan	Kansai Medical University; RIKEN	Kurosaki, T (corresponding author), Kansai Med Univ, Dept Mol Genet, Inst Liver Res, Moriguchi, Osaka 5708506, Japan.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Levin SD, 1999, J IMMUNOL, V162, P677; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Xu SL, 2002, J EXP MED, V196, P197, DOI 10.1084/jem.20020172; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	18	8	8	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					13	15		10.1038/ni0103-13	http://dx.doi.org/10.1038/ni0103-13			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496972				2022-12-18	WOS:000180053000008
J	Petrie, HT; van Ewijk, W				Petrie, HT; van Ewijk, W			Thymus by numbers	NATURE IMMUNOLOGY			English	Editorial Material							CELL; FATE	The identity of the thymic epithelium precursor has been elusive. A marker is now shown to identify a population of cells that can give rise to a functional thymus.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Biol Mol, Leiden, Netherlands	Memorial Sloan Kettering Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Petrie, HT (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	petrieh@mskcc.org; vanewijk@lumc.nl						BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; ROPKE C, 1995, DEV IMMUNOL, V4, P149, DOI 10.1155/1995/23168; Shortman K, 1990, Semin Immunol, V2, P3; Wu Li, 1998, P285	12	8	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					604	605		10.1038/ni0702-604	http://dx.doi.org/10.1038/ni0702-604			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087415				2022-12-18	WOS:000176441700007
J	Karre, K				Karre, K			Clever, cleverer, cleverest	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; MOUSE CYTOMEGALOVIRUS; NKG2D RECEPTOR; RECOGNITION; ACTIVATION; MOLECULES	Some strains of mice fail to mount an efficient NK cell response to MCMV infection. With the use of deletion mutants, the in vivo basis for MCMV resistance to killing by NK cells is revealed.	Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden	Karolinska Institutet	Karre, K (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden.							ARASE H, 2001, SCIENECEXPRESS  0411; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Sjolin H, 2002, J EXP MED, V195, P825, DOI 10.1084/jem.20011427; SMITH HRC, 2002, IN PRESS P NATL ACAD; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	17	8	8	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					505	506		10.1038/ni0602-505	http://dx.doi.org/10.1038/ni0602-505			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032560				2022-12-18	WOS:000175874700005
J	Dorfman, JR; Stefanova, I; Yasutomo, K; Germain, RN				Dorfman, JR; Stefanova, I; Yasutomo, K; Germain, RN			Class II essential for CD4 survival - Response	NATURE IMMUNOLOGY			English	Letter							T-CELL-RECEPTOR; MHC CLASS-II; LYMPHOCYTES-T; COMPLEX; REQUIRES; EXPANSION; MOLECULES; MEMORY; NAIVE; PROLIFERATION		NIH, Lymphocyte Biol Sect, Immunol Lab, Bethesda, MD 20892 USA; Univ Tokushima, Sch Med, Dept Pediat, Tokushima 7708853, Japan	National Institutes of Health (NIH) - USA; Tokushima University	Dorfman, JR (corresponding author), NIH, Lymphocyte Biol Sect, Immunol Lab, Bldg 10,Room 11N311, Bethesda, MD 20892 USA.		Dorfman, Jeffrey R/M-4218-2017; Dorfman, Jeffrey R/B-4854-2011; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Dorfman, Jeffrey R/0000-0001-9938-8911; 				Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Boursalian TE, 1999, J IMMUNOL, V162, P3795; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GUNTER KC, 1987, NATURE, V326, P505, DOI 10.1038/326505a0; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Mary F, 1999, EUR J IMMUNOL, V29, P3887, DOI 10.1002/(SICI)1521-4141(199912)29:12<3887::AID-IMMU3887>3.0.CO;2-A; MIZUOCHI T, 1988, J EXP MED, V168, P437, DOI 10.1084/jem.168.1.437; MOINGEON P, 1992, P NATL ACAD SCI USA, V89, P1492, DOI 10.1073/pnas.89.4.1492; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Muranski P, 2000, J IMMUNOL, V164, P3087, DOI 10.4049/jimmunol.164.6.3087; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	27	8	8	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					136	137		10.1038/84231	http://dx.doi.org/10.1038/84231			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175807				2022-12-18	WOS:000166778700010
J	Dorshkind, K				Dorshkind, K			Understanding how pre-B cells come of age	NATURE IMMUNOLOGY			English	News Item							INTERLEUKIN-7; RECEPTOR; MICE		Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.							Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Levin SD, 1999, J IMMUNOL, V162, P677; MONTECINORODRIG.E, 1998, BIOL B CELL T CELL D, P197; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rameshwar P, 1997, ACTA HAEMATOL-BASEL, V98, P59; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	15	8	8	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					369	370		10.1038/80802	http://dx.doi.org/10.1038/80802			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062491				2022-12-18	WOS:000165076100005
J	Li, ZL; Ma, R; Ma, SB; Tian, L; Lu, T; Zhang, JY; Mundy-Bosse, BL; Zhang, B; Marcucci, G; Caligiuri, MA; Yu, JH				Li, Zhenlong; Ma, Rui; Ma, Shoubao; Tian, Lei; Lu, Ting; Zhang, Jianying; Mundy-Bosse, Bethany L.; Zhang, Bin; Marcucci, Guido; Caligiuri, Michael A.; Yu, Jianhua			ILC1s control leukemia stem cell fate and limit development of AML	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; INTERFERON-GAMMA; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; PROGRESSION; MICE	How ILC1s respond to cancer cells is somewhat controversial. Here, the authors show that IFN gamma released by ILC1s can control acute myeloid leukemia by promoting leukemia stem cell apoptosis and favoring their differentiation into non-leukemic cells. Type I innate lymphoid cells (ILC1s) are critical regulators of inflammation and immunity in mammalian tissues. However, their function in cancer is mostly undefined. Here, we show that a high density of ILC1s induces leukemia stem cell (LSC) apoptosis in mice. At a lower density, ILC1s prevent LSCs from differentiating into leukemia progenitors and promote their differentiation into non-leukemic cells, thus blocking the production of terminal myeloid blasts. All of these effects, which require ILC1s to produce interferon-gamma after cell-cell contact with LSCs, converge to suppress leukemogenesis in vivo. Conversely, the antileukemia potential of ILC1s wanes when JAK-STAT or PI3K-AKT signaling is inhibited. The relevant antileukemic properties of ILC1s are also functional in healthy individuals and impaired in individuals with acute myeloid leukemia (AML). Collectively, these findings identify ILC1s as anticancer immune cells that might be suitable for AML immunotherapy and provide a potential strategy to treat AML and prevent relapse of the disease.	[Li, Zhenlong; Ma, Rui; Ma, Shoubao; Tian, Lei; Lu, Ting; Caligiuri, Michael A.; Yu, Jianhua] City Hope Natl Med Ctr, Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Los Angeles, CA 91010 USA; [Li, Zhenlong; Ma, Rui; Ma, Shoubao; Tian, Lei; Lu, Ting; Caligiuri, Michael A.; Yu, Jianhua] City Hope Natl Med Ctr, Natl Med Ctr, Hematol Malignancies Res Inst, Los Angeles, CA 91010 USA; [Zhang, Jianying] City Hope Natl Med Ctr, Natl Med Ctr, Dept Computat & Quantitat, Los Angeles, CA USA; [Mundy-Bosse, Bethany L.] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Zhang, Bin; Marcucci, Guido] City Hope Natl Med Ctr, Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol Malignancies Translat Sci, Los Angeles, CA USA; [Caligiuri, Michael A.; Yu, Jianhua] City Hope Natl Med Ctr, Comprehens Canc Ctr, Los Angeles, CA 91010 USA; [Yu, Jianhua] City Hope Natl Med Ctr, Dept Immunooncol, Los Angeles, CA 91010 USA	City of Hope; City of Hope; City of Hope; University System of Ohio; Ohio State University; City of Hope; City of Hope; City of Hope	Caligiuri, MA; Yu, JH (corresponding author), City Hope Natl Med Ctr, Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Los Angeles, CA 91010 USA.; Caligiuri, MA; Yu, JH (corresponding author), City Hope Natl Med Ctr, Natl Med Ctr, Hematol Malignancies Res Inst, Los Angeles, CA 91010 USA.; Caligiuri, MA; Yu, JH (corresponding author), City Hope Natl Med Ctr, Comprehens Canc Ctr, Los Angeles, CA 91010 USA.; Yu, JH (corresponding author), City Hope Natl Med Ctr, Dept Immunooncol, Los Angeles, CA 91010 USA.	mcaligiuri@coh.org; jiayu@coh.org			National Institutes of Health [CA210087, CA265095, CA163205, NS106170, AI129582, CA247550, CA264512, CA223400]; Leukemia and Lymphoma Society [1364-19]; National Cancer Institute of the National Institutes of Health [P30CA033572]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (CA210087, CA265095 and CA163205 to M.A.C.; NS106170, AI129582, CA247550, CA264512 and CA223400 to J.Y.) and the Leukemia and Lymphoma Society (1364-19 to J.Y.). Research reported in this publication also included work performed in the Hematopoietic Tissue Biorepository Core supported by the National Cancer Institute of the National Institutes of Health under grant number P30CA033572. We appreciate S.T. Wilkinson and L. Sage for editing the manuscript. Images were created with BioRender.com and Adobe Photoshop.	Adane B, 2019, CELL REP, V27, P238, DOI 10.1016/j.celrep.2019.03.009; Almishri W, 2016, J INNATE IMMUN, V8, P617, DOI 10.1159/000448077; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appelbaum F R, 2001, Hematology Am Soc Hematol Educ Program, P62; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ballester G, 2007, ONCOLOGY-NY, V21, P1576; Bank U, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14782-3; Berrien-Elliott MM, 2020, CANCER DISCOV, V10, P1854, DOI 10.1158/2159-8290.CD-20-0312; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Filen JJ, 2009, MOL CELL PROTEOMICS, V8, P32, DOI 10.1074/mcp.M800139-MCP200; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Goc J, 2021, CELL, V184, P5015, DOI 10.1016/j.cell.2021.07.029; Houshmand M, 2019, WORLD J STEM CELLS, V11, P476, DOI 10.4252/wjsc.v11.i8.476; Joshi K, 2019, ADV EXP MED BIOL, V1143, P95, DOI 10.1007/978-981-13-7342-8_5; Klose CSN, 2020, CELL RES, V30, P475, DOI 10.1038/s41422-020-0323-8; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; Laouedj M, 2017, BLOOD, V129, P1980, DOI 10.1182/blood-2016-09-738005; Levis M, 2020, BLOOD ADV, V4, P1178, DOI 10.1182/bloodadvances.2019000174; Ma SB, 2021, J EXP MED, V218, DOI 10.1084/jem.20210279; Maloy KJ, 2013, IMMUNITY, V38, P630, DOI 10.1016/j.immuni.2013.03.005; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nabekura T, 2020, IMMUNITY, V52, P96, DOI 10.1016/j.immuni.2019.11.004; Nair R, 2021, LEUKEMIA, V35, P299, DOI 10.1038/s41375-020-01069-1; Park SM, 2019, CELL STEM CELL, V24, P153, DOI 10.1016/j.stem.2018.10.016; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Razaghi A, 2016, J BIOTECHNOL, V240, P48, DOI 10.1016/j.jbiotec.2016.10.022; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon JP, 2021, IMMUNITY, V54, P276, DOI 10.1016/j.immuni.2020.12.004; Sharma A, 2015, LEUKEMIA, V29, P157, DOI 10.1038/leu.2014.162; Shipounova IN, 2010, B EXP BIOL MED+, V149, P293, DOI 10.1007/s10517-010-0930-3; Smith M, 2004, CRIT REV ONCOL HEMAT, V50, P197, DOI 10.1016/j.critrevonc.2003.11.002; Song MJ, 2019, CANCER RES, V79, P3737, DOI 10.1158/0008-5472.CAN-19-0596; Srivastava S, 2021, CANCER CELL, V39, P193, DOI 10.1016/j.ccell.2020.11.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Yamashita M, 2020, NAT REV CANCER, V20, P365, DOI 10.1038/s41568-020-0260-3; Zhang B, 2018, NAT MED, V24, P450, DOI 10.1038/nm.4499; Zorko NA, 2012, BLOOD, V120, P1130, DOI 10.1182/blood-2012-03-415067	49	7	7	2	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					718	+		10.1038/s41590-022-01198-y	http://dx.doi.org/10.1038/s41590-022-01198-y		APR 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35487987	Green Accepted			2022-12-18	WOS:000788971400001
J	Perry, JA; Shallberg, L; Clark, JT; Gullicksrud, JA; DeLong, JH; Douglas, BB; Hart, AP; Lanzar, Z; O'Dea, K; Konradt, C; Park, J; Kuchroo, JR; Grubaugh, D; Zaretsky, AG; Brodsky, IE; Malefyt, RD; Christian, DA; Sharpe, AH; Hunter, CA				Perry, Joseph A.; Shallberg, Lindsey; Clark, Joseph T.; Gullicksrud, Jodi A.; DeLong, Jonathan H.; Douglas, Bonnie B.; Hart, Andrew P.; Lanzar, Zachary; O'Dea, Keenan; Konradt, Christoph; Park, Jeongho; Kuchroo, Juhi R.; Grubaugh, Daniel; Zaretsky, Arielle Glatman; Brodsky, Igor E.; Malefyt, Rene de Waal; Christian, David A.; Sharpe, Arlene H.; Hunter, Christopher A.			PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection	NATURE IMMUNOLOGY			English	Article							LEISHMANIA-MAJOR; SELF-ANTIGEN; PD-1; RECEPTOR; IL-2; REG; TCR; PERSISTENCE; RESISTANCE; AFFINITY	Phenotypic and transcriptional profiling of regulatory T (T-reg) cells at homeostasis reveals that T cell receptor activation promotes T-reg cells with an effector phenotype (eT(reg)) characterized by the production of interleukin-10 and expression of the inhibitory receptor PD-1. At homeostasis, blockade of the PD-1 pathway results in enhanced eT(reg) cell activity, whereas during infection with Toxoplasma gondii, early interferon-gamma upregulates myeloid cell expression of PD-L1 associated with reduced T-reg cell populations. In infected mice, blockade of PD-L1, complete deletion of PD-1 or lineage-specific deletion of PD-1 in T-reg cells prevents loss of eT(reg) cells. These interventions resulted in a reduced ratio of pathogen-specific effector T cells: eT(reg) cells and increased levels of interleukin-10 that mitigated the development of immunopathology, but which could compromise parasite control. Thus, eT(reg) cell expression of PD-1 acts as a sensor to rapidly tune the pool of eT(reg) cells at homeostasis and during inflammatory processes. Perry et al. demonstrate that regulatory T (T-reg) cell function is restrained by the cell-autonomous action of the checkpoint inhibitor molecule PD-1. This PD-1-dependent mechanism tunes T-reg cell function during homeostasis and infection.	[Perry, Joseph A.; Shallberg, Lindsey; Clark, Joseph T.; Gullicksrud, Jodi A.; DeLong, Jonathan H.; Douglas, Bonnie B.; Lanzar, Zachary; O'Dea, Keenan; Konradt, Christoph; Park, Jeongho; Grubaugh, Daniel; Zaretsky, Arielle Glatman; Brodsky, Igor E.; Christian, David A.; Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Hart, Andrew P.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Konradt, Christoph] Purdue Univ, Coll Vet Med, W Lafayette, IN 47907 USA; [Kuchroo, Juhi R.; Sharpe, Arlene H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Malefyt, Rene de Waal] Merck & Co Inc, Kenilworth, NJ USA	University of Pennsylvania; University of Pennsylvania; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Harvard Medical School; Merck & Company	Hunter, CA (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu		O'Dea, Keenan/0000-0001-9278-0697; Lanzar, Zachary/0000-0001-7229-0973; Clark, Joseph/0000-0001-7764-6000; Perry, Joseph/0000-0003-2341-8461; DeLong, Jonathan/0000-0002-2032-8228; Hart, Andrew/0000-0003-4821-7834	National Institute of Allergy and Infectious Diseases [R01 AI125563, R01 AI41158, P01 AI039671, P01 AI056299, T32-CA-009140]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Institute of Allergy and Infectious Diseases R01 AI125563 and R01 AI41158 grants, awarded to C.A.H; in addition to P01 AI039671 and P01 AI056299 grants, awarded to A.H.S. J.A.P. was supported by a training grant, T32-CA-009140. We thank W. Pear for mentorship and guidance during the formation of this project. We also thank L. `Enzo' Burton for patience and encouragement.	Bally APR, 2016, J IMMUNOL, V196, P2431, DOI 10.4049/jimmunol.1502643; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Benson A, 2012, J IMMUNOL, V188, P800, DOI 10.4049/jimmunol.1100769; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen XF, 2014, EUR J IMMUNOL, V44, P2603, DOI 10.1002/eji.201344423; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Ellestad KK, 2014, EUR J IMMUNOL, V44, P3560, DOI 10.1002/eji.201444688; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Galili T, 2018, BIOINFORMATICS, V34, P1600, DOI 10.1093/bioinformatics/btx657; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Holt MP, 2017, J IMMUNOL, V198, P1503, DOI 10.4049/jimmunol.1601670; Hossain DMS, 2018, J CLIN INVEST, V128, P644, DOI 10.1172/JCI94586; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kauffman KD, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf3861; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Klover PJ, 2010, NEOPLASIA, V12, P899, DOI 10.1593/neo.10716; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kornete M, 2017, AUTOIMMUNITY, V50, P354, DOI 10.1080/08916934.2017.1364368; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; McBerry C, 2014, EUR J IMMUNOL, V44, P469, DOI 10.1002/eji.201343658; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Ogishi M, 2021, NAT MED, V27, P1646, DOI 10.1038/s41591-021-01388-5; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pack AD, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007410; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Sprouse ML, 2018, J IMMUNOL, V200, P909, DOI 10.4049/jimmunol.1700156; TAN CL, 2020, J EXP MED; Thornton AM, 2019, EUR J IMMUNOL, V49, P398, DOI 10.1002/eji.201847935; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Wang S, 2019, MBIO, V10, DOI 10.1128/mBio.00935-19; Wohn C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba1896; Wyss L, 2016, NAT IMMUNOL, V17, P1093, DOI 10.1038/ni.3522; XU D, 2013, PLOS ONE; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	59	7	7	8	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					743	+		10.1038/s41590-022-01170-w	http://dx.doi.org/10.1038/s41590-022-01170-w		APR 2022	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35437326	Green Accepted			2022-12-18	WOS:000784104500001
J	Wragg, KM; Lee, WS; Koutsakos, M; Tan, HX; Amarasena, T; Reynaldi, A; Gare, G; Konstandopoulos, P; Field, KR; Esterbauer, R; Kent, HE; Davenport, MP; Wheatley, AK; Kent, SJ; Juno, JA				Wragg, Kathleen M.; Lee, Wen Shi; Koutsakos, Marios; Tan, Hyon-Xhi; Amarasena, Thakshila; Reynaldi, Arnold; Gare, Grace; Konstandopoulos, Penny; Field, Kirsty R.; Esterbauer, Robyn; Kent, Helen E.; Davenport, Miles P.; Wheatley, Adam K.; Kent, Stephen J.; Juno, Jennifer A.			Establishment and recall of SARS-CoV-2 spike epitope-specific CD4(+) T cell memory	NATURE IMMUNOLOGY			English	Article							INFECTION; RESPONSES	Wragg and colleagues use MHC class II tetramers and TCR beta sequencing to track clonal populations of spike-specific CD4(+) cT(FH) cells from cohorts of convalescent individuals with coronavirus disease 2019 or SARS-CoV-2-vaccinated individuals over 15 months. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination elicit CD4(+) T cell responses to the spike protein, including circulating follicular helper T (cT(FH)) cells that correlate with neutralizing antibodies. Using a novel HLA-DRB1*15:01/S-751 tetramer to track spike-specific CD4(+) T cells, we show that primary infection or vaccination induces robust S-751-specific CXCR5(-) and cT(FH) cell memory responses. Secondary exposure induced recall of CD4(+) T cells with a transitory CXCR3(+) phenotype, and drove expansion of cT(FH) cells transiently expressing ICOS, CD38 and PD-1. In both contexts, cells exhibited a restricted T cell antigen receptor repertoire, including a highly public clonotype and considerable clonotypic overlap between CXCR5(-) and cT(FH) populations. Following a third vaccine dose, the rapid re-expansion of spike-specific CD4(+) T cells contrasted with the comparatively delayed increase in antibody titers. Overall, we demonstrate that stable pools of cT(FH) and memory CD4(+) T cells established by infection and/or vaccination are efficiently recalled upon antigen reexposure and may contribute to long-term protection against SARS-CoV-2.	[Wragg, Kathleen M.; Lee, Wen Shi; Koutsakos, Marios; Tan, Hyon-Xhi; Amarasena, Thakshila; Gare, Grace; Konstandopoulos, Penny; Field, Kirsty R.; Esterbauer, Robyn; Kent, Helen E.; Wheatley, Adam K.; Kent, Stephen J.; Juno, Jennifer A.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Reynaldi, Arnold; Davenport, Miles P.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Kent, Stephen J.] Monash Univ, Melbourne Sexual Hlth Ctr, Alfred Hosp, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Dept Infect Dis, Alfred Hosp, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Kent, SJ; Juno, JA (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Melbourne Sexual Hlth Ctr, Alfred Hosp, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Dept Infect Dis, Alfred Hosp, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.	skent@unimelb.edu.au; jennifer.juno@unimelb.edu.au		Kent, Stephen/0000-0002-8539-4891; Davenport, Miles/0000-0002-4751-1831; Lee, Wen Shi/0000-0001-7285-4054; Field, Kirsty/0000-0001-6238-5362	National Health and Medical Research Council (NHMRC) [GNT2004398]; NHMRC program grant [1149990]; Medical Research Future Fund [GNT2005544]; Victorian Government; NHMRC Investigator grants [1195698, 1173027, 1173433, 1136322, 2009308]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Future Fund(Medical Research Future Fund (MRFF)); Victorian Government; NHMRC Investigator grants(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the study participants for their involvement and provision of samples. We thank V. Jameson at the Melbourne Cytometry Platform (Melbourne Brain Centre node) for the provision of cell sorting services, and C. Batten for technical assistance. This work was funded by a National Health and Medical Research Council (NHMRC) Ideas Grant to J.A.J. (GNT2004398), NHMRC program grant to S.J.K. and M.P.D. (1149990), a Medical Research Future Fund grant to J.A.J., A.K.W. and S.J.K. (GNT2005544) and the Victorian Government. M.K., M.P.D., A.K.W., S.J.K. and J.A.J. are funded by NHMRC Investigator grants (1195698, 1173027, 1173433, 1136322 and 2009308, respectively). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; [Anonymous], 2021, MED, DOI DOI 10.1164/RCCM.202009-3442OC; Baumjohann D, 2021, EUR J IMMUNOL, V51, P1325, DOI 10.1002/eji.202049148; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Chang CM, 2021, J CLIN IMMUNOL, V41, P1131, DOI 10.1007/s10875-021-01045-z; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Crotty S, 2021, SCIENCE, V372, P1392, DOI 10.1126/science.abj2258; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dash P, 2015, METHODS MOL BIOL, V1343, P181, DOI 10.1007/978-1-4939-2963-4_15; Dykema AG, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146922; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gilbert Peter B, 2021, medRxiv, DOI 10.1101/2021.08.09.21261290; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Gong F, 2020, J CLIN INVEST, V130, P6588, DOI 10.1172/JCI141054; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guvenel A, 2020, J CLIN INVEST, V130, P523, DOI 10.1172/JCI131696; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Hill DL, 2021, ELIFE, V10, DOI [10.7554/eLife.70554, 10.7554/eLife.70554.sa1, 10.7554/eLife.70554.sa2]; Huber JE, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1129; James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Kared H, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145476; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Koutsakos M, 2022, J LEUKOCYTE BIOL, V111, P355, DOI 10.1002/JLB.5MR0821-464R; Koutsakos M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100208; Lakshmanappa YS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20642-x; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Minervina AA, 2021, ELIFE, V10, DOI 10.7554/eLife.63502; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Painter MM, 2021, IMMUNITY, V54, P2133, DOI 10.1016/j.immuni.2021.08.001; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Prendecki M, 2021, LANCET, V397, P1178, DOI 10.1016/S0140-6736(21)00502-X; Raziorrouh B, 2016, GASTROENTEROLOGY, V150, P696, DOI 10.1053/j.gastro.2015.11.005; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Tauzin A, 2021, CELL HOST MICROBE, V29, P1137, DOI 10.1016/j.chom.2021.06.001; Wheatley AK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21444-5; Woldemeskel BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149335; Yang JB, 2013, INT IMMUNOL, V25, P447, DOI 10.1093/intimm/dxt005; Zhang J, 2021, NAT MICROBIOL, V6, P51, DOI 10.1038/s41564-020-00824-5	52	7	7	3	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					768	+		10.1038/s41590-022-01175-5	http://dx.doi.org/10.1038/s41590-022-01175-5		MAR 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35314848	Green Submitted, Bronze			2022-12-18	WOS:000771340600002
J	Shan, Q; Hu, SS; Zhu, SQ; Chen, X; Badovinac, VP; Peng, WQ; Zang, CZ; Xue, HH				Shan, Qiang; Hu, Shengen Shawn; Zhu, Shaoqi; Chen, Xia; Badovinac, Vladimir P.; Peng, Weiqun; Zang, Chongzhi; Xue, Hai-Hui			Tcf1 preprograms the mobilization of glycolysis in central memory CD8(+) T cells during recall responses	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; EFFECTOR; DIFFERENTIATION; ACTIVATION; EXPRESSION; GENERATION; DIVERSITY; CAPACITY; ELEMENTS; DEPENDS	Xue and colleagues show that the transcription factor Tcf1 preprograms a transcriptional program that supports the bioenergetic and proliferative needs of CD8(+) central memory T cells in case of a secondary challenge. The mechanisms underlying the heightened protection mediated by central memory CD8(+) T (T-CM) cells remain unclear. Here we show that the transcription factor Tcf1 was required in resting T-CM cells to generate secondary effector CD8(+) T cells and to clear pathogens during recall responses. Recall stimulation of CD8(+) T-CM cells caused extensive reprogramming of the transcriptome and chromatin accessibility, leading to rapid induction of glycolytic enzymes, cell cycle regulators and transcriptional regulators, including Id3. This cluster of genes did not require Tcf1 in resting CD8(+) T-CM cells, but depended on Tcf1 for optimal induction and chromatin opening in recall-stimulated CD8(+) T-CM cells. Tcf1 bound extensively to these recall-induced gene loci in resting CD8(+) T-CM cells and mediated chromatin interactions that positioned these genes in architectural proximity with poised enhancers. Thus, Tcf1 preprogramed a transcriptional program that supported the bioenergetic and proliferative needs of CD8(+) T-CM cells in case of a secondary challenge.	[Shan, Qiang; Chen, Xia; Xue, Hai-Hui] Hackensack Univ, Ctr Discovery & Innovat, Med Ctr, Nutley, NJ 07601 USA; [Hu, Shengen Shawn; Peng, Weiqun; Zang, Chongzhi] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Zhu, Shaoqi] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Zang, Chongzhi] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Xue, Hai-Hui] New Jersey Vet Affairs Hlth Care Syst, E Orange, NJ 07018 USA	Hackensack University Medical Center; University of Virginia; George Washington University; University of Iowa; University of Virginia	Xue, HH (corresponding author), Hackensack Univ, Ctr Discovery & Innovat, Med Ctr, Nutley, NJ 07601 USA.; Zang, CZ (corresponding author), Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA.; Zang, CZ (corresponding author), Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA.; Xue, HH (corresponding author), New Jersey Vet Affairs Hlth Care Syst, E Orange, NJ 07018 USA.	zang@virginia.edu; haihui.xue@hmh-cdi.org	Zang, Chongzhi/D-1445-2011	Zang, Chongzhi/0000-0003-4812-3627; Xue, Hai-Hui/0000-0002-9163-7669; Peng, Weiqun/0000-0001-5521-9091	National Institutes of Health [AI121080, AI139874, AI112579, GM134880, AI114543]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the University of Iowa Flow Cytometry Core facility (J. Fishbaugh, H. Vignes and G. Rasmussen) and the HMH-CDI Flow Cytometry Core facility (M. Poulus and W. Tsao) for cell sorting, B. Wagner (University of Iowa Free Radical and Radiation Biology Core) and P. Ramalingam (HMH-CDI) for assistance with the use of Seahorse Extracellular Flux Analyzer, and K. Zhao (NHLBI, NIH) for sharing the Hi-C protocol. This study is supported, in part, by grants from the National Institutes of Health (AI121080 and AI139874 to H.-H.X. and W.P.; AI112579 to H.-H.X. and C.Z.; and GM134880 and AI114543 to V.P.B.).	Alavattam KG, 2019, NAT STRUCT MOL BIOL, V26, P175, DOI 10.1038/s41594-019-0189-y; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Gullicksrud JA, 2017, J IMMUNOL, V199, P911, DOI 10.4049/jimmunol.1700595; Gullicksrud Jodi A, 2017, [Frontiers in Biology, 生物学前沿], V12, P83; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; He S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02187-8; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Kim BH, 2008, MOL PHARMACOL, V73, P1309, DOI 10.1124/mol.107.041251; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0683-0; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; Martin MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005219; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Nora EP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19283-x; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Raghu D, 2019, TRENDS IMMUNOL, V40, P1149, DOI 10.1016/j.it.2019.10.006; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Shan Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26159-1; Shan Q, 2021, CELL MOL IMMUNOL, V18, P1262, DOI 10.1038/s41423-020-0436-5; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Utzschneider DT, 2018, CELL REP, V22, P3454, DOI 10.1016/j.celrep.2018.03.020; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Verma V, 2021, NAT IMMUNOL, V22, P53, DOI 10.1038/s41590-020-00818-9; Wang ZJ, 2021, BIOINFORMATICS, V37, P3075, DOI 10.1093/bioinformatics/btab173; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhao XD, 2022, NAT REV IMMUNOL, V22, P147, DOI 10.1038/s41577-021-00563-6; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895	56	7	7	3	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					386	+		10.1038/s41590-022-01131-3	http://dx.doi.org/10.1038/s41590-022-01131-3		FEB 2022	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35190717	Green Accepted			2022-12-18	WOS:000758974500003
J	Shukla, V; Samaniego-Castruita, D; Dong, Z; Gonzalez-Avalos, E; Yan, QQ; Sarma, K; Rao, A				Shukla, Vipul; Samaniego-Castruita, Daniela; Dong, Zhen; Gonzalez-Avalos, Edahi; Yan, Qingqing; Sarma, Kavitha; Rao, Anjana			TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures	NATURE IMMUNOLOGY			English	Article							DNA METHYLATION; PROTEINS; 5-METHYLCYTOSINE; DIFFERENTIATION; 5-HYDROXYMETHYLCYTOSINE; TRANSLOCATION; CONNECTIONS; REGULATORS; HELICASES; ROLES	Enzymes of the TET family are methylcytosine dioxygenases that undergo frequent mutational or functional inactivation in human cancers. Recurrent loss-of-function mutations in TET proteins are frequent in human diffuse large B cell lymphoma (DLBCL). Here, we investigate the role of TET proteins in B cell homeostasis and development of B cell lymphomas with features of DLBCL. We show that deletion of Tet2 and Tet3 genes in mature B cells in mice perturbs B cell homeostasis and results in spontaneous development of germinal center (GC)-derived B cell lymphomas with increased G-quadruplexes and R-loops. At a genome-wide level, G-quadruplexes and R-loops were associated with increased DNA double-strand breaks (DSBs) at immunoglobulin switch regions. Deletion of the DNA methyltransferase DNMT1 in TET-deficient B cells prevented expansion of GC B cells, diminished the accumulation of G-quadruplexes and R-loops and delayed B lymphoma development, consistent with the opposing functions of DNMT and TET enzymes in DNA methylation and demethylation. Clustered regularly interspaced short palindromic repeats (CRISPR)-mediated depletion of nucleases and helicases that regulate G-quadruplexes and R-loops decreased the viability of TET-deficient B cells. Our studies suggest a molecular mechanism by which TET loss of function might predispose to the development of B cell malignancies. Shukla, Samaniego-Castruita and colleagues show that loss of TET methylcytosine dioxygenases in B cells is associated with increased DNA-RNA hybrids and G-quadruplex DNA structures in parallel with genomic instability and development of germinal center-derived lymphomas.	[Shukla, Vipul; Samaniego-Castruita, Daniela; Dong, Zhen; Gonzalez-Avalos, Edahi; Rao, Anjana] La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Samaniego-Castruita, Daniela] Univ Calif San Diego, Biol Sci Grad Program, La Jolla, CA USA; [Gonzalez-Avalos, Edahi] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA USA; [Yan, Qingqing; Sarma, Kavitha] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA USA; [Yan, Qingqing; Sarma, Kavitha] Univ Penn, Epigenet Inst, Philadelphia, PA USA; [Rao, Anjana] Univ San Diego, Dept Pharmacol, La Jolla, CA 92110 USA; [Rao, Anjana] Univ San Diego, Moores Canc Ctr, La Jolla, CA 92110 USA; [Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Shukla, Vipul] Northwestern Univ, Dept Cell & Dev Biol, Chicago, IL USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; The Wistar Institute; University of Pennsylvania; University of San Diego; University of San Diego; Northwestern University	Rao, A (corresponding author), La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Univ San Diego, Dept Pharmacol, La Jolla, CA 92110 USA.; Rao, A (corresponding author), Univ San Diego, Moores Canc Ctr, La Jolla, CA 92110 USA.; Rao, A (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.	arao@lji.org	Yan, Qingqing/AAA-4144-2022	dong, zhen/0000-0001-6706-3899; Rao, Anjana/0000-0002-1870-1775	NIH [NIH S10OD016262, NIH S10RR027366, DP2-NS105576, R35 CA210043, R01 AI109842, AI128589, K99/R00 CA248835]; DOE Office of Science User Facility [DE-AC02-05CH11231]; Shared Instrumentation Grant (SIG) Program (S10) [NovaSeq 6000 S10OD025052, HiSeq 2500 S10OD016262]; Leukemia and Lymphoma Society Postdoctoral Fellowship [5463-18]; K99/R00 award from the National Cancer Institute [CA248835]; University of California Institute for Mexico; University of California Institute for United States; El Consejo Nacional de Ciencia y Tecnologia (UCMEXUS/CONACYT) pre-doctoral fellowship; LLS [5463-18]; LJI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science User Facility(United States Department of Energy (DOE)); Shared Instrumentation Grant (SIG) Program (S10); Leukemia and Lymphoma Society Postdoctoral Fellowship(Leukemia and Lymphoma Society); K99/R00 award from the National Cancer Institute; University of California Institute for Mexico; University of California Institute for United States; El Consejo Nacional de Ciencia y Tecnologia (UCMEXUS/CONACYT) pre-doctoral fellowship; LLS; LJI	We thank H. Yuita and I. Lopez-Moyado for generating the ERT2-cre Tet1<SUP>fl/fl</SUP> Tet2<SUP>fl/fl</SUP> Tet3<SUP>fl/fl</SUP>, ERT2-cre TKO mice, D. Kitamura at the Tokyo University of Science for sharing the 40LB cells, U. Basu and B. Laffleur at Columbia University for help with the HTGTS protocol, our collaborators at Cambridge Epigenetix (UK) for providing the 5hmC mapping kits, the LJI Flow Cytometry Core team (C. Kim, D. Hinz, C. Dillingham, M Haynes and S. Ellis) for help with cell sorting and the LJI next-generation sequencing core members (J. Day, S. Alarcon, H. Dose, K. Tanaguay and A. Hernandez) for help with sequencing. The BD FACSAria II is supported by the NIH (NIH S10OD016262, NIH S10RR027366), and our research used resources of the Advanced Light Source, which is a DOE Office of Science User Facility under contract number DE-AC02-05CH11231. The NovaSeq 6000 and the HiSeq 2500 were acquired through the Shared Instrumentation Grant (SIG) Program (S10) (NovaSeq 6000 S10OD025052 and HiSeq 2500 S10OD016262). K.S. acknowledges support from NIH grant DP2-NS105576. V.S. was supported by a Leukemia and Lymphoma Society Postdoctoral Fellowship (grant ID 5463-18) and currently by a K99/R00 award from the National Cancer Institute (grant ID CA248835). D.S.-C. and E.G.-A. were supported by University of California Institute for Mexico and the United States and El Consejo Nacional de Ciencia y Tecnologia (UCMEXUS/CONACYT) pre-doctoral fellowship. This work is supported by the NIH grants R35 CA210043, R01 AI109842 and AI128589 to A.R. and K99/R00 CA248835, research funds from LLS grant 5463-18 and the Tullie and Rickey families SPARK award from LJI to V.S.	An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Chedin F, 2021, EMBO J, V40, DOI 10.15252/embj.2020106394; Chedin F, 2016, TRENDS GENET, V32, P828, DOI 10.1016/j.tig.2016.10.002; Chen L, 2017, MOL CELL, V68, P745, DOI 10.1016/j.molcel.2017.10.008; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Crossley MP, 2019, MOL CELL, V73, P398, DOI 10.1016/j.molcel.2019.01.024; Crossley MP, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202101092; De Magis A, 2019, P NATL ACAD SCI USA, V116, P816, DOI 10.1073/pnas.1810409116; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez PM, 2018, CANCER DISCOV, V8, P1632, DOI 10.1158/2159-8290.CD-18-0657; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kafer GR, 2016, CELL REP, V14, P1283, DOI 10.1016/j.celrep.2016.01.035; Kang J, 2015, P NATL ACAD SCI USA, V112, pE4236, DOI 10.1073/pnas.1510510112; Kharat SS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aba8091; Kieffer-Kwon KR, 2017, MOL CELL, V67, P566, DOI 10.1016/j.molcel.2017.07.013; Ko M, 2015, CURR OPIN CELL BIOL, V37, P91, DOI 10.1016/j.ceb.2015.10.009; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konig F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178875; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li YX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-232; Lio CW, 2016, ELIFE, V5, DOI 10.7554/eLife.18290; Lio CWJ, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-019-9973-4; Lio CWJ, 2019, BLOOD, V134, P1487, DOI 10.1182/blood.2019791475; Lio CWJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7523; Lopez-Moyado IF, 2019, P NATL ACAD SCI USA, V116, P16933, DOI 10.1073/pnas.1903059116; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao SQ, 2018, NAT STRUCT MOL BIOL, V25, P951, DOI 10.1038/s41594-018-0131-8; Miglietta G, 2020, NUCLEIC ACIDS RES, V48, P11942, DOI 10.1093/nar/gkaa944; Muller S, 2012, ORG BIOMOL CHEM, V10, P6537, DOI 10.1039/c2ob25830g; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Niehrs C, 2020, NAT REV MOL CELL BIO, V21, P167, DOI 10.1038/s41580-019-0206-3; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabkin Charles S, 2008, J Natl Cancer Inst Monogr, P48, DOI 10.1093/jncimonographs/lgn002; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rosikiewicz W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5872; Sabharwal NC, 2014, FEBS J, V281, P1726, DOI 10.1111/febs.12734; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka S, 2020, NAT IMMUNOL, V21, P950, DOI 10.1038/s41590-020-0700-y; Tsagaratou A, 2017, NAT IMMUNOL, V18, P45, DOI 10.1038/ni.3630; Wang YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08033-9; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432; Xu Ying-Zhi, 2020, NAR Cancer, V2, pzcaa029, DOI 10.1093/narcan/zcaa029; Yan QQ, 2019, CELL REP, V29, P1369, DOI 10.1016/j.celrep.2019.09.052; Yewdell WT, 2020, IMMUNITY, V53, P952, DOI 10.1016/j.immuni.2020.10.003; Young RM, 2015, P NATL ACAD SCI USA, V112, P13447, DOI 10.1073/pnas.1514944112; Zhang W, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0081-z; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	75	7	7	11	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					99	+		10.1038/s41590-021-01087-w	http://dx.doi.org/10.1038/s41590-021-01087-w		DEC 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937926	Green Accepted			2022-12-18	WOS:000733276000002
J	Weisel, NM; Joachim, SM; Smita, S; Callahan, D; Elsner, RA; Conter, LJ; Chikina, M; Farber, DL; Weisel, FJ; Shlomchik, MJ				Weisel, Nadine M.; Joachim, Stephen M.; Smita, Shuchi; Callahan, Derrick; Elsner, Rebecca A.; Conter, Laura J.; Chikina, Maria; Farber, Donna L.; Weisel, Florian J.; Shlomchik, Mark J.			Surface phenotypes of naive and memory B cells in mouse and human tissues	NATURE IMMUNOLOGY			English	Article							MURINE MEMORY; EXPRESSION; RESPONSES; POPULATION; SUBSETS; MAINTENANCE; COMPARTMENT; INFECTION; GENES; BLOOD	Weisel and colleagues provide a resource that phenotypically profiles naive and memory B cells and provides a comparative analysis of memory B cells found in humans versus mice. Memory B cells (MBCs) protect the body from recurring infections. MBCs differ from their naive counterparts (NBCs) in many ways, but functional and surface marker differences are poorly characterized. In addition, although mice are the prevalent model for human immunology, information is limited concerning the nature of homology in B cell compartments. To address this, we undertook an unbiased, large-scale screening of both human and mouse MBCs for their differential expression of surface markers. By correlating the expression of such markers with extensive panels of known markers in high-dimensional flow cytometry, we comprehensively identified numerous surface proteins that are differentially expressed between MBCs and NBCs. The combination of these markers allows for the identification of MBCs in humans and mice and provides insight into their functional differences. These results will greatly enhance understanding of humoral immunity and can be used to improve immune monitoring.	[Weisel, Nadine M.; Joachim, Stephen M.; Smita, Shuchi; Callahan, Derrick; Elsner, Rebecca A.; Conter, Laura J.; Chikina, Maria; Weisel, Florian J.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Smita, Shuchi; Chikina, Maria] Univ Pittsburgh, Dept Computat & Syst Biol, Sch Med, Pittsburgh, PA USA; [Farber, Donna L.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA; [Farber, Donna L.] Columbia Univ, Dept Surg, Med Ctr, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	mshlomch@pitt.edu		Weisel, Florian/0000-0002-8679-9241; Farber, Donna/0000-0001-8236-9183; Shlomchik, Mark/0000-0002-2152-0959	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants [R01 AI043603, P01 AI106697]	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants	We thank D. Carpenter for organ acquisition, the transplant coordinators at LiveOnNY for tissues from organ donors and members of the laboratory of D. Farber at Columbia University for providing access to human organ donor tissue samples. We thank M. Berkey for supporting experimental procedures. We thank BioLegend, in particular A. Cornett and N. Lucas, for providing reagents. This work was funded by National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants R01 AI043603 (M.J.S.) and P01 AI106697 (M.J.S. and D.L.F.).	Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Carpenter DJ, 2018, AM J TRANSPLANT, V18, P74, DOI 10.1111/ajt.14434; CHAN JKC, 1988, HISTOPATHOLOGY, V12, P461, DOI 10.1111/j.1365-2559.1988.tb01967.x; Conter LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092009; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Glass DR, 2020, IMMUNITY, V53, P217, DOI 10.1016/j.immuni.2020.06.013; Good KL, 2007, P NATL ACAD SCI USA, V104, P13420, DOI 10.1073/pnas.0703872104; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Gosselin D, 2015, CELL, V160, P351, DOI 10.1016/j.cell.2014.12.024; Grimsholm O, 2020, CELL REP, V30, P2963, DOI 10.1016/j.celrep.2020.02.022; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Koethe S, 2011, J LEUKOCYTE BIOL, V90, P5, DOI 10.1189/jlb.0710404; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Llinas L, 2011, IMMUNOL LETT, V134, P113, DOI 10.1016/j.imlet.2010.10.009; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Mahanonda R, 2016, J IMMUNOL, V197, P715, DOI 10.4049/jimmunol.1600540; Nair N, 2016, MUCOSAL IMMUNOL, V9, P68, DOI 10.1038/mi.2015.36; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; Oh JE, 2019, NATURE, V571, P122, DOI 10.1038/s41586-019-1285-1; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Palm AKE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01787; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI200112462; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stensson, 2014, J IMMUNOL, V192; Sweet RA, 2013, J IMMUNOL, V190, P1974, DOI 10.4049/jimmunol.1202816; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Weisel FJ, 2010, J IMMUNOL, V185, P4011, DOI 10.4049/jimmunol.1001540; Weisel NM, 2020, BLOOD, V136, P2774, DOI 10.1182/blood.2019002782; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Wong R, 2019, IMMUNOLOGY, V156, P120, DOI 10.1111/imm.13019; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; Zhao YC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04029-7; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	59	7	7	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					135	+		10.1038/s41590-021-01078-x	http://dx.doi.org/10.1038/s41590-021-01078-x		DEC 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937918	Green Accepted			2022-12-18	WOS:000733276000006
J	Buckley, CD; Chernajovsky, L; Chernajovsky, Y; Modis, LK; O'Neill, LA; Brown, D; Connor, R; Coutts, D; Waterman, EA; Tak, PP				Buckley, Christopher D.; Chernajovsky, Lorna; Chernajovsky, Yuti; Modis, Louise K.; O'Neill, Luke A.; Brown, Doug; Connor, Rachel; Coutts, David; Waterman, Elizabeth A.; Tak, Paul P.			Immune-mediated inflammation across disease boundaries: breaking down research silos	NATURE IMMUNOLOGY			English	Editorial Material							MECHANISMS	If new treatments for immune-mediated inflammatory diseases (IMIDs) are to emerge, then a radical new approach that moves the field from one that is based on clinical signs and symptoms to one that is based on immunological and molecular mechanisms is urgently needed. This requires a new way of thinking: that IMIDs should be approached as having shared common pathogenic cells and pathways, and that therapies should be targeted at these cells and processes rather than clinical features.	[Buckley, Christopher D.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Chernajovsky, Lorna; Chernajovsky, Yuti; Tak, Paul P.] Lorna & Yuti Chernajovsky Biomed Res Fdn, Whitstable, England; [Chernajovsky, Yuti] Queen Mary Univ London, London, England; [Modis, Louise K.] GSK, Immunol Res, Stevenage, Herts, England; [Modis, Louise K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Brown, Doug] British Soc Immunol, London, England; [Connor, Rachel] Juvenile Diabet Res Fdn, London, England; [Coutts, David] Multiple Sclerosis Soc, London, England; [Waterman, Elizabeth A.] Versus Arthrit, Chesterfield, England; [Tak, Paul P.] Univ Cambridge, Cambridge, England; [Tak, Paul P.] Candel Therapeut, Needham, MA USA; [Tak, Paul P.] Multimorbid Steering Grp, Strateg Prior Fund, Swindon, Wilts, England	University of Oxford; University of London; Queen Mary University London; GlaxoSmithKline; Trinity College Dublin; University of London; University College London; University of Cambridge	Chernajovsky, Y (corresponding author), Lorna & Yuti Chernajovsky Biomed Res Fdn, Whitstable, England.; Chernajovsky, Y (corresponding author), Queen Mary Univ London, London, England.	yuti@chernajovskyfoundation.org.uk	Buckley, Christopher/AAN-6378-2021	Buckley, Christopher/0000-0001-6924-6402				Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Corcoran SE, 2021, PHARMACOL REV, V73, P968, DOI 10.1124/pharmrev.120.000171; David T, 2018, CLIN EXP IMMUNOL, V193, P3, DOI 10.1111/cei.13101; Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z; Dinse GE, 2020, ARTHRITIS RHEUMATOL, V72, P1026, DOI 10.1002/art.41214; Gerlag DM, 2019, ANN RHEUM DIS, V78, P179, DOI 10.1136/annrheumdis-2017-212763; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Krishna MT, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00476-2019; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Robinson D, 2006, CURR MED RES OPIN, V22, P989, DOI 10.1185/030079906X104641; Shen N, 2012, NAT REV RHEUMATOL, V8, P701, DOI 10.1038/nrrheum.2012.142; Shooshtari P, 2017, AM J HUM GENET, V101, P75, DOI 10.1016/j.ajhg.2017.06.001; Sims EK, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc8980; Tough DF, 2016, NAT REV DRUG DISCOV, V15, P835, DOI 10.1038/nrd.2016.185; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wijbrandts CA, 2017, MAYO CLIN PROC, V92, P1129, DOI 10.1016/j.mayocp.2017.05.009; WORTHINGTON J, 1995, CLIN EXP IMMUNOL, V101, P390; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003	20	7	7	4	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1344	1348		10.1038/s41590-021-01044-7	http://dx.doi.org/10.1038/s41590-021-01044-7		OCT 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34675389				2022-12-18	WOS:000709652200002
J	Cao, XT				Cao, Xuetao			ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Editorial Material								Conjugation of the ubiquitin-like protein ISG15 to targets (ISGylation) benefits antiviral defense. However, SARS-CoV-2 induces human macrophages to preferentially secrete ISG15 via its papain-like protease, and extracellular non-conjugated ISG15 acts as a cytokine to exacerbate SARS-CoV-2-triggered inflammation.	[Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China	Nankai University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.	caoxt@immunol.org						Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Liu GQ, 2021, NAT MICROBIOL, V6, P467, DOI 10.1038/s41564-021-00884-1; Lowery SA, 2021, CELL HOST MICROBE, V29, P1052, DOI 10.1016/j.chom.2021.05.004; Munnur D, 2021, NAT IMMUNOL, V22, P1416, DOI 10.1038/s41590-021-01035-8; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Speer SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11496; Swaim CD, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107772; Yamada T, 2021, NAT IMMUNOL, V22, P820, DOI 10.1038/s41590-021-00942-0; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	11	7	7	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1360	1362		10.1038/s41590-021-01056-3	http://dx.doi.org/10.1038/s41590-021-01056-3		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34671145	Bronze			2022-12-18	WOS:000709237900003
J	Gensollen, T; Lin, X; Zhang, T; Pyzik, M; See, P; Glickman, JN; Ginhoux, F; Waldor, M; Salmi, M; Rantakari, P; Blumberg, RS				Gensollen, Thomas; Lin, Xi; Zhang, Ting; Pyzik, Michal; See, Peter; Glickman, Jonathan N.; Ginhoux, Florent; Waldor, Matthew; Salmi, Marko; Rantakari, Pia; Blumberg, Richard S.			Embryonic macrophages function during early life to determine invariant natural killer T cell levels at barrier surfaces	NATURE IMMUNOLOGY			English	Article							OXAZOLONE COLITIS; DENDRITIC CELLS; COLONIZATION; MICROBIOTA; INTESTINE; MONOCYTES; SHAPES; MODEL; CD1D	It is increasingly recognized that immune development within mucosal tissues is under the control of environmental factors during early life. However, the cellular mechanisms that underlie such temporally and regionally restrictive governance of these processes are unclear. Here, we uncover an extrathymic pathway of immune development within the colon that is controlled by embryonic but not bone marrow-derived macrophages, which determines the ability of these organs to receive invariant natural killer T (iNKT) cells and allow them to establish local residency. Consequently, early-life perturbations of fetal-derived macrophages result in persistent decreases of mucosal iNKT cells and is associated with later-life susceptibility or resistance to iNKT cell-associated mucosal disorders. These studies uncover a host developmental program orchestrated by ontogenically distinct macrophages that is regulated by microbiota, and they reveal an important postnatal function of macrophages that emerge in fetal life. Invariant natural killer T (iNKT) cells populate barrier surfaces during an early-life window. Blumberg and colleagues demonstrate that such barrier surface iNKT cells develop via an extrathymic pathway dependent on a specialized population of embryo-derived macrophages.	[Gensollen, Thomas; Lin, Xi; Zhang, Ting; Pyzik, Michal; Waldor, Matthew; Blumberg, Richard S.] Harvard Med Sch, Div Gastroenterol, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhang, Ting; Waldor, Matthew] Howard Hughes Med Inst, Boston, MA 02115 USA; [See, Peter; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Glickman, Jonathan N.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Salmi, Marko; Rantakari, Pia] Univ Turku, Inst Biomed, Turku, Finland; [Salmi, Marko] Univ Turku, MediC Res Lab, Turku, Finland; [Rantakari, Pia] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Rantakari, Pia] Abo Akad Univ, Turku, Finland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Harvard University; Beth Israel Deaconess Medical Center; University of Turku; University of Turku; University of Turku; Abo Akademi University	Blumberg, RS (corresponding author), Harvard Med Sch, Div Gastroenterol, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	rblumberg@bwh.harvard.edu	Pyzik, Michal/AAC-7220-2019	Waldor, Matthew/0000-0003-1843-7000; /0000-0002-9834-5490; Rantakari, Pia/0000-0003-1638-5075; Pyzik, Michal/0000-0003-2591-6202; Glickman, Jonathan/0000-0003-0910-2655; Lin, Xi/0000-0003-2526-5163; Ginhoux, Florent/0000-0002-2857-7755	NIAID NIH HHS [P01 AI073748] Funding Source: Medline; NIDDK NIH HHS [R37 DK044319, R01 DK051362, R01 DK088199, R01 DK053056, P30 DK034854, R01 DK044319, R56 DK053056] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arrunategui-Correa V, 2004, CELL IMMUNOL, V227, P109, DOI 10.1016/j.cellimm.2004.02.003; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Boisset JC, 2018, NAT METHODS, V15, P547, DOI 10.1038/s41592-018-0009-z; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Iyer SS, 2018, CELL, V173, P1123, DOI 10.1016/j.cell.2018.04.037; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Rantakari P, 2016, NATURE, V538, P392, DOI 10.1038/nature19814; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Sudo T, 1995, ONCOGENE, V11, P2469; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zhang T, 2017, P NATL ACAD SCI USA, V114, P6334, DOI 10.1073/pnas.1702077114; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	39	7	7	2	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					699	+		10.1038/s41590-021-00934-0	http://dx.doi.org/10.1038/s41590-021-00934-0			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34040226	Green Accepted			2022-12-18	WOS:000655170400013
J	Madkaikar, M; Gupta, N; Yadav, RM; Bargir, UA				Madkaikar, Manisha; Gupta, Nivedita; Yadav, Reetika Malik; Bargir, Umair Ahmed			India's crusade against COVID-19	NATURE IMMUNOLOGY			English	Editorial Material								The COVID-19 response in India has been rapid, strategic and multipronged and has adapted to the evolving pandemic situation.	[Madkaikar, Manisha; Yadav, Reetika Malik; Bargir, Umair Ahmed] ICMR Natl Inst Immunohematol, Dept Pediat Immunol & Leucocyte Biol, Mumbai, Maharashtra, India; [Gupta, Nivedita] Indian Council Med Res, Div Epidemiol & Communicable Dis, New Delhi, India	Indian Council of Medical Research (ICMR)	Madkaikar, M (corresponding author), ICMR Natl Inst Immunohematol, Dept Pediat Immunol & Leucocyte Biol, Mumbai, Maharashtra, India.	madkaikarmanisha@gmail.com	Bargir, Umair Ahmed/AAR-4202-2020	Bargir, Umair Ahmed/0000-0001-6785-8042; Madkaikar, Manisha/0000-0001-6380-3116; Yadav`, Reetika/0000-0002-5030-0437					0	7	8	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					258	259		10.1038/s41590-021-00876-7	http://dx.doi.org/10.1038/s41590-021-00876-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627877	Bronze			2022-12-18	WOS:000621567200003
J	Murakami, K; Sasaki, H; Nishiyama, A; Kurotaki, D; Kawase, W; Ban, T; Nakabayashi, J; Kanzaki, S; Sekita, Y; Nakajima, H; Ozato, K; Kimura, T; Tamura, T				Murakami, Koichi; Sasaki, Haruka; Nishiyama, Akira; Kurotaki, Daisuke; Kawase, Wataru; Ban, Tatsuma; Nakabayashi, Jun; Kanzaki, Satoko; Sekita, Yoichi; Nakajima, Hideaki; Ozato, Keiko; Kimura, Tohru; Tamura, Tomohiko			A RUNX-CBF beta-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes	NATURE IMMUNOLOGY			English	Article								The transcription factor IRF8 is essential for the development of monocytes and dendritic cells (DCs), whereas it inhibits neutrophilic differentiation. It is unclear how Irf8 expression is regulated and how this single transcription factor supports the generation of both monocytes and DCs. Here, we identified a RUNX-CBF beta-driven enhancer 56 kb downstream of the Irf8 transcription start site. Deletion of this enhancer in vivo significantly decreased Irf8 expression throughout the myeloid lineage from the progenitor stages, thus resulting in loss of common DC progenitors and overproduction of Ly6C(+) monocytes. We demonstrated that high, low or null expression of IRF8 in hematopoietic progenitor cells promotes differentiation toward type 1 conventional DCs, Ly6C(+) monocytes or neutrophils, respectively, via epigenetic regulation of distinct sets of enhancers in cooperation with other transcription factors. Our results illustrate the mechanism through which IRF8 controls the lineage choice in a dose-dependent manner within the myeloid cell system. The transcription factor IRF8 is required for both DC and monocyte differentiation from common myeloid progenitors. Tamura and colleagues identify an enhancer (+56 kb) in the Irf8 locus that regulates early myeloid lineage choice.	[Murakami, Koichi; Sasaki, Haruka; Nishiyama, Akira; Kurotaki, Daisuke; Kawase, Wataru; Ban, Tatsuma; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa, Japan; [Murakami, Koichi; Nakabayashi, Jun; Tamura, Tomohiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Kanzaki, Satoko; Sekita, Yoichi; Kimura, Tohru] Kitasato Univ, Sch Sci, Dept Biosci, Lab Stem Cell Biol, Sagamihara, Kanagawa, Japan; [Nakajima, Hideaki] Yokohama City Univ, Grad Sch Med, Dept Stem Cell & Immune Regulat, Yokohama, Kanagawa, Japan; [Ozato, Keiko] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	Yokohama City University; Yokohama City University; Kitasato University; Yokohama City University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nishiyama, A; Tamura, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa, Japan.; Tamura, T (corresponding author), Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan.	nishiyaa@yokohama-cu.ac.jp; tamurat@yokohama-cu.ac.jp		SEKITA, YOICHI/0000-0002-6230-8719; Kimura, Tohru/0000-0001-9227-0996	Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18K19345, 15H04860, 19K07372]; Uehara Memorial Foundation Research Grant; Japanese Society of Hematology Research Grant; MEXT Joint Usage/Research Center Program at the Advanced Medical Research Center, Yokohama City University	Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology (MEXT); Uehara Memorial Foundation Research Grant(Uehara Memorial Foundation); Japanese Society of Hematology Research Grant; MEXT Joint Usage/Research Center Program at the Advanced Medical Research Center, Yokohama City University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank M. Ichino, I. Harada, M. Yoshinari, S. Honma, H. Sato, G. R. Sato and M. Tachikawa at Yokohama City University for their help with the experiments. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology (MEXT; grant nos. 18K19345 and 15H04860 to T.T. and 19K07372 to A.N.); a Uehara Memorial Foundation Research Grant (to T.T.); a Japanese Society of Hematology Research Grant (to T.T.); and the MEXT Joint Usage/Research Center Program at the Advanced Medical Research Center, Yokohama City University (funding for Y.S., T.K. and T.T.).	Anderson DA, 2021, NAT REV IMMUNOL, V21, P101, DOI 10.1038/s41577-020-00413-x; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Ban T, 2016, IMMUNITY, V45, P319, DOI 10.1016/j.immuni.2016.07.015; Behrens K, 2016, BLOOD, V127, P3369, DOI 10.1182/blood-2015-09-668129; Bigley V, 2018, J ALLERGY CLIN IMMUN, V141, P2234, DOI 10.1016/j.jaci.2017.08.044; Briscoe J, 2015, DEVELOPMENT, V142, P3996, DOI 10.1242/dev.129452; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cytlak U, 2020, IMMUNITY, V53, P353, DOI 10.1016/j.immuni.2020.07.003; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Hamey FK, 2017, P NATL ACAD SCI USA, V114, P5822, DOI 10.1073/pnas.1610609114; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Kawano Y, 2018, BLOOD, V131, P2026, DOI 10.1182/blood-2017-09-805259; Kim S, 2020, IMMUNITY, V53, P759, DOI 10.1016/j.immuni.2020.07.018; Kurotaki D, 2019, BLOOD, V133, P1803, DOI 10.1182/blood-2018-06-857789; Kurotaki D, 2018, CELL REP, V22, P2628, DOI 10.1016/j.celrep.2018.02.048; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Sakai K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50318-6; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Sigvardsson M, 2012, BLOOD, V120, P3630, DOI 10.1182/blood-2012-09-455113; Stadhouders R, 2019, NATURE, V569, P345, DOI 10.1038/s41586-019-1182-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura A, 2017, BLOOD, V130, P1809, DOI 10.1182/blood-2017-03-772962; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2015, INT J HEMATOL, V101, P342, DOI 10.1007/s12185-015-1761-9; Volk A, 2018, CANCER CELL, V34, P707, DOI 10.1016/j.ccell.2018.10.004; Weinreb C, 2020, SCIENCE, V367, DOI 10.1126/science.aaw3381; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilkinson AC, 2017, CELL SYST, V5, P319, DOI 10.1016/j.cels.2017.07.004; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021	63	7	7	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					301	+		10.1038/s41590-021-00871-y	http://dx.doi.org/10.1038/s41590-021-00871-y		FEB 2021	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33603226				2022-12-18	WOS:000619508500002
J	Hammad, H; Lambrecht, BN				Hammad, Hamida; Lambrecht, Bart N.			Wnt and Hippo pathways in regulatory T cells: a NOTCH above in asthma	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMATION	The activation of the Notch4-Wnt-GDF15 axis in induced regulatory T (T(reg)cells) dampens their immunoregulatory function and turns them into T(H)2 and T(H)17 cytokine producers, allowing them to maintain ongoing allergic asthma.	[Hammad, Hamida; Lambrecht, Bart N.] VIB Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium; [Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Erasmus University Rotterdam; Erasmus MC	Hammad, H (corresponding author), VIB Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium.; Hammad, H (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.	Hamida.hammad@ugent.be	Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834	European Research Council [789384] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Geng J, 2017, NAT IMMUNOL, V18, P1270, DOI 10.1038/ni1117-1270c; Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3; Rigas D, 2017, J ALLERGY CLIN IMMUN, V139, P1468, DOI 10.1016/j.jaci.2016.08.034; Tindemans I, 2017, J ALLERGY CLIN IMMUN, V140, P1079, DOI 10.1016/j.jaci.2016.11.046; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Verhamme FM, 2017, MUCOSAL IMMUNOL, V10, P1400, DOI 10.1038/mi.2017.3; Verhein KC, 2015, ENVIRON HEALTH PERSP, V123, P799, DOI 10.1289/ehp.1408852; Xia MC, 2018, J ALLERGY CLIN IMMUN, V142, P1243, DOI 10.1016/j.jaci.2018.03.009; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	12	7	7	4	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1313	1314		10.1038/s41590-020-0797-z	http://dx.doi.org/10.1038/s41590-020-0797-z		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32968284	Green Accepted, Green Published			2022-12-18	WOS:000572295100001
J	Akassoglou, K				Akassoglou, Katerina			The immunology of blood: connecting the dots at the neurovascular interface	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; TRANSGENIC MICE; FIBRINOGEN; DEGENERATION; DEMYELINATION; INFLAMMATION; MODEL; REMYELINATION; FIBRINOLYSIS	Katerina Akassoglou recounts how her work on the mechanisms and functions of blood leaks in the brain led to the discovery of fibrin-targeting immunotherapy.	[Akassoglou, Katerina] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Akassoglou, K (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA.	kakassoglou@gladstone.ucsf.edu		Akassoglou, Katerina/0000-0002-2632-1465	NIH/NINDS [R35 NS097976]; Department of Defense [MS160082]; Dagmar Dolby Family Fund; Edward and Pearl Fein Trust; Simon Family Trust; NIH/NIA [RF1 AG064926]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); Dagmar Dolby Family Fund; Edward and Pearl Fein Trust; Simon Family Trust; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I am especially grateful to all my current and former laboratory members for their creativity, grit and exceptional contributions. I thank my mentors, collaborators and colleagues for their enthusiasm and continued support. Thanks to Hans Lassmann, Sidney Strickland, Jay L. Degen, George Kollias, Moses V. Chao, Mark A. Petersen and Kathryn Claiborn for critical reading of this manuscript. K.A. is currently supported by NIH/NINDS R35 NS097976, NIH/NIA RF1 AG064926, Department of Defense MS160082, the Dagmar Dolby Family Fund, the Edward and Pearl Fein Trust and the Simon Family Trust. Lastly, I am grateful to the University of California, San Diego; Gladstone Institutes; and the University of California, San Francisco for promoting a culture of discovery and innovation.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Akassoglou K, 2002, BIOL CHEM, V383, P37, DOI 10.1515/BC.2002.004; Akassoglou K, 1997, J IMMUNOL, V158, P438; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Coller BS, 1996, HAEMOSTASIS, V26, P285; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; CROSS AH, 1995, J NEUROIMMUNOL, V58, P117, DOI 10.1016/0165-5728(95)00007-O; Davalos D, 2014, ANN NEUROL, V75, P303, DOI 10.1002/ana.24078; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Kassiotis G, 1999, EUR J IMMUNOL, V29, P912, DOI 10.1002/(SICI)1521-4141(199903)29:03<912::AID-IMMU912>3.0.CO;2-G; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Lee NJ, 2018, BRAIN, V141, P1637, DOI 10.1093/brain/awy082; Mendiola AS, 2020, NAT IMMUNOL, V21, P513, DOI 10.1038/s41590-020-0654-0; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; PATERSON PY, 1976, FED PROC, V35, P2428; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Petersen MA, 2017, NEURON, V96, P1003, DOI 10.1016/j.neuron.2017.10.008; Pous L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14466-y; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; Rindfleisch E., 1863, ARCH PATHOL ANAT PH, V26, P474, DOI [10.1007/BF01878008, DOI 10.1007/BF01878008]; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Ugarova TP, 2003, BIOCHEMISTRY-US, V42, P9365, DOI 10.1021/bi034057k; Vilcek J, 2016, LOVE SCI MEMOIR	36	7	7	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					710	712		10.1038/s41590-020-0671-z	http://dx.doi.org/10.1038/s41590-020-0671-z			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577008	Green Accepted			2022-12-18	WOS:000542863800007
J	Murphy, MP; O'Neill, LAJ				Murphy, Michael P.; O'Neill, Luke A. J.			How should we talk about metabolism?	NATURE IMMUNOLOGY			English	Article							SUCCINATE; IMMUNITY; SIGNAL	Immunologists used to avoid metabolism, but that is no longer possible. Now that we must talk about it, how can we do so in a way that enhances and clarifies our understanding of the role metabolism plays in the immune response?	[Murphy, Michael P.] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England; [O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Trinity College Dublin	Murphy, MP (corresponding author), Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.; O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	mpm@mrc-mbu.cam.ac.uk; laoneill@tcd.ie	; Murphy, Michael/C-2120-2009	O'Neill, Luke/0000-0002-4333-2748; Murphy, Michael/0000-0003-1115-9618	UK Medical Research Council [MC_UU_00015/5]; Wellcome Trust [110159/Z/15/Z]; MRC [MC_UU_00015/8, MC_UU_00015/5] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in the laboratory of M.P.M. is supported by a grant from the UK Medical Research Council (MC_UU_00015/5) and by a Wellcome Trust Investigator award (110159/Z/15/Z). Work in the laboratory of L.A.O. is supported by the Wellcome Trust.	Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chandel N.S., 2015, NAVIGATING METABOLIS; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Hindupur SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019141; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Nicholls David G., 2013, BIOENERGETICS, V4; Ryan DG, 2019, NAT METAB, V1, P16, DOI 10.1038/s42255-018-0014-7; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	12	7	7	2	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					713	715		10.1038/s41590-020-0691-8	http://dx.doi.org/10.1038/s41590-020-0691-8		MAY 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32409776				2022-12-18	WOS:000532876500001
J	Gratz, IK; Campbell, DJ				Gratz, Iris K.; Campbell, Daniel J.			Resident memory T cells show that it is never too late to change your ways	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN SKIN	Immunological memory is a crucial feature of adaptive immunity. A new report proposes a novel 'outside-in' mechanism by which a recall immune response may be initiated from the tissue, rather than secondary lymphoid organs.	[Gratz, Iris K.] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Gratz, Iris K.; Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Gratz, Iris K.] Paracelsus Med Univ, EB House Austria, Dept Dermatol, Univ Hosp, Salzburg, Austria; [Campbell, Daniel J.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	Salzburg University; Benaroya Research Institute; Paracelsus Private Medical University; University of Washington; University of Washington Seattle	Gratz, IK (corresponding author), Univ Salzburg, Dept Biosci, Salzburg, Austria.; Gratz, IK (corresponding author), Benaroya Res Inst, Seattle, WA 98101 USA.; Gratz, IK (corresponding author), Paracelsus Med Univ, EB House Austria, Dept Dermatol, Univ Hosp, Salzburg, Austria.	iris.gratz@sbg.ac.at; campbell@benaroyaresearch.org	Gratz, Iris K/L-6267-2015	Gratz, Iris K/0000-0001-7470-7277				Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Olszewski WL, 1995, CLIN DERMATOL, V13, P473, DOI 10.1016/0738-081X(95)00087-V; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tripathi SK, 2014, IMMUNOL REV, V261, P62, DOI 10.1111/imr.12204; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302	13	7	7	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					359	360		10.1038/s41590-020-0637-1	http://dx.doi.org/10.1038/s41590-020-0637-1		MAR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205885				2022-12-18	WOS:000519843600008
J	Burbage, M; Gros, M; Amigorena, S				Burbage, Marianne; Gros, Marine; Amigorena, Sebastian			Translate less, prime better, to improve anti-tumor responses	NATURE IMMUNOLOGY			English	Editorial Material							CROSS-PRESENTATION	The N-6-methyladenosine (m(6)A) RNA-modification pathway affects numerous aspects of immune responses. A new study now demonstrates that m(6)A modification of transcripts encoding lysosomal proteases limits the efficiency of tumor-antigen cross-presentation.	[Burbage, Marianne; Gros, Marine; Amigorena, Sebastian] PSL Res Univ, Inst Curie, INSERM, U932, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Amigorena, S (corresponding author), PSL Res Univ, Inst Curie, INSERM, U932, Paris, France.	sebastian.amigorena@curie.fr	Burbage, Marianne/GLQ-7327-2022	Burbage, Marianne/0000-0003-0686-2608; GROS, Marine/0000-0003-3914-7264				Alloatti A, 2017, J EXP MED, V214, P2231, DOI 10.1084/jem.20170229; Gros M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00041; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Theisen DJ, 2019, CANCER IMMUNOL RES, V7, P29, DOI 10.1158/2326-6066.CIR-18-0138; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z	12	7	8	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					518	520		10.1038/s41590-019-0371-8	http://dx.doi.org/10.1038/s41590-019-0371-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30936492				2022-12-18	WOS:000465084800006
J	Guermonprez, P; Helft, J				Guermonprez, Pierre; Helft, Julie			Inflammasome activation: a monocyte lineage privilege	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; MACROPHAGES	Inflammasomes have been reported to function in a wide variety of innate immune cells; however, their activity now seems to be more restricted than previously thought.	[Guermonprez, Pierre] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immmunobiol, Ctr Inflammat Biol & Canc Immunol, London, England; [Guermonprez, Pierre] Sorbonne Paris Cite Univ, CNRS, INSERM1149, ERL8252,Paris Diderot,Ctr Inflammat Res, Paris, France; [Helft, Julie] PSL Res Univ, Inst Curie, Immun & Canc Dept, INSERM,U932, Paris, France	University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Guermonprez, P (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immmunobiol, Ctr Inflammat Biol & Canc Immunol, London, England.; Guermonprez, P (corresponding author), Sorbonne Paris Cite Univ, CNRS, INSERM1149, ERL8252,Paris Diderot,Ctr Inflammat Res, Paris, France.	pierre.guermonprez@kcl.ac.uk; julie.helft@curie.fr	Helft, Julie/ABE-6179-2020; Guermonprez, Pierre/ABE-7718-2020	Helft, Julie/0000-0002-2733-1972; Guermonprez, Pierre/0000-0001-5621-2262	Medical Research Council [MR/K01241X/1] Funding Source: Medline; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/K001868/1] Funding Source: Medline; BBSRC [BB/M029735/1] Funding Source: UKRI; MRC [MR/K01241X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barbet G, 2018, IMMUNITY, V48, P584, DOI 10.1016/j.immuni.2018.02.015; BHARDWAJ N, 1988, CELL IMMUNOL, V114, P405, DOI 10.1016/0008-8749(88)90332-2; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Luft T, 2002, J IMMUNOL, V168, P713, DOI 10.4049/jimmunol.168.2.713; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Westerterp M, 2017, CELL METAB, V25, P1294, DOI 10.1016/j.cmet.2017.04.005	16	7	7	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					383	385		10.1038/s41590-019-0348-7	http://dx.doi.org/10.1038/s41590-019-0348-7			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30858619				2022-12-18	WOS:000461904200009
J	Fredman, G				Fredman, Gabrielle			DELineating resolution of inflammation	NATURE IMMUNOLOGY			English	Editorial Material							LIPID MEDIATORS	The resolution of inflammation is a protective response. The identification and characterization of new players that boost this response might inform the development of novel therapies for non-resolving inflammatory diseases.	[Fredman, Gabrielle] Albany Med Coll, Dept Mol & Cellular Physiol, New York, NY 12208 USA	Albany Medical College	Fredman, G (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, New York, NY 12208 USA.	fredmag@amc.edu		Fredman, Gabrielle/0000-0001-9974-0962	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119587] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL119587] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kourtzelis I, 2019, NAT IMMUNOL, V20, P40, DOI 10.1038/s41590-018-0249-1; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202	10	7	8	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					2	3		10.1038/s41590-018-0278-9	http://dx.doi.org/10.1038/s41590-018-0278-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538337				2022-12-18	WOS:000456273900006
J	Visan, I				Visan, Ioana			Targeting TGF-beta in cancer	NATURE IMMUNOLOGY			English	Editorial Material																			0	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					316	316		10.1038/s41590-018-0076-4	http://dx.doi.org/10.1038/s41590-018-0076-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563626				2022-12-18	WOS:000428151000002
J	Silver, JS; Humbles, AA				Silver, Jonathan S.; Humbles, Alison A.			NK cells join the plasticity party	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; T-CELLS; SUBSETS	The cytokine TGF-beta allows tumors to evade the immune system by converting conventional natural killer cells into type 1 innate lymphoid cells devoid of cytotoxic function.	[Silver, Jonathan S.; Humbles, Alison A.] MedImmune, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Humbles, AA (corresponding author), MedImmune, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA.	humblesa@medimmune.com						Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Crome SQ, 2017, NAT MED, V23, P368, DOI 10.1038/nm.4278; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005	12	7	7	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					959	960		10.1038/ni.3817	http://dx.doi.org/10.1038/ni.3817			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28829441				2022-12-18	WOS:000408137700004
J	Marino, E; Richards, JL; McLeod, KH; Stanley, D; Yap, YA; Knight, J; McKenzie, C; Kranich, J; Oliveira, AC; Rossello, FJ; Krishnamurthy, B; Nefzger, CM; Macia, L; Thorburn, A; Baxter, AG; Morahan, G; Wong, LH; Polo, JM; Moore, RJ; Lockett, TJ; Clarke, JM; Topping, DL; Harrison, LC; Mackay, CR				Marino, Eliana; Richards, James L.; McLeod, Keiran H.; Stanley, Dragana; Yap, Yu Anne; Knight, Jacinta; McKenzie, Craig; Kranich, Jan; Oliveira, Ana Carolina; Rossello, Fernando J.; Krishnamurthy, Balasubramanian; Nefzger, Christian M.; Macia, Laurence; Thorburn, Alison; Baxter, Alan G.; Morahan, Grant; Wong, Lee H.; Polo, Jose M.; Moore, Robert J.; Lockett, Trevor J.; Clarke, Julie M.; Topping, David L.; Harrison, Leonard C.; Mackay, Charles R.			Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes (vol 18, pg 552, 2017)	NATURE IMMUNOLOGY			English	Correction													Mariño, Eliana/GPK-6544-2022; Oliveira, Ana Carolina/GRF-1435-2022; Moore, Robert J/D-8352-2011; Rossello, Fernando/B-1208-2015; Oliveira, Ana Carolina/O-6791-2014; Stanley, Dragana/AAC-2596-2020; Lockett, Trevor J/H-8970-2013	Moore, Robert J/0000-0002-0776-5861; Rossello, Fernando/0000-0003-3885-8777; Oliveira, Ana Carolina/0000-0002-0036-3720; Stanley, Dragana/0000-0001-7019-4726; Lockett, Trevor J/0000-0002-8063-071X				Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713	1	7	8	3	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					951	951		10.1038/ni0817-951c	http://dx.doi.org/10.1038/ni0817-951c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722715	Bronze			2022-12-18	WOS:000405821100020
J	Visan, I				Visan, Ioana			Alzheimer's disease microglia	NATURE IMMUNOLOGY			English	Editorial Material																			0	7	7	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					876	876						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU7IO	28722716				2022-12-18	WOS:000424026000004
J	Silva-Santos, B; Strid, J				Silva-Santos, Bruno; Strid, Jessica			gamma delta T cells get adaptive	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW; TRANSPLANTATION; REPERTOIRE		[Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Strid, Jessica] Imperial Coll London, Dept Med, Div Immunol & Inflammat, London, England	Universidade de Lisboa; Imperial College London	Strid, J (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, London, England.	j.strid@imperial.ac.uk		Silva-Santos, Bruno/0000-0003-4141-9302				Bertaina A, 2014, BLOOD, V124, P822, DOI 10.1182/blood-2014-03-563817; Davey MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14760; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Pauza CD, 2015, CELL IMMUNOL, V296, P22, DOI 10.1016/j.cellimm.2015.02.010; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rossol R, 1998, BRIT J HAEMATOL, V100, P728, DOI 10.1046/j.1365-2141.1998.00630.x; SHERWOOD AM, 2011, SCI TRANSL MED, V90, pRA61; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Wu CJ, 2000, BLOOD, V95, P352	13	7	7	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					370	372		10.1038/ni.3705	http://dx.doi.org/10.1038/ni.3705			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323258	Green Submitted			2022-12-18	WOS:000396815800004
J	Dempsey, LA				Dempsey, Laurie A.			CyTOF analysis of anti-tumor responses	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	7	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					254	254						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU8PC	28198832	Bronze			2022-12-18	WOS:000424114800006
J	Bruchard, M; Rebe, C; Derangere, V; Togbe, D; Ryffel, B; Boidot, R; Humblin, E; Hamman, A; Chalmin, F; Berger, H; Chevriaux, A; Limagne, E; Apetoh, L; Vegran, F; Ghiringhelli, F				Bruchard, Melanie; Rebe, Cedric; Derangere, Valentin; Togbe, Dieudonnee; Ryffel, Bernhard; Boidot, Romain; Humblin, Etienne; Hamman, Arlette; Chalmin, Fanny; Berger, Helene; Chevriaux, Angelique; Limagne, Emeric; Apetoh, Lionel; Vegran, Frederique; Ghiringhelli, Francois			The receptor NLRP3 is a transcriptional regulator of T(H)2 differentiation (vol 16, pg 859, 2015)	NATURE IMMUNOLOGY			English	Correction													Apetoh, Lionel/AIC-2384-2022; Apetoh, Lionel/G-3310-2014; Bruchard, Melanie/E-6508-2017; REBE, Cédric/AAD-4316-2019; Togbe, Dieudonnee/AAE-1135-2020; VEGRAN, Frédérique/H-4792-2017; VEGRAN, Frederique/O-9986-2018	Apetoh, Lionel/0000-0002-2774-438X; Apetoh, Lionel/0000-0002-2774-438X; Bruchard, Melanie/0000-0003-0004-2887; REBE, Cédric/0000-0001-8831-145X; Togbe, Dieudonnee/0000-0001-6658-414X; VEGRAN, Frederique/0000-0002-4377-1441; ghiringhelli, francois/0000-0002-5465-8305; Chalmin, Fanny/0000-0002-0855-9453; Humblin, Etienne/0000-0002-4559-6106; Emeric, Limagne/0000-0002-1098-8441				Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202	1	7	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1292	1292		10.1038/ni1215-1292a	http://dx.doi.org/10.1038/ni1215-1292a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26580508	Bronze			2022-12-18	WOS:000365062100013
J	Gurung, P; Man, SM; Kanneganti, TD				Gurung, Prajwal; Man, Si Ming; Kanneganti, Thirumala-Devi			A 20 is a regulator of necroptosis	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; A20; UBIQUITINATION; KINASE	The anti-inflammatory molecule A20 inhibits necroptotic cell death by inhibiting ubiquitination of the kinase RIPK3 at the Lys5 residue and preventing excessive formation of the RIPK1-RIPK3 necroptotic complex.	[Gurung, Prajwal; Man, Si Ming; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Gurung, P (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Man, Si Ming/AAE-9168-2019; Man, Si Ming/O-6223-2015; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Man, Si Ming/0000-0002-5079-2857; Man, Si Ming/0000-0002-5079-2857; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Gurung, Prajwal/0000-0002-7451-9433	NIAMS NIH HHS [R01 AR056296] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Giordano M, 2014, P NATL ACAD SCI USA, V111, P11115, DOI 10.1073/pnas.1406259111; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vande Walle V, 2014, NATURE, V512, P69; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	12	7	8	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					596	597		10.1038/ni.3174	http://dx.doi.org/10.1038/ni.3174			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988900				2022-12-18	WOS:000354751900011
J	Diefenbach, A				Diefenbach, Andreas			Profiling the diversity of innate lymphoid cells	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; RECEPTOR		[Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55122 Mainz, Germany; [Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Diefenbach, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55122 Mainz, Germany.	diefenbach@uni-mainz.de	Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530				Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5	12	7	8	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					222	224		10.1038/ni.3107	http://dx.doi.org/10.1038/ni.3107			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689434				2022-12-18	WOS:000349842100003
J	Roux, BT; Lindsay, MA				Roux, Benoit T.; Lindsay, Mark A.			LincRNA signatures in human lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							LONG NONCODING RNAS; DIFFERENTIATION; ACTIVATION; MECHANISMS; EXPRESSION		[Roux, Benoit T.; Lindsay, Mark A.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Roux, BT (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	m.a.lindsay@bath.ac.uk		Lindsay, Mark/0000-0003-4807-5506	BBSRC [BB/K006223/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K006223/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020	13	7	8	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					220	222		10.1038/ni.3106	http://dx.doi.org/10.1038/ni.3106			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689433	Green Submitted, Green Accepted			2022-12-18	WOS:000349842100002
J	Bilsborough, J; Viney, JL				Bilsborough, Janine; Viney, Joanne L.			GPR15: a tale of two species	NATURE IMMUNOLOGY			English	Editorial Material							INDUCED COLITIS		[Bilsborough, Janine] Cedars Sinai Med Ctr, Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA; [Bilsborough, Janine] Cedars Sinai Med Ctr, Inst Immunobiol, Los Angeles, CA 90048 USA; [Viney, Joanne L.] Biogen Idec Inc, Immunol Res, Cambridge, MA USA	Cedars Sinai Medical Center; Biogen	Bilsborough, J (corresponding author), Cedars Sinai Med Ctr, Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA.	jo.viney@biogenidec.com						Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Heiber M, 1996, GENOMICS, V32, P462, DOI 10.1006/geno.1996.0143; Keshav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060094; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Mosli MH, 2014, DRUGS, V74, P297, DOI 10.1007/s40265-013-0176-2; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; Poole RM, 2014, DRUGS, V74, P1293, DOI 10.1007/s40265-014-0253-1; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Wang CH, 2010, INFLAMM BOWEL DIS, V16, P1751, DOI 10.1002/ibd.21266	12	7	8	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					137	139		10.1038/ni.3084	http://dx.doi.org/10.1038/ni.3084			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594457				2022-12-18	WOS:000348143100004
J	Bowie, AG				Bowie, Andrew G.			Rad50 and CARD9, missing links in cytosolic DNA-stimulated inflammation	NATURE IMMUNOLOGY			English	Editorial Material							INTRACELLULAR DNA; SENSOR	The DNA-damage sensor Rad50 couples the sensing of cytosolic DNA to the innate immunological adaptor CARD9 to stimulate DNA-dependent activation of the transcription factor NF-kappa B. This facilitates DNA virus stimulated production of the cytokine IL-1 beta.	Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Bhat N, 2014, EUR J IMMUNOL, V44, P634, DOI 10.1002/eji.201344127; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	11	7	7	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					534	536		10.1038/ni.2894	http://dx.doi.org/10.1038/ni.2894			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840992				2022-12-18	WOS:000336419300009
J	Norton, M; Screaton, RA				Norton, Matthew; Screaton, Robert A.			SGK1: master and commander of the fate of helper T cells	NATURE IMMUNOLOGY			English	Editorial Material							PATHOGENIC T(H)17 CELLS; PHOSPHORYLATION; EXPRESSION; INDUCTION		[Norton, Matthew; Screaton, Robert A.] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Screaton, Robert A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Screaton, Robert A.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Norton, M (corresponding author), Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada.	rob@arc.cheo.ca						Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yano T, 2014, CIRC RES, V114, P1268, DOI 10.1161/CIRCRESAHA.114.303562; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	15	7	7	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					411	413		10.1038/ni.2875	http://dx.doi.org/10.1038/ni.2875			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747705				2022-12-18	WOS:000334667900005
J	[Anonymous]				[Anonymous]			Immunity in the tissues	NATURE IMMUNOLOGY			English	Editorial Material														Dempsey, Laurie/0000-0002-3304-796X					0	7	7	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					977	977		10.1038/ni.2722	http://dx.doi.org/10.1038/ni.2722			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048118				2022-12-18	WOS:000324584700001
J	Willcox, CR; Mohammed, F; Willcox, BE				Willcox, Carrie R.; Mohammed, Fiyaz; Willcox, Benjamin E.			Resolving the mystery of pyrophosphate antigen presentation	NATURE IMMUNOLOGY			English	Editorial Material							DELTA T-CELLS; RECOGNITION; RECEPTOR; ACTIVATION		[Willcox, Carrie R.; Mohammed, Fiyaz; Willcox, Benjamin E.] Univ Birmingham, Sch Canc Sci, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Willcox, CR (corresponding author), Univ Birmingham, Sch Canc Sci, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England.	b.willcox@bham.ac.uk						Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; FISCH P, 1990, SCIENCE, V250, P1269, DOI 10.1126/science.1978758; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Kato Y, 2003, J IMMUNOL, V170, P3608, DOI 10.4049/jimmunol.170.7.3608; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231	14	7	7	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					886	887		10.1038/ni.2689	http://dx.doi.org/10.1038/ni.2689			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959177				2022-12-18	WOS:000323377700003
J	Witherden, DA; Havran, WL				Witherden, Deborah A.; Havran, Wendy L.			EPCR: a stress trigger for gamma delta T cells	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN RECOGNITION; RECEPTOR	The mechanism by which gamma delta T cells are triggered to respond to stress elicited by infection or malignancy has remained a mystery. New data identify endothelial protein C receptor as a stress ligand for gamma delta T cells that is induced by cytomegalovirus infection.	[Witherden, Deborah A.; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Witherden, DA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	havran@scripps.edu						Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Bonneville M, 2005, MICROBES INFECT, V7, P503, DOI 10.1016/j.micinf.2005.03.004; Bukowski JF, 1998, J IMMUNOL, V161, P286; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Miyagawa F, 2001, J IMMUNOL, V167, P6773, DOI 10.4049/jimmunol.167.12.6773; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698	13	7	7	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					812	814		10.1038/ni.2398	http://dx.doi.org/10.1038/ni.2398			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910386				2022-12-18	WOS:000307863600007
J	Lehuen, A; Fazilleau, N				Lehuen, Agnes; Fazilleau, Nicolas			Innate iNKT cell help to B cells: fast but does not last	NATURE IMMUNOLOGY			English	News Item							INVARIANT NKT CELLS; T-CELLS; ANTIBODY; INFECTION	Harnessing invariant natural killer T cells can boost various immune responses. Two studies now shed light on the direct interaction between those cells and B cells that induce strong primary B cell responses.	[Lehuen, Agnes] Univ Paris 05, INSERM, U986, Hop Cochin St Vincent de Paul, Paris, France; [Fazilleau, Nicolas] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, INSERM, U1043,CNRS,Unite Mixte Rech 5282, F-31062 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lehuen, A (corresponding author), Univ Paris 05, INSERM, U986, Hop Cochin St Vincent de Paul, Paris, France.	agnes.lehuen@inserm.fr	Fazilleau, Nicolas/J-9883-2014	Lehuen, Agnes/0000-0002-0450-3321; Fazilleau, Nicolas/0000-0002-3574-5614				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Belperron AA, 2005, J IMMUNOL, V174, P5681, DOI 10.4049/jimmunol.174.9.5681; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Diana J, 2009, EUR J IMMUNOL, V39, P3283, DOI 10.1002/eji.200939800; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Hansen DS, 2003, EUR J IMMUNOL, V33, P2588, DOI 10.1002/eji.200323666; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657	13	7	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					11	13		10.1038/ni.2186	http://dx.doi.org/10.1038/ni.2186			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179271				2022-12-18	WOS:000298412800003
J	Ludewig, B; Cervantes-Barragan, L				Ludewig, Burkhard; Cervantes-Barragan, Luisa			CD169(+) macrophages take the bullet	NATURE IMMUNOLOGY			English	News Item							SUBCAPSULAR SINUS MACROPHAGES; INFECTION; VIRUSES; ISG15; RESPONSES; UBP43	Lifting the protective shield provided by the type I interferon system selectively in CD169(+) splenic macrophages enforces localized viral replication. Such controlled release of virus amplifies adaptive antiviral immune responses.	[Ludewig, Burkhard] Kantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Cervantes-Barragan, Luisa] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Kantonsspital St. Gallen; Washington University (WUSTL)	Ludewig, B (corresponding author), Kantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland.	burkhard.ludewig@kssg.ch						Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Oehen S, 2002, J IMMUNOL, V169, P1453, DOI 10.4049/jimmunol.169.3.1453; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	12	7	7	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					13	14		10.1038/ni.2189	http://dx.doi.org/10.1038/ni.2189			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179272				2022-12-18	WOS:000298412800004
J	Oestreich, KJ; Weinmann, AS				Oestreich, Kenneth J.; Weinmann, Amy S.			Ikaros changes the face of NuRD remodeling	NATURE IMMUNOLOGY			English	News Item							MI-2/NURD COMPLEX; CHROMATIN	The inclusion of the transcription factor Ikaros in the NuRD chromatin-remodeling complex regulates both the targeting and activity of the NuRD complex in lymphocytes, thereby influencing developmental gene-expression programs.	[Oestreich, Kenneth J.; Weinmann, Amy S.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Oestreich, KJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	weinmann@u.washington.edu						Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	12	7	7	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					16	18		10.1038/ni.2191	http://dx.doi.org/10.1038/ni.2191			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179274				2022-12-18	WOS:000298412800006
J	Godfrey, DI; Pellicci, DG; Rossjohn, J				Godfrey, Dale I.; Pellicci, Daniel G.; Rossjohn, Jamie			Beta-testing NKT cell self-reactivity	NATURE IMMUNOLOGY			English	Editorial Material							KILLER T-CELLS; RECOGNITION; GLYCOLIPIDS; ACTIVATION	Natural killer T cells (NKT cells) recognize lipid-based antigens presented by CD1d. The mammalian glycolipid beta-glucosylceramide, a ubiquitous self antigen for NKT cells, is upregulated by microbial danger signals, which leads to activation of NKT cells in the absence of foreign glycolipid antigen.	[Godfrey, Dale I.; Pellicci, Daniel G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Melbourne; Monash University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	godfrey@unimelb.edu.au	Pellicci, Daniel/AAX-8539-2020; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Godfrey, Dale/0000-0002-3009-5472; Pellicci, Daniel/0000-0001-5305-2398				Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Godfrey DI, 2011, J EXP MED, V208, P1121, DOI 10.1084/jem.20110983; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Zigmond E, 2007, GUT, V56, P82, DOI 10.1136/gut.2006.095497	15	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1135	1137		10.1038/ni.2162	http://dx.doi.org/10.1038/ni.2162			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22089211				2022-12-18	WOS:000297202700005
J	Jabri, B; Barreiro, LB				Jabri, Bana; Barreiro, Luis B.			Don't move: LRRK2 arrests NFAT in the cytoplasm	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; NONCODING RNAS	The kinase LRRK2 is a risk factor for inflammatory bowel disease. New data show that LLRK2 blocks the transport of NFAT to the nucleus and that LLRK2 deficiency results in enhanced susceptibility to experimental colitis in mice.	[Jabri, Bana] Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Barreiro, Luis B.] Univ Montreal, Dept Pediat, Fac Med, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada	University of Chicago; University of Chicago; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Jabri, B (corresponding author), Univ Chicago, Dept Med, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Barreiro, Luis/I-7772-2015	Barreiro, Luis/0000-0001-9456-367X				Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901	12	7	7	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1029	1030		10.1038/ni.2139	http://dx.doi.org/10.1038/ni.2139			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012435				2022-12-18	WOS:000296500100006
J	Skon, CN; Jameson, SC				Skon, Cara N.; Jameson, Stephen C.			Fox factors fight over T cell quiescence	NATURE IMMUNOLOGY			English	Editorial Material							NAIVE; IL-7; HOMEOSTASIS; SURVIVAL; RECEPTOR; PATHWAY	The transcription factor Foxp1 helps maintain the quiescence of naive T cells by inhibiting IL-7R alpha expression and diminishing signaling by the kinase Erk.	[Skon, Cara N.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Skon, CN (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Skon-Hegg, Cara/0000-0003-0703-3553				Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Johnson SE, 2008, J IMMUNOL, V180, P8109, DOI 10.4049/jimmunol.180.12.8109; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	12	7	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					522	+		10.1038/ni.2040	http://dx.doi.org/10.1038/ni.2040			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21587312				2022-12-18	WOS:000290707100012
J	Thrasher, AJ; Segal, AW				Thrasher, Adrian J.; Segal, Anthony W.			A phagocyte dilemma...	NATURE IMMUNOLOGY			English	Editorial Material							NADPH OXIDASE ACTIVITY; MACROPHAGES; NEUTROPHILS; EXPRESSION		[Thrasher, Adrian J.] UCL, Ctr Immunodeficiency, London, England; [Segal, Anthony W.] UCL, Dept Mol Med, London, England	University of London; University College London; University of London; University College London	Thrasher, AJ (corresponding author), UCL, Ctr Immunodeficiency, London, England.	a.thrasher@ich.ucl.ac.uk		Segal, Anthony/0000-0001-7602-9043; Thrasher, Adrian/0000-0002-6097-6115	Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish; Wellcome Trust [081695, 090233] Funding Source: Medline	Great Ormond Street Hospital Childrens Charity; Wellcome Trust(Wellcome TrustEuropean Commission)		Baldridge L.W., 1932, AM J PHYSIOL, V103, P235; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; CHETTY M, 1995, BIOCHEM J, V306, P141, DOI 10.1042/bj3060141; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; LEVY R, 1991, J IMMUNOL, V147, P3066; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Rahman FZ, 2009, IMMUNOLOGY, V128, P253, DOI 10.1111/j.1365-2567.2009.03112.x; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; SEGAL AW, 1981, BIOCHEM J, V196, P363, DOI 10.1042/bj1960363; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shaw G.B., 1911, DOCTORS DILEMMA TRAG, V28; Yu LX, 1999, J BIOL CHEM, V274, P4364, DOI 10.1074/jbc.274.7.4364	15	7	7	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					201	202		10.1038/ni0311-201	http://dx.doi.org/10.1038/ni0311-201			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21321592	Green Accepted			2022-12-18	WOS:000287354400006
J	Motohashi, H; Igarashi, K				Motohashi, Hozumi; Igarashi, Kazuhiko			MafB as a type I interferon rheostat	NATURE IMMUNOLOGY			English	Editorial Material							INDUCTION	Type I interferons are produced by almost all nucleated cells in response to virus infection. MafB is now shown to modulate the efficiency of interferon production by setting a threshold for IRF3-dependent transcription.	[Motohashi, Hozumi; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan; [Motohashi, Hozumi] Tohoku Univ, Grad Sch Med, Ctr Radioisotope Sci, Sendai, Miyagi 980, Japan; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Motohashi, H (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan.	hozumim@med.tohoku.ac.jp; igarashi@med.tohoku.ac.jp	Motohashi, Hozumi/AAZ-2628-2020	Igarashi, Kazuhiko/0000-0002-2470-2475				Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Kurokawa H, 2009, MOL CELL BIOL, V29, P6232, DOI 10.1128/MCB.00708-09; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Yang Ying, 2007, Einstein J Biol Med, V23, P2	12	7	7	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					695	696		10.1038/ni0810-695	http://dx.doi.org/10.1038/ni0810-695			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644578				2022-12-18	WOS:000280149400009
J	Relman, DA				Relman, David A.			The biological century: coming to terms with risk in the life sciences	NATURE IMMUNOLOGY			English	Article								Although the life sciences promise huge benefits, the possibility of doing harm from deliberate misuse of knowledge is an increasingly worrisome issue. Discussion and mitigation of these risks by life scientists must be encouraged.	[Relman, David A.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Med, Palo Alto, CA 94304 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354				BENFORD G, 1992, MAGAZINE FANTASY AUG, P73; Berg P, 2008, NATURE, V455, P290, DOI 10.1038/455290a; Casadevall A, 2010, NAT REV MICROBIOL, V8, P149, DOI 10.1038/nrmicro2299; Graham Bob, 2008, WORLD RISK REPORT CO; *I MED, 2005, MICR THREATS HLTH EM; Institute of Medicine and National Research Council, 2006, GLOB BIOS FUT LIF SC; MOWATTLARSSEN R, 2010, AL QAEDA WEAPONS MAS, P1; National Research Council, 2003, BIOT RES AG TERR CON; National Security Council, 2009, NAT STRAT COUNT BIOL; Petro JB, 2003, SCIENCE, V302, P1898, DOI 10.1126/science.1092493; Stanford MM, 2005, TRENDS IMMUNOL, V26, P339, DOI 10.1016/j.it.2005.04.001; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; 2009, FED REG         1127	13	7	9	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					275	278		10.1038/ni0410-275	http://dx.doi.org/10.1038/ni0410-275			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300132				2022-12-18	WOS:000275849500002
J	van der Merwe, PA; Dunne, PD; Klenerman, D; Davis, SJ				van der Merwe, P. Anton; Dunne, Paul D.; Klenerman, David; Davis, Simon J.			Taking T cells beyond the diffraction limit	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; RECEPTOR MICROCLUSTERS; ACTIVATION	Recent advances in microscopy have enabled imaging of cell surface receptors at ever higher resolutions. A report using the latest technology now provides evidence that the T cell antigen receptor and the adaptor Lat are confined to small islands, which cluster together after triggering of the T cell antigen receptor.	[van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England; [Dunne, Paul D.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Davis, Simon J.] Univ Oxford, Nuffield Dept Clin Med, Weatherall Inst Mol Med, Med Res Council,Human Immunol Unit, Oxford, England	University of Oxford; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England.	anton.vandermerwe@path.ox.ac.uk		Klenerman, David/0000-0001-7116-6954	MRC [G9722488] Funding Source: UKRI; Medical Research Council [G9722488, G19/31] Funding Source: Medline; Wellcome Trust [081894] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	12	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					51	52		10.1038/ni0110-51	http://dx.doi.org/10.1038/ni0110-51			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016513				2022-12-18	WOS:000272855300011
J	[Anonymous]				[Anonymous]			A case of junk science, conflict and hype	NATURE IMMUNOLOGY			English	Editorial Material								Despite accumulating evidence that vaccines are safe, vaccination uptake is falling, driving a resurgence in old scourges of society.											0	7	7	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1317	1317		10.1038/ni1208-1317	http://dx.doi.org/10.1038/ni1208-1317			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008926	Bronze			2022-12-18	WOS:000260888700001
J	Velazquez, P; Waite, JC; Dustin, ML				Velazquez, Peter; Waite, Janelle C.; Dustin, Michael L.			Dynamics of host defense: the view at the front lines	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELL ACTIVATION; IN-VIVO; T-CELLS; LISTERIA-MONOCYTOGENES; CLEARANCE; INFECTION; DISTINCT; ANTIGEN; SYSTEM; INJURY	Relatively few studies have used live tissue microscopy to evaluate how the immune system responds to pathogens. In this commentary we discuss the challenges of imaging infectious processes and the questions that can be addressed with these dynamic approaches.	NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055037, R21AI055037, P01AI071195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK078153] Funding Source: NIH RePORTER; NCI NIH HHS [CA09161] Funding Source: Medline; NIAID NIH HHS [AI71195, AI55037] Funding Source: Medline; NIDDK NIH HHS [DK78153] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MARCO AJ, 1991, J COMP PATHOL, V105, P1, DOI 10.1016/S0021-9975(08)80057-6; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nolte MA, 2000, EUR J IMMUNOL, V30, P626; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Velazquez P, 2005, SPRINGER SEMIN IMMUN, V26, P453, DOI 10.1007/s00281-004-0189-8; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883	32	7	7	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1153	1157		10.1038/ni1520	http://dx.doi.org/10.1038/ni1520			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952039				2022-12-18	WOS:000250338900004
J	Yoneyama, M; Fujita, T				Yoneyama, Mitsutoshi; Fujita, Takashi			Cytoplasmic double-stranded DNA sensor	NATURE IMMUNOLOGY			English	Editorial Material							RECOGNITION; GENE	A new study in Nature identifies a long-sought cytoplasmic 'sensor' that is responsible, at least in part, for interferon responses induced by double- stranded DNA.	Kyoto Univ, Inst Virus Res, Lab Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Lab Mol Genet, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Fujita T, 2006, SCIENCE, V314, P935, DOI 10.1126/science.1135756; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Rothenburg S, 2002, NUCLEIC ACIDS RES, V30, P993, DOI 10.1093/nar/30.4.993; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	11	7	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					907	908		10.1038/ni0907-907	http://dx.doi.org/10.1038/ni0907-907			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712341				2022-12-18	WOS:000248918200006
J	Frederick, TJ; Miller, SD				Frederick, Terra J.; Miller, Stephen D.			Arresting autoimmunity by blocking beta-arrestin 1	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ENCEPHALOMYELITIS; INFLAMMATION; EXPRESSION		Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Frederick, TJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu						Begolka WS, 1998, J IMMUNOL, V161, P4437; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Nguyen K, 2002, J IMMUNOL, V168, P4440, DOI 10.4049/jimmunol.168.9.4440; Okuda Y, 2002, J NEUROIMMUNOL, V131, P115, DOI 10.1016/S0165-5728(02)00267-9; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Vroon A, 2003, J NEUROIMMUNOL, V137, P79, DOI 10.1016/S0165-5728(03)00050-X; Wekerle H, 1991, Acta Neurol (Napoli), V13, P197; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	12	7	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					791	792		10.1038/ni0807-791	http://dx.doi.org/10.1038/ni0807-791			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17641656				2022-12-18	WOS:000248169400003
J	Winandy, S; Brown, M				Winandy, Susan; Brown, Melissa			No DL1 notch ligand? GATA be a mast cell	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR GATA-3; IN-VITRO; EXPRESSION; SPECIFICATION; LINEAGE		Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Winandy, S (corresponding author), Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	m-brown12@northwestern.edu						Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	13	7	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					796	799		10.1038/ni0807-796	http://dx.doi.org/10.1038/ni0807-796			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17641659				2022-12-18	WOS:000248169400006
J	Davis, MM				Davis, Mark M.			Blimp-1 over Budapest	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; B-CELL; DIFFERENTIATION; REPRESSOR; MATURATION; SEQUENCES	Blimp-1 is a transcription factor that affects the expression of hundreds of genes in lymphocytes. Recent work confirmed its role in the maturation of B cells into immunoglobulin-secreting plasmablasts, as well as in the control of T cell homeostasis and tolerance. What follows is a short history of how Blimp-1 was discovered.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X				BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; DAVIS MM, 1982, UCLA SYMP MOL CELL B, V24, P215; DAVIS R, 1987, CELL, V24, P987; DWORKIN MB, 1980, DEV BIOL, V76, P435, DOI 10.1016/0012-1606(80)90392-9; GALAU GA, 1976, CELL, V7, P487, DOI 10.1016/0092-8674(76)90200-2; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; MATHER EL, 1981, CELL, V23, P369, DOI 10.1016/0092-8674(81)90132-X; SARGENT T D, 1983, Science (Washington D C), V222, P135, DOI 10.1126/science.6688681; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711	17	7	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					445	447		10.1038/ni0507-445	http://dx.doi.org/10.1038/ni0507-445			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440448				2022-12-18	WOS:000245831600003
J	Kahn, ML; Koretzky, GA				Kahn, Mark L.; Koretzky, Gary A.			Integrins and ITAMs: more than just good neighbors	NATURE IMMUNOLOGY			English	Editorial Material							PROTEIN-TYROSINE KINASE; ACTIVATION; NEUTROPHILS; DOMAINS; SYK; ALPHA(IIB)BETA(3); REQUIREMENT; PLATELETS; PP72(SYK); COLLAGEN	New data show that integrin signaling by the Syk tyrosine kinase requires adaptors, such as DAP12, that have immunoreceptor tyrosine-based activation motifs.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Kahn, ML (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021					Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Judd BA, 2002, J EXP MED, V195, P705, DOI 10.1084/jem.20011583; Kellermann SA, 2002, IMMUNOL REV, V186, P172, DOI 10.1034/j.1600-065X.2002.18615.x; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Newbrough SA, 2003, IMMUNITY, V19, P759; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Wonerow P, 2002, BIOCHEM J, V364, P755, DOI 10.1042/BJ20020128; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200	15	7	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1286	1288		10.1038/ni1206-1286	http://dx.doi.org/10.1038/ni1206-1286			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110948				2022-12-18	WOS:000242125200009
J	Rose, NR				Rose, Noel R.			Life amidst the contrivances	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE-THYROIDITIS; HASHIMOTOS DISEASE; ORGAN SPECIFICITY; ANTIBODIES; RABBIT	The established dogma of `horror autotoxicus' was overturned 50 years ago with the publication of a paper showing that autoimmune thyroiditis could be induced in animals. Noel Rose recounts the events that led to the establishment of autoimmunity as a cause of disease.	Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Johns Hopkins Ctr Autoimmune Dis Res, Baltimore, MD 21205 USA; Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rose, NR (corresponding author), Johns Hopkins Sch Med, Dept Pathol, 615 N Wolfe St, Baltimore, MD 21205 USA.	nrrose@jhsph.edu						Afanasyeva M., 2004, INFECT AUTOIMMUNITY, V3, P299; BACON LD, 1974, SCIENCE, V186, P274, DOI 10.1126/science.186.4160.274; DONIACH D, 1957, J CLIN ENDOCR METAB, V17, P1293, DOI 10.1210/jcem-17-11-1293; EHRLICH P, 1910, STUDIES IMMUNITY; MIESCHER P, 1954, EXPERIENTIA, V10, P252, DOI 10.1007/BF02157392; ROITT IM, 1956, LANCET, V271, P820; ROSE NR, 1956, J IMMUNOL, V76, P417; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rose NR, 1999, ENVIRON HEALTH PERSP, V107, P749, DOI 10.2307/3434337; ROSE NR, 1993, IMMUNOLOGIC REVOLUTI, P403; ROSE NR, 1955, IMMUNOLOGY MAKING MO, P231; SILVERMAN DA, 1974, SCIENCE, V184, P162, DOI 10.1126/science.184.4133.162; VLADUTIU AO, 1971, SCIENCE, V174, P1137, DOI 10.1126/science.174.4014.1137; VONFELLENBERG R, 1968, INT ARCH ALLER A IMM, V33, P454, DOI 10.1159/000230061; WELCH P, 1973, J IMMUNOL, V110, P575; WITEBSKY E, 1957, JAMA-J AM MED ASSOC, V164, P1439, DOI 10.1001/jama.1957.02980130015004; WITEBSKY E, 1956, J IMMUNOL, V76, P408	18	7	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1009	1011		10.1038/ni1006-1009	http://dx.doi.org/10.1038/ni1006-1009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985493				2022-12-18	WOS:000241437100003
J	Fillatreau, S; Radbruch, A				Fillatreau, Simon; Radbruch, Andreas			IRF4 - a factor for class switching and antibody secretion	NATURE IMMUNOLOGY			English	Editorial Material							CENTER B-CELLS; DIFFERENTIATION; EXPRESSION; PROTEIN	Cognate antigen triggers B cells to undergo antibody maturation and terminal differentiation into antibody-secreting plasma cells. The transcription factor IRF4, which is essential for early B cell development, is also influential at these later stages of B cell development and function.	Deutsch Rheuma Forschungszentrum, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ)	Fillatreau, S (corresponding author), Deutsch Rheuma Forschungszentrum, D-10117 Berlin, Germany.	radbruch@drfz.de		Fillatreau, Simon/0000-0002-7730-9917; Radbruch, Andreas/0000-0001-5753-0000				Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Gupta S, 2001, J IMMUNOL, V166, P6104, DOI 10.4049/jimmunol.166.10.6104; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572	8	7	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					704	706		10.1038/ni0706-704	http://dx.doi.org/10.1038/ni0706-704			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785887				2022-12-18	WOS:000238377700008
J	Smale, ST; Dorshkind, K				Smale, ST; Dorshkind, K			Hematopoiesis flies high with Ikaros	NATURE IMMUNOLOGY			English	Editorial Material							COMMON LYMPHOID PROGENITORS; BONE-MARROW; STEM-CELLS; IDENTIFICATION; TRANSCRIPTION; DEFECTS; GENE; MICE		Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smale, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu; kdorshki@mednet.ucla.edu						Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	12	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					367	369		10.1038/ni0406-367	http://dx.doi.org/10.1038/ni0406-367			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550201				2022-12-18	WOS:000236171000008
J	de Jonge, WJ; van der Zanden, EP; O The, F; Bijlsma, MF; van Westerloo, DJ; Bennink, RJ; Berthoud, HR; Uematsu, S; Akira, S; van den Wijngaard, RM; Boeckxstaens, GE				de Jonge, WJ; van der Zanden, EP; O The, F; Bijlsma, MF; van Westerloo, DJ; Bennink, RJ; Berthoud, HR; Uematsu, S; Akira, S; van den Wijngaard, RM; Boeckxstaens, GE			Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway (vol 6, pg 844, 2005)	NATURE IMMUNOLOGY			English	Correction													Boeckxstaens, Guy/AAP-2502-2020; van den Wijngaard, Rene M/D-2116-2011; Berthoud, Hans-Rudolf/N-1950-2017					de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229	1	7	7	1	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					954	954		10.1038/ni0905-954b	http://dx.doi.org/10.1038/ni0905-954b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX		Bronze			2022-12-18	WOS:000231369800027
J	Williams, MA; Bevan, MJ				Williams, MA; Bevan, MJ			T cell memory: fixed or flexible?	NATURE IMMUNOLOGY			English	Editorial Material							EFFECTOR; SUBSETS; IMMUNITY; DISTINCT	Contrary to results of previous studies using high frequencies of T cell receptor-transgenic T cells, new data indicate that when naive precursor frequencies approach endogenous levels, CD8(+) effector and central memory T cell lineage commitment is fixed.	Univ Washington, Dept Immunol, Seattle, WA 98155 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98155 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Williams, MA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98155 USA.	mbevan@u.washington.edu		Williams, Matthew/0000-0002-4721-4482				Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	12	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					752	754		10.1038/ni0805-752	http://dx.doi.org/10.1038/ni0805-752			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034429				2022-12-18	WOS:000230646200006
J	von Boehmer, H				von Boehmer, H			Notch in lymphopoiesis and T cell polarization	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; PROGENITORS; CD4		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu						Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Nam Y, 2002, CURR OPIN CHEM BIOL, V6, P501, DOI 10.1016/S1367-5931(02)00346-0; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217	17	7	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					641	642		10.1038/ni0705-641	http://dx.doi.org/10.1038/ni0705-641			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970933				2022-12-18	WOS:000229975500003
J	Wilson, IA; Stanfield, RL				Wilson, IA; Stanfield, RL			MHC restriction: slip-sliding away	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; TCR; PEPTIDE; RECOGNITION; SPECIFICITY; BINDING	A newly identified crystal structure for an autoimmune TCR bound to peptide-MHC shows a highly unusual docking mode. Is this an anomaly or a new twist on MHC restriction?	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Stanfield, Robyn/AAH-3190-2019					Buslepp J, 2003, J IMMUNOL, V170, P373, DOI 10.4049/jimmunol.170.1.373; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hausmann S, 1999, J IMMUNOL, V162, P338; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	12	7	7	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					434	435		10.1038/ni0505-434	http://dx.doi.org/10.1038/ni0505-434			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843798				2022-12-18	WOS:000228634300007
J	Lehrer, RI				Lehrer, RI			Paradise lost and paradigm found	NATURE IMMUNOLOGY			English	Editorial Material							CYSTEINE-RICH PEPTIDES; PANETH CELLS; ANTIMICROBIAL PEPTIDE; SMALL-INTESTINE; FAMILY; DEFENSIN; DOMAIN; GENE	Antimicrobial peptides are essential effectors of gut immunity. The cryptdin-related sequence peptides represent a newly identified large family of antimicrobial peptides that form dimers to increase diversity.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lehrer, RI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	rlehrer@mednet.ucla.edu						Ganz T, 2000, NAT IMMUNOL, V1, P99, DOI 10.1038/77884; HUTTNER KM, 1994, GENOMICS, V24, P99, DOI 10.1006/geno.1994.1586; Jang WS, 2002, FEBS LETT, V521, P81, DOI 10.1016/S0014-5793(02)02827-2; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461; METCHNIKOFF E, 1905, IMMUNITY INFECT DIS, P423; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Yang YS, 2003, BIOCHEMISTRY-US, V42, P4669, DOI 10.1021/bi027133c; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O	12	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					775	776		10.1038/ni0804-775	http://dx.doi.org/10.1038/ni0804-775			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282557				2022-12-18	WOS:000222955600005
J	Nossal, GJV				Nossal, GJV			A healthier climate for the funding of vaccine research	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNIZATION	Vaccination is a marvel of scientific endeavor that benefits the masses. Yet the laissez-faire economy may not provide a sufficient push for vaccine research and development. The current climate that drives this globally important venture is examined here.	Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	University of Melbourne	Nossal, GJV (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.							CHEDE E, 2003, NATURE, V424, P241; Del Giudice G, 2001, ANNU REV IMMUNOL, V19, P523, DOI 10.1146/annurev.immunol.19.1.523; HEILMAN C, 2003, JORDAN REPORT 20 ANN; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lee CL, 2003, CANCER EPIDEM BIOMAR, V12, P57; Malakoff D, 2003, SCIENCE, V301, P1450; Nossal GJV, 2000, NAT IMMUNOL, V1, P5, DOI 10.1038/76852; Nossal GJV, 1999, SCIENCE, V284, P587; NOSSAL GJV, 2003, FUNDAMENTAL IMMUNOLO, V5, P1319; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769	10	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					457	459		10.1038/ni0504-457	http://dx.doi.org/10.1038/ni0504-457			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116107				2022-12-18	WOS:000221101100003
J	McDonald, C; Nunez, G				McDonald, C; Nunez, G			Mindin the fort	NATURE IMMUNOLOGY			English	Editorial Material							MUTATIONS; RECEPTORS; SPONDIN; MICE	The immune system uses many sensors to detect and report microbial invaders. Most of these sensors are associated with immune cells, but the extracellular matrix also seems to be essential for this sentinel duty.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	McDonald, C (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014	McDonald, Christine/0000-0002-6745-9487				Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744	9	7	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					16	18		10.1038/ni0104-16	http://dx.doi.org/10.1038/ni0104-16			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699402				2022-12-18	WOS:000187635800008
J	Abraham, RT				Abraham, RT			Rap1 redux	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL; INTEGRIN ACTIVATION; SIGNALS		Burnham Inst, Program Signal Transduct, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Abraham, RT (corresponding author), Burnham Inst, Program Signal Transduct, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Abraham RT, 2002, NAT IMMUNOL, V3, P212, DOI 10.1038/ni0302-212; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9	11	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					725	727		10.1038/ni0803-725	http://dx.doi.org/10.1038/ni0803-725			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888790				2022-12-18	WOS:000184441500006
J	Murphy, KM				Murphy, KM			In search of the CTD	NATURE IMMUNOLOGY			English	Letter							PARADIGM		Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.							BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155	5	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					645	645		10.1038/ni0703-645	http://dx.doi.org/10.1038/ni0703-645			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830141	Bronze			2022-12-18	WOS:000183952500008
